<?xml version='1.0' encoding='utf8' standalone='yes'?>
<collection><source></source>
<date>2021-12-13</date>
<key></key>
<document><id>2304460</id><passage><offset>0</offset><text>Roles of fetal G gamma-globin promoter elements and the adult beta-globin 3' enhancer in the stage-specific expression of globin genes. The human fetal G gamma-globin and adult beta-globin genes are expressed in a tissue- and developmental stage-specific pattern in transgenic mice: the G gamma gene in embryonic cells and the beta gene in fetal and adult erythroid cells. Several of the cis-acting DNA sequences thought to be responsible for these patterns of expression are located 5' to the G gamma-globin gene and 3' to the beta-globin gene. To further define the locations and functional roles of these elements, we examined the effects of 5' truncations on the expression of the G gamma-globin gene, as well as the ability of G gamma-globin upstream sequences to alter the developmental regulation of a beta-globin gene, as well as the ability of G gamma-globin upstream sequences to alter the developmental regulation of a beta-globin gene. We found that sequences between -201 and -136 are essential for expression of the G gamma-globin gene, whereas those upstream of -201 have little effect on the level or tissue or stage specificity of G gamma-globin expression. The G gamma-globin upstream sequences from -201 to -136 were, furthermore, capable of activating a linked beta-globin gene in embryonic blood cells; however, a G gamma-globin fragment from -383 to -206 was similarly active in this assay, and the complete fragment from -383 to -136 was considerably more active than either of the smaller fragments, suggesting the presence of multiple cis-acting elements for embryonic blood cells. Our data also suggested the possibility of a negative regulatory element between -201 and -136. These results are discussed in relation to several DNA elements in the G gamma-globin upstream region, which have been shown to bind nuclear factors in erythroid cells. Finally, we observed that removal of the beta-globin 3'-flanking sequences, including the 3' enhancer, from the G gamma-globin upstream-beta-globin hybrid gene resulted in a 25-fold reduction in expression in embryonic blood cells. This suggests that the beta-globin 3' enhancer is potentially active at the embryonic stage and thus cannot be solely responsible for the fetal or adult specificity of the beta-globin gene.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="15" length="32"/><text>G gamma-globin promoter elements</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="62" length="23"/><text>beta-globin 3' enhancer</text></annotation><annotation id="3"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="152" length="14"/><text>G gamma-globin</text></annotation><annotation id="4"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="287" length="7"/><text>G gamma</text></annotation><annotation id="5"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="327" length="9"/><text>beta gene</text></annotation><annotation id="6"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="528" length="11"/><text>beta-globin</text></annotation><annotation id="7"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="685" length="14"/><text>G gamma-globin</text></annotation><annotation id="8"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="732" length="14"/><text>G gamma-globin</text></annotation><annotation id="9"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="809" length="11"/><text>beta-globin</text></annotation><annotation id="10"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="853" length="14"/><text>G gamma-globin</text></annotation><annotation id="11"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="930" length="11"/><text>beta-globin</text></annotation><annotation id="12"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1030" length="14"/><text>G gamma-globin</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1962" length="11"/><text>3' enhancer</text></annotation><annotation id="14"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1148" length="14"/><text>G gamma-globin</text></annotation><annotation id="15"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1179" length="14"/><text>G gamma-globin</text></annotation><annotation id="16"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="1281" length="11"/><text>beta-globin</text></annotation><annotation id="17"><infon key="identifier">0000381</infon><infon key="type">TISSUE</infon><location offset="1301" length="21"/><text>embryonic blood cells</text></annotation><annotation id="18"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1335" length="14"/><text>G gamma-globin</text></annotation><annotation id="19"><infon key="identifier">0000381</infon><infon key="type">TISSUE</infon><location offset="1584" length="21"/><text>embryonic blood cells</text></annotation><annotation id="20"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1774" length="14"/><text>G gamma-globin</text></annotation><annotation id="21"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1855" length="15"/><text>erythroid cells</text></annotation><annotation id="22"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="1913" length="11"/><text>beta-globin</text></annotation><annotation id="23"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="1984" length="14"/><text>G gamma-globin</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2127" length="23"/><text>beta-globin 3' enhancer</text></annotation><annotation id="25"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="2008" length="11"/><text>beta-globin</text></annotation><annotation id="26"><infon key="identifier">0000381</infon><infon key="type">TISSUE</infon><location offset="2081" length="21"/><text>embryonic blood cells</text></annotation><annotation id="27"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="2276" length="11"/><text>beta-globin</text></annotation><annotation id="28"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="177" length="11"/><text>beta-globin</text></annotation><annotation id="29"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="2127" length="11"/><text>beta-globin</text></annotation><annotation id="30"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="15" length="14"/><text>G gamma-globin</text></annotation><annotation id="31"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="140" length="5"/><text>human</text></annotation><annotation id="32"><infon key="identifier">0000669</infon><infon key="type">TISSUE</infon><location offset="303" length="15"/><text>embryonic cells</text></annotation><annotation id="33"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="277" length="4"/><text>mice</text></annotation><annotation id="34"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="62" length="11"/><text>beta-globin</text></annotation><annotation id="35"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="356" length="15"/><text>erythroid cells</text></annotation><annotation id="36"><infon key="identifier">3048</infon><infon key="type">GENE</infon><location offset="494" length="14"/><text>G gamma-globin</text></annotation></passage></document>
<document><id>2339058</id><passage><offset>0</offset><text>A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation. The locus activating region (LAR), contained within 30 kb of chromatin flanking the human beta-globin gene cluster, has recently been shown to be essential for high level beta-globin gene expression. To determine the effect of fragments containing LAR sequences on globin gene expression, mRNA from a marked gamma-globin gene linked to LAR fragments was assayed in stably transfected K562 erythroleukemia cells. DNaseI hypersensitive site II (HS II), located 10.9 kb upstream of the epsilon-globin gene, was required for high level gamma-globin gene expression. We also showed that a 46 bp enhancer element within HS II was necessary and sufficient for the increased gamma-globin gene expression observed with hemin induced erythroid maturation of K562 cells. These results localize a distant regulatory element important for activation of globin genes during human erythroid cell maturation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="30"/><text>46 base pair enhancer sequence</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="746" length="35"/><text>46 bp enhancer element within HS II</text></annotation><annotation id="3"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="333" length="11"/><text>beta-globin</text></annotation><annotation id="4"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="470" length="12"/><text>gamma-globin</text></annotation><annotation id="5"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="645" length="14"/><text>epsilon-globin</text></annotation><annotation id="6"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="829" length="12"/><text>gamma-globin</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1022" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="246" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="910" length="10"/><text>K562 cells</text></annotation><annotation id="10"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="886" length="9"/><text>erythroid</text></annotation><annotation id="11"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="110" length="12"/><text>gamma-globin</text></annotation><annotation id="12"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="546" length="26"/><text>K562 erythroleukemia cells</text></annotation><annotation id="13"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1028" length="14"/><text>erythroid cell</text></annotation><annotation id="14"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="135" length="9"/><text>erythroid</text></annotation><annotation id="15"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="252" length="11"/><text>beta-globin</text></annotation></passage></document>
<document><id>2835657</id><passage><offset>0</offset><text>A cell-specific enhancer of the mouse alpha 1-antitrypsin gene has multiple functional regions and corresponding protein-binding sites. We have previously described the isolation and characterization of genomic clones corresponding to the mouse alpha 1-antitrypsin gene (Krauter et al., DNA 5:29-36, 1986). In this report, we have analyzed the DNA sequences upstream of the RNA start site that direct hepatoma cell-specific expression of this gene when incorporated into recombinant plasmids. The 160 nucleotides 5' to the cap site direct low-level expression in hepatoma cells, and sequences between -520 and -160 bp upstream of the RNA start site functioned as a cell-specific enhancer of expression both with the alpha 1-antitrypsin promoter and when combined with a functional beta-globin promoter. Within the enhancer region, three binding sites for proteins present in hepatoma nuclear extracts were identified. The location of each site was positioned, using both methylation protection and methylation interference experiments. Each protein-binding site correlated with a functionally important region necessary for full enhancer activity. These experiments demonstrated a complex arrangement of regulatory elements comprising the alpha 1-antitrypsin enhancer. Significant qualitative differences exist between the findings presented here and the cis-acting elements operative in regulating expression of the human alpha 1-antitrypsin gene (Ciliberto et al., Cell 41:531-540, 1985; De Simone et al., EMBO J. 6:2759-2766, 1987).</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="60"/><text>cell-specific enhancer of the mouse alpha 1-antitrypsin gene</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="583" length="65"/><text>sequences between -520 and -160 bp upstream of the RNA start site</text></annotation><annotation id="3"><infon key="identifier">5265</infon><infon key="type">GENE</infon><location offset="245" length="19"/><text>alpha 1-antitrypsin</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="401" length="13"/><text>hepatoma cell</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="563" length="14"/><text>hepatoma cells</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="665" length="22"/><text>cell-specific enhancer</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="875" length="8"/><text>hepatoma</text></annotation><annotation id="8"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="781" length="11"/><text>beta-globin</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1417" length="5"/><text>human</text></annotation><annotation id="10"><infon key="identifier">5265</infon><infon key="type">GENE</infon><location offset="1423" length="19"/><text>alpha 1-antitrypsin</text></annotation><annotation id="11"><infon key="identifier">5265</infon><infon key="type">GENE</infon><location offset="1239" length="19"/><text>alpha 1-antitrypsin</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="716" length="28"/><text>alpha 1-antitrypsin promoter</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="781" length="20"/><text>beta-globin promoter</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="814" length="15"/><text>enhancer region</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="32" length="5"/><text>mouse</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1239" length="28"/><text>alpha 1-antitrypsin enhancer</text></annotation><annotation id="17"><infon key="identifier">5265</infon><infon key="type">GENE</infon><location offset="38" length="19"/><text>alpha 1-antitrypsin</text></annotation><annotation id="18"><infon key="identifier">5265</infon><infon key="type">GENE</infon><location offset="716" length="19"/><text>alpha 1-antitrypsin</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="239" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>9878258</id><passage><offset>0</offset><text>A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5' boundary area of the human beta-globin locus control region. Transcription of the human beta-like globin genes in erythroid cells is regulated by the far-upstream locus control region (LCR). In an attempt to define the 5' border of the LCR, we have cloned and sequenced 5 kb of new upstream DNA. We found an LTR retrotransposon belonging to the ERV-9 family of human endogenous retroviruses in the apparent 5' boundary area of the LCR. This ERV-9 LTR contains an unusual U3 enhancer region composed of 14 tandem repeats with recurrent GATA, CACCC, and CCAAT motifs. This LTR is conserved in human and gorilla, indicating its evolutionary stability in the genomes of the higher primates. In both recombinant constructs and the endogenous human genome, the LTR enhancer and promoter activate the transcription of cis-linked DNA preferentially in erythroid cells. Our findings suggest the possibility that this LTR retrotransposon may serve a relevant host function in regulating the transcription of the beta-globin LCR.</text><annotation id="1"><infon key="identifier">11745</infon><infon key="type">SPECIES</infon><location offset="30" length="33"/><text>human endogenous retrovirus ERV-9</text></annotation><annotation id="2"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="929" length="15"/><text>erythroid cells</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="556" length="18"/><text>U3 enhancer region</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="840" length="12"/><text>LTR enhancer</text></annotation><annotation id="5"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="112" length="32"/><text>beta-globin locus control region</text></annotation><annotation id="6"><infon key="identifier">11745</infon><infon key="type">SPECIES</infon><location offset="430" length="5"/><text>ERV-9</text></annotation><annotation id="7"><infon key="identifier">11745</infon><infon key="type">SPECIES</infon><location offset="526" length="5"/><text>ERV-9</text></annotation><annotation id="8"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="1087" length="15"/><text>beta-globin LCR</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="857" length="8"/><text>promoter</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="620" length="29"/><text>GATA, CACCC, and CCAAT motifs</text></annotation><annotation id="11"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="248" length="20"/><text>locus control region</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="106" length="5"/><text>human</text></annotation><annotation id="13"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="270" length="3"/><text>LCR</text></annotation><annotation id="14"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="321" length="3"/><text>LCR</text></annotation><annotation id="15"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="516" length="3"/><text>LCR</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="167" length="5"/><text>human</text></annotation><annotation id="17"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="446" length="29"/><text>human endogenous retroviruses</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="676" length="5"/><text>human</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="822" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="199" length="15"/><text>erythroid cells</text></annotation><annotation id="21"><infon key="identifier">9592</infon><infon key="type">SPECIES</infon><location offset="686" length="7"/><text>gorilla</text></annotation><annotation id="22"><infon key="identifier">9443</infon><infon key="type">SPECIES</infon><location offset="762" length="8"/><text>primates</text></annotation></passage></document>
<document><id>10523648</id><passage><offset>0</offset><text>Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin. We investigated the requirements for enhancer-promoter communication by using the human beta-globin locus control region (LCR) DNase I-hypersensitive site 2 (HS2) enhancer and the epsilon-globin gene in chromatinized minichromosomes in erythroid cells. Activation of globin genes during development is accompanied by localized alterations of chromatin structure, and CACCC binding factors and GATA-1, which interact with both globin promoters and the LCR, are believed to be critical for globin gene transcription activation. We found that an HS2 element mutated in its GATA motif failed to remodel the epsilon-globin promoter or activate transcription yet HS2 nuclease accessibility did not change. Accessibility and transcription were reduced at promoters with mutated GATA-1 or CACCC sites. Strikingly, these mutations also resulted in reduced accessibility at HS2. In the absence of a globin gene, HS2 is similarly resistant to nuclease digestion. In contrast to observations in Saccharomyces cerevisiae, HS2-dependent promoter remodeling was diminished when we mutated the TATA box, crippling transcription. This mutation also reduced HS2 accessibility. The results indicate that the epsilon-globin promoter and HS2 interact both structurally and functionally and that both upstream activators and the basal transcription apparatus contribute to the interaction. Further, at least in this instance, transcription activation and promoter remodeling by a distant enhancer are not separable.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="47" length="16"/><text>distant enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="72" length="28"/><text>epsilon-globin gene promoter</text></annotation><annotation id="3"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="608" length="3"/><text>LCR</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1235" length="8"/><text>TATA box</text></annotation><annotation id="5"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="245" length="32"/><text>beta-globin locus control region</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="239" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="279" length="3"/><text>LCR</text></annotation><annotation id="8"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="337" length="14"/><text>epsilon-globin</text></annotation><annotation id="9"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="72" length="14"/><text>epsilon-globin</text></annotation><annotation id="10"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="550" length="6"/><text>GATA-1</text></annotation><annotation id="11"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="700" length="3"/><text>HS2</text></annotation><annotation id="12"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="760" length="14"/><text>epsilon-globin</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="245" length="83"/><text>beta-globin locus control region (LCR) DNase I-hypersensitive site 2 (HS2) enhancer</text></annotation><annotation id="14"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="814" length="3"/><text>HS2</text></annotation><annotation id="15"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="1346" length="14"/><text>epsilon-globin</text></annotation><annotation id="16"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="1021" length="3"/><text>HS2</text></annotation><annotation id="17"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="1059" length="3"/><text>HS2</text></annotation><annotation id="18"><infon key="identifier">4932</infon><infon key="type">SPECIES</infon><location offset="1140" length="24"/><text>Saccharomyces cerevisiae</text></annotation><annotation id="19"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="1166" length="3"/><text>HS2</text></annotation><annotation id="20"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="1297" length="3"/><text>HS2</text></annotation><annotation id="21"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="928" length="6"/><text>GATA-1</text></annotation><annotation id="22"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="1374" length="3"/><text>HS2</text></annotation><annotation id="23"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="393" length="15"/><text>erythroid cells</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="760" length="23"/><text>epsilon-globin promoter</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="524" length="21"/><text>CACCC binding factors</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="928" length="21"/><text>GATA-1 or CACCC sites</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1615" length="16"/><text>distant enhancer</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="727" length="10"/><text>GATA motif</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1346" length="23"/><text>epsilon-globin promoter</text></annotation></passage></document>
<document><id>10595394</id><passage><offset>0</offset><text>The gammaPE complex contains both SATB1 and HOXB2 and has positive and negative roles in human gamma-globin gene regulation. A large nuclear protein complex, termed gammaPE (for gamma-globin promoter and enhancer binding factor), binds to five sites located 5' and 3' of the human y-globin gene. Two proteins, SATB1 (special A-T-rich binding protein 1) and HOXB2, can bind to yPE binding sites. SATB1 binds to nuclear matrix-attachment sites, and HOXB2 is a homeodomain protein important in neural development that is also expressed during erythropoiesis. The present work showed that antisera directed against either SATB1 or HOXB2 reacted specifically with the entire gammaPE complex in electrophoretic mobility shift assays (EMSAs), suggesting that the two proteins can bind to the gammaPE binding site simultaneously. When SATB1 or HOXB2 was expressed in vitro, they could bind independently to gammaPE binding sites in EMSA. Interestingly, the proteins expressed in vitro competed effectively with each other for the gammaPE binding site, suggesting that this may occur under certain conditions in vivo. Transient cotransfections of a HOXB2 cDNA and a y-globin-luciferase reporter gene construct into cells expressing SATB1 suggested that SATB1 has a positive and HOXB2 a negative regulatory effect on transcription. Taking into account their potentially opposing effects and binding activities, SATB1 and HOXB2 may modulate the amount of gamma-globin mRNA expressed during development and differentiation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="785" length="20"/><text>gammaPE binding site</text></annotation><annotation id="2"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="447" length="5"/><text>HOXB2</text></annotation><annotation id="3"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="618" length="5"/><text>SATB1</text></annotation><annotation id="4"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="627" length="5"/><text>HOXB2</text></annotation><annotation id="5"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="827" length="5"/><text>SATB1</text></annotation><annotation id="6"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="836" length="5"/><text>HOXB2</text></annotation><annotation id="7"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="1140" length="5"/><text>HOXB2</text></annotation><annotation id="8"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1223" length="5"/><text>SATB1</text></annotation><annotation id="9"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1244" length="5"/><text>SATB1</text></annotation><annotation id="10"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="1269" length="5"/><text>HOXB2</text></annotation><annotation id="11"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1401" length="5"/><text>SATB1</text></annotation><annotation id="12"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="34" length="5"/><text>SATB1</text></annotation><annotation id="13"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="1411" length="5"/><text>HOXB2</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1022" length="20"/><text>gammaPE binding site</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="376" length="17"/><text>yPE binding sites</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="899" length="21"/><text>gammaPE binding sites</text></annotation><annotation id="17"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="44" length="5"/><text>HOXB2</text></annotation><annotation id="18"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="1444" length="12"/><text>gamma-globin</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="89" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="275" length="5"/><text>human</text></annotation><annotation id="21"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="95" length="12"/><text>gamma-globin</text></annotation><annotation id="22"><infon key="identifier">15135</infon><infon key="type">GENE</infon><location offset="281" length="8"/><text>y-globin</text></annotation><annotation id="23"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="310" length="5"/><text>SATB1</text></annotation><annotation id="24"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="317" length="34"/><text>special A-T-rich binding protein 1</text></annotation><annotation id="25"><infon key="identifier">3212</infon><infon key="type">GENE</infon><location offset="357" length="5"/><text>HOXB2</text></annotation><annotation id="26"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="395" length="5"/><text>SATB1</text></annotation></passage></document>
<document><id>10688646</id><passage><offset>0</offset><text>Loading of DNA-binding factors to an erythroid enhancer. The HS-40 enhancer is the major cis-acting regulatory element responsible for the developmental stage- and erythroid lineage-specific expression of the human alpha-like globin genes, the embryonic zeta and the adult alpha2/alpha/1. A model has been proposed in which competitive factor binding at one of the HS-40 motifs, 3'-NA, modulates the capability of HS-40 to activate the embryonic zeta-globin promoter. Furthermore, this modulation was thought to be mediated through configurational changes of the HS-40 enhanceosome during development. In this study, we have further investigated the molecular basis of this model. First, human erythroid K562 cells stably integrated with various HS-40 mutants cis linked to a human alpha-globin promoter-growth hormone hybrid gene were analyzed by genomic footprinting and expression analysis. By the assay, we demonstrate that factors bound at different motifs of HS-40 indeed act in concert to build a fully functional enhanceosome. Thus, modification of factor binding at a single motif could drastically change the configuration and function of the HS-40 enhanceosome. Second, a specific 1-bp, GC--&gt;TA mutation in the 3'-NA motif of HS-40, 3'-NA(II), has been shown previously to cause significant derepression of the embryonic zeta-globin promoter activity in erythroid cells. This derepression was hypothesized to be regulated through competitive binding of different nuclear factors, in particular AP1 and NF-E2, to the 3'-NA motif. By gel mobility shift and transient cotransfection assays, we now show that 3'-NA(II) mutation completely abolishes the binding of small MafK homodimer. Surprisingly, NF-E2 as well as AP1 can still bind to the 3'-NA(II) sequence. The association constants of both NF-E2 and AP1 are similar to their interactions with the wild-type 3'-NA motif. However, the 3'-NA(II) mutation causes an approximately twofold reduction of the binding affinity of NF-E2 factor to the 3'-NA motif. This reduction of affinity could be accounted for by a twofold-higher rate of dissociation of the NF-E2-3'-NA(II) complex. Finally, we show by chromatin immunoprecipitation experiments that only binding of NF-E2, not AP1, could be detected in vivo in K562 cells around the HS-40 region. These data exclude a role for AP1 in the developmental regulation of the human alpha-globin locus via the 3'-NA motif of HS-40 in embryonic/fetal erythroid cells. Furthermore, extrapolation of the in vitro binding studies suggests that factors other than NF-E2, such as the small Maf homodimers, are likely involved in the regulation of the HS-40 function in vivo.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="47" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="365" length="12"/><text>HS-40 motifs</text></annotation><annotation id="3"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="1707" length="5"/><text>NF-E2</text></annotation><annotation id="4"><infon key="identifier">2354</infon><infon key="type">GENE</infon><location offset="1724" length="3"/><text>AP1</text></annotation><annotation id="5"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="1804" length="5"/><text>NF-E2</text></annotation><annotation id="6"><infon key="identifier">2354</infon><infon key="type">GENE</infon><location offset="1814" length="3"/><text>AP1</text></annotation><annotation id="7"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="1985" length="5"/><text>NF-E2</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="2116" length="23"/><text>NF-E2-3'-NA(II) complex</text></annotation><annotation id="9"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="2224" length="5"/><text>NF-E2</text></annotation><annotation id="10"><infon key="identifier">2354</infon><infon key="type">GENE</infon><location offset="2235" length="3"/><text>AP1</text></annotation><annotation id="11"><infon key="identifier">2354</infon><infon key="type">GENE</infon><location offset="2335" length="3"/><text>AP1</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2378" length="5"/><text>human</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="446" length="20"/><text>zeta-globin promoter</text></annotation><annotation id="14"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="2560" length="5"/><text>NF-E2</text></annotation><annotation id="15"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="37" length="9"/><text>erythroid</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="61" length="14"/><text>HS-40 enhancer</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="414" length="5"/><text>HS-40</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="563" length="18"/><text>HS-40 enhanceosome</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="965" length="5"/><text>HS-40</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="746" length="5"/><text>HS-40</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="379" length="5"/><text>3'-NA</text></annotation><annotation id="22"><infon key="identifier">3050</infon><infon key="type">GENE</infon><location offset="254" length="4"/><text>zeta</text></annotation><annotation id="23"><infon key="identifier">3040</infon><infon key="type">GENE</infon><location offset="273" length="6"/><text>alpha2</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1153" length="18"/><text>HS-40 enhanceosome</text></annotation><annotation id="25"><infon key="identifier">3039</infon><infon key="type">GENE</infon><location offset="280" length="7"/><text>alpha/1</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1222" length="20"/><text>3'-NA motif of HS-40</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1244" length="9"/><text>3'-NA(II)</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="2269" length="10"/><text>K562 cells</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1527" length="11"/><text>3'-NA motif</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1616" length="9"/><text>3'-NA(II)</text></annotation><annotation id="31"><infon key="identifier">7975</infon><infon key="type">GENE</infon><location offset="1677" length="4"/><text>MafK</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1750" length="18"/><text>3'-NA(II) sequence</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1871" length="11"/><text>3'-NA motif</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1897" length="9"/><text>3'-NA(II)</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1332" length="20"/><text>zeta-globin promoter</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="2005" length="11"/><text>3'-NA motif</text></annotation><annotation id="37"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="2451" length="15"/><text>erythroid cells</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2291" length="12"/><text>HS-40 region</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="2411" length="20"/><text>3'-NA motif of HS-40</text></annotation><annotation id="40"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="164" length="17"/><text>erythroid lineage</text></annotation><annotation id="41"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="2585" length="3"/><text>Maf</text></annotation><annotation id="42"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2646" length="5"/><text>HS-40</text></annotation><annotation id="43"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2426" length="5"/><text>HS-40</text></annotation><annotation id="44"><infon key="attribute">CANCER</infon><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="694" length="20"/><text>erythroid K562 cells</text></annotation><annotation id="45"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="688" length="5"/><text>human</text></annotation><annotation id="46"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="209" length="5"/><text>human</text></annotation><annotation id="47"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="782" length="21"/><text>alpha-globin promoter</text></annotation><annotation id="48"><infon key="identifier">3039</infon><infon key="type">GENE</infon><location offset="2384" length="12"/><text>alpha-globin</text></annotation><annotation id="49"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="804" length="14"/><text>growth hormone</text></annotation><annotation id="50"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="365" length="5"/><text>HS-40</text></annotation><annotation id="51"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1237" length="5"/><text>HS-40</text></annotation><annotation id="52"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1021" length="12"/><text>enhanceosome</text></annotation><annotation id="53"><infon key="identifier">3050</infon><infon key="type">GENE</infon><location offset="446" length="11"/><text>zeta-globin</text></annotation><annotation id="54"><infon key="identifier">3050</infon><infon key="type">GENE</infon><location offset="1332" length="11"/><text>zeta-globin</text></annotation><annotation id="55"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1365" length="15"/><text>erythroid cells</text></annotation><annotation id="56"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="776" length="5"/><text>human</text></annotation><annotation id="57"><infon key="identifier">2354</infon><infon key="type">GENE</infon><location offset="1505" length="3"/><text>AP1</text></annotation><annotation id="58"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="1513" length="5"/><text>NF-E2</text></annotation></passage></document>
<document><id>10891470</id><passage><offset>0</offset><text>Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. The human beta-globin locus control region (LCR) confers high-level, tissue-specific expression to the beta-globin genes. Tandem Maf recognition elements (MAREs) within the hypersensitive site 2 (HS2) subregion of the LCR are important for the strong enhancer activity of the LCR. Multiple proteins are capable of interacting with these sites in vitro, including the erythroid cell- and megakaryocyte-specific transcription factor, NF-E2. The importance of NF-E2 for beta-globin gene expression is evident in murine erythroleukemia cells lacking the p45 subunit of NF-E2. These CB3 cells have a severe defect in alpha- and beta-globin gene transcription, which can be restored by expression of NF-E2. However, mice nullizygous for p45 express nearly normal levels of beta-globin. Thus, either a redundant factor(s) exists in mice that can functionally replace NF-E2, or NF-E2 does not function through the LCR to regulate beta-globin gene expression. To address this issue, we asked whether NF-E2 binds directly to the tandem MAREs of HS2 in intact cells. Using a chromatin immunoprecipitation assay, we provide evidence for NF-E2 binding directly and specifically to HS2 in living erythroleukemia cells and in mouse fetal liver. The specific immunoisolation of HS2 sequences was dependent on the presence of p45 and on intact MAREs within HS2. These results support a direct role for NF-E2 in the regulation of beta-globin gene expression through activation of the LCR.</text><annotation id="1"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="22" length="5"/><text>NF-E2</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="621" length="6"/><text>murine</text></annotation><annotation id="3"><infon key="identifier">0000426</infon><infon key="type">TISSUE</infon><location offset="628" length="21"/><text>erythroleukemia cells</text></annotation><annotation id="4"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="662" length="3"/><text>p45</text></annotation><annotation id="5"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="677" length="5"/><text>NF-E2</text></annotation><annotation id="6"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="735" length="11"/><text>beta-globin</text></annotation><annotation id="7"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="806" length="5"/><text>NF-E2</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="822" length="4"/><text>mice</text></annotation><annotation id="9"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="843" length="3"/><text>p45</text></annotation><annotation id="10"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="879" length="11"/><text>beta-globin</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="937" length="4"/><text>mice</text></annotation><annotation id="12"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="479" length="14"/><text>erythroid cell</text></annotation><annotation id="13"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="972" length="5"/><text>NF-E2</text></annotation><annotation id="14"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="982" length="5"/><text>NF-E2</text></annotation><annotation id="15"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="1034" length="11"/><text>beta-globin</text></annotation><annotation id="16"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="1103" length="5"/><text>NF-E2</text></annotation><annotation id="17"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="1237" length="5"/><text>NF-E2</text></annotation><annotation id="18"><infon key="identifier">0000426</infon><infon key="type">TISSUE</infon><location offset="1294" length="21"/><text>erythroleukemia cells</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1323" length="5"/><text>mouse</text></annotation><annotation id="20"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="1421" length="3"/><text>p45</text></annotation><annotation id="21"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="1497" length="5"/><text>NF-E2</text></annotation><annotation id="22"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="1524" length="11"/><text>beta-globin</text></annotation><annotation id="23"><infon key="type">TISSUE</infon><location offset="690" length="9"/><text>CB3 cells</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="116" length="5"/><text>human</text></annotation><annotation id="25"><infon key="identifier">15121</infon><infon key="type">GENE</infon><location offset="724" length="6"/><text>alpha-</text></annotation><annotation id="26"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="122" length="32"/><text>beta-globin locus control region</text></annotation><annotation id="27"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="156" length="3"/><text>LCR</text></annotation><annotation id="28"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="215" length="11"/><text>beta-globin</text></annotation><annotation id="29"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="330" length="3"/><text>LCR</text></annotation><annotation id="30"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="388" length="3"/><text>LCR</text></annotation><annotation id="31"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="1018" length="3"/><text>LCR</text></annotation><annotation id="32"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="1335" length="5"/><text>liver</text></annotation><annotation id="33"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="1578" length="3"/><text>LCR</text></annotation><annotation id="34"><infon key="identifier">0000843</infon><infon key="type">TISSUE</infon><location offset="499" length="13"/><text>megakaryocyte</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="267" length="5"/><text>MAREs</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1138" length="5"/><text>MAREs</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1439" length="5"/><text>MAREs</text></annotation><annotation id="38"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="62" length="32"/><text>beta-globin locus control region</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="241" length="24"/><text>Maf recognition elements</text></annotation><annotation id="40"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="544" length="5"/><text>NF-E2</text></annotation><annotation id="41"><infon key="identifier">18022</infon><infon key="type">GENE</infon><location offset="569" length="5"/><text>NF-E2</text></annotation><annotation id="42"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="579" length="11"/><text>beta-globin</text></annotation></passage></document>
<document><id>12861010</id><passage><offset>0</offset><text>A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus. In order to create an extended map of chromatin features within a mammalian multigene locus, we have determined the extent of nuclease sensitivity and the pattern of histone modifications associated with the mouse beta-globin genes in adult erythroid tissue. We show that the nuclease-sensitive domain encompasses the beta-globin genes along with several flanking olfactory receptor genes that are inactive in erythroid cells. We describe enhancer-blocking or boundary elements on either side of the locus that are bound in vivo by the transcription factor CTCF, but we found that they do not coincide with transitions in nuclease sensitivity flanking the locus or with patterns of histone modifications within it. In addition, histone hyperacetylation and dimethylation of histone H3 K4 are not uniform features of the nuclease-sensitive mouse beta-globin domain but rather define distinct subdomains within it. Our results reveal a complex chromatin landscape for the active beta-globin locus and illustrate the complexity of broad structural changes that accompany gene activation.</text><annotation id="1"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="350" length="11"/><text>beta-globin</text></annotation><annotation id="2"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="546" length="15"/><text>erythroid cells</text></annotation><annotation id="3"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="981" length="11"/><text>beta-globin</text></annotation><annotation id="4"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="202" length="9"/><text>mammalian</text></annotation><annotation id="5"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="377" length="9"/><text>erythroid</text></annotation><annotation id="6"><infon key="identifier">13018</infon><infon key="type">GENE</infon><location offset="693" length="4"/><text>CTCF</text></annotation><annotation id="7"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="1113" length="11"/><text>beta-globin</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="111" length="5"/><text>mouse</text></annotation><annotation id="9"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="117" length="11"/><text>beta-globin</text></annotation><annotation id="10"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="454" length="11"/><text>beta-globin</text></annotation></passage></document>
<document><id>15371553</id><passage><offset>0</offset><text>An insulator blocks spreading of histone acetylation and interferes with RNA polymerase II transfer between an enhancer and gene. We studied the mechanism by which an insulator interrupts enhancer signaling to a gene using stably replicated chromatin templates containing the human beta-globin locus control region HS2 enhancer and a target globin gene. The chicken beta-globin 5' HS4 (cHS4) insulator acted as a positional enhancer blocker, inhibiting promoter remodeling and transcription activation only when placed between the enhancer and gene. Enhancer blocking by cHS4 reduced histone hyperacetylation across a zone extending from the enhancer to the gene and inhibited recruitment of CBP and p300 to HS2. Enhancer blocking also led to accumulation of RNA polymerase II at HS2 and within cHS4, accompanied by its diminution at the gene promoter. The enhancer blocking effects were completely attributable to the CTCF binding site in cHS4. These findings provide experimental evidence for the involvement of spreading in establishment of a broad zone of histone modification by an enhancer, as well as for blocking by an insulator of the transfer of RNA polymerase II from an enhancer to a promoter.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="111" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1087" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1182" length="8"/><text>enhancer</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1196" length="8"/><text>promoter</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="276" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">9031</infon><infon key="type">SPECIES</infon><location offset="358" length="7"/><text>chicken</text></annotation><annotation id="7"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="692" length="3"/><text>CBP</text></annotation><annotation id="8"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="700" length="4"/><text>p300</text></annotation><annotation id="9"><infon key="identifier">6710</infon><infon key="type">GENE</infon><location offset="708" length="3"/><text>HS2</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="282" length="45"/><text>beta-globin locus control region HS2 enhancer</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="919" length="17"/><text>CTCF binding site</text></annotation><annotation id="12"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="282" length="32"/><text>beta-globin locus control region</text></annotation><annotation id="13"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="919" length="4"/><text>CTCF</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="531" length="8"/><text>enhancer</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="642" length="8"/><text>enhancer</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="843" length="8"/><text>promoter</text></annotation></passage></document>
<document><id>15798207</id><passage><offset>0</offset><text>Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases. The mouse immunoglobulin kappa (Igkappa) gene contains an intronic enhancer and two enhancers downstream of its transcription unit. Using chromosome conformation capture technology, we demonstrate that rearranged and actively transcribed Igkappa alleles in MPC-11 plasmacytoma cells exhibit mutual interactions over 22 kb between these three enhancers and Vkappa gene promoters. In addition, the 5' region of the active transcription unit exhibits a continuum of interactions with downstream chromatin segments. We also observe interactions between Ei and E3' with 3' boundary sequences 24 kb downstream of Ed, adjacent to a neighboring housekeeping gene. Very similar interactions between the enhancers are also exhibited by normal B cells isolated from mouse splenic tissue but not by germ line transcriptionally inactive alleles of T cells or P815 mastocytoma cells, which exhibit a seemingly linear chromatin organization. These results fit a looping mechanism for enhancer function like in the beta-globin locus and suggest a dynamic modulation of the spatial organization of the active Igkappa locus. Chromatin immunoprecipitation experiments reveal that the interacting Igkappa gene cis-acting sequences are associated with AP-4, E47, and p65NF-kappaB, potential protein candidates that may be responsible for initiating and/or maintaining the formation of these higher-order complexes. However, S107 plasmacytoma cells that lack NF-kappaB still exhibit mutual interactions between the Igkappa gene enhancers.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="203" length="17"/><text>intronic enhancer</text></annotation><annotation id="2"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="155" length="30"/><text>immunoglobulin kappa (Igkappa)</text></annotation><annotation id="3"><infon key="identifier">692182</infon><infon key="type">GENE</infon><location offset="383" length="7"/><text>Igkappa</text></annotation><annotation id="4"><infon key="identifier">0000456</infon><infon key="type">TISSUE</infon><location offset="1548" length="23"/><text>S107 plasmacytoma cells</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="900" length="5"/><text>mouse</text></annotation><annotation id="6"><infon key="identifier">15127</infon><infon key="type">GENE</infon><location offset="1144" length="11"/><text>beta-globin</text></annotation><annotation id="7"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="1237" length="7"/><text>Igkappa</text></annotation><annotation id="8"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="1322" length="7"/><text>Igkappa</text></annotation><annotation id="9"><infon key="identifier">21423</infon><infon key="type">GENE</infon><location offset="1382" length="3"/><text>E47</text></annotation><annotation id="10"><infon key="identifier">19697</infon><infon key="type">GENE</infon><location offset="1391" length="12"/><text>p65NF-kappaB</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="72" length="21"/><text>Vkappa gene promoters</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="225" length="50"/><text>two enhancers downstream of its transcription unit</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="839" length="9"/><text>enhancers</text></annotation><annotation id="14"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="878" length="7"/><text>B cells</text></annotation><annotation id="15"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="980" length="7"/><text>T cells</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1638" length="22"/><text>Igkappa gene enhancers</text></annotation><annotation id="17"><infon key="identifier">0001089</infon><infon key="type">TISSUE</infon><location offset="402" length="25"/><text>MPC-11 plasmacytoma cells</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="694" length="2"/><text>Ei</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="701" length="3"/><text>E3'</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="752" length="2"/><text>Ed</text></annotation><annotation id="21"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="1638" length="7"/><text>Igkappa</text></annotation><annotation id="22"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1582" length="9"/><text>NF-kappaB</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="481" length="15"/><text>three enhancers</text></annotation><annotation id="24"><infon key="identifier">83383</infon><infon key="type">GENE</infon><location offset="1376" length="4"/><text>AP-4</text></annotation><annotation id="25"><infon key="identifier">0000985</infon><infon key="type">TISSUE</infon><location offset="991" length="22"/><text>P815 mastocytoma cells</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="501" length="21"/><text>Vkappa gene promoters</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="32" length="31"/><text>three transcriptional enhancers</text></annotation><annotation id="28"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="149" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>17283048</id><passage><offset>0</offset><text>Beta-globin intergenic transcription and histone acetylation dependent on an enhancer. Histone acetyltransferases are associated with the elongating RNA polymerase II (Pol II) complex, supporting the idea that histone acetylation and transcription are intertwined mechanistically in gene coding sequences. Here, we studied the establishment and function of histone acetylation and transcription in noncoding sequences by using a model locus linking the beta-globin HS2 enhancer and the embryonic epsilon-globin gene in chromatin. An intact HS2 enhancer that recruits RNA Pol II is required for intergenic transcription and histone H3 acetylation and K4 methylation between the enhancer and target gene. RNA Pol II recruitment to the target gene TATA box is not required for the intergenic transcription or intergenic histone modifications, strongly implying that they are properties conferred by the enhancer. However, Pol II recruitment at HS2, intergenic transcription, and intergenic histone modification are not sufficient for transcription or modification of the target gene: these changes require initiation at the TATA box of the gene. The results suggest that intergenic and genic transcription complexes are independent and possibly differ from one another.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="77" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="453" length="24"/><text>beta-globin HS2 enhancer</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="540" length="12"/><text>HS2 enhancer</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="677" length="8"/><text>enhancer</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="900" length="8"/><text>enhancer</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="745" length="8"/><text>TATA box</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1121" length="8"/><text>TATA box</text></annotation><annotation id="8"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="453" length="11"/><text>beta-globin</text></annotation><annotation id="9"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="0" length="11"/><text>Beta-globin</text></annotation><annotation id="10"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="496" length="14"/><text>epsilon-globin</text></annotation></passage></document>
<document><id>18202151</id><passage><offset>0</offset><text>An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. Receptor activator of nuclear factor-kappaB ligand (RANKL) is a TNF-like factor that is both produced by osteoblasts, mesenchymal cells, and activated T cells and required for osteoclast maturation and survival. The gene is up-regulated by the two primary calcemic hormones, 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and PTH. Previous studies have indicated that five enhancer regions located significantly upstream of the mouse Rankl transcriptional start site mediate up-regulation by 1,25(OH)2D3 and PTH. The most distal of these, termed mRLD5, is highly conserved in the human gene at -96 kb where it was also shown to be functionally active. Four additional mouse Rankl upstream enhancers are also highly conserved in the human gene at -20, -25, -75, and -87 kb. In the present studies, we characterized the activity of these regions, explored their capacity to mediate the actions of 1,25(OH)2D3, and identified the vitamin D response elements contained within the two most proximal segments. Interestingly, whereas the most distal of the five enhancers is the dominant mediator of 1,25(OH)2D3 activity in the mouse Rankl gene, that role in the human gene is manifested by the most proximal element at -20 kb. Importantly, activity at this region in response to 1,25(OH)2D3 was associated with a significant increase in histone acetylation as well as the enhanced recruitment of RNA polymerase II. Both likely reflect the primary role of this enhancer in human RANKL gene expression. Our studies confirm the complex nature of RANKL regulation and indicate that although the five enhancers are evolutionarily conserved across several species, their relative contributions to RANKL expression in response to 1,25(OH)2D3 may be different.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="3" length="99"/><text>enhancer 20 kilobases upstream of the human receptor activator of nuclear factor-kappaB ligand gene</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="699" length="5"/><text>mRLD5</text></annotation><annotation id="3"><infon key="identifier">5741</infon><infon key="type">GENE</infon><location offset="479" length="3"/><text>PTH</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1607" length="8"/><text>enhancer</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1738" length="14"/><text>five enhancers</text></annotation><annotation id="6"><infon key="identifier">19226</infon><infon key="type">GENE</infon><location offset="661" length="3"/><text>PTH</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="733" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">21943</infon><infon key="type">GENE</infon><location offset="587" length="5"/><text>Rankl</text></annotation><annotation id="9"><infon key="identifier">21943</infon><infon key="type">GENE</infon><location offset="827" length="5"/><text>Rankl</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="885" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1274" length="5"/><text>mouse</text></annotation><annotation id="12"><infon key="identifier">21943</infon><infon key="type">GENE</infon><location offset="1280" length="5"/><text>Rankl</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1180" length="37"/><text>the most distal of the five enhancers</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1309" length="5"/><text>human</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1619" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">8600</infon><infon key="type">GENE</infon><location offset="1625" length="5"/><text>RANKL</text></annotation><annotation id="17"><infon key="identifier">8600</infon><infon key="type">GENE</infon><location offset="1690" length="5"/><text>RANKL</text></annotation><annotation id="18"><infon key="identifier">8600</infon><infon key="type">GENE</infon><location offset="1838" length="5"/><text>RANKL</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="581" length="5"/><text>mouse</text></annotation><annotation id="20"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="266" length="11"/><text>osteoblasts</text></annotation><annotation id="21"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="279" length="17"/><text>mesenchymal cells</text></annotation><annotation id="22"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="312" length="7"/><text>T cells</text></annotation><annotation id="23"><infon key="identifier">0000968</infon><infon key="type">TISSUE</infon><location offset="337" length="10"/><text>osteoclast</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="899" length="3"/><text>-20</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="904" length="3"/><text>-25</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="909" length="3"/><text>-75</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="918" length="6"/><text>-87 kb</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1341" length="31"/><text>most proximal element at -20 kb</text></annotation><annotation id="29"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="821" length="5"/><text>mouse</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="521" length="98"/><text>five enhancer regions located significantly upstream of the mouse Rankl transcriptional start site</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="805" length="46"/><text>Four additional mouse Rankl upstream enhancers</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1125" length="30"/><text>the two most proximal segments</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="744" length="9"/><text>at -96 kb</text></annotation><annotation id="34"><infon key="identifier">8600</infon><infon key="type">GENE</infon><location offset="161" length="50"/><text>Receptor activator of nuclear factor-kappaB ligand</text></annotation><annotation id="35"><infon key="identifier">8600</infon><infon key="type">GENE</infon><location offset="213" length="5"/><text>RANKL</text></annotation></passage></document>
<document><id>18552207</id><passage><offset>0</offset><text>Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Low-level expression of multiple lineage-specific genes is a hallmark of hematopoietic stem cells (HSCs). HSCs predominantly express genes specific for the myeloid or megakaryocytic-erythroid lineages, whereas the transcription of lymphoid specific genes appears to begin after lymphoid specification. It has been demonstrated for a number of genes that epigenetic priming occurs before gene expression and lineage specification; however, little is known about how epigenetic priming of lymphoid genes is regulated. To address the question of how B cell-restricted expression is established, we studied activation of the Cd19 gene during hematopoietic development. We identified a B cell-specific upstream enhancer and showed that the developmental regulation of Cd19 expression involves precisely coordinated alterations in transcription factor binding and chromatin remodeling at Cd19 cis-regulatory elements. In multipotent progenitor cells, Cd19 chromatin is first remodeled at the upstream enhancer, and this remodeling is associated with binding of E2A. This is followed by the binding of EBF and PAX5 during B-cell differentiation. The Cd19 promoter is transcriptionally activated only after PAX5 binding. Our experiments give important mechanistic insights into how widely expressed and B lineage-specific transcription factors cooperate to mediate the developmental regulation of lymphoid genes during hematopoiesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="791" length="33"/><text>B cell-specific upstream enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1096" length="17"/><text>upstream enhancer</text></annotation><annotation id="3"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1213" length="4"/><text>PAX5</text></annotation><annotation id="4"><infon key="identifier">0001096</infon><infon key="type">TISSUE</infon><location offset="341" length="8"/><text>lymphoid</text></annotation><annotation id="5"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1309" length="4"/><text>PAX5</text></annotation><annotation id="6"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1225" length="6"/><text>B-cell</text></annotation><annotation id="7"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="183" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="8"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="209" length="4"/><text>HSCs</text></annotation><annotation id="9"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="216" length="4"/><text>HSCs</text></annotation><annotation id="10"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="266" length="7"/><text>myeloid</text></annotation><annotation id="11"><infon key="identifier">0001549</infon><infon key="type">TISSUE</infon><location offset="277" length="33"/><text>megakaryocytic-erythroid lineages</text></annotation><annotation id="12"><infon key="identifier">0001096</infon><infon key="type">TISSUE</infon><location offset="388" length="8"/><text>lymphoid</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1253" length="13"/><text>Cd19 promoter</text></annotation><annotation id="14"><infon key="identifier">0001096</infon><infon key="type">TISSUE</infon><location offset="597" length="8"/><text>lymphoid</text></annotation><annotation id="15"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="748" length="13"/><text>hematopoietic</text></annotation><annotation id="16"><infon key="identifier">6929</infon><infon key="type">GENE</infon><location offset="1165" length="3"/><text>E2A</text></annotation><annotation id="17"><infon key="identifier">0001096</infon><infon key="type">TISSUE</infon><location offset="1499" length="8"/><text>lymphoid</text></annotation><annotation id="18"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="42" length="6"/><text>B cell</text></annotation><annotation id="19"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="657" length="6"/><text>B cell</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="0" length="9"/><text>Stem cell</text></annotation><annotation id="21"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="791" length="6"/><text>B cell</text></annotation><annotation id="22"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="1253" length="4"/><text>Cd19</text></annotation><annotation id="23"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="92" length="5"/><text>mouse</text></annotation><annotation id="24"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="98" length="4"/><text>Cd19</text></annotation><annotation id="25"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="731" length="4"/><text>Cd19</text></annotation><annotation id="26"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="873" length="4"/><text>Cd19</text></annotation><annotation id="27"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="992" length="4"/><text>Cd19</text></annotation><annotation id="28"><infon key="identifier">12478</infon><infon key="type">GENE</infon><location offset="1055" length="4"/><text>Cd19</text></annotation><annotation id="29"><infon key="identifier">13591</infon><infon key="type">GENE</infon><location offset="1205" length="3"/><text>EBF</text></annotation></passage></document>
<document><id>18984737</id><passage><offset>0</offset><text>Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. OBJECTIVE: The activation of beta-cell genes, particularly of those encoding preproinsulin, requires an appropriate euchromatin (or "open") DNA template characterized by hypermethylation of Lys4 of histone H3. We hypothesized that this modification is maintained in islet beta-cells by the action of the histone methyltransferase Set7/9. RESEARCH DESIGN AND METHODS: To identify the role of Set7/9, we characterized its expression pattern and gene regulation and studied its function using RNA interference in both cell lines and primary mouse islets. RESULTS: Within the pancreas, Set7/9 protein shows striking specificity for islet cells, including alpha- and beta-cells, as well as occasional cells within ducts. Consistent with these findings, the Set7/9 gene promoter contained an islet-specific enhancer located between -5,768 and -6,030 base pairs (relative to the transcriptional start site) that exhibited Pdx1-responsive activation in beta-cells. To study Set7/9 function, we depleted insulinoma cells and primary mouse islets of Set7/9 protein using siRNA. Following siRNA treatment, we observed striking repression of genes involved in glucose-stimulated insulin secretion, including Ins1/2, Glut2, and MafA. These changes in transcription were accompanied by loss of dimethylated H3 Lys4 and RNA polymerase II recruitment, particularly at the Ins1/2 and Glut2 genes. Consistent with these data, depletion of Set7/9 in islets led to defects in glucose-stimulated Ca(2+) mobilization and insulin secretion. CONCLUSIONS: We conclude that Set7/9 is required for normal beta-cell function, likely through the maintenance of euchromatin structure at genes necessary for glucose-stimulated insulin secretion.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="852" length="20"/><text>Set7/9 gene promoter</text></annotation><annotation id="2"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="886" length="5"/><text>islet</text></annotation><annotation id="3"><infon key="identifier">0000632</infon><infon key="type">TISSUE</infon><location offset="1095" length="16"/><text>insulinoma cells</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1124" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="1140" length="6"/><text>Set7/9</text></annotation><annotation id="6"><infon key="identifier">16258</infon><infon key="type">GENE</infon><location offset="1296" length="4"/><text>Ins1</text></annotation><annotation id="7"><infon key="identifier">20526</infon><infon key="type">GENE</infon><location offset="1304" length="5"/><text>Glut2</text></annotation><annotation id="8"><infon key="identifier">378435</infon><infon key="type">GENE</infon><location offset="1315" length="4"/><text>MafA</text></annotation><annotation id="9"><infon key="identifier">16258</infon><infon key="type">GENE</infon><location offset="1456" length="4"/><text>Ins1</text></annotation><annotation id="10"><infon key="identifier">20526</infon><infon key="type">GENE</infon><location offset="1467" length="5"/><text>Glut2</text></annotation><annotation id="11"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="1521" length="6"/><text>Set7/9</text></annotation><annotation id="12"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="1648" length="6"/><text>Set7/9</text></annotation><annotation id="13"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="18" length="6"/><text>Set7/9</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="901" length="98"/><text>enhancer located between -5,768 and -6,030 base pairs (relative to the transcriptional start site)</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="129" length="9"/><text>beta-cell</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="366" length="16"/><text>islet beta-cells</text></annotation><annotation id="17"><infon key="type">TISSUE</infon><location offset="728" length="11"/><text>islet cells</text></annotation><annotation id="18"><infon key="type">TISSUE</infon><location offset="751" length="6"/><text>alpha-</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="762" length="10"/><text>beta-cells</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="1045" length="10"/><text>beta-cells</text></annotation><annotation id="21"><infon key="type">TISSUE</infon><location offset="1678" length="9"/><text>beta-cell</text></annotation><annotation id="22"><infon key="identifier">16259</infon><infon key="type">GENE</infon><location offset="1301" length="1"/><text>2</text></annotation><annotation id="23"><infon key="identifier">16259</infon><infon key="type">GENE</infon><location offset="1461" length="1"/><text>2</text></annotation><annotation id="24"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="430" length="6"/><text>Set7/9</text></annotation><annotation id="25"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="78" length="5"/><text>islet</text></annotation><annotation id="26"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="644" length="6"/><text>islets</text></annotation><annotation id="27"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="1130" length="6"/><text>islets</text></annotation><annotation id="28"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="672" length="8"/><text>pancreas</text></annotation><annotation id="29"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="852" length="6"/><text>Set7/9</text></annotation><annotation id="30"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="491" length="6"/><text>Set7/9</text></annotation><annotation id="31"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="638" length="5"/><text>mouse</text></annotation><annotation id="32"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="682" length="6"/><text>Set7/9</text></annotation><annotation id="33"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="1531" length="6"/><text>islets</text></annotation><annotation id="34"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1015" length="4"/><text>Pdx1</text></annotation><annotation id="35"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="1066" length="6"/><text>Set7/9</text></annotation></passage></document>
<document><id>19041414</id><passage><offset>0</offset><text>Smad3 activates the Sox9-dependent transcription on chromatin. Transforming growth factor (TGF)-beta has an essential role for the Sry-type high-mobility-group box (Sox)-regulated chondrogenesis. Chondrogenic differentiation is also controlled by chromatin-mediated transcription. We have previously reported that TGF-beta-regulated Smad3 induces chondrogenesis through the activation of Sox9-dependent transcription. However, the cross-talk between TGF-beta signal and Sox9 on chromatin-mediated transcription has not been elucidated. In the present study, we investigated the activity of Smad3, Sox9, and coactivator p300 using an in vitro chromatin assembly model. Luciferase reporter assays revealed that Smad3 stimulated the Sox9-mediated transcription in a TGF-beta-dependent manner. Recombinant Sox9 associated with phosphorylated Smad3/4 and recognized the enhancer region of type II collagen gene. In vitro transcription and S1 nuclease assays showed that Smad3 and p300 cooperatively activated the Sox9-dependent transcription on chromatin template. The combination treatment of phosphorylated Smad3, Sox9, and p300 were necessary for the activation of chromatin-mediated transcription. These findings suggest that TGF-beta signal Smad3 plays a key role for chromatin remodeling to induce chondrogenesis via its association with Sox9.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="865" length="40"/><text>enhancer region of type II collagen gene</text></annotation><annotation id="2"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Smad3</text></annotation><annotation id="3"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="597" length="4"/><text>Sox9</text></annotation><annotation id="4"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="619" length="4"/><text>p300</text></annotation><annotation id="5"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="709" length="5"/><text>Smad3</text></annotation><annotation id="6"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="730" length="4"/><text>Sox9</text></annotation><annotation id="7"><infon key="identifier">21803</infon><infon key="type">GENE</infon><location offset="763" length="8"/><text>TGF-beta</text></annotation><annotation id="8"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="802" length="4"/><text>Sox9</text></annotation><annotation id="9"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="838" length="5"/><text>Smad3</text></annotation><annotation id="10"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="965" length="5"/><text>Smad3</text></annotation><annotation id="11"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="975" length="4"/><text>p300</text></annotation><annotation id="12"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1008" length="4"/><text>Sox9</text></annotation><annotation id="13"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="20" length="4"/><text>Sox9</text></annotation><annotation id="14"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="1104" length="5"/><text>Smad3</text></annotation><annotation id="15"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1111" length="4"/><text>Sox9</text></annotation><annotation id="16"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="1121" length="4"/><text>p300</text></annotation><annotation id="17"><infon key="identifier">21803</infon><infon key="type">GENE</infon><location offset="1225" length="8"/><text>TGF-beta</text></annotation><annotation id="18"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="1241" length="5"/><text>Smad3</text></annotation><annotation id="19"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1339" length="4"/><text>Sox9</text></annotation><annotation id="20"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="131" length="3"/><text>Sry</text></annotation><annotation id="21"><infon key="identifier">17128</infon><infon key="type">GENE</infon><location offset="844" length="1"/><text>4</text></annotation><annotation id="22"><infon key="identifier">12824</infon><infon key="type">GENE</infon><location offset="884" length="16"/><text>type II collagen</text></annotation><annotation id="23"><infon key="identifier">21803</infon><infon key="type">GENE</infon><location offset="63" length="37"/><text>Transforming growth factor (TGF)-beta</text></annotation><annotation id="24"><infon key="identifier">21803</infon><infon key="type">GENE</infon><location offset="314" length="8"/><text>TGF-beta</text></annotation><annotation id="25"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="333" length="5"/><text>Smad3</text></annotation><annotation id="26"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="388" length="4"/><text>Sox9</text></annotation><annotation id="27"><infon key="identifier">21803</infon><infon key="type">GENE</infon><location offset="450" length="8"/><text>TGF-beta</text></annotation><annotation id="28"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="470" length="4"/><text>Sox9</text></annotation><annotation id="29"><infon key="identifier">17127</infon><infon key="type">GENE</infon><location offset="590" length="5"/><text>Smad3</text></annotation></passage></document>
<document><id>19141476</id><passage><offset>0</offset><text>Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. The onset of pancreas development in the foregut endoderm is marked by activation of the homeobox gene Pdx1 (IPF1). Pdx1 is essential for the expansion of the pancreatic primordium and the development of endocrine islets. The control of Pdx1 expression has been only partially elucidated. We demonstrate here that the winged-helix transcription factors Foxa1 and Foxa2 co-occupy multiple regulatory domains in the Pdx1 gene. Compound conditional ablation of both Foxa1 and Foxa2 in the pancreatic primordium results in complete loss of Pdx1 expression and severe pancreatic hypoplasia. Mutant mice exhibit hyperglycemia with severely disrupted acinar and islet development, and die shortly after birth. Assessment of developmental markers in the mutant pancreas revealed a failure in the expansion of the pancreatic anlage, a blockage of exocrine and endocrine cell differentiation, and an arrest at the primitive duct stage. Comparing their relative developmental activity, we find that Foxa2 is the major regulator in promoting pancreas development and cell differentiation. Using chromatin immunoprecipitations (ChIP) and ChIP sequencing (ChIPSeq) of fetal pancreas and islet chromatin, we demonstrate that Foxa1 and Foxa2 predominantly occupy a distal enhancer at -6.4 kb relative to the transcriptional start site in the Pdx1 gene. In addition, occupancy of the well-characterized proximal Pdx1 enhancer by Foxa1 and Foxa2 is developmental stage-dependent. Thus, the regulation of Pdx1 expression by Foxa1 and Foxa2 is a key early event controlling the expansion and differentiation of the pancreatic primordia.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="22" length="14"/><text>Pdx1 enhancers</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1344" length="86"/><text>distal enhancer at -6.4 kb relative to the transcriptional start site in the Pdx1 gene</text></annotation><annotation id="3"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="448" length="5"/><text>Foxa1</text></annotation><annotation id="4"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="458" length="5"/><text>Foxa2</text></annotation><annotation id="5"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="509" length="4"/><text>Pdx1</text></annotation><annotation id="6"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="558" length="5"/><text>Foxa1</text></annotation><annotation id="7"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="568" length="5"/><text>Foxa2</text></annotation><annotation id="8"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="631" length="4"/><text>Pdx1</text></annotation><annotation id="9"><infon key="identifier">0010802</infon><infon key="type">DISEASE</infon><location offset="658" length="21"/><text>pancreatic hypoplasia</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="688" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">0002909</infon><infon key="type">DISEASE</infon><location offset="701" length="13"/><text>hyperglycemia</text></annotation><annotation id="12"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1083" length="5"/><text>Foxa2</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1481" length="22"/><text>proximal Pdx1 enhancer</text></annotation><annotation id="14"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="1305" length="5"/><text>Foxa1</text></annotation><annotation id="15"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1315" length="5"/><text>Foxa2</text></annotation><annotation id="16"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="1690" length="20"/><text>pancreatic primordia</text></annotation><annotation id="17"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="254" length="21"/><text>pancreatic primordium</text></annotation><annotation id="18"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="1507" length="5"/><text>Foxa1</text></annotation><annotation id="19"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1517" length="5"/><text>Foxa2</text></annotation><annotation id="20"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1581" length="4"/><text>Pdx1</text></annotation><annotation id="21"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="1600" length="5"/><text>Foxa1</text></annotation><annotation id="22"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1610" length="5"/><text>Foxa2</text></annotation><annotation id="23"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="750" length="5"/><text>islet</text></annotation><annotation id="24"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="848" length="8"/><text>pancreas</text></annotation><annotation id="25"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="22" length="4"/><text>Pdx1</text></annotation><annotation id="26"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="900" length="17"/><text>pancreatic anlage</text></annotation><annotation id="27"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="1125" length="8"/><text>pancreas</text></annotation><annotation id="28"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="1255" length="8"/><text>pancreas</text></annotation><annotation id="29"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="73" length="8"/><text>pancreas</text></annotation><annotation id="30"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="108" length="8"/><text>pancreas</text></annotation><annotation id="31"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="144" length="8"/><text>endoderm</text></annotation><annotation id="32"><infon key="identifier">0000650</infon><infon key="type">TISSUE</infon><location offset="299" length="16"/><text>endocrine islets</text></annotation><annotation id="33"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="581" length="21"/><text>pancreatic primordium</text></annotation><annotation id="34"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="1268" length="5"/><text>islet</text></annotation><annotation id="35"><infon key="identifier">15375</infon><infon key="type">GENE</infon><location offset="40" length="5"/><text>Foxa1</text></annotation><annotation id="36"><infon key="identifier">0000507</infon><infon key="type">TISSUE</infon><location offset="136" length="7"/><text>foregut</text></annotation><annotation id="37"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1421" length="4"/><text>Pdx1</text></annotation><annotation id="38"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1490" length="4"/><text>Pdx1</text></annotation><annotation id="39"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="50" length="5"/><text>Foxa2</text></annotation><annotation id="40"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="198" length="4"/><text>Pdx1</text></annotation><annotation id="41"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="204" length="4"/><text>IPF1</text></annotation><annotation id="42"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="211" length="4"/><text>Pdx1</text></annotation><annotation id="43"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="332" length="4"/><text>Pdx1</text></annotation></passage></document>
<document><id>19345119</id><passage><offset>0</offset><text>Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Pax5 is an essential regulator of B cell identity and function. Here, we used transgenesis and deletion mapping to identify a potent enhancer in intron 5 of the Pax5 locus. This enhancer in combination with the promoter region was sufficient to recapitulate the B lymphoid expression of Pax5. The enhancer was silenced by DNA methylation in embryonic stem cells, but became activated in multipotent hematopoietic progenitors. It contained functional binding sites for the transcription factors PU.1, IRF4, IRF8, and NF-kappaB, suggesting that these regulators contribute to sequential enhancer activation in hematopoietic progenitors and during B cell development. In contrast, the promoter region was repressed by Polycomb group proteins in non-B cells and was activated only at the onset of pro-B cell development through induction of chromatin remodeling by the transcription factor EBF1. These experiments demonstrate a stepwise activation of Pax5 in early lymphopoiesis and provide mechanistic insights into the process of B cell commitment.</text><annotation id="1"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="374" length="10"/><text>B lymphoid</text></annotation><annotation id="2"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="146" length="6"/><text>B cell</text></annotation><annotation id="3"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="399" length="4"/><text>Pax5</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="562" length="75"/><text>binding sites for the transcription factors PU.1, IRF4, IRF8, and NF-kappaB</text></annotation><annotation id="5"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="273" length="4"/><text>Pax5</text></annotation><annotation id="6"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="858" length="7"/><text>B cells</text></annotation><annotation id="7"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="60" length="6"/><text>B cell</text></annotation><annotation id="8"><infon key="identifier">1879</infon><infon key="type">GENE</infon><location offset="998" length="4"/><text>EBF1</text></annotation><annotation id="9"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1059" length="4"/><text>Pax5</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="36" length="51"/><text>promoter regions of the B cell commitment gene Pax5</text></annotation><annotation id="11"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="83" length="4"/><text>Pax5</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="245" length="38"/><text>enhancer in intron 5 of the Pax5 locus</text></annotation><annotation id="13"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="453" length="20"/><text>embryonic stem cells</text></annotation><annotation id="14"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="511" length="25"/><text>hematopoietic progenitors</text></annotation><annotation id="15"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="757" length="6"/><text>B cell</text></annotation><annotation id="16"><infon key="identifier">0003104</infon><infon key="type">TISSUE</infon><location offset="905" length="10"/><text>pro-B cell</text></annotation><annotation id="17"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1140" length="6"/><text>B cell</text></annotation><annotation id="18"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="606" length="4"/><text>PU.1</text></annotation><annotation id="19"><infon key="identifier">16364</infon><infon key="type">GENE</infon><location offset="612" length="4"/><text>IRF4</text></annotation><annotation id="20"><infon key="identifier">15900</infon><infon key="type">GENE</infon><location offset="618" length="4"/><text>IRF8</text></annotation><annotation id="21"><infon key="identifier">18033</infon><infon key="type">GENE</infon><location offset="628" length="9"/><text>NF-kappaB</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="290" length="8"/><text>enhancer</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="323" length="15"/><text>promoter region</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="409" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="720" length="25"/><text>hematopoietic progenitors</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="794" length="15"/><text>promoter region</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="23" length="8"/><text>enhancer</text></annotation><annotation id="28"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="112" length="4"/><text>Pax5</text></annotation></passage></document>
<document><id>19467240</id><passage><offset>0</offset><text>A far-upstream Oct-1 motif regulates cytokine-induced transcription of the human inducible nitric oxide synthase gene. Transcriptional regulation of the human inducible nitric oxide synthase (hiNOS) gene is highly complex and requires an orchestrated flow of positive and negative transcription factors that bind to specific cis-acting upstream response elements. Very little specific information exists about the far-upstream region of the hiNOS gene. Oct-1 protein belongs to the Pit-Oct-Unc domain transcription factor family and is constitutively expressed in all dividing cells. It is essential for proliferation, differentiation, and other key cell processes. However, the role of Oct-1 in regulating hiNOS gene expression has not been reported. In this work, the octamer sequence 5'-ATGCAAAT-3' at -10.2 kb in the hiNOS promoter was identified as high-affinity Oct-1 binding by electrophoretic mobility shift assay in vitro and chromatin immunoprecipitation assay in vivo. Mutation of Oct-1 motif at -10.2 kb in the hiNOS promoter decreased cytokine-induced hiNOS promoter activity by 40%. Cytokine-induced hiNOS promoter activity was also significantly reduced by Oct-1 small interfering RNA targeting. Overexpression of Oct-1 increased cytokine-induced hiNOS protein expression in primary human hepatocytes. Furthermore, the Oct-1 motif at -10.2 kb of the hiNOS promoter conferred increased transcriptional activity to the heterologous thymidine kinase promoter irrespective of cytokine induction. Taken together, this work identifies a far-upstream functional Oct-1 enhancer motif at -10.2 kb in the hiNOS promoter that regulates cytokine-induced hiNOS gene transcription and further underscores tight control mechanisms regulating the expression of the hiNOS gene.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="2" length="24"/><text>far-upstream Oct-1 motif</text></annotation><annotation id="2"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="75" length="37"/><text>human inducible nitric oxide synthase</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="992" length="45"/><text>Oct-1 motif at -10.2 kb in the hiNOS promoter</text></annotation><annotation id="4"><infon key="identifier">0000575</infon><infon key="type">TISSUE</infon><location offset="1304" length="11"/><text>hepatocytes</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1334" length="45"/><text>Oct-1 motif at -10.2 kb of the hiNOS promoter</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1546" length="78"/><text>far-upstream functional Oct-1 enhancer motif at -10.2 kb in the hiNOS promoter</text></annotation><annotation id="7"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="821" length="14"/><text>hiNOS promoter</text></annotation><annotation id="8"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="1023" length="14"/><text>hiNOS promoter</text></annotation><annotation id="9"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="1065" length="14"/><text>hiNOS promoter</text></annotation><annotation id="10"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="1114" length="14"/><text>hiNOS promoter</text></annotation><annotation id="11"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="1365" length="14"/><text>hiNOS promoter</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1445" length="25"/><text>thymidine kinase promoter</text></annotation><annotation id="13"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="153" length="37"/><text>human inducible nitric oxide synthase</text></annotation><annotation id="14"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr17,26072592,26074592</infon><infon key="type">PROMOTER</infon><infon key="identifier">17,26072592,26074592</infon><infon key="gb">unk</infon><location offset="1610" length="14"/><text>hiNOS promoter</text></annotation><annotation id="15"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="441" length="5"/><text>hiNOS</text></annotation><annotation id="16"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="707" length="5"/><text>hiNOS</text></annotation><annotation id="17"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1657" length="5"/><text>hiNOS</text></annotation><annotation id="18"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1764" length="5"/><text>hiNOS</text></annotation><annotation id="19"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1262" length="5"/><text>hiNOS</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1298" length="5"/><text>human</text></annotation><annotation id="21"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="821" length="5"/><text>hiNOS</text></annotation><annotation id="22"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1023" length="5"/><text>hiNOS</text></annotation><annotation id="23"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1065" length="5"/><text>hiNOS</text></annotation><annotation id="24"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="453" length="5"/><text>Oct-1</text></annotation><annotation id="25"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1114" length="5"/><text>hiNOS</text></annotation><annotation id="26"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1365" length="5"/><text>hiNOS</text></annotation><annotation id="27"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1610" length="5"/><text>hiNOS</text></annotation><annotation id="28"><infon key="identifier">7083</infon><infon key="type">GENE</infon><location offset="1445" length="16"/><text>thymidine kinase</text></annotation><annotation id="29"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="15" length="5"/><text>Oct-1</text></annotation><annotation id="30"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="992" length="5"/><text>Oct-1</text></annotation><annotation id="31"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="1334" length="5"/><text>Oct-1</text></annotation><annotation id="32"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="1570" length="5"/><text>Oct-1</text></annotation><annotation id="33"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="687" length="5"/><text>Oct-1</text></annotation><annotation id="34"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="868" length="5"/><text>Oct-1</text></annotation><annotation id="35"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="1172" length="5"/><text>Oct-1</text></annotation><annotation id="36"><infon key="identifier">18986</infon><infon key="type">GENE</infon><location offset="1229" length="5"/><text>Oct-1</text></annotation><annotation id="37"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="192" length="5"/><text>hiNOS</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="770" length="65"/><text>octamer sequence 5'-ATGCAAAT-3' at -10.2 kb in the hiNOS promoter</text></annotation></passage></document>
<document><id>19708858</id><passage><offset>0</offset><text>The human urocortin 2 gene is regulated by hypoxia: identification of a hypoxia-responsive element in the 3'-flanking region. Ucn2 (urocortin 2) has been shown to exert potent beneficial effects in the cardiovascular system, including inhibition of apoptosis, improvement of cardiomyocyte contractility and decrease of oxidative stress. The mechanisms that contribute to the regulation of hUcn2 (human Ucn2) expression in cardiovascular pathologies are not known. In the present study, we analysed the mechanism by which hypoxia, a major stimulus in ischaemic heart disease, regulates Ucn2 gene expression. Hypoxia and CPX (ciclopirox olamine), which prevents proteolytic degradation of HIF (hypoxia-inducible factor), significantly increased hUcn2 mRNA levels in TE-671 cells. Gene silencing of endogenous HIF1alpha abolishes this increase. Hypoxia and CPX activated a luciferase-linked fragment of the 3'FLR (3'-flanking region) of the hUcn2 gene containing two putative HREs (hypoxia-response elements), HRE1 and HRE2. Site-directed mutagenesis experiments demonstrated that HRE1 is required for HIF1alpha-dependent luciferase activation. This activation was conserved in constructs with the 3'FLR fragment placed upstream of the luciferase gene, indicating an enhancer function for HRE1. Competition assays revealed direct binding between HRE1 and HIF1alpha. Regulation of Ucn2 by hypoxia was confirmed in rat neonatal cardiomyocytes and in cardiac-derived H9c2 cells transfected with constructs of the 3'FLR of the hUcn2 gene. In conclusion, our study demonstrates that hypoxia induces hUcn2 expression via a specific HRE in the 3'FLR of the hUcn2 gene, which interacts with the transcription factor HIF1alpha. Hypoxia-mediated stimulation of cardioprotective Ucn2 may help to preserve cardiac function and prevent apoptosis in ischaemic conditions in the heart.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1264" length="26"/><text>enhancer function for HRE1</text></annotation><annotation id="2"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="275" length="13"/><text>cardiomyocyte</text></annotation><annotation id="3"><infon key="identifier">0005053</infon><infon key="type">DISEASE</infon><location offset="550" length="23"/><text>ischaemic heart disease</text></annotation><annotation id="4"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="585" length="4"/><text>Ucn2</text></annotation><annotation id="5"><infon key="type">DISEASE</infon><location offset="607" length="7"/><text>Hypoxia</text></annotation><annotation id="6"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="743" length="5"/><text>hUcn2</text></annotation><annotation id="7"><infon key="identifier">3091</infon><infon key="type">GENE</infon><location offset="807" length="9"/><text>HIF1alpha</text></annotation><annotation id="8"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="938" length="5"/><text>hUcn2</text></annotation><annotation id="9"><infon key="identifier">3091</infon><infon key="type">GENE</infon><location offset="1099" length="9"/><text>HIF1alpha</text></annotation><annotation id="10"><infon key="identifier">3091</infon><infon key="type">GENE</infon><location offset="1352" length="9"/><text>HIF1alpha</text></annotation><annotation id="11"><infon key="identifier">170896</infon><infon key="type">GENE</infon><location offset="1377" length="4"/><text>Ucn2</text></annotation><annotation id="12"><infon key="identifier">0001879</infon><infon key="type">TISSUE</infon><location offset="1445" length="26"/><text>cardiac-derived H9c2 cells</text></annotation><annotation id="13"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="4" length="17"/><text>human urocortin 2</text></annotation><annotation id="14"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="1520" length="5"/><text>hUcn2</text></annotation><annotation id="15"><infon key="type">DISEASE</infon><location offset="1575" length="7"/><text>hypoxia</text></annotation><annotation id="16"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="1591" length="5"/><text>hUcn2</text></annotation><annotation id="17"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1861" length="5"/><text>heart</text></annotation><annotation id="18"><infon key="identifier">3091</infon><infon key="type">GENE</infon><location offset="1705" length="9"/><text>HIF1alpha</text></annotation><annotation id="19"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="1765" length="4"/><text>Ucn2</text></annotation><annotation id="20"><infon key="identifier">0005053</infon><infon key="type">DISEASE</infon><location offset="1833" length="20"/><text>ischaemic conditions</text></annotation><annotation id="21"><infon key="type">DISEASE</infon><location offset="692" length="7"/><text>hypoxia</text></annotation><annotation id="22"><infon key="type">DISEASE</infon><location offset="43" length="7"/><text>hypoxia</text></annotation><annotation id="23"><infon key="identifier">10116</infon><infon key="type">SPECIES</infon><location offset="1410" length="3"/><text>rat</text></annotation><annotation id="24"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="126" length="4"/><text>Ucn2</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="960" length="17"/><text>two putative HREs</text></annotation><annotation id="26"><infon key="identifier">0002605</infon><infon key="type">TISSUE</infon><location offset="764" length="12"/><text>TE-671 cells</text></annotation><annotation id="27"><infon key="type">DISEASE</infon><location offset="842" length="7"/><text>Hypoxia</text></annotation><annotation id="28"><infon key="type">DISEASE</infon><location offset="1716" length="7"/><text>Hypoxia</text></annotation><annotation id="29"><infon key="type">DISEASE</infon><location offset="1385" length="7"/><text>hypoxia</text></annotation><annotation id="30"><infon key="type">DISEASE</infon><location offset="72" length="7"/><text>hypoxia</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="979" length="26"/><text>hypoxia-response elements)</text></annotation><annotation id="32"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1423" length="14"/><text>cardiomyocytes</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1007" length="4"/><text>HRE1</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1016" length="4"/><text>HRE2</text></annotation><annotation id="35"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="132" length="11"/><text>urocortin 2</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1078" length="4"/><text>HRE1</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1286" length="4"/><text>HRE1</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1343" length="4"/><text>HRE1</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1623" length="34"/><text>HRE in the 3'FLR of the hUcn2 gene</text></annotation><annotation id="40"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="1647" length="5"/><text>hUcn2</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="72" length="52"/><text>hypoxia-responsive element in the 3'-flanking region</text></annotation><annotation id="42"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="389" length="5"/><text>hUcn2</text></annotation><annotation id="43"><infon key="identifier">0000088</infon><infon key="type">TISSUE</infon><location offset="202" length="21"/><text>cardiovascular system</text></annotation><annotation id="44"><infon key="identifier">90226</infon><infon key="type">GENE</infon><location offset="396" length="10"/><text>human Ucn2</text></annotation><annotation id="45"><infon key="identifier">0004995</infon><infon key="type">DISEASE</infon><location offset="422" length="26"/><text>cardiovascular pathologies</text></annotation><annotation id="46"><infon key="type">DISEASE</infon><location offset="521" length="7"/><text>hypoxia</text></annotation></passage></document>
<document><id>19773398</id><passage><offset>0</offset><text>X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. CONTEXT: X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism (AHCH) is known to be caused by coding mutations in the nuclear receptor subfamily 0, group B, member 1 (NR0B1) gene, encoding the transcriptional repressor dosage-sensitive sex-reversal adrenal hypoplasia critical region on the X chromosome protein 1 (DAX1). OBJECTIVE/PATIENTS: Four males in a family were affected by AHCH. Our aim was to locate the genetic cause of their disease, knowing that they had no mutation in the obvious candidate gene, NR0B1. DESIGN: Linkage analysis of the X chromosome and mutational screening of conserved noncoding regions upstream of NR0B1 were performed. To functionally characterize the genetic defect, studies of transcription and expression of DAX1 and steroidogenic factor 1 (SF-1) were done. RESULTS: A 60 Mb inversion on the X chromosome with one of the inversion breakpoints located in a conserved noncoding region 4 kb upstream of NR0B1 was detected. The inversion causes relocation of a putative SF-1 binding site implicated in murine gonadal development. A reporter construct lacking this enhancer element upstream of NR0B1 was unresponsive to SF-1 transcriptional activation. Immunohistochemistry suggested that the inversion leads to SF-1 silencing in the patients' testes both in childhood and in adult life. CONCLUSION: We report a noncoding mutation causing AHCH, an inversion resulting in a phenotype similar to what is caused by intragenic NR0B1 null mutations. The inversion seems to disrupt and/or relocate regulatory sites crucial in DAX1 expression.</text><annotation id="1"><infon key="identifier">0010264</infon><infon key="type">DISEASE</infon><location offset="0" length="38"/><text>X-linked congenital adrenal hypoplasia</text></annotation><annotation id="2"><infon key="identifier">0010264</infon><infon key="type">DISEASE</infon><location offset="430" length="31"/><text>sex-reversal adrenal hypoplasia</text></annotation><annotation id="3"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="509" length="4"/><text>DAX1</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1229" length="6"/><text>murine</text></annotation><annotation id="5"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="576" length="4"/><text>AHCH</text></annotation><annotation id="6"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="705" length="5"/><text>NR0B1</text></annotation><annotation id="7"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="825" length="5"/><text>NR0B1</text></annotation><annotation id="8"><infon key="identifier">0003847</infon><infon key="type">DISEASE</infon><location offset="880" length="14"/><text>genetic defect</text></annotation><annotation id="9"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="939" length="4"/><text>DAX1</text></annotation><annotation id="10"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="948" length="22"/><text>steroidogenic factor 1</text></annotation><annotation id="11"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="1470" length="6"/><text>testes</text></annotation><annotation id="12"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="44" length="29"/><text>hypogonadotropic hypogonadism</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1291" length="34"/><text>enhancer element upstream of NR0B1</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1097" length="39"/><text>noncoding region 4 kb upstream of NR0B1</text></annotation><annotation id="15"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1346" length="4"/><text>SF-1</text></annotation><annotation id="16"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1438" length="4"/><text>SF-1</text></annotation><annotation id="17"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="1565" length="4"/><text>AHCH</text></annotation><annotation id="18"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="1649" length="5"/><text>NR0B1</text></annotation><annotation id="19"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="1746" length="4"/><text>DAX1</text></annotation><annotation id="20"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="972" length="4"/><text>SF-1</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1197" length="17"/><text>SF-1 binding site</text></annotation><annotation id="22"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="1131" length="5"/><text>NR0B1</text></annotation><annotation id="23"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="154" length="5"/><text>NR0B1</text></annotation><annotation id="24"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="1320" length="5"/><text>NR0B1</text></annotation><annotation id="25"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1197" length="4"/><text>SF-1</text></annotation><annotation id="26"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="161" length="4"/><text>DAX1</text></annotation><annotation id="27"><infon key="identifier">0010264</infon><infon key="type">DISEASE</infon><location offset="182" length="38"/><text>X-linked congenital adrenal hypoplasia</text></annotation><annotation id="28"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="226" length="29"/><text>hypogonadotropic hypogonadism</text></annotation><annotation id="29"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="257" length="4"/><text>AHCH</text></annotation><annotation id="30"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="312" length="47"/><text>nuclear receptor subfamily 0, group B, member 1</text></annotation><annotation id="31"><infon key="identifier">190</infon><infon key="type">GENE</infon><location offset="361" length="5"/><text>NR0B1</text></annotation></passage></document>
<document><id>20042469</id><passage><offset>0</offset><text>c-Maf activates the promoter and enhancer of the IL-21 gene, and TGF-beta inhibits c-Maf-induced IL-21 production in CD4+ T cells. Previous studies have shown that IL-6 potently induces IL-21 production in CD4(+) T cells, whereas TGF-beta inhibits IL-6-induced IL-21 production in CD4(+) T cells. In this study, we addressed the mechanisms underlying the transcriptional regulation of IL-21 production in CD4(+) T cells. We found that IL-6 induced c-Maf expression in CD4(+) T cells and that the enforced expression of c-Maf induced IL-21 production in CD4(+) T cells without IL-6, IL-4/STAT6 signaling, or an autocrine effect of IL-21. Moreover, we found that c-Maf directly bound to and activated IL-21P and the CNS-2 enhancer through MARE sites. On the other hand, we also found that although TGF-beta up-regulated IL-6-induced c-Maf expression in CD4(+) T cells, TGF-beta inhibited c-Maf-induced IL-21 production in CD4(+) T cells. Finally, we found that Foxp3 bound to IL-21P and the CNS-2 enhancer and inhibited c-Maf-induced IL-21 production modestly but significantly in CD4(+) T cells. Taken together, these results suggest that c-Maf induces IL-21 production directly in CD4(+) T cells by activating IL-21P and the CNS-2 enhancer and that TGF-beta suppresses c-Maf-induced IL-21 production in CD4(+) T cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="20" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="164" length="4"/><text>IL-6</text></annotation><annotation id="3"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="186" length="5"/><text>IL-21</text></annotation><annotation id="4"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="230" length="8"/><text>TGF-beta</text></annotation><annotation id="5"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="248" length="4"/><text>IL-6</text></annotation><annotation id="6"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="261" length="5"/><text>IL-21</text></annotation><annotation id="7"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="385" length="5"/><text>IL-21</text></annotation><annotation id="8"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="435" length="4"/><text>IL-6</text></annotation><annotation id="9"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="448" length="5"/><text>c-Maf</text></annotation><annotation id="10"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="519" length="5"/><text>c-Maf</text></annotation><annotation id="11"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="533" length="5"/><text>IL-21</text></annotation><annotation id="12"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="851" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="13"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="576" length="4"/><text>IL-6</text></annotation><annotation id="14"><infon key="identifier">3565</infon><infon key="type">GENE</infon><location offset="582" length="4"/><text>IL-4</text></annotation><annotation id="15"><infon key="identifier">6778</infon><infon key="type">GENE</infon><location offset="587" length="5"/><text>STAT6</text></annotation><annotation id="16"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="630" length="5"/><text>IL-21</text></annotation><annotation id="17"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="661" length="5"/><text>c-Maf</text></annotation><annotation id="18"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="796" length="8"/><text>TGF-beta</text></annotation><annotation id="19"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="818" length="4"/><text>IL-6</text></annotation><annotation id="20"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="831" length="5"/><text>c-Maf</text></annotation><annotation id="21"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="867" length="8"/><text>TGF-beta</text></annotation><annotation id="22"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="886" length="5"/><text>c-Maf</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="989" length="14"/><text>CNS-2 enhancer</text></annotation><annotation id="24"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="900" length="5"/><text>IL-21</text></annotation><annotation id="25"><infon key="identifier">50943</infon><infon key="type">GENE</infon><location offset="959" length="5"/><text>Foxp3</text></annotation><annotation id="26"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="1018" length="5"/><text>c-Maf</text></annotation><annotation id="27"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="1032" length="5"/><text>IL-21</text></annotation><annotation id="28"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="1138" length="5"/><text>c-Maf</text></annotation><annotation id="29"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="1152" length="5"/><text>IL-21</text></annotation><annotation id="30"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1249" length="8"/><text>TGF-beta</text></annotation><annotation id="31"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="1269" length="5"/><text>c-Maf</text></annotation><annotation id="32"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="1283" length="5"/><text>IL-21</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="33" length="26"/><text>enhancer of the IL-21 gene</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1225" length="14"/><text>CNS-2 enhancer</text></annotation><annotation id="35"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="117" length="12"/><text>CD4+ T cells</text></annotation><annotation id="36"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="281" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="37"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="405" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="38"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="468" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="39"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="553" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="737" length="10"/><text>MARE sites</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="699" length="6"/><text>IL-21P</text></annotation><annotation id="42"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="714" length="14"/><text>CNS-2 enhancer</text></annotation><annotation id="43"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="920" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="44"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="974" length="6"/><text>IL-21P</text></annotation><annotation id="45"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>c-Maf</text></annotation><annotation id="46"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1079" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="47"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1181" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="48"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1210" length="6"/><text>IL-21P</text></annotation><annotation id="49"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1303" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="50"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="49" length="5"/><text>IL-21</text></annotation><annotation id="51"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="206" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="52"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="65" length="8"/><text>TGF-beta</text></annotation><annotation id="53"><infon key="identifier">4094</infon><infon key="type">GENE</infon><location offset="83" length="5"/><text>c-Maf</text></annotation><annotation id="54"><infon key="identifier">59067</infon><infon key="type">GENE</infon><location offset="97" length="5"/><text>IL-21</text></annotation></passage></document>
<document><id>20061391</id><passage><offset>0</offset><text>Nuclear factor kappaB- and specificity protein 1-dependent p53-mediated bi-directional regulation of the human manganese superoxide dismutase gene. Tumor suppressor p53 is known to activate certain sets of genes while suppressing others. However, whether p53 can both activate and suppress the same gene is unclear. To address this question, concentration-dependent p53 effect on the manganese superoxide dismutase (MnSOD) gene was investigated. By transfecting p53 in PC-3 cells, we demonstrate that low concentrations of p53 increase while high concentrations suppress MnSOD expression. The physiological relevance of this effect was determined in vitro and in vivo using combined UVB-mediated activation and small interference RNA-mediated suppression of p53. Results were consistent with the bi-directional effect of p53 on MnSOD expression. MnSOD-promoter/enhancer analysis demonstrates that p53 is suppressive to the promoter activity regardless of the presence or absence of putative p53 binding sites. However, a low level of p53 increases MnSOD gene transcription in the presence of the intronic-enhancer element, and this effect is dependent on nuclear-factor kappaB (NF-kappaB) binding sites. Expression of p53 enhances nuclear levels of p65 with corresponding increase in the DNA-binding activity of NF-kappaB as detected by electrophoretic mobility shift and chromatin immunoprecipitation assays. Transfection of p65 small interference RNA reduces the positive effect of p53 on MnSOD gene transcription. These data suggest that p65 can overcome the negative effect of p53 on MnSOD expression. However, when the level of p53 was further increased, the suppressive effect of p53 outweighed the positive effect of p65 and led to the suppression of MnSOD gene transcription. These results demonstrated that p53 can both suppress and induce MnSOD expression depending on the balance of promoter and enhancer binding transcription factors.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1096" length="25"/><text>intronic-enhancer element</text></annotation><annotation id="2"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="991" length="3"/><text>p53</text></annotation><annotation id="3"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="462" length="3"/><text>p53</text></annotation><annotation id="4"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="523" length="3"/><text>p53</text></annotation><annotation id="5"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="571" length="5"/><text>MnSOD</text></annotation><annotation id="6"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="758" length="3"/><text>p53</text></annotation><annotation id="7"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="821" length="3"/><text>p53</text></annotation><annotation id="8"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="828" length="5"/><text>MnSOD</text></annotation><annotation id="9"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="897" length="3"/><text>p53</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1155" length="47"/><text>nuclear-factor kappaB (NF-kappaB) binding sites</text></annotation><annotation id="11"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1034" length="3"/><text>p53</text></annotation><annotation id="12"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="1048" length="5"/><text>MnSOD</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="991" length="17"/><text>p53 binding sites</text></annotation><annotation id="14"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1218" length="3"/><text>p53</text></annotation><annotation id="15"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1249" length="3"/><text>p65</text></annotation><annotation id="16"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1312" length="9"/><text>NF-kappaB</text></annotation><annotation id="17"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1426" length="3"/><text>p65</text></annotation><annotation id="18"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1484" length="3"/><text>p53</text></annotation><annotation id="19"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="1491" length="5"/><text>MnSOD</text></annotation><annotation id="20"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1541" length="3"/><text>p65</text></annotation><annotation id="21"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1581" length="3"/><text>p53</text></annotation><annotation id="22"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="1588" length="5"/><text>MnSOD</text></annotation><annotation id="23"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1633" length="3"/><text>p53</text></annotation><annotation id="24"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="59" length="3"/><text>p53</text></annotation><annotation id="25"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1686" length="3"/><text>p53</text></annotation><annotation id="26"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1724" length="3"/><text>p65</text></annotation><annotation id="27"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="1758" length="5"/><text>MnSOD</text></annotation><annotation id="28"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1816" length="3"/><text>p53</text></annotation><annotation id="29"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="1849" length="5"/><text>MnSOD</text></annotation><annotation id="30"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="0" length="21"/><text>Nuclear factor kappaB</text></annotation><annotation id="31"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="148" length="20"/><text>Tumor suppressor p53</text></annotation><annotation id="32"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1155" length="21"/><text>nuclear-factor kappaB</text></annotation><annotation id="33"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1178" length="9"/><text>NF-kappaB</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0001061</infon><infon key="type">TISSUE</infon><location offset="469" length="10"/><text>PC-3 cells</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="105" length="5"/><text>human</text></annotation><annotation id="36"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="111" length="30"/><text>manganese superoxide dismutase</text></annotation><annotation id="37"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="255" length="3"/><text>p53</text></annotation><annotation id="38"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="366" length="3"/><text>p53</text></annotation><annotation id="39"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="384" length="30"/><text>manganese superoxide dismutase</text></annotation><annotation id="40"><infon key="identifier">6648</infon><infon key="type">GENE</infon><location offset="416" length="5"/><text>MnSOD</text></annotation></passage></document>
<document><id>20093418</id><passage><offset>0</offset><text>Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Recent studies have identified FKBP51 (FK506-binding protein 51) as a sensitive biomarker of corticosteroid responsiveness in vivo. In this work, we have elucidated the molecular mechanisms underlying the induction of FKBP51 by the glucocorticoid receptor (GR) in human A549 lung cancer cells showing robust accumulation of FKBP51 mRNA in response to dexamethasone exposure. Our quantitative chromatin immunoprecipitation scans and enhancer activity analyses indicate that activation of the FKBP51 locus by glucocorticoids in vivo is triggered by the loading of GR to enhancers at about 34 kb 5' and about 87 kb 3' of the transcription start site. Interestingly, the region encompassing these enhancers is bordered by CCCTC-binding factor- and cohesin-binding sites. Dexamethasone treatment also decreased the histone density at several regions of the gene, which was paralleled with the occupancy of SWI/SNF chromatin remodeling complexes within the locus. Moreover, silencing of BRM subunit of the SWI/SNF complex blunted the glucocorticoid induction of the locus. The proximal promoter region along with the major intronic enhancer at approximately 87 kb, at which the GR binding peaked, had elevated levels of histone 3 acetylation and H3K4 trimethylation, whereas H3K36 trimethylation more generally marked the gene body and reflected the occupancy of RNA polymerase II. The occurrence of these active chromatin marks within the FKBP51 locus before glucocorticoid exposure suggests that it is poised for transcription in A549 cells. Taken together, these results indicate that the holo-GR is capable of activating transcription and evoking changes in chromatin structure through distant-acting enhancers.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="808" length="47"/><text>CCCTC-binding factor- and cohesin-binding sites</text></annotation><annotation id="2"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="414" length="6"/><text>FKBP51</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0000018</infon><infon key="type">TISSUE</infon><location offset="360" length="22"/><text>A549 lung cancer cells</text></annotation><annotation id="4"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="652" length="2"/><text>GR</text></annotation><annotation id="5"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="1262" length="2"/><text>GR</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="658" length="78"/><text>enhancers at about 34 kb 5' and about 87 kb 3' of the transcription start site</text></annotation><annotation id="7"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="41" length="6"/><text>FKBP51</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="783" length="9"/><text>enhancers</text></annotation><annotation id="9"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="121" length="6"/><text>FKBP51</text></annotation><annotation id="10"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="129" length="24"/><text>FK506-binding protein 51</text></annotation><annotation id="11"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="308" length="6"/><text>FKBP51</text></annotation><annotation id="12"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="581" length="6"/><text>FKBP51</text></annotation><annotation id="13"><infon key="identifier">6595</infon><infon key="type">GENE</infon><location offset="1071" length="3"/><text>BRM</text></annotation><annotation id="14"><infon key="identifier">2289</infon><infon key="type">GENE</infon><location offset="1524" length="6"/><text>FKBP51</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0000018</infon><infon key="type">TISSUE</infon><location offset="1616" length="10"/><text>A549 cells</text></annotation><annotation id="16"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="1681" length="2"/><text>GR</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1161" length="24"/><text>proximal promoter region</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1201" length="46"/><text>major intronic enhancer at approximately 87 kb</text></annotation><annotation id="19"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="808" length="20"/><text>CCCTC-binding factor</text></annotation><annotation id="20"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="0" length="23"/><text>Glucocorticoid receptor</text></annotation><annotation id="21"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="322" length="23"/><text>glucocorticoid receptor</text></annotation><annotation id="22"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="347" length="2"/><text>GR</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="354" length="5"/><text>human</text></annotation></passage></document>
<document><id>20864515</id><passage><offset>0</offset><text>Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. OBJECTIVE: We investigated the function of the Prep1 gene in insulin-dependent glucose homeostasis in liver. RESEARCH DESIGN AND METHODS: Prep1 action on insulin glucoregulatory function has been analyzed in liver of Prep1-hypomorphic mice (Prep1(i/i)), which express 2-3% of Prep1 mRNA. RESULTS: Based on euglycemic hyperinsulinemic clamp studies and measurement of glycogen content, livers from Prep1(i/i) mice feature increased sensitivity to insulin. Tyrosine phosphorylation of both insulin receptor (IR) and insulin receptor substrate (IRS)1/2 was significantly enhanced in Prep1(i/i) livers accompanied by a specific downregulation of the SYP and SHP1 tyrosine phosphatases. Prep1 overexpression in HepG2 liver cells upregulated SYP and SHP1 and inhibited insulin-induced IR and IRS1/2 phosphorylation and was accompanied by reduced glycogen content. Consistently, overexpression of the Prep1 partner Pbx1, but not of p160MBP, mimicked Prep1 effects on tyrosine phosphorylations, glycogen content, and on SYP and SHP1 expression. In Prep1 overexpressing cells, antisense silencing of SHP1, but not that of SYP, rescued insulin-dependent IR phosphorylation and glycogen accumulation. Both Prep1 and Pbx1 bind SHP1 promoter at a site located between nucleotides -2,113 and -1,778. This fragment features enhancer activity and induces luciferase function by 7-, 6-, and 30-fold, respectively, in response to Prep1, Pbx1, or both. CONCLUSIONS: SHP1, a known silencer of insulin signal, is a transcriptional target of Prep1. In liver, transcriptional activation of SHP1 gene by Prep1 attenuates insulin signal transduction and reduces glucose storage.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr6,124718594,124718929</infon><infon key="type">ENHANCER</infon><infon key="identifier">6,124718594,124718929</infon><infon key="gb">unk</infon><location offset="1407" length="35"/><text>fragment features enhancer activity</text></annotation><annotation id="2"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Prep1</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="524" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="696" length="5"/><text>Prep1</text></annotation><annotation id="5"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="770" length="4"/><text>SHP1</text></annotation><annotation id="6"><infon key="identifier">5316</infon><infon key="type">GENE</infon><location offset="798" length="5"/><text>Prep1</text></annotation><annotation id="7"><infon key="identifier">20977</infon><infon key="type">GENE</infon><location offset="852" length="3"/><text>SYP</text></annotation><annotation id="8"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="860" length="4"/><text>SHP1</text></annotation><annotation id="9"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1010" length="5"/><text>Prep1</text></annotation><annotation id="10"><infon key="identifier">18514</infon><infon key="type">GENE</infon><location offset="1024" length="4"/><text>Pbx1</text></annotation><annotation id="11"><infon key="identifier">18432</infon><infon key="type">GENE</infon><location offset="1041" length="7"/><text>p160MBP</text></annotation><annotation id="12"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1059" length="5"/><text>Prep1</text></annotation><annotation id="13"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="89" length="4"/><text>SHP1</text></annotation><annotation id="14"><infon key="identifier">20977</infon><infon key="type">GENE</infon><location offset="1128" length="3"/><text>SYP</text></annotation><annotation id="15"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="1136" length="4"/><text>SHP1</text></annotation><annotation id="16"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1156" length="5"/><text>Prep1</text></annotation><annotation id="17"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="1207" length="4"/><text>SHP1</text></annotation><annotation id="18"><infon key="identifier">20977</infon><infon key="type">GENE</infon><location offset="1229" length="3"/><text>SYP</text></annotation><annotation id="19"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1311" length="5"/><text>Prep1</text></annotation><annotation id="20"><infon key="identifier">18514</infon><infon key="type">GENE</infon><location offset="1321" length="4"/><text>Pbx1</text></annotation><annotation id="21"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1528" length="5"/><text>Prep1</text></annotation><annotation id="22"><infon key="identifier">18514</infon><infon key="type">GENE</infon><location offset="1535" length="4"/><text>Pbx1</text></annotation><annotation id="23"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="1563" length="4"/><text>SHP1</text></annotation><annotation id="24"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="163" length="5"/><text>Prep1</text></annotation><annotation id="25"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1636" length="5"/><text>Prep1</text></annotation><annotation id="26"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="1683" length="4"/><text>SHP1</text></annotation><annotation id="27"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="1696" length="5"/><text>Prep1</text></annotation><annotation id="28"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="51" length="5"/><text>liver</text></annotation><annotation id="29"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="218" length="5"/><text>liver</text></annotation><annotation id="30"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="324" length="5"/><text>liver</text></annotation><annotation id="31"><infon key="identifier">384783</infon><infon key="type">GENE</infon><location offset="664" length="1"/><text>2</text></annotation><annotation id="32"><infon key="identifier">20977</infon><infon key="type">GENE</infon><location offset="762" length="3"/><text>SYP</text></annotation><annotation id="33"><infon key="identifier">0000599</infon><infon key="type">TISSUE</infon><location offset="822" length="17"/><text>HepG2 liver cells</text></annotation><annotation id="34"><infon key="identifier">384783</infon><infon key="type">GENE</infon><location offset="907" length="1"/><text>2</text></annotation><annotation id="35"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="254" length="5"/><text>Prep1</text></annotation><annotation id="36"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="1646" length="5"/><text>liver</text></annotation><annotation id="37"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="707" length="6"/><text>livers</text></annotation><annotation id="38"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="501" length="6"/><text>livers</text></annotation><annotation id="39"><infon key="identifier">16367</infon><infon key="type">GENE</infon><location offset="630" length="33"/><text>insulin receptor substrate (IRS)1</text></annotation><annotation id="40"><infon key="identifier">16367</infon><infon key="type">GENE</infon><location offset="902" length="4"/><text>IRS1</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1331" length="13"/><text>SHP1 promoter</text></annotation><annotation id="42"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr6,124718594,124718929</infon><infon key="type">ENHANCER</infon><infon key="identifier">6,124718594,124718929</infon><infon key="gb">unk</infon><location offset="1350" length="50"/><text>site located between nucleotides -2,113 and -1,778</text></annotation><annotation id="43"><infon key="identifier">15170</infon><infon key="type">GENE</infon><location offset="1331" length="4"/><text>SHP1</text></annotation><annotation id="44"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="333" length="5"/><text>Prep1</text></annotation><annotation id="45"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="351" length="4"/><text>mice</text></annotation><annotation id="46"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="357" length="5"/><text>Prep1</text></annotation><annotation id="47"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="392" length="5"/><text>Prep1</text></annotation><annotation id="48"><infon key="identifier">18771</infon><infon key="type">GENE</infon><location offset="513" length="5"/><text>Prep1</text></annotation></passage></document>
<document><id>20878775</id><passage><offset>0</offset><text>Conserved regulatory motifs in osteogenic gene promoters integrate cooperative effects of canonical Wnt and BMP pathways. Osteoblast differentiation depends on the coordinated network of evolutionary conserved transcription factors during bone formation and homeostasis. Evidence indicates that bone morphogenetic protein (BMP) and Wnt proteins regulate several steps of skeletal development. Here, we provide a molecular description of the cooperative effects of BMP and Wnt canonical pathway on the expression of the early osteogenic genes Dlx5, Msx2, and Runx2 in C2C12 cells, primary cultures of bone marrow-mesenchymal stem cells, and organotypic calvarial cultures. Coordinated regulation of these genes leads to the cooperative activation of their downstream osteogenic target gene osterix. Induction of these genes is mediated through enhancer regions with an evolutionary conserved structure encompassing both Smad and TCF/LEF1 DNA-binding sites. Formation of a cooperative complex is mediated through DNA binding of Smads and TCF4/beta-catenin to their cognate sequences, as well as protein-protein interactions between them. The formation of these cooperative transcriptional complexes results in a more efficient recruitment of coactivators such as p300. We propose that evolutionary conserved regulatory regions in specific osteogenic master genes are key integrative modules during osteogenesis.</text><annotation id="1"><infon key="identifier">121340</infon><infon key="type">GENE</infon><location offset="789" length="7"/><text>osterix</text></annotation><annotation id="2"><infon key="identifier">0003298</infon><infon key="type">TISSUE</infon><location offset="600" length="34"/><text>bone marrow-mesenchymal stem cells</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="919" length="35"/><text>Smad and TCF/LEF1 DNA-binding sites</text></annotation><annotation id="4"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="122" length="10"/><text>Osteoblast</text></annotation><annotation id="5"><infon key="identifier">0001328</infon><infon key="type">TISSUE</infon><location offset="652" length="9"/><text>calvarial</text></annotation><annotation id="6"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="542" length="4"/><text>Dlx5</text></annotation><annotation id="7"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="239" length="4"/><text>bone</text></annotation><annotation id="8"><infon key="identifier">17702</infon><infon key="type">GENE</infon><location offset="548" length="4"/><text>Msx2</text></annotation><annotation id="9"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="558" length="5"/><text>Runx2</text></annotation><annotation id="10"><infon key="identifier">0000165</infon><infon key="type">TISSUE</infon><location offset="567" length="11"/><text>C2C12 cells</text></annotation><annotation id="11"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="1036" length="4"/><text>TCF4</text></annotation><annotation id="12"><infon key="identifier">12387</infon><infon key="type">GENE</infon><location offset="1041" length="12"/><text>beta-catenin</text></annotation><annotation id="13"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="1261" length="4"/><text>p300</text></annotation></passage></document>
<document><id>20952403</id><passage><offset>0</offset><text>Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. Although it is well known that RET gene is strongly activated by retinoic acid (RA) in neuroblastoma cells, the mechanisms underlying such activation are still poorly understood. Here we show that a complex series of molecular events, that include modifications of both chromatin and DNA methylation state, accompany RA-mediated RET activation. Our results indicate that the primary epigenetic determinants of RA-induced RET activation differ between enhancer and promoter regions. At promoter region, the main mark of RET activation was the increase of H3K4me3 levels while no significant changes of the methylation state of H3K27 and H3K9 were observed. At RET enhancer region a bipartite chromatin domain was detected in unstimulated cells and a prompt demethylation of H3K27me3 marked RET gene activation upon RA exposure. Moreover, ChIP experiments demonstrated that EZH2 and MeCP2 repressor complexes were associated to the heavily methylated enhancer region in the absence of RA while both complexes were displaced during RA stimulation. Finally, our data show that a demethylation of a specific CpG site at the enhancer region could favor the displacement of MeCP2 from the heavily methylated RET enhancer region providing a novel potential mechanism for transcriptional regulation of methylated RA-regulated loci.</text><annotation id="1"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="787" length="3"/><text>RET</text></annotation><annotation id="2"><infon key="identifier">0000931</infon><infon key="type">TISSUE</infon><location offset="215" length="19"/><text>neuroblastoma cells</text></annotation><annotation id="3"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="457" length="3"/><text>RET</text></annotation><annotation id="4"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="549" length="3"/><text>RET</text></annotation><annotation id="5"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="647" length="3"/><text>RET</text></annotation><annotation id="6"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="1329" length="3"/><text>RET</text></annotation><annotation id="7"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="917" length="3"/><text>RET</text></annotation><annotation id="8"><infon key="identifier">2146</infon><infon key="type">GENE</infon><location offset="1000" length="4"/><text>EZH2</text></annotation><annotation id="9"><infon key="identifier">4204</infon><infon key="type">GENE</infon><location offset="1009" length="5"/><text>MeCP2</text></annotation><annotation id="10"><infon key="identifier">4204</infon><infon key="type">GENE</infon><location offset="1295" length="5"/><text>MeCP2</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="613" length="15"/><text>promoter region</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="787" length="19"/><text>RET enhancer region</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1077" length="15"/><text>enhancer region</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1247" length="15"/><text>enhancer region</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1329" length="19"/><text>RET enhancer region</text></annotation><annotation id="16"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="68" length="3"/><text>RET</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0000931</infon><infon key="type">TISSUE</infon><location offset="107" length="19"/><text>neuroblastoma cells</text></annotation><annotation id="18"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="159" length="3"/><text>RET</text></annotation></passage></document>
<document><id>20952659</id><passage><offset>0</offset><text>Opioid-induced chemokine expression requires NF-kappaB activity: the role of PKCzeta. Opioid receptor agonists induce broad immunomodulatory activity, which substantially alters host defense and the inflammatory response. Previous studies have shown that the MOR selective agonist DAMGO has the capacity to increase the expression of the proinflammatory chemokines CCL2, CCL5, and CXCL10 in human PBMCs. NF-kappaB is a transcription factor that plays a pivotal role in innate and adaptive immune responses. We report that NF-kappaB is a vital player in the DAMGO-induced, MOR-mediated regulation of chemokine expression. Results show that NF-kappaB inhibitors prevent the induction of CCL2 expression in response to DAMGO administration and that the NF-kappaB subunit, p65, is phosphorylated at serine residues 311 and 536 in response to MOR activation. Furthermore, we demonstrate that PKCzeta is phosphorylated following DAMGO-induced MOR activation, and this kinase is essential for NF-kappaB activation as well as CCL2 expression and transcriptional activity. Finally, ChIP analysis shows that DAMGO administration induces binding of p65 to the enhancer region of the CCL2 promoter. These data are consistent with the notion that MOR activation promotes a proinflammatory response, which involves NF-kappaB activation. Our results also suggest a significant and novel role for PKCzeta as an essential participant in the MOR-mediated regulation of proinflammatory chemokine expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1149" length="36"/><text>enhancer region of the CCL2 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1172" length="13"/><text>CCL2 promoter</text></annotation><annotation id="3"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="769" length="3"/><text>p65</text></annotation><annotation id="4"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="838" length="3"/><text>MOR</text></annotation><annotation id="5"><infon key="identifier">5590</infon><infon key="type">GENE</infon><location offset="887" length="7"/><text>PKCzeta</text></annotation><annotation id="6"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="937" length="3"/><text>MOR</text></annotation><annotation id="7"><infon key="identifier">6347</infon><infon key="type">GENE</infon><location offset="1018" length="4"/><text>CCL2</text></annotation><annotation id="8"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1138" length="3"/><text>p65</text></annotation><annotation id="9"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="750" length="9"/><text>NF-kappaB</text></annotation><annotation id="10"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="1234" length="3"/><text>MOR</text></annotation><annotation id="11"><infon key="identifier">5590</infon><infon key="type">GENE</infon><location offset="1381" length="7"/><text>PKCzeta</text></annotation><annotation id="12"><infon key="identifier">6347</infon><infon key="type">GENE</infon><location offset="1172" length="4"/><text>CCL2</text></annotation><annotation id="13"><infon key="identifier">5590</infon><infon key="type">GENE</infon><location offset="77" length="7"/><text>PKCzeta</text></annotation><annotation id="14"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="1424" length="3"/><text>MOR</text></annotation><annotation id="15"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="986" length="9"/><text>NF-kappaB</text></annotation><annotation id="16"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="404" length="9"/><text>NF-kappaB</text></annotation><annotation id="17"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="45" length="9"/><text>NF-kappaB</text></annotation><annotation id="18"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="522" length="9"/><text>NF-kappaB</text></annotation><annotation id="19"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="639" length="9"/><text>NF-kappaB</text></annotation><annotation id="20"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1301" length="9"/><text>NF-kappaB</text></annotation><annotation id="21"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="259" length="3"/><text>MOR</text></annotation><annotation id="22"><infon key="identifier">6347</infon><infon key="type">GENE</infon><location offset="365" length="4"/><text>CCL2</text></annotation><annotation id="23"><infon key="identifier">6352</infon><infon key="type">GENE</infon><location offset="371" length="4"/><text>CCL5</text></annotation><annotation id="24"><infon key="identifier">3627</infon><infon key="type">GENE</infon><location offset="381" length="6"/><text>CXCL10</text></annotation><annotation id="25"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="391" length="5"/><text>human</text></annotation><annotation id="26"><infon key="identifier">4988</infon><infon key="type">GENE</infon><location offset="572" length="3"/><text>MOR</text></annotation><annotation id="27"><infon key="identifier">6347</infon><infon key="type">GENE</infon><location offset="685" length="4"/><text>CCL2</text></annotation></passage></document>
<document><id>21051589</id><passage><offset>0</offset><text>Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells. Interleukin-6 (IL-6) is involved in regulation of cell growth and survival of prostate carcinoma cells. Previous studies suggest that IL-6 promotes prostate cancer progression through the induction of an androgen-independent response. In this study, we evaluated the mechanisms by which IL-6 regulates the gene expression of prostate-specific antigen (PSA) in human prostate LNCaP carcinoma cells. (3)H-thymidine incorporation assays revealed that IL-6 treatment inhibited the proliferation of LNCaP cells. Results of enzyme-linked immunosorbent assay (ELISA) and immunoblot assays indicated that IL-6 treatment enhanced PSA gene expression. Similar results were found in LNCaP cells that had been engineered to stably overexpress IL-6. Although forced overexpression of c-Myc-associated zinc finger protein (MAZ) induced PSA promoter activity, mutation of the MAZ response elements had little effect on IL-6-induced PSA promoter activity. Results from 5'-deletion reporter assays revealed that the effects of IL-6 appear to be mediated via an androgen enhancer region (24801 to 23933), which is dependent on the signal transducer and activator of the transcription 3 (STAT3) pathway, and a region located at 2193 to 241 base pairs upstream of the translational initiation site of the human PSA gene, which did not respond to androgen or STAT3. Results of reporter assays, immunoblot assays, and ELISA revealed that the heat shock protein 90 (Hsp90) inhibitors 17-allyamino-17-demethoxygeldanamycin and geldanamycin blocked IL-6-induced PSA gene expression. Those results suggest that IL-6 upregulates PSA gene expression and that Hsp90 plays a novel role in the activation of IL-6 on PSA gene expression in an androgen-independent manner.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="943" length="12"/><text>PSA promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1038" length="12"/><text>PSA promoter</text></annotation><annotation id="3"><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="269" length="15"/><text>prostate cancer</text></annotation><annotation id="4"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="408" length="4"/><text>IL-6</text></annotation><annotation id="5"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="446" length="25"/><text>prostate-specific antigen</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="481" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0001321</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="487" length="30"/><text>prostate LNCaP carcinoma cells</text></annotation><annotation id="8"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="569" length="4"/><text>IL-6</text></annotation><annotation id="9"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="718" length="4"/><text>IL-6</text></annotation><annotation id="10"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="742" length="3"/><text>PSA</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="793" length="11"/><text>LNCaP cells</text></annotation><annotation id="12"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="852" length="4"/><text>IL-6</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1174" length="32"/><text>enhancer region (24801 to 23933)</text></annotation><annotation id="14"><infon key="identifier">4150</infon><infon key="type">GENE</infon><location offset="930" length="3"/><text>MAZ</text></annotation><annotation id="15"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1234" length="54"/><text>signal transducer and activator of the transcription 3</text></annotation><annotation id="16"><infon key="identifier">4150</infon><infon key="type">GENE</infon><location offset="982" length="3"/><text>MAZ</text></annotation><annotation id="17"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1025" length="4"/><text>IL-6</text></annotation><annotation id="18"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="473" length="3"/><text>PSA</text></annotation><annotation id="19"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1131" length="4"/><text>IL-6</text></annotation><annotation id="20"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1290" length="5"/><text>STAT3</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1406" length="5"/><text>human</text></annotation><annotation id="22"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1412" length="3"/><text>PSA</text></annotation><annotation id="23"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1459" length="5"/><text>STAT3</text></annotation><annotation id="24"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="20" length="13"/><text>interleukin-6</text></annotation><annotation id="25"><infon key="identifier">3320</infon><infon key="type">GENE</infon><location offset="1541" length="21"/><text>heat shock protein 90</text></annotation><annotation id="26"><infon key="identifier">3320</infon><infon key="type">GENE</infon><location offset="1564" length="5"/><text>Hsp90</text></annotation><annotation id="27"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1645" length="4"/><text>IL-6</text></annotation><annotation id="28"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1658" length="3"/><text>PSA</text></annotation><annotation id="29"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1706" length="4"/><text>IL-6</text></annotation><annotation id="30"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1723" length="3"/><text>PSA</text></annotation><annotation id="31"><infon key="identifier">3320</infon><infon key="type">GENE</infon><location offset="1752" length="5"/><text>Hsp90</text></annotation><annotation id="32"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1798" length="4"/><text>IL-6</text></annotation><annotation id="33"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1806" length="3"/><text>PSA</text></annotation><annotation id="34"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="892" length="5"/><text>c-Myc</text></annotation><annotation id="35"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="44" length="25"/><text>prostate-specific antigen</text></annotation><annotation id="36"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="615" length="11"/><text>LNCaP cells</text></annotation><annotation id="37"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="943" length="3"/><text>PSA</text></annotation><annotation id="38"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1038" length="3"/><text>PSA</text></annotation><annotation id="39"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="89" length="30"/><text>prostate LNCaP carcinoma cells</text></annotation><annotation id="40"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="121" length="13"/><text>Interleukin-6</text></annotation><annotation id="41"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="136" length="4"/><text>IL-6</text></annotation><annotation id="42"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="199" length="24"/><text>prostate carcinoma cells</text></annotation><annotation id="43"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="255" length="4"/><text>IL-6</text></annotation></passage></document>
<document><id>21056086</id><passage><offset>0</offset><text>Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription. Bone morphogenetic protein 2 (BMP2) stimulates expression of the inhibitors of DNA binding (Id) 1, 2, and 3 in a variety of cell types. Here, we examined mechanisms mediating BMP2-stimulated Id3 transcription in murine gonadotropes. Using a combination of quantitative RT-PCR, promoter-reporter analyses, over-expression, and RNA interference approaches, we demonstrate that BMP2 signals via the BMPR2 and BMPR1A (ALK3) receptors and intracellular signaling proteins SMADs 1 and 5 to stimulate Id3 transcription. We further define a novel 6-bp cis-element mediating BMP2- and SMAD-dependent transcription, though this site does not appear to bind SMADs directly. A specific DNA binding protein complex binds to this element, but its constituent protein(s) remain undetermined. Recently, a more distal enhancer was shown to mediate BMP4-induction of the human ID3 gene in ovarian cancer cells. This enhancer is conserved in the murine gene and we demonstrate its role in BMP2-induced Id3 promoter activity in gonadotropes. Conversely, the proximal cis-element defined here is also conserved in human ID3 and we demonstrate its functional role in BMP2-induction of ID3 transcription. Finally, we show that the two regulatory elements also mediate BMP2-induction of Id3 promoter activity in murine fibroblasts. Collectively, we have defined a general mechanism whereby BMP2 regulates Id3/ID3 transcription in different cell types and in different species.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="903" length="15"/><text>distal enhancer</text></annotation><annotation id="2"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="139" length="4"/><text>BMP2</text></annotation><annotation id="3"><infon key="identifier">3397</infon><infon key="type">GENE</infon><location offset="174" length="32"/><text>inhibitors of DNA binding (Id) 1</text></annotation><annotation id="4"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="284" length="4"/><text>BMP2</text></annotation><annotation id="5"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="300" length="3"/><text>Id3</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="321" length="6"/><text>murine</text></annotation><annotation id="7"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="484" length="4"/><text>BMP2</text></annotation><annotation id="8"><infon key="identifier">12168</infon><infon key="type">GENE</infon><location offset="505" length="5"/><text>BMPR2</text></annotation><annotation id="9"><infon key="identifier">12166</infon><infon key="type">GENE</infon><location offset="515" length="6"/><text>BMPR1A</text></annotation><annotation id="10"><infon key="identifier">12166</infon><infon key="type">GENE</infon><location offset="523" length="4"/><text>ALK3</text></annotation><annotation id="11"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="576" length="7"/><text>SMADs 1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1007" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="603" length="3"/><text>Id3</text></annotation><annotation id="14"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="1092" length="3"/><text>Id3</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="980" length="20"/><text>ovarian cancer cells</text></annotation><annotation id="16"><infon key="identifier">652</infon><infon key="type">GENE</infon><location offset="940" length="4"/><text>BMP4</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="962" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="968" length="3"/><text>ID3</text></annotation><annotation id="19"><infon key="identifier">0002482</infon><infon key="type">TISSUE</infon><location offset="1117" length="12"/><text>gonadotropes</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1036" length="6"/><text>murine</text></annotation><annotation id="21"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="1079" length="4"/><text>BMP2</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1147" length="20"/><text>proximal cis-element</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1092" length="12"/><text>Id3 promoter</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1202" length="5"/><text>human</text></annotation><annotation id="25"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="1208" length="3"/><text>ID3</text></annotation><annotation id="26"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="1254" length="4"/><text>BMP2</text></annotation><annotation id="27"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="1272" length="3"/><text>ID3</text></annotation><annotation id="28"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="1354" length="4"/><text>BMP2</text></annotation><annotation id="29"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="1404" length="11"/><text>fibroblasts</text></annotation><annotation id="30"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1397" length="6"/><text>murine</text></annotation><annotation id="31"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="1475" length="4"/><text>BMP2</text></annotation><annotation id="32"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="1490" length="3"/><text>Id3</text></annotation><annotation id="33"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="1494" length="3"/><text>ID3</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1372" length="12"/><text>Id3 promoter</text></annotation><annotation id="35"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="1372" length="3"/><text>Id3</text></annotation><annotation id="36"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="675" length="4"/><text>BMP2</text></annotation><annotation id="37"><infon key="identifier">3398</infon><infon key="type">GENE</infon><location offset="208" length="1"/><text>2</text></annotation><annotation id="38"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="215" length="1"/><text>3</text></annotation><annotation id="39"><infon key="identifier">0002482</infon><infon key="type">TISSUE</infon><location offset="328" length="12"/><text>gonadotropes</text></annotation><annotation id="40"><infon key="identifier">17129</infon><infon key="type">GENE</infon><location offset="588" length="1"/><text>5</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="648" length="65"/><text>6-bp cis-element mediating BMP2- and SMAD-dependent transcription</text></annotation><annotation id="42"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="14" length="28"/><text>bone morphogenetic protein 2</text></annotation><annotation id="43"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="44" length="4"/><text>BMP2</text></annotation><annotation id="44"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="61" length="26"/><text>inhibitor of DNA binding 3</text></annotation><annotation id="45"><infon key="identifier">15903</infon><infon key="type">GENE</infon><location offset="89" length="3"/><text>Id3</text></annotation><annotation id="46"><infon key="identifier">650</infon><infon key="type">GENE</infon><location offset="109" length="28"/><text>Bone morphogenetic protein 2</text></annotation></passage></document>
<document><id>21087445</id><passage><offset>0</offset><text>Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin. The aim of this study was to determine the genetic regulation of macrophage migration inhibitory factor (MIF). DNase I hypersensitivity was used to identify potential hypersensitive sites (HS) across the MIF gene locus. Reporter gene assays were performed in different human cell lines with constructs containing the native or mutated HS element. Following phylogenetic and transcription factor binding profiling, electrophoretic mobility shift assay (EMSA) and RNA interference were performed and the effects of incubation with mithramycin, an antibiotic that binds GC boxes, were also studied. An HS centred on the first intron of MIF was identified. The HS acted as an enhancer in human T lymphoblasts (CEMC7A), human embryonic kidney cells (HEK293T) and human monocytic cells (THP-1), but not in a fibroblast-like synoviocyte (FLS) cell line (SW982) or cultured FLS derived from rheumatoid arthritis (RA) patients. Two cis-elements within the first intron were found to be responsible for the enhancer activity. Mutation of the consensus Sp1 GC box on each cis-element abrogated enhancer activity and EMSA indicated Sp1 binding to one of the cis-elements contained in the intron. SiRNA knock-down of Sp1 alone or Sp1 and Sp3 together was incomplete and did not alter the enhancer activity. Mithramycin inhibited expression of MIF in CEMC7A cells. This effect was specific to the intronic enhancer and was not seen on the MIF promoter. These results identify a novel, cell type-specific enhancer of MIF. The enhancer appears to be driven by Sp1 or related Sp family members and is highly sensitive to inhibition via mithramycin.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="26" length="78"/><text>cell type-specific intronic enhancer of macrophage migration inhibitory factor</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1065" length="40"/><text>Two cis-elements within the first intron</text></annotation><annotation id="3"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="106" length="3"/><text>MIF</text></annotation><annotation id="4"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="211" length="38"/><text>macrophage migration inhibitory factor</text></annotation><annotation id="5"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="251" length="3"/><text>MIF</text></annotation><annotation id="6"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="350" length="3"/><text>MIF</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="415" length="5"/><text>human</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="803" length="2"/><text>HS</text></annotation><annotation id="9"><infon key="type">TISSUE</infon><location offset="852" length="6"/><text>CEMC7A</text></annotation><annotation id="10"><infon key="identifier">0002181</infon><infon key="type">TISSUE</infon><location offset="861" length="28"/><text>human embryonic kidney cells</text></annotation><annotation id="11"><infon key="identifier">0001370</infon><infon key="type">TISSUE</infon><location offset="904" length="21"/><text>human monocytic cells</text></annotation><annotation id="12"><infon key="identifier">0001370</infon><infon key="type">TISSUE</infon><location offset="927" length="5"/><text>THP-1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1178" length="20"/><text>consensus Sp1 GC box</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1281" length="47"/><text>one of the cis-elements contained in the intron</text></annotation><annotation id="15"><infon key="identifier">6670</infon><infon key="type">GENE</infon><location offset="1371" length="3"/><text>Sp3</text></annotation><annotation id="16"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="1476" length="3"/><text>MIF</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1207" length="11"/><text>cis-element</text></annotation><annotation id="18"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="1648" length="3"/><text>MIF</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="713" length="9"/><text>GC boxes,</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="830" length="20"/><text>human T lymphoblasts</text></annotation><annotation id="21"><infon key="identifier">0002181</infon><infon key="type">TISSUE</infon><location offset="891" length="7"/><text>HEK293T</text></annotation><annotation id="22"><infon key="identifier">0006386</infon><infon key="type">TISSUE</infon><location offset="948" length="43"/><text>fibroblast-like synoviocyte (FLS) cell line</text></annotation><annotation id="23"><infon key="identifier">0006386</infon><infon key="type">TISSUE</infon><location offset="993" length="5"/><text>SW982</text></annotation><annotation id="24"><infon key="identifier">6667</infon><infon key="type">GENE</infon><location offset="1266" length="3"/><text>Sp1</text></annotation><annotation id="25"><infon key="type">TISSUE</infon><location offset="1003" length="60"/><text>cultured FLS derived from rheumatoid arthritis (RA) patients</text></annotation><annotation id="26"><infon key="identifier">6667</infon><infon key="type">GENE</infon><location offset="1350" length="3"/><text>Sp1</text></annotation><annotation id="27"><infon key="identifier">6667</infon><infon key="type">GENE</infon><location offset="1363" length="3"/><text>Sp1</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1529" length="17"/><text>intronic enhancer</text></annotation><annotation id="29"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="66" length="38"/><text>macrophage migration inhibitory factor</text></annotation><annotation id="30"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="779" length="3"/><text>MIF</text></annotation><annotation id="31"><infon key="identifier">4282</infon><infon key="type">GENE</infon><location offset="1571" length="3"/><text>MIF</text></annotation><annotation id="32"><infon key="identifier">6667</infon><infon key="type">GENE</infon><location offset="1188" length="3"/><text>Sp1</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="1483" length="6"/><text>CEMC7A</text></annotation><annotation id="34"><infon key="identifier">6667</infon><infon key="type">GENE</infon><location offset="1690" length="3"/><text>Sp1</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1571" length="12"/><text>MIF promoter</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1617" length="34"/><text>cell type-specific enhancer of MIF</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1657" length="8"/><text>enhancer</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="745" length="37"/><text>HS centred on the first intron of MIF</text></annotation></passage></document>
<document><id>21185279</id><passage><offset>0</offset><text>The Pou5f1/Pou3f-dependent but SoxB-independent regulation of conserved enhancer N2 initiates Sox2 expression during epiblast to neural plate stages in vertebrates. The transcription factor Sox2 is a core component of the pluripotency control circuits in the early embryo, and later controls many aspects of neural development. Here, we demonstrate that Sox2 expression in the epiblast (mouse blastoderm) and anterior neural plate (ANP) is determined by the upstream enhancer N2. The mouse enhancer N2 exhibits strong activity in mouse ES cells, epiblast and ANP, and is regulated correctly in chicken and zebrafish embryos. Targeted deletion of this enhancer in mouse embryos caused a large reduction of Sox2 expression to 10% of that of wild-type levels in epiblast and ANP. However, this was tolerated by mouse embryo, probably due to functional compensation by Sox3. The activity of enhancer N2 depends on phylogenetically conserved bipartite POU factor-binding motifs in a 73-bp core sequence that function synergistically, but this activation does not involve Sox2. The major POU factor expressed at the epiblastic stage is Pou5f1 (Oct3/4), while those in the anterior neural plate are Pou3f factors (Oct6, Brn2 etc.). These factors are gradually exchanged during the transition from epiblast to ANP stages in mouse embryos and epiblast stem cells (EpiSC). Consistently, enhancer N2 activity changes from full Pou5f1 dependence to Pou3f dependence during the development of neural plate cells (NPC) from EpiSC, as assessed by specific POU factor knockdown in these cells. Zebrafish mutant embryos completely devoid of Pou5f1 activity failed to activate enhancer N2 and to express Sox2 in the blastoderm and ANP, and these defects were rescued by exogenous supply of pou5f1. Previously, Pou5f1-Sox2 synergism-dependent Sox2 activation through enhancer SRR2 in ES cells has been highlighted, but this mechanism is limited to ES cells and amniotes. In contrast, the enhancer N2-mediated, POU factor-dependent activation of Sox2, without involvement of Sox2, is a phylogenetically conserved core mechanism that functions in gene regulatory networks at early embryonic stages.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="651" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="4" length="6"/><text>Pou5f1</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="663" length="5"/><text>mouse</text></annotation><annotation id="4"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="705" length="4"/><text>Sox2</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="808" length="5"/><text>mouse</text></annotation><annotation id="6"><infon key="identifier">20675</infon><infon key="type">GENE</infon><location offset="865" length="4"/><text>Sox3</text></annotation><annotation id="7"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1066" length="4"/><text>Sox2</text></annotation><annotation id="8"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1130" length="6"/><text>Pou5f1</text></annotation><annotation id="9"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1138" length="6"/><text>Oct3/4</text></annotation><annotation id="10"><infon key="identifier">18991</infon><infon key="type">GENE</infon><location offset="1207" length="4"/><text>Oct6</text></annotation><annotation id="11"><infon key="identifier">18992</infon><infon key="type">GENE</infon><location offset="1213" length="4"/><text>Brn2</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1316" length="5"/><text>mouse</text></annotation><annotation id="13"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="94" length="4"/><text>Sox2</text></annotation><annotation id="14"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1416" length="6"/><text>Pou5f1</text></annotation><annotation id="15"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1578" length="9"/><text>Zebrafish</text></annotation><annotation id="16"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1624" length="6"/><text>Pou5f1</text></annotation><annotation id="17"><infon key="identifier">378723</infon><infon key="type">GENE</infon><location offset="1686" length="4"/><text>Sox2</text></annotation><annotation id="18"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1772" length="6"/><text>pou5f1</text></annotation><annotation id="19"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="1792" length="6"/><text>Pou5f1</text></annotation><annotation id="20"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1799" length="4"/><text>Sox2</text></annotation><annotation id="21"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1824" length="4"/><text>Sox2</text></annotation><annotation id="22"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="2026" length="4"/><text>Sox2</text></annotation><annotation id="23"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="2055" length="4"/><text>Sox2</text></annotation><annotation id="24"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="190" length="4"/><text>Sox2</text></annotation><annotation id="25"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="117" length="8"/><text>epiblast</text></annotation><annotation id="26"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="129" length="12"/><text>neural plate</text></annotation><annotation id="27"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="377" length="8"/><text>epiblast</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="393" length="10"/><text>blastoderm</text></annotation><annotation id="29"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="409" length="21"/><text>anterior neural plate</text></annotation><annotation id="30"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="432" length="3"/><text>ANP</text></annotation><annotation id="31"><infon key="type">TISSUE</infon><location offset="536" length="8"/><text>ES cells</text></annotation><annotation id="32"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="546" length="8"/><text>epiblast</text></annotation><annotation id="33"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="559" length="3"/><text>ANP</text></annotation><annotation id="34"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="759" length="8"/><text>epiblast</text></annotation><annotation id="35"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="354" length="4"/><text>Sox2</text></annotation><annotation id="36"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="772" length="3"/><text>ANP</text></annotation><annotation id="37"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="1166" length="21"/><text>anterior neural plate</text></annotation><annotation id="38"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="1290" length="8"/><text>epiblast</text></annotation><annotation id="39"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="1302" length="3"/><text>ANP</text></annotation><annotation id="40"><infon key="type">TISSUE</infon><location offset="1334" length="19"/><text>epiblast stem cells</text></annotation><annotation id="41"><infon key="type">TISSUE</infon><location offset="1355" length="5"/><text>EpiSC</text></annotation><annotation id="42"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="1480" length="18"/><text>neural plate cells</text></annotation><annotation id="43"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="1500" length="3"/><text>NPC</text></annotation><annotation id="44"><infon key="type">TISSUE</infon><location offset="1510" length="5"/><text>EpiSC</text></annotation><annotation id="45"><infon key="type">TISSUE</infon><location offset="1698" length="10"/><text>blastoderm</text></annotation><annotation id="46"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="387" length="5"/><text>mouse</text></annotation><annotation id="47"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="1713" length="3"/><text>ANP</text></annotation><annotation id="48"><infon key="type">TISSUE</infon><location offset="1865" length="8"/><text>ES cells</text></annotation><annotation id="49"><infon key="type">TISSUE</infon><location offset="1929" length="8"/><text>ES cells</text></annotation><annotation id="50"><infon key="identifier">7742</infon><infon key="type">SPECIES</infon><location offset="152" length="11"/><text>vertebrates</text></annotation><annotation id="51"><infon key="type">TISSUE</infon><location offset="1942" length="8"/><text>amniotes</text></annotation><annotation id="52"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="72" length="11"/><text>enhancer N2</text></annotation><annotation id="53"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="616" length="7"/><text>embryos</text></annotation><annotation id="54"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="458" length="20"/><text>upstream enhancer N2</text></annotation><annotation id="55"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="490" length="11"/><text>enhancer N2</text></annotation><annotation id="56"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="887" length="11"/><text>enhancer N2</text></annotation><annotation id="57"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="484" length="5"/><text>mouse</text></annotation><annotation id="58"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="1377" length="11"/><text>enhancer N2</text></annotation><annotation id="59"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="1659" length="11"/><text>enhancer N2</text></annotation><annotation id="60"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1848" length="13"/><text>enhancer SRR2</text></annotation><annotation id="61"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,34645597,34646134</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,34645597,34646134</infon><infon key="gb">unk</infon><location offset="1969" length="11"/><text>enhancer N2</text></annotation><annotation id="62"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="669" length="7"/><text>embryos</text></annotation><annotation id="63"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1595" length="7"/><text>embryos</text></annotation><annotation id="64"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1322" length="7"/><text>embryos</text></annotation><annotation id="65"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="530" length="5"/><text>mouse</text></annotation><annotation id="66"><infon key="identifier">9031</infon><infon key="type">SPECIES</infon><location offset="594" length="7"/><text>chicken</text></annotation><annotation id="67"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="606" length="9"/><text>zebrafish</text></annotation></passage></document>
<document><id>21310710</id><passage><offset>0</offset><text>The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR. The 279-bp major breakpoint region (mbr) within the 3'-untranslated region (3'-UTR) of the BCL2 gene is a binding site of special AT-rich sequence binding protein 1 (SATB1) that is well known to participate in the long-range regulation of gene transcription. Our previous studies have revealed that the mbr could regulate BCL2 transcription over a 200-kb distance and this regulatory function was closely related to SATB1. This study is to explore the underlying mechanism and its relevance to cellular apoptosis. With chromosome conformation capture (3C) and chromatin immunoprecipitation (ChIP) assays we demonstrated that the mbr could physically interact with BCL2 promoter through SATB1-mediated chromatin looping, which was required for epigenetic modifications of the promoter, CREB accessibility and high expression of the BCL2 gene. During early apoptosis, SATB1 was a key regulator of BCL2 expression. Inhibition of SATB1 cleavage by treatment of cells with a caspase-6 inhibitor or overexpression of mutant SATB1 that was resistant to caspase-6, inhibited disassembly of the SATB1-mediated chromatin loop and restored the BCL2 mRNA level in Jurkat cells. These data revealed a novel mechanism of BCL2 regulation and mechanistically link SATB1-mediated long-range interaction with the regulation of a gene controlling apoptosis pathway for the first time.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr18,60786011,60788011</infon><infon key="type">PROMOTER</infon><infon key="identifier">18,60786011,60788011</infon><infon key="gb">unk</infon><location offset="131" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr18,60786011,60788011</infon><infon key="type">PROMOTER</infon><infon key="identifier">18,60786011,60788011</infon><infon key="gb">unk</infon><location offset="965" length="8"/><text>promoter</text></annotation><annotation id="3"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="1021" length="4"/><text>BCL2</text></annotation><annotation id="4"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1056" length="5"/><text>SATB1</text></annotation><annotation id="5"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="1085" length="4"/><text>BCL2</text></annotation><annotation id="6"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1116" length="5"/><text>SATB1</text></annotation><annotation id="7"><infon key="identifier">839</infon><infon key="type">GENE</infon><location offset="1160" length="9"/><text>caspase-6</text></annotation><annotation id="8"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1208" length="5"/><text>SATB1</text></annotation><annotation id="9"><infon key="identifier">839</infon><infon key="type">GENE</infon><location offset="1236" length="9"/><text>caspase-6</text></annotation><annotation id="10"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1276" length="5"/><text>SATB1</text></annotation><annotation id="11"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="1323" length="4"/><text>BCL2</text></annotation><annotation id="12"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="1397" length="4"/><text>BCL2</text></annotation><annotation id="13"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="4" length="4"/><text>BCL2</text></annotation><annotation id="14"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="1438" length="5"/><text>SATB1</text></annotation><annotation id="15"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="32" length="42"/><text>special AT-rich sequence binding protein 1</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="1342" length="12"/><text>Jurkat cells</text></annotation><annotation id="17"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr18,60786011,60788011</infon><infon key="type">PROMOTER</infon><infon key="identifier">18,60786011,60788011</infon><infon key="gb">unk</infon><location offset="854" length="13"/><text>BCL2 promoter</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="194" length="160"/><text>279-bp major breakpoint region (mbr) within the 3'-untranslated region (3'-UTR) of the BCL2 gene is a binding site of special AT-rich sequence binding protein 1</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="819" length="3"/><text>mbr</text></annotation><annotation id="20"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="281" length="4"/><text>BCL2</text></annotation><annotation id="21"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="312" length="42"/><text>special AT-rich sequence binding protein 1</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="493" length="3"/><text>mbr</text></annotation><annotation id="23"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="854" length="4"/><text>BCL2</text></annotation><annotation id="24"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="356" length="5"/><text>SATB1</text></annotation><annotation id="25"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="512" length="4"/><text>BCL2</text></annotation><annotation id="26"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="606" length="5"/><text>SATB1</text></annotation><annotation id="27"><infon key="identifier">6304</infon><infon key="type">GENE</infon><location offset="876" length="5"/><text>SATB1</text></annotation><annotation id="28"><infon key="identifier">1385</infon><infon key="type">GENE</infon><location offset="975" length="4"/><text>CREB</text></annotation></passage></document>
<document><id>21331042</id><passage><offset>0</offset><text>Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells. The classical view of neural plate development held that it arises from the ectoderm, after its separation from the mesodermal and endodermal lineages. However, recent cell-lineage-tracing experiments indicate that the caudal neural plate and paraxial mesoderm are generated from common bipotential axial stem cells originating from the caudal lateral epiblast. Tbx6 null mutant mouse embryos which produce ectopic neural tubes at the expense of paraxial mesoderm must provide a clue to the regulatory mechanism underlying this neural versus mesodermal fate choice. Here we demonstrate that Tbx6-dependent regulation of Sox2 determines the fate of axial stem cells. In wild-type embryos, enhancer N1 of the neural primordial gene Sox2 is activated in the caudal lateral epiblast, and the cells staying in the superficial layer sustain N1 activity and activate Sox2 expression in the neural plate. In contrast, the cells destined to become mesoderm activate Tbx6 and turn off enhancer N1 before migrating into the paraxial mesoderm compartment. In Tbx6 mutant embryos, however, enhancer N1 activity persists in the paraxial mesoderm compartment, eliciting ectopic Sox2 activation and transforming the paraxial mesoderm into neural tubes. An enhancer-N1-specific deletion mutation introduced into Tbx6 mutant embryos prevented this Sox2 activation in the mesodermal compartment and subsequent development of ectopic neural tubes, indicating that Tbx6 regulates Sox2 via enhancer N1. Tbx6-dependent repression of Wnt3a in the paraxial mesodermal compartment is implicated in this regulatory process. Paraxial mesoderm-specific misexpression of a Sox2 transgene in wild-type embryos resulted in ectopic neural tube development. Thus, Tbx6 represses Sox2 by inactivating enhancer N1 to inhibit neural development, and this is an essential step for the specification of paraxial mesoderm from the axial stem cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="777" length="11"/><text>enhancer N1</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1064" length="11"/><text>enhancer N1</text></annotation><annotation id="3"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="680" length="4"/><text>Tbx6</text></annotation><annotation id="4"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="709" length="4"/><text>Sox2</text></annotation><annotation id="5"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="819" length="4"/><text>Sox2</text></annotation><annotation id="6"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="949" length="4"/><text>Sox2</text></annotation><annotation id="7"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1046" length="4"/><text>Tbx6</text></annotation><annotation id="8"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1136" length="4"/><text>Tbx6</text></annotation><annotation id="9"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1252" length="4"/><text>Sox2</text></annotation><annotation id="10"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1384" length="4"/><text>Tbx6</text></annotation><annotation id="11"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1419" length="4"/><text>Sox2</text></annotation><annotation id="12"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1533" length="4"/><text>Tbx6</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1166" length="11"/><text>enhancer N1</text></annotation><annotation id="14"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1548" length="4"/><text>Sox2</text></annotation><annotation id="15"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1570" length="4"/><text>Tbx6</text></annotation><annotation id="16"><infon key="identifier">22416</infon><infon key="type">GENE</infon><location offset="1599" length="5"/><text>Wnt3a</text></annotation><annotation id="17"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1732" length="4"/><text>Sox2</text></annotation><annotation id="18"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="1819" length="4"/><text>Tbx6</text></annotation><annotation id="19"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1834" length="4"/><text>Sox2</text></annotation><annotation id="20"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1212" length="8"/><text>mesoderm</text></annotation><annotation id="21"><infon key="type">TISSUE</infon><location offset="71" length="16"/><text>axial stem cells</text></annotation><annotation id="22"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="768" length="7"/><text>embryos</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1329" length="11"/><text>enhancer-N1</text></annotation><annotation id="24"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="111" length="12"/><text>neural plate</text></annotation><annotation id="25"><infon key="identifier">0000315</infon><infon key="type">TISSUE</infon><location offset="165" length="8"/><text>ectoderm</text></annotation><annotation id="26"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="315" length="12"/><text>neural plate</text></annotation><annotation id="27"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="341" length="8"/><text>mesoderm</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="388" length="16"/><text>axial stem cells</text></annotation><annotation id="29"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="441" length="8"/><text>epiblast</text></annotation><annotation id="30"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="474" length="7"/><text>embryos</text></annotation><annotation id="31"><infon key="identifier">0001057</infon><infon key="type">TISSUE</infon><location offset="504" length="12"/><text>neural tubes</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1557" length="11"/><text>enhancer N1</text></annotation><annotation id="33"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="544" length="8"/><text>mesoderm</text></annotation><annotation id="34"><infon key="type">TISSUE</infon><location offset="737" length="16"/><text>axial stem cells</text></annotation><annotation id="35"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="859" length="8"/><text>epiblast</text></annotation><annotation id="36"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1028" length="8"/><text>mesoderm</text></annotation><annotation id="37"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1111" length="8"/><text>mesoderm</text></annotation><annotation id="38"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1148" length="7"/><text>embryos</text></annotation><annotation id="39"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1298" length="8"/><text>mesoderm</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1855" length="11"/><text>enhancer N1</text></annotation><annotation id="41"><infon key="identifier">0001057</infon><infon key="type">TISSUE</infon><location offset="1312" length="12"/><text>neural tubes</text></annotation><annotation id="42"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1396" length="7"/><text>embryos</text></annotation><annotation id="43"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1442" length="22"/><text>mesodermal compartment</text></annotation><annotation id="44"><infon key="identifier">0001057</infon><infon key="type">TISSUE</infon><location offset="1503" length="12"/><text>neural tubes</text></annotation><annotation id="45"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1621" length="22"/><text>mesodermal compartment</text></annotation><annotation id="46"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1695" length="8"/><text>mesoderm</text></annotation><annotation id="47"><infon key="identifier">0001057</infon><infon key="type">TISSUE</infon><location offset="1788" length="11"/><text>neural tube</text></annotation><annotation id="48"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1760" length="7"/><text>embryos</text></annotation><annotation id="49"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1962" length="8"/><text>mesoderm</text></annotation><annotation id="50"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>Tbx6</text></annotation><annotation id="51"><infon key="type">TISSUE</infon><location offset="1980" length="16"/><text>axial stem cells</text></annotation><annotation id="52"><infon key="identifier">18128</infon><infon key="type">GENE</infon><location offset="924" length="2"/><text>N1</text></annotation><annotation id="53"><infon key="identifier">0001765</infon><infon key="type">TISSUE</infon><location offset="972" length="12"/><text>neural plate</text></annotation><annotation id="54"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="15" length="4"/><text>Sox2</text></annotation><annotation id="55"><infon key="identifier">21389</infon><infon key="type">GENE</infon><location offset="451" length="4"/><text>Tbx6</text></annotation><annotation id="56"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="468" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>21368045</id><passage><offset>0</offset><text>The gonadotropin-releasing hormone cell-specific element is required for normal puberty and estrous cyclicity. Appropriate tissue-specific gene expression of gonadotropin-releasing hormone (GnRH) is critical for pubertal development and maintenance of reproductive competence. In these studies, a common element in the mouse GnRH (mGnRH) promoter, between -2806 and -2078 bp, is shown to mediate differential regulation of hypothalamic and ovarian mGnRH expression. To further characterize this region, we generated a knock-out mouse (GREKO(-/-)) with a deletion of the mGnRH promoter fragment between -2806 and -2078 bp. GnRH mRNA expression in the brain of GREKO(-/-) was less than the expression in wild-type mice; however, immunohistochemical analysis revealed no difference between the numbers of GnRH neurons among groups. GnRH mRNA expression in the ovary was fivefold higher in GREKO(-/-). The immunohistochemical staining for GnRH in the ovary increased in surface epithelial and granulosa cells and also in the corpora lutea of GREKO(-/-) mice. The reproductive phenotype revealed that the mean day of vaginal opening was delayed, and additionally, there was a significant decrease in the length of proestrus and diestrus-metestrus phases of the estrous cycle, resulting in a shortened estrous cycle in GREKO(-/-) mice. This work supports the hypothesis that the region of the GnRH promoter contained between -2806 and -2078 bp acts as a cell-specific enhancer in the GnRH neuron and as a repressor in the ovary. Deletion of this region in vivo implicates the GnRH promoter in mediating pubertal development and periodic reproductive cycling, and forms the foundation to define the nuclear proteins important for puberty and estrous cycling in mammals.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="570" length="14"/><text>mGnRH promoter</text></annotation><annotation id="2"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="325" length="4"/><text>GnRH</text></annotation><annotation id="3"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="448" length="5"/><text>mGnRH</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="528" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="650" length="5"/><text>brain</text></annotation><annotation id="6"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="622" length="4"/><text>GnRH</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="712" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="802" length="4"/><text>GnRH</text></annotation><annotation id="9"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="829" length="4"/><text>GnRH</text></annotation><annotation id="10"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="935" length="4"/><text>GnRH</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1049" length="4"/><text>mice</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1387" length="13"/><text>GnRH promoter</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1324" length="4"/><text>mice</text></annotation><annotation id="14"><infon key="attribute">SUFFICIENT</infon><infon key="comment">14,67742375,67743103</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,67742375,67743103</infon><infon key="gb">unk</infon><location offset="1419" length="18"/><text>-2806 and -2078 bp</text></annotation><annotation id="15"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1478" length="4"/><text>GnRH</text></annotation><annotation id="16"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1754" length="7"/><text>mammals</text></annotation><annotation id="17"><infon key="identifier">0000542</infon><infon key="type">TISSUE</infon><location offset="989" length="15"/><text>granulosa cells</text></annotation><annotation id="18"><infon key="comment">14,67742375,67743103</infon><infon key="attribute">SUFFICIENT</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,67742375,67743103</infon><infon key="gb">unk</infon><location offset="356" length="18"/><text>-2806 and -2078 bp</text></annotation><annotation id="19"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="331" length="5"/><text>mGnRH</text></annotation><annotation id="20"><infon key="attribute">SUFFICIENT</infon><infon key="comment">14,67742375,67743103</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,67742375,67743103</infon><infon key="gb">unk</infon><location offset="602" length="18"/><text>-2806 and -2078 bp</text></annotation><annotation id="21"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="807" length="7"/><text>neurons</text></annotation><annotation id="22"><infon key="identifier">0000975</infon><infon key="type">TISSUE</infon><location offset="857" length="5"/><text>ovary</text></annotation><annotation id="23"><infon key="attribute">SUFFICIENT</infon><infon key="comment">14,67742375,67743103</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,67742375,67743103</infon><infon key="gb">unk</infon><location offset="1448" length="22"/><text>cell-specific enhancer</text></annotation><annotation id="24"><infon key="identifier">0000975</infon><infon key="type">TISSUE</infon><location offset="947" length="5"/><text>ovary</text></annotation><annotation id="25"><infon key="identifier">0000414</infon><infon key="type">TISSUE</infon><location offset="974" length="10"/><text>epithelial</text></annotation><annotation id="26"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="570" length="5"/><text>mGnRH</text></annotation><annotation id="27"><infon key="identifier">0000292</infon><infon key="type">TISSUE</infon><location offset="1021" length="13"/><text>corpora lutea</text></annotation><annotation id="28"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1387" length="4"/><text>GnRH</text></annotation><annotation id="29"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="1483" length="6"/><text>neuron</text></annotation><annotation id="30"><infon key="identifier">0000975</infon><infon key="type">TISSUE</infon><location offset="1516" length="5"/><text>ovary</text></annotation><annotation id="31"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1570" length="4"/><text>GnRH</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1570" length="13"/><text>GnRH promoter</text></annotation><annotation id="33"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="4" length="30"/><text>gonadotropin-releasing hormone</text></annotation><annotation id="34"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="158" length="30"/><text>gonadotropin-releasing hormone</text></annotation><annotation id="35"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="190" length="4"/><text>GnRH</text></annotation><annotation id="36"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="319" length="5"/><text>mouse</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="325" length="21"/><text>GnRH (mGnRH) promoter</text></annotation></passage></document>
<document><id>21378152</id><passage><offset>0</offset><text>TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes. BACKGROUND: Wilms' tumor suppressor gene (WT1) is essential for normal podocyte function, and transforming growth factor (TGF)-beta contributes to focal segmental glomerulosclerosis (FSGS). We aimed to address whether TGF-beta affects WT1 expression in podocytes. METHODS: A human podocyte cell line treated with TGF-beta1 and kidneys in Alb/TGF-beta1-transgenic mice were analyzed for WT1 expression. RESULTS: In cultured podocytes, TGF-beta1 reduced WT1 protein expression determined by western blotting beginning at 8 h and decreased WT1 messenger RNA (mRNA) expression measured by quantitative reverse transcription-polymerase chain reaction beginning at 3 h. Knockdown of Smad4 by small hairpin (sh) RNA partially rescued the TGF-beta1-induced reduction of both WT1 protein and mRNA expressions in the cultured podocytes. TGF-beta1 did not alter luciferase activity of the reporter construct for a human WT1 promoter but reduced that for a human WT1 5' enhancer construct, suggesting that TGF-beta1 may regulate WT1 expression by altering the 5' enhancer activity. In the transgenic mice, WT1 protein expression in podocytes was decreased at 1 and 3 weeks of age, while glomeruloclerosis developed after 3 weeks. CONCLUSION: TGF-beta1 reduces WT1 expression in cultured human podocytes and podocytes in mice before overt glomerulosclerosis begins. The effects are at least partially Smad4 dependent. Our findings identify a novel pathway linking TGF-beta1 to podocyte injury and FSGS. The WT1 reduction may be a useful marker for early podocyte injury.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1023" length="15"/><text>WT1 5' enhancer</text></annotation><annotation id="2"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="290" length="8"/><text>TGF-beta</text></annotation><annotation id="3"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="307" length="3"/><text>WT1</text></annotation><annotation id="4"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="353" length="18"/><text>podocyte cell line</text></annotation><annotation id="5"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="385" length="9"/><text>TGF-beta1</text></annotation><annotation id="6"><infon key="identifier">213</infon><infon key="type">GENE</infon><location offset="410" length="3"/><text>Alb</text></annotation><annotation id="7"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="414" length="9"/><text>TGF-beta1</text></annotation><annotation id="8"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="495" length="9"/><text>podocytes</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="435" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">22431</infon><infon key="type">GENE</infon><location offset="458" length="3"/><text>WT1</text></annotation><annotation id="11"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="506" length="9"/><text>TGF-beta1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1120" length="11"/><text>5' enhancer</text></annotation><annotation id="13"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="524" length="3"/><text>WT1</text></annotation><annotation id="14"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="609" length="3"/><text>WT1</text></annotation><annotation id="15"><infon key="identifier">4089</infon><infon key="type">GENE</infon><location offset="749" length="5"/><text>Smad4</text></annotation><annotation id="16"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="803" length="9"/><text>TGF-beta1</text></annotation><annotation id="17"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="839" length="3"/><text>WT1</text></annotation><annotation id="18"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="899" length="9"/><text>TGF-beta1</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="981" length="12"/><text>WT1 promoter</text></annotation><annotation id="20"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="1192" length="9"/><text>podocytes</text></annotation><annotation id="21"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="1353" length="9"/><text>podocytes</text></annotation><annotation id="22"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="1367" length="9"/><text>podocytes</text></annotation><annotation id="23"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="0" length="9"/><text>TGF-beta1</text></annotation><annotation id="24"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1066" length="9"/><text>TGF-beta1</text></annotation><annotation id="25"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="1089" length="3"/><text>WT1</text></annotation><annotation id="26"><infon key="identifier">0019722</infon><infon key="type">DISEASE</infon><location offset="1613" length="15"/><text>podocyte injury</text></annotation><annotation id="27"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1160" length="4"/><text>mice</text></annotation><annotation id="28"><infon key="identifier">22431</infon><infon key="type">GENE</infon><location offset="1166" length="3"/><text>WT1</text></annotation><annotation id="29"><infon key="identifier">0000490</infon><infon key="type">DISEASE</infon><location offset="1247" length="17"/><text>glomeruloclerosis</text></annotation><annotation id="30"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1302" length="9"/><text>TGF-beta1</text></annotation><annotation id="31"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="1320" length="3"/><text>WT1</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1347" length="5"/><text>human</text></annotation><annotation id="33"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1380" length="4"/><text>mice</text></annotation><annotation id="34"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="61" length="9"/><text>podocytes</text></annotation><annotation id="35"><infon key="identifier">0000490</infon><infon key="type">DISEASE</infon><location offset="1398" length="18"/><text>glomerulosclerosis</text></annotation><annotation id="36"><infon key="identifier">4089</infon><infon key="type">GENE</infon><location offset="1460" length="5"/><text>Smad4</text></annotation><annotation id="37"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1523" length="9"/><text>TGF-beta1</text></annotation><annotation id="38"><infon key="identifier">0019722</infon><infon key="type">DISEASE</infon><location offset="1536" length="15"/><text>podocyte injury</text></annotation><annotation id="39"><infon key="identifier">0005363</infon><infon key="type">DISEASE</infon><location offset="1556" length="4"/><text>FSGS</text></annotation><annotation id="40"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="1566" length="3"/><text>WT1</text></annotation><annotation id="41"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="975" length="5"/><text>human</text></annotation><annotation id="42"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="18" length="28"/><text>Wilms' tumor suppressor gene</text></annotation><annotation id="43"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="143" length="8"/><text>podocyte</text></annotation><annotation id="44"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="325" length="9"/><text>podocytes</text></annotation><annotation id="45"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="84" length="28"/><text>Wilms' tumor suppressor gene</text></annotation><annotation id="46"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="399" length="7"/><text>kidneys</text></annotation><annotation id="47"><infon key="identifier">0002295</infon><infon key="type">TISSUE</infon><location offset="888" length="9"/><text>podocytes</text></annotation><annotation id="48"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1017" length="5"/><text>human</text></annotation><annotation id="49"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="347" length="5"/><text>human</text></annotation><annotation id="50"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="1023" length="3"/><text>WT1</text></annotation><annotation id="51"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="981" length="3"/><text>WT1</text></annotation><annotation id="52"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="114" length="3"/><text>WT1</text></annotation><annotation id="53"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="166" length="37"/><text>transforming growth factor (TGF)-beta</text></annotation><annotation id="54"><infon key="identifier">0005363</infon><infon key="type">DISEASE</infon><location offset="219" length="34"/><text>focal segmental glomerulosclerosis</text></annotation><annotation id="55"><infon key="identifier">0005363</infon><infon key="type">DISEASE</infon><location offset="255" length="4"/><text>FSGS</text></annotation></passage></document>
<document><id>21385855</id><passage><offset>0</offset><text>A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Fetal hemoglobin (HbF) is regulated as a multigenic trait. By genome-wide association study, we confirmed that HBS1L-MYB intergenic polymorphisms (HMIP) and BCL11A polymorphisms are highly associated with HbF in Chinese beta-thalassemia heterozygotes. In this population, the variance in HbF resulting from the HMIP is 13.5%; that resulting from the BCL11A polymorphism is 6.4%. To identify the functional variant in HMIP, we used 1000 Genomes Project data, single nucleotide polymorphism imputation, comparisons of association results across populations, potential transcription factor binding sites, and analysis of phylogenetic conservation. Based on these studies, a hitherto unreported association between HbF expression and a 3-bp deletion, between 135 460 326 and 135 460 328 bp on chromosome 6q23 was found. This 3-bp deletion is in complete linkage disequilibrium with rs9399137, which is the single nucleotide polymorphism in HMIP most significantly associated with HbF among Chinese, Europeans, and Africans. Chromatin immunoprecipitation assays confirmed erythropoiesis-related transcription factors binding to this region in K562 cells. Based on transient expression of a luciferase reporter plasmid, the DNA fragment encompassing the 3-bp deletion polymorphism has enhancer-like activity that is further augmented by the introduction of the 3-bp deletion. This 3-bp deletion polymorphism is probably the most significant functional motif accounting for HMIP modulation of HbF in all 3 populations.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1323" length="83"/><text>DNA fragment encompassing the 3-bp deletion polymorphism has enhancer-like activity</text></annotation><annotation id="2"><infon key="identifier">10767</infon><infon key="type">GENE</infon><location offset="23" length="5"/><text>HBS1L</text></annotation><annotation id="3"><infon key="identifier">0019402</infon><infon key="type">DISEASE</infon><location offset="325" length="16"/><text>beta-thalassemia</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="317" length="7"/><text>Chinese</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1091" length="7"/><text>Chinese</text></annotation><annotation id="6"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="29" length="3"/><text>MYB</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1100" length="9"/><text>Europeans</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1115" length="8"/><text>Africans</text></annotation><annotation id="9"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="1243" length="10"/><text>K562 cells</text></annotation><annotation id="10"><infon key="identifier">10767</infon><infon key="type">GENE</infon><location offset="216" length="5"/><text>HBS1L</text></annotation><annotation id="11"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="222" length="3"/><text>MYB</text></annotation><annotation id="12"><infon key="identifier">53335</infon><infon key="type">GENE</infon><location offset="262" length="6"/><text>BCL11A</text></annotation><annotation id="13"><infon key="identifier">53335</infon><infon key="type">GENE</infon><location offset="455" length="6"/><text>BCL11A</text></annotation><annotation id="14"><infon key="comment">chr6:135097880:T,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs9399137</infon><location offset="983" length="9"/><text>rs9399137</text></annotation></passage></document>
<document><id>21402921</id><passage><offset>0</offset><text>PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers. Unraveling the complexity of transcriptional programs coded by different cell types has been one of the central goals of cell biology. By using genome-wide location analysis, we examined how two different cell types generate different responses to the NF-kappaB signaling pathway. We showed that, after TNF-alpha treatment, the NF-kappaB p65 subunit binds to distinct genome locations and subsequently induces different subsets of genes in human monocytic THP-1 cells versus HeLa cells. Interestingly, the differential p65 binding in two cell types correlates with preexisting cell type-specific enhancers before TNF-alpha stimulation, marked by histone modifications. We also found that two transcription factors, PU.1 and C/EBPalpha, appear to synergistically mediate enhancer creation and affect NF-kappaB target selection in THP-1 cells. In HeLa cells, coexpression of PU.1 and C/EBPalpha conferred TNF-alpha responsiveness to a subset of THP-1-specific NF-kappaB target genes. These results suggest that the diversity of transcriptional programs in mammalian cells arises, at least in part, from preexisting enhancers that are established by cell-specific transcription factors.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0000567</infon><infon key="type">TISSUE</infon><location offset="613" length="10"/><text>HeLa cells</text></annotation><annotation id="2"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="476" length="3"/><text>p65</text></annotation><annotation id="3"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1192" length="9"/><text>mammalian</text></annotation><annotation id="4"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="657" length="3"/><text>p65</text></annotation><annotation id="5"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="751" length="9"/><text>TNF-alpha</text></annotation><annotation id="6"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="853" length="4"/><text>PU.1</text></annotation><annotation id="7"><infon key="identifier">1050</infon><infon key="type">GENE</infon><location offset="862" length="10"/><text>C/EBPalpha</text></annotation><annotation id="8"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="937" length="9"/><text>NF-kappaB</text></annotation><annotation id="9"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="1011" length="4"/><text>PU.1</text></annotation><annotation id="10"><infon key="identifier">1050</infon><infon key="type">GENE</infon><location offset="1020" length="10"/><text>C/EBPalpha</text></annotation><annotation id="11"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1041" length="9"/><text>TNF-alpha</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0001370</infon><infon key="type">TISSUE</infon><location offset="584" length="21"/><text>monocytic THP-1 cells</text></annotation><annotation id="13"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1096" length="9"/><text>NF-kappaB</text></annotation><annotation id="14"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="109" length="8"/><text>monocyte</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="578" length="5"/><text>human</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0001370</infon><infon key="type">TISSUE</infon><location offset="967" length="11"/><text>THP-1 cells</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0000567</infon><infon key="type">TISSUE</infon><location offset="983" length="10"/><text>HeLa cells</text></annotation><annotation id="18"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>PU.1</text></annotation><annotation id="19"><infon key="identifier">1050</infon><infon key="type">GENE</infon><location offset="9" length="12"/><text>C/EBP(alpha)</text></annotation><annotation id="20"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="67" length="9"/><text>NF-kappaB</text></annotation><annotation id="21"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="390" length="9"/><text>NF-kappaB</text></annotation><annotation id="22"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="441" length="9"/><text>TNF-alpha</text></annotation><annotation id="23"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="466" length="9"/><text>NF-kappaB</text></annotation></passage></document>
<document><id>21424707</id><passage><offset>0</offset><text>cAMP target sequences enhCRE and CNRE sense low-salt intake to increase human renin gene expression in vivo. This study aimed to assess the role of cAMP target sequences enhancer cAMP response element (enhCRE) and cAMP and overlapping negative response element (CNRE) in the control of human renin gene (REN) in vivo. enhCRE and CNRE were silenced by mutations in a 12.2-kb human renin promoter fused to LacZ reporter gene. This construct was used to generate transgenic mice (RENMut-LacZ). The expression of the transgene was correctly targeted to the juxtaglomerular portions of renal afferent arterioles which express endogenous mouse renin. Therefore, enhCRE and CNRE do not seem to be relevant for the control of the cell-specific expression of the human renin gene. The beta-adrenoreceptor agonist isoproterenol (10 mg/kg/day, for 2 days) stimulated the endogenous renin, but not the LacZ mRNA expression. Treatment of RENMut-LacZ mice with the angiotensin converting enzyme inhibitor (enalapril 10 mg/kg/day, for 7 days) or their crossing to angiotensin receptor type 1a knockout mice led to increased renin and LacZ mRNA levels. Renin expression was upregulated by low-salt diet (0.03% NaCl, for 10 days) and downregulated by high-salt diet (4% NaCl, for 10 days). In contrast, low-salt diet did not influence, while high-salt diet inhibited the expression of LacZ. In summary, enhCRE and CNRE appear to be necessary for the transactivation of the human renin gene through beta-adrenoreceptors and by low-salt diet. Our data also suggest that different intracellular mechanisms mediate the effect of low- and high-salt intake on renin expression in vivo.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="380" length="14"/><text>renin promoter</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="471" length="4"/><text>mice</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="632" length="5"/><text>mouse</text></annotation><annotation id="4"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="638" length="5"/><text>renin</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="754" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="760" length="5"/><text>renin</text></annotation><annotation id="7"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="871" length="5"/><text>renin</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="937" length="4"/><text>mice</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1087" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="1109" length="5"/><text>renin</text></annotation><annotation id="11"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="1137" length="5"/><text>Renin</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="72" length="5"/><text>human</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1456" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="1462" length="5"/><text>renin</text></annotation><annotation id="15"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="1637" length="5"/><text>renin</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="33" length="4"/><text>CNRE</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="148" length="52"/><text>cAMP target sequences enhancer cAMP response element</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="202" length="6"/><text>enhCRE</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="22" length="6"/><text>enhCRE</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="214" length="46"/><text>cAMP and overlapping negative response element</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="262" length="4"/><text>CNRE</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="318" length="6"/><text>enhCRE</text></annotation><annotation id="23"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="78" length="5"/><text>renin</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="329" length="4"/><text>CNRE</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1386" length="6"/><text>enhCRE</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1397" length="4"/><text>CNRE</text></annotation><annotation id="27"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="374" length="5"/><text>human</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="0" length="21"/><text>cAMP target sequences</text></annotation><annotation id="29"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="380" length="5"/><text>renin</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="286" length="5"/><text>human</text></annotation><annotation id="31"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="292" length="5"/><text>renin</text></annotation><annotation id="32"><infon key="identifier">5972</infon><infon key="type">GENE</infon><location offset="304" length="3"/><text>REN</text></annotation><annotation id="33"><infon key="identifier">0001997</infon><infon key="type">TISSUE</infon><location offset="596" length="10"/><text>arterioles</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="656" length="6"/><text>enhCRE</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="667" length="4"/><text>CNRE</text></annotation></passage></document>
<document><id>21445863</id><passage><offset>0</offset><text>Transcriptional regulation and spatial organisation of the human AML1/RUNX1 gene. The transcription factor RUNX1 is a key regulator of haematopoiesis in vertebrates. In humans, the 260-kb long gene coding for this transcription factor is located on chromosome 21. This gene is transcribed from two alternative promoters that are commonly referred to as the distal and the proximal promoters. In model experiments, these two promoters were found to be active in cells of different lineages, although RUNX1 is preferentially expressed in haematopoietic cells. In the present study, we attempted to identify the regulatory elements that could guide tissue-specific expression of the RUNX1 gene. Two such regulatory elements were found within the RUNX1 gene. One of these elements, located within intron 1, is a haematopoietic-specific enhancer. The second regulatory element, located within intron 5.2, contributes to the formation of an active chromatin hub, which integrates the above-mentioned enhancer and the P1 and P2 promoters.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="372" length="18"/><text>proximal promoters</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="169" length="6"/><text>humans</text></annotation><annotation id="3"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="499" length="5"/><text>RUNX1</text></annotation><annotation id="4"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="680" length="5"/><text>RUNX1</text></annotation><annotation id="5"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="743" length="5"/><text>RUNX1</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="420" length="13"/><text>two promoters</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="294" length="25"/><text>two alternative promoters</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="786" length="15"/><text>within intron 1</text></annotation><annotation id="9"><infon key="identifier">7742</infon><infon key="type">SPECIES</infon><location offset="153" length="11"/><text>vertebrates</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="357" length="6"/><text>distal</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="808" length="32"/><text>haematopoietic-specific enhancer</text></annotation><annotation id="12"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="536" length="20"/><text>haematopoietic cells</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="853" length="45"/><text>regulatory element, located within intron 5.2</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1011" length="2"/><text>P1</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="994" length="8"/><text>enhancer</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1018" length="12"/><text>P2 promoters</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="59" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="65" length="4"/><text>AML1</text></annotation><annotation id="19"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="70" length="5"/><text>RUNX1</text></annotation><annotation id="20"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="107" length="5"/><text>RUNX1</text></annotation></passage></document>
<document><id>21445905</id><passage><offset>0</offset><text>Analysis of a SNP linked to lactase persistence: An exercise for teaching molecular biology techniques to undergraduates. Recent experimental evidence indicates that the ability of adults to tolerate milk, cheese, and other lactose-containing dairy products is an autosomal dominant trait that co-evolved with dairy farming in Central Europe about 7,500 years ago. Among persons of European descent, this trait is strongly associated with a C to T substitution at a polymorphic site 13,910 bp upstream of the lactase gene. This mutation results in the persistent expression of lactase into adulthood enabling individuals carrying a T(-13,910) allele to digest lactose as adults. In this report, we describe a laboratory exercise for an undergraduate molecular biology course in which students determine their own genotype at the -13,910 polymorphic site and correlate this with their ability to tolerate dairy products. The exercise is used as a tool to teach basic molecular biology procedures such as agarose gel electrophoresis, PCR1, and DNA sequencing. Students are actively engaged in the learning process, not only by analyzing their own DNA but also by applying their knowledge and skills to answer an authentic question. The exercise is also integrated with lecture material on the control of gene expression at the transcriptional level, in particular, how transcription factors can influence the activity of a promoter by binding to cis-acting DNA regulatory elements located within the proximal promoter of a gene or distant enhancer regions.</text><annotation id="1"><infon key="identifier">3938</infon><infon key="type">GENE</infon><location offset="28" length="7"/><text>lactase</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="371" length="7"/><text>persons</text></annotation><annotation id="3"><infon key="identifier">3938</infon><infon key="type">GENE</infon><location offset="509" length="7"/><text>lactase</text></annotation><annotation id="4"><infon key="identifier">3938</infon><infon key="type">GENE</infon><location offset="577" length="7"/><text>lactase</text></annotation></passage></document>
<document><id>21454523</id><passage><offset>0</offset><text>Cohesin mediates chromatin interactions that regulate mammalian beta-globin expression. The beta-globin locus undergoes dynamic chromatin interaction changes in differentiating erythroid cells that are thought to be important for proper globin gene expression. However, the underlying mechanisms are unclear. The CCCTC-binding factor, CTCF, binds to the insulator elements at the 5' and 3' boundaries of the locus, but these sites were shown to be dispensable for globin gene activation. We found that, upon induction of differentiation, cohesin and the cohesin loading factor Nipped-B-like (Nipbl) bind to the locus control region (LCR) at the CTCF insulator and distal enhancer regions as well as at the specific target globin gene that undergoes activation upon differentiation. Nipbl-dependent cohesin binding is critical for long-range chromatin interactions, both between the CTCF insulator elements and between the LCR distal enhancer and the target gene. We show that the latter interaction is important for globin gene expression in vivo and in vitro. Furthermore, the results indicate that such cohesin-mediated chromatin interactions associated with gene regulation are sensitive to the partial reduction of Nipbl caused by heterozygous mutation. This provides the first direct evidence that Nipbl haploinsufficiency affects cohesin-mediated chromatin interactions and gene expression. Our results reveal that dynamic Nipbl/cohesin binding is critical for developmental chromatin organization and the gene activation function of the LCR in mammalian cells.</text><annotation id="1"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="611" length="20"/><text>locus control region</text></annotation><annotation id="2"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="1303" length="5"/><text>Nipbl</text></annotation><annotation id="3"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="633" length="3"/><text>LCR</text></annotation><annotation id="4"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="1429" length="5"/><text>Nipbl</text></annotation><annotation id="5"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1551" length="9"/><text>mammalian</text></annotation><annotation id="6"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="1544" length="3"/><text>LCR</text></annotation><annotation id="7"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="92" length="11"/><text>beta-globin</text></annotation><annotation id="8"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="64" length="11"/><text>beta-globin</text></annotation><annotation id="9"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="177" length="15"/><text>erythroid cells</text></annotation><annotation id="10"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="313" length="20"/><text>CCCTC-binding factor</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="922" length="19"/><text>LCR distal enhancer</text></annotation><annotation id="12"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="54" length="9"/><text>mammalian</text></annotation><annotation id="13"><infon key="identifier">109580095</infon><infon key="type">GENE</infon><location offset="922" length="3"/><text>LCR</text></annotation><annotation id="14"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="335" length="4"/><text>CTCF</text></annotation><annotation id="15"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="577" length="13"/><text>Nipped-B-like</text></annotation><annotation id="16"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="592" length="5"/><text>Nipbl</text></annotation><annotation id="17"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="645" length="4"/><text>CTCF</text></annotation><annotation id="18"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="782" length="5"/><text>Nipbl</text></annotation><annotation id="19"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="882" length="4"/><text>CTCF</text></annotation><annotation id="20"><infon key="identifier">25836</infon><infon key="type">GENE</infon><location offset="1219" length="5"/><text>Nipbl</text></annotation></passage></document>
<document><id>21464046</id><passage><offset>0</offset><text>Nkx2-5 represses Gata1 gene expression and modulates the cellular fate of cardiac progenitors during embryogenesis. BACKGROUND: Recent studies suggest that the hematopoietic and cardiac lineages have close ontogenic origins, and that an early mesodermal cell population has the potential to differentiate into both lineages. Studies also suggest that specification of these lineages is inversely regulated. However, the transcriptional networks that govern the cell fate specification of these progenitors are incompletely defined. METHODS AND RESULTS: Here, we show that Nkx2-5 regulates the hematopoietic/erythroid fate of the mesoderm precursors early during cardiac morphogenesis. Using transgenic technologies to isolate Nkx2-5 expressing cells, we observed an induction of the erythroid molecular program, including Gata1, in the Nkx2-5-null embryos. We further observed that overexpression of Nkx2-5 with an Nkx2-5-inducible embryonic stem cell system significantly repressed Gata1 gene expression and suppressed the hematopoietic/erythroid potential, but not the endothelial potential, of the embryonic stem cells. This suppression was cell-autonomous, and was partially rescued by overexpressing Gata1. In addition, we demonstrated that Nkx2-5 binds to the Gata1 gene enhancer and represses the transcriptional activity of the Gata1 gene. CONCLUSIONS: Our results demonstrate that the hematopoietic/erythroid cell fate is suppressed via Nkx2-5 during mesodermal fate determination, and that the Gata1 gene is one of the targets that are suppressed by Nkx2-5.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1266" length="19"/><text>Gata1 gene enhancer</text></annotation><annotation id="2"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>Nkx2-5</text></annotation><annotation id="3"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="1205" length="5"/><text>Gata1</text></annotation><annotation id="4"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="1246" length="6"/><text>Nkx2-5</text></annotation><annotation id="5"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="1394" length="13"/><text>hematopoietic</text></annotation><annotation id="6"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="1336" length="5"/><text>Gata1</text></annotation><annotation id="7"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="1446" length="6"/><text>Nkx2-5</text></annotation><annotation id="8"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="1504" length="5"/><text>Gata1</text></annotation><annotation id="9"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="1560" length="6"/><text>Nkx2-5</text></annotation><annotation id="10"><infon key="identifier">0001035</infon><infon key="type">TISSUE</infon><location offset="160" length="13"/><text>hematopoietic</text></annotation><annotation id="11"><infon key="type">TISSUE</infon><location offset="178" length="16"/><text>cardiac lineages</text></annotation><annotation id="12"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="848" length="7"/><text>embryos</text></annotation><annotation id="13"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="17" length="5"/><text>Gata1</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="74" length="19"/><text>cardiac progenitors</text></annotation><annotation id="15"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="243" length="15"/><text>mesodermal cell</text></annotation><annotation id="16"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="1266" length="5"/><text>Gata1</text></annotation><annotation id="17"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="607" length="9"/><text>erythroid</text></annotation><annotation id="18"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="629" length="8"/><text>mesoderm</text></annotation><annotation id="19"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1038" length="9"/><text>erythroid</text></annotation><annotation id="20"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="783" length="9"/><text>erythroid</text></annotation><annotation id="21"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="932" length="19"/><text>embryonic stem cell</text></annotation><annotation id="22"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="572" length="6"/><text>Nkx2-5</text></annotation><annotation id="23"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1101" length="20"/><text>embryonic stem cells</text></annotation><annotation id="24"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1408" length="14"/><text>erythroid cell</text></annotation><annotation id="25"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="726" length="6"/><text>Nkx2-5</text></annotation><annotation id="26"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="822" length="5"/><text>Gata1</text></annotation><annotation id="27"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="836" length="6"/><text>Nkx2-5</text></annotation><annotation id="28"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="900" length="6"/><text>Nkx2-5</text></annotation><annotation id="29"><infon key="identifier">18091</infon><infon key="type">GENE</infon><location offset="915" length="6"/><text>Nkx2-5</text></annotation><annotation id="30"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="983" length="5"/><text>Gata1</text></annotation></passage></document>
<document><id>21464207</id><passage><offset>0</offset><text>Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter. Endothelial cell activation and dysfunction underlie many vascular disorders, including atherosclerosis and inflammation. Here, we show that interleukin-4 (IL-4) markedly induced vascular cell adhesion molecule 1 (VCAM-1), both in cultured endothelial cells and in the intact endothelium in mice. Combined treatment with IL-4 and tumor necrosis factor alpha (TNF-alpha) resulted in further, sustained induction of VCAM-1 expression. IL-4-mediated induction of VCAM-1 and secondary monocyte adhesion was predominantly regulated by the transcription factor STAT6. Genome-wide survey of IL-4-mediated STAT6 binding from sequential chromatin-immunoprecipitation with deep sequencing (chromatin immunoprecipitation sequencing [ChIP-seq]) in endothelial cells revealed regions of transient and sustained transcription factor binding. Through the combination of DNA microarrays and ChIP-seq at the same time points, the majority of IL-4-responsive genes were shown to be STAT6 dependent and associated with direct STAT6 binding to their promoter. IL-4-mediated stable binding of STAT6 led to sustained target gene expression. Moreover, our strategy led to the identification of a novel functionally important STAT6 binding site within 16 kb upstream of the VCAM-1 gene. Taken together, these findings support a critical role for STAT6 in mediating IL-4 signal transduction in endothelial cells. Identification of a novel IL-4-mediated VCAM-1 enhancer may provide a foundation for targeted therapy in vascular disease.</text><annotation id="1"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="611" length="8"/><text>monocyte</text></annotation><annotation id="2"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="286" length="4"/><text>IL-4</text></annotation><annotation id="3"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="309" length="33"/><text>vascular cell adhesion molecule 1</text></annotation><annotation id="4"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="344" length="6"/><text>VCAM-1</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="421" length="4"/><text>mice</text></annotation><annotation id="6"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="451" length="4"/><text>IL-4</text></annotation><annotation id="7"><infon key="identifier">21926</infon><infon key="type">GENE</infon><location offset="460" length="27"/><text>tumor necrosis factor alpha</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1332" length="59"/><text>STAT6 binding site within 16 kb upstream of the VCAM-1 gene</text></annotation><annotation id="9"><infon key="identifier">21926</infon><infon key="type">GENE</infon><location offset="489" length="9"/><text>TNF-alpha</text></annotation><annotation id="10"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="544" length="6"/><text>VCAM-1</text></annotation><annotation id="11"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="563" length="4"/><text>IL-4</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1544" length="29"/><text>IL-4-mediated VCAM-1 enhancer</text></annotation><annotation id="13"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="590" length="6"/><text>VCAM-1</text></annotation><annotation id="14"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="685" length="5"/><text>STAT6</text></annotation><annotation id="15"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="714" length="4"/><text>IL-4</text></annotation><annotation id="16"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="728" length="5"/><text>STAT6</text></annotation><annotation id="17"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="1055" length="4"/><text>IL-4</text></annotation><annotation id="18"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="1094" length="5"/><text>STAT6</text></annotation><annotation id="19"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="1137" length="5"/><text>STAT6</text></annotation><annotation id="20"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="1170" length="4"/><text>IL-4</text></annotation><annotation id="21"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="1202" length="5"/><text>STAT6</text></annotation><annotation id="22"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="370" length="17"/><text>endothelial cells</text></annotation><annotation id="23"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="41" length="13"/><text>interleukin-4</text></annotation><annotation id="24"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="1558" length="6"/><text>VCAM-1</text></annotation><annotation id="25"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="1452" length="5"/><text>STAT6</text></annotation><annotation id="26"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="1471" length="4"/><text>IL-4</text></annotation><annotation id="27"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="1544" length="4"/><text>IL-4</text></annotation><annotation id="28"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="866" length="17"/><text>endothelial cells</text></annotation><annotation id="29"><infon key="identifier">0005385</infon><infon key="type">DISEASE</infon><location offset="1623" length="16"/><text>vascular disease</text></annotation><annotation id="30"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="86" length="33"/><text>vascular cell adhesion molecule 1</text></annotation><annotation id="31"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="130" length="16"/><text>Endothelial cell</text></annotation><annotation id="32"><infon key="identifier">0000393</infon><infon key="type">TISSUE</infon><location offset="406" length="11"/><text>endothelium</text></annotation><annotation id="33"><infon key="identifier">22329</infon><infon key="type">GENE</infon><location offset="1380" length="6"/><text>VCAM-1</text></annotation><annotation id="34"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="65" length="5"/><text>STAT6</text></annotation><annotation id="35"><infon key="identifier">20852</infon><infon key="type">GENE</infon><location offset="1332" length="5"/><text>STAT6</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="86" length="42"/><text>vascular cell adhesion molecule 1 promoter</text></annotation><annotation id="37"><infon key="identifier">0005385</infon><infon key="type">DISEASE</infon><location offset="188" length="18"/><text>vascular disorders</text></annotation><annotation id="38"><infon key="identifier">0005311</infon><infon key="type">DISEASE</infon><location offset="218" length="15"/><text>atherosclerosis</text></annotation><annotation id="39"><infon key="identifier">0021166</infon><infon key="type">DISEASE</infon><location offset="238" length="12"/><text>inflammation</text></annotation><annotation id="40"><infon key="identifier">16189</infon><infon key="type">GENE</infon><location offset="271" length="13"/><text>interleukin-4</text></annotation></passage></document>
<document><id>21494683</id><passage><offset>0</offset><text>Genetic and metabolic characterization of insomnia. Insomnia is reported to chronically affect 10~15% of the adult population. However, very little is known about the genetics and metabolism of insomnia. Here we surveyed 10,038 Korean subjects whose genotypes have been previously profiled on a genome-wide scale. About 16.5% reported insomnia and displayed distinct metabolic changes reflecting an increase in insulin secretion, a higher risk of diabetes, and disrupted calcium signaling. Insomnia-associated genotypic differences were highly concentrated within genes involved in neural function. The most significant SNPs resided in ROR1 and PLCB1, genes known to be involved in bipolar disorder and schizophrenia, respectively. Putative enhancers, as indicated by the histone mark H3K4me1, were discovered within both genes near the significant SNPs. In neuronal cells, the enhancers were bound by PAX6, a neural transcription factor that is essential for central nervous system development. Open chromatin signatures were found on the enhancers in human pancreas, a tissue where PAX6 is known to play a role in insulin secretion. In PLCB1, CTCF was found to bind downstream of the enhancer and interact with PAX6, suggesting that it can probably inhibit gene activation by PAX6. PLCB4, a circadian gene that is closely located downstream of PLCB1, was identified as a candidate target gene. Hence, dysregulation of ROR1, PLCB1, or PLCB4 by PAX6 and CTCF may be one mechanism that links neural and pancreatic dysfunction not only in insomnia but also in the relevant psychiatric disorders that are accompanied with circadian rhythm disruption and metabolic syndrome.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="741" length="9"/><text>enhancers</text></annotation><annotation id="2"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="858" length="14"/><text>neuronal cells</text></annotation><annotation id="3"><infon key="identifier">4919</infon><infon key="type">GENE</infon><location offset="636" length="4"/><text>ROR1</text></annotation><annotation id="4"><infon key="identifier">23236</infon><infon key="type">GENE</infon><location offset="645" length="5"/><text>PLCB1</text></annotation><annotation id="5"><infon key="identifier">0004985</infon><infon key="type">DISEASE</infon><location offset="682" length="16"/><text>bipolar disorder</text></annotation><annotation id="6"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="703" length="13"/><text>schizophrenia</text></annotation><annotation id="7"><infon key="identifier">5080</infon><infon key="type">GENE</infon><location offset="902" length="4"/><text>PAX6</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1053" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">5080</infon><infon key="type">GENE</infon><location offset="1084" length="4"/><text>PAX6</text></annotation><annotation id="10"><infon key="identifier">23236</infon><infon key="type">GENE</infon><location offset="1138" length="5"/><text>PLCB1</text></annotation><annotation id="11"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1145" length="4"/><text>CTCF</text></annotation><annotation id="12"><infon key="identifier">5080</infon><infon key="type">GENE</infon><location offset="1213" length="4"/><text>PAX6</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="878" length="9"/><text>enhancers</text></annotation><annotation id="14"><infon key="identifier">5080</infon><infon key="type">GENE</infon><location offset="1278" length="4"/><text>PAX6</text></annotation><annotation id="15"><infon key="identifier">5332</infon><infon key="type">GENE</infon><location offset="1284" length="5"/><text>PLCB4</text></annotation><annotation id="16"><infon key="identifier">23236</infon><infon key="type">GENE</infon><location offset="1346" length="5"/><text>PLCB1</text></annotation><annotation id="17"><infon key="identifier">4919</infon><infon key="type">GENE</infon><location offset="1420" length="4"/><text>ROR1</text></annotation><annotation id="18"><infon key="identifier">23236</infon><infon key="type">GENE</infon><location offset="1426" length="5"/><text>PLCB1</text></annotation><annotation id="19"><infon key="identifier">5332</infon><infon key="type">GENE</infon><location offset="1436" length="5"/><text>PLCB4</text></annotation><annotation id="20"><infon key="identifier">5080</infon><infon key="type">GENE</infon><location offset="1445" length="4"/><text>PAX6</text></annotation><annotation id="21"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1454" length="4"/><text>CTCF</text></annotation><annotation id="22"><infon key="identifier">0005071</infon><infon key="type">DISEASE</infon><location offset="1491" length="6"/><text>neural</text></annotation><annotation id="23"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="1537" length="8"/><text>insomnia</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1186" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">0002025</infon><infon key="type">DISEASE</infon><location offset="1571" length="21"/><text>psychiatric disorders</text></annotation><annotation id="26"><infon key="identifier">0024361</infon><infon key="type">DISEASE</infon><location offset="1619" length="27"/><text>circadian rhythm disruption</text></annotation><annotation id="27"><infon key="identifier">0004955</infon><infon key="type">DISEASE</infon><location offset="1651" length="18"/><text>metabolic syndrome</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="810" length="43"/><text>within both genes near the significant SNPs</text></annotation><annotation id="29"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="960" length="22"/><text>central nervous system</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1040" length="9"/><text>enhancers</text></annotation><annotation id="31"><infon key="identifier">0002356</infon><infon key="type">DISEASE</infon><location offset="1502" length="22"/><text>pancreatic dysfunction</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="228" length="6"/><text>Korean</text></annotation><annotation id="33"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="42" length="8"/><text>insomnia</text></annotation><annotation id="34"><infon key="identifier">0000988</infon><infon key="type">TISSUE</infon><location offset="1059" length="8"/><text>pancreas</text></annotation><annotation id="35"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="52" length="8"/><text>Insomnia</text></annotation><annotation id="36"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="194" length="8"/><text>insomnia</text></annotation><annotation id="37"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="335" length="8"/><text>insomnia</text></annotation><annotation id="38"><infon key="identifier">0005015</infon><infon key="type">DISEASE</infon><location offset="447" length="8"/><text>diabetes</text></annotation><annotation id="39"><infon key="identifier">0013600</infon><infon key="type">DISEASE</infon><location offset="490" length="8"/><text>Insomnia</text></annotation></passage></document>
<document><id>21527503</id><passage><offset>0</offset><text>Progesterone receptor directly inhibits beta-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. Differentiated HC-11 cells ectopically expressing progesterone receptor (PR) were used to explore the molecular mechanisms by which progesterone suppresses beta-casein gene transcription induced by prolactin (PRL) and glucocorticoids in the mammary gland. As detected by chromatin immunoprecipitation assays, treatment of cells with the progestin agonist R5020 induced a rapid recruitment (5 min) of PR to the proximal promoter (-235 bp) and distal enhancer (-6 kb upstream of transcription start site) of beta-casein. PR remained bound for 4 h and was dissociated by 24 h after treatment. Despite efficient binding, the hormone agonist-occupied PR did not stimulate transcription of the beta-casein gene. Recruitment of signal transducer and activator of transcription 5a, glucocorticoid receptor, and the CCAAT enhancer binding protein beta to the enhancer and proximal promoter of beta-casein induced by PRL and glucocorticoids was blocked by progestin cotreatment, whereas PR binding was induced under these conditions. PRL/glucocorticoid-induced histone acetylation and the recruitment of the coactivator p300 and RNA polymerase II required for gene activation were also inhibited by progestin. In addition, progestin prevented dissociation of the corepressors Yin and Yang 1 and histone deacetylase 3 from the promoter, and demethylation of lysine 9 of histone 3 induced by PRL and glucocorticoids. These studies are consistent with the conclusion that progesterone interferes with PRL/glucocorticoid induction of beta-casein transcription by a physical interaction of PR with the promoter and enhancer that blocks assembly of a transcriptional activation complex and dissociation of corepressors and promotes repressive chromatin modifications. These studies define a novel mechanism of steroid receptor-mediated transcriptional repression of a physiologically important gene in mammary gland development and differentiation.</text><annotation id="1"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="863" length="11"/><text>beta-casein</text></annotation><annotation id="2"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="0" length="21"/><text>Progesterone receptor</text></annotation><annotation id="3"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="225" length="21"/><text>progesterone receptor</text></annotation><annotation id="4"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="248" length="2"/><text>PR</text></annotation><annotation id="5"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="373" length="9"/><text>prolactin</text></annotation><annotation id="6"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="384" length="3"/><text>PRL</text></annotation><annotation id="7"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="575" length="2"/><text>PR</text></annotation><annotation id="8"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="694" length="2"/><text>PR</text></annotation><annotation id="9"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="821" length="2"/><text>PR</text></annotation><annotation id="10"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="896" length="51"/><text>signal transducer and activator of transcription 5a</text></annotation><annotation id="11"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="949" length="23"/><text>glucocorticoid receptor</text></annotation><annotation id="12"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="40" length="11"/><text>beta-casein</text></annotation><annotation id="13"><infon key="identifier">0000817</infon><infon key="type">TISSUE</infon><location offset="2061" length="13"/><text>mammary gland</text></annotation><annotation id="14"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="1082" length="3"/><text>PRL</text></annotation><annotation id="15"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="1152" length="2"/><text>PR</text></annotation><annotation id="16"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="1199" length="3"/><text>PRL</text></annotation><annotation id="17"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1285" length="4"/><text>p300</text></annotation><annotation id="18"><infon key="identifier">8841</infon><infon key="type">GENE</infon><location offset="1460" length="21"/><text>histone deacetylase 3</text></annotation><annotation id="19"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="1555" length="3"/><text>PRL</text></annotation><annotation id="20"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="1663" length="3"/><text>PRL</text></annotation><annotation id="21"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="1750" length="2"/><text>PR</text></annotation><annotation id="22"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="331" length="11"/><text>beta-casein</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="585" length="27"/><text>proximal promoter (-235 bp)</text></annotation><annotation id="24"><infon key="identifier">0004300</infon><infon key="type">TISSUE</infon><location offset="74" length="24"/><text>mammary epithelial cells</text></annotation><annotation id="25"><infon key="identifier">0003892</infon><infon key="type">TISSUE</infon><location offset="190" length="11"/><text>HC-11 cells</text></annotation><annotation id="26"><infon key="identifier">0000817</infon><infon key="type">TISSUE</infon><location offset="416" length="13"/><text>mammary gland</text></annotation><annotation id="27"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="1695" length="11"/><text>beta-casein</text></annotation><annotation id="28"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1441" length="14"/><text>Yin and Yang 1</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="617" length="75"/><text>distal enhancer (-6 kb upstream of transcription start site) of beta-casein</text></annotation><annotation id="30"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="681" length="11"/><text>beta-casein</text></annotation><annotation id="31"><infon key="identifier">1447</infon><infon key="type">GENE</infon><location offset="1059" length="11"/><text>beta-casein</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="982" length="35"/><text>CCAAT enhancer binding protein beta</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1025" length="8"/><text>enhancer</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1038" length="32"/><text>proximal promoter of beta-casein</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1491" length="8"/><text>promoter</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1762" length="8"/><text>promoter</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1775" length="8"/><text>enhancer</text></annotation></passage></document>
<document><id>21527504</id><passage><offset>0</offset><text>Class-C SOX transcription factors control GnRH gene expression via the intronic transcriptional enhancer. GnRH is a pivotal hypothalamic neurohormone governing reproduction and sexual development. Because transcriptional regulation is crucial for the spatial and temporal expression of the GnRH gene, a region approximately 3.0 kb upstream of the mammalian GnRH promoter has been extensive studied. In the present study, we demonstrate a transcription-enhancer located in the first intron (intron A) region of the GnRH gene. This transcriptional enhancer harbors putative sex-determining region Y-related high-mobility-group box (SOX) family transcription factor-binding sites, which are well conserved across many mammalian species. The class-C SOX member proteins (SOX-C) (SOX4 and SOX11) specifically augment this transcriptional activation by binding to these SOX-binding sites. In accordance, SOX11 is highly enriched in immortalized GnRH-producing GT1-1 cells, and suppression of its expression significantly decreases GnRH gene expression as well as GnRH secretion. Chromatin immunoprecipitation shows that endogenous SOX-C factors recognize and bind to the intronic enhancer in GT1-1 cells and the hypothalamus. Accompanying immunohistochemical analysis demonstrates that SOX4 or SOX11 are highly expressed in the majority of hypothalamic GnRH neurons in adult mice. Taken together, these findings demonstrate that SOX-C transcription factors function as important transcriptional regulators of cell type-specific GnRH gene expression by acting on the intronic transcriptional enhancer.</text><annotation id="1"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="347" length="9"/><text>mammalian</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1369" length="4"/><text>mice</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="438" length="85"/><text>transcription-enhancer located in the first intron (intron A) region of the GnRH gene</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="595" length="81"/><text>Y-related high-mobility-group box (SOX) family transcription factor-binding sites</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="864" length="17"/><text>SOX-binding sites</text></annotation><annotation id="6"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="42" length="4"/><text>GnRH</text></annotation><annotation id="7"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="290" length="4"/><text>GnRH</text></annotation><annotation id="8"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="514" length="4"/><text>GnRH</text></annotation><annotation id="9"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="357" length="4"/><text>GnRH</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="530" length="24"/><text>transcriptional enhancer</text></annotation><annotation id="11"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="715" length="9"/><text>mammalian</text></annotation><annotation id="12"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="939" length="4"/><text>GnRH</text></annotation><annotation id="13"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1025" length="4"/><text>GnRH</text></annotation><annotation id="14"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1057" length="4"/><text>GnRH</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1165" length="17"/><text>intronic enhancer</text></annotation><annotation id="16"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1347" length="4"/><text>GnRH</text></annotation><annotation id="17"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1522" length="4"/><text>GnRH</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1560" length="33"/><text>intronic transcriptional enhancer</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="71" length="33"/><text>intronic transcriptional enhancer</text></annotation><annotation id="20"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="106" length="4"/><text>GnRH</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="357" length="13"/><text>GnRH promoter</text></annotation><annotation id="22"><infon key="identifier">20677</infon><infon key="type">GENE</infon><location offset="775" length="4"/><text>SOX4</text></annotation><annotation id="23"><infon key="identifier">0003899</infon><infon key="type">TISSUE</infon><location offset="1186" length="11"/><text>GT1-1 cells</text></annotation><annotation id="24"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="1352" length="7"/><text>neurons</text></annotation><annotation id="25"><infon key="identifier">20666</infon><infon key="type">GENE</infon><location offset="784" length="5"/><text>SOX11</text></annotation><annotation id="26"><infon key="identifier">20666</infon><infon key="type">GENE</infon><location offset="898" length="5"/><text>SOX11</text></annotation><annotation id="27"><infon key="identifier">0000614</infon><infon key="type">TISSUE</infon><location offset="1206" length="12"/><text>hypothalamus</text></annotation><annotation id="28"><infon key="identifier">20677</infon><infon key="type">GENE</infon><location offset="1280" length="4"/><text>SOX4</text></annotation><annotation id="29"><infon key="identifier">20666</infon><infon key="type">GENE</infon><location offset="1288" length="5"/><text>SOX11</text></annotation><annotation id="30"><infon key="identifier">0003899</infon><infon key="type">TISSUE</infon><location offset="954" length="11"/><text>GT1-1 cells</text></annotation></passage></document>
<document><id>21533051</id><passage><offset>0</offset><text>Multiple Wnt/ss-catenin responsive enhancers align with the MYC promoter through long-range chromatin loops. Inappropriate activation of c-Myc (MYC) gene expression by the Wnt/ss-catenin signaling pathway is required for colorectal carcinogenesis. The elevated MYC levels in colon cancer cells are attributed in part to ss-catenin/TCF4 transcription complexes that are assembled at proximal Wnt/ss-catenin responsive enhancers (WREs). Recent studies suggest that additional WREs that control MYC expression reside far upstream of the MYC transcription start site. Here, I report the characterization of five novel WREs that localize to a region over 400 kb upstream from MYC. These WREs harbor nucleosomes with post-translational histone modifications that demarcate enhancer and gene promoter regions. Using quantitative chromatin conformation capture, I show that the distal WREs are aligned with the MYC promoter through large chromatin loops. The chromatin loops are not restricted to colon cancer cells, but are also found in kidney epithelial and lung fibroblast cell lines that lack de-regulated Wnt signaling and nuclear ss-catenin/TCF4 complexes. While each chromatin loop is detected in quiescent cells, the positioning of three of the five distal enhancers with the MYC promoter is induced by serum mitogens. These findings suggest that the architecture of the MYC promoter is comprised of distal elements that are juxtaposed through large chromatin loops and that ss-catenin/TCF4 complexes utilize this conformation to activate MYC expression in colon cancer cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="60" length="12"/><text>MYC promoter</text></annotation><annotation id="2"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="137" length="5"/><text>c-Myc</text></annotation><annotation id="3"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="144" length="3"/><text>MYC</text></annotation><annotation id="4"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="534" length="3"/><text>MYC</text></annotation><annotation id="5"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="261" length="3"/><text>MYC</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="428" length="4"/><text>WREs</text></annotation><annotation id="7"><infon key="identifier">6925</infon><infon key="type">GENE</infon><location offset="331" length="4"/><text>TCF4</text></annotation><annotation id="8"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="492" length="3"/><text>MYC</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1233" length="34"/><text>three of the five distal enhancers</text></annotation><annotation id="10"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="671" length="3"/><text>MYC</text></annotation><annotation id="11"><infon key="identifier">0000586</infon><infon key="type">TISSUE</infon><location offset="989" length="18"/><text>colon cancer cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="382" length="44"/><text>proximal Wnt/ss-catenin responsive enhancers</text></annotation><annotation id="13"><infon key="identifier">0005545</infon><infon key="type">TISSUE</infon><location offset="1031" length="17"/><text>kidney epithelial</text></annotation><annotation id="14"><infon key="identifier">6925</infon><infon key="type">GENE</infon><location offset="1140" length="4"/><text>TCF4</text></annotation><annotation id="15"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1277" length="3"/><text>MYC</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1372" length="3"/><text>MYC</text></annotation><annotation id="17"><infon key="identifier">6925</infon><infon key="type">GENE</infon><location offset="1487" length="4"/><text>TCF4</text></annotation><annotation id="18"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1540" length="3"/><text>MYC</text></annotation><annotation id="19"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="903" length="3"/><text>MYC</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="9" length="35"/><text>Wnt/ss-catenin responsive enhancers</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="474" length="4"/><text>WREs</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="603" length="71"/><text>five novel WREs that localize to a region over 400 kb upstream from MYC</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="682" length="4"/><text>WREs</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="870" length="11"/><text>distal WREs</text></annotation><annotation id="25"><infon key="identifier">0000161</infon><infon key="type">TISSUE</infon><location offset="1053" length="26"/><text>lung fibroblast cell lines</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="507" length="55"/><text>reside far upstream of the MYC transcription start site</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="903" length="12"/><text>MYC promoter</text></annotation><annotation id="28"><infon key="identifier">0000586</infon><infon key="type">TISSUE</infon><location offset="1558" length="18"/><text>colon cancer cells</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1277" length="12"/><text>MYC promoter</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1372" length="12"/><text>MYC promoter</text></annotation><annotation id="31"><infon key="identifier">0000586</infon><infon key="type">TISSUE</infon><location offset="275" length="18"/><text>colon cancer cells</text></annotation></passage></document>
<document><id>21536859</id><passage><offset>0</offset><text>ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer. The Ets-related gene (ERG) is an Ets-transcription factor required for normal blood stem cell development. ERG expression is down-regulated during early T-lymphopoiesis but maintained in T-acute lymphoblastic leukemia (T-ALL), where it is recognized as an independent risk factor for adverse outcome. However, it is unclear whether ERG is directly involved in the pathogenesis of T-ALL and how its expression is regulated. Here we demonstrate that transgenic expression of ERG causes T-ALL in mice and that its knockdown reduces the proliferation of human MOLT4 T-ALL cells. We further demonstrate that ERG expression in primary human T-ALL cells is mediated by the binding of other T-cell oncogenes SCL/TAL1, LMO2, and LYL1 in concert with ERG, FLI1, and GATA3 to the ERG +85 enhancer. This enhancer is not active in normal T cells but in transgenic mice targets expression to fetal liver c-kit(+) cells, adult bone marrow stem/progenitors and early CD4(-)CD8(-) double-negative thymic progenitors. Taken together, these data illustrate that ERG promotes T-ALL and that failure to extinguish activity of stem cell enhancers associated with regulatory transcription factors such as ERG can contribute to the development of leukemia.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="891" length="16"/><text>ERG +85 enhancer</text></annotation><annotation id="2"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="309" length="30"/><text>T-acute lymphoblastic leukemia</text></annotation><annotation id="3"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="341" length="5"/><text>T-ALL</text></annotation><annotation id="4"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="454" length="3"/><text>ERG</text></annotation><annotation id="5"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="502" length="5"/><text>T-ALL</text></annotation><annotation id="6"><infon key="identifier">0000873</infon><infon key="type">TISSUE</infon><location offset="678" length="17"/><text>MOLT4 T-ALL cells</text></annotation><annotation id="7"><infon key="identifier">13876</infon><infon key="type">GENE</infon><location offset="595" length="3"/><text>ERG</text></annotation><annotation id="8"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="606" length="5"/><text>T-ALL</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="615" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="757" length="11"/><text>T-ALL cells</text></annotation><annotation id="11"><infon key="type">TISSUE</infon><location offset="1006" length="20"/><text>liver c-kit(+) cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="914" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="725" length="3"/><text>ERG</text></annotation><annotation id="14"><infon key="identifier">0004052</infon><infon key="type">TISSUE</infon><location offset="1034" length="16"/><text>bone marrow stem</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="672" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="822" length="8"/><text>SCL/TAL1</text></annotation><annotation id="17"><infon key="identifier">4005</infon><infon key="type">GENE</infon><location offset="832" length="4"/><text>LMO2</text></annotation><annotation id="18"><infon key="identifier">4066</infon><infon key="type">GENE</infon><location offset="842" length="4"/><text>LYL1</text></annotation><annotation id="19"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="863" length="3"/><text>ERG</text></annotation><annotation id="20"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="868" length="4"/><text>FLI1</text></annotation><annotation id="21"><infon key="identifier">2625</infon><infon key="type">GENE</infon><location offset="878" length="5"/><text>GATA3</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="102" length="18"/><text>stem cell enhancer</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="82" length="14"/><text>leukemic cells</text></annotation><annotation id="24"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="947" length="7"/><text>T cells</text></annotation><annotation id="25"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="973" length="4"/><text>mice</text></annotation><annotation id="26"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1165" length="3"/><text>ERG</text></annotation><annotation id="27"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1178" length="5"/><text>T-ALL</text></annotation><annotation id="28"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1304" length="3"/><text>ERG</text></annotation><annotation id="29"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1345" length="8"/><text>leukemia</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="751" length="5"/><text>human</text></annotation><annotation id="31"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="805" length="6"/><text>T-cell</text></annotation><annotation id="32"><infon key="type">TISSUE</infon><location offset="1073" length="47"/><text>CD4(-)CD8(-) double-negative thymic progenitors</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="1227" length="9"/><text>stem cell</text></annotation><annotation id="34"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>ERG</text></annotation><annotation id="35"><infon key="type">TISSUE</infon><location offset="102" length="9"/><text>stem cell</text></annotation><annotation id="36"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="891" length="3"/><text>ERG</text></annotation><annotation id="37"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="13" length="30"/><text>T-acute lymphoblastic leukemia</text></annotation><annotation id="38"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="200" length="15"/><text>blood stem cell</text></annotation><annotation id="39"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="126" length="16"/><text>Ets-related gene</text></annotation><annotation id="40"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="144" length="3"/><text>ERG</text></annotation><annotation id="41"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="229" length="3"/><text>ERG</text></annotation></passage></document>
<document><id>21549805</id><passage><offset>0</offset><text>Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5. OBJECTIVE: The transcription factor PAX5 is essential for the activation of B-cell-specific genes and for the silencing of myeloid-specific genes. We previously determined the molecular mechanism by which PAX5 silences the myeloid-specific colony-stimulating-factor-receptor (Csf1R) gene and showed that PAX5 directly binds to the Csf1r promoter as well as to an intronic enhancer that generates an antisense transcript in B cells. Here we examine the role of PAX5 in the regulation of sense and antisense transcription in B cells. MATERIALS AND METHODS: We performed PAX5-specific chromatin immunoprecipitation analyses across the Csfr1 locus. We investigated the role of PAX5 in regulating Csf1r sense and antisense promoter activity by transient transfections and by employing a Pax5(-/-) pro-B-cell line expressing an inducible PAX5 protein. PAX5 interacting factors were identified by pull-down experiments. The role of the transcription factor Sp3 in driving antisense promoter expression was examined in B cells from Sp3 knockout mice. RESULTS: PAX5 differentially regulates the Csf1r promoter and the promoter of the antisense transcript. PAX5 interferes with PU.1 transactivation at the sense promoter by binding to a PAX5 consensus sequence. At the antisense promoter, PAX5 does not specifically recognize DNA, but interacts with Sp3 to upregulate antisense promoter activity. Antisense promoter activation by PAX5 is dependent on the presence of its partial homeo-domain. CONCLUSIONS: We demonstrate that PAX5 regulates Csf1r in B cells by reducing the frequency of binding of the basal transcription machinery to the promoter and by activating antisense RNA expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="460" length="14"/><text>Csf1r promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1516" length="18"/><text>Antisense promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1758" length="8"/><text>promoter</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="72" length="11"/><text>Csf1R locus</text></annotation><annotation id="5"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="123" length="4"/><text>PAX5</text></annotation><annotation id="6"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="165" length="4"/><text>PAX5</text></annotation><annotation id="7"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="334" length="4"/><text>PAX5</text></annotation><annotation id="8"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="405" length="5"/><text>Csf1R</text></annotation><annotation id="9"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="433" length="4"/><text>PAX5</text></annotation><annotation id="10"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="552" length="7"/><text>B cells</text></annotation><annotation id="11"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="589" length="4"/><text>PAX5</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="492" length="17"/><text>intronic enhancer</text></annotation><annotation id="13"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="697" length="4"/><text>PAX5</text></annotation><annotation id="14"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="802" length="4"/><text>PAX5</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="821" length="11"/><text>Csf1r sense</text></annotation><annotation id="16"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="911" length="4"/><text>Pax5</text></annotation><annotation id="17"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="961" length="4"/><text>PAX5</text></annotation><annotation id="18"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="975" length="4"/><text>PAX5</text></annotation><annotation id="19"><infon key="identifier">20687</infon><infon key="type">GENE</infon><location offset="1079" length="3"/><text>Sp3</text></annotation><annotation id="20"><infon key="identifier">20687</infon><infon key="type">GENE</infon><location offset="1153" length="3"/><text>Sp3</text></annotation><annotation id="21"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1166" length="4"/><text>mice</text></annotation><annotation id="22"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1181" length="4"/><text>PAX5</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="761" length="11"/><text>Csfr1 locus</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1356" length="23"/><text>PAX5 consensus sequence</text></annotation><annotation id="25"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1276" length="4"/><text>PAX5</text></annotation><annotation id="26"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="1660" length="5"/><text>Csf1r</text></annotation><annotation id="27"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1408" length="4"/><text>PAX5</text></annotation><annotation id="28"><infon key="identifier">20687</infon><infon key="type">GENE</infon><location offset="1469" length="3"/><text>Sp3</text></annotation><annotation id="29"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1549" length="4"/><text>PAX5</text></annotation><annotation id="30"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1645" length="4"/><text>PAX5</text></annotation><annotation id="31"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1669" length="7"/><text>B cells</text></annotation><annotation id="32"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="1297" length="4"/><text>PU.1</text></annotation><annotation id="33"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="205" length="6"/><text>B-cell</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1094" length="18"/><text>antisense promoter</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="837" length="18"/><text>antisense promoter</text></annotation><annotation id="36"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="87" length="7"/><text>B cells</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="27" length="5"/><text>sense</text></annotation><annotation id="38"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="369" length="34"/><text>colony-stimulating-factor-receptor</text></annotation><annotation id="39"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="652" length="7"/><text>B cells</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="37" length="18"/><text>antisense promoter</text></annotation><annotation id="41"><infon key="identifier">0003103</infon><infon key="type">TISSUE</infon><location offset="921" length="15"/><text>pro-B-cell line</text></annotation><annotation id="42"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1140" length="7"/><text>B cells</text></annotation><annotation id="43"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="252" length="7"/><text>myeloid</text></annotation><annotation id="44"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="352" length="7"/><text>myeloid</text></annotation><annotation id="45"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1215" length="14"/><text>Csf1r promoter</text></annotation><annotation id="46"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="72" length="5"/><text>Csf1R</text></annotation><annotation id="47"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="761" length="5"/><text>Csfr1</text></annotation><annotation id="48"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="821" length="5"/><text>Csf1r</text></annotation><annotation id="49"><infon key="identifier">12978</infon><infon key="type">GENE</infon><location offset="1215" length="5"/><text>Csf1r</text></annotation><annotation id="50"><infon key="identifier">18507</infon><infon key="type">GENE</infon><location offset="1356" length="4"/><text>PAX5</text></annotation><annotation id="51"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1238" length="36"/><text>promoter of the antisense transcript</text></annotation><annotation id="52"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1325" length="14"/><text>sense promoter</text></annotation><annotation id="53"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1388" length="18"/><text>antisense promoter</text></annotation><annotation id="54"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1487" length="18"/><text>antisense promoter</text></annotation></passage></document>
<document><id>21556051</id><passage><offset>0</offset><text>Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. The UBE2C oncogene is overexpressed in many types of solid tumours including the lethal castration-resistant prostate cancer (CRPC). The underlying mechanisms causing UBE2C gene overexpression in CRPC are not fully understood. Here, we show that CRPC-specific enhancers drive UBE2C overexpression in both AR-negative and -positive CRPC cells. We further show that co-activator MED1 recruitment to the UBE2C enhancers is required for long-range UBE2C enhancer/promoter interactions. Importantly, we find that the molecular mechanism underlying MED1-mediated chromatin looping involves PI3K/AKT phosphorylated MED1-mediated recruitment of FoxA1, RNA polymerase II and TATA binding protein and their subsequent interactions at the UBE2C locus. MED1 phosphorylation leads to UBE2C locus looping, UBE2C gene expression and cell growth. Our results not only define a causal role of a post-translational modification (phosphorylation) of a co-activator (MED1) in forming or sustaining an active chromatin structure, but also suggest that development of specific therapies for CRPC should take account of targeting phosphorylated MED1.</text><annotation id="1"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="8" length="4"/><text>MED1</text></annotation><annotation id="2"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="22" length="5"/><text>UBE2C</text></annotation><annotation id="3"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="471" length="4"/><text>MED1</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="495" length="15"/><text>UBE2C enhancers</text></annotation><annotation id="5"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="637" length="4"/><text>MED1</text></annotation><annotation id="6"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="683" length="3"/><text>AKT</text></annotation><annotation id="7"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="702" length="4"/><text>MED1</text></annotation><annotation id="8"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="731" length="5"/><text>FoxA1</text></annotation><annotation id="9"><infon key="identifier">6908</infon><infon key="type">GENE</infon><location offset="760" length="20"/><text>TATA binding protein</text></annotation><annotation id="10"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="822" length="5"/><text>UBE2C</text></annotation><annotation id="11"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="835" length="4"/><text>MED1</text></annotation><annotation id="12"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="865" length="5"/><text>UBE2C</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="49" length="36"/><text>castration-resistant prostate cancer</text></annotation><annotation id="14"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="886" length="5"/><text>UBE2C</text></annotation><annotation id="15"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="1041" length="4"/><text>MED1</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="1163" length="4"/><text>CRPC</text></annotation><annotation id="17"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="1216" length="4"/><text>MED1</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0001033</infon><infon key="type">TISSUE</infon><location offset="425" length="10"/><text>CRPC cells</text></annotation><annotation id="19"><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="340" length="4"/><text>CRPC</text></annotation><annotation id="20"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="399" length="2"/><text>AR</text></annotation><annotation id="21"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="495" length="5"/><text>UBE2C</text></annotation><annotation id="22"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="98" length="5"/><text>UBE2C</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="153" length="7"/><text>tumours</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="182" length="36"/><text>castration-resistant prostate cancer</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="220" length="4"/><text>CRPC</text></annotation><annotation id="26"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="261" length="5"/><text>UBE2C</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="290" length="4"/><text>CRPC</text></annotation><annotation id="28"><infon key="identifier">11065</infon><infon key="type">GENE</infon><location offset="370" length="5"/><text>UBE2C</text></annotation></passage></document>
<document><id>21566115</id><passage><offset>0</offset><text>A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3. Deregulated IL-12 and IL-23 production from activated myeloid lineage cells is a key driver of numerous T cell-dependent autoimmune and inflammatory diseases. IL-12 and IL-23 share a common p40 subunit encoded by Il12b, which is negatively regulated at the transcriptional level by the STAT3 (signal transducer and activator of transcription 3)-activating anti-inflammatory cytokine IL-10. We found that IL-10 targets an enhancer 10 kb upstream of the Il12b transcriptional start site. Within the enhancer, a single 10-bp site is required for the inhibitory effects of IL-10 and is bound by NFIL3 (nuclear factor, interleukin 3-regulated), a B-ZIP transcription factor. Myeloid cells lacking NFIL3 produce excessive IL-12p40 and increased IL-12p70. Thus, the STAT3-dependent expression of NFIL3 is a key component of a negative feedback pathway in myeloid cells that suppresses proinflammatory responses.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="24"/><text>distal enhancer in Il12b</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="574" length="63"/><text>enhancer 10 kb upstream of the Il12b transcriptional start site</text></annotation><annotation id="3"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="366" length="5"/><text>Il12b</text></annotation><annotation id="4"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="439" length="5"/><text>STAT3</text></annotation><annotation id="5"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="446" length="50"/><text>signal transducer and activator of transcription 3</text></annotation><annotation id="6"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="536" length="5"/><text>IL-10</text></annotation><annotation id="7"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="557" length="5"/><text>IL-10</text></annotation><annotation id="8"><infon key="identifier">4783</infon><infon key="type">GENE</infon><location offset="751" length="39"/><text>nuclear factor, interleukin 3-regulated</text></annotation><annotation id="9"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="722" length="5"/><text>IL-10</text></annotation><annotation id="10"><infon key="identifier">4783</infon><infon key="type">GENE</infon><location offset="744" length="5"/><text>NFIL3</text></annotation><annotation id="11"><infon key="identifier">4783</infon><infon key="type">GENE</infon><location offset="845" length="5"/><text>NFIL3</text></annotation><annotation id="12"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="912" length="5"/><text>STAT3</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="650" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="identifier">4783</infon><infon key="type">GENE</infon><location offset="942" length="5"/><text>NFIL3</text></annotation><annotation id="15"><infon key="identifier">0007179</infon><infon key="type">DISEASE</infon><location offset="274" length="10"/><text>autoimmune</text></annotation><annotation id="16"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="823" length="13"/><text>Myeloid cells</text></annotation><annotation id="17"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="869" length="8"/><text>IL-12p40</text></annotation><annotation id="18"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="1001" length="13"/><text>myeloid cells</text></annotation><annotation id="19"><infon key="identifier">51561</infon><infon key="type">GENE</infon><location offset="175" length="5"/><text>IL-23</text></annotation><annotation id="20"><infon key="identifier">51561</infon><infon key="type">GENE</infon><location offset="322" length="5"/><text>IL-23</text></annotation><annotation id="21"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="21" length="5"/><text>Il12b</text></annotation><annotation id="22"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="605" length="5"/><text>Il12b</text></annotation><annotation id="23"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="207" length="21"/><text>myeloid lineage cells</text></annotation><annotation id="24"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="78" length="5"/><text>STAT3</text></annotation><annotation id="25"><infon key="identifier">4783</infon><infon key="type">GENE</infon><location offset="146" length="5"/><text>NFIL3</text></annotation><annotation id="26"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="257" length="6"/><text>T cell</text></annotation><annotation id="27"><infon key="identifier">0021166</infon><infon key="type">DISEASE</infon><location offset="289" length="21"/><text>inflammatory diseases</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="662" length="17"/><text>single 10-bp site</text></annotation><annotation id="29"><infon key="identifier">3578</infon><infon key="type">GENE</infon><location offset="343" length="3"/><text>p40</text></annotation></passage></document>
<document><id>21652712</id><passage><offset>0</offset><text>Suppression of the pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter by sterol regulatory element-binding protein-1c (SREBP-1c). Overexpression of sterol regulatory element-binding protein-1c (SREBP-1c) in beta cells causes impaired insulin secretion and beta cell dysfunction associated with diminished pancreatic duodenal homeodomain transcription factor-1 (PDX-1) expression in vitro and in vivo. To identify the molecular mechanism responsible for this effect, the mouse Pdx-1 gene promoter (2.7 kb) was analyzed in beta cell and non-beta cell lines. Despite no apparent sterol regulatory element-binding protein-binding sites, the Pdx-1 promoter was suppressed by SREBP-1c in beta cells in a dose-dependent manner. PDX-1 activated its own promoter. The E-box (-104/-99 bp) in the proximal region, occupied by ubiquitously expressed upstream stimulatory factors (USFs), was crucial for the PDX-1-positive autoregulatory loop through direct PDX-1 USF binding. This positive feedback activation was a prerequisite for SREBP-1c suppression of the promoter in non-beta cells. SREBP-1c and PDX-1 directly interact through basic helix-loop-helix and homeobox domains, respectively. This robust SREBP-1c PDX-1 complex interferes with PDX-1 USF formation and inhibits the recruitment of PDX-1 coactivators. SREBP-1c also inhibits PDX-1 binding to the previously described PDX-1-binding site (-2721/-2646 bp) in the distal enhancer region of the Pdx-1 promoter. Endogenous up-regulation of SREBP-1c in INS-1 cells through the activation of liver X receptor and retinoid X receptor by 9-cis-retinoic acid and 22-hydroxycholesterol inhibited PDX-1 mRNA and protein expression. Conversely, SREBP-1c RNAi restored Pdx-1 mRNA and protein levels. Through these multiple mechanisms, SREBP-1c, when induced in a lipotoxic state, repressed PDX-1 expression contributing to the inhibition of insulin expression and beta cell dysfunction.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="766" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1070" length="8"/><text>promoter</text></annotation><annotation id="3"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="742" length="5"/><text>PDX-1</text></annotation><annotation id="4"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="916" length="5"/><text>PDX-1</text></annotation><annotation id="5"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="966" length="5"/><text>PDX-1</text></annotation><annotation id="6"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1042" length="8"/><text>SREBP-1c</text></annotation><annotation id="7"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1098" length="8"/><text>SREBP-1c</text></annotation><annotation id="8"><infon key="identifier">29535</infon><infon key="type">GENE</infon><location offset="1111" length="5"/><text>PDX-1</text></annotation><annotation id="9"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1214" length="8"/><text>SREBP-1c</text></annotation><annotation id="10"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1223" length="5"/><text>PDX-1</text></annotation><annotation id="11"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1253" length="5"/><text>PDX-1</text></annotation><annotation id="12"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1305" length="5"/><text>PDX-1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1433" length="44"/><text>distal enhancer region of the Pdx-1 promoter</text></annotation><annotation id="14"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1325" length="8"/><text>SREBP-1c</text></annotation><annotation id="15"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1348" length="5"/><text>PDX-1</text></annotation><annotation id="16"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1507" length="8"/><text>SREBP-1c</text></annotation><annotation id="17"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1657" length="5"/><text>PDX-1</text></annotation><annotation id="18"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1704" length="8"/><text>SREBP-1c</text></annotation><annotation id="19"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1727" length="5"/><text>Pdx-1</text></annotation><annotation id="20"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="1793" length="8"/><text>SREBP-1c</text></annotation><annotation id="21"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1848" length="5"/><text>PDX-1</text></annotation><annotation id="22"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="228" length="10"/><text>beta cells</text></annotation><annotation id="23"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="277" length="9"/><text>beta cell</text></annotation><annotation id="24"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="94" length="44"/><text>sterol regulatory element-binding protein-1c</text></annotation><annotation id="25"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="326" length="54"/><text>pancreatic duodenal homeodomain transcription factor-1</text></annotation><annotation id="26"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="542" length="9"/><text>beta cell</text></annotation><annotation id="27"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="703" length="10"/><text>beta cells</text></annotation><annotation id="28"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="1557" length="5"/><text>liver</text></annotation><annotation id="29"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1390" length="5"/><text>PDX-1</text></annotation><annotation id="30"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="1922" length="9"/><text>beta cell</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="19" length="71"/><text>pancreatic duodenal homeodomain transcription factor-1 (Pdx-1) promoter</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="497" length="28"/><text>Pdx-1 gene promoter (2.7 kb)</text></annotation><annotation id="33"><infon key="identifier">0000716</infon><infon key="type">TISSUE</infon><location offset="560" length="15"/><text>beta cell lines</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="658" length="14"/><text>Pdx-1 promoter</text></annotation><annotation id="35"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="140" length="8"/><text>SREBP-1c</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="597" length="55"/><text>sterol regulatory element-binding protein-binding sites</text></annotation><annotation id="37"><infon key="identifier">0000783</infon><infon key="type">TISSUE</infon><location offset="1086" length="10"/><text>beta cells</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1390" length="87"/><text>PDX-1-binding site (-2721/-2646 bp) in the distal enhancer region of the Pdx-1 promoter</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1463" length="14"/><text>Pdx-1 promoter</text></annotation><annotation id="40"><infon key="identifier">0002135</infon><infon key="type">TISSUE</infon><location offset="1519" length="11"/><text>INS-1 cells</text></annotation><annotation id="41"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="1463" length="5"/><text>Pdx-1</text></annotation><annotation id="42"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="780" length="42"/><text>E-box (-104/-99 bp) in the proximal region</text></annotation><annotation id="43"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="19" length="54"/><text>pancreatic duodenal homeodomain transcription factor-1</text></annotation><annotation id="44"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="75" length="5"/><text>Pdx-1</text></annotation><annotation id="45"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="497" length="5"/><text>Pdx-1</text></annotation><annotation id="46"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="169" length="44"/><text>sterol regulatory element-binding protein-1c</text></annotation><annotation id="47"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="658" length="5"/><text>Pdx-1</text></annotation><annotation id="48"><infon key="identifier">78968</infon><infon key="type">GENE</infon><location offset="597" length="41"/><text>sterol regulatory element-binding protein</text></annotation><annotation id="49"><infon key="identifier">78968</infon><infon key="type">GENE</infon><location offset="215" length="8"/><text>SREBP-1c</text></annotation><annotation id="50"><infon key="identifier">18609</infon><infon key="type">GENE</infon><location offset="382" length="5"/><text>PDX-1</text></annotation><annotation id="51"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="491" length="5"/><text>mouse</text></annotation><annotation id="52"><infon key="identifier">20787</infon><infon key="type">GENE</infon><location offset="691" length="8"/><text>SREBP-1c</text></annotation></passage></document>
<document><id>21665992</id><passage><offset>0</offset><text>A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the selective loss of motor neurons. Several susceptibility genes for ALS have been reported; however, ALS etiology and pathogenesis remain largely unknown. To identify further ALS-susceptibility genes, we conducted a large-scale case-control association study using gene-based tag single-nucleotide polymorphisms (SNPs). A functional SNP (rs2275294) was found to be significantly associated with ALS through a stepwise screening approach (combined P= 9.3 x 10(-10), odds ratio = 1.32). The SNP was located in an enhancer region of ZNF512B, a transcription factor of unknown biological function, and the susceptibility allele showed decreased activity and decreased binding to nuclear proteins. ZNF512B over-expression increased transforming growth factor-beta (TGF-beta) signaling, while knockdown had the opposite effect. ZNF512B expression was increased in the anterior horn motor neurons of the spinal cord of ALS patients when compared with controls.  Our results strongly suggest that ZNF512B is an important positive regulator of TGF-beta signaling and that decreased ZNF512B expression increases susceptibility to ALS.</text><annotation id="1"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="24" length="7"/><text>ZNF512B</text></annotation><annotation id="2"><infon key="type">VARIANT</infon><infon key="identifier">rs2275294</infon><location offset="536" length="9"/><text>rs2275294</text></annotation><annotation id="3"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="112" length="29"/><text>Amyotrophic lateral sclerosis</text></annotation><annotation id="4"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="143" length="3"/><text>ALS</text></annotation><annotation id="5"><infon key="identifier">0005559</infon><infon key="type">DISEASE</infon><location offset="153" length="25"/><text>neurodegenerative disease</text></annotation><annotation id="6"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="266" length="3"/><text>ALS</text></annotation><annotation id="7"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="299" length="3"/><text>ALS</text></annotation><annotation id="8"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="373" length="3"/><text>ALS</text></annotation><annotation id="9"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="593" length="3"/><text>ALS</text></annotation><annotation id="10"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="1110" length="3"/><text>ALS</text></annotation><annotation id="11"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="1318" length="3"/><text>ALS</text></annotation><annotation id="12"><infon key="identifier">0000312</infon><infon key="type">TISSUE</infon><location offset="218" length="13"/><text>motor neurons</text></annotation><annotation id="13"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="891" length="7"/><text>ZNF512B</text></annotation><annotation id="14"><infon key="identifier">0005151</infon><infon key="type">TISSUE</infon><location offset="1060" length="13"/><text>anterior horn</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="709" length="26"/><text>enhancer region of ZNF512B</text></annotation><annotation id="16"><infon key="identifier">0000312</infon><infon key="type">TISSUE</infon><location offset="1074" length="13"/><text>motor neurons</text></annotation><annotation id="17"><infon key="identifier">0001279</infon><infon key="type">TISSUE</infon><location offset="1095" length="11"/><text>spinal cord</text></annotation><annotation id="18"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="728" length="7"/><text>ZNF512B</text></annotation><annotation id="19"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="925" length="31"/><text>transforming growth factor-beta</text></annotation><annotation id="20"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="958" length="8"/><text>TGF-beta</text></annotation><annotation id="21"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="1020" length="7"/><text>ZNF512B</text></annotation><annotation id="22"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="1187" length="7"/><text>ZNF512B</text></annotation><annotation id="23"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1233" length="8"/><text>TGF-beta</text></annotation><annotation id="24"><infon key="identifier">57473</infon><infon key="type">GENE</infon><location offset="1271" length="7"/><text>ZNF512B</text></annotation><annotation id="25"><infon key="identifier">0004976</infon><infon key="type">DISEASE</infon><location offset="69" length="29"/><text>amyotrophic lateral sclerosis</text></annotation></passage></document>
<document><id>21673114</id><passage><offset>0</offset><text>Combinatorial regulation of photoreceptor differentiation factor, neural retina leucine zipper gene NRL, revealed by in vivo promoter analysis. Development and homeostasis require stringent spatiotemporal control of gene expression patterns that are established, to a large extent, by combinatorial action of transcription regulatory proteins. The bZIP transcription factor NRL (neural retina leucine zipper) is critical for rod versus cone photoreceptor cell fate choice during retinal development and acts as a molecular switch to produce rods from postmitotic precursors. Loss of Nrl in mouse leads to a cone-only retina, whereas ectopic expression of Nrl in photoreceptor precursors generates rods. To decipher the transcriptional regulatory mechanisms upstream of Nrl, we identified putative cis-control elements in the Nrl promoter/enhancer region by examining cross-species sequence conservation. Using in vivo transfection of promoter-reporter constructs into the mouse retina, we show that a 0.9-kb sequence upstream of the Nrl transcription initiation site is sufficient to drive reporter gene expression in photoreceptors. We further define a 0.3-kb sequence including a proximal promoter (cluster A1) and an enhancer (cluster B) that can direct rod-specific expression in vivo. Electrophoretic mobility shift assays using mouse retinal nuclear extracts, in combination with specific antibodies, demonstrate the binding of retinoid-related orphan nuclear receptor beta (RORbeta), cone rod homeobox, orthodenticle homolog 2, and cyclic AMP response element-binding protein to predicted consensus elements within clusters A and B. Our studies demonstrate Nrl as a direct transcriptional target of RORbeta and suggest that combinatorial action of multiple regulatory factors modulates the expression of Nrl in developing and mature retina.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr14,55518040,55518674</infon><infon key="type">PROMOTER</infon><infon key="identifier">14,55518040,55518674</infon><infon key="gb">unk</infon><location offset="1182" length="17"/><text>proximal promoter</text></annotation><annotation id="2"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="1033" length="3"/><text>Nrl</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1334" length="5"/><text>mouse</text></annotation><annotation id="4"><infon key="identifier">225998</infon><infon key="type">GENE</infon><location offset="1481" length="7"/><text>RORbeta</text></annotation><annotation id="5"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="1664" length="3"/><text>Nrl</text></annotation><annotation id="6"><infon key="identifier">225998</infon><infon key="type">GENE</infon><location offset="1706" length="7"/><text>RORbeta</text></annotation><annotation id="7"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="1811" length="3"/><text>Nrl</text></annotation><annotation id="8"><infon key="identifier">4901</infon><infon key="type">GENE</infon><location offset="66" length="28"/><text>neural retina leucine zipper</text></annotation><annotation id="9"><infon key="identifier">4901</infon><infon key="type">GENE</infon><location offset="379" length="28"/><text>neural retina leucine zipper</text></annotation><annotation id="10"><infon key="identifier">0001175</infon><infon key="type">TISSUE</infon><location offset="617" length="6"/><text>retina</text></annotation><annotation id="11"><infon key="identifier">0001175</infon><infon key="type">TISSUE</infon><location offset="978" length="6"/><text>retina</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1220" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">0001036</infon><infon key="type">TISSUE</infon><location offset="436" length="4"/><text>cone</text></annotation><annotation id="14"><infon key="identifier">225998</infon><infon key="type">GENE</infon><location offset="1434" length="45"/><text>retinoid-related orphan nuclear receptor beta</text></annotation><annotation id="15"><infon key="identifier">0001175</infon><infon key="type">TISSUE</infon><location offset="1840" length="6"/><text>retina</text></annotation><annotation id="16"><infon key="identifier">0001036</infon><infon key="type">TISSUE</infon><location offset="607" length="4"/><text>cone</text></annotation><annotation id="17"><infon key="identifier">0001024</infon><infon key="type">TISSUE</infon><location offset="425" length="3"/><text>rod</text></annotation><annotation id="18"><infon key="identifier">0001060</infon><infon key="type">TISSUE</infon><location offset="441" length="18"/><text>photoreceptor cell</text></annotation><annotation id="19"><infon key="identifier">0001024</infon><infon key="type">TISSUE</infon><location offset="541" length="4"/><text>rods</text></annotation><annotation id="20"><infon key="identifier">0001024</infon><infon key="type">TISSUE</infon><location offset="697" length="4"/><text>rods</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="825" length="12"/><text>Nrl promoter</text></annotation><annotation id="22"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr14,55518040,55518674</infon><infon key="type">PROMOTER</infon><infon key="identifier">14,55518040,55518674</infon><infon key="gb">unk</infon><location offset="1201" length="10"/><text>cluster A1</text></annotation><annotation id="23"><infon key="identifier">4901</infon><infon key="type">GENE</infon><location offset="100" length="3"/><text>NRL</text></annotation><annotation id="24"><infon key="identifier">0001024</infon><infon key="type">TISSUE</infon><location offset="1257" length="3"/><text>rod</text></annotation><annotation id="25"><infon key="identifier">0001036</infon><infon key="type">TISSUE</infon><location offset="1491" length="4"/><text>cone</text></annotation><annotation id="26"><infon key="identifier">0001024</infon><infon key="type">TISSUE</infon><location offset="1496" length="3"/><text>rod</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1230" length="9"/><text>cluster B</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1596" length="42"/><text>consensus elements within clusters A and B</text></annotation><annotation id="29"><infon key="identifier">1385</infon><infon key="type">GENE</infon><location offset="1539" length="43"/><text>cyclic AMP response element-binding protein</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="838" length="15"/><text>enhancer region</text></annotation><annotation id="31"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1510" length="23"/><text>orthodenticle homolog 2</text></annotation><annotation id="32"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="825" length="3"/><text>Nrl</text></annotation><annotation id="33"><infon key="identifier">4901</infon><infon key="type">GENE</infon><location offset="374" length="3"/><text>NRL</text></annotation><annotation id="34"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="583" length="3"/><text>Nrl</text></annotation><annotation id="35"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="590" length="5"/><text>mouse</text></annotation><annotation id="36"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="655" length="3"/><text>Nrl</text></annotation><annotation id="37"><infon key="identifier">18185</infon><infon key="type">GENE</infon><location offset="769" length="3"/><text>Nrl</text></annotation><annotation id="38"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="972" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>21681857</id><passage><offset>0</offset><text>N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy. N-acetylglutamate synthase (NAGS) catalyzes the conversion of glutamate and acetyl-CoA to NAG, the essential allosteric activator of carbamyl phosphate synthetase I, the first urea cycle enzyme in mammals. A 17-year-old female with recurrent hyperammonemia attacks, the cause of which remained undiagnosed for 8 years in spite of multiple molecular and biochemical investigations, showed markedly enhanced ureagenesis (measured by isotope incorporation) in response to N-carbamylglutamate (NCG). This led to sequencing of the regulatory regions of the NAGS gene and identification of a deleterious single-base substitution in the upstream enhancer. The homozygous mutation (c.-3064C&gt;A), affecting a highly conserved nucleotide within the hepatic nuclear factor 1 (HNF-1) binding site, was not found in single nucleotide polymorphism databases and in a screen of 1,086 alleles from a diverse population. Functional assays demonstrated that this mutation decreases transcription and binding of HNF-1 to the NAGS gene, while a consensus HNF-1 binding sequence enhances binding to HNF-1 and increases transcription. Oral daily NCG therapy restored ureagenesis in this patient, normalizing her biochemical markers, and allowing discontinuation of alternate pathway therapy and normalization of her diet with no recurrence of hyperammonemia. Inc.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="117" length="25"/><text>enhancer of the NAGS gene</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="799" length="17"/><text>upstream enhancer</text></annotation><annotation id="3"><infon key="identifier">162417</infon><infon key="type">GENE</infon><location offset="1174" length="4"/><text>NAGS</text></annotation><annotation id="4"><infon key="identifier">6927</infon><infon key="type">GENE</infon><location offset="907" length="24"/><text>hepatic nuclear factor 1</text></annotation><annotation id="5"><infon key="identifier">6927</infon><infon key="type">GENE</infon><location offset="1246" length="5"/><text>HNF-1</text></annotation><annotation id="6"><infon key="identifier">0004739</infon><infon key="type">DISEASE</infon><location offset="1489" length="14"/><text>hyperammonemia</text></annotation><annotation id="7"><infon key="identifier">6927</infon><infon key="type">GENE</infon><location offset="933" length="5"/><text>HNF-1</text></annotation><annotation id="8"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="366" length="7"/><text>mammals</text></annotation><annotation id="9"><infon key="comment">chr12:121413282</infon><infon key="type">VARIANT</infon><infon key="identifier">chr12:121413282</infon><location offset="843" length="10"/><text>c.-3064C&gt;A</text></annotation><annotation id="10"><infon key="identifier">6927</infon><infon key="type">GENE</infon><location offset="1203" length="5"/><text>HNF-1</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1193" length="32"/><text>consensus HNF-1 binding sequence</text></annotation><annotation id="12"><infon key="identifier">162417</infon><infon key="type">GENE</infon><location offset="169" length="26"/><text>N-acetylglutamate synthase</text></annotation><annotation id="13"><infon key="identifier">162417</infon><infon key="type">GENE</infon><location offset="197" length="4"/><text>NAGS</text></annotation><annotation id="14"><infon key="identifier">0004739</infon><infon key="type">DISEASE</infon><location offset="411" length="14"/><text>hyperammonemia</text></annotation><annotation id="15"><infon key="identifier">162417</infon><infon key="type">GENE</infon><location offset="721" length="4"/><text>NAGS</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="907" length="45"/><text>hepatic nuclear factor 1 (HNF-1) binding site</text></annotation><annotation id="17"><infon key="identifier">162417</infon><infon key="type">GENE</infon><location offset="133" length="4"/><text>NAGS</text></annotation><annotation id="18"><infon key="identifier">6927</infon><infon key="type">GENE</infon><location offset="1161" length="5"/><text>HNF-1</text></annotation></passage></document>
<document><id>21689639</id><passage><offset>0</offset><text>A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation. NANOG is a homeodomain-containing transcription factor that is essential for the maintenance of pluripotency and self-renewal in embryonic stem cells. However, the molecular mechanisms underlying the regulation of NANOG expression in human cells remain largely unknown. Here, we investigated the role of Tcf/Lef response elements located in the enhancer of the human NANOG gene. We found that forced expression of Lef1 or beta-catenin stimulated human NANOG promoter activity, while shRNA-mediated knockdown of beta-catenin reduced Lef1-induced NANOG promoter activation. Deletion or mutation of the Tcf/Lef element within the enhancer region of the human NANOG gene completely abrogated Lef1-induced NANOG promoter activity. The results of a chromatin immunoprecipitation assay demonstrated that Lef1 and beta-catenin bind to the Tcf/Lef element in the enhancer region of the NANOG gene. Forced expression of GSK-3beta inhibited basal, Lef1-induced, and beta-catenin-induced NANOG promoter activity, while treatment with the GSK-3beta inhibitor SB216763 resulted in the accumulation of beta-catenin and NANOG protein. Furthermore, Dvl-1-induced NANOG promoter activity was abrogated by the expression of beta-catenin shRNA. Stable overexpression of Dvl-1 caused beta-catenin and NANOG to accumulate. These results indicate that the Tcf/Lef response element in the enhancer region of the human NANOG gene is able to stimulate NANOG gene transcription.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="29" length="39"/><text>enhancer region of the human NANOG gene</text></annotation><annotation id="2"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="58" length="5"/><text>NANOG</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1471" length="39"/><text>enhancer region of the human NANOG gene</text></annotation><annotation id="4"><infon key="identifier">51176</infon><infon key="type">GENE</infon><location offset="520" length="4"/><text>Lef1</text></annotation><annotation id="5"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="235" length="20"/><text>embryonic stem cells</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="706" length="66"/><text>Tcf/Lef element within the enhancer region of the human NANOG gene</text></annotation><annotation id="7"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="106" length="5"/><text>NANOG</text></annotation><annotation id="8"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="320" length="5"/><text>NANOG</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="340" length="5"/><text>human</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="410" length="73"/><text>Tcf/Lef response elements located in the enhancer of the human NANOG gene</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="2" length="66"/><text>Tcf/Lef element within the enhancer region of the human NANOG gene</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="937" length="56"/><text>Tcf/Lef element in the enhancer region of the NANOG gene</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="451" length="32"/><text>enhancer of the human NANOG gene</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1439" length="71"/><text>Tcf/Lef response element in the enhancer region of the human NANOG gene</text></annotation><annotation id="15"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="528" length="12"/><text>beta-catenin</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="552" length="5"/><text>human</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="52" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="617" length="12"/><text>beta-catenin</text></annotation><annotation id="19"><infon key="identifier">51176</infon><infon key="type">GENE</infon><location offset="638" length="4"/><text>Lef1</text></annotation><annotation id="20"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="473" length="5"/><text>NANOG</text></annotation><annotation id="21"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="762" length="5"/><text>NANOG</text></annotation><annotation id="22"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="983" length="5"/><text>NANOG</text></annotation><annotation id="23"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1500" length="5"/><text>NANOG</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="558" length="14"/><text>NANOG promoter</text></annotation><annotation id="25"><infon key="identifier">51176</infon><infon key="type">GENE</infon><location offset="794" length="4"/><text>Lef1</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1494" length="5"/><text>human</text></annotation><annotation id="27"><infon key="identifier">51176</infon><infon key="type">GENE</infon><location offset="903" length="4"/><text>Lef1</text></annotation><annotation id="28"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="912" length="12"/><text>beta-catenin</text></annotation><annotation id="29"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="467" length="5"/><text>human</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="756" length="5"/><text>human</text></annotation><annotation id="31"><infon key="identifier">2932</infon><infon key="type">GENE</infon><location offset="1016" length="9"/><text>GSK-3beta</text></annotation><annotation id="32"><infon key="identifier">51176</infon><infon key="type">GENE</infon><location offset="1043" length="4"/><text>Lef1</text></annotation><annotation id="33"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1061" length="12"/><text>beta-catenin</text></annotation><annotation id="34"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="558" length="5"/><text>NANOG</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="651" length="14"/><text>NANOG promoter</text></annotation><annotation id="36"><infon key="identifier">2932</infon><infon key="type">GENE</infon><location offset="1132" length="9"/><text>GSK-3beta</text></annotation><annotation id="37"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1193" length="12"/><text>beta-catenin</text></annotation><annotation id="38"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1210" length="5"/><text>NANOG</text></annotation><annotation id="39"><infon key="identifier">1855</infon><infon key="type">GENE</infon><location offset="1238" length="5"/><text>Dvl-1</text></annotation><annotation id="40"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="651" length="5"/><text>NANOG</text></annotation><annotation id="41"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1311" length="12"/><text>beta-catenin</text></annotation><annotation id="42"><infon key="identifier">1855</infon><infon key="type">GENE</infon><location offset="1356" length="5"/><text>Dvl-1</text></annotation><annotation id="43"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1369" length="12"/><text>beta-catenin</text></annotation><annotation id="44"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1386" length="5"/><text>NANOG</text></annotation><annotation id="45"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="807" length="5"/><text>NANOG</text></annotation><annotation id="46"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="733" length="39"/><text>enhancer region of the human NANOG gene</text></annotation><annotation id="47"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1082" length="5"/><text>NANOG</text></annotation><annotation id="48"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1252" length="5"/><text>NANOG</text></annotation><annotation id="49"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="1532" length="5"/><text>NANOG</text></annotation><annotation id="50"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="807" length="14"/><text>NANOG promoter</text></annotation><annotation id="51"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="960" length="33"/><text>enhancer region of the NANOG gene</text></annotation><annotation id="52"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1082" length="14"/><text>NANOG promoter</text></annotation><annotation id="53"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1252" length="14"/><text>NANOG promoter</text></annotation></passage></document>
<document><id>21711161</id><passage><offset>0</offset><text>Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region. Activation of the human growth hormone gene (hGH-N) is linked to a locus control region (LCR) containing four (I-III, V) hypersensitive sites (HS). Pit-1 binding to HS I/II is required for efficient pituitary expression. However, inclusion of HS III and V, located about 28 and 32 kb upstream of the hGH-N gene, respectively, is also required for consistent hGH-N expression levels in vivo. HS V is referred to as a boundary for the hGH LCR, but no specific enhancer blocking or barrier function is reported. We examined a 547 bp fragment containing HS V sequences (nucleotides -32,718/-32,172 relative to hGH-N) for enhancer-blocking activity using a well-established transient gene transfer system and assessed these sequences for CCCTC binding factor (CTCF), which is linked to enhancer-blocking activity. The 547 bp HS V fragment decreased enhancer activity with a reverse-orientation preference when inserted between HS III enhancer sequences and a minimal thymidine kinase promoter (TKp). These sequences are associated with CTCF in human pituitary and nonpituitary chromatin. Enhancer-blocking activity with an orientation preference was further localized to a 45 bp sub-fragment, with evidence of CTCF and upstream binding factor 1 (USF1) binding; USF1 is linked more closely with barrier function. The presence of yin and yang 1 (Yy1) that cooperates with CTCF in the regulation of X-chromosome inactivation was also seen. A decrease in CTCF and Yy1 RNA levels was associated with a significant reduction in enhancer-blocking activity. Assessment of CpG-dinucleotides in the TKp indicates that the presence of HS V sequences are associated with an increased incidence of CpG-dinucleotide methylation of the GC box region. These data support association of CTCF and enhancer-blocking activity with HS V that is consistent with a role as a (LCR) boundary element and also implicates Yy1 in this process.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1117" length="3"/><text>TKp</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="85" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">106128904</infon><infon key="type">GENE</infon><location offset="91" length="35"/><text>growth hormone locus control region</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="146" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="152" length="14"/><text>growth hormone</text></annotation><annotation id="6"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="173" length="5"/><text>hGH-N</text></annotation><annotation id="7"><infon key="identifier">5449</infon><infon key="type">GENE</infon><location offset="276" length="5"/><text>Pit-1</text></annotation><annotation id="8"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="428" length="5"/><text>hGH-N</text></annotation><annotation id="9"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="486" length="5"/><text>hGH-N</text></annotation><annotation id="10"><infon key="identifier">51236</infon><infon key="type">GENE</infon><location offset="734" length="5"/><text>hGH-N</text></annotation><annotation id="11"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="861" length="20"/><text>CCCTC binding factor</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1712" length="3"/><text>TKp</text></annotation><annotation id="13"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="883" length="4"/><text>CTCF</text></annotation><annotation id="14"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1159" length="4"/><text>CTCF</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1167" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1333" length="4"/><text>CTCF</text></annotation><annotation id="17"><infon key="identifier">7391</infon><infon key="type">GENE</infon><location offset="1342" length="25"/><text>upstream binding factor 1</text></annotation><annotation id="18"><infon key="identifier">7391</infon><infon key="type">GENE</infon><location offset="1369" length="4"/><text>USF1</text></annotation><annotation id="19"><infon key="identifier">7391</infon><infon key="type">GENE</infon><location offset="1384" length="4"/><text>USF1</text></annotation><annotation id="20"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1451" length="14"/><text>yin and yang 1</text></annotation><annotation id="21"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1467" length="3"/><text>Yy1</text></annotation><annotation id="22"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1493" length="4"/><text>CTCF</text></annotation><annotation id="23"><infon key="identifier">106128904</infon><infon key="type">GENE</infon><location offset="195" length="20"/><text>locus control region</text></annotation><annotation id="24"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1574" length="4"/><text>CTCF</text></annotation><annotation id="25"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1583" length="3"/><text>Yy1</text></annotation><annotation id="26"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1893" length="4"/><text>CTCF</text></annotation><annotation id="27"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="2018" length="3"/><text>Yy1</text></annotation><annotation id="28"><infon key="identifier">106128904</infon><infon key="type">GENE</infon><location offset="1976" length="3"/><text>LCR</text></annotation><annotation id="29"><infon key="identifier">7083</infon><infon key="type">GENE</infon><location offset="1090" length="16"/><text>thymidine kinase</text></annotation><annotation id="30"><infon key="identifier">106128904</infon><infon key="type">GENE</infon><location offset="217" length="3"/><text>LCR</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1050" length="25"/><text>HS III enhancer sequences</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1090" length="25"/><text>thymidine kinase promoter</text></annotation><annotation id="33"><infon key="identifier">0000427</infon><infon key="type">TISSUE</infon><location offset="327" length="9"/><text>pituitary</text></annotation><annotation id="34"><infon key="identifier">0000427</infon><infon key="type">TISSUE</infon><location offset="1173" length="9"/><text>pituitary</text></annotation><annotation id="35"><infon key="identifier">106128904</infon><infon key="type">GENE</infon><location offset="561" length="7"/><text>hGH LCR</text></annotation></passage></document>
<document><id>21797989</id><passage><offset>0</offset><text>Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer. BACKGROUND: Hundreds of genes, including muscle creatine kinase (MCK), are differentially expressed in fast- and slow-twitch muscle fibers, but the fiber type-specific regulatory mechanisms are not well understood. RESULTS: Modulatory region 1 (MR1) is a 1-kb regulatory region within MCK intron 1 that is highly active in terminally differentiating skeletal myocytes in vitro. A MCK small intronic enhancer (MCK-SIE) containing a paired E-box/myocyte enhancer factor 2 (MEF2) regulatory motif resides within MR1. The SIE's transcriptional activity equals that of the extensively characterized 206-bp MCK 5'-enhancer, but the MCK-SIE is flanked by regions that can repress its activity via the individual and combined effects of about 15 different but highly conserved 9- to 24-bp sequences. ChIP and ChIP-Seq analyses indicate that the SIE and the MCK 5'-enhancer are occupied by MyoD, myogenin and MEF2. Many other E-boxes located within or immediately adjacent to intron 1 are not occupied by MyoD or myogenin. Transgenic analysis of a 6.5-kb MCK genomic fragment containing the 5'-enhancer and proximal promoter plus the 3.2-kb intron 1, with and without MR1, indicates that MR1 is critical for MCK expression in slow- and intermediate-twitch muscle fibers (types I and IIa, respectively), but is not required for expression in fast-twitch muscle fibers (types IIb and IId). CONCLUSIONS: In this study, we discovered that MR1 is critical for MCK expression in slow- and intermediate-twitch muscle fibers and that MR1's positive transcriptional activity depends on a paired E-box MEF2 site motif within a SIE. This is the first study to delineate the DNA controls for MCK expression in different skeletal muscle fiber types.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="54" length="40"/><text>muscle creatine kinase intronic enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="476" length="27"/><text>MCK small intronic enhancer</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="1255" length="3"/><text>MR1</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="505" length="7"/><text>MCK-SIE</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="614" length="3"/><text>SIE</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="722" length="7"/><text>MCK-SIE</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="933" length="3"/><text>SIE</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1013" length="58"/><text>E-boxes located within or immediately adjacent to intron 1</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1178" length="11"/><text>5'-enhancer</text></annotation><annotation id="10"><infon key="identifier">0002321</infon><infon key="type">TISSUE</infon><location offset="1323" length="33"/><text>intermediate-twitch muscle fibers</text></annotation><annotation id="11"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="977" length="4"/><text>MyoD</text></annotation><annotation id="12"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="983" length="8"/><text>myogenin</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="527" length="62"/><text>paired E-box/myocyte enhancer factor 2 (MEF2) regulatory motif</text></annotation><annotation id="14"><infon key="identifier">4205</infon><infon key="type">GENE</infon><location offset="996" length="4"/><text>MEF2</text></annotation><annotation id="15"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="1092" length="4"/><text>MyoD</text></annotation><annotation id="16"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="1100" length="8"/><text>myogenin</text></annotation><annotation id="17"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="1142" length="3"/><text>MCK</text></annotation><annotation id="18"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="1295" length="3"/><text>MCK</text></annotation><annotation id="19"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="1542" length="3"/><text>MCK</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1704" length="3"/><text>SIE</text></annotation><annotation id="21"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="1767" length="3"/><text>MCK</text></annotation><annotation id="22"><infon key="identifier">0001813</infon><infon key="type">TISSUE</infon><location offset="1469" length="3"/><text>IId</text></annotation><annotation id="23"><infon key="identifier">0001812</infon><infon key="type">TISSUE</infon><location offset="209" length="25"/><text>slow-twitch muscle fibers</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="690" length="22"/><text>206-bp MCK 5'-enhancer</text></annotation><annotation id="25"><infon key="identifier">0004392</infon><infon key="type">TISSUE</infon><location offset="446" length="17"/><text>skeletal myocytes</text></annotation><annotation id="26"><infon key="identifier">0001812</infon><infon key="type">TISSUE</infon><location offset="1358" length="7"/><text>types I</text></annotation><annotation id="27"><infon key="identifier">0002321</infon><infon key="type">TISSUE</infon><location offset="1370" length="3"/><text>IIa</text></annotation><annotation id="28"><infon key="identifier">0001813</infon><infon key="type">TISSUE</infon><location offset="1428" length="25"/><text>fast-twitch muscle fibers</text></annotation><annotation id="29"><infon key="identifier">0001813</infon><infon key="type">TISSUE</infon><location offset="1455" length="9"/><text>types IIb</text></annotation><annotation id="30"><infon key="identifier">0001812</infon><infon key="type">TISSUE</infon><location offset="1560" length="5"/><text>slow-</text></annotation><annotation id="31"><infon key="identifier">0002321</infon><infon key="type">TISSUE</infon><location offset="1570" length="33"/><text>intermediate-twitch muscle fibers</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1666" length="41"/><text>paired E-box MEF2 site motif within a SIE</text></annotation><annotation id="33"><infon key="identifier">0002319</infon><infon key="type">TISSUE</infon><location offset="1795" length="21"/><text>skeletal muscle fiber</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="320" length="73"/><text>Modulatory region 1 (MR1) is a 1-kb regulatory region within MCK intron 1</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="945" length="15"/><text>MCK 5'-enhancer</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="1275" length="3"/><text>MR1</text></annotation><annotation id="37"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="54" length="22"/><text>muscle creatine kinase</text></annotation><annotation id="38"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="476" length="3"/><text>MCK</text></annotation><annotation id="39"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="697" length="3"/><text>MCK</text></annotation><annotation id="40"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="722" length="3"/><text>MCK</text></annotation><annotation id="41"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="945" length="3"/><text>MCK</text></annotation><annotation id="42"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="381" length="3"/><text>MCK</text></annotation><annotation id="43"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1194" length="17"/><text>proximal promoter</text></annotation><annotation id="44"><infon key="identifier">0001812</infon><infon key="type">TISSUE</infon><location offset="1313" length="5"/><text>slow-</text></annotation><annotation id="45"><infon key="identifier">0001813</infon><infon key="type">TISSUE</infon><location offset="199" length="5"/><text>fast-</text></annotation><annotation id="46"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="137" length="22"/><text>muscle creatine kinase</text></annotation><annotation id="47"><infon key="identifier">1158</infon><infon key="type">GENE</infon><location offset="161" length="3"/><text>MCK</text></annotation></passage></document>
<document><id>21822303</id><passage><offset>0</offset><text>Sox2 expression in breast tumours and activation in breast cancer stem cells. The cancer stem cell (CSC) model does not imply that tumours are generated from transformed tissue stem cells. The target of transformation could be a tissue stem cell, a progenitor cell, or a differentiated cell that acquires self-renewal ability. The observation that induced pluripotency reprogramming and cancer are related has lead to the speculation that CSCs may arise through a reprogramming-like mechanism. Expression of pluripotency genes (Oct4, Nanog and Sox2) was tested in breast tumours by immunohistochemistry and it was found that Sox2 is expressed in early stage breast tumours. However, expression of Oct4 or Nanog was not found. Mammosphere formation in culture was used to reveal stem cell properties, where expression of Sox2, but not Oct4 or Nanog, was induced. Over-expression of Sox2 increased mammosphere formation, effect dependent on continuous Sox2 expression; furthermore, Sox2 knockdown prevented mammosphere formation and delayed tumour formation in xenograft tumour initiation models. Induction of Sox2 expression was achieved through activation of the distal enhancer of Sox2 promoter upon sphere formation, the same element that controls Sox2 transcription in pluripotent stem cells. These findings suggest that reactivation of Sox2 represents an early step in breast tumour initiation, explaining tumour heterogeneity by placing the tumour-initiating event in any cell along the axis of mammary differentiation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1163" length="32"/><text>distal enhancer of Sox2 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1182" length="13"/><text>Sox2 promoter</text></annotation><annotation id="3"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="544" length="4"/><text>Sox2</text></annotation><annotation id="4"><infon key="identifier">0021100</infon><infon key="type">DISEASE</infon><location offset="658" length="14"/><text>breast tumours</text></annotation><annotation id="5"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="625" length="4"/><text>Sox2</text></annotation><annotation id="6"><infon key="identifier">0021100</infon><infon key="type">DISEASE</infon><location offset="564" length="14"/><text>breast tumours</text></annotation><annotation id="7"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="697" length="4"/><text>Oct4</text></annotation><annotation id="8"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="705" length="5"/><text>Nanog</text></annotation><annotation id="9"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="820" length="4"/><text>Sox2</text></annotation><annotation id="10"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="834" length="4"/><text>Oct4</text></annotation><annotation id="11"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="842" length="5"/><text>Nanog</text></annotation><annotation id="12"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="881" length="4"/><text>Sox2</text></annotation><annotation id="13"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>Sox2</text></annotation><annotation id="14"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="950" length="4"/><text>Sox2</text></annotation><annotation id="15"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="980" length="4"/><text>Sox2</text></annotation><annotation id="16"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1039" length="6"/><text>tumour</text></annotation><annotation id="17"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1069" length="6"/><text>tumour</text></annotation><annotation id="18"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1108" length="4"/><text>Sox2</text></annotation><annotation id="19"><infon key="identifier">0021100</infon><infon key="type">DISEASE</infon><location offset="1373" length="13"/><text>breast tumour</text></annotation><annotation id="20"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1250" length="4"/><text>Sox2</text></annotation><annotation id="21"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1340" length="4"/><text>Sox2</text></annotation><annotation id="22"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1410" length="6"/><text>tumour</text></annotation><annotation id="23"><infon key="type">TISSUE</infon><location offset="236" length="9"/><text>stem cell</text></annotation><annotation id="24"><infon key="identifier">0021100</infon><infon key="type">DISEASE</infon><location offset="19" length="14"/><text>breast tumours</text></annotation><annotation id="25"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1446" length="6"/><text>tumour</text></annotation><annotation id="26"><infon key="type">TISSUE</infon><location offset="249" length="15"/><text>progenitor cell</text></annotation><annotation id="27"><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="100" length="3"/><text>CSC</text></annotation><annotation id="28"><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="439" length="4"/><text>CSCs</text></annotation><annotation id="29"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="1272" length="22"/><text>pluripotent stem cells</text></annotation><annotation id="30"><infon key="type">TISSUE</infon><location offset="778" length="9"/><text>stem cell</text></annotation><annotation id="31"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1182" length="4"/><text>Sox2</text></annotation><annotation id="32"><infon key="identifier">0006293</infon><infon key="type">TISSUE</infon><location offset="52" length="24"/><text>breast cancer stem cells</text></annotation><annotation id="33"><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="82" length="16"/><text>cancer stem cell</text></annotation><annotation id="34"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="131" length="7"/><text>tumours</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="387" length="6"/><text>cancer</text></annotation><annotation id="36"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="528" length="4"/><text>Oct4</text></annotation><annotation id="37"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="534" length="5"/><text>Nanog</text></annotation></passage></document>
<document><id>21868451</id><passage><offset>0</offset><text>The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells. The estrogen receptor alpha (ERalpha) is a master regulator of gene expression and works along with cooperating transcription factors in mediating the actions of the hormone estradiol (E2) in ER-positive tissues and breast tumors. Here, we report that expression of paired-like homeodomain transcription factor (PITX1), a tumor suppressor and member of the homeobox family of transcription factors, is robustly up-regulated by E2 in several ERalpha-positive breast cancer cell lines via ERalpha-dependent interaction between the proximal promoter and an enhancer region 5' upstream of the PITX1 gene. Overexpression of PITX1 selectively inhibited the transcriptional activity of ERalpha and ERbeta, while enhancing the activities of the glucocorticoid receptor and progesterone receptor. Reduction of PITX1 by small interfering RNA enhanced ERalpha-dependent transcriptional regulation of a subset of ERalpha target genes. The consensus PITX1 binding motif was found to be present in 28% of genome-wide ERalpha binding sites and was in close proximity to estrogen response elements in a subset of ERalpha binding sites, and E2 treatment enhanced PITX1 as well as ERalpha recruitment to these binding sites. These studies identify PITX1 as a new ERalpha transcriptional target that acts as a repressor to coordinate and fine tune target-specific, ERalpha-mediated transcriptional activity in human breast cancer cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="667" length="17"/><text>proximal promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="692" length="45"/><text>enhancer region 5' upstream of the PITX1 gene</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1141" length="21"/><text>ERalpha binding sites</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0000356</infon><infon key="type">TISSUE</infon><location offset="579" length="41"/><text>ERalpha-positive breast cancer cell lines</text></annotation><annotation id="5"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="625" length="7"/><text>ERalpha</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1235" length="21"/><text>ERalpha binding sites</text></annotation><annotation id="7"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="757" length="5"/><text>PITX1</text></annotation><annotation id="8"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="817" length="7"/><text>ERalpha</text></annotation><annotation id="9"><infon key="identifier">2100</infon><infon key="type">GENE</infon><location offset="829" length="6"/><text>ERbeta</text></annotation><annotation id="10"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="939" length="5"/><text>PITX1</text></annotation><annotation id="11"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="979" length="7"/><text>ERalpha</text></annotation><annotation id="12"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1039" length="7"/><text>ERalpha</text></annotation><annotation id="13"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="44" length="5"/><text>PITX1</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1065" length="29"/><text>consensus PITX1 binding motif</text></annotation><annotation id="15"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="875" length="23"/><text>glucocorticoid receptor</text></annotation><annotation id="16"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="903" length="21"/><text>progesterone receptor</text></annotation><annotation id="17"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="1284" length="5"/><text>PITX1</text></annotation><annotation id="18"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1301" length="7"/><text>ERalpha</text></annotation><annotation id="19"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="1368" length="5"/><text>PITX1</text></annotation><annotation id="20"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1383" length="7"/><text>ERalpha</text></annotation><annotation id="21"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1484" length="7"/><text>ERalpha</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1529" length="5"/><text>human</text></annotation><annotation id="23"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="727" length="5"/><text>PITX1</text></annotation><annotation id="24"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="90" length="23"/><text>estrogen receptor-alpha</text></annotation><annotation id="25"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1141" length="7"/><text>ERalpha</text></annotation><annotation id="26"><infon key="identifier">0000150</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="117" length="19"/><text>breast cancer cells</text></annotation><annotation id="27"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1235" length="7"/><text>ERalpha</text></annotation><annotation id="28"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="1075" length="5"/><text>PITX1</text></annotation><annotation id="29"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="579" length="7"/><text>ERalpha</text></annotation><annotation id="30"><infon key="attribute">CANCER</infon><infon key="type">DISEASE</infon><location offset="354" length="13"/><text>breast tumors</text></annotation><annotation id="31"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="142" length="23"/><text>estrogen receptor alpha</text></annotation><annotation id="32"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="167" length="7"/><text>ERalpha</text></annotation><annotation id="33"><infon key="attribute">CANCER</infon><infon key="identifier">0006801</infon><infon key="type">DISEASE</infon><location offset="460" length="5"/><text>tumor</text></annotation><annotation id="34"><infon key="identifier">5307</infon><infon key="type">GENE</infon><location offset="450" length="5"/><text>PITX1</text></annotation><annotation id="35"><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="1535" length="19"/><text>breast cancer cells</text></annotation></passage></document>
<document><id>22160855</id><passage><offset>0</offset><text>Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions. Oct4 is a POU domain homeobox gene, expressed in undifferentiated embryonal carcinoma and embryonic stem cells and is quickly down-regulated upon induction of differentiation. Transcriptional repression of Oct4 is followed by pronounced epigenetic changes on the regulatory region of the gene. Oct4 has a long upstream regulatory region of about 2,600 bp, consisting of proximal enhancer (PE), distal enhancer (DE), and proximal promoter (PP). In this study, we induced differentiation of a human embryonic carcinoma cell line, NT2, under two different adherent and non-adherent culture conditions, and compared histone modifications as the epigenetic marks on the regulatory region of Oct4 gene after 3 days of differentiation. Using chromatin immunoprecipitation coupled with real-time PCR technique, it was shown that the after induction of differentiation the repressive epigenetic marks of hypoacetylation and methylation on lysine-9 of histone H3 occurred very effectively on the upstream of Oct4, especially in PP region. Also, comparing the two culturing systems it was shown that methylation of lysine-9 of H3 histone was more drastic in PE region of adherent cells rather than suspension cells. This epigenetic profile was in agreement with the difference observed in the expression level of Oct4 in these two culturing systems. The current study clearly shows the effective role of cell culture condition on the epigenetic regulation of gene expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="519" length="17"/><text>proximal enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="543" length="15"/><text>distal enhancer</text></annotation><annotation id="3"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="835" length="4"/><text>Oct4</text></annotation><annotation id="4"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1147" length="4"/><text>Oct4</text></annotation><annotation id="5"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1451" length="4"/><text>Oct4</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="640" length="5"/><text>human</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="459" length="44"/><text>upstream regulatory region of about 2,600 bp</text></annotation><annotation id="8"><infon key="identifier">0000891</infon><infon key="type">TISSUE</infon><location offset="87" length="9"/><text>NT2 cells</text></annotation><annotation id="9"><infon key="identifier">0001437</infon><infon key="type">TISSUE</infon><location offset="646" length="29"/><text>embryonic carcinoma cell line</text></annotation><annotation id="10"><infon key="identifier">0001437</infon><infon key="type">TISSUE</infon><location offset="677" length="3"/><text>NT2</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="560" length="2"/><text>DE</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="569" length="17"/><text>proximal promoter</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1296" length="9"/><text>PE region</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1167" length="9"/><text>PP region</text></annotation><annotation id="15"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="239" length="20"/><text>embryonic stem cells</text></annotation><annotation id="16"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="35" length="4"/><text>Oct4</text></annotation><annotation id="17"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="149" length="4"/><text>Oct4</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0005440</infon><infon key="type">DISEASE</infon><location offset="215" length="19"/><text>embryonal carcinoma</text></annotation><annotation id="19"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="355" length="4"/><text>Oct4</text></annotation><annotation id="20"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="443" length="4"/><text>Oct4</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="538" length="2"/><text>PE</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="588" length="2"/><text>PP</text></annotation></passage></document>
<document><id>22212979</id><passage><offset>0</offset><text>Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure. BACKGROUND: Castration-resistant prostate cancers (CRPCs) overexpress often androgen receptor (AR). Here, we investigated the effect of AR overexpression on the dynamics of AR loading and RNA polymerase II (RNA Pol II) recruitment to chromatin. Acetylation of histone 3 (AcH3) on lysines 9 and 14 (K9 and K14) was also studied. METHODS: We used an LNCaP-based AR overexpression cell line model that includes a control line and two sublines, LNCaP-ARmo and LNCaP-ARhi, which overexpress AR twofold to threefold and fourfold to fivefold, respectively. Cells were exposed to 1 or 100 nM of dihydrotestosterone (DHT). Chromatin immunoprecipitation (ChIP) on the promoters and enhancers of prostate specific antigen (PSA) and transmembrane protease, serine 2 (TMPRSS2) genes was performed. qRT-PCR was used to measure the levels of PSA and TMPRSS2 transcripts. RESULTS: Upon stimulation with 1 nM DHT, AR and RNA Pol II were recruited onto PSA and TMPRSS2 enhancer regions to a greater extent (P &lt; 0.05) in AR-overexpressing cells compared to control cells. The difference in AR loading between the control and AR-overexpressing cells was abolished by a higher DHT concentration. The ratio of AcH3/H3 was increased in AR-overexpressing cells. The induction of transcription of PSA and TMPRSS2 occurred earlier in the AR-overexpressing cells. CONCLUSIONS: Our findings suggest that the levels of AR potentiate the recruitment of the AR, as well as components of the basic transcription machinery, to chromatin and affect the acetylation of histones in the presence of low levels of androgens. These changes result in enhanced gene transcription of AR target genes.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="769" length="9"/><text>promoters</text></annotation><annotation id="2"><infon key="identifier">3861</infon><infon key="type">GENE</infon><location offset="416" length="3"/><text>K14</text></annotation><annotation id="3"><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="567" length="10"/><text>LNCaP-ARhi</text></annotation><annotation id="4"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="823" length="3"/><text>PSA</text></annotation><annotation id="5"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="597" length="2"/><text>AR</text></annotation><annotation id="6"><infon key="identifier">7113</infon><infon key="type">GENE</infon><location offset="832" length="32"/><text>transmembrane protease, serine 2</text></annotation><annotation id="7"><infon key="identifier">7113</infon><infon key="type">GENE</infon><location offset="866" length="7"/><text>TMPRSS2</text></annotation><annotation id="8"><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="552" length="10"/><text>LNCaP-ARmo</text></annotation><annotation id="9"><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="459" length="39"/><text>LNCaP-based AR overexpression cell line</text></annotation><annotation id="10"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="938" length="3"/><text>PSA</text></annotation><annotation id="11"><infon key="identifier">7113</infon><infon key="type">GENE</infon><location offset="946" length="7"/><text>TMPRSS2</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1046" length="32"/><text>PSA and TMPRSS2 enhancer regions</text></annotation><annotation id="13"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1008" length="2"/><text>AR</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="783" length="38"/><text>enhancers of prostate specific antigen</text></annotation><annotation id="15"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="796" length="25"/><text>prostate specific antigen</text></annotation><annotation id="16"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1113" length="2"/><text>AR</text></annotation><annotation id="17"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1182" length="2"/><text>AR</text></annotation><annotation id="18"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1217" length="2"/><text>AR</text></annotation><annotation id="19"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1324" length="2"/><text>AR</text></annotation><annotation id="20"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1383" length="3"/><text>PSA</text></annotation><annotation id="21"><infon key="identifier">7113</infon><infon key="type">GENE</infon><location offset="1391" length="7"/><text>TMPRSS2</text></annotation><annotation id="22"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1423" length="2"/><text>AR</text></annotation><annotation id="23"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="0" length="17"/><text>Androgen receptor</text></annotation><annotation id="24"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1501" length="2"/><text>AR</text></annotation><annotation id="25"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1538" length="2"/><text>AR</text></annotation><annotation id="26"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1753" length="2"/><text>AR</text></annotation><annotation id="27"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1046" length="3"/><text>PSA</text></annotation><annotation id="28"><infon key="identifier">7113</infon><infon key="type">GENE</infon><location offset="1054" length="7"/><text>TMPRSS2</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="123" length="37"/><text>Castration-resistant prostate cancers</text></annotation><annotation id="30"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="162" length="5"/><text>CRPCs</text></annotation><annotation id="31"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="187" length="17"/><text>androgen receptor</text></annotation><annotation id="32"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="206" length="2"/><text>AR</text></annotation><annotation id="33"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="247" length="2"/><text>AR</text></annotation><annotation id="34"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="284" length="2"/><text>AR</text></annotation></passage></document>
<document><id>22253448</id><passage><offset>0</offset><text>Role of runt-related transcription factor 3 (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 (NCR1/NKp46), an activating natural killer (NK) cell receptor. Natural cytotoxicity receptor 1 (NCR1), also known as NKp46, is a natural killer (NK) lymphocyte-activating receptor. It is involved in major aspects of NK immune function and shows a high degree of lineage specificity in blood and bone marrow. The nature of its NK-restricted expression is not well understood. In this study, we confirm that human NCR1 NK-specific expression is achieved at the mRNA level. We found two key cis-regulatory elements in the immediate vicinity upstream of the gene. One element acts as an essential promoter, whereas the other acts as a tissue-dependent enhancer/repressor. This latter regulatory element contains a runt related-transcription factor (RUNX) recognition motif that preferentially binds RUNX3. Interfering with RUNX proteins using a dominant negative form results in decreased Ncr1 expression. RUNX3 overexpression had the opposite effect. These findings shed light on the role of RUNX3 in the control of an important NK-activating receptor.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="698" length="18"/><text>essential promoter</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="400" length="5"/><text>blood</text></annotation><annotation id="3"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="232" length="5"/><text>NKp46</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="521" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="527" length="4"/><text>NCR1</text></annotation><annotation id="6"><infon key="identifier">864</infon><infon key="type">GENE</infon><location offset="910" length="5"/><text>RUNX3</text></annotation><annotation id="7"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="1000" length="4"/><text>Ncr1</text></annotation><annotation id="8"><infon key="identifier">864</infon><infon key="type">GENE</infon><location offset="1017" length="5"/><text>RUNX3</text></annotation><annotation id="9"><infon key="identifier">864</infon><infon key="type">GENE</infon><location offset="1104" length="5"/><text>RUNX3</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="595" length="78"/><text>two key cis-regulatory elements in the immediate vicinity upstream of the gene</text></annotation><annotation id="11"><infon key="identifier">0000141</infon><infon key="type">TISSUE</infon><location offset="410" length="11"/><text>bone marrow</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="825" length="58"/><text>runt related-transcription factor (RUNX) recognition motif</text></annotation><annotation id="13"><infon key="identifier">864</infon><infon key="type">GENE</infon><location offset="8" length="35"/><text>runt-related transcription factor 3</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="746" length="25"/><text>tissue-dependent enhancer</text></annotation><annotation id="15"><infon key="identifier">864</infon><infon key="type">GENE</infon><location offset="45" length="5"/><text>RUNX3</text></annotation><annotation id="16"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="83" length="31"/><text>natural cytotoxicity receptor 1</text></annotation><annotation id="17"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="116" length="4"/><text>NCR1</text></annotation><annotation id="18"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="121" length="5"/><text>NKp46</text></annotation><annotation id="19"><infon key="identifier">3824</infon><infon key="type">GENE</infon><location offset="143" length="33"/><text>natural killer (NK) cell receptor</text></annotation><annotation id="20"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="178" length="31"/><text>Natural cytotoxicity receptor 1</text></annotation><annotation id="21"><infon key="identifier">9437</infon><infon key="type">GENE</infon><location offset="211" length="4"/><text>NCR1</text></annotation></passage></document>
<document><id>22260630</id><passage><offset>0</offset><text>Regulation of human microsomal prostaglandin E synthase-1 by IL-1beta requires a distal enhancer element with a unique role for C/EBPbeta. The studies of PGE2 (prostaglandin E2) biosynthesis have focused primarily on the role of cyclo-oxygenases. Efforts have shifted towards the specific PGE2 terminal synthases, particularly mPGES-1 (microsomal PGE synthase 1), which has emerged as the crucial inducible synthase with roles in pain, cancer and inflammation. mPGES-1 is induced by pro-inflammatory cytokines with studies focusing on the proximal promoter, mediated specifically through Egr-1 (early growth-response factor 1). Numerous studies demonstrate that the mPGES-1 promoter (PTGES) alone cannot account for the level of IL-1beta (interleukin 1beta) induction. We identified two DNase I-hypersensitive sites within the proximal promoter near the Egr-1 element and a novel distal site near -8.6 kb. Functional analysis of the distal site revealed two elements that co-operate with basal promoter expression and a stimulus-dependent enhancer. A specific binding site for C/EBPbeta (CCAAT/enhancer-binding protein beta) in the enhancer was directly responsible for inducible enhancer activity. ChIP (chromatin immunoprecipitation) analysis demonstrated constitutive Egr-1 binding to the promoter and induced RNA polymerase II and C/EBPbeta binding to the promoter and enhancer respectively. Knockout/knockdown studies established a functional role for C/EBPbeta in mPGES-1 gene regulation and the documented interaction between Egr-1 and C/EBPbeta highlights the proximal promoter co-operation with a novel distal enhancer element in regulating inducible mPGES-1 expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="81" length="23"/><text>distal enhancer element</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="539" length="17"/><text>proximal promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1360" length="8"/><text>promoter</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1373" length="8"/><text>enhancer</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1568" length="17"/><text>proximal promoter</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1612" length="23"/><text>distal enhancer element</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="14" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="20" length="37"/><text>microsomal prostaglandin E synthase-1</text></annotation><annotation id="9"><infon key="identifier">3553</infon><infon key="type">GENE</infon><location offset="61" length="8"/><text>IL-1beta</text></annotation><annotation id="10"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="128" length="9"/><text>C/EBPbeta</text></annotation><annotation id="11"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="327" length="7"/><text>mPGES-1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="666" length="16"/><text>mPGES-1 promoter</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="436" length="6"/><text>cancer</text></annotation><annotation id="14"><infon key="identifier">0021166</infon><infon key="type">DISEASE</infon><location offset="447" length="12"/><text>inflammation</text></annotation><annotation id="15"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="461" length="7"/><text>mPGES-1</text></annotation><annotation id="16"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="588" length="5"/><text>Egr-1</text></annotation><annotation id="17"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="595" length="30"/><text>early growth-response factor 1</text></annotation><annotation id="18"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="684" length="5"/><text>PTGES</text></annotation><annotation id="19"><infon key="identifier">3553</infon><infon key="type">GENE</infon><location offset="729" length="8"/><text>IL-1beta</text></annotation><annotation id="20"><infon key="identifier">3553</infon><infon key="type">GENE</infon><location offset="739" length="17"/><text>interleukin 1beta</text></annotation><annotation id="21"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="854" length="5"/><text>Egr-1</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="827" length="17"/><text>proximal promoter</text></annotation><annotation id="23"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="1271" length="5"/><text>Egr-1</text></annotation><annotation id="24"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1335" length="9"/><text>C/EBPbeta</text></annotation><annotation id="25"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1457" length="9"/><text>C/EBPbeta</text></annotation><annotation id="26"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="1470" length="7"/><text>mPGES-1</text></annotation><annotation id="27"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="1533" length="5"/><text>Egr-1</text></annotation><annotation id="28"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1543" length="9"/><text>C/EBPbeta</text></annotation><annotation id="29"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="1660" length="7"/><text>mPGES-1</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="994" length="8"/><text>promoter</text></annotation><annotation id="31"><infon key="identifier">80142</infon><infon key="type">GENE</infon><location offset="154" length="4"/><text>PGE2</text></annotation><annotation id="32"><infon key="identifier">80142</infon><infon key="type">GENE</infon><location offset="160" length="16"/><text>prostaglandin E2</text></annotation><annotation id="33"><infon key="identifier">80142</infon><infon key="type">GENE</infon><location offset="289" length="4"/><text>PGE2</text></annotation><annotation id="34"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="336" length="25"/><text>microsomal PGE synthase 1</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1020" length="27"/><text>stimulus-dependent enhancer</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1060" length="80"/><text>binding site for C/EBPbeta (CCAAT/enhancer-binding protein beta) in the enhancer</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1132" length="8"/><text>enhancer</text></annotation><annotation id="38"><infon key="identifier">9536</infon><infon key="type">GENE</infon><location offset="666" length="7"/><text>mPGES-1</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1292" length="8"/><text>promoter</text></annotation></passage></document>
<document><id>22264824</id><passage><offset>0</offset><text>Intragenic enhancers act as alternative promoters. A substantial amount of organismal complexity is thought to be encoded by enhancers which specify the location, timing, and levels of gene expression. In mammals there are more enhancers than promoters which are distributed both between and within genes. Here we show that activated, intragenic enhancers frequently act as alternative tissue-specific promoters producing a class of abundant, spliced, multiexonic poly(A)(+) RNAs (meRNAs) which reflect the host gene's structure. meRNAs make a substantial and unanticipated contribution to the complexity of the transcriptome, appearing as alternative isoforms of the host gene. The low protein-coding potential of meRNAs suggests that many meRNAs may be byproducts of enhancer activation or underlie as-yet-unidentified RNA-encoded functions. Distinguishing between meRNAs and mRNAs will transform our interpretation of dynamic changes in transcription both at the level of individual genes and of the genome as a whole.</text><annotation id="1"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="205" length="7"/><text>mammals</text></annotation></passage></document>
<document><id>22265404</id><passage><offset>0</offset><text>Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Higher-order chromosomal organization for transcription regulation is poorly understood in eukaryotes. Using genome-wide Chromatin Interaction Analysis with Paired-End-Tag sequencing (ChIA-PET), we mapped long-range chromatin interactions associated with RNA polymerase II in human cells and uncovered widespread promoter-centered intragenic, extragenic, and intergenic interactions. These interactions further aggregated into higher-order clusters, wherein proximal and distal genes were engaged through promoter-promoter interactions. Most genes with promoter-promoter interactions were active and transcribed cooperatively, and some interacting promoters could influence each other implying combinatorial complexity of transcriptional controls. Comparative analyses of different cell lines showed that cell-specific chromatin interactions could provide structural frameworks for cell-specific transcription, and suggested significant enrichment of enhancer-promoter interactions for cell-specific functions. Furthermore, genetically-identified disease-associated noncoding elements were found to be spatially engaged with corresponding genes through long-range interactions. Overall, our study provides insights into transcription regulation by three-dimensional chromatin interactions for both housekeeping and cell-specific genes in human cells.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1447" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="385" length="5"/><text>human</text></annotation></passage></document>
<document><id>22303449</id><passage><offset>0</offset><text>ISL1 directly regulates FGF10 transcription during human cardiac outflow formation. The LIM homeodomain gene Islet-1 (ISL1) encodes a transcription factor that has been associated with the multipotency of human cardiac progenitors, and in mice enables the correct deployment of second heart field (SHF) cells to become the myocardium of atria, right ventricle and outflow tract. Other markers have been identified that characterize subdomains of the SHF, such as the fibroblast growth factor Fgf10 in its anterior region. While functional evidence of its essential contribution has been demonstrated in many vertebrate species, SHF expression of Isl1 has been shown in only some models. We examined the relationship between human ISL1 and FGF10 within the embryonic time window during which the linear heart tube remodels into four chambers. ISL1 transcription demarcated an anatomical region supporting the conserved existence of a SHF in humans, and transcription factors of the GATA family were co-expressed therein. In conjunction, we identified a novel enhancer containing a highly conserved ISL1 consensus binding site within the FGF10 first intron. ChIP and EMSA demonstrated its direct occupation by ISL1. Transcription mediated by ISL1 from this FGF10 intronic element was enhanced by the presence of GATA4 and TBX20 cardiac transcription factors. Finally, transgenic mice confirmed that endogenous factors bound the human FGF10 intronic enhancer to drive reporter expression in the developing cardiac outflow tract. These findings highlight the interest of examining developmental regulatory networks directly in human tissues, when possible, to assess candidate non-coding regions that may be responsible for congenital malformations.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1058" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1432" length="23"/><text>FGF10 intronic enhancer</text></annotation><annotation id="3"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="646" length="4"/><text>Isl1</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="724" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="730" length="4"/><text>ISL1</text></annotation><annotation id="6"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="739" length="5"/><text>FGF10</text></annotation><annotation id="7"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="842" length="4"/><text>ISL1</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="940" length="6"/><text>humans</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1097" length="57"/><text>ISL1 consensus binding site within the FGF10 first intron</text></annotation><annotation id="10"><infon key="type">TISSUE</infon><location offset="211" length="19"/><text>cardiac progenitors</text></annotation><annotation id="11"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="467" length="10"/><text>fibroblast</text></annotation><annotation id="12"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="1208" length="4"/><text>ISL1</text></annotation><annotation id="13"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>ISL1</text></annotation><annotation id="14"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="1240" length="4"/><text>ISL1</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1255" length="22"/><text>FGF10 intronic element</text></annotation><annotation id="16"><infon key="identifier">2626</infon><infon key="type">GENE</infon><location offset="1310" length="5"/><text>GATA4</text></annotation><annotation id="17"><infon key="identifier">57057</infon><infon key="type">GENE</infon><location offset="1320" length="5"/><text>TBX20</text></annotation><annotation id="18"><infon key="type">TISSUE</infon><location offset="1503" length="21"/><text>cardiac outflow tract</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1377" length="4"/><text>mice</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1426" length="5"/><text>human</text></annotation><annotation id="21"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="1432" length="5"/><text>FGF10</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1623" length="5"/><text>human</text></annotation><annotation id="23"><infon key="identifier">0000839</infon><infon key="type">DISEASE</infon><location offset="1720" length="24"/><text>congenital malformations</text></annotation><annotation id="24"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="24" length="5"/><text>FGF10</text></annotation><annotation id="25"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="1097" length="4"/><text>ISL1</text></annotation><annotation id="26"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="1136" length="5"/><text>FGF10</text></annotation><annotation id="27"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="1255" length="5"/><text>FGF10</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="278" length="18"/><text>second heart field</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="298" length="3"/><text>SHF</text></annotation><annotation id="30"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="323" length="10"/><text>myocardium</text></annotation><annotation id="31"><infon key="identifier">0000903</infon><infon key="type">TISSUE</infon><location offset="337" length="5"/><text>atria</text></annotation><annotation id="32"><infon key="identifier">0001630</infon><infon key="type">TISSUE</infon><location offset="344" length="15"/><text>right ventricle</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="364" length="13"/><text>outflow tract</text></annotation><annotation id="34"><infon key="type">TISSUE</infon><location offset="450" length="3"/><text>SHF</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="51" length="5"/><text>human</text></annotation><annotation id="36"><infon key="identifier">7742</infon><infon key="type">SPECIES</infon><location offset="608" length="10"/><text>vertebrate</text></annotation><annotation id="37"><infon key="type">TISSUE</infon><location offset="628" length="3"/><text>SHF</text></annotation><annotation id="38"><infon key="identifier">0006180</infon><infon key="type">TISSUE</infon><location offset="795" length="17"/><text>linear heart tube</text></annotation><annotation id="39"><infon key="type">TISSUE</infon><location offset="933" length="3"/><text>SHF</text></annotation><annotation id="40"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="109" length="7"/><text>Islet-1</text></annotation><annotation id="41"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="118" length="4"/><text>ISL1</text></annotation><annotation id="42"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="205" length="5"/><text>human</text></annotation><annotation id="43"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="239" length="4"/><text>mice</text></annotation><annotation id="44"><infon key="identifier">2255</infon><infon key="type">GENE</infon><location offset="492" length="5"/><text>Fgf10</text></annotation></passage></document>
<document><id>22323542</id><passage><offset>0</offset><text>A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igkappa gene expression. The mouse Igkappa gene locus has three known transcriptional enhancers: an intronic enhancer (Ei), a 3' enhancer (E3'), and a further downstream enhancer (Ed). We previously discovered, using the chromosome conformation-capture technique, that Ei and E3' interact with a novel DNA sequence near the 3' end of the Igkappa locus, specifically in B cells. In the present investigation, we examined the function of this far downstream element. The sequence is evolutionarily conserved and exhibits a plasmacytoma cell-specific DNase I-hypersensitive site in chromatin, henceforth termed HS10 in the locus. HS10 acts as a coactivator of E3' in transient transfection assays. Although HS10(-/-) mice exhibited normal patterns of B cell development, they were tested further along with E3'(-/-) and Ed(-/-) mice for their Igkappa expression levels in plasma cells, as well as for both allelic and isotype exclusion in splenic B cells. HS10(-/-) and Ed(-/-), but not E3'(-/-), mice exhibited 2.5-fold lower levels of Igkappa expression in antigenically challenged plasma cells. E3'(-/-) mice, but not HS10(-/-) mice, exhibited impaired IgL isotype and allelic exclusion in splenic B cells. We have suggestive results that Ed may also weakly participate in these processes. In addition, HS10(-/-) mice no longer exhibited regional chromosome interactions with E3', and they exhibited modestly reduced somatic hypermutation in the Jkappa-Ckappa intronic region in germinal center B cells from Peyer's patches. We conclude that the HS10, E3', and Ed differentially regulate Igkappa gene dynamics.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="207" length="2"/><text>Ei</text></annotation><annotation id="2"><infon key="identifier">0001087</infon><infon key="type">TISSUE</infon><location offset="609" length="17"/><text>plasmacytoma cell</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="802" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="913" length="4"/><text>mice</text></annotation><annotation id="5"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="928" length="7"/><text>Igkappa</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1082" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="1122" length="7"/><text>Igkappa</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1192" length="4"/><text>mice</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1216" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">111519</infon><infon key="type">GENE</infon><location offset="1241" length="3"/><text>IgL</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1401" length="4"/><text>mice</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="188" length="17"/><text>intronic enhancer</text></annotation><annotation id="13"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="1676" length="7"/><text>Igkappa</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="146" length="37"/><text>three known transcriptional enhancers</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="41" length="9"/><text>enhancers</text></annotation><annotation id="16"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="457" length="7"/><text>B cells</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="60" length="2"/><text>Ed</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="227" length="3"/><text>E3'</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="268" length="2"/><text>Ed</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="357" length="2"/><text>Ei</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="364" length="3"/><text>E3'</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="214" length="11"/><text>3' enhancer</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="745" length="3"/><text>E3'</text></annotation><annotation id="24"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="836" length="6"/><text>B cell</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="892" length="3"/><text>E3'</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="905" length="2"/><text>Ed</text></annotation><annotation id="27"><infon key="identifier">0000392</infon><infon key="type">TISSUE</infon><location offset="957" length="12"/><text>plasma cells</text></annotation><annotation id="28"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1032" length="7"/><text>B cells</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1055" length="2"/><text>Ed</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1072" length="3"/><text>E3'</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="247" length="19"/><text>downstream enhancer</text></annotation><annotation id="32"><infon key="identifier">0000392</infon><infon key="type">TISSUE</infon><location offset="1169" length="12"/><text>plasma cells</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1183" length="3"/><text>E3'</text></annotation><annotation id="34"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1286" length="7"/><text>B cells</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1327" length="2"/><text>Ed</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1464" length="3"/><text>E3'</text></annotation><annotation id="37"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1583" length="7"/><text>B cells</text></annotation><annotation id="38"><infon key="identifier">0001784</infon><infon key="type">TISSUE</infon><location offset="1596" length="15"/><text>Peyer's patches</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1640" length="3"/><text>E3'</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1649" length="2"/><text>Ed</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="52" length="3"/><text>E3'</text></annotation><annotation id="42"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="88" length="7"/><text>Igkappa</text></annotation><annotation id="43"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="117" length="5"/><text>mouse</text></annotation><annotation id="44"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="123" length="7"/><text>Igkappa</text></annotation><annotation id="45"><infon key="identifier">243469</infon><infon key="type">GENE</infon><location offset="426" length="7"/><text>Igkappa</text></annotation></passage></document>
<document><id>22337891</id><passage><offset>0</offset><text>Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. Mutations in the Wnt/beta-catenin pathway occur in most colorectal cancers (CRCs), and these mutations lead to increased nuclear accumulation of the beta-catenin transcriptional co-activator. In the nucleus, beta-catenin associates with TCF/LEF sequence specific transcription factors to activate target gene expression. The Hippo pathway restricts cellular growth by preventing nuclear accumulation of the Yes-associated protein (YAP) transcriptional co-activator. YAP expression is elevated in CRCs suggesting that, like Wnt/beta-catenin signaling, the Hippo pathway may contribute to colorectal carcinogenesis. Regulation of YAP at the post-translational level has been well studied but the transcription factors that control YAP gene expression are unknown. Here we demonstrate that beta-catenin/TCF4 complexes bind a DNA enhancer element within the first intron of the YAP gene to drive YAP expression in CRC cells. As such, reducing beta-catenin expression in CRC cells using shRNAs leads to decreased YAP mRNA and protein levels. YAP is abundantly expressed in the cytoplasm and nuclei of several established human colon cancer cell lines and this localization pattern is insensitive to plating density. Finally, we show that YAP expression is elevated in the majority of a panel of primary human colorectal tumors compared with its expression in uninvolved colonic mucosa, and that YAP and beta-catenin localize to the nuclear compartment of tumor cells. Together, these results implicate YAP as an oncogene whose expression is driven by aberrant Wnt/beta-catenin signaling in human CRC cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="935" length="60"/><text>DNA enhancer element within the first intron of the YAP gene</text></annotation><annotation id="2"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="4" length="12"/><text>beta-catenin</text></annotation><annotation id="3"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="350" length="7"/><text>TCF/LEF</text></annotation><annotation id="4"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="520" length="22"/><text>Yes-associated protein</text></annotation><annotation id="5"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="544" length="3"/><text>YAP</text></annotation><annotation id="6"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="579" length="3"/><text>YAP</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="609" length="4"/><text>CRCs</text></annotation><annotation id="8"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="640" length="12"/><text>beta-catenin</text></annotation><annotation id="9"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="987" length="3"/><text>YAP</text></annotation><annotation id="10"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="741" length="3"/><text>YAP</text></annotation><annotation id="11"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="842" length="3"/><text>YAP</text></annotation><annotation id="12"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="900" length="12"/><text>beta-catenin</text></annotation><annotation id="13"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="37" length="22"/><text>Yes-associated protein</text></annotation><annotation id="14"><infon key="identifier">6925</infon><infon key="type">GENE</infon><location offset="913" length="4"/><text>TCF4</text></annotation><annotation id="15"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1005" length="3"/><text>YAP</text></annotation><annotation id="16"><infon key="identifier">0001615</infon><infon key="type">TISSUE</infon><location offset="1023" length="9"/><text>CRC cells</text></annotation><annotation id="17"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1052" length="12"/><text>beta-catenin</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0001615</infon><infon key="type">TISSUE</infon><location offset="1079" length="9"/><text>CRC cells</text></annotation><annotation id="19"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1121" length="3"/><text>YAP</text></annotation><annotation id="20"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1150" length="3"/><text>YAP</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1229" length="5"/><text>human</text></annotation><annotation id="22"><infon key="identifier">0000271</infon><infon key="type">TISSUE</infon><location offset="1478" length="14"/><text>colonic mucosa</text></annotation><annotation id="23"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="61" length="3"/><text>YAP</text></annotation><annotation id="24"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1346" length="3"/><text>YAP</text></annotation><annotation id="25"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1411" length="5"/><text>human</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0005335</infon><infon key="type">DISEASE</infon><location offset="1417" length="17"/><text>colorectal tumors</text></annotation><annotation id="27"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1503" length="3"/><text>YAP</text></annotation><annotation id="28"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1511" length="12"/><text>beta-catenin</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1563" length="11"/><text>tumor cells</text></annotation><annotation id="30"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1610" length="3"/><text>YAP</text></annotation><annotation id="31"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1672" length="12"/><text>beta-catenin</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1698" length="5"/><text>human</text></annotation><annotation id="33"><infon key="attribute">CANCER</infon><infon key="identifier">0001615</infon><infon key="type">TISSUE</infon><location offset="1704" length="9"/><text>CRC cells</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0001615</infon><infon key="type">TISSUE</infon><location offset="85" length="26"/><text>colorectal carcinoma cells</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0000797</infon><infon key="type">TISSUE</infon><location offset="1235" length="23"/><text>colon cancer cell lines</text></annotation><annotation id="36"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="134" length="12"/><text>beta-catenin</text></annotation><annotation id="37"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="169" length="18"/><text>colorectal cancers</text></annotation><annotation id="38"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="189" length="4"/><text>CRCs</text></annotation><annotation id="39"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="262" length="12"/><text>beta-catenin</text></annotation><annotation id="40"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="321" length="12"/><text>beta-catenin</text></annotation></passage></document>
<document><id>22370642</id><passage><offset>0</offset><text>The nuclear cofactor RAC3/AIB1/SRC-3 enhances Nrf2 signaling by interacting with transactivation domains. Nuclear factor erythroid 2-related factor 2 (Nrf2, NM 006164, 605 AA) is essential for the antioxidant responsive element (ARE)-mediated expression of a group of detoxifying antioxidant genes that detoxify carcinogens and protect against oxidative stress. Several proteins have been identified as Nrf2-interacting molecules. In this study, we found that the overexpression of receptor-associated coactivator 3 (RAC3)/AIB-1/steroid receptor coactivator-3, a nuclear coregulator and oncogene frequently amplified in human breast cancers, induced heme oxygenase-1 (HO-1) through Nrf2 transactivation in HeLa cells. Next, we determined the interaction between RAC3 and Nrf2 proteins using a co-immunoprecipitation assay and fluorescence resonance energy transfer analysis. The results showed that RAC3 bound directly to the Nrf2 protein in the nucleus. Subsequently, we identified the interacting domains of Nrf2 and RAC3 using a glutathione S-transferase pull-down assay. The results showed that both the N-terminal RAC3-pasB and C-terminal RAC3-R3B3 domains were tightly bound to the Neh4 and Neh5 transactivation domains. Furthermore, chromatin immunoprecipitation showed that RAC3 bound tightly to the ARE enhancer region of the HO-1 promoter via Nrf2 binding. These data suggest that Nrf2 activation is modulated and directly controlled through interactions with the RAC3 protein in HeLa cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1308" length="40"/><text>ARE enhancer region of the HO-1 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1335" length="13"/><text>HO-1 promoter</text></annotation><annotation id="3"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="517" length="4"/><text>RAC3</text></annotation><annotation id="4"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="529" length="30"/><text>steroid receptor coactivator-3</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="620" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="626" length="14"/><text>breast cancers</text></annotation><annotation id="7"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="650" length="16"/><text>heme oxygenase-1</text></annotation><annotation id="8"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="668" length="4"/><text>HO-1</text></annotation><annotation id="9"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="682" length="4"/><text>Nrf2</text></annotation><annotation id="10"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="762" length="4"/><text>RAC3</text></annotation><annotation id="11"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="771" length="4"/><text>Nrf2</text></annotation><annotation id="12"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="899" length="4"/><text>RAC3</text></annotation><annotation id="13"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="21" length="4"/><text>RAC3</text></annotation><annotation id="14"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="926" length="4"/><text>Nrf2</text></annotation><annotation id="15"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1010" length="4"/><text>Nrf2</text></annotation><annotation id="16"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="1019" length="4"/><text>RAC3</text></annotation><annotation id="17"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="1119" length="4"/><text>RAC3</text></annotation><annotation id="18"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="1144" length="4"/><text>RAC3</text></annotation><annotation id="19"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="1282" length="4"/><text>RAC3</text></annotation><annotation id="20"><infon key="identifier">0000567</infon><infon key="type">TISSUE</infon><location offset="1490" length="10"/><text>HeLa cells</text></annotation><annotation id="21"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1353" length="4"/><text>Nrf2</text></annotation><annotation id="22"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1391" length="4"/><text>Nrf2</text></annotation><annotation id="23"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="1474" length="4"/><text>RAC3</text></annotation><annotation id="24"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="26" length="4"/><text>AIB1</text></annotation><annotation id="25"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1335" length="4"/><text>HO-1</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="197" length="30"/><text>antioxidant responsive element</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="229" length="3"/><text>ARE</text></annotation><annotation id="28"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="523" length="5"/><text>AIB-1</text></annotation><annotation id="29"><infon key="identifier">0000567</infon><infon key="type">TISSUE</infon><location offset="706" length="10"/><text>HeLa cells</text></annotation><annotation id="30"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="31" length="5"/><text>SRC-3</text></annotation><annotation id="31"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="46" length="4"/><text>Nrf2</text></annotation><annotation id="32"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="106" length="43"/><text>Nuclear factor erythroid 2-related factor 2</text></annotation><annotation id="33"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="151" length="4"/><text>Nrf2</text></annotation><annotation id="34"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="403" length="4"/><text>Nrf2</text></annotation><annotation id="35"><infon key="identifier">8202</infon><infon key="type">GENE</infon><location offset="482" length="33"/><text>receptor-associated coactivator 3</text></annotation></passage></document>
<document><id>22378757</id><passage><offset>0</offset><text>NEUROG3 is a critical downstream effector for STAT3-regulated differentiation of mammalian stem and progenitor spermatogonia. Spermatogenesis relies on coordinated differentiation of stem and progenitor spermatogonia, and the transcription factor STAT3 is essential for this process in mammals. Here we studied the THY1+ spermatogonial population in mouse testes, which contains spermatogonial stem cells (SSC) and non-stem cell progenitor spermatogonia, to further define the downstream mechanism regulating differentiation. Transcript abundance for the bHLH transcription factor Neurog3 was found to be significantly reduced upon transient inhibition of STAT3 signaling in these cells and exposure to GDNF, a key growth factor regulating self-renewal of SSCs, suppressed activation of STAT3 and in accordance Neurog3 gene expression. Moreover, STAT3 was found to bind the distal Neurog3 promoter/enhancer region in THY1+ spermatogonia and regulate transcription. Transient inhibition of Neurog3 expression in cultures of proliferating THY1+ spermatogonia increased stem cell content after several self-renewal cycles without effecting overall proliferation of the cells, indicating impaired differentiation of SSCs to produce progenitor spermatogonia. Furthermore, cultured THY1+ spermatogonia with induced deficiency of Neurog3 were found to be incapable of differentiation in vivo following transplantation into testes of recipient mice. Collectively, these results establish a mechanism by which activation of STAT3 regulates the expression of NEUROG3 to subsequently drive differentiation of SSC and progenitor spermatogonia in the mammalian germline.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="874" length="23"/><text>distal Neurog3 promoter</text></annotation><annotation id="2"><infon key="identifier">2668</infon><infon key="type">GENE</infon><location offset="703" length="4"/><text>GDNF</text></annotation><annotation id="3"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="787" length="5"/><text>STAT3</text></annotation><annotation id="4"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="811" length="7"/><text>Neurog3</text></annotation><annotation id="5"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="846" length="5"/><text>STAT3</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="898" length="15"/><text>enhancer region</text></annotation><annotation id="7"><infon key="identifier">7070</infon><infon key="type">GENE</infon><location offset="917" length="4"/><text>THY1</text></annotation><annotation id="8"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="989" length="7"/><text>Neurog3</text></annotation><annotation id="9"><infon key="identifier">7070</infon><infon key="type">GENE</infon><location offset="1037" length="4"/><text>THY1</text></annotation><annotation id="10"><infon key="identifier">21838</infon><infon key="type">GENE</infon><location offset="1276" length="4"/><text>THY1</text></annotation><annotation id="11"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="1323" length="7"/><text>Neurog3</text></annotation><annotation id="12"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="0" length="7"/><text>NEUROG3</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1436" length="4"/><text>mice</text></annotation><annotation id="14"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1515" length="5"/><text>STAT3</text></annotation><annotation id="15"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="1549" length="7"/><text>NEUROG3</text></annotation><annotation id="16"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1638" length="9"/><text>mammalian</text></annotation><annotation id="17"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="1617" length="13"/><text>spermatogonia</text></annotation><annotation id="18"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="111" length="13"/><text>spermatogonia</text></annotation><annotation id="19"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="1416" length="6"/><text>testes</text></annotation><annotation id="20"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="203" length="13"/><text>spermatogonia</text></annotation><annotation id="21"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="286" length="7"/><text>mammals</text></annotation><annotation id="22"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="356" length="6"/><text>testes</text></annotation><annotation id="23"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="46" length="5"/><text>STAT3</text></annotation><annotation id="24"><infon key="type">TISSUE</infon><location offset="379" length="25"/><text>spermatogonial stem cells</text></annotation><annotation id="25"><infon key="type">TISSUE</infon><location offset="406" length="3"/><text>SSC</text></annotation><annotation id="26"><infon key="type">TISSUE</infon><location offset="419" length="34"/><text>stem cell progenitor spermatogonia</text></annotation><annotation id="27"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="923" length="13"/><text>spermatogonia</text></annotation><annotation id="28"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="1043" length="13"/><text>spermatogonia</text></annotation><annotation id="29"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="1239" length="13"/><text>spermatogonia</text></annotation><annotation id="30"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="1282" length="13"/><text>spermatogonia</text></annotation><annotation id="31"><infon key="type">TISSUE</infon><location offset="1067" length="9"/><text>stem cell</text></annotation><annotation id="32"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="881" length="7"/><text>Neurog3</text></annotation><annotation id="33"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="81" length="9"/><text>mammalian</text></annotation><annotation id="34"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="247" length="5"/><text>STAT3</text></annotation><annotation id="35"><infon key="identifier">21838</infon><infon key="type">GENE</infon><location offset="315" length="4"/><text>THY1</text></annotation><annotation id="36"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="350" length="5"/><text>mouse</text></annotation><annotation id="37"><infon key="identifier">50674</infon><infon key="type">GENE</infon><location offset="581" length="7"/><text>Neurog3</text></annotation><annotation id="38"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="656" length="5"/><text>STAT3</text></annotation></passage></document>
<document><id>22396734</id><passage><offset>0</offset><text>Mapping and functional characterisation of a CTCF-dependent insulator element at the 3' border of the murine Scl transcriptional domain. The Scl gene encodes a transcription factor essential for haematopoietic development. Scl transcription is regulated by a panel of cis-elements spread over 55 kb with the most distal 3' element being located downstream of the neighbouring gene Map17, which is co-regulated with Scl in haematopoietic cells. The Scl/Map17 domain is flanked upstream by the ubiquitously expressed Sil gene and downstream by a cluster of Cyp genes active in liver, but the mechanisms responsible for delineating the domain boundaries remain unclear. Here we report identification of a DNaseI hypersensitive site at the 3' end of the Scl/Map17 domain and 45 kb downstream of the Scl transcription start site. This element is located at the boundary of active and inactive chromatin, does not function as a classical tissue-specific enhancer, binds CTCF and is both necessary and sufficient for insulator function in haematopoietic cells in vitro. Moreover, in a transgenic reporter assay, tissue-specific expression of the Scl promoter in brain was increased by incorporation of 350 bp flanking fragments from the +45 element. Our data suggests that the +45 region functions as a boundary element that separates the Scl/Map17 and Cyp transcriptional domains, and raise the possibility that this element may be useful for improving tissue-specific expression of transgenic constructs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1139" length="12"/><text>Scl promoter</text></annotation><annotation id="2"><infon key="identifier">67182</infon><infon key="type">GENE</infon><location offset="1336" length="5"/><text>Map17</text></annotation><annotation id="3"><infon key="identifier">228005</infon><infon key="type">GENE</infon><location offset="1346" length="3"/><text>Cyp</text></annotation><annotation id="4"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="109" length="3"/><text>Scl</text></annotation><annotation id="5"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="141" length="3"/><text>Scl</text></annotation><annotation id="6"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="422" length="20"/><text>haematopoietic cells</text></annotation><annotation id="7"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="575" length="5"/><text>liver</text></annotation><annotation id="8"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="1032" length="20"/><text>haematopoietic cells</text></annotation><annotation id="9"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="1155" length="5"/><text>brain</text></annotation><annotation id="10"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="223" length="3"/><text>Scl</text></annotation><annotation id="11"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="415" length="3"/><text>Scl</text></annotation><annotation id="12"><infon key="identifier">13018</infon><infon key="type">GENE</infon><location offset="45" length="4"/><text>CTCF</text></annotation><annotation id="13"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="448" length="3"/><text>Scl</text></annotation><annotation id="14"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="750" length="3"/><text>Scl</text></annotation><annotation id="15"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="795" length="3"/><text>Scl</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="932" length="24"/><text>tissue-specific enhancer</text></annotation><annotation id="17"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1139" length="3"/><text>Scl</text></annotation><annotation id="18"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="102" length="6"/><text>murine</text></annotation><annotation id="19"><infon key="identifier">67182</infon><infon key="type">GENE</infon><location offset="381" length="5"/><text>Map17</text></annotation><annotation id="20"><infon key="identifier">67182</infon><infon key="type">GENE</infon><location offset="452" length="5"/><text>Map17</text></annotation><annotation id="21"><infon key="identifier">20460</infon><infon key="type">GENE</infon><location offset="515" length="3"/><text>Sil</text></annotation><annotation id="22"><infon key="identifier">228005</infon><infon key="type">GENE</infon><location offset="555" length="3"/><text>Cyp</text></annotation><annotation id="23"><infon key="identifier">67182</infon><infon key="type">GENE</infon><location offset="754" length="5"/><text>Map17</text></annotation><annotation id="24"><infon key="identifier">13018</infon><infon key="type">GENE</infon><location offset="964" length="4"/><text>CTCF</text></annotation></passage></document>
<document><id>22401818</id><passage><offset>0</offset><text>Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages. The stem cell leukemia (Scl)/Tal1 gene is essential for normal blood and endothelial development, and is expressed in hematopoietic stem cells (HSCs), progenitors, erythroid, megakaryocytic, and mast cells. The Scl +19 enhancer is active in HSCs and progenitor cells, megakaryocytes, and mast cells, but not mature erythroid cells. Here we demonstrate that in vivo deletion of the Scl +19 enhancer (Scl(Delta19/Delta19)) results in viable mice with normal Scl expression in mature hematopoietic lineages. By contrast, Scl expression is reduced in the stem/progenitor compartment and flow cytometry analysis revealed that the HSC and megakaryocyte-erythroid progenitor populations are enlarged in Scl(Delta19/Delta19) mice. The increase in HSC numbers contributed to enhanced expansion in bone marrow transplantation assays, but did not affect multilineage repopulation or stress responses. These results affirm that the Scl +19 enhancer plays a key role in the development of hematopoietic stem/progenitor cells, but is not necessary for mature hematopoietic lineages. Moreover, active histone marks across the Scl locus were significantly reduced in Scl(Delta19/Delta19) fetal liver cells without major changes in steady-state messenger RNA levels, suggesting post-transcriptional compensation for loss of a regulatory element, a result that might be widely relevant given the frequent observation of mild phenotypes after deletion of regulatory elements.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="16" length="16"/><text>Scl +19 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="344" length="16"/><text>Scl +19 enhancer</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="850" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="47" length="15"/><text>blood stem cell</text></annotation><annotation id="5"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="147" length="8"/><text>leukemia</text></annotation><annotation id="6"><infon key="identifier">0004911</infon><infon key="type">TISSUE</infon><location offset="780" length="20"/><text>erythroid progenitor</text></annotation><annotation id="7"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="421" length="10"/><text>mast cells</text></annotation><annotation id="8"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="328" length="10"/><text>mast cells</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1284" length="20"/><text>Scl(Delta19/Delta19)</text></annotation><annotation id="10"><infon key="identifier">0000141</infon><infon key="type">TISSUE</infon><location offset="921" length="11"/><text>bone marrow</text></annotation><annotation id="11"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="196" length="5"/><text>blood</text></annotation><annotation id="12"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="251" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="514" length="16"/><text>Scl +19 enhancer</text></annotation><annotation id="14"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="277" length="4"/><text>HSCs</text></annotation><annotation id="15"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="297" length="9"/><text>erythroid</text></annotation><annotation id="16"><infon key="identifier">0000843</infon><infon key="type">TISSUE</infon><location offset="308" length="14"/><text>megakaryocytic</text></annotation><annotation id="17"><infon key="identifier">0000843</infon><infon key="type">TISSUE</infon><location offset="401" length="14"/><text>megakaryocytes</text></annotation><annotation id="18"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="374" length="4"/><text>HSCs</text></annotation><annotation id="19"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="448" length="15"/><text>erythroid cells</text></annotation><annotation id="20"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="589" length="3"/><text>Scl</text></annotation><annotation id="21"><infon key="identifier">0001035</infon><infon key="type">TISSUE</infon><location offset="614" length="22"/><text>hematopoietic lineages</text></annotation><annotation id="22"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="758" length="3"/><text>HSC</text></annotation><annotation id="23"><infon key="identifier">0000843</infon><infon key="type">TISSUE</infon><location offset="766" length="13"/><text>megakaryocyte</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1053" length="16"/><text>Scl +19 enhancer</text></annotation><annotation id="25"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1109" length="35"/><text>hematopoietic stem/progenitor cells</text></annotation><annotation id="26"><infon key="identifier">0001035</infon><infon key="type">TISSUE</infon><location offset="1178" length="22"/><text>hematopoietic lineages</text></annotation><annotation id="27"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1244" length="3"/><text>Scl</text></annotation><annotation id="28"><infon key="identifier">0000224</infon><infon key="type">TISSUE</infon><location offset="1311" length="11"/><text>liver cells</text></annotation><annotation id="29"><infon key="identifier">0001035</infon><infon key="type">TISSUE</infon><location offset="117" length="14"/><text>blood lineages</text></annotation><annotation id="30"><infon key="type">TISSUE</infon><location offset="137" length="9"/><text>stem cell</text></annotation><annotation id="31"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="16" length="3"/><text>Scl</text></annotation><annotation id="32"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="344" length="3"/><text>Scl</text></annotation><annotation id="33"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="514" length="3"/><text>Scl</text></annotation><annotation id="34"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="532" length="3"/><text>Scl</text></annotation><annotation id="35"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="872" length="3"/><text>HSC</text></annotation><annotation id="36"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="829" length="3"/><text>Scl</text></annotation><annotation id="37"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1053" length="3"/><text>Scl</text></annotation><annotation id="38"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1284" length="3"/><text>Scl</text></annotation><annotation id="39"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="156" length="10"/><text>(Scl)/Tal1</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="532" length="20"/><text>Scl(Delta19/Delta19)</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="829" length="20"/><text>Scl(Delta19/Delta19)</text></annotation><annotation id="42"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="572" length="4"/><text>mice</text></annotation><annotation id="43"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="651" length="3"/><text>Scl</text></annotation></passage></document>
<document><id>22543974</id><passage><offset>0</offset><text>Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Recent studies have identified the genetic underpinnings of a growing number of diseases through targeted exome sequencing. However, this strategy ignores the large component of the genome that does not code for proteins, but is nonetheless biologically functional. To address the possible involvement of regulatory variation in congenital heart diseases (CHDs), we searched for regulatory mutations impacting the activity of TBX5, a dosage-dependent transcription factor with well-defined roles in the heart and limb development that has been associated with the Holt-Oram syndrome (heart-hand syndrome), a condition that affects 1/100 000 newborns. Using a combination of genomics, bioinformatics and mouse genetic engineering, we scanned ~700 kb of the TBX5 locus in search of cis-regulatory elements. We uncovered three enhancers that collectively recapitulate the endogenous expression pattern of TBX5 in the developing heart. We re-sequenced these enhancer elements in a cohort of non-syndromic patients with isolated atrial and/or ventricular septal defects, the predominant cardiac defects of the Holt-Oram syndrome, and identified a patient with a homozygous mutation in an enhancer ~90 kb downstream of TBX5. Notably, we demonstrate that this single-base-pair mutation abrogates the ability of the enhancer to drive expression within the heart in vivo using both mouse and zebrafish transgenic models. Given the population-wide frequency of this variant, we estimate that 1/100 000 individuals would be homozygous for this variant, highlighting that a significant number of CHD associated with TBX5 dysfunction might arise from non-coding mutations in TBX5 heart enhancers, effectively decoupling the heart and hand phenotypes of the Holt-Oram syndrome.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="26" length="13"/><text>TBX5 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="902" length="15"/><text>three enhancers</text></annotation><annotation id="3"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="510" length="4"/><text>TBX5</text></annotation><annotation id="4"><infon key="identifier">0007732</infon><infon key="type">DISEASE</infon><location offset="648" length="18"/><text>Holt-Oram syndrome</text></annotation><annotation id="5"><infon key="identifier">0007732</infon><infon key="type">DISEASE</infon><location offset="668" length="19"/><text>heart-hand syndrome</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="787" length="5"/><text>mouse</text></annotation><annotation id="7"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="840" length="4"/><text>TBX5</text></annotation><annotation id="8"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="986" length="4"/><text>TBX5</text></annotation><annotation id="9"><infon key="identifier">0007732</infon><infon key="type">DISEASE</infon><location offset="1828" length="18"/><text>Holt-Oram syndrome</text></annotation><annotation id="10"><infon key="identifier">0020290</infon><infon key="type">DISEASE</infon><location offset="1108" length="40"/><text>atrial and/or ventricular septal defects</text></annotation><annotation id="11"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="1297" length="4"/><text>TBX5</text></annotation><annotation id="12"><infon key="identifier">0007732</infon><infon key="type">DISEASE</infon><location offset="1189" length="18"/><text>Holt-Oram syndrome</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1038" length="17"/><text>enhancer elements</text></annotation><annotation id="14"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="1746" length="4"/><text>TBX5</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1457" length="5"/><text>mouse</text></annotation><annotation id="16"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1467" length="9"/><text>zebrafish</text></annotation><annotation id="17"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="1668" length="3"/><text>CHD</text></annotation><annotation id="18"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="1688" length="4"/><text>TBX5</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1267" length="34"/><text>enhancer ~90 kb downstream of TBX5</text></annotation><annotation id="20"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="587" length="5"/><text>heart</text></annotation><annotation id="21"><infon key="identifier">0001492</infon><infon key="type">TISSUE</infon><location offset="597" length="4"/><text>limb</text></annotation><annotation id="22"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1009" length="5"/><text>heart</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1392" length="8"/><text>enhancer</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1746" length="20"/><text>TBX5 heart enhancers</text></annotation><annotation id="25"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="26" length="4"/><text>TBX5</text></annotation><annotation id="26"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="58" length="24"/><text>congenital heart disease</text></annotation><annotation id="27"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="413" length="25"/><text>congenital heart diseases</text></annotation><annotation id="28"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="440" length="4"/><text>CHDs</text></annotation></passage></document>
<document><id>22701669</id><passage><offset>0</offset><text>An evolutionarily conserved enhancer regulates Bmp4 expression in developing incisor and limb bud. To elucidate the transcriptional regulation of Bmp4 expression during organogenesis, we used phylogenetic footprinting and transgenic reporter analyses to identify Bmp4 cis-regulatory modules (CRMs). These analyses identified a regulatory region located ~46 kb upstream of the mouse Bmp4 transcription start site that had previously been shown to direct expression in lateral plate mesoderm. We refined this regulatory region to a 396-bp minimal enhancer, and show that it recapitulates features of endogenous Bmp4 expression in developing mandibular arch ectoderm and incisor epithelium during the initiation-stage of tooth development. In addition, this enhancer directs expression in the apical ectodermal ridge (AER) of the developing limb and in anterior and posterior limb mesenchyme. Transcript profiling of E11.5 mouse incisor dental lamina, together with protein binding microarray (PBM) analyses, allowed identification of a conserved DNA binding motif in the Bmp4 enhancer for Pitx homeoproteins, which are also expressed in the developing mandibular and incisor epithelium. In vitro electrophoretic mobility shift assays (EMSA) and in vivo transgenic reporter mutational analyses revealed that this site supports Pitx binding and that the site is necessary to recapitulate aspects of endogenous Bmp4 expression in developing craniofacial and limb tissues. Finally, Pitx2 chromatin immunoprecipitation (ChIP) demonstrated direct binding of Pitx2 to this Bmp4 enhancer site in a dental epithelial cell line. These results establish a direct molecular regulatory link between Pitx family members and Bmp4 gene expression in developing incisor epithelium.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="28" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="530" length="23"/><text>396-bp minimal enhancer</text></annotation><annotation id="3"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="609" length="4"/><text>Bmp4</text></annotation><annotation id="4"><infon key="identifier">0001492</infon><infon key="type">TISSUE</infon><location offset="838" length="4"/><text>limb</text></annotation><annotation id="5"><infon key="identifier">0001751</infon><infon key="type">TISSUE</infon><location offset="1150" length="10"/><text>mandibular</text></annotation><annotation id="6"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="1406" length="4"/><text>Bmp4</text></annotation><annotation id="7"><infon key="identifier">18741</infon><infon key="type">GENE</infon><location offset="1476" length="5"/><text>Pitx2</text></annotation><annotation id="8"><infon key="identifier">18741</infon><infon key="type">GENE</infon><location offset="1550" length="5"/><text>Pitx2</text></annotation><annotation id="9"><infon key="identifier">0001723</infon><infon key="type">TISSUE</infon><location offset="1588" length="27"/><text>dental epithelial cell line</text></annotation><annotation id="10"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="1708" length="4"/><text>Bmp4</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="327" length="84"/><text>regulatory region located ~46 kb upstream of the mouse Bmp4 transcription start site</text></annotation><annotation id="12"><infon key="identifier">0001741</infon><infon key="type">TISSUE</infon><location offset="77" length="7"/><text>incisor</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="755" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="identifier">0001640</infon><infon key="type">TISSUE</infon><location offset="89" length="8"/><text>limb bud</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1044" length="61"/><text>DNA binding motif in the Bmp4 enhancer for Pitx homeoproteins</text></annotation><annotation id="16"><infon key="identifier">0000315</infon><infon key="type">TISSUE</infon><location offset="639" length="24"/><text>mandibular arch ectoderm</text></annotation><annotation id="17"><infon key="identifier">0000397</infon><infon key="type">TISSUE</infon><location offset="718" length="5"/><text>tooth</text></annotation><annotation id="18"><infon key="identifier">0005563</infon><infon key="type">TISSUE</infon><location offset="926" length="21"/><text>incisor dental lamina</text></annotation><annotation id="19"><infon key="identifier">0001723</infon><infon key="type">TISSUE</infon><location offset="1165" length="18"/><text>incisor epithelium</text></annotation><annotation id="20"><infon key="identifier">0006387</infon><infon key="type">TISSUE</infon><location offset="1436" length="12"/><text>craniofacial</text></annotation><annotation id="21"><infon key="identifier">0001492</infon><infon key="type">TISSUE</infon><location offset="1453" length="4"/><text>limb</text></annotation><annotation id="22"><infon key="identifier">0001723</infon><infon key="type">TISSUE</infon><location offset="1743" length="18"/><text>incisor epithelium</text></annotation><annotation id="23"><infon key="identifier">0001393</infon><infon key="type">TISSUE</infon><location offset="873" length="15"/><text>limb mesenchyme</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1069" length="13"/><text>Bmp4 enhancer</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1305" length="31"/><text>this site supports Pitx binding</text></annotation><annotation id="26"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="920" length="5"/><text>mouse</text></annotation><annotation id="27"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="1069" length="4"/><text>Bmp4</text></annotation><annotation id="28"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="1564" length="4"/><text>Bmp4</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1564" length="18"/><text>Bmp4 enhancer site</text></annotation><annotation id="30"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="47" length="4"/><text>Bmp4</text></annotation><annotation id="31"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="146" length="4"/><text>Bmp4</text></annotation><annotation id="32"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="263" length="4"/><text>Bmp4</text></annotation><annotation id="33"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="467" length="22"/><text>lateral plate mesoderm</text></annotation><annotation id="34"><infon key="identifier">0001723</infon><infon key="type">TISSUE</infon><location offset="668" length="18"/><text>incisor epithelium</text></annotation></passage></document>
<document><id>22728936</id><passage><offset>0</offset><text>TBX5 drives Scn5a expression to regulate cardiac conduction system function. Cardiac conduction system (CCS) disease, which results in disrupted conduction and impaired cardiac rhythm, is common with significant morbidity and mortality. Current treatment options are limited, and rational efforts to develop cell-based and regenerative therapies require knowledge of the molecular networks that establish and maintain CCS function. Recent genome-wide association studies (GWAS) have identified numerous loci associated with adult human CCS function, including TBX5 and SCN5A. We hypothesized that TBX5, a critical developmental transcription factor, regulates transcriptional networks required for mature CCS function. We found that deletion of Tbx5 from the mature murine ventricular conduction system (VCS), including the AV bundle and bundle branches, resulted in severe VCS functional consequences, including loss of fast conduction, arrhythmias, and sudden death. Ventricular contractile function and the VCS fate map remained unchanged in VCS-specific Tbx5 knockouts. However, key mediators of fast conduction, including Nav1.5, which is encoded by Scn5a, and connexin 40 (Cx40), demonstrated Tbx5-dependent expression in the VCS. We identified a TBX5-responsive enhancer downstream of Scn5a sufficient to drive VCS expression in vivo, dependent on canonical T-box binding sites. Our results establish a direct molecular link between Tbx5 and Scn5a and elucidate a hierarchy between human GWAS loci that affects function of the mature VCS, establishing a paradigm for understanding the molecular pathology of CCS disease.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1253" length="44"/><text>TBX5-responsive enhancer downstream of Scn5a</text></annotation><annotation id="2"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>TBX5</text></annotation><annotation id="3"><infon key="identifier">6331</infon><infon key="type">GENE</infon><location offset="569" length="5"/><text>SCN5A</text></annotation><annotation id="4"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="597" length="4"/><text>TBX5</text></annotation><annotation id="5"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="745" length="4"/><text>Tbx5</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="766" length="6"/><text>murine</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1365" length="19"/><text>T-box binding sites</text></annotation><annotation id="8"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="418" length="3"/><text>CCS</text></annotation><annotation id="9"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="1010" length="3"/><text>VCS</text></annotation><annotation id="10"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="536" length="3"/><text>CCS</text></annotation><annotation id="11"><infon key="identifier">6331</infon><infon key="type">GENE</infon><location offset="12" length="5"/><text>Scn5a</text></annotation><annotation id="12"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="705" length="3"/><text>CCS</text></annotation><annotation id="13"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="1058" length="4"/><text>Tbx5</text></annotation><annotation id="14"><infon key="identifier">6331</infon><infon key="type">GENE</infon><location offset="1127" length="6"/><text>Nav1.5</text></annotation><annotation id="15"><infon key="identifier">20271</infon><infon key="type">GENE</infon><location offset="1155" length="5"/><text>Scn5a</text></annotation><annotation id="16"><infon key="identifier">14613</infon><infon key="type">GENE</infon><location offset="1166" length="11"/><text>connexin 40</text></annotation><annotation id="17"><infon key="identifier">14613</infon><infon key="type">GENE</infon><location offset="1179" length="4"/><text>Cx40</text></annotation><annotation id="18"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="1199" length="4"/><text>Tbx5</text></annotation><annotation id="19"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="773" length="29"/><text>ventricular conduction system</text></annotation><annotation id="20"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="804" length="3"/><text>VCS</text></annotation><annotation id="21"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="874" length="3"/><text>VCS</text></annotation><annotation id="22"><infon key="identifier">0005449</infon><infon key="type">DISEASE</infon><location offset="77" length="39"/><text>Cardiac conduction system (CCS) disease</text></annotation><annotation id="23"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="1045" length="3"/><text>VCS</text></annotation><annotation id="24"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="1440" length="4"/><text>Tbx5</text></annotation><annotation id="25"><infon key="identifier">20271</infon><infon key="type">GENE</infon><location offset="1449" length="5"/><text>Scn5a</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1489" length="5"/><text>human</text></annotation><annotation id="27"><infon key="identifier">0005449</infon><infon key="type">DISEASE</infon><location offset="1615" length="11"/><text>CCS disease</text></annotation><annotation id="28"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="1232" length="3"/><text>VCS</text></annotation><annotation id="29"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="1318" length="3"/><text>VCS</text></annotation><annotation id="30"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="1541" length="3"/><text>VCS</text></annotation><annotation id="31"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="41" length="25"/><text>cardiac conduction system</text></annotation><annotation id="32"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="1253" length="4"/><text>TBX5</text></annotation><annotation id="33"><infon key="identifier">20271</infon><infon key="type">GENE</infon><location offset="1292" length="5"/><text>Scn5a</text></annotation><annotation id="34"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="824" length="9"/><text>AV bundle</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="530" length="5"/><text>human</text></annotation><annotation id="36"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="838" length="15"/><text>bundle branches</text></annotation><annotation id="37"><infon key="identifier">6910</infon><infon key="type">GENE</infon><location offset="560" length="4"/><text>TBX5</text></annotation></passage></document>
<document><id>22761896</id><passage><offset>0</offset><text>Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity. BACKGROUND: Precise coordination of the hypothalamic-pituitary-gonadal axis orchestrates the normal reproductive function. As a central regulator, the appropriate synthesis and secretion of gonadotropin-releasing hormone I (GnRH-I) from the hypothalamus is essential for the coordination. Recently, emerging evidence indicates that histone deacetylases (HDACs) play an important role in maintaining normal reproductive function. In this study, we identify the potential effects of HDACs on Gnrh1 gene transcription. METHODOLOGY/PRINCIPAL FINDINGS: Inhibition of HDACs activities by trichostatin A (TSA) and valproic acid (VPA) promptly and dramatically repressed transcription of Gnrh1 gene in the mouse immortalized mature GnRH neuronal cells GT1-7. The suppression was connected with a specific region of Gnrh1 gene promoter, which contains two consensus Otx2 binding sites. Otx2 has been known to activate the basal and also enhancer-driven transcription of Gnrh1 gene. The transcriptional activity of Otx2 is negatively modulated by Grg4, a member of the Groucho-related-gene (Grg) family. In the present study, the expression of Otx2 was downregulated by TSA and VPA in GT1-7 cells, accompanied with the opposite changes of Grg4 expression. Chromatin immunoprecipitation and electrophoretic mobility shift assays demonstrated that the DNA-binding activity of Otx2 to Gnrh1 gene was suppressed by TSA and VPA. Overexpression of Otx2 partly abolished the TSA- and VPA-induced downregulation of Gnrh1 gene expression. CONCLUSIONS/SIGNIFICANCE: Our data indicate that HDAC inhibitors downregulate Gnrh1 gene expression via repressing Otx2-driven transcriptional activity. This study should provide an insight for our understanding on the effects of HDACs in the reproductive system and suggests that HDACs could be potential novel targets for the therapy of GnRH-related diseases.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="939" length="19"/><text>Gnrh1 gene promoter</text></annotation><annotation id="2"><infon key="identifier">0002708</infon><infon key="type">TISSUE</infon><location offset="1307" length="11"/><text>GT1-7 cells</text></annotation><annotation id="3"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1137" length="4"/><text>Otx2</text></annotation><annotation id="4"><infon key="identifier">21888</infon><infon key="type">GENE</infon><location offset="1169" length="4"/><text>Grg4</text></annotation><annotation id="5"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="861" length="20"/><text>neuronal cells GT1-7</text></annotation><annotation id="6"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="939" length="5"/><text>Gnrh1</text></annotation><annotation id="7"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1266" length="4"/><text>Otx2</text></annotation><annotation id="8"><infon key="identifier">21888</infon><infon key="type">GENE</infon><location offset="1361" length="4"/><text>Grg4</text></annotation><annotation id="9"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1496" length="4"/><text>Otx2</text></annotation><annotation id="10"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1504" length="5"/><text>Gnrh1</text></annotation><annotation id="11"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1564" length="4"/><text>Otx2</text></annotation><annotation id="12"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1629" length="5"/><text>Gnrh1</text></annotation><annotation id="13"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="94" length="4"/><text>Otx2</text></annotation><annotation id="14"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1730" length="5"/><text>Gnrh1</text></annotation><annotation id="15"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1767" length="4"/><text>Otx2</text></annotation><annotation id="16"><infon key="identifier">0005039</infon><infon key="type">DISEASE</infon><location offset="1991" length="21"/><text>GnRH-related diseases</text></annotation><annotation id="17"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="989" length="4"/><text>Otx2</text></annotation><annotation id="18"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="30" length="32"/><text>gonadotropin-releasing hormone I</text></annotation><annotation id="19"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="322" length="32"/><text>gonadotropin-releasing hormone I</text></annotation><annotation id="20"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="356" length="6"/><text>GnRH-I</text></annotation><annotation id="21"><infon key="identifier">0000614</infon><infon key="type">TISSUE</infon><location offset="373" length="12"/><text>hypothalamus</text></annotation><annotation id="22"><infon key="identifier">0000614;0001073;0000534</infon><infon key="type">TISSUE</infon><location offset="172" length="35"/><text>hypothalamic-pituitary-gonadal axis</text></annotation><annotation id="23"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="622" length="5"/><text>Gnrh1</text></annotation><annotation id="24"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="812" length="5"/><text>Gnrh1</text></annotation><annotation id="25"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="830" length="5"/><text>mouse</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="975" length="32"/><text>two consensus Otx2 binding sites</text></annotation><annotation id="27"><infon key="identifier">0000081</infon><infon key="type">TISSUE</infon><location offset="1895" length="19"/><text>reproductive system</text></annotation><annotation id="28"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1009" length="4"/><text>Otx2</text></annotation><annotation id="29"><infon key="identifier">14714</infon><infon key="type">GENE</infon><location offset="1093" length="5"/><text>Gnrh1</text></annotation></passage></document>
<document><id>22771493</id><passage><offset>0</offset><text>Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells. We have studied the regulation of ATAD2 gene expression by androgens in prostate cells. ATAD2 is a coactivator of the androgen receptor (AR) and the MYC protein. We showed that ATAD2 expression is directly regulated by AR via an AR binding sequence (ARBS) located in the distal enhancer of its regulatory region. The gene is also regulated by the E2F1 transcription factor. Using knockdown and chromatin immunoprecipitation technique approaches, we could demonstrate that AR and E2F1 functionally collaborate and physically interact between each other. From the analysis of chromatin conformation, we conclude that this cooperation results from a chromatin looping over the ATAD2 promoter region between the ARBS and E2F1 binding site in an androgen-dependent manner. Furthermore, we could show that several genes overexpressed in prostate cancer and potentially involved in several aspects of tumor development have an ARBS and an E2F1 binding site in their regulatory regions and exhibit the same mechanism of regulation by both transcription factors as ATAD2.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="412" length="15"/><text>distal enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="815" length="21"/><text>ATAD2 promoter region</text></annotation><annotation id="3"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="360" length="2"/><text>AR</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="370" length="57"/><text>AR binding sequence (ARBS) located in the distal enhancer</text></annotation><annotation id="5"><infon key="identifier">1869</infon><infon key="type">GENE</infon><location offset="488" length="4"/><text>E2F1</text></annotation><annotation id="6"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="613" length="2"/><text>AR</text></annotation><annotation id="7"><infon key="identifier">1869</infon><infon key="type">GENE</infon><location offset="620" length="4"/><text>E2F1</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="849" length="4"/><text>ARBS</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="858" length="17"/><text>E2F1 binding site</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="972" length="15"/><text>prostate cancer</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1035" length="5"/><text>tumor</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1073" length="17"/><text>E2F1 binding site</text></annotation><annotation id="13"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="27" length="17"/><text>androgen receptor</text></annotation><annotation id="14"><infon key="identifier">29028</infon><infon key="type">GENE</infon><location offset="1197" length="5"/><text>ATAD2</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1061" length="4"/><text>ARBS</text></annotation><annotation id="16"><infon key="identifier">29028</infon><infon key="type">GENE</infon><location offset="815" length="5"/><text>ATAD2</text></annotation><annotation id="17"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="370" length="2"/><text>AR</text></annotation><annotation id="18"><infon key="identifier">0001019</infon><infon key="type">TISSUE</infon><location offset="125" length="14"/><text>prostate cells</text></annotation><annotation id="19"><infon key="identifier">0001019</infon><infon key="type">TISSUE</infon><location offset="213" length="14"/><text>prostate cells</text></annotation><annotation id="20"><infon key="identifier">1869</infon><infon key="type">GENE</infon><location offset="858" length="4"/><text>E2F1</text></annotation><annotation id="21"><infon key="identifier">1869</infon><infon key="type">GENE</infon><location offset="1073" length="4"/><text>E2F1</text></annotation><annotation id="22"><infon key="identifier">1869</infon><infon key="type">GENE</infon><location offset="49" length="4"/><text>E2F1</text></annotation><annotation id="23"><infon key="identifier">29028</infon><infon key="type">GENE</infon><location offset="175" length="5"/><text>ATAD2</text></annotation><annotation id="24"><infon key="identifier">29028</infon><infon key="type">GENE</infon><location offset="229" length="5"/><text>ATAD2</text></annotation><annotation id="25"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="259" length="17"/><text>androgen receptor</text></annotation><annotation id="26"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="278" length="2"/><text>AR</text></annotation><annotation id="27"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="290" length="3"/><text>MYC</text></annotation><annotation id="28"><infon key="identifier">29028</infon><infon key="type">GENE</infon><location offset="318" length="5"/><text>ATAD2</text></annotation></passage></document>
<document><id>22877652</id><passage><offset>0</offset><text>Androgen receptor repression of gonadotropin-releasing hormone gene transcription via enhancer 1. Gonadotropin-releasing hormone (GnRH) plays a major role in the hypothalamic-pituitary-gonadal (HPG) axis, and synthesis and secretion of GnRH are regulated by gonadal steroid hormones. Disruptions in androgen levels are involved in a number of reproductive defects, including hypogonadotropic hypogonadism and polycystic ovarian syndrome. Androgens down-regulate GnRH mRNA synthesis in vivo and in vitro via an androgen receptor (AR)-dependent mechanism. Methyltrienolone (R1881), a synthetic AR agonist, represses GnRH expression through multiple sites in the proximal promoter. In this study, we show AR also represses GnRH transcription via the major enhancer (GnRH-E1). A multimer of the -1800/-1766 region was repressed by R1881 treatment. Mutation of two bases, -1792 and -1791, resulted in decreased basal activity and a loss of AR-mediated repression. AR bound to the -1796/-1791 sequence in electrophoretic mobility shift assays, indicating a direct interaction with DNA or other transcription factors in this region. We conclude that AR repression of GnRH-E1 acts via multiple AR-responsive regions, including the site at -1792/-1791.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="86" length="10"/><text>enhancer 1</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="660" length="17"/><text>proximal promoter</text></annotation><annotation id="3"><infon key="identifier">0008487</infon><infon key="type">DISEASE</infon><location offset="409" length="27"/><text>polycystic ovarian syndrome</text></annotation><annotation id="4"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="462" length="4"/><text>GnRH</text></annotation><annotation id="5"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="510" length="17"/><text>androgen receptor</text></annotation><annotation id="6"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="529" length="2"/><text>AR</text></annotation><annotation id="7"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="592" length="2"/><text>AR</text></annotation><annotation id="8"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="614" length="4"/><text>GnRH</text></annotation><annotation id="9"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="702" length="2"/><text>AR</text></annotation><annotation id="10"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="720" length="4"/><text>GnRH</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="763" length="7"/><text>GnRH-E1</text></annotation><annotation id="12"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="935" length="2"/><text>AR</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="747" length="14"/><text>major enhancer</text></annotation><annotation id="14"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="959" length="2"/><text>AR</text></annotation><annotation id="15"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1143" length="2"/><text>AR</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1160" length="7"/><text>GnRH-E1</text></annotation><annotation id="17"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1186" length="2"/><text>AR</text></annotation><annotation id="18"><infon key="identifier">0000614;0001073;0000534</infon><infon key="type">TISSUE</infon><location offset="162" length="41"/><text>hypothalamic-pituitary-gonadal (HPG) axis</text></annotation><annotation id="19"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="763" length="4"/><text>GnRH</text></annotation><annotation id="20"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="1160" length="4"/><text>GnRH</text></annotation><annotation id="21"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="0" length="17"/><text>Androgen receptor</text></annotation><annotation id="22"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="32" length="30"/><text>gonadotropin-releasing hormone</text></annotation><annotation id="23"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="98" length="30"/><text>Gonadotropin-releasing hormone</text></annotation><annotation id="24"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="130" length="4"/><text>GnRH</text></annotation><annotation id="25"><infon key="identifier">2796</infon><infon key="type">GENE</infon><location offset="236" length="4"/><text>GnRH</text></annotation><annotation id="26"><infon key="identifier">0005039</infon><infon key="type">DISEASE</infon><location offset="343" length="20"/><text>reproductive defects</text></annotation><annotation id="27"><infon key="identifier">0018555</infon><infon key="type">DISEASE</infon><location offset="375" length="29"/><text>hypogonadotropic hypogonadism</text></annotation></passage></document>
<document><id>23024062</id><passage><offset>0</offset><text>Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP. Recent studies indicate that cyclic AMP (cAMP) induces cytotoxic T lymphocyte antigen (CTLA) 4. CTLA4 is expressed in T cells, and is a negative regulator of T cell activation. CTLA4 expression is regulated by T cell receptor plus CD28 (adaptive immune signaling) at both the transcriptional and post-transcriptional level. Here, we examine the pathways by which cAMP regulates CTLA4 expression, focusing on transcriptional activation. Elevating intracellular cAMP levels by cell-permeable cAMP analogs, the adenylyl cyclase activator, forskolin, or phosphodiesterase inhibitors increases CTLA4 mRNA expression in EL4 murine T cells and primary CD4(+) T cells. Activation of protein kinase A (using the protein kinase A-selective agonist, N6-phenyladenosine-cAMP), but not exchange proteins activated by cAMP (using the exchange proteins activated by cAMP-selective 8-pCPT-2Me-cAMP), increases CTLA4 promoter activity. Mutation constructs of the CTLA4 promoter uncover an enhancer binding site located within the -150 to -130 bp region relative to the transcription start site. Promoter analysis and chromatin immunoprecipitation assays suggest that cAMP response element-binding is a putative transcription factor induced by cAMP. We have previously shown that CTLA4 mediates decreased pulmonary inflammation in an LPS-induced murine model of acute lung injury (ALI). We observed that LPS can induce CTLA4 transcription via the same cAMP-inducible promoter region. The immunosuppressant, rapamycin, decreases cAMP and LPS-induced CTLA4 transcription in vitro. In vivo, LPS induces cAMP accumulation in bronchoalveolar lavage fluid, bronchoalveolar lavage cells, and lung tissues in ALI. We demonstrate that rapamycin decreases cAMP accumulation and CTLA4 expression in ALI. Together, these data suggest that cAMP may negatively regulate pulmonary inflammatory responses in vivo and in vitro by altering CTLA4 expression.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr1,60908875,60908895</infon><infon key="type">ENHANCER</infon><infon key="identifier">1,60908875,60908895</infon><infon key="gb">unk</infon><location offset="1034" length="104"/><text>enhancer binding site located within the -150 to -130 bp region relative to the transcription start site</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1511" length="15"/><text>promoter region</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1390" length="6"/><text>murine</text></annotation><annotation id="4"><infon key="identifier">0015796</infon><infon key="type">DISEASE</infon><location offset="1406" length="17"/><text>acute lung injury</text></annotation><annotation id="5"><infon key="identifier">0015796</infon><infon key="type">DISEASE</infon><location offset="1425" length="3"/><text>ALI</text></annotation><annotation id="6"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1463" length="5"/><text>CTLA4</text></annotation><annotation id="7"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1593" length="5"/><text>CTLA4</text></annotation><annotation id="8"><infon key="identifier">0015796</infon><infon key="type">DISEASE</infon><location offset="1745" length="3"/><text>ALI</text></annotation><annotation id="9"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1812" length="5"/><text>CTLA4</text></annotation><annotation id="10"><infon key="identifier">0015796</infon><infon key="type">DISEASE</infon><location offset="1832" length="3"/><text>ALI</text></annotation><annotation id="11"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1966" length="5"/><text>CTLA4</text></annotation><annotation id="12"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="14" length="32"/><text>cytotoxic T lymphocyte antigen 4</text></annotation><annotation id="13"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="117" length="39"/><text>cytotoxic T lymphocyte antigen (CTLA) 4</text></annotation><annotation id="14"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="180" length="7"/><text>T cells</text></annotation><annotation id="15"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="220" length="6"/><text>T cell</text></annotation><annotation id="16"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="272" length="6"/><text>T cell</text></annotation><annotation id="17"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="687" length="7"/><text>T cells</text></annotation><annotation id="18"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="707" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="19"><infon key="identifier">0000155</infon><infon key="type">TISSUE</infon><location offset="1695" length="28"/><text>bronchoalveolar lavage cells</text></annotation><annotation id="20"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="1729" length="4"/><text>lung</text></annotation><annotation id="21"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="956" length="5"/><text>CTLA4</text></annotation><annotation id="22"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1008" length="5"/><text>CTLA4</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="956" length="14"/><text>CTLA4 promoter</text></annotation><annotation id="24"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="158" length="5"/><text>CTLA4</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1008" length="14"/><text>CTLA4 promoter</text></annotation><annotation id="26"><infon key="identifier">0000155</infon><infon key="type">TISSUE</infon><location offset="1665" length="28"/><text>bronchoalveolar lavage fluid</text></annotation><annotation id="27"><infon key="identifier">1385</infon><infon key="type">GENE</infon><location offset="1212" length="29"/><text>cAMP response element-binding</text></annotation><annotation id="28"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="239" length="5"/><text>CTLA4</text></annotation><annotation id="29"><infon key="identifier">940</infon><infon key="type">GENE</infon><location offset="293" length="4"/><text>CD28</text></annotation><annotation id="30"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="440" length="5"/><text>CTLA4</text></annotation><annotation id="31"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="651" length="5"/><text>CTLA4</text></annotation><annotation id="32"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="680" length="6"/><text>murine</text></annotation><annotation id="33"><infon key="identifier">1493</infon><infon key="type">GENE</infon><location offset="1324" length="5"/><text>CTLA4</text></annotation></passage></document>
<document><id>23154183</id><passage><offset>0</offset><text>Regulation of cooperative function of the Il12b enhancer and promoter by the interferon regulatory factors 3 and 5. The regulation of the Il12b gene, encoding the shared p40 subcomponent for IL-12 and IL-23, is critical for innate immune responses and subsequent T cell polarization. This gene is robustly induced upon Toll-like receptor (TLR) stimulation, wherein an enhancer located 10kb upstream of the transcription start site is required for promoter activity; however, the underlying mechanisms that regulate this enhancer in cooperation with the promoter has remained elusive. We show here that the Il12b enhancer contains functional ISREs for recognition by interferon regulatory factors (IRFs), and provide evidence that TLR-activated IRF5 mediates cooperativity of the enhancer with the promoter which also contains ISREs. By contrast, IRF3 activated by cytosolic RIG-I-like receptor (RLR) signaling binds to these ISREs and causes gene suppression. Consistently, IRF5 binding is accompanied with chromatin remodeling of both regulatory regions and the formation of a productive transcriptional complex containing other transcription factors, whereas these events are inhibited by IRF3 binding. We show that the ISREs embedded in the enhancer are indeed critical for its activation by IRF5. We also adduce evidence that the 5' sequences of the enhancer and promoter ISREs, all of which deviate from consensus ISREs, critically affect the function of IRF3. The dual commitment of these IRFs in the regulation of the Il12b enhancer and promoter is unique and may have implications for understanding the evolution of this gene.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="42" length="14"/><text>Il12b enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="61" length="8"/><text>promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1525" length="14"/><text>Il12b enhancer</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1544" length="8"/><text>promoter</text></annotation><annotation id="5"><infon key="identifier">3578</infon><infon key="type">GENE</infon><location offset="170" length="3"/><text>p40</text></annotation><annotation id="6"><infon key="identifier">3661</infon><infon key="type">GENE</infon><location offset="77" length="31"/><text>interferon regulatory factors 3</text></annotation><annotation id="7"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="138" length="5"/><text>Il12b</text></annotation><annotation id="8"><infon key="identifier">51561</infon><infon key="type">GENE</infon><location offset="201" length="5"/><text>IL-23</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="826" length="5"/><text>ISREs</text></annotation><annotation id="10"><infon key="identifier">3663</infon><infon key="type">GENE</infon><location offset="744" length="4"/><text>IRF5</text></annotation><annotation id="11"><infon key="identifier">3661</infon><infon key="type">GENE</infon><location offset="846" length="4"/><text>IRF3</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="368" length="62"/><text>enhancer located 10kb upstream of the transcription start site</text></annotation><annotation id="13"><infon key="identifier">79132</infon><infon key="type">GENE</infon><location offset="874" length="19"/><text>RIG-I-like receptor</text></annotation><annotation id="14"><infon key="identifier">79132</infon><infon key="type">GENE</infon><location offset="895" length="3"/><text>RLR</text></annotation><annotation id="15"><infon key="identifier">3663</infon><infon key="type">GENE</infon><location offset="974" length="4"/><text>IRF5</text></annotation><annotation id="16"><infon key="identifier">3661</infon><infon key="type">GENE</infon><location offset="1191" length="4"/><text>IRF3</text></annotation><annotation id="17"><infon key="identifier">3663</infon><infon key="type">GENE</infon><location offset="1295" length="4"/><text>IRF5</text></annotation><annotation id="18"><infon key="identifier">3661</infon><infon key="type">GENE</infon><location offset="1460" length="4"/><text>IRF3</text></annotation><annotation id="19"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="42" length="5"/><text>Il12b</text></annotation><annotation id="20"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="606" length="5"/><text>Il12b</text></annotation><annotation id="21"><infon key="identifier">3663</infon><infon key="type">GENE</infon><location offset="113" length="1"/><text>5</text></annotation><annotation id="22"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="263" length="6"/><text>T cell</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="641" length="5"/><text>ISREs</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="925" length="5"/><text>ISREs</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1222" length="5"/><text>ISREs</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1334" length="47"/><text>5' sequences of the enhancer and promoter ISREs</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1409" length="15"/><text>consensus ISREs</text></annotation><annotation id="28"><infon key="identifier">3593</infon><infon key="type">GENE</infon><location offset="1525" length="5"/><text>Il12b</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="520" length="8"/><text>enhancer</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="553" length="8"/><text>promoter</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="606" length="14"/><text>Il12b enhancer</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="779" length="8"/><text>enhancer</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="797" length="8"/><text>promoter</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1244" length="8"/><text>enhancer</text></annotation></passage></document>
<document><id>23159876</id><passage><offset>0</offset><text>Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions. Bone-specific transcription factors promote differentiation of mesenchymal precursors toward the osteoblastic cell phenotype. Among them, Runx2 and Osterix have been widely accepted as master osteogenic factors, since neither Runx2 nor Osterix null mice form mature osteoblasts. Recruitment of Osterix to a number of promoters of bone-specific genes has been shown. However, little is known about the functional interactions between Osterix and the Col1a1 promoter. In this study we determined in several mesenchymal and osteoblastic cell types that either BMP-2 or Osterix overexpression increased Col1a1 transcription. We identified consensus Sp1 sequences, located in the proximal promoter and in the bone-enhancer, as Osterix binding regions in the Col1a1 promoter in vitro and in vivo. Furthermore, we show that p38 or Erk MAPK signaling is required for maximal transcriptional effects on Col1a1 expression. Runx2 has been shown to activate Col1a1 expression through binding to sites which are located close to the Sp1 sites where Osterix binds. Our data show that overexpression of Runx2 and Osterix leads to a cooperative effect on the expression of the Col1a1 endogenous gene and its promoter reporter construct. These effects mainly affect the long isoform of Osterix which suggest that the two Osterix isoforms might display some differential effects on the transactivation of bone-specific genes.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="75" length="13"/><text>bone enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="93" length="25"/><text>proximal promoter regions</text></annotation><annotation id="3"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="258" length="5"/><text>Runx2</text></annotation><annotation id="4"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="268" length="7"/><text>Osterix</text></annotation><annotation id="5"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="346" length="5"/><text>Runx2</text></annotation><annotation id="6"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="356" length="7"/><text>Osterix</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="369" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="414" length="7"/><text>Osterix</text></annotation><annotation id="9"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="553" length="7"/><text>Osterix</text></annotation><annotation id="10"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="625" length="11"/><text>mesenchymal</text></annotation><annotation id="11"><infon key="identifier">12156</infon><infon key="type">GENE</infon><location offset="677" length="5"/><text>BMP-2</text></annotation><annotation id="12"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="686" length="7"/><text>Osterix</text></annotation><annotation id="13"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="450" length="4"/><text>bone</text></annotation><annotation id="14"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="719" length="6"/><text>Col1a1</text></annotation><annotation id="15"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="842" length="7"/><text>Osterix</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1092" length="77"/><text>binding to sites which are located close to the Sp1 sites where Osterix binds</text></annotation><annotation id="17"><infon key="identifier">26416</infon><infon key="type">GENE</infon><location offset="937" length="3"/><text>p38</text></annotation><annotation id="18"><infon key="identifier">26413</infon><infon key="type">GENE</infon><location offset="944" length="3"/><text>Erk</text></annotation><annotation id="19"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="1507" length="4"/><text>bone</text></annotation><annotation id="20"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="1014" length="6"/><text>Col1a1</text></annotation><annotation id="21"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="1033" length="5"/><text>Runx2</text></annotation><annotation id="22"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="1066" length="6"/><text>Col1a1</text></annotation><annotation id="23"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="75" length="4"/><text>bone</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="569" length="15"/><text>Col1a1 promoter</text></annotation><annotation id="25"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="1208" length="5"/><text>Runx2</text></annotation><annotation id="26"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="1218" length="7"/><text>Osterix</text></annotation><annotation id="27"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="1281" length="6"/><text>Col1a1</text></annotation><annotation id="28"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="1389" length="7"/><text>Osterix</text></annotation><annotation id="29"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="1424" length="7"/><text>Osterix</text></annotation><annotation id="30"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="824" length="4"/><text>bone</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="58" length="9"/><text>Sp1 sites</text></annotation><annotation id="32"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="569" length="6"/><text>Col1a1</text></annotation><annotation id="33"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="120" length="4"/><text>Bone</text></annotation><annotation id="34"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="183" length="22"/><text>mesenchymal precursors</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="795" length="17"/><text>proximal promoter</text></annotation><annotation id="36"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="217" length="17"/><text>osteoblastic cell</text></annotation><annotation id="37"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="386" length="11"/><text>osteoblasts</text></annotation><annotation id="38"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="641" length="17"/><text>osteoblastic cell</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="755" length="82"/><text>consensus Sp1 sequences, located in the proximal promoter and in the bone-enhancer</text></annotation><annotation id="40"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="873" length="6"/><text>Col1a1</text></annotation><annotation id="41"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="1156" length="7"/><text>Osterix</text></annotation><annotation id="42"><infon key="identifier">20683</infon><infon key="type">GENE</infon><location offset="58" length="3"/><text>Sp1</text></annotation><annotation id="43"><infon key="identifier">20683</infon><infon key="type">GENE</infon><location offset="765" length="3"/><text>Sp1</text></annotation><annotation id="44"><infon key="identifier">20683</infon><infon key="type">GENE</infon><location offset="1140" length="3"/><text>Sp1</text></annotation><annotation id="45"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="824" length="13"/><text>bone-enhancer</text></annotation><annotation id="46"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="873" length="15"/><text>Col1a1 promoter</text></annotation><annotation id="47"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="842" length="46"/><text>Osterix binding regions in the Col1a1 promoter</text></annotation><annotation id="48"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="0" length="7"/><text>Osterix</text></annotation><annotation id="49"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="16" length="6"/><text>Col1a1</text></annotation></passage></document>
<document><id>23184392</id><passage><offset>0</offset><text>Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragment. Common cardiovascular progenitor cells are characterized and induced by expression of the transcription factor MesP1. To characterize this population we used a 3.4-kb promoter fragment previously described by our group. This served to isolate MesP1-positive cells from differentiating ES stem cells via magnetic cell sorting based on a truncated CD4 surface marker. As this proximal promoter fragment omits a distal non-cardiovasculogenic enhancer region, we were able to achieve a synchronized fraction of highly enriched cardiovascular progenitors. These led to about 90% of cells representing the three cardiovascular lineages: cardiomyocytes, endothelial cells and smooth muscle cells as evident from protein and mRNA analyses. In addition, electrophysiological and pharmacological parameters of the cardiomyocytic fraction show that almost all correspond to the multipotent early/intermediate cardiomyocyte subtype at day 18 of differentiation. Further differentiation of these cells was not impaired as evident from strong and synchronous beating at later stages. Our work contributes to the understanding of the earliest cardiovasculogenic events and may become an important prerequisite for cell therapy, tissue engineering and pharmacological testing in the culture dish using pluripotent stem cell-derived as well as directly reprogrammed cardiovascular cell types. Likewise, these cells provide an ideal source for large-scale transcriptome and proteome analyses.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="261" length="24"/><text>3.4-kb promoter fragment</text></annotation><annotation id="2"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="748" length="17"/><text>endothelial cells</text></annotation><annotation id="3"><infon key="identifier">0004576</infon><infon key="type">TISSUE</infon><location offset="770" length="19"/><text>smooth muscle cells</text></annotation><annotation id="4"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="1387" length="21"/><text>pluripotent stem cell</text></annotation><annotation id="5"><infon key="type">TISSUE</infon><location offset="108" length="31"/><text>cardiovascular progenitor cells</text></annotation><annotation id="6"><infon key="identifier">17292</infon><infon key="type">GENE</infon><location offset="76" length="5"/><text>MesP1</text></annotation><annotation id="7"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="999" length="13"/><text>cardiomyocyte</text></annotation><annotation id="8"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="732" length="14"/><text>cardiomyocytes</text></annotation><annotation id="9"><infon key="type">TISSUE</infon><location offset="1450" length="19"/><text>cardiovascular cell</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="475" length="26"/><text>proximal promoter fragment</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="510" length="45"/><text>distal non-cardiovasculogenic enhancer region</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="69" length="30"/><text>3.4-kb MesP1 promoter fragment</text></annotation><annotation id="13"><infon key="identifier">17292</infon><infon key="type">GENE</infon><location offset="212" length="5"/><text>MesP1</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="344" length="20"/><text>MesP1-positive cells</text></annotation><annotation id="15"><infon key="identifier">920</infon><infon key="type">GENE</infon><location offset="447" length="3"/><text>CD4</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="34" length="24"/><text>cardiovascular stem cell</text></annotation><annotation id="17"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="386" length="13"/><text>ES stem cells</text></annotation></passage></document>
<document><id>23273978</id><passage><offset>0</offset><text>eRNAs are required for p53-dependent enhancer activity and gene transcription. Binding within or nearby target genes involved in cell proliferation and survival enables the p53 tumor suppressor gene to regulate their transcription and cell-cycle progression. Using genome-wide chromatin-binding profiles, we describe binding of p53 also to regions located distantly from any known p53 target gene. Interestingly, many of these regions possess conserved p53-binding sites and all known hallmarks of enhancer regions. We demonstrate that these p53-bound enhancer regions (p53BERs) indeed contain enhancer activity and interact intrachromosomally with multiple neighboring genes to convey long-distance p53-dependent transcription regulation. Furthermore, p53BERs produce, in a p53-dependent manner, enhancer RNAs (eRNAs) that are required for efficient transcriptional enhancement of interacting target genes and induction of a p53-dependent cell-cycle arrest. Thus, our results ascribe transcription enhancement activity to p53 with the capacity to regulate multiple genes from a single genomic binding site. Moreover, eRNA production from p53BERs is required for efficient p53 transcription enhancement.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="542" length="26"/><text>p53-bound enhancer regions</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1139" length="7"/><text>p53BERs</text></annotation><annotation id="3"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="328" length="3"/><text>p53</text></annotation><annotation id="4"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="381" length="3"/><text>p53</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="453" length="17"/><text>p53-binding sites</text></annotation><annotation id="6"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1173" length="3"/><text>p53</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="797" length="13"/><text>enhancer RNAs</text></annotation><annotation id="8"><infon key="attribute">RNA,INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="812" length="5"/><text>eRNAs</text></annotation><annotation id="9"><infon key="attribute">RNA,INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1118" length="4"/><text>eRNA</text></annotation><annotation id="10"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="542" length="3"/><text>p53</text></annotation><annotation id="11"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="453" length="3"/><text>p53</text></annotation><annotation id="12"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="700" length="3"/><text>p53</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="570" length="7"/><text>p53BERs</text></annotation><annotation id="14"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="23" length="3"/><text>p53</text></annotation><annotation id="15"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="173" length="3"/><text>p53</text></annotation><annotation id="16"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="775" length="3"/><text>p53</text></annotation><annotation id="17"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="926" length="3"/><text>p53</text></annotation><annotation id="18"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1023" length="3"/><text>p53</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="753" length="7"/><text>p53BERs</text></annotation></passage></document>
<document><id>23302769</id><passage><offset>0</offset><text>Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia. LMO1 is a transcriptional regulator and a T-acute lymphoblastic leukaemia (T-ALL) oncogene. Although first identified in association with a chromosomal translocation in T-ALL, the ectopic expression of LMO1 occurs far more frequently in the absence of any known mutation involving its locus. Given that LMO1 is barely expressed in any haematopoietic lineage, and activation of transcriptional drivers in leukaemic cells is not well described, we investigated the regulation of this gene in normal haematopoietic and leukaemic cells. We show that LMO1 has two promoters that drive reporter gene expression in transgenic mice to neural tissues known to express endogenous LMO1. The LMO1 promoters display bivalent histone marks in multiple blood lineages including T-cells, and a 3' flanking region at LMO1 +57 contains a transcriptional enhancer that is active in developing blood cells in transgenic mouse embryos. The LMO1 promoters become activated in T-ALL together with the 3' enhancer, which is bound in primary T-ALL cells by SCL/TAL1 and GATA3. Taken together, our results show that LMO1 is poised for expression in normal progenitors, where activation of SCL/TAL1 together with a breakdown of epigenetic repression of LMO1 regulatory elements induces ectopic LMO1 expression that contributes to the development and maintenance of T-ALL.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="37" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="128" length="4"/><text>LMO1</text></annotation><annotation id="3"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="170" length="31"/><text>T-acute lymphoblastic leukaemia</text></annotation><annotation id="4"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="203" length="5"/><text>T-ALL</text></annotation><annotation id="5"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="297" length="5"/><text>T-ALL</text></annotation><annotation id="6"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="330" length="4"/><text>LMO1</text></annotation><annotation id="7"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="431" length="4"/><text>LMO1</text></annotation><annotation id="8"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="674" length="4"/><text>LMO1</text></annotation><annotation id="9"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1034" length="7"/><text>embryos</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="747" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="798" length="4"/><text>LMO1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="683" length="13"/><text>two promoters</text></annotation><annotation id="13"><infon key="identifier">0001035</infon><infon key="type">TISSUE</infon><location offset="866" length="14"/><text>blood lineages</text></annotation><annotation id="14"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="928" length="4"/><text>LMO1</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1028" length="5"/><text>mouse</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="1145" length="11"/><text>T-ALL cells</text></annotation><annotation id="17"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1082" length="5"/><text>T-ALL</text></annotation><annotation id="18"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="808" length="4"/><text>LMO1</text></annotation><annotation id="19"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1160" length="8"/><text>SCL/TAL1</text></annotation><annotation id="20"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="1173" length="5"/><text>GATA3</text></annotation><annotation id="21"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="1218" length="4"/><text>LMO1</text></annotation><annotation id="22"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1291" length="8"/><text>SCL/TAL1</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="808" length="14"/><text>LMO1 promoters</text></annotation><annotation id="24"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="1354" length="4"/><text>LMO1</text></annotation><annotation id="25"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="1395" length="4"/><text>LMO1</text></annotation><annotation id="26"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1466" length="5"/><text>T-ALL</text></annotation><annotation id="27"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="1047" length="4"/><text>LMO1</text></annotation><annotation id="28"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="463" length="22"/><text>haematopoietic lineage</text></annotation><annotation id="29"><infon key="identifier">0001271</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="532" length="15"/><text>leukaemic cells</text></annotation><annotation id="30"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="625" length="14"/><text>haematopoietic</text></annotation><annotation id="31"><infon key="identifier">0001271</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="644" length="15"/><text>leukaemic cells</text></annotation><annotation id="32"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="891" length="7"/><text>T-cells</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="948" length="24"/><text>transcriptional enhancer</text></annotation><annotation id="34"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1002" length="5"/><text>blood</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1047" length="14"/><text>LMO1 promoters</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1106" length="11"/><text>3' enhancer</text></annotation><annotation id="37"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="60" length="9"/><text>leukaemia</text></annotation><annotation id="38"><infon key="identifier">109594</infon><infon key="type">GENE</infon><location offset="79" length="4"/><text>LMO1</text></annotation><annotation id="39"><infon key="identifier">0005525</infon><infon key="type">DISEASE</infon><location offset="110" length="16"/><text>T-cell leukaemia</text></annotation></passage></document>
<document><id>23307821</id><passage><offset>0</offset><text>Essential and unexpected role of Yin Yang 1 to promote mesodermal cardiac differentiation. RATIONALE: Cardiogenesis is regulated by a complex interplay between transcription factors. However, little is known about how these interactions regulate the transition from mesodermal precursors to cardiac progenitor cells (CPCs). OBJECTIVE: To identify novel regulators of mesodermal cardiac lineage commitment. METHODS AND RESULTS: We performed a bioinformatic-based transcription factor binding site analysis on upstream promoter regions of genes that are enriched in embryonic stem cell-derived CPCs. From 32 candidate transcription factors screened, we found that Yin Yang 1 (YY1), a repressor of sarcomeric gene expression, is present in CPCs in vivo. Interestingly, we uncovered the ability of YY1 to transcriptionally activate Nkx2.5, a key marker of early cardiogenic commitment. YY1 regulates Nkx2.5 expression via a 2.1-kb cardiac-specific enhancer as demonstrated by in vitro luciferase-based assays, in vivo chromatin immunoprecipitation, and genome-wide sequencing analysis. Furthermore, the ability of YY1 to activate Nkx2.5 expression depends on its cooperative interaction with Gata4 at a nearby chromatin. Cardiac mesoderm-specific loss-of-function of YY1 resulted in early embryonic lethality. This was corroborated in vitro by embryonic stem cell-based assays in which we showed that the overexpression of YY1 enhanced the cardiogenic differentiation of embryonic stem cells into CPCs. CONCLUSIONS: These results demonstrate an essential and unexpected role for YY1 to promote cardiogenesis as a transcriptional activator of Nkx2.5 and other CPC-enriched genes.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="920" length="32"/><text>2.1-kb cardiac-specific enhancer</text></annotation><annotation id="2"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1110" length="3"/><text>YY1</text></annotation><annotation id="3"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="1126" length="6"/><text>Nkx2.5</text></annotation><annotation id="4"><infon key="identifier">2626</infon><infon key="type">GENE</infon><location offset="1188" length="5"/><text>Gata4</text></annotation><annotation id="5"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1263" length="3"/><text>YY1</text></annotation><annotation id="6"><infon key="type">TISSUE</infon><location offset="378" length="15"/><text>cardiac lineage</text></annotation><annotation id="7"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1419" length="3"/><text>YY1</text></annotation><annotation id="8"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="1575" length="3"/><text>YY1</text></annotation><annotation id="9"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="1638" length="6"/><text>Nkx2.5</text></annotation><annotation id="10"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="33" length="10"/><text>Yin Yang 1</text></annotation><annotation id="11"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="266" length="21"/><text>mesodermal precursors</text></annotation><annotation id="12"><infon key="type">TISSUE</infon><location offset="317" length="4"/><text>CPCs</text></annotation><annotation id="13"><infon key="type">TISSUE</infon><location offset="592" length="4"/><text>CPCs</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="737" length="4"/><text>CPCs</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="1493" length="4"/><text>CPCs</text></annotation><annotation id="16"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="564" length="19"/><text>embryonic stem cell</text></annotation><annotation id="17"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="1217" length="16"/><text>Cardiac mesoderm</text></annotation><annotation id="18"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1340" length="19"/><text>embryonic stem cell</text></annotation><annotation id="19"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1467" length="20"/><text>embryonic stem cells</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="1655" length="3"/><text>CPC</text></annotation><annotation id="21"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="662" length="10"/><text>Yin Yang 1</text></annotation><annotation id="22"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="674" length="3"/><text>YY1</text></annotation><annotation id="23"><infon key="type">TISSUE</infon><location offset="291" length="24"/><text>cardiac progenitor cells</text></annotation><annotation id="24"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="794" length="3"/><text>YY1</text></annotation><annotation id="25"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="828" length="6"/><text>Nkx2.5</text></annotation><annotation id="26"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="882" length="3"/><text>YY1</text></annotation><annotation id="27"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="896" length="6"/><text>Nkx2.5</text></annotation></passage></document>
<document><id>23321477</id><passage><offset>0</offset><text>Hypoxic adaptation engages the CBP/CREST-induced coactivator complex of Creb-HIF-1alpha in transactivating murine neuroblastic glucose transporter. We have shown in vitro a hypoxia-induced time-dependent increase in facilitative glucose transporter isoform 3 (GLUT3) expression in N2A murine neuroblasts. This increase in GLUT3 expression is partially reliant on a transcriptional increase noted in actinomycin D and cycloheximide pretreatment experiments. Transient transfection assays in N2A neuroblasts using murine glut3-luciferase reporter constructs mapped the hypoxia-induced enhancer activities to -857- to -573-bp and -203- to -177-bp regions. Hypoxia-exposed N2A nuclear extracts demonstrated an increase in HIF-1alpha and p-Creb binding to HRE (-828 to -824 bp) and AP-1 (-187 to -180 bp) cis-elements, respectively, in electromobility shift and supershift assays, which was confirmed by chromatin immunoprecipitation assays. In addition, the interaction of CBP with Creb and HIF-1alpha and CREST with CBP in hypoxia was detected by coimmunoprecipitation. Furthermore, small interference (si)RNA targeting Creb in these cells decreased endogenous Creb concentrations that reduced by twofold hypoxia-induced glut3 gene transcription. Thus, in N2A neuroblasts, phosphorylated HIF-1alpha and Creb mediated the hypoxia-induced increase in glut3 transcription. Coactivation by the Ca++-dependent CREST and CBP proteins may enhance cross-talk between p-Creb-AP-1 and HIF-1alpha/HRE of the glut3 gene. Collectively, these processes can facilitate an adaptive response to hypoxic energy depletion targeted at enhancing glucose transport and minimizing injury while fueling the proliferative potential of neuroblasts.</text><annotation id="1"><infon key="identifier">12914</infon><infon key="type">GENE</infon><location offset="31" length="3"/><text>CBP</text></annotation><annotation id="2"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="519" length="5"/><text>glut3</text></annotation><annotation id="3"><infon key="identifier">15251</infon><infon key="type">GENE</infon><location offset="718" length="10"/><text>HIF-1alpha</text></annotation><annotation id="4"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="735" length="4"/><text>Creb</text></annotation><annotation id="5"><infon key="identifier">12914</infon><infon key="type">GENE</infon><location offset="969" length="3"/><text>CBP</text></annotation><annotation id="6"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="978" length="4"/><text>Creb</text></annotation><annotation id="7"><infon key="identifier">15251</infon><infon key="type">GENE</infon><location offset="987" length="10"/><text>HIF-1alpha</text></annotation><annotation id="8"><infon key="identifier">269397</infon><infon key="type">GENE</infon><location offset="1002" length="5"/><text>CREST</text></annotation><annotation id="9"><infon key="identifier">12914</infon><infon key="type">GENE</infon><location offset="1013" length="3"/><text>CBP</text></annotation><annotation id="10"><infon key="type">DISEASE</infon><location offset="1020" length="7"/><text>hypoxia</text></annotation><annotation id="11"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="1117" length="4"/><text>Creb</text></annotation><annotation id="12"><infon key="identifier">269397</infon><infon key="type">GENE</infon><location offset="35" length="5"/><text>CREST</text></annotation><annotation id="13"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="1158" length="4"/><text>Creb</text></annotation><annotation id="14"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="1218" length="5"/><text>glut3</text></annotation><annotation id="15"><infon key="identifier">15251</infon><infon key="type">GENE</infon><location offset="1285" length="10"/><text>HIF-1alpha</text></annotation><annotation id="16"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="1300" length="4"/><text>Creb</text></annotation><annotation id="17"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="1346" length="5"/><text>glut3</text></annotation><annotation id="18"><infon key="identifier">269397</infon><infon key="type">GENE</infon><location offset="1402" length="5"/><text>CREST</text></annotation><annotation id="19"><infon key="identifier">12914</infon><infon key="type">GENE</infon><location offset="1412" length="3"/><text>CBP</text></annotation><annotation id="20"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="1458" length="4"/><text>Creb</text></annotation><annotation id="21"><infon key="identifier">15251</infon><infon key="type">GENE</infon><location offset="1472" length="10"/><text>HIF-1alpha</text></annotation><annotation id="22"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="1494" length="5"/><text>glut3</text></annotation><annotation id="23"><infon key="identifier">12912</infon><infon key="type">GENE</infon><location offset="72" length="4"/><text>Creb</text></annotation><annotation id="24"><infon key="identifier">16476</infon><infon key="type">GENE</infon><location offset="1463" length="4"/><text>AP-1</text></annotation><annotation id="25"><infon key="identifier">16476</infon><infon key="type">GENE</infon><location offset="777" length="4"/><text>AP-1</text></annotation><annotation id="26"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="229" length="29"/><text>glucose transporter isoform 3</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="583" length="68"/><text>enhancer activities to -857- to -573-bp and -203- to -177-bp regions</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="751" length="61"/><text>HRE (-828 to -824 bp) and AP-1 (-187 to -180 bp) cis-elements</text></annotation><annotation id="29"><infon key="type">DISEASE</infon><location offset="567" length="7"/><text>hypoxia</text></annotation><annotation id="30"><infon key="type">DISEASE</infon><location offset="1202" length="7"/><text>hypoxia</text></annotation><annotation id="31"><infon key="type">DISEASE</infon><location offset="1318" length="7"/><text>hypoxia</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1483" length="3"/><text>HRE</text></annotation><annotation id="33"><infon key="identifier">15251</infon><infon key="type">GENE</infon><location offset="77" length="10"/><text>HIF-1alpha</text></annotation><annotation id="34"><infon key="type">DISEASE</infon><location offset="653" length="7"/><text>Hypoxia</text></annotation><annotation id="35"><infon key="identifier">0000932</infon><infon key="type">TISSUE</infon><location offset="490" length="15"/><text>N2A neuroblasts</text></annotation><annotation id="36"><infon key="type">DISEASE</infon><location offset="173" length="7"/><text>hypoxia</text></annotation><annotation id="37"><infon key="identifier">0000932</infon><infon key="type">TISSUE</infon><location offset="1253" length="15"/><text>N2A neuroblasts</text></annotation><annotation id="38"><infon key="identifier">0000930</infon><infon key="type">TISSUE</infon><location offset="1707" length="11"/><text>neuroblasts</text></annotation><annotation id="39"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="107" length="6"/><text>murine</text></annotation><annotation id="40"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="260" length="5"/><text>GLUT3</text></annotation><annotation id="41"><infon key="identifier">0000932</infon><infon key="type">TISSUE</infon><location offset="281" length="22"/><text>N2A murine neuroblasts</text></annotation><annotation id="42"><infon key="identifier">20527</infon><infon key="type">GENE</infon><location offset="322" length="5"/><text>GLUT3</text></annotation><annotation id="43"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="512" length="6"/><text>murine</text></annotation></passage></document>
<document><id>23443045</id><passage><offset>0</offset><text>FOXA1 mediates p16(INK4a) activation during cellular senescence. Mechanisms governing the transcription of p16(INK4a), one of the master regulators of cellular senescence, have been extensively studied. However, little is known about chromatin dynamics taking place at its promoter and distal enhancer. Here, we report that Forkhead box A1 protein (FOXA1) is significantly upregulated in both replicative and oncogene-induced senescence, and in turn activates transcription of p16(INK4a) through multiple mechanisms. In addition to acting as a classic sequence-specific transcriptional activator, FOXA1 binding leads to a decrease in nucleosome density at the p16(INK4a) promoter in senescent fibroblasts. Moreover, FOXA1, itself a direct target of Polycomb-mediated repression, antagonizes Polycomb function at the p16(INK4a) locus. Finally, a systematic survey of putative FOXA1 binding sites in the p16(INK4a) genomic region revealed an ~150 kb distal element that could loop back to the promoter and potentiate p16(INK4a) expression. Overall, our findings establish several mechanisms by which FOXA1 controls p16(INK4a) expression during cellular senescence.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="273" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="286" length="15"/><text>distal enhancer</text></annotation><annotation id="3"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="349" length="5"/><text>FOXA1</text></annotation><annotation id="4"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="477" length="3"/><text>p16</text></annotation><annotation id="5"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="481" length="5"/><text>INK4a</text></annotation><annotation id="6"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="597" length="5"/><text>FOXA1</text></annotation><annotation id="7"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="693" length="11"/><text>fibroblasts</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="875" length="19"/><text>FOXA1 binding sites</text></annotation><annotation id="9"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="716" length="5"/><text>FOXA1</text></annotation><annotation id="10"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="816" length="3"/><text>p16</text></annotation><annotation id="11"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="820" length="5"/><text>INK4a</text></annotation><annotation id="12"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="660" length="3"/><text>p16</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="660" length="19"/><text>p16(INK4a) promoter</text></annotation><annotation id="14"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="902" length="3"/><text>p16</text></annotation><annotation id="15"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="906" length="5"/><text>INK4a</text></annotation><annotation id="16"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="1015" length="3"/><text>p16</text></annotation><annotation id="17"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="1019" length="5"/><text>INK4a</text></annotation><annotation id="18"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="1098" length="5"/><text>FOXA1</text></annotation><annotation id="19"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="1113" length="3"/><text>p16</text></annotation><annotation id="20"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="1117" length="5"/><text>INK4a</text></annotation><annotation id="21"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="664" length="5"/><text>INK4a</text></annotation><annotation id="22"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="875" length="5"/><text>FOXA1</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="991" length="8"/><text>promoter</text></annotation><annotation id="24"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>FOXA1</text></annotation><annotation id="25"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="15" length="3"/><text>p16</text></annotation><annotation id="26"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="19" length="5"/><text>INK4a</text></annotation><annotation id="27"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="107" length="3"/><text>p16</text></annotation><annotation id="28"><infon key="identifier">1029</infon><infon key="type">GENE</infon><location offset="111" length="5"/><text>INK4a</text></annotation><annotation id="29"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="324" length="15"/><text>Forkhead box A1</text></annotation></passage></document>
<document><id>23636943</id><passage><offset>0</offset><text>Enhancer transcripts mark active estrogen receptor binding sites. We have integrated and analyzed a large number of data sets from a variety of genomic assays using a novel computational pipeline to provide a global view of estrogen receptor 1 (ESR1; a.k.a. ERalpha) enhancers in MCF-7 human breast cancer cells. Using this approach, we have defined a class of primary transcripts (eRNAs) that are transcribed uni- or bidirectionally from estrogen receptor binding sites (ERBSs) with an average transcription unit length of ~3-5 kb. The majority are up-regulated by short treatments with estradiol (i.e., 10, 25, or 40 min) with kinetics that precede or match the induction of the target genes. The production of eRNAs at ERBSs is strongly correlated with the enrichment of a number of genomic features that are associated with enhancers (e.g., H3K4me1, H3K27ac, EP300/CREBBP, RNA polymerase II, open chromatin architecture), as well as enhancer looping to target gene promoters. In the absence of eRNA production, strong enrichment of these features is not observed, even though ESR1 binding is evident. We find that flavopiridol, a CDK9 inhibitor that blocks transcription elongation, inhibits eRNA production but does not affect other molecular indicators of enhancer activity, suggesting that eRNA production occurs after the assembly of active enhancers. Finally, we show that an enhancer transcription "signature" based on GRO-seq data can be used for de novo enhancer prediction across cell types. Together, our studies shed new light on the activity of ESR1 at its enhancer sites and provide new insights about enhancer function.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="224" length="52"/><text>estrogen receptor 1 (ESR1; a.k.a. ERalpha) enhancers</text></annotation><annotation id="2"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="258" length="7"/><text>ERalpha</text></annotation><annotation id="3"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1561" length="4"/><text>ESR1</text></annotation><annotation id="4"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="439" length="17"/><text>estrogen receptor</text></annotation><annotation id="5"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="863" length="5"/><text>EP300</text></annotation><annotation id="6"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="869" length="6"/><text>CREBBP</text></annotation><annotation id="7"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1080" length="4"/><text>ESR1</text></annotation><annotation id="8"><infon key="identifier">1025</infon><infon key="type">GENE</infon><location offset="1134" length="4"/><text>CDK9</text></annotation><annotation id="9"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="280" length="31"/><text>MCF-7 human breast cancer cells</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="439" length="31"/><text>estrogen receptor binding sites</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="472" length="5"/><text>ERBSs</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="722" length="5"/><text>ERBSs</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="33" length="31"/><text>estrogen receptor binding sites</text></annotation><annotation id="14"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="224" length="19"/><text>estrogen receptor 1</text></annotation><annotation id="15"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="245" length="4"/><text>ESR1</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1561" length="26"/><text>ESR1 at its enhancer sites</text></annotation></passage></document>
<document><id>23642367</id><passage><offset>0</offset><text>Mesp1 patterns mesoderm into cardiac, hematopoietic, or skeletal myogenic progenitors in a context-dependent manner. Mesp1 is regarded as the master regulator of cardiovascular development, initiating the cardiac transcription factor cascade to direct the generation of cardiac mesoderm. To define the early embryonic cell population that responds to Mesp1, we performed pulse inductions of gene expression over tight temporal windows following embryonic stem cell differentiation. Remarkably, instead of promoting cardiac differentiation in the initial wave of mesoderm, Mesp1 binds to the Tal1 (Scl) +40 kb enhancer and generates Flk-1+ precursors expressing Etv2 (ER71) and Tal1 that undergo hematopoietic differentiation. The second wave of mesoderm responds to Mesp1 by differentiating into PDGFRalpha+ precursors that undergo cardiac differentiation. Furthermore, in the absence of serum-derived factors, Mesp1 promotes skeletal myogenic differentiation. Lineage tracing revealed that the majority of yolk sac and many adult hematopoietic cells derive from Mesp1+ precursors. Thus, Mesp1 is a context-dependent determination factor, integrating the stage of differentiation and the signaling environment to specify different lineage outcomes.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="591" length="26"/><text>Tal1 (Scl) +40 kb enhancer</text></annotation><annotation id="2"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Mesp1</text></annotation><annotation id="3"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="766" length="5"/><text>Mesp1</text></annotation><annotation id="4"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="911" length="5"/><text>Mesp1</text></annotation><annotation id="5"><infon key="type">TISSUE</infon><location offset="29" length="7"/><text>cardiac</text></annotation><annotation id="6"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="1088" length="5"/><text>Mesp1</text></annotation><annotation id="7"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="38" length="13"/><text>hematopoietic</text></annotation><annotation id="8"><infon key="type">TISSUE</infon><location offset="56" length="29"/><text>skeletal myogenic progenitors</text></annotation><annotation id="9"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="15" length="8"/><text>mesoderm</text></annotation><annotation id="10"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="270" length="16"/><text>cardiac mesoderm</text></annotation><annotation id="11"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="562" length="8"/><text>mesoderm</text></annotation><annotation id="12"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="1063" length="5"/><text>Mesp1</text></annotation><annotation id="13"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="117" length="5"/><text>Mesp1</text></annotation><annotation id="14"><infon key="identifier">0000574</infon><infon key="type">TISSUE</infon><location offset="1031" length="19"/><text>hematopoietic cells</text></annotation><annotation id="15"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="591" length="4"/><text>Tal1</text></annotation><annotation id="16"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="445" length="19"/><text>embryonic stem cell</text></annotation><annotation id="17"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="597" length="3"/><text>Scl</text></annotation><annotation id="18"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="351" length="5"/><text>Mesp1</text></annotation><annotation id="19"><infon key="identifier">55897</infon><infon key="type">GENE</infon><location offset="572" length="5"/><text>Mesp1</text></annotation><annotation id="20"><infon key="identifier">0000839</infon><infon key="type">TISSUE</infon><location offset="745" length="8"/><text>mesoderm</text></annotation><annotation id="21"><infon key="identifier">3791</infon><infon key="type">GENE</infon><location offset="632" length="5"/><text>Flk-1</text></annotation><annotation id="22"><infon key="identifier">2116</infon><infon key="type">GENE</infon><location offset="661" length="4"/><text>Etv2</text></annotation><annotation id="23"><infon key="identifier">2116</infon><infon key="type">GENE</infon><location offset="667" length="4"/><text>ER71</text></annotation><annotation id="24"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="677" length="4"/><text>Tal1</text></annotation></passage></document>
<document><id>23644027</id><passage><offset>0</offset><text>Two novel and functional DNA sequence variants within an upstream enhancer of the human NKX2-5 gene in ventricular septal defects. Mortality in patients with congenital heart disease (CHD) is significantly increased even with successful surgeries. The main causes are late cardiac complications, such as heart failure and arrhythmia, probably due to genetic defects. To date, genetic causes for CHD remain largely unknown. NKX2-5 gene encodes a highly conserved homeobox transcription factor, which is essential to the heart development in embryos and cardiac function in adults. Mutations in NKX2-5 gene have been implicated in diverse types of CHD, including ventricular septal defect (VSD). As NKX2-5 is a dosage-sensitive regulator, we have speculated that changed NKX2-5 levels may mediate CHD development by influencing cardiac gene regulatory network. In previous studies, we have analyzed the NKX2-5 gene promoter and a proximal enhancer in VSD patients. In the present study, we further genetically and functionally analyzed an upstream enhancer of the NKX2-5 gene in large cohorts of VSD patients (n=340) and controls (n=347). Two novel heterozygous DNA sequence variants (DSVs), g.17483576C&gt;G and g.17483564C&gt;T, were identified in three VSD patients, but none in controls. Functionally, these two DSVs significantly decreased the activity of the enhancer (P&lt;0.01). Another novel heterozygous DSV, g.17483557Ins, was found in both VSD patients and controls with similar frequencies (P&gt;0.05). Taken together, our data suggested that the DSVs within the upstream enhancer of the NKX2-5 gene may contribute to a small number of VSD. Therefore, genetic studies of CHD may provide insight into designing novel therapies for adult CHD patients.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="57" length="42"/><text>upstream enhancer of the human NKX2-5 gene</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="901" length="20"/><text>NKX2-5 gene promoter</text></annotation><annotation id="3"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="184" length="3"/><text>CHD</text></annotation><annotation id="4"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="88" length="6"/><text>NKX2-5</text></annotation><annotation id="5"><infon key="identifier">0005252</infon><infon key="type">DISEASE</infon><location offset="304" length="13"/><text>heart failure</text></annotation><annotation id="6"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="1062" length="6"/><text>NKX2-5</text></annotation><annotation id="7"><infon key="identifier">0003847</infon><infon key="type">DISEASE</infon><location offset="350" length="15"/><text>genetic defects</text></annotation><annotation id="8"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="395" length="3"/><text>CHD</text></annotation><annotation id="9"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="423" length="6"/><text>NKX2-5</text></annotation><annotation id="10"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="593" length="6"/><text>NKX2-5</text></annotation><annotation id="11"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="646" length="3"/><text>CHD</text></annotation><annotation id="12"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="661" length="25"/><text>ventricular septal defect</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="928" length="17"/><text>proximal enhancer</text></annotation><annotation id="14"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="688" length="3"/><text>VSD</text></annotation><annotation id="15"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="697" length="6"/><text>NKX2-5</text></annotation><annotation id="16"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="769" length="6"/><text>NKX2-5</text></annotation><annotation id="17"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="795" length="3"/><text>CHD</text></annotation><annotation id="18"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="1587" length="6"/><text>NKX2-5</text></annotation><annotation id="19"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="949" length="3"/><text>VSD</text></annotation><annotation id="20"><infon key="identifier">1482</infon><infon key="type">GENE</infon><location offset="901" length="6"/><text>NKX2-5</text></annotation><annotation id="21"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="1094" length="3"/><text>VSD</text></annotation><annotation id="22"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="1248" length="3"/><text>VSD</text></annotation><annotation id="23"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="1441" length="3"/><text>VSD</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1037" length="36"/><text>upstream enhancer of the NKX2-5 gene</text></annotation><annotation id="25"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="1635" length="3"/><text>VSD</text></annotation><annotation id="26"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="1670" length="3"/><text>CHD</text></annotation><annotation id="27"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="1735" length="3"/><text>CHD</text></annotation><annotation id="28"><infon key="type">VARIANT</infon><location offset="1190" length="13"/><text>g.17483576C&gt;G</text></annotation><annotation id="29"><infon key="type">VARIANT</infon><location offset="1208" length="13"/><text>g.17483564C&gt;T</text></annotation><annotation id="30"><infon key="type">VARIANT</infon><location offset="1408" length="13"/><text>g.17483557Ins</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1357" length="8"/><text>enhancer</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1562" length="36"/><text>upstream enhancer of the NKX2-5 gene</text></annotation><annotation id="33"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="519" length="5"/><text>heart</text></annotation><annotation id="34"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="540" length="7"/><text>embryos</text></annotation><annotation id="35"><infon key="identifier">0002070</infon><infon key="type">DISEASE</infon><location offset="103" length="26"/><text>ventricular septal defects</text></annotation><annotation id="36"><infon key="identifier">0005453</infon><infon key="type">DISEASE</infon><location offset="158" length="24"/><text>congenital heart disease</text></annotation></passage></document>
<document><id>23659698</id><passage><offset>0</offset><text>Finding of IFNgamma gene enhancers and their core sequences. DNA segmentation methods were used to study which fragments of the human IFNgamma gene possess enhancer activity. The human IFNgamma gene was divided into 240-bp fragments, which were inserted between the GFP gene and the Alu tandem sequence to determine whether the inserted sequences eliminate the inhibition induced by the Alu tandem sequence. We found that five different 240-bp fragments (FUIFN3F3R, IFN4F4R, IFN6F6R, IFN21F21R, and IFN22F22R) and two 60-bp core sequences (IFN6-2F2R and IFN21-3-4F3-4R) derived from the IFNgamma gene contain enhancers that can activate the GFP reporter gene. These enhancers may be targets of IFNgamma gene expression regulation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="11" length="23"/><text>IFNgamma gene enhancers</text></annotation><annotation id="2"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="694" length="8"/><text>IFNgamma</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="475" length="7"/><text>IFN6F6R</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="484" length="9"/><text>IFN21F21R</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="499" length="9"/><text>IFN22F22R</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="514" length="24"/><text>two 60-bp core sequences</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="540" length="9"/><text>IFN6-2F2R</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="554" length="14"/><text>IFN21-3-4F3-4R</text></annotation><annotation id="9"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="11" length="8"/><text>IFNgamma</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="422" length="31"/><text>five different 240-bp fragments</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="666" length="9"/><text>enhancers</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="455" length="9"/><text>FUIFN3F3R</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="128" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="134" length="8"/><text>IFNgamma</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="179" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="185" length="8"/><text>IFNgamma</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="466" length="7"/><text>IFN4F4R</text></annotation></passage></document>
<document><id>23675462</id><passage><offset>0</offset><text>Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction. Mitogen- and stress-activated protein kinases 1 and 2 (MSK1 and MSK2), activated downstream of the ERK- and p38-mitogen-activated protein kinase pathways are involved in cell survival, proliferation and differentiation. Following mitogenic or stress stimuli, they mediate the nucleosomal response, which includes phosphorylation of histone H3 at serine 10 (H3S10ph) coupled with transcriptional activation of immediate-early genes. While MSK1 and MSK2 are closely related, their relative roles may vary with cellular context and/or stimuli. However, our knowledge of MSK2 recruitment to immediate-early genes is limited, as research has primarily focused on MSK1. Here, we demonstrate that both MSK1 and MSK2, regulate the phorbol ester 12-O-tetradecanoylphorbol-13-acetate induced expression of the breast cancer marker gene, trefoil factor 1 (TFF1), by phosphorylating H3S10 at its 5' regulatory regions. The MSK-mediated phosphorylation of H3S10 promotes the recruitment of 14-3-3 isoforms and BRG1, the ATPase subunit of the BAF/PBAF remodeling complex, to the enhancer and upstream promoter elements of TFF1. The recruited chromatin remodeling activity leads to the RNA polymerase II carboxy-terminal domain phosphorylation at the TFF1 promoter, initiating TFF1 expression in MCF-7 breast cancer cells. Moreover, we show that MSK1 or MSK2 is recruited to TFF1 regulatory regions, but as components of different multiprotein complexes.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1172" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="identifier">8986</infon><infon key="type">GENE</infon><location offset="554" length="4"/><text>MSK2</text></annotation><annotation id="3"><infon key="identifier">8986</infon><infon key="type">GENE</infon><location offset="674" length="4"/><text>MSK2</text></annotation><annotation id="4"><infon key="identifier">9252</infon><infon key="type">GENE</infon><location offset="765" length="4"/><text>MSK1</text></annotation><annotation id="5"><infon key="identifier">9252</infon><infon key="type">GENE</infon><location offset="802" length="4"/><text>MSK1</text></annotation><annotation id="6"><infon key="identifier">8986</infon><infon key="type">GENE</infon><location offset="811" length="4"/><text>MSK2</text></annotation><annotation id="7"><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="907" length="13"/><text>breast cancer</text></annotation><annotation id="8"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="934" length="16"/><text>trefoil factor 1</text></annotation><annotation id="9"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="952" length="4"/><text>TFF1</text></annotation><annotation id="10"><infon key="identifier">6597</infon><infon key="type">GENE</infon><location offset="1104" length="4"/><text>BRG1</text></annotation><annotation id="11"><infon key="identifier">1769</infon><infon key="type">GENE</infon><location offset="1114" length="6"/><text>ATPase</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1343" length="13"/><text>TFF1 promoter</text></annotation><annotation id="13"><infon key="identifier">8815</infon><infon key="type">GENE</infon><location offset="1136" length="3"/><text>BAF</text></annotation><annotation id="14"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="1215" length="4"/><text>TFF1</text></annotation><annotation id="15"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="1388" length="25"/><text>MCF-7 breast cancer cells</text></annotation><annotation id="16"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="1369" length="4"/><text>TFF1</text></annotation><annotation id="17"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="1343" length="4"/><text>TFF1</text></annotation><annotation id="18"><infon key="identifier">9252</infon><infon key="type">GENE</infon><location offset="1438" length="4"/><text>MSK1</text></annotation><annotation id="19"><infon key="identifier">8986</infon><infon key="type">GENE</infon><location offset="1446" length="4"/><text>MSK2</text></annotation><annotation id="20"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="1467" length="4"/><text>TFF1</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1185" length="34"/><text>upstream promoter elements of TFF1</text></annotation><annotation id="22"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="79" length="16"/><text>trefoil factor 1</text></annotation><annotation id="23"><infon key="identifier">1432</infon><infon key="type">GENE</infon><location offset="215" length="3"/><text>p38</text></annotation><annotation id="24"><infon key="identifier">9252</infon><infon key="type">GENE</infon><location offset="162" length="4"/><text>MSK1</text></annotation><annotation id="25"><infon key="identifier">8986</infon><infon key="type">GENE</infon><location offset="171" length="4"/><text>MSK2</text></annotation><annotation id="26"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="206" length="3"/><text>ERK</text></annotation><annotation id="27"><infon key="identifier">9252</infon><infon key="type">GENE</infon><location offset="545" length="4"/><text>MSK1</text></annotation></passage></document>
<document><id>23872150</id><passage><offset>0</offset><text>Estrogen modulates plasminogen promoter activity. Postmenopausal women treated with estrogen hormone replacement therapy and female patients with hypoplasminogenemia receiving oral contraceptives show increasing plasminogen (PLG) concentrations. The elevated PLG levels are in contrast to the estrogen dependent decline of lipoptrotein(a) [Lp(a)], whose main protein component apolipoprotein(a) [APO(a)] is highly homologous to PLG in protein and gene structure and is also located in its immediate vicinity on chromosome 6q26. The intergenic region between both genes comprises several transcription-regulatory regions with enhancer sequences that increase the basal activity of the PLG core promoter. Using luciferase reporter assays we demonstrate that the minimal PLG promoter is insensitive to estrogen. However, an estrogen response element located 11.5 kb upstream of the PLG transcription start site is able to convey a dramatic estrogen-dependent elevation of PLG-minimal promoter driven reporter gene expression. In contrast, the activating effect of two additional enhancer elements, among them an DNase I hypersensitivity region that has been shown to regulate the APO(a) minimal promoter activity, is abrogated by estrogen. Thus, the identified estrogen-responsive elements provide a gene and tissue specific framework by which PLG expression is regulated and whose activity is orchestrated by yet unknown accessory factors.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="821" length="86"/><text>estrogen response element located 11.5 kb upstream of the PLG transcription start site</text></annotation><annotation id="2"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="212" length="11"/><text>plasminogen</text></annotation><annotation id="3"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="225" length="3"/><text>PLG</text></annotation><annotation id="4"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="259" length="3"/><text>PLG</text></annotation><annotation id="5"><infon key="identifier">4018</infon><infon key="type">GENE</infon><location offset="377" length="17"/><text>apolipoprotein(a)</text></annotation><annotation id="6"><infon key="identifier">4018</infon><infon key="type">GENE</infon><location offset="396" length="6"/><text>APO(a)</text></annotation><annotation id="7"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="428" length="3"/><text>PLG</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1061" length="32"/><text>two additional enhancer elements</text></annotation><annotation id="9"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="684" length="3"/><text>PLG</text></annotation><annotation id="10"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="768" length="3"/><text>PLG</text></annotation><annotation id="11"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="969" length="3"/><text>PLG</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="684" length="17"/><text>PLG core promoter</text></annotation><annotation id="13"><infon key="identifier">4018</infon><infon key="type">GENE</infon><location offset="1177" length="6"/><text>APO(a)</text></annotation><annotation id="14"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="1341" length="3"/><text>PLG</text></annotation><annotation id="15"><infon key="identifier">5340</infon><infon key="type">GENE</infon><location offset="879" length="3"/><text>PLG</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="760" length="20"/><text>minimal PLG promoter</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="969" length="20"/><text>PLG-minimal promoter</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1258" length="28"/><text>estrogen-responsive elements</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1177" length="23"/><text>APO(a) minimal promoter</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="19" length="20"/><text>plasminogen promoter</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="65" length="5"/><text>women</text></annotation><annotation id="22"><infon key="identifier">0009009</infon><infon key="type">DISEASE</infon><location offset="146" length="19"/><text>hypoplasminogenemia</text></annotation></passage></document>
<document><id>23884959</id><passage><offset>0</offset><text>Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases. Oxygen concentration in prostate cancer tissue is significantly low, i.e. ~0.3% O2. This study showed that pathological hypoxia (&lt;0.5% O2) increased the expression of androgen receptor (AR) target genes such as prostate-specific antigen (PSA) and kallikrein-related peptidase 2 in LNCaP human prostate cancer cells by modifying the quantity and activity of related Jumonji C domain-containing histone demethylases (JMJDs). Under pathological hypoxia, the catalytic activities of JMJD2A, JMJD2C and Jumonji/ARID domain-containing protein 1B (JARID1B) were blocked due to the lack of their substrate, i.e. oxygen. Chromatin immunoprecipitation analyses showed that hypoxia increased the appearance of H3K9me3 and H3K4me3, substrates of JMJD2s and JARID1B, respectively, in the PSA enhancer. In contrast, JMJD1A, which demethylates both H3K9me2 and H3K9me1, maintained its catalytic activity even under severe hypoxia. Furthermore, hypoxia increased the expression of JMJD1A. Hypoxia and androgen additively increased the recruitment of JMJD1A and p300 on the enhancer region of PSA through interaction with the hypoxia-inducible factor-1alpha and AR, both of which bind the PSA enhancer. Thus, hypoxia enhanced the demethylation of H3K9me2 and H3K9me1, leading to provide unmethylated H3K9 residues that are substrates for histone acetyltransferase, p300. Consequently, hypoxia increased the acetylation of histones of the PSA enhancer, which facilitates its transcription.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="938" length="12"/><text>PSA enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1220" length="22"/><text>enhancer region of PSA</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="444" length="33"/><text>LNCaP human prostate cancer cells</text></annotation><annotation id="4"><infon key="type">DISEASE</infon><location offset="1136" length="7"/><text>Hypoxia</text></annotation><annotation id="5"><infon key="type">DISEASE</infon><location offset="0" length="7"/><text>Hypoxia</text></annotation><annotation id="6"><infon key="type">DISEASE</infon><location offset="605" length="7"/><text>hypoxia</text></annotation><annotation id="7"><infon key="identifier">9682</infon><infon key="type">GENE</infon><location offset="642" length="6"/><text>JMJD2A</text></annotation><annotation id="8"><infon key="identifier">23081</infon><infon key="type">GENE</infon><location offset="650" length="6"/><text>JMJD2C</text></annotation><annotation id="9"><infon key="identifier">10765</infon><infon key="type">GENE</infon><location offset="661" length="41"/><text>Jumonji/ARID domain-containing protein 1B</text></annotation><annotation id="10"><infon key="identifier">10765</infon><infon key="type">GENE</infon><location offset="704" length="7"/><text>JARID1B</text></annotation><annotation id="11"><infon key="type">DISEASE</infon><location offset="826" length="7"/><text>hypoxia</text></annotation><annotation id="12"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="938" length="3"/><text>PSA</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1335" length="12"/><text>PSA enhancer</text></annotation><annotation id="14"><infon key="identifier">10765</infon><infon key="type">GENE</infon><location offset="908" length="7"/><text>JARID1B</text></annotation><annotation id="15"><infon key="identifier">55818</infon><infon key="type">GENE</infon><location offset="965" length="6"/><text>JMJD1A</text></annotation><annotation id="16"><infon key="type">DISEASE</infon><location offset="1070" length="7"/><text>hypoxia</text></annotation><annotation id="17"><infon key="type">DISEASE</infon><location offset="1092" length="7"/><text>hypoxia</text></annotation><annotation id="18"><infon key="identifier">55818</infon><infon key="type">GENE</infon><location offset="1128" length="6"/><text>JMJD1A</text></annotation><annotation id="19"><infon key="identifier">55818</infon><infon key="type">GENE</infon><location offset="1197" length="6"/><text>JMJD1A</text></annotation><annotation id="20"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1208" length="4"/><text>p300</text></annotation><annotation id="21"><infon key="identifier">3091</infon><infon key="type">GENE</infon><location offset="1272" length="31"/><text>hypoxia-inducible factor-1alpha</text></annotation><annotation id="22"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1308" length="2"/><text>AR</text></annotation><annotation id="23"><infon key="type">DISEASE</infon><location offset="1355" length="7"/><text>hypoxia</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1584" length="12"/><text>PSA enhancer</text></annotation><annotation id="25"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1511" length="4"/><text>p300</text></annotation><annotation id="26"><infon key="type">DISEASE</infon><location offset="1531" length="7"/><text>hypoxia</text></annotation><annotation id="27"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1239" length="3"/><text>PSA</text></annotation><annotation id="28"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="401" length="3"/><text>PSA</text></annotation><annotation id="29"><infon key="identifier">3817</infon><infon key="type">GENE</infon><location offset="410" length="30"/><text>kallikrein-related peptidase 2</text></annotation><annotation id="30"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1335" length="3"/><text>PSA</text></annotation><annotation id="31"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1584" length="3"/><text>PSA</text></annotation><annotation id="32"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="35" length="25"/><text>prostate-specific antigen</text></annotation><annotation id="33"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="187" length="15"/><text>prostate cancer</text></annotation><annotation id="34"><infon key="type">DISEASE</infon><location offset="283" length="7"/><text>hypoxia</text></annotation><annotation id="35"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="330" length="17"/><text>androgen receptor</text></annotation><annotation id="36"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="349" length="2"/><text>AR</text></annotation><annotation id="37"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="374" length="25"/><text>prostate-specific antigen</text></annotation></passage></document>
<document><id>23993744</id><passage><offset>0</offset><text>eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Transcription factors and DNA regulatory binding motifs are fundamental components of the gene regulatory network. Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA). In particular, multiple regions were transcribed to eRNA within the regulatory region of MYOD1, including previously characterized distal regulatory regions (DRR) and core enhancer (CE). While (CE)RNA enhanced RNA polymerase II (Pol II) occupancy and transcription at MYOD1, (DRR)RNA acted to activate the downstream myogenic genes. The deployment of transcriptional machinery to appropriate loci is contingent on chromatin accessibility, a rate-limiting step preceding Pol II assembly. By nuclease sensitivity assay, we found that eRNAs regulate genomic access of the transcriptional complex to defined regulatory regions. In conclusion, our data suggest that eRNAs contribute to establishing a cell-type-specific transcriptional circuitry by directing chromatin-remodeling events.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="583" length="13"/><text>core enhancer</text></annotation><annotation id="2"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="322" length="4"/><text>MyoD</text></annotation><annotation id="3"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="331" length="8"/><text>Myogenin</text></annotation><annotation id="4"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="505" length="5"/><text>MYOD1</text></annotation><annotation id="5"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="684" length="5"/><text>MYOD1</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="598" length="2"/><text>CE</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="609" length="7"/><text>(CE)RNA</text></annotation></passage></document>
<document><id>24000349</id><passage><offset>0</offset><text>Sequence-specific promoter elements regulate temporal-specific changes in chromatin required for testis-specific activation of the Pgk2 gene. The phosphoglycerate kinase-2 (Pgk2) gene is regulated in a tissue-, cell type-, and developmental stage-specific manner during spermatogenesis and is required for normal sperm motility and fertility in mammals. Activation of Pgk2 transcription is regulated by testis-specific demethylation of DNA and binding of testis-specific transcription factors to enhancer and core promoter elements. Here, we show that chromatin remodeling including reconfiguration of nucleosomes and changes in histone modifications is also associated with transcriptional activation of the Pgk2 gene during spermatogenesis. Developmental studies indicate that the order of events involved in transcriptional activation of the Pgk2 gene includes demethylation of DNA in T1- and T2-prospermatogonia, binding of a factor to the CAAT box in type A and B spermatogonia, followed by recruitment of chromatin remodeling factors, displacement of a nucleosome from the Pgk2 promoter region, binding of factors to the Pgk2 core promoter and enhancer regions, and, finally, initiation of transcription in primary spermatocytes. Transgene studies show that Pgk2 core promoter elements are required to direct demethylation of DNA and reconfiguration of nucleosomes, whereas both enhancer and core promoter elements are required to direct changes in histone modifications and initiation of transcription. These results provide novel insight into the developmental order of molecular events required to activate tissue-specific transcription of the Pgk2 gene, the distinct elements in the 5'-regulatory region of the Pgk2 gene that regulate each of these events, and the relationship among these events in that each step in this process appears to be a necessary prerequisite for the subsequent step.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="18" length="17"/><text>promoter elements</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="496" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="146" length="25"/><text>phosphoglycerate kinase-2</text></annotation><annotation id="4"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="173" length="4"/><text>Pgk2</text></annotation><annotation id="5"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="368" length="4"/><text>Pgk2</text></annotation><annotation id="6"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="709" length="4"/><text>Pgk2</text></annotation><annotation id="7"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="845" length="4"/><text>Pgk2</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1079" length="20"/><text>Pgk2 promoter region</text></annotation><annotation id="9"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="1264" length="4"/><text>Pgk2</text></annotation><annotation id="10"><infon key="identifier">0006348</infon><infon key="type">TISSUE</infon><location offset="956" length="6"/><text>type A</text></annotation><annotation id="11"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="1653" length="4"/><text>Pgk2</text></annotation><annotation id="12"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="1721" length="4"/><text>Pgk2</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="509" length="22"/><text>core promoter elements</text></annotation><annotation id="14"><infon key="identifier">0006349</infon><infon key="type">TISSUE</infon><location offset="967" length="15"/><text>B spermatogonia</text></annotation><annotation id="15"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="97" length="6"/><text>testis</text></annotation><annotation id="16"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="345" length="7"/><text>mammals</text></annotation><annotation id="17"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="403" length="6"/><text>testis</text></annotation><annotation id="18"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="455" length="6"/><text>testis</text></annotation><annotation id="19"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="1127" length="4"/><text>Pgk2</text></annotation><annotation id="20"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="1079" length="4"/><text>Pgk2</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1127" length="18"/><text>Pgk2 core promoter</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1150" length="16"/><text>enhancer regions</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1264" length="27"/><text>Pgk2 core promoter elements</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1385" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1398" length="22"/><text>core promoter elements</text></annotation><annotation id="26"><infon key="identifier">5232</infon><infon key="type">GENE</infon><location offset="131" length="4"/><text>Pgk2</text></annotation></passage></document>
<document><id>24014243</id><passage><offset>0</offset><text>The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation. Epigenetic histone modifications play critical roles in the control of self-renewal and differentiation of hematopoietic stem cells (HSCs). Mysm1 is a recently identified histone H2A deubiquitinase with essential and intrinsic roles for maintaining functional HSCs. In this study, in addition to confirming this function of Mysm1, by using Mysm1-deficient (Mysm1(-/-)) mice, we provide more evidence for how Mysm1 controls HSC homeostasis. Mysm1 deletion drives HSCs from quiescence into rapid cycling and increases their apoptotic rate, resulting in an exhaustion of the stem cell pool, which leads to an impaired self-renewal and lineage reconstituting abilities in the Mysm1-deficient mice. Our study identified Gfi1 as one of the candidate genes responsible for the HSC defect in Mysm1-deficient mice. Mechanistic studies revealed that Mysm1 modulates histone modifications and directs the recruitment of key transcriptional factors such as Gata2 and Runx1 to the Gfi1 locus in HSCs. We found that Mysm1 directly associates with the Gfi1 enhancer element and promotes its transcription through Gata2 and Runx1 transactivation. Thus, our study not only elaborates on the initial reports of Mysm1 association with HSC homeostasis but also delineates a possible epigenetic mechanism through which Mysm1 carries out this function in the HSCs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1164" length="21"/><text>Gfi1 enhancer element</text></annotation><annotation id="2"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="89" length="5"/><text>Mysm1</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="815" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">14581</infon><infon key="type">GENE</infon><location offset="842" length="4"/><text>Gfi1</text></annotation><annotation id="5"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="897" length="3"/><text>HSC</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="927" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="967" length="5"/><text>Mysm1</text></annotation><annotation id="8"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="1072" length="5"/><text>Gata2</text></annotation><annotation id="9"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1082" length="5"/><text>Runx1</text></annotation><annotation id="10"><infon key="identifier">14581</infon><infon key="type">GENE</infon><location offset="1095" length="4"/><text>Gfi1</text></annotation><annotation id="11"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="1129" length="5"/><text>Mysm1</text></annotation><annotation id="12"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="234" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="13"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="267" length="5"/><text>Mysm1</text></annotation><annotation id="14"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="1225" length="5"/><text>Gata2</text></annotation><annotation id="15"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1235" length="5"/><text>Runx1</text></annotation><annotation id="16"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="1320" length="5"/><text>Mysm1</text></annotation><annotation id="17"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="1425" length="5"/><text>Mysm1</text></annotation><annotation id="18"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="911" length="5"/><text>Mysm1</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="699" length="9"/><text>stem cell</text></annotation><annotation id="20"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="260" length="4"/><text>HSCs</text></annotation><annotation id="21"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="15" length="23"/><text>hematopoietic stem cell</text></annotation><annotation id="22"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="387" length="4"/><text>HSCs</text></annotation><annotation id="23"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="550" length="3"/><text>HSC</text></annotation><annotation id="24"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="451" length="5"/><text>Mysm1</text></annotation><annotation id="25"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="589" length="4"/><text>HSCs</text></annotation><annotation id="26"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1109" length="4"/><text>HSCs</text></annotation><annotation id="27"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1464" length="4"/><text>HSCs</text></annotation><annotation id="28"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1343" length="3"/><text>HSC</text></annotation><annotation id="29"><infon key="identifier">14581</infon><infon key="type">GENE</infon><location offset="1164" length="4"/><text>Gfi1</text></annotation><annotation id="30"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="467" length="5"/><text>Mysm1</text></annotation><annotation id="31"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="484" length="5"/><text>Mysm1</text></annotation><annotation id="32"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="496" length="4"/><text>mice</text></annotation><annotation id="33"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="535" length="5"/><text>Mysm1</text></annotation><annotation id="34"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="567" length="5"/><text>Mysm1</text></annotation><annotation id="35"><infon key="identifier">320713</infon><infon key="type">GENE</infon><location offset="799" length="5"/><text>Mysm1</text></annotation></passage></document>
<document><id>24157522</id><passage><offset>0</offset><text>A novel regulatory element for Shh expression in the lung and gut of mouse embryos. Hedgehog (Hh) signaling plays pivotal roles in morphogenesis of several embryonic tissues, including the primitive gut. In the mouse embryo, Sonic hedgehog (Shh) is expressed in endodermal epithelia from the oral cavity to the intestine, and contributes to cell proliferation in the underlying mesenchyme and subsequent differentiation into the gastrointestinal smooth muscle. Three evolutionary conserved non-coding sequences in the region upstream of the Shh coding sequence contain endoderm-specific enhancers for Shh expression. Although Shh expression in the endodermal epithelial lining is mostly attributed to these three enhancers, none of them regulates gene expression in the gastroesophageal epithelium. Here, we found that a 1.7Kb fragment located 100Kb upstream of the Shh coding sequence contains a functional element for Shh expression in endodermal organs, including the esophagus and stomach. Compared with the three known endodermal enhancers, this novel enhancer shows less evolutionary conservation, even among rodents. In mouse embryonic endodermal tissues, the seamless expression of Shh is achieved by a patchwork of multiple enhancers with different rates of evolution.</text><annotation id="1"><infon key="identifier">0001578</infon><infon key="type">TISSUE</infon><location offset="770" length="27"/><text>gastroesophageal epithelium</text></annotation><annotation id="2"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="241" length="3"/><text>Shh</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="569" length="27"/><text>endoderm-specific enhancers</text></annotation><annotation id="4"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="601" length="3"/><text>Shh</text></annotation><annotation id="5"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="626" length="3"/><text>Shh</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="897" length="37"/><text>functional element for Shh expression</text></annotation><annotation id="7"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="53" length="4"/><text>lung</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1127" length="5"/><text>mouse</text></annotation><annotation id="9"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1190" length="3"/><text>Shh</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1012" length="32"/><text>three known endodermal enhancers</text></annotation><annotation id="11"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="62" length="3"/><text>gut</text></annotation><annotation id="12"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="75" length="7"/><text>embryos</text></annotation><annotation id="13"><infon key="identifier">0001090</infon><infon key="type">TISSUE</infon><location offset="292" length="11"/><text>oral cavity</text></annotation><annotation id="14"><infon key="identifier">0000648</infon><infon key="type">TISSUE</infon><location offset="311" length="9"/><text>intestine</text></annotation><annotation id="15"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="94" length="2"/><text>Hh</text></annotation><annotation id="16"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="262" length="20"/><text>endodermal epithelia</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="707" length="15"/><text>three enhancers</text></annotation><annotation id="18"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="541" length="3"/><text>Shh</text></annotation><annotation id="19"><infon key="identifier">0000959</infon><infon key="type">TISSUE</infon><location offset="971" length="9"/><text>esophagus</text></annotation><annotation id="20"><infon key="identifier">0001307</infon><infon key="type">TISSUE</infon><location offset="985" length="7"/><text>stomach</text></annotation><annotation id="21"><infon key="identifier">0005024</infon><infon key="type">TISSUE</infon><location offset="429" length="30"/><text>gastrointestinal smooth muscle</text></annotation><annotation id="22"><infon key="identifier">0001393</infon><infon key="type">TISSUE</infon><location offset="378" length="10"/><text>mesenchyme</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1057" length="8"/><text>enhancer</text></annotation><annotation id="24"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="866" length="3"/><text>Shh</text></annotation><annotation id="25"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="199" length="3"/><text>gut</text></annotation><annotation id="26"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="569" length="8"/><text>endoderm</text></annotation><annotation id="27"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="920" length="3"/><text>Shh</text></annotation><annotation id="28"><infon key="identifier">9989</infon><infon key="type">SPECIES</infon><location offset="1115" length="7"/><text>rodents</text></annotation><annotation id="29"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="31" length="3"/><text>Shh</text></annotation><annotation id="30"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="69" length="5"/><text>mouse</text></annotation><annotation id="31"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="84" length="8"/><text>Hedgehog</text></annotation><annotation id="32"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="211" length="5"/><text>mouse</text></annotation><annotation id="33"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="225" length="14"/><text>Sonic hedgehog</text></annotation></passage></document>
<document><id>24204311</id><passage><offset>0</offset><text>The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating oligodendrocytes. Myelin is essential for rapid saltatory conduction and is produced by Schwann cells in the peripheral nervous system and oligodendrocytes in the central nervous system. In both cell types the transcription factor Sox10 is an essential component of the myelin-specific regulatory network. Here we identify Myrf as an oligodendrocyte-specific target of Sox10 and map a Sox10 responsive enhancer to an evolutionarily conserved element in intron 1 of the Myrf gene. Once induced, Myrf cooperates with Sox10 to implement the myelination program as evident from the physical interaction between both proteins and the synergistic activation of several myelin-specific genes. This is strongly reminiscent of the situation in Schwann cells where Sox10 first induces and then cooperates with Krox20 during myelination. Our analyses indicate that the regulatory network for myelination in oligodendrocytes is organized along similar general principles as the one in Schwann cells, but is differentially implemented.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="491" length="25"/><text>Sox10 responsive enhancer</text></annotation><annotation id="2"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="26" length="5"/><text>Sox10</text></annotation><annotation id="3"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="861" length="5"/><text>Sox10</text></annotation><annotation id="4"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="906" length="6"/><text>Krox20</text></annotation><annotation id="5"><infon key="identifier">0001028</infon><infon key="type">TISSUE</infon><location offset="215" length="25"/><text>peripheral nervous system</text></annotation><annotation id="6"><infon key="identifier">0000962</infon><infon key="type">TISSUE</infon><location offset="245" length="16"/><text>oligodendrocytes</text></annotation><annotation id="7"><infon key="identifier">0000962</infon><infon key="type">TISSUE</infon><location offset="440" length="15"/><text>oligodendrocyte</text></annotation><annotation id="8"><infon key="identifier">0001220</infon><infon key="type">TISSUE</infon><location offset="841" length="13"/><text>Schwann cells</text></annotation><annotation id="9"><infon key="identifier">0000962</infon><infon key="type">TISSUE</infon><location offset="1002" length="16"/><text>oligodendrocytes</text></annotation><annotation id="10"><infon key="identifier">0001220</infon><infon key="type">TISSUE</infon><location offset="1079" length="13"/><text>Schwann cells</text></annotation><annotation id="11"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="269" length="22"/><text>central nervous system</text></annotation><annotation id="12"><infon key="identifier">0000962</infon><infon key="type">TISSUE</infon><location offset="106" length="16"/><text>oligodendrocytes</text></annotation><annotation id="13"><infon key="identifier">745</infon><infon key="type">GENE</infon><location offset="36" length="4"/><text>Myrf</text></annotation><annotation id="14"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="491" length="5"/><text>Sox10</text></annotation><annotation id="15"><infon key="identifier">745</infon><infon key="type">GENE</infon><location offset="575" length="4"/><text>Myrf</text></annotation><annotation id="16"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="337" length="5"/><text>Sox10</text></annotation><annotation id="17"><infon key="identifier">745</infon><infon key="type">GENE</infon><location offset="429" length="4"/><text>Myrf</text></annotation><annotation id="18"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="475" length="5"/><text>Sox10</text></annotation><annotation id="19"><infon key="identifier">0001220</infon><infon key="type">TISSUE</infon><location offset="194" length="13"/><text>Schwann cells</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="556" length="28"/><text>in intron 1 of the Myrf gene</text></annotation><annotation id="21"><infon key="identifier">745</infon><infon key="type">GENE</infon><location offset="600" length="4"/><text>Myrf</text></annotation><annotation id="22"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="621" length="5"/><text>Sox10</text></annotation></passage></document>
<document><id>24212882</id><passage><offset>0</offset><text>Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. The contribution of cis-regulatory mutations to human disease remains poorly understood. Whole-genome sequencing can identify all noncoding variants, yet the discrimination of causal regulatory mutations represents a formidable challenge. We used epigenomic annotation in human embryonic stem cell (hESC)-derived pancreatic progenitor cells to guide the interpretation of whole-genome sequences from individuals with isolated pancreatic agenesis. This analysis uncovered six different recessive mutations in a previously uncharacterized ~400-bp sequence located 25 kb downstream of PTF1A (encoding pancreas-specific transcription factor 1a) in ten families with pancreatic agenesis. We show that this region acts as a developmental enhancer of PTF1A and that the mutations abolish enhancer activity. These mutations are the most common cause of isolated pancreatic agenesis. Integrating genome sequencing and epigenomic annotation in a disease-relevant cell type can thus uncover new noncoding elements underlying human development and disease.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="25" length="21"/><text>distal PTF1A enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="801" length="31"/><text>developmental enhancer of PTF1A</text></annotation><annotation id="3"><infon key="identifier">256297</infon><infon key="type">GENE</infon><location offset="827" length="5"/><text>PTF1A</text></annotation><annotation id="4"><infon key="identifier">256297</infon><infon key="type">GENE</infon><location offset="665" length="5"/><text>PTF1A</text></annotation><annotation id="5"><infon key="identifier">0009832</infon><infon key="type">DISEASE</infon><location offset="509" length="19"/><text>pancreatic agenesis</text></annotation><annotation id="6"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="355" length="25"/><text>human embryonic stem cell</text></annotation><annotation id="7"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="382" length="4"/><text>hESC</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="620" length="50"/><text>~400-bp sequence located 25 kb downstream of PTF1A</text></annotation><annotation id="9"><infon key="identifier">0009832</infon><infon key="type">DISEASE</infon><location offset="62" length="19"/><text>pancreatic agenesis</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="131" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">256297</infon><infon key="type">GENE</infon><location offset="681" length="41"/><text>pancreas-specific transcription factor 1a</text></annotation><annotation id="12"><infon key="identifier">256297</infon><infon key="type">GENE</infon><location offset="32" length="5"/><text>PTF1A</text></annotation><annotation id="13"><infon key="identifier">0009832</infon><infon key="type">DISEASE</infon><location offset="745" length="19"/><text>pancreatic agenesis</text></annotation><annotation id="14"><infon key="identifier">0009832</infon><infon key="type">DISEASE</infon><location offset="937" length="19"/><text>pancreatic agenesis</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1097" length="5"/><text>human</text></annotation></passage></document>
<document><id>24257627</id><passage><offset>0</offset><text>Asymmetric activation of Dll4-Notch signaling by Foxn4 and proneural factors activates BMP/TGFbeta signaling to specify V2b interneurons in the spinal cord. During development of the ventral spinal cord, the V2 interneurons emerge from p2 progenitors and diversify into two major subtypes, V2a and V2b, that play key roles in locomotor coordination. Dll4-mediated Notch activation in a subset of p2 precursors constitutes the crucial first step towards generating neuronal diversity in this domain. The mechanism behind the asymmetric Notch activation and downstream signaling events are, however, unknown at present. We show here that the Ascl1 and Neurog basic helix-loop-helix (bHLH) proneural factors are expressed in a mosaic pattern in p2 progenitors and that Foxn4 is required for setting and maintaining this expression mosaic. By binding directly to a conserved Dll4 enhancer, Foxn4 and Ascl1 activate Dll4 expression, whereas Neurog proteins prevent this effect, thereby resulting in asymmetric activation of Dll4 expression in V2 precursors expressing different combinations of proneural and Foxn4 transcription factors. Lineage tracing using the Cre-LoxP system reveals selective expression of Dll4 in V2a precursors, whereas Dll4 expression is initially excluded from V2b precursors. We provide evidence that BMP/TGFbeta signaling is activated in V2b precursors and that Dll4-mediated Notch signaling is responsible for this activation. Using a gain-of-function approach and by inhibiting BMP/TGFbeta signal transduction with pathway antagonists and RNAi knockdown, we further demonstrate that BMP/TGFbeta signaling is both necessary and sufficient for V2b fate specification. Our data together thus suggest that the mosaic expression of Foxn4 and proneural factors may serve as the trigger to initiate asymmetric Dll4-Notch and subsequent BMP/TGFbeta signaling events required for neuronal diversity in the V2 domain.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="871" length="13"/><text>Dll4 enhancer</text></annotation><annotation id="2"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="25" length="4"/><text>Dll4</text></annotation><annotation id="3"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="911" length="4"/><text>Dll4</text></annotation><annotation id="4"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="1019" length="4"/><text>Dll4</text></annotation><annotation id="5"><infon key="identifier">116810</infon><infon key="type">GENE</infon><location offset="1103" length="5"/><text>Foxn4</text></annotation><annotation id="6"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="1206" length="4"/><text>Dll4</text></annotation><annotation id="7"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="1238" length="4"/><text>Dll4</text></annotation><annotation id="8"><infon key="type">TISSUE</infon><location offset="1360" length="14"/><text>V2b precursors</text></annotation><annotation id="9"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="1384" length="4"/><text>Dll4</text></annotation><annotation id="10"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="1666" length="3"/><text>V2b</text></annotation><annotation id="11"><infon key="identifier">116810</infon><infon key="type">GENE</infon><location offset="1751" length="5"/><text>Foxn4</text></annotation><annotation id="12"><infon key="identifier">116810</infon><infon key="type">GENE</infon><location offset="49" length="5"/><text>Foxn4</text></annotation><annotation id="13"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="1827" length="4"/><text>Dll4</text></annotation><annotation id="14"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="120" length="16"/><text>V2b interneurons</text></annotation><annotation id="15"><infon key="identifier">0001279</infon><infon key="type">TISSUE</infon><location offset="144" length="11"/><text>spinal cord</text></annotation><annotation id="16"><infon key="identifier">0001279</infon><infon key="type">TISSUE</infon><location offset="191" length="11"/><text>spinal cord</text></annotation><annotation id="17"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="208" length="15"/><text>V2 interneurons</text></annotation><annotation id="18"><infon key="type">TISSUE</infon><location offset="236" length="14"/><text>p2 progenitors</text></annotation><annotation id="19"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="290" length="3"/><text>V2a</text></annotation><annotation id="20"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="871" length="4"/><text>Dll4</text></annotation><annotation id="21"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="298" length="3"/><text>V2b</text></annotation><annotation id="22"><infon key="type">TISSUE</infon><location offset="396" length="13"/><text>p2 precursors</text></annotation><annotation id="23"><infon key="type">TISSUE</infon><location offset="742" length="14"/><text>p2 progenitors</text></annotation><annotation id="24"><infon key="type">TISSUE</infon><location offset="1214" length="14"/><text>V2a precursors</text></annotation><annotation id="25"><infon key="type">TISSUE</infon><location offset="1281" length="14"/><text>V2b precursors</text></annotation><annotation id="26"><infon key="identifier">0003811</infon><infon key="type">TISSUE</infon><location offset="1921" length="2"/><text>V2</text></annotation><annotation id="27"><infon key="identifier">54485</infon><infon key="type">GENE</infon><location offset="350" length="4"/><text>Dll4</text></annotation><annotation id="28"><infon key="identifier">17172</infon><infon key="type">GENE</infon><location offset="640" length="5"/><text>Ascl1</text></annotation><annotation id="29"><infon key="identifier">116810</infon><infon key="type">GENE</infon><location offset="766" length="5"/><text>Foxn4</text></annotation><annotation id="30"><infon key="type">TISSUE</infon><location offset="1038" length="13"/><text>V2 precursors</text></annotation><annotation id="31"><infon key="identifier">116810</infon><infon key="type">GENE</infon><location offset="886" length="5"/><text>Foxn4</text></annotation><annotation id="32"><infon key="identifier">17172</infon><infon key="type">GENE</infon><location offset="896" length="5"/><text>Ascl1</text></annotation></passage></document>
<document><id>24285714</id><passage><offset>0</offset><text>Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation. Cancer cells frequently depend on chromatin regulatory activities to maintain a malignant phenotype. Here, we show that leukemia cells require the mammalian SWI/SNF chromatin remodeling complex for their survival and aberrant self-renewal potential. While Brg1, an ATPase subunit of SWI/SNF, is known to suppress tumor formation in several cell types, we found that leukemia cells instead rely on Brg1 to support their oncogenic transcriptional program, which includes Myc as one of its key targets. To account for this context-specific function, we identify a cluster of lineage-specific enhancers located 1.7 Mb downstream from Myc that are occupied by SWI/SNF as well as the BET protein Brd4. Brg1 is required at these distal elements to maintain transcription factor occupancy and for long-range chromatin looping interactions with the Myc promoter. Notably, these distal Myc enhancers coincide with a region that is focally amplified in ~3% of acute myeloid leukemias. Together, these findings define a leukemia maintenance function for SWI/SNF that is linked to enhancer-mediated gene regulation, providing general insights into how cancer cells exploit transcriptional coactivators to maintain oncogenic gene expression programs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="806" length="15"/><text>distal elements</text></annotation><annotation id="2"><infon key="identifier">6597</infon><infon key="type">GENE</infon><location offset="340" length="4"/><text>Brg1</text></annotation><annotation id="3"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="397" length="5"/><text>tumor</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="450" length="8"/><text>leukemia</text></annotation><annotation id="5"><infon key="identifier">6597</infon><infon key="type">GENE</infon><location offset="481" length="4"/><text>Brg1</text></annotation><annotation id="6"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="68" length="3"/><text>Myc</text></annotation><annotation id="7"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="553" length="3"/><text>Myc</text></annotation><annotation id="8"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="714" length="3"/><text>Myc</text></annotation><annotation id="9"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="774" length="4"/><text>Brd4</text></annotation><annotation id="10"><infon key="identifier">6597</infon><infon key="type">GENE</infon><location offset="780" length="4"/><text>Brg1</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0001271</infon><infon key="type">TISSUE</infon><location offset="204" length="14"/><text>leukemia cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="924" length="12"/><text>Myc promoter</text></annotation><annotation id="13"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="924" length="3"/><text>Myc</text></annotation><annotation id="14"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="1033" length="23"/><text>acute myeloid leukemias</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1092" length="8"/><text>leukemia</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="953" length="20"/><text>distal Myc enhancers</text></annotation><annotation id="17"><infon key="type">TISSUE</infon><location offset="84" length="12"/><text>Cancer cells</text></annotation><annotation id="18"><infon key="identifier">0010643</infon><infon key="type">DISEASE</infon><location offset="19" length="14"/><text>acute leukemia</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="1223" length="12"/><text>cancer cells</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="645" length="72"/><text>cluster of lineage-specific enhancers located 1.7 Mb downstream from Myc</text></annotation><annotation id="21"><infon key="identifier">1769</infon><infon key="type">GENE</infon><location offset="349" length="6"/><text>ATPase</text></annotation><annotation id="22"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="231" length="9"/><text>mammalian</text></annotation></passage></document>
<document><id>24288367</id><passage><offset>0</offset><text>Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression. A number of genome-wide analyses have revealed that estrogen receptor alpha binding to and regulation of its target genes correlate with binding of FOXA1, a pioneer factor, to nearby DNA sites in MCF-7 breast cancer cells. The enhancer element-specific histone H3K4me1/2 mark is enriched at the specific FOXA1/ERalpha recruitment sites in chromatin, but the mechanism by which these enhancer marks are established in chromatin before hormone treatment is unclear. Here, we show that mixed-lineage leukemia 1 (MLL1) protein is a key determinant that maintains permissive chromatin structure of the TFF1 enhancer region. MLL1 occupies the TFF1 enhancer region and methylates H3K4 before hormone stimulation. In vitro, MLL1 binds directly to the CpG-rich region of the TFF1 enhancer, and its binding is dependent on hypomethylation of DNA. Furthermore, the depletion of MLL1 in MCF-7 cells results in a dramatic decrease of chromatin accessibility and recruitment of FOXA1 and ERalpha to the enhancer element. Our study defines the mechanism by which MLL1 nucleates histone H3K4 methylation marks in CpG-enriched regions to maintain permissive chromatin architecture and allow FOXA1 and estrogen receptor alpha binding to transcriptional regulatory sites in breast cancer cells.</text><annotation id="1"><infon key="identifier">0000093</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1016" length="11"/><text>MCF-7 cells</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="337" length="25"/><text>MCF-7 breast cancer cells</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="368" length="16"/><text>enhancer element</text></annotation><annotation id="4"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="445" length="5"/><text>FOXA1</text></annotation><annotation id="5"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="451" length="7"/><text>ERalpha</text></annotation><annotation id="6"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="624" length="24"/><text>mixed-lineage leukemia 1</text></annotation><annotation id="7"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="650" length="4"/><text>MLL1</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="884" length="36"/><text>CpG-rich region of the TFF1 enhancer</text></annotation><annotation id="9"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="760" length="4"/><text>MLL1</text></annotation><annotation id="10"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="738" length="4"/><text>TFF1</text></annotation><annotation id="11"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="857" length="4"/><text>MLL1</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="1396" length="19"/><text>breast cancer cells</text></annotation><annotation id="13"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="778" length="4"/><text>TFF1</text></annotation><annotation id="14"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="1008" length="4"/><text>MLL1</text></annotation><annotation id="15"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="1105" length="5"/><text>FOXA1</text></annotation><annotation id="16"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1115" length="7"/><text>ERalpha</text></annotation><annotation id="17"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="1189" length="4"/><text>MLL1</text></annotation><annotation id="18"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="1315" length="5"/><text>FOXA1</text></annotation><annotation id="19"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1325" length="23"/><text>estrogen receptor alpha</text></annotation><annotation id="20"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="907" length="4"/><text>TFF1</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="738" length="20"/><text>TFF1 enhancer region</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="778" length="20"/><text>TFF1 enhancer region</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="907" length="13"/><text>TFF1 enhancer</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1130" length="16"/><text>enhancer element</text></annotation><annotation id="25"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="68" length="24"/><text>mixed-lineage leukemia 1</text></annotation><annotation id="26"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="193" length="23"/><text>estrogen receptor alpha</text></annotation><annotation id="27"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="289" length="5"/><text>FOXA1</text></annotation></passage></document>
<document><id>24321386</id><passage><offset>0</offset><text>Transcriptional regulation of human ferredoxin reductase through an intronic enhancer in steroidogenic cells. Ferredoxin reductase (FDXR, also known as adrenodoxin reductase) is a mitochondrial flavoprotein that transfers electrons from NADPH to mitochondrial cytochrome P450 enzymes, mediating the function of an iron-sulfur cluster protein, ferredoxin. FDXR functions in various metabolic processes including steroidogenesis. It is well known that multiple steroidogenic enzymes are regulated by a transcription factor steroidogenic factor-1 (SF-1, also known as Ad4BP). Previously, we have shown that SF-1 transduction causes human mesenchymal stem cell differentiation into steroidogenic cells. Genome-wide analysis of differentiated cells, using a combination of DNA microarray and promoter tiling array analyses, showed that FDXR is a novel SF-1 target gene. In this study, the transcriptional regulatory mechanism of FDXR was examined in steroidogenic cells. A chromatin immunoprecipitation assay revealed that a novel SF-1 binding region was located within intron 2 of the human FDXR gene. Luciferase reporter assays showed that FDXR transcription was activated through the novel SF-1 binding site within intron 2. Endogenous SF-1 knockdown in human adrenocortical H295R and KGN cells decreased FDXR expression. In H295R cells, strong binding of two histone markers of active enhancers, histones H3K27ac and H3K4me2, were detected near the SF-1 binding site within intron 2. Furthermore, the binding of these histone markers was decreased concurrent with SF-1 knockdown in H295R cells. These results indicated that abundant FDXR expression in these steroidogenic cells was maintained through SF-1 binding to the intronic enhancer of the FDXR gene.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="68" length="17"/><text>intronic enhancer</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="945" length="19"/><text>steroidogenic cells</text></annotation><annotation id="3"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="521" length="22"/><text>steroidogenic factor-1</text></annotation><annotation id="4"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="565" length="5"/><text>Ad4BP</text></annotation><annotation id="5"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="604" length="4"/><text>SF-1</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="629" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="831" length="4"/><text>FDXR</text></annotation><annotation id="8"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="847" length="4"/><text>SF-1</text></annotation><annotation id="9"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="924" length="4"/><text>FDXR</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1026" length="70"/><text>SF-1 binding region was located within intron 2 of the human FDXR gene</text></annotation><annotation id="11"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="1745" length="4"/><text>FDXR</text></annotation><annotation id="12"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1026" length="4"/><text>SF-1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1448" length="33"/><text>SF-1 binding site within intron 2</text></annotation><annotation id="14"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="1137" length="4"/><text>FDXR</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1188" length="33"/><text>SF-1 binding site within intron 2</text></annotation><annotation id="16"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1234" length="4"/><text>SF-1</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1252" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="1303" length="4"/><text>FDXR</text></annotation><annotation id="19"><infon key="identifier">0002588</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1581" length="11"/><text>H295R cells</text></annotation><annotation id="20"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1563" length="4"/><text>SF-1</text></annotation><annotation id="21"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="1632" length="4"/><text>FDXR</text></annotation><annotation id="22"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1700" length="4"/><text>SF-1</text></annotation><annotation id="23"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1188" length="4"/><text>SF-1</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1720" length="34"/><text>intronic enhancer of the FDXR gene</text></annotation><annotation id="25"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="1448" length="4"/><text>SF-1</text></annotation><annotation id="26"><infon key="type">TISSUE</infon><location offset="89" length="19"/><text>steroidogenic cells</text></annotation><annotation id="27"><infon key="identifier">2516</infon><infon key="type">GENE</infon><location offset="545" length="4"/><text>SF-1</text></annotation><annotation id="28"><infon key="identifier">0003298</infon><infon key="type">TISSUE</infon><location offset="635" length="21"/><text>mesenchymal stem cell</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="678" length="19"/><text>steroidogenic cells</text></annotation><annotation id="30"><infon key="identifier">0002588</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1258" length="20"/><text>adrenocortical H295R</text></annotation><annotation id="31"><infon key="identifier">0005671</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1283" length="9"/><text>KGN cells</text></annotation><annotation id="32"><infon key="attribute">CANCER</infon><infon key="identifier">0002588</infon><infon key="type">TISSUE</infon><location offset="1323" length="11"/><text>H295R cells</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="1657" length="19"/><text>steroidogenic cells</text></annotation><annotation id="34"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="1087" length="4"/><text>FDXR</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="30" length="5"/><text>human</text></annotation><annotation id="36"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="36" length="20"/><text>ferredoxin reductase</text></annotation><annotation id="37"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="110" length="20"/><text>Ferredoxin reductase</text></annotation><annotation id="38"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="132" length="4"/><text>FDXR</text></annotation><annotation id="39"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="152" length="21"/><text>adrenodoxin reductase</text></annotation><annotation id="40"><infon key="identifier">2232</infon><infon key="type">GENE</infon><location offset="355" length="4"/><text>FDXR</text></annotation></passage></document>
<document><id>24332044</id><passage><offset>0</offset><text>Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Diffuse large B cell lymphoma (DLBCL) is a biologically heterogeneous and clinically aggressive disease. Here, we explore the role of bromodomain and extra-terminal domain (BET) proteins in DLBCL, using integrative chemical genetics and functional epigenomics. We observe highly asymmetric loading of bromodomain 4 (BRD4) at enhancers, with approximately 33% of all BRD4 localizing to enhancers at 1.6% of occupied genes. These super-enhancers prove particularly sensitive to bromodomain inhibition, explaining the selective effect of BET inhibitors on oncogenic and lineage-specific transcriptional circuits. Functional study of genes marked by super-enhancers identifies DLBCLs dependent on OCA-B and suggests a strategy for discovering unrecognized cancer dependencies. Translational studies performed on a comprehensive panel of DLBCLs establish a therapeutic rationale for evaluating BET inhibitors in this disease.</text><annotation id="1"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="423" length="4"/><text>BRD4</text></annotation><annotation id="2"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="473" length="4"/><text>BRD4</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="780" length="6"/><text>DLBCLs</text></annotation><annotation id="4"><infon key="identifier">5450</infon><infon key="type">GENE</infon><location offset="800" length="5"/><text>OCA-B</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="859" length="6"/><text>cancer</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="940" length="6"/><text>DLBCLs</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="76" length="29"/><text>diffuse large B cell lymphoma</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="107" length="29"/><text>Diffuse large B cell lymphoma</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="138" length="5"/><text>DLBCL</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0018905</infon><infon key="type">DISEASE</infon><location offset="297" length="5"/><text>DLBCL</text></annotation><annotation id="11"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="408" length="13"/><text>bromodomain 4</text></annotation></passage></document>
<document><id>24332857</id><passage><offset>0</offset><text>Switch enhancers interpret TGF-beta and Hippo signaling to control cell fate in human embryonic stem cells. A small toolkit of morphogens is used repeatedly to direct development, raising the question of how context dictates interpretation of the same cue. One example is the transforming growth factor beta (TGF-beta) pathway that in human embryonic stem cells fulfills two opposite functions: pluripotency maintenance and mesendoderm (ME) specification. Using proteomics coupled to analysis of genome occupancy, we uncover a regulatory complex composed of transcriptional effectors of the Hippo pathway (TAZ/YAP/TEAD), the TGF-beta pathway (SMAD2/3), and the pluripotency regulator OCT4 (TSO). TSO collaborates with NuRD repressor complexes to buffer pluripotency gene expression while suppressing ME genes. Importantly, the SMAD DNA binding partner FOXH1, a major specifier of ME, is found near TSO elements, and upon fate specification we show that TSO is disrupted with subsequent SMAD-FOXH1 induction of ME. These studies define switch-enhancer elements and provide a framework to understand how cellular context dictates interpretation of the same morphogen signal in development.</text><annotation id="1"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="649" length="1"/><text>3</text></annotation><annotation id="2"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="643" length="5"/><text>SMAD2</text></annotation><annotation id="3"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="684" length="4"/><text>OCT4</text></annotation><annotation id="4"><infon key="identifier">8928</infon><infon key="type">GENE</infon><location offset="852" length="5"/><text>FOXH1</text></annotation><annotation id="5"><infon key="identifier">8928</infon><infon key="type">GENE</infon><location offset="991" length="5"/><text>FOXH1</text></annotation><annotation id="6"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="1010" length="2"/><text>ME</text></annotation><annotation id="7"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="80" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="8"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="335" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="9"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="424" length="11"/><text>mesendoderm</text></annotation><annotation id="10"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="437" length="2"/><text>ME</text></annotation><annotation id="11"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="880" length="2"/><text>ME</text></annotation><annotation id="12"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="27" length="8"/><text>TGF-beta</text></annotation><annotation id="13"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="800" length="2"/><text>ME</text></annotation><annotation id="14"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="276" length="31"/><text>transforming growth factor beta</text></annotation><annotation id="15"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="309" length="8"/><text>TGF-beta</text></annotation><annotation id="16"><infon key="identifier">6901</infon><infon key="type">GENE</infon><location offset="606" length="3"/><text>TAZ</text></annotation><annotation id="17"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="610" length="3"/><text>YAP</text></annotation><annotation id="18"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="625" length="8"/><text>TGF-beta</text></annotation></passage></document>
<document><id>24362753</id><passage><offset>0</offset><text>Genetic determinants of neuroglobin transcription. Neuroglobin (NGB) is a neuron-specific vertebrate globin shown to protect against hypoxia, ischemia, oxidative stress and the toxic effects of Amyloid-beta. Following on our and others' results highlighting the importance of NGB expression in disease, we searched for genetic determinants of its expression. We found that a microRNA expressed with the NGB transcript shows significant target enrichments in the angiogenesis pathway and the Alzheimer disease/presenilin pathway. Using reporter constructs we identified potential promoter/enhancer elements between the transcription start site and 1,142 bp upstream. Using 184 post-mortem temporal lobe samples we replicated the reported negative effect of age, and after genotyping tagging SNPs we found one (rs981471) showing a significant correlation with the gene's expression and another (rs8014408) showing an interaction with age, the rare C allele being correlated with higher expression and faster decline. The two SNPs are towards the 3' end of NGB within the same LD block, 52 Kb apart and modestly correlated (r (2) = 0.5). Next generation sequencing of the same 184 temporal lobe samples and 79 confirmed AD patients across the entire gene region (including &gt;12 Kb on the 3' and 5' flank) revealed limited coding variation, suggesting purifying selection of NGB, but did not identify regulatory or disease associated rare variants. A dinucleotide repeat in intron 1 with extensive evidence of functionality showed interesting but inconclusive results, as it was not amenable to further molecular analysis.</text><annotation id="1"><infon key="identifier">0001355</infon><infon key="type">TISSUE</infon><location offset="688" length="13"/><text>temporal lobe</text></annotation><annotation id="2"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="403" length="3"/><text>NGB</text></annotation><annotation id="3"><infon key="identifier">0004975</infon><infon key="type">DISEASE</infon><location offset="491" length="17"/><text>Alzheimer disease</text></annotation><annotation id="4"><infon key="comment">rs981471</infon><infon key="type">VARIANT</infon><infon key="identifier">rs981471</infon><location offset="809" length="8"/><text>rs981471</text></annotation><annotation id="5"><infon key="comment">rs8014408</infon><infon key="type">VARIANT</infon><infon key="identifier">rs8014408</infon><location offset="893" length="9"/><text>rs8014408</text></annotation><annotation id="6"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1054" length="3"/><text>NGB</text></annotation><annotation id="7"><infon key="identifier">0004975</infon><infon key="type">DISEASE</infon><location offset="1217" length="2"/><text>AD</text></annotation><annotation id="8"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1370" length="3"/><text>NGB</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="579" length="85"/><text>promoter/enhancer elements between the transcription start site and 1,142 bp upstream</text></annotation><annotation id="10"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="74" length="6"/><text>neuron</text></annotation><annotation id="11"><infon key="identifier">7742</infon><infon key="type">SPECIES</infon><location offset="90" length="10"/><text>vertebrate</text></annotation><annotation id="12"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="24" length="11"/><text>neuroglobin</text></annotation><annotation id="13"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="51" length="11"/><text>Neuroglobin</text></annotation><annotation id="14"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="64" length="3"/><text>NGB</text></annotation><annotation id="15"><infon key="type">DISEASE</infon><location offset="133" length="7"/><text>hypoxia</text></annotation><annotation id="16"><infon key="identifier">0005053</infon><infon key="type">DISEASE</infon><location offset="142" length="8"/><text>ischemia</text></annotation><annotation id="17"><infon key="identifier">0001355</infon><infon key="type">TISSUE</infon><location offset="1178" length="13"/><text>temporal lobe</text></annotation><annotation id="18"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="276" length="3"/><text>NGB</text></annotation></passage></document>
<document><id>24413736</id><passage><offset>0</offset><text>Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Type 2 diabetes affects over 300 million people, causing severe complications and premature death, yet the underlying molecular mechanisms are largely unknown. Pancreatic islet dysfunction is central in type 2 diabetes pathogenesis, and understanding islet genome regulation could therefore provide valuable mechanistic insights. We have now mapped and examined the function of human islet cis-regulatory networks. We identify genomic sequences that are targeted by islet transcription factors to drive islet-specific gene activity and show that most such sequences reside in clusters of enhancers that form physical three-dimensional chromatin domains. We find that sequence variants associated with type 2 diabetes and fasting glycemia are enriched in these clustered islet enhancers and identify trait-associated variants that disrupt DNA binding and islet enhancer activity. Our studies illustrate how islet transcription factors interact functionally with the epigenome and provide systematic evidence that the dysregulation of islet enhancers is relevant to the mechanisms underlying type 2 diabetes.</text><annotation id="1"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="11" length="5"/><text>islet</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="467" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">0005148</infon><infon key="type">DISEASE</infon><location offset="790" length="15"/><text>type 2 diabetes</text></annotation><annotation id="4"><infon key="identifier">0002908</infon><infon key="type">DISEASE</infon><location offset="810" length="16"/><text>fasting glycemia</text></annotation><annotation id="5"><infon key="identifier">0005148</infon><infon key="type">DISEASE</infon><location offset="1179" length="15"/><text>type 2 diabetes</text></annotation><annotation id="6"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="340" length="5"/><text>islet</text></annotation><annotation id="7"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="473" length="5"/><text>islet</text></annotation><annotation id="8"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="943" length="5"/><text>islet</text></annotation><annotation id="9"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="555" length="5"/><text>islet</text></annotation><annotation id="10"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="592" length="5"/><text>islet</text></annotation><annotation id="11"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="995" length="5"/><text>islet</text></annotation><annotation id="12"><infon key="identifier">0000991</infon><infon key="type">TISSUE</infon><location offset="1122" length="5"/><text>islet</text></annotation><annotation id="13"><infon key="identifier">0005148</infon><infon key="type">DISEASE</infon><location offset="47" length="15"/><text>type 2 diabetes</text></annotation><annotation id="14"><infon key="identifier">0005148</infon><infon key="type">DISEASE</infon><location offset="89" length="15"/><text>Type 2 diabetes</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="130" length="6"/><text>people</text></annotation><annotation id="16"><infon key="identifier">0002356</infon><infon key="type">DISEASE</infon><location offset="249" length="28"/><text>Pancreatic islet dysfunction</text></annotation><annotation id="17"><infon key="identifier">0005148</infon><infon key="type">DISEASE</infon><location offset="292" length="15"/><text>type 2 diabetes</text></annotation></passage></document>
<document><id>24443471</id><passage><offset>0</offset><text>Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition. Thousands of putative enhancers are characterized in the human genome, yet few have been shown to have a functional role in cancer progression. Inhibiting oncokinases, such as EGFR, ALK, ERBB2, and BRAF, is a mainstay of current cancer therapy but is hindered by innate drug resistance mediated by up-regulation of the HGF receptor, MET. The mechanisms mediating such genomic responses to targeted therapy are unknown. Here, we identify lineage-specific enhancers at the MET locus for multiple common tumor types, including a melanoma lineage-specific enhancer 63 kb downstream from the MET TSS. This enhancer displays inducible chromatin looping with the MET promoter to up-regulate MET expression upon BRAF inhibition. Epigenomic analysis demonstrated that the melanocyte-specific transcription factor, MITF, mediates this enhancer function. Targeted genomic deletion (&lt;7 bp) of the MITF motif within the MET enhancer suppressed inducible chromatin looping and innate drug resistance, while maintaining MITF-dependent, inhibitor-induced melanoma cell differentiation. Epigenomic analysis can thus guide functional disruption of regulatory DNA to decouple pro- and anti-oncogenic functions of a dominant transcription factor and block innate resistance to oncokinase therapy.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr7,116374406,116376406</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,116374406,116376406</infon><infon key="gb">unk</infon><location offset="622" length="68"/><text>melanoma lineage-specific enhancer 63 kb downstream from the MET TSS</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr7,116374406,116376406</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,116374406,116376406</infon><infon key="gb">unk</infon><location offset="697" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="429" length="3"/><text>MET</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="597" length="5"/><text>tumor</text></annotation><annotation id="5"><infon key="identifier">0000849</infon><infon key="type">TISSUE</infon><location offset="622" length="16"/><text>melanoma lineage</text></annotation><annotation id="6"><infon key="identifier">673</infon><infon key="type">GENE</infon><location offset="800" length="4"/><text>BRAF</text></annotation><annotation id="7"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="901" length="4"/><text>MITF</text></annotation><annotation id="8"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="1101" length="4"/><text>MITF</text></annotation><annotation id="9"><infon key="identifier">0000848</infon><infon key="type">TISSUE</infon><location offset="1135" length="13"/><text>melanoma cell</text></annotation><annotation id="10"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="567" length="3"/><text>MET</text></annotation><annotation id="11"><infon key="identifier">0000847</infon><infon key="type">TISSUE</infon><location offset="859" length="10"/><text>melanocyte</text></annotation><annotation id="12"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="780" length="3"/><text>MET</text></annotation><annotation id="13"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr7,116374406,116376406</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,116374406,116376406</infon><infon key="gb">unk</infon><location offset="921" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="981" length="34"/><text>MITF motif within the MET enhancer</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="752" length="12"/><text>MET promoter</text></annotation><annotation id="16"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr7,116374406,116376406</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,116374406,116376406</infon><infon key="gb">unk</infon><location offset="1003" length="12"/><text>MET enhancer</text></annotation><annotation id="17"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="683" length="3"/><text>MET</text></annotation><annotation id="18"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="1003" length="3"/><text>MET</text></annotation><annotation id="19"><infon key="identifier">4233</infon><infon key="type">GENE</infon><location offset="752" length="3"/><text>MET</text></annotation><annotation id="20"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="981" length="4"/><text>MITF</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="153" length="5"/><text>human</text></annotation><annotation id="22"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="220" length="6"/><text>cancer</text></annotation><annotation id="23"><infon key="identifier">1956</infon><infon key="type">GENE</infon><location offset="272" length="4"/><text>EGFR</text></annotation><annotation id="24"><infon key="identifier">238</infon><infon key="type">GENE</infon><location offset="278" length="3"/><text>ALK</text></annotation><annotation id="25"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="283" length="5"/><text>ERBB2</text></annotation><annotation id="26"><infon key="identifier">673</infon><infon key="type">GENE</infon><location offset="294" length="4"/><text>BRAF</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="325" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>24510239</id><passage><offset>0</offset><text>ABCC4 copy number variation is associated with susceptibility to esophageal squamous cell carcinoma. Esophageal squamous cell carcinoma (ESCC) is the eighth most common cause of cancer-related death worldwide. However, previous genome-wide single nucleotide polymorphism association analyses have not explained the high heritability associated with ESCC. In this study, we performed genome-wide copy number variation (CNV) analysis on 128 discordant sibling pairs to identify novel genes that contribute to ESCC susceptibility. A total of 57 774 individual CNVs were identified, and an interactive network of common CNV-associated genes was constructed, which showed that several ABC transporter genes contain CNVs in ESCC patients. Independent validation of a CNV at 13q32.1 in 1048 northern Chinese Han subjects demonstrated that the amplification of ABCC4 significantly correlated with ESCC risk [odds ratio: 3.36 (1.65-7.93), P = 0.0013]. Immunohistochemistry staining suggested that high copy numbers correlated with increased protein levels. High expression of ABCC4 was an independent poor prognostic factor for ESCC [relative risk: 1.73 (1.10-2.73), P = 0.0181]. The CNV region showed strong enhancer activity. Furthermore, inhibition of ABCC4 protein in ESCC cells decreased cell proliferation and motility via the inhibition of COX-2, PGE2 receptors and c-Myc expression; AKT, extracellular signal-regulated kinase and cAMP response element-binding protein phosphorylation; and beta-catenin nuclear translocation in ESCC cells. In conclusion, the CNV at 13q32.1 is associated with ESCC susceptibility, and a gene within this locus, ABCC4, activates the oncogenic pathways in ESCC and thus facilitates cancer cell development and progression. A direct genetic contribution of ESCC risk through CNV common variants was determined in this study, and ABCC4 might therefore have predictive and therapeutic potential for ESCC.</text><annotation id="1"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>ABCC4</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="889" length="4"/><text>ESCC</text></annotation><annotation id="3"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="1067" length="5"/><text>ABCC4</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1119" length="4"/><text>ESCC</text></annotation><annotation id="5"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="1246" length="5"/><text>ABCC4</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0002861</infon><infon key="type">TISSUE</infon><location offset="1263" length="10"/><text>ESCC cells</text></annotation><annotation id="7"><infon key="identifier">4513</infon><infon key="type">GENE</infon><location offset="1338" length="5"/><text>COX-2</text></annotation><annotation id="8"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1364" length="5"/><text>c-Myc</text></annotation><annotation id="9"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1382" length="3"/><text>AKT</text></annotation><annotation id="10"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1488" length="12"/><text>beta-catenin</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0002861</infon><infon key="type">TISSUE</infon><location offset="1526" length="10"/><text>ESCC cells</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="65" length="34"/><text>esophageal squamous cell carcinoma</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1591" length="4"/><text>ESCC</text></annotation><annotation id="14"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="1642" length="5"/><text>ABCC4</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1685" length="4"/><text>ESCC</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="1711" length="11"/><text>cancer cell</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1785" length="4"/><text>ESCC</text></annotation><annotation id="18"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="1857" length="5"/><text>ABCC4</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1925" length="4"/><text>ESCC</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1175" length="10"/><text>CNV region</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="793" length="7"/><text>Chinese</text></annotation><annotation id="22"><infon key="identifier">1385</infon><infon key="type">GENE</infon><location offset="1429" length="37"/><text>cAMP response element-binding protein</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="101" length="34"/><text>Esophageal squamous cell carcinoma</text></annotation><annotation id="24"><infon key="identifier">80142</infon><infon key="type">GENE</infon><location offset="1345" length="4"/><text>PGE2</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="137" length="4"/><text>ESCC</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="178" length="6"/><text>cancer</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="349" length="4"/><text>ESCC</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="507" length="4"/><text>ESCC</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="718" length="4"/><text>ESCC</text></annotation><annotation id="30"><infon key="identifier">10257</infon><infon key="type">GENE</infon><location offset="853" length="5"/><text>ABCC4</text></annotation></passage></document>
<document><id>24564208</id><passage><offset>0</offset><text>Dynamic reorganization of the AC16 cardiomyocyte transcriptome in response to TNFalpha signaling revealed by integrated genomic analyses. BACKGROUND: Defining cell type-specific transcriptomes in mammals can be challenging, especially for unannotated regions of the genome. We have developed an analytical pipeline called groHMM for annotating primary transcripts using global nuclear run-on sequencing (GRO-seq) data. Herein, we use this pipeline to characterize the transcriptome of an immortalized adult human ventricular cardiomyocyte cell line (AC16) in response to signaling by tumor necrosis factor alpha (TNFalpha), which is controlled in part by NF-kappaB, a key transcriptional regulator of inflammation. A unique aspect of this work is the use of the RNA polymerase II (Pol II) inhibitor alpha-amanitin, which we used to define a set of RNA polymerase I and III (Pol I and Pol III) transcripts. RESULTS: Using groHMM, we identified ~30,000 coding and non-coding transcribed regions in AC16 cells, which includes a set of unique Pol I and Pol III primary transcripts. Many of these transcripts have not been annotated previously, including enhancer RNAs originating from NF-kappaB binding sites. In addition, we observed that AC16 cells rapidly and dynamically reorganize their transcriptomes in response to TNFalpha stimulation in an NF-kappaB-dependent manner, switching from a basal state to a proinflammatory state affecting a spectrum of cardiac-associated protein-coding and non-coding genes. Moreover, we observed distinct Pol II dynamics for up- and downregulated genes, with a rapid release of Pol II into productive elongation for TNFalpha-stimulated genes. As expected, the TNFalpha-induced changes in the AC16 transcriptome resulted in corresponding changes in cognate mRNA and protein levels in a similar manner, but with delayed kinetics. CONCLUSIONS: Our studies illustrate how computational genomics can be used to characterize the signal-regulated transcriptome in biologically relevant cell types, providing new information about how the human genome is organized, transcribed and regulated. In addition, they show how alpha-amanitin can be used to reveal the Pol I and Pol III transcriptome. Furthermore, they shed new light on the regulation of the cardiomyocyte transcriptome in response to a proinflammatory signal and help to clarify the link between inflammation and cardiomyocyte function at the transcriptional level.</text><annotation id="1"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="78" length="8"/><text>TNFalpha</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1181" length="23"/><text>NF-kappaB binding sites</text></annotation><annotation id="3"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="30" length="18"/><text>AC16 cardiomyocyte</text></annotation><annotation id="4"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="196" length="7"/><text>mammals</text></annotation><annotation id="5"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="550" length="4"/><text>AC16</text></annotation><annotation id="6"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="655" length="9"/><text>NF-kappaB</text></annotation><annotation id="7"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1236" length="10"/><text>AC16 cells</text></annotation><annotation id="8"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1181" length="9"/><text>NF-kappaB</text></annotation><annotation id="9"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1727" length="4"/><text>AC16</text></annotation><annotation id="10"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="2279" length="13"/><text>cardiomyocyte</text></annotation><annotation id="11"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="2401" length="13"/><text>cardiomyocyte</text></annotation><annotation id="12"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="513" length="35"/><text>ventricular cardiomyocyte cell line</text></annotation><annotation id="13"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1345" length="9"/><text>NF-kappaB</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="507" length="5"/><text>human</text></annotation><annotation id="15"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="584" length="27"/><text>tumor necrosis factor alpha</text></annotation><annotation id="16"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="996" length="10"/><text>AC16 cells</text></annotation><annotation id="17"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="613" length="8"/><text>TNFalpha</text></annotation><annotation id="18"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1318" length="8"/><text>TNFalpha</text></annotation><annotation id="19"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1651" length="8"/><text>TNFalpha</text></annotation><annotation id="20"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1695" length="8"/><text>TNFalpha</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2066" length="5"/><text>human</text></annotation></passage></document>
<document><id>24662484</id><passage><offset>0</offset><text>Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. The human 8q24 gene desert contains multiple enhancers that form tissue-specific long-range chromatin loops with the MYC oncogene, but how chromatin looping at the MYC locus is regulated remains poorly understood. Here we demonstrate that a long noncoding RNA (lncRNA), CCAT1-L, is transcribed specifically in human colorectal cancers from a locus 515 kb upstream of MYC. This lncRNA plays a role in MYC transcriptional regulation and promotes long-range chromatin looping. Importantly, the CCAT1-L locus is located within a strong super-enhancer and is spatially close to MYC. Knockdown of CCAT1-L reduced long-range interactions between the MYC promoter and its enhancers. In addition, CCAT1-L interacts with CTCF and modulates chromatin conformation at these loop regions. These results reveal an important role of a previously unannotated lncRNA in gene regulation at the MYC locus.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="120" length="44"/><text>8q24 gene desert contains multiple enhancers</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="642" length="14"/><text>super-enhancer</text></annotation><annotation id="3"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="274" length="3"/><text>MYC</text></annotation><annotation id="4"><infon key="identifier">100507056</infon><infon key="type">GENE</infon><location offset="380" length="5"/><text>CCAT1</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="420" length="5"/><text>human</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="426" length="18"/><text>colorectal cancers</text></annotation><annotation id="7"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="477" length="3"/><text>MYC</text></annotation><annotation id="8"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="510" length="3"/><text>MYC</text></annotation><annotation id="9"><infon key="identifier">100507056</infon><infon key="type">GENE</infon><location offset="601" length="5"/><text>CCAT1</text></annotation><annotation id="10"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="683" length="3"/><text>MYC</text></annotation><annotation id="11"><infon key="identifier">100507056</infon><infon key="type">GENE</infon><location offset="701" length="5"/><text>CCAT1</text></annotation><annotation id="12"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="753" length="3"/><text>MYC</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="753" length="12"/><text>MYC promoter</text></annotation><annotation id="14"><infon key="identifier">100507056</infon><infon key="type">GENE</infon><location offset="798" length="5"/><text>CCAT1</text></annotation><annotation id="15"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="821" length="4"/><text>CTCF</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="986" length="3"/><text>MYC</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="774" length="9"/><text>enhancers</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="0" length="5"/><text>Human</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="6" length="17"/><text>colorectal cancer</text></annotation><annotation id="20"><infon key="identifier">100507056</infon><infon key="type">GENE</infon><location offset="33" length="5"/><text>CCAT1</text></annotation><annotation id="21"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="99" length="3"/><text>MYC</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="114" length="5"/><text>human</text></annotation><annotation id="23"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="227" length="3"/><text>MYC</text></annotation></passage></document>
<document><id>24692107</id><passage><offset>0</offset><text>Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression. Runx2 is essential for osteoblast differentiation and chondrocyte maturation. The expression of Runx2 is the first requisite step for the lineage determination from mesenchymal stem cells to osteoblasts. Although the transcript from Runx2 distal promoter is majorly expressed in osteoblasts, the promoter failed to direct green fluorescent protein (GFP) expression to osteoblasts. To find the regulatory region, we generated GFP reporter mice driven by a bacterial artificial chromosome (BAC) of Runx2 locus, and succeeded in the reproduction of endogenous Runx2 expression. By serially deleting it, we identified a 343-bp enhancer, which directed GFP expression specifically to osteoblasts, about 30 kb upstream of the distal promoter. The sequence of the 343-bp enhancer was highly conserved among mouse, human, dog, horse, opossum, and chicken. Dlx5, Mef2c, Tcf7, Ctnnb1, Sp7, Smad1, and Sox6, which localized on the enhancer region in primary osteoblasts, synergistically upregulated the enhancer activity, whereas Msx2 downregulated the activity in mouse osteoblastic MC3T3-E1 cells. Msx2 was predominantly bound to the enhancer in mouse multipotent mesenchymal C3H10T1/2 cells, whereas Dlx5 was predominantly bound to the enhancer in MC3T3-E1 cells. Dlx5 and Mef2 directly bound to the enhancer, and the binding sites were required for the osteoblast-specific expression in mice, whereas the other factors bound to the enhancer by protein-protein interaction. The enhancer was characterized by the presence of the histone variant H2A.Z, the enrichment of histone H3 mono- and dimethylated at Lys4 and acetylated at Lys18 and Lys27, but the depletion of histone H3 trimethylated at Lys4 in primary osteoblasts. These findings indicated that the enhancer, which had typical histone modifications for enhancers, contains sufficient elements to direct Runx2 expression to osteoblasts, and that Dlx5 and Mef2, which formed an enhanceosome with Tcf7, Ctnnb1, Sp7, Smad1, and Sox6, play an essential role in the osteoblast-specific activation of the enhancer.   2014 American Society for Bone and Mineral Research.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="31" length="14"/><text>runx2 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="315" length="21"/><text>Runx2 distal promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1374" length="8"/><text>enhancer</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1507" length="8"/><text>enhancer</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1552" length="8"/><text>enhancer</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1832" length="8"/><text>enhancer</text></annotation><annotation id="7"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="1956" length="11"/><text>osteoblasts</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2131" length="8"/><text>enhancer</text></annotation><annotation id="9"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>Dlx5</text></annotation><annotation id="10"><infon key="identifier">17260</infon><infon key="type">GENE</infon><location offset="9" length="4"/><text>mef2</text></annotation><annotation id="11"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="50" length="10"/><text>osteoblast</text></annotation><annotation id="12"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="82" length="5"/><text>Runx2</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="378" length="8"/><text>promoter</text></annotation><annotation id="14"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="178" length="5"/><text>Runx2</text></annotation><annotation id="15"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="361" length="11"/><text>osteoblasts</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="520" length="4"/><text>mice</text></annotation><annotation id="17"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="578" length="5"/><text>Runx2</text></annotation><annotation id="18"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="639" length="5"/><text>Runx2</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="882" length="5"/><text>mouse</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="889" length="5"/><text>human</text></annotation><annotation id="21"><infon key="identifier">9615</infon><infon key="type">SPECIES</infon><location offset="896" length="3"/><text>dog</text></annotation><annotation id="22"><infon key="identifier">9796</infon><infon key="type">SPECIES</infon><location offset="901" length="5"/><text>horse</text></annotation><annotation id="23"><infon key="identifier">9031</infon><infon key="type">SPECIES</infon><location offset="921" length="7"/><text>chicken</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="698" length="15"/><text>343-bp enhancer</text></annotation><annotation id="25"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="930" length="4"/><text>Dlx5</text></annotation><annotation id="26"><infon key="identifier">17260</infon><infon key="type">GENE</infon><location offset="936" length="5"/><text>Mef2c</text></annotation><annotation id="27"><infon key="identifier">21414</infon><infon key="type">GENE</infon><location offset="943" length="4"/><text>Tcf7</text></annotation><annotation id="28"><infon key="identifier">12387</infon><infon key="type">GENE</infon><location offset="949" length="6"/><text>Ctnnb1</text></annotation><annotation id="29"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="957" length="3"/><text>Sp7</text></annotation><annotation id="30"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="962" length="5"/><text>Smad1</text></annotation><annotation id="31"><infon key="identifier">20679</infon><infon key="type">GENE</infon><location offset="973" length="4"/><text>Sox6</text></annotation><annotation id="32"><infon key="identifier">17702</infon><infon key="type">GENE</infon><location offset="1101" length="4"/><text>Msx2</text></annotation><annotation id="33"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1136" length="5"/><text>mouse</text></annotation><annotation id="34"><infon key="identifier">17702</infon><infon key="type">GENE</infon><location offset="1171" length="4"/><text>Msx2</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="802" length="15"/><text>distal promoter</text></annotation><annotation id="36"><infon key="identifier">0004058</infon><infon key="type">TISSUE</infon><location offset="1237" length="27"/><text>mesenchymal C3H10T1/2 cells</text></annotation><annotation id="37"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="1274" length="4"/><text>Dlx5</text></annotation><annotation id="38"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="1338" length="4"/><text>Dlx5</text></annotation><annotation id="39"><infon key="identifier">17260</infon><infon key="type">GENE</infon><location offset="1347" length="4"/><text>Mef2</text></annotation><annotation id="40"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1462" length="4"/><text>mice</text></annotation><annotation id="41"><infon key="identifier">51788</infon><infon key="type">GENE</infon><location offset="1618" length="5"/><text>H2A.Z</text></annotation><annotation id="42"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="1936" length="5"/><text>Runx2</text></annotation><annotation id="43"><infon key="identifier">13395</infon><infon key="type">GENE</infon><location offset="1978" length="4"/><text>Dlx5</text></annotation><annotation id="44"><infon key="identifier">17260</infon><infon key="type">GENE</infon><location offset="1987" length="4"/><text>Mef2</text></annotation><annotation id="45"><infon key="identifier">21414</infon><infon key="type">GENE</infon><location offset="2027" length="4"/><text>Tcf7</text></annotation><annotation id="46"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="839" length="15"/><text>343-bp enhancer</text></annotation><annotation id="47"><infon key="identifier">12387</infon><infon key="type">GENE</infon><location offset="2033" length="6"/><text>Ctnnb1</text></annotation><annotation id="48"><infon key="identifier">170574</infon><infon key="type">GENE</infon><location offset="2041" length="3"/><text>Sp7</text></annotation><annotation id="49"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="2046" length="5"/><text>Smad1</text></annotation><annotation id="50"><infon key="identifier">20679</infon><infon key="type">GENE</infon><location offset="2057" length="4"/><text>Sox6</text></annotation><annotation id="51"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="780" length="37"/><text>30 kb upstream of the distal promoter</text></annotation><annotation id="52"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2009" length="12"/><text>enhanceosome</text></annotation><annotation id="53"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="105" length="10"/><text>osteoblast</text></annotation><annotation id="54"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="136" length="11"/><text>chondrocyte</text></annotation><annotation id="55"><infon key="identifier">0003298</infon><infon key="type">TISSUE</infon><location offset="247" length="22"/><text>mesenchymal stem cells</text></annotation><annotation id="56"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="273" length="11"/><text>osteoblasts</text></annotation><annotation id="57"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1002" length="15"/><text>enhancer region</text></annotation><annotation id="58"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="450" length="11"/><text>osteoblasts</text></annotation><annotation id="59"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="761" length="11"/><text>osteoblasts</text></annotation><annotation id="60"><infon key="identifier">9272</infon><infon key="type">SPECIES</infon><location offset="908" length="7"/><text>opossum</text></annotation><annotation id="61"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="1029" length="11"/><text>osteoblasts</text></annotation><annotation id="62"><infon key="identifier">0001957</infon><infon key="type">TISSUE</infon><location offset="1155" length="14"/><text>MC3T3-E1 cells</text></annotation><annotation id="63"><infon key="identifier">0001957</infon><infon key="type">TISSUE</infon><location offset="1322" length="14"/><text>MC3T3-E1 cells</text></annotation><annotation id="64"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="31" length="5"/><text>runx2</text></annotation><annotation id="65"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="1428" length="10"/><text>osteoblast</text></annotation><annotation id="66"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="1785" length="11"/><text>osteoblasts</text></annotation><annotation id="67"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="2093" length="10"/><text>osteoblast</text></annotation><annotation id="68"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1219" length="5"/><text>mouse</text></annotation><annotation id="69"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="315" length="5"/><text>Runx2</text></annotation><annotation id="70"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1207" length="8"/><text>enhancer</text></annotation><annotation id="71"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1310" length="8"/><text>enhancer</text></annotation></passage></document>
<document><id>24703844</id><passage><offset>0</offset><text>Evolution of Alu elements toward enhancers. The human genome contains approximately one million Alu repetitive elements comprising 10% of the genome, yet their functions are not well understood. Here, we show that Alu elements resemble enhancers. Alu elements are bound by two well-phased nucleosomes that contain histones bearing marks of active chromatin, and they show tissue-specific enrichment for the enhancer mark H3K4me1. A proportion of Alu elements were experimentally validated as bona fide active enhancers with an in vitro reporter assay. In addition, Hi-C data indicate that Alus show long-range interactions with gene promoters. We also find that Alus are generally more conserved when located in the proximal upstream region of genes. Their similarity to enhancers becomes more prominent with their age in the human genome, following a clear evolutionary continuum reminiscent of the evolutionary pattern of proto-genes. Therefore, we conclude that some Alu elements can function as enhancers and propose that many more may be proto-enhancers that serve as a repertoire for the de novo birth of enhancers.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="826" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="48" length="5"/><text>human</text></annotation></passage></document>
<document><id>24703906</id><passage><offset>0</offset><text>A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Chromosomal inversion between 3q21 and 3q26 results in high-risk acute myeloid leukemia (AML). In this study, we identified a mechanism whereby a GATA2 distal hematopoietic enhancer (G2DHE or -77-kb enhancer) is brought into close proximity to the EVI1 gene in inv(3)(q21;q26) inversions, leading to leukemogenesis. We examined the contribution of G2DHE to leukemogenesis by creating a bacterial artificial chromosome (BAC) transgenic model that recapitulates the inv(3)(q21;q26) allele. Transgenic mice harboring a linked BAC developed leukemia accompanied by EVI1 overexpression-neoplasia that was not detected in mice bearing the same transgene but that was missing the GATA2 enhancer. These results establish the mechanistic basis underlying the pathogenesis of a severe form of leukemia through aberrant expression of the EVI1 proto-oncogene.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="256" length="35"/><text>GATA2 distal hematopoietic enhancer</text></annotation><annotation id="2"><infon key="identifier">14013</infon><infon key="type">GENE</infon><location offset="358" length="4"/><text>EVI1</text></annotation><annotation id="3"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="256" length="5"/><text>GATA2</text></annotation><annotation id="4"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="783" length="5"/><text>GATA2</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="609" length="4"/><text>mice</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="647" length="8"/><text>leukemia</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="726" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="893" length="8"/><text>leukemia</text></annotation><annotation id="9"><infon key="identifier">14013</infon><infon key="type">GENE</infon><location offset="937" length="4"/><text>EVI1</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="302" length="15"/><text>-77-kb enhancer</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="783" length="14"/><text>GATA2 enhancer</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="9" length="28"/><text>GATA2 hematopoietic enhancer</text></annotation><annotation id="13"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="9" length="5"/><text>GATA2</text></annotation><annotation id="14"><infon key="identifier">14013</infon><infon key="type">GENE</infon><location offset="93" length="4"/><text>EVI1</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="175" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="199" length="3"/><text>AML</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="293" length="5"/><text>G2DHE</text></annotation></passage></document>
<document><id>24705708</id><passage><offset>0</offset><text>YY1 acts as a transcriptional activator of Hoxa5 gene expression in mouse organogenesis. The Hox gene family encodes homeodomain-containing transcriptional regulators that confer positional information to axial and paraxial tissues in the developing embryo. The dynamic Hox gene expression pattern requires mechanisms that differentially control Hox transcription in a precise spatio-temporal fashion. This implies an integrated regulation of neighbouring Hox genes achieved through the sharing and the selective use of defined enhancer sequences. The Hoxa5 gene plays a crucial role in lung and gut organogenesis. To position Hoxa5 in the regulatory hierarchy that drives organ morphogenesis, we searched for cis-acting regulatory sequences and associated trans-acting factors required for Hoxa5 expression in the developing lung and gut. Using mouse transgenesis, we identified two DNA regions included in a 1.5-kb XbaI-XbaI fragment located in the Hoxa4-Hoxa5 intergenic domain and known to control Hoxa4 organ expression. The multifunctional YY1 transcription factor binds the two regulatory sequences in vitro and in vivo. Moreover, the mesenchymal deletion of the Yy1 gene function in mice results in a Hoxa5-like lung phenotype with decreased Hoxa5 and Hoxa4 gene expression. Thus, YY1 acts as a positive regulator of Hoxa5 expression in the developing lung and gut. Our data also support a role for YY1 in the coordinated expression of Hox genes for correct organogenesis.</text><annotation id="1"><infon key="identifier">22632</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>YY1</text></annotation><annotation id="2"><infon key="identifier">15401</infon><infon key="type">GENE</infon><location offset="1002" length="5"/><text>Hoxa4</text></annotation><annotation id="3"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="957" length="5"/><text>Hoxa5</text></annotation><annotation id="4"><infon key="identifier">22632</infon><infon key="type">GENE</infon><location offset="1170" length="3"/><text>Yy1</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1191" length="4"/><text>mice</text></annotation><annotation id="6"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="1209" length="5"/><text>Hoxa5</text></annotation><annotation id="7"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="1250" length="5"/><text>Hoxa5</text></annotation><annotation id="8"><infon key="identifier">15401</infon><infon key="type">GENE</infon><location offset="1260" length="5"/><text>Hoxa4</text></annotation><annotation id="9"><infon key="identifier">22632</infon><infon key="type">GENE</infon><location offset="1289" length="3"/><text>YY1</text></annotation><annotation id="10"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="1325" length="5"/><text>Hoxa5</text></annotation><annotation id="11"><infon key="identifier">22632</infon><infon key="type">GENE</infon><location offset="1407" length="3"/><text>YY1</text></annotation><annotation id="12"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="43" length="5"/><text>Hoxa5</text></annotation><annotation id="13"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="596" length="3"/><text>gut</text></annotation><annotation id="14"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="587" length="4"/><text>lung</text></annotation><annotation id="15"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="826" length="4"/><text>lung</text></annotation><annotation id="16"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="1220" length="4"/><text>lung</text></annotation><annotation id="17"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="1360" length="4"/><text>lung</text></annotation><annotation id="18"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="835" length="3"/><text>gut</text></annotation><annotation id="19"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="1369" length="3"/><text>gut</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="880" length="100"/><text>two DNA regions included in a 1.5-kb XbaI-XbaI fragment located in the Hoxa4-Hoxa5 intergenic domain</text></annotation><annotation id="21"><infon key="identifier">22632</infon><infon key="type">GENE</infon><location offset="1046" length="3"/><text>YY1</text></annotation><annotation id="22"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="68" length="5"/><text>mouse</text></annotation><annotation id="23"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="552" length="5"/><text>Hoxa5</text></annotation><annotation id="24"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="627" length="5"/><text>Hoxa5</text></annotation><annotation id="25"><infon key="identifier">15402</infon><infon key="type">GENE</infon><location offset="791" length="5"/><text>Hoxa5</text></annotation><annotation id="26"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="846" length="5"/><text>mouse</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1046" length="59"/><text>YY1 transcription factor binds the two regulatory sequences</text></annotation><annotation id="28"><infon key="identifier">15401</infon><infon key="type">GENE</infon><location offset="951" length="5"/><text>Hoxa4</text></annotation></passage></document>
<document><id>24734888</id><passage><offset>0</offset><text>A mouse renin distal enhancer is essential for blood pressure homeostasis in BAC-rescued renin-null mutant mice. Renin is predominantly expressed in juxtaglomerular cells in the kidney and regulates blood pressure homeostasis. To examine possible in vivo functions of a mouse distal enhancer (mdE), we generated transgenic mice (TgM) carrying either wild-type or mdE-deficient renin BACs (bacterial artificial chromosome), integrated at the identical chromosomal site. In the kidneys of the TgM, the mdE contributed 80% to basal renin promoter activity. To test for possible physiological roles for the mdE, renin BAC transgenes were used to rescue the hypotensive renin-null mice. Interestingly, renal renin expression in the Tg(BAC):renin-null compound mice was indistinguishable between the wild-type and mutant BAC carriers. Surprisingly, however, the plasma renin activity and angiotensin I concentration in the mdE compound mutant mice were significantly lower than the same parameters in the control mice, and the mutants were consistently hypotensive, demonstrating that blood pressure homeostasis is regulated through transcriptional cis elements controlling renin activity.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="8" length="21"/><text>renin distal enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="270" length="21"/><text>mouse distal enhancer</text></annotation><annotation id="3"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="89" length="5"/><text>renin</text></annotation><annotation id="4"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="113" length="5"/><text>Renin</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="676" length="4"/><text>mice</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="755" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="identifier">11606</infon><infon key="type">GENE</infon><location offset="882" length="13"/><text>angiotensin I</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="937" length="4"/><text>mice</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1007" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="377" length="5"/><text>renin</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="363" length="3"/><text>mdE</text></annotation><annotation id="12"><infon key="identifier">0005158</infon><infon key="type">TISSUE</infon><location offset="149" length="21"/><text>juxtaglomerular cells</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="917" length="3"/><text>mdE</text></annotation><annotation id="14"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="178" length="6"/><text>kidney</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="529" length="14"/><text>renin promoter</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="603" length="3"/><text>mdE</text></annotation><annotation id="17"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="476" length="7"/><text>kidneys</text></annotation><annotation id="18"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="665" length="5"/><text>renin</text></annotation><annotation id="19"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="608" length="5"/><text>renin</text></annotation><annotation id="20"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="703" length="5"/><text>renin</text></annotation><annotation id="21"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="735" length="5"/><text>renin</text></annotation><annotation id="22"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="863" length="5"/><text>renin</text></annotation><annotation id="23"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="1168" length="5"/><text>renin</text></annotation><annotation id="24"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="2" length="5"/><text>mouse</text></annotation><annotation id="25"><infon key="type">TISSUE</infon><location offset="199" length="5"/><text>blood</text></annotation><annotation id="26"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="8" length="5"/><text>renin</text></annotation><annotation id="27"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="270" length="5"/><text>mouse</text></annotation><annotation id="28"><infon key="identifier">19701</infon><infon key="type">GENE</infon><location offset="529" length="5"/><text>renin</text></annotation><annotation id="29"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="107" length="4"/><text>mice</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="500" length="3"/><text>mdE</text></annotation><annotation id="31"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="323" length="4"/><text>mice</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="293" length="3"/><text>mdE</text></annotation><annotation id="33"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1079" length="5"/><text>blood</text></annotation><annotation id="34"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="47" length="5"/><text>blood</text></annotation></passage></document>
<document><id>24778216</id><passage><offset>0</offset><text>Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. The androgen receptor (AR) is a key factor that regulates the behavior and fate of prostate cancer cells. The AR-regulated network is activated when AR binds enhancer elements and modulates specific enhancer-promoter looping. Kallikrein-related peptidase 3 (KLK3), which codes for prostate-specific antigen (PSA), is a well-known AR-regulated gene and its upstream enhancers produce bidirectional enhancer RNAs (eRNAs), termed KLK3e. Here, we demonstrate that KLK3e facilitates the spatial interaction of the KLK3 enhancer and the KLK2 promoter and enhances long-distance KLK2 transcriptional activation. KLK3e carries the core enhancer element derived from the androgen response element III (ARE III), which is required for the interaction of AR and Mediator 1 (Med1). Furthermore, we show that KLK3e processes RNA-dependent enhancer activity depending on the integrity of core enhancer elements. The transcription of KLK3e was detectable and its expression is significantly correlated with KLK3 (R(2) = 0.6213, P &lt; 5 x 10(-11)) and KLK2 (R(2) = 0.5893, P &lt; 5 x 10(-10)) in human prostate tissues. Interestingly, RNAi silencing of KLK3e resulted in a modest negative effect on prostate cancer cell proliferation. Accordingly, we report that an androgen-induced eRNA scaffolds the AR-associated protein complex that modulates chromosomal architecture and selectively enhances AR-dependent gene expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="614" length="13"/><text>KLK3 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="565" length="5"/><text>KLK3e</text></annotation><annotation id="3"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="29" length="17"/><text>androgen receptor</text></annotation><annotation id="4"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="109" length="17"/><text>androgen receptor</text></annotation><annotation id="5"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="128" length="2"/><text>AR</text></annotation><annotation id="6"><infon key="identifier">0001033</infon><infon key="type">TISSUE</infon><location offset="188" length="21"/><text>prostate cancer cells</text></annotation><annotation id="7"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="215" length="2"/><text>AR</text></annotation><annotation id="8"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="254" length="2"/><text>AR</text></annotation><annotation id="9"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="331" length="30"/><text>Kallikrein-related peptidase 3</text></annotation><annotation id="10"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="363" length="4"/><text>KLK3</text></annotation><annotation id="11"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="386" length="25"/><text>prostate-specific antigen</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="636" length="13"/><text>KLK2 promoter</text></annotation><annotation id="13"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="435" length="2"/><text>AR</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="710" length="5"/><text>KLK3e</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="901" length="5"/><text>KLK3e</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="1024" length="5"/><text>KLK3e</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="1237" length="5"/><text>KLK3e</text></annotation><annotation id="18"><infon key="identifier">3817</infon><infon key="type">GENE</infon><location offset="677" length="4"/><text>KLK2</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="502" length="13"/><text>enhancer RNAs</text></annotation><annotation id="20"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="849" length="2"/><text>AR</text></annotation><annotation id="21"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="856" length="10"/><text>Mediator 1</text></annotation><annotation id="22"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="868" length="4"/><text>Med1</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="767" length="29"/><text>androgen response element III</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="517" length="5"/><text>eRNAs</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="461" length="18"/><text>upstream enhancers</text></annotation><annotation id="26"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="1097" length="4"/><text>KLK3</text></annotation><annotation id="27"><infon key="identifier">3817</infon><infon key="type">GENE</infon><location offset="1139" length="4"/><text>KLK2</text></annotation><annotation id="28"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1180" length="5"/><text>human</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="728" length="21"/><text>core enhancer element</text></annotation><annotation id="30"><infon key="attribute">RNA,INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1350" length="21"/><text>androgen-induced eRNA</text></annotation><annotation id="31"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1481" length="2"/><text>AR</text></annotation><annotation id="32"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="614" length="4"/><text>KLK3</text></annotation><annotation id="33"><infon key="identifier">3817</infon><infon key="type">GENE</infon><location offset="636" length="4"/><text>KLK2</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="798" length="7"/><text>ARE III</text></annotation><annotation id="35"><infon key="identifier">0001129</infon><infon key="type">TISSUE</infon><location offset="1186" length="8"/><text>prostate</text></annotation><annotation id="36"><infon key="attribute">CANCER</infon><infon key="identifier">0001033</infon><infon key="type">TISSUE</infon><location offset="1283" length="20"/><text>prostate cancer cell</text></annotation><annotation id="37"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="1386" length="2"/><text>AR</text></annotation><annotation id="38"><infon key="identifier">354</infon><infon key="type">GENE</infon><location offset="413" length="3"/><text>PSA</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="532" length="5"/><text>KLK3e</text></annotation></passage></document>
<document><id>24788237</id><passage><offset>0</offset><text>The identification of an ESCC susceptibility SNP rs920778 that regulates the expression of lncRNA HOTAIR via a novel intronic enhancer. Long noncoding RNA (lncRNA) HOX transcript antisense RNA (HOTAIR), which could induce genome-wide retargeting of polycomb-repressive complex 2, trimethylates histone H3 lysine-27 (H3K27me3) and deregulation of multiple downstream genes, is involved in development and progression of esophageal squamous cell carcinoma (ESCC). We hypothesized that the functional single nucleotide polymorphisms (SNP) in HOTAIR may affect HOTAIR expression and/or its function and, thus, ESCC risk. Therefore, we examined the association between three haplotype-tagging SNPs (htSNP) across the whole HOTAIR locus and ESCC risk as well as the functional relevance of an ESCC susceptibility SNP rs920778. Genotypes were determined in three independent case-control sets consisted of 2098 ESCC patients and 2150 controls. The allele-specific regulation on HOTAIR expression by the rs920778 SNP was investigated in vitro and in vivo. We found that the HOTAIR rs920778 TT carriers had a 1.37-fold, 1.78-fold and 2.08-fold increased ESCC risk in Jinan, Shijiazhuang and Huaian populations, respectively, compared with the CC carriers (P = 0.003, 7.7 x 10(-4) and 5.9 x 10(-4)). During inspecting functional relevance of the rs920778 SNP, we identified a novel intronic HOTAIR enhancer locating between +1719bp and +2353bp from the transcriptional start site through reporter assays. Moreover, there is an allelic regulation of rs920778 on HOTAIR expression via this enhancer in both ESCC cell lines and normal esophageal tissue specimens, with higher HOTAIR expression among T allele carriers. These results demonstrate that functional genetic variants influencing lncRNA regulation may explain a fraction of ESCC genetic basis.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:chr12,54357811,54358445</infon><infon key="type">ENHANCER</infon><infon key="identifier">12,54357811,54358445</infon><infon key="gb">hg</infon><location offset="111" length="23"/><text>novel intronic enhancer</text></annotation><annotation id="2"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="1381" length="6"/><text>HOTAIR</text></annotation><annotation id="3"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="557" length="6"/><text>HOTAIR</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="606" length="4"/><text>ESCC</text></annotation><annotation id="5"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="718" length="6"/><text>HOTAIR</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="735" length="4"/><text>ESCC</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="787" length="4"/><text>ESCC</text></annotation><annotation id="8"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="811" length="8"/><text>rs920778</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="904" length="4"/><text>ESCC</text></annotation><annotation id="10"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="971" length="6"/><text>HOTAIR</text></annotation><annotation id="11"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="996" length="8"/><text>rs920778</text></annotation><annotation id="12"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="1066" length="6"/><text>HOTAIR</text></annotation><annotation id="13"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:chr12,54357811,54358445</infon><infon key="type">ENHANCER</infon><infon key="identifier">12,54357811,54358445</infon><infon key="gb">hg</infon><location offset="1578" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="1073" length="8"/><text>rs920778</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1145" length="4"/><text>ESCC</text></annotation><annotation id="16"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="1336" length="8"/><text>rs920778</text></annotation><annotation id="17"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:chr12,54357811,54358445</infon><infon key="type">ENHANCER</infon><infon key="identifier">12,54357811,54358445</infon><infon key="gb">hg</infon><location offset="1372" length="97"/><text>intronic HOTAIR enhancer locating between +1719bp and +2353bp from the transcriptional start site</text></annotation><annotation id="18"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="1539" length="8"/><text>rs920778</text></annotation><annotation id="19"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="1551" length="6"/><text>HOTAIR</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0002861</infon><infon key="type">TISSUE</infon><location offset="1595" length="15"/><text>ESCC cell lines</text></annotation><annotation id="21"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="1663" length="6"/><text>HOTAIR</text></annotation><annotation id="22"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="1821" length="4"/><text>ESCC</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="25" length="4"/><text>ESCC</text></annotation><annotation id="24"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="164" length="28"/><text>HOX transcript antisense RNA</text></annotation><annotation id="25"><infon key="comment">rs920778</infon><infon key="type">VARIANT</infon><infon key="identifier">rs920778</infon><location offset="49" length="8"/><text>rs920778</text></annotation><annotation id="26"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="98" length="6"/><text>HOTAIR</text></annotation><annotation id="27"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="194" length="6"/><text>HOTAIR</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="419" length="34"/><text>esophageal squamous cell carcinoma</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0005580</infon><infon key="type">DISEASE</infon><location offset="455" length="4"/><text>ESCC</text></annotation><annotation id="30"><infon key="identifier">100124700</infon><infon key="type">GENE</infon><location offset="539" length="6"/><text>HOTAIR</text></annotation></passage></document>
<document><id>24797517</id><passage><offset>0</offset><text>The histone lysine demethylase JMJD3/KDM6B is recruited to p53 bound promoters and enhancer elements in a p53 dependent manner. The JmjC domain-containing protein JMJD3/KDM6B catalyses the demethylation of H3K27me3 and H3K27me2. JMJD3 appears to be highly regulated at the transcriptional level and is upregulated in response to diverse stimuli such as differentiation inducers and stress signals. Accordingly, JMJD3 has been linked to the regulation of different biological processes such as differentiation of embryonic stem cells, inflammatory responses in macrophages, and induction of cellular senescence via regulation of the INK4A-ARF locus. Here we show here that JMJD3 interacts with the tumour suppressor protein p53. We find that the interaction is dependent on the p53 tetramerization domain. Following DNA damage, JMJD3 is transcriptionally upregulated and by performing genome-wide mapping of JMJD3, we demonstrate that it binds genes involved in basic cellular processes, as well as genes regulating cell cycle, response to stress and apoptosis. Moreover, we find that JMJD3 binding sites show significant overlap with p53 bound promoters and enhancer elements. The binding of JMJD3 to p53 target sites is increased in response to DNA damage, and we demonstrate that the recruitment of JMJD3 to these sites is dependent on p53 expression. Therefore, we propose a model in which JMJD3 is recruited to p53 responsive elements via its interaction with p53 and speculate that JMJD3 could act as a fail-safe mechanism to remove low levels of H3K27me3 and H3K27me2 to allow for efficient acetylation of H3K27.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1084" length="19"/><text>JMJD3 binding sites</text></annotation><annotation id="2"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="229" length="5"/><text>JMJD3</text></annotation><annotation id="3"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="411" length="5"/><text>JMJD3</text></annotation><annotation id="4"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="672" length="5"/><text>JMJD3</text></annotation><annotation id="5"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="59" length="3"/><text>p53</text></annotation><annotation id="6"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="723" length="3"/><text>p53</text></annotation><annotation id="7"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="777" length="3"/><text>p53</text></annotation><annotation id="8"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="827" length="5"/><text>JMJD3</text></annotation><annotation id="9"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="907" length="5"/><text>JMJD3</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="83" length="17"/><text>enhancer elements</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1158" length="17"/><text>enhancer elements</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1134" length="19"/><text>p53 bound promoters</text></annotation><annotation id="13"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="1192" length="5"/><text>JMJD3</text></annotation><annotation id="14"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1134" length="3"/><text>p53</text></annotation><annotation id="15"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="1301" length="5"/><text>JMJD3</text></annotation><annotation id="16"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1338" length="3"/><text>p53</text></annotation><annotation id="17"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="1393" length="5"/><text>JMJD3</text></annotation><annotation id="18"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1415" length="3"/><text>p53</text></annotation><annotation id="19"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1464" length="3"/><text>p53</text></annotation><annotation id="20"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="1487" length="5"/><text>JMJD3</text></annotation><annotation id="21"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="512" length="20"/><text>embryonic stem cells</text></annotation><annotation id="22"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="1084" length="5"/><text>JMJD3</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1201" length="16"/><text>p53 target sites</text></annotation><annotation id="24"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="560" length="11"/><text>macrophages</text></annotation><annotation id="25"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1201" length="3"/><text>p53</text></annotation><annotation id="26"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="31" length="5"/><text>JMJD3</text></annotation><annotation id="27"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="37" length="5"/><text>KDM6B</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="59" length="19"/><text>p53 bound promoters</text></annotation><annotation id="29"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="106" length="3"/><text>p53</text></annotation><annotation id="30"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="163" length="5"/><text>JMJD3</text></annotation><annotation id="31"><infon key="identifier">23135</infon><infon key="type">GENE</infon><location offset="169" length="5"/><text>KDM6B</text></annotation></passage></document>
<document><id>24812424</id><passage><offset>0</offset><text>Sleep fragmentation during late gestation induces metabolic perturbations and epigenetic changes in adiponectin gene expression in male adult offspring mice. Sleep fragmentation (SF) is a common condition among pregnant women, particularly during late gestation. Gestational perturbations promote the emergence of adiposity and metabolic disease risk in offspring, most likely through epigenetic modifications. Adiponectin (AdipoQ) expression inversely correlates with obesity and insulin resistance. The effects of SF during late gestation on metabolic function and AdipoQ expression in visceral white adipose tissue (VWAT) of offspring mice are unknown. Male offspring mice were assessed at 24 weeks after dams were exposed to SF or control sleep during late gestation. Increased food intake, body weight, VWAT mass, and insulin resistance, with reductions in AdipoQ expression in VWAT, emerged in SF offspring. Increased DNMT3a and -b and global DNA methylation and reduced histone acetyltransferase activity and TET1, -2, and -3 expression were detected in VWAT of SF offspring. Reductions in 5-hydroxymethylcytosine and H3K4m3 and an increase in DNA 5-methylcytosine and H3K9m2 in the promoter and enhancer regions of AdipoQ emerged in adipocytes from VWAT and correlated with AdipoQ expression. SF during late gestation induces epigenetic modifications in AdipoQ in male offspring mouse VWAT adipocytes along with a metabolic syndrome-like phenotype. Thus, altered gestational environments elicited by SF impose the emergence of adverse, long-lasting metabolic consequences in the next generation.</text><annotation id="1"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="100" length="11"/><text>adiponectin</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="638" length="4"/><text>mice</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="671" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">0005015</infon><infon key="type">DISEASE</infon><location offset="823" length="18"/><text>insulin resistance</text></annotation><annotation id="5"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="862" length="6"/><text>AdipoQ</text></annotation><annotation id="6"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="1016" length="4"/><text>TET1</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1190" length="8"/><text>promoter</text></annotation><annotation id="8"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="1282" length="6"/><text>AdipoQ</text></annotation><annotation id="9"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="1362" length="6"/><text>AdipoQ</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1387" length="5"/><text>mouse</text></annotation><annotation id="11"><infon key="identifier">0004955</infon><infon key="type">DISEASE</infon><location offset="1422" length="18"/><text>metabolic syndrome</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="152" length="4"/><text>mice</text></annotation><annotation id="13"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="588" length="29"/><text>visceral white adipose tissue</text></annotation><annotation id="14"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="619" length="4"/><text>VWAT</text></annotation><annotation id="15"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="808" length="4"/><text>VWAT</text></annotation><annotation id="16"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="883" length="4"/><text>VWAT</text></annotation><annotation id="17"><infon key="identifier">13435</infon><infon key="type">GENE</infon><location offset="924" length="6"/><text>DNMT3a</text></annotation><annotation id="18"><infon key="identifier">13436</infon><infon key="type">GENE</infon><location offset="936" length="1"/><text>b</text></annotation><annotation id="19"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="1023" length="1"/><text>2</text></annotation><annotation id="20"><infon key="identifier">194388</infon><infon key="type">GENE</infon><location offset="1031" length="1"/><text>3</text></annotation><annotation id="21"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="1061" length="4"/><text>VWAT</text></annotation><annotation id="22"><infon key="identifier">0000443</infon><infon key="type">TISSUE</infon><location offset="1241" length="10"/><text>adipocytes</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="220" length="5"/><text>women</text></annotation><annotation id="24"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="1257" length="4"/><text>VWAT</text></annotation><annotation id="25"><infon key="identifier">0000443</infon><infon key="type">TISSUE</infon><location offset="1398" length="10"/><text>adipocytes</text></annotation><annotation id="26"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="1223" length="6"/><text>AdipoQ</text></annotation><annotation id="27"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="158" length="19"/><text>Sleep fragmentation</text></annotation><annotation id="28"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="0" length="19"/><text>Sleep fragmentation</text></annotation><annotation id="29"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="179" length="2"/><text>SF</text></annotation><annotation id="30"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="516" length="2"/><text>SF</text></annotation><annotation id="31"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="729" length="2"/><text>SF</text></annotation><annotation id="32"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="1301" length="2"/><text>SF</text></annotation><annotation id="33"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="1508" length="2"/><text>SF</text></annotation><annotation id="34"><infon key="identifier">0005066</infon><infon key="type">DISEASE</infon><location offset="328" length="17"/><text>metabolic disease</text></annotation><annotation id="35"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="900" length="2"/><text>SF</text></annotation><annotation id="36"><infon key="identifier">0003406</infon><infon key="type">DISEASE</infon><location offset="1069" length="2"/><text>SF</text></annotation><annotation id="37"><infon key="identifier">0001456</infon><infon key="type">TISSUE</infon><location offset="1393" length="4"/><text>VWAT</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1203" length="26"/><text>enhancer regions of AdipoQ</text></annotation><annotation id="39"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="411" length="11"/><text>Adiponectin</text></annotation><annotation id="40"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="424" length="6"/><text>AdipoQ</text></annotation><annotation id="41"><infon key="identifier">0005139</infon><infon key="type">DISEASE</infon><location offset="469" length="7"/><text>obesity</text></annotation><annotation id="42"><infon key="identifier">0005015</infon><infon key="type">DISEASE</infon><location offset="481" length="18"/><text>insulin resistance</text></annotation><annotation id="43"><infon key="identifier">11450</infon><infon key="type">GENE</infon><location offset="567" length="6"/><text>AdipoQ</text></annotation></passage></document>
<document><id>24842713</id><passage><offset>0</offset><text>Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Position effects due to disruption of distant cis-regulatory regions have been reported for over 40 human gene loci; however, the underlying mechanisms of long-range gene regulation remain largely unknown. We report on two patients with alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) caused by overlapping genomic deletions that included a distant FOXF1 transcriptional enhancer mapping 0.3 Mb upstream to FOXF1 on 16q24.1. In one patient with atypical late-onset ACDMPV, a ~1.5 Mb deletion removed the proximal 43% of this enhancer, leaving the lung-specific long non-coding RNA (lncRNA) gene LINC01081 intact. In the second patient with severe neonatal-onset ACDMPV, an overlapping ~194 kb deletion disrupted LINC01081. Both deletions arose de novo on maternal copy of the chromosome 16, supporting the notion that FOXF1 is paternally imprinted in the human lungs. RNAi-mediated knock-down of LINC01081 in normal fetal lung fibroblasts showed that this lncRNA positively regulates FOXF1 transcript level, further indicating that decrease in LINC01081 expression can contribute to development of ACDMPV.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="28" length="22"/><text>distant FOXF1 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="538" length="82"/><text>distant FOXF1 transcriptional enhancer mapping 0.3 Mb upstream to FOXF1 on 16q24.1</text></annotation><annotation id="3"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="474" length="6"/><text>ACDMPV</text></annotation><annotation id="4"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="859" length="6"/><text>ACDMPV</text></annotation><annotation id="5"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="744" length="4"/><text>lung</text></annotation><annotation id="6"><infon key="identifier">101154687</infon><infon key="type">GENE</infon><location offset="792" length="9"/><text>LINC01081</text></annotation><annotation id="7"><infon key="identifier">101154687</infon><infon key="type">GENE</infon><location offset="909" length="9"/><text>LINC01081</text></annotation><annotation id="8"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1015" length="5"/><text>FOXF1</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1052" length="5"/><text>human</text></annotation><annotation id="10"><infon key="identifier">101154687</infon><infon key="type">GENE</infon><location offset="1093" length="9"/><text>LINC01081</text></annotation><annotation id="11"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1181" length="5"/><text>FOXF1</text></annotation><annotation id="12"><infon key="identifier">101154687</infon><infon key="type">GENE</infon><location offset="1241" length="9"/><text>LINC01081</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="722" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="1295" length="6"/><text>ACDMPV</text></annotation><annotation id="15"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="1058" length="5"/><text>lungs</text></annotation><annotation id="16"><infon key="identifier">0000764</infon><infon key="type">TISSUE</infon><location offset="1119" length="16"/><text>lung fibroblasts</text></annotation><annotation id="17"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="662" length="6"/><text>ACDMPV</text></annotation><annotation id="18"><infon key="identifier">101154687</infon><infon key="type">GENE</infon><location offset="78" length="9"/><text>LINC01081</text></annotation><annotation id="19"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="103" length="65"/><text>alveolar capillary dysplasia with misalignment of pulmonary veins</text></annotation><annotation id="20"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="36" length="5"/><text>FOXF1</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="270" length="5"/><text>human</text></annotation><annotation id="22"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="407" length="65"/><text>alveolar capillary dysplasia with misalignment of pulmonary veins</text></annotation><annotation id="23"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="546" length="5"/><text>FOXF1</text></annotation></passage></document>
<document><id>24905168</id><passage><offset>0</offset><text>Reorganization of enhancer patterns in transition from naive to primed pluripotency. Naive and primed pluripotency is characterized by distinct signaling requirements, transcriptomes, and developmental properties, but both cellular states share key transcriptional regulators: Oct4, Sox2, and Nanog. Here, we demonstrate that transition between these two pluripotent states is associated with widespread Oct4 relocalization, mirrored by global rearrangement of enhancer chromatin landscapes. Our genomic and biochemical analyses identified candidate mediators of primed state-specific Oct4 binding, including Otx2 and Zic2/3. Even when differentiation cues are blocked, premature Otx2 overexpression is sufficient to exit the naive state, induce transcription of a substantial subset of primed pluripotency-associated genes, and redirect Oct4 to previously inaccessible enhancer sites. However, the ability of Otx2 to engage new enhancer regions is determined by its levels, cis-encoded properties of the sites, and the signaling environment. Our results illuminate regulatory mechanisms underlying pluripotency and suggest that the capacity of transcription factors such as Otx2 and Oct4 to pioneer new enhancer sites is highly context dependent.</text><annotation id="1"><infon key="identifier">7547</infon><infon key="type">GENE</infon><location offset="623" length="1"/><text>3</text></annotation><annotation id="2"><infon key="identifier">5015</infon><infon key="type">GENE</infon><location offset="609" length="4"/><text>Otx2</text></annotation><annotation id="3"><infon key="identifier">7546</infon><infon key="type">GENE</infon><location offset="618" length="4"/><text>Zic2</text></annotation><annotation id="4"><infon key="identifier">5015</infon><infon key="type">GENE</infon><location offset="680" length="4"/><text>Otx2</text></annotation><annotation id="5"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="838" length="4"/><text>Oct4</text></annotation><annotation id="6"><infon key="identifier">5015</infon><infon key="type">GENE</infon><location offset="910" length="4"/><text>Otx2</text></annotation><annotation id="7"><infon key="identifier">5015</infon><infon key="type">GENE</infon><location offset="1175" length="4"/><text>Otx2</text></annotation><annotation id="8"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1184" length="4"/><text>Oct4</text></annotation><annotation id="9"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="277" length="4"/><text>Oct4</text></annotation><annotation id="10"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="283" length="4"/><text>Sox2</text></annotation><annotation id="11"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="293" length="5"/><text>Nanog</text></annotation><annotation id="12"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="404" length="4"/><text>Oct4</text></annotation><annotation id="13"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="585" length="4"/><text>Oct4</text></annotation></passage></document>
<document><id>24915132</id><passage><offset>0</offset><text>Identification of two regulatory elements controlling Fucosyltransferase 7 transcription in murine CD4+ T cells. Fucosyltransferase VII encoded by the gene Fut7 is essential in CD4(+) T cells for the generation of E- and P-selectin ligands (E- and P-lig) which facilitate recruitment of lymphocytes into inflamed tissues and into the skin. This study aimed to identify regulatory elements controlling the inducible Fut7 expression in CD4(+) T cells that occurs upon activation and differentiation of naive T cells into effector cells. Comparative analysis of the histone modification pattern in non-hematopoetic cells and CD4(+) T cell subsets revealed a differential histone modification pattern within the Fut7 locus including a conserved non-coding sequence (CNS) identified by cross-species conservation comparison suggesting that regulatory elements are confined to this region. Cloning of the CNS located about 500 bp upstream of the Fut7 locus, into a luciferase reporter vector elicited reporter activity after transfection of the alphabeta-WT T cell line, but not after transfection of primary murine CD4(+) Th1 cells. As quantification of different Fut7 transcripts revealed a predominance of transcripts lacking the first exons in primary Th1 cells we searched for an alternative promoter. Cloning of an intragenic region spanning a 1kb region upstream of exon 4 into an enhancer-containing vector indeed elicited promoter activity. Interestingly, also the CNS enhanced activity of this intragenic minimal promoter in reporter assays in primary Th1 cells suggesting that both elements interact in primary CD4(+) T cells to induce Fut7 transcription.</text><annotation id="1"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="334" length="4"/><text>skin</text></annotation><annotation id="2"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="415" length="4"/><text>Fut7</text></annotation><annotation id="3"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="708" length="4"/><text>Fut7</text></annotation><annotation id="4"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="940" length="4"/><text>Fut7</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1103" length="6"/><text>murine</text></annotation><annotation id="6"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="1159" length="4"/><text>Fut7</text></annotation><annotation id="7"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="1641" length="4"/><text>Fut7</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1315" length="58"/><text>intragenic region spanning a 1kb region upstream of exon 4</text></annotation><annotation id="9"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="99" length="12"/><text>CD4+ T cells</text></annotation><annotation id="10"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="177" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="11"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="622" length="13"/><text>CD4(+) T cell</text></annotation><annotation id="12"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="434" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="13"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="506" length="7"/><text>T cells</text></annotation><annotation id="14"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="1110" length="16"/><text>CD4(+) Th1 cells</text></annotation><annotation id="15"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="1250" length="9"/><text>Th1 cells</text></annotation><annotation id="16"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="1556" length="9"/><text>Th1 cells</text></annotation><annotation id="17"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1616" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1498" length="27"/><text>intragenic minimal promoter</text></annotation><annotation id="19"><infon key="identifier">0001045</infon><infon key="type">TISSUE</infon><location offset="1052" length="11"/><text>T cell line</text></annotation><annotation id="20"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="54" length="20"/><text>Fucosyltransferase 7</text></annotation><annotation id="21"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="92" length="6"/><text>murine</text></annotation><annotation id="22"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="113" length="22"/><text>Fucosyltransferase VII</text></annotation><annotation id="23"><infon key="identifier">14347</infon><infon key="type">GENE</infon><location offset="156" length="4"/><text>Fut7</text></annotation></passage></document>
<document><id>24916375</id><passage><offset>0</offset><text>Human skin color is influenced by an intergenic DNA polymorphism regulating transcription of the nearby BNC2 pigmentation gene. Single nucleotide polymorphisms (SNPs) found to be statistically significant when associated with human diseases, and other phenotypes are most often located in non-coding regions of the genome. One example is rs10765819 located in the first intron of the BNC2 gene previously associated with (saturation of) human skin color. Here, we demonstrate that a nearby intergenic SNP (rs12350739) in high linkage disequilibrium with rs10756819 is likely the causal DNA variant for the observed BNC2 skin color association. The highly conserved region surrounding rs12350739 functions as an enhancer element regulating BNC2 transcription in human melanocytes, while the activity of this enhancer element depends on the allelic status of rs12350739. When the rs12350739-AA allele is present, the chromatin at the region surrounding rs12350739 is inaccessible and the enhancer element is only slightly active, resulting in low expression of BNC2, corresponding with light skin pigmentation. When the rs12350739-GG allele is present however, the chromatin at the region surrounding rs12350739 is more accessible and the enhancer is active, resulting in a higher expression of BNC2, corresponding with dark skin pigmentation. Overall, we demonstrate the identification of the functional DNA variant that explains the BNC2 skin color association signal, providing another important step towards further understanding human pigmentation genetics beyond statistical association. We thus deliver a clear example of how an intergenic non-coding DNA variant modulates the regulatory potential of the enhancer element it is located within, which in turn results in allele-dependent differential gene expression affecting variation in common human traits.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="0" length="5"/><text>Human</text></annotation><annotation id="2"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="104" length="4"/><text>BNC2</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="761" length="5"/><text>human</text></annotation><annotation id="4"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="857" length="10"/><text>rs12350739</text></annotation><annotation id="5"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="878" length="10"/><text>rs12350739</text></annotation><annotation id="6"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="951" length="10"/><text>rs12350739</text></annotation><annotation id="7"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="1059" length="4"/><text>BNC2</text></annotation><annotation id="8"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="1118" length="10"/><text>rs12350739</text></annotation><annotation id="9"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="1199" length="10"/><text>rs12350739</text></annotation><annotation id="10"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="1293" length="4"/><text>BNC2</text></annotation><annotation id="11"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="1433" length="4"/><text>BNC2</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1532" length="5"/><text>human</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="226" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1850" length="5"/><text>human</text></annotation><annotation id="15"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="506" length="10"/><text>rs12350739</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="986" length="16"/><text>enhancer element</text></annotation><annotation id="17"><infon key="identifier">0000847</infon><infon key="type">TISSUE</infon><location offset="767" length="11"/><text>melanocytes</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="807" length="16"/><text>enhancer element</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="711" length="16"/><text>enhancer element</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1237" length="8"/><text>enhancer</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1710" length="16"/><text>enhancer element</text></annotation><annotation id="22"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="6" length="4"/><text>skin</text></annotation><annotation id="23"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="443" length="4"/><text>skin</text></annotation><annotation id="24"><infon key="comment">hg38:11,88998060,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs10765819</infon><location offset="338" length="10"/><text>rs10765819</text></annotation><annotation id="25"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="1438" length="4"/><text>skin</text></annotation><annotation id="26"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="620" length="4"/><text>skin</text></annotation><annotation id="27"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="1090" length="4"/><text>skin</text></annotation><annotation id="28"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="1323" length="4"/><text>skin</text></annotation><annotation id="29"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="384" length="4"/><text>BNC2</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="437" length="5"/><text>human</text></annotation><annotation id="31"><infon key="attribute">TYPO</infon><infon key="comment">hg38:11,88998060,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs10756819</infon><location offset="554" length="10"/><text>rs10756819</text></annotation><annotation id="32"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="615" length="4"/><text>BNC2</text></annotation><annotation id="33"><infon key="comment">hg38:9,16885019,G,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs12350739</infon><location offset="684" length="10"/><text>rs12350739</text></annotation><annotation id="34"><infon key="identifier">54796</infon><infon key="type">GENE</infon><location offset="739" length="4"/><text>BNC2</text></annotation></passage></document>
<document><id>24997565</id><passage><offset>0</offset><text>Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility. A characteristic feature of asthma is the aberrant accumulation, differentiation or function of memory CD4(+) T cells that produce type 2 cytokines (TH2 cells). By mapping genome-wide histone modification profiles for subsets of T cells isolated from peripheral blood of healthy and asthmatic individuals, we identified enhancers with known and potential roles in the normal differentiation of human TH1 cells and TH2 cells. We discovered disease-specific enhancers in T cells that differ between healthy and asthmatic individuals. Enhancers that gained the histone H3 Lys4 dimethyl (H3K4me2) mark during TH2 cell development showed the highest enrichment for asthma-associated single nucleotide polymorphisms (SNPs), which supported a pathogenic role for TH2 cells in asthma. In silico analysis of cell-specific enhancers revealed transcription factors, microRNAs and genes potentially linked to human TH2 cell differentiation. Our results establish the feasibility and utility of enhancer profiling in well-defined populations of specialized cell types involved in disease pathogenesis.</text><annotation id="1"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="367" length="7"/><text>T cells</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="532" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="538" length="9"/><text>TH1 cells</text></annotation><annotation id="4"><infon key="identifier">0004979</infon><infon key="type">DISEASE</infon><location offset="798" length="6"/><text>asthma</text></annotation><annotation id="5"><infon key="identifier">0004979</infon><infon key="type">DISEASE</infon><location offset="907" length="6"/><text>asthma</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1035" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="607" length="7"/><text>T cells</text></annotation><annotation id="8"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="79" length="15"/><text>TH2 memory cell</text></annotation><annotation id="9"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="234" length="51"/><text>memory CD4(+) T cells that produce type 2 cytokines</text></annotation><annotation id="10"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="287" length="9"/><text>TH2 cells</text></annotation><annotation id="11"><infon key="identifier">0000553</infon><infon key="type">TISSUE</infon><location offset="389" length="16"/><text>peripheral blood</text></annotation><annotation id="12"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="552" length="9"/><text>TH2 cells</text></annotation><annotation id="13"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="894" length="9"/><text>TH2 cells</text></annotation><annotation id="14"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="743" length="8"/><text>TH2 cell</text></annotation><annotation id="15"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="1041" length="8"/><text>TH2 cell</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="31" length="5"/><text>human</text></annotation><annotation id="17"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="37" length="7"/><text>T cells</text></annotation><annotation id="18"><infon key="identifier">0004979</infon><infon key="type">DISEASE</infon><location offset="115" length="6"/><text>asthma</text></annotation><annotation id="19"><infon key="identifier">0004979</infon><infon key="type">DISEASE</infon><location offset="166" length="6"/><text>asthma</text></annotation></passage></document>
<document><id>25030696</id><passage><offset>0</offset><text>The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages. RXR signaling is predicted to have a major impact in macrophages, but neither the biological consequence nor the genomic basis of its ligand activation is known. Comprehensive genome-wide studies were carried out to map liganded RXR-mediated transcriptional changes, active binding sites, and cistromic interactions in the context of the macrophage genome architecture. The macrophage RXR cistrome has 5200 genomic binding sites, which are not impacted by ligand. Active enhancers are characterized by PU.1 binding, an increase of enhancer RNA, and P300 recruitment. Using these features, 387 liganded RXR-bound enhancers were linked to 226 genes, which predominantly reside in CTCF/cohesin-limited functional domains. These findings were molecularly validated using chromosome conformation capture (3C) and 3C combined with sequencing (3C-seq), and we show that selected long-range enhancers communicate with promoters via stable or RXR-induced loops and that some of the enhancers interact with each other, forming an interchromosomal network. A set of angiogenic genes, including Vegfa, has liganded RXR-controlled enhancers and provides the macrophage with a novel inducible program.</text><annotation id="1"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="600" length="4"/><text>PU.1</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1071" length="9"/><text>enhancers</text></annotation><annotation id="3"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="647" length="4"/><text>P300</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1192" length="33"/><text>liganded RXR-controlled enhancers</text></annotation><annotation id="5"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="776" length="4"/><text>CTCF</text></annotation><annotation id="6"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="1181" length="5"/><text>Vegfa</text></annotation><annotation id="7"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="472" length="10"/><text>macrophage</text></annotation><annotation id="8"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1243" length="10"/><text>macrophage</text></annotation><annotation id="9"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="151" length="11"/><text>macrophages</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="483" length="43"/><text>RXR cistrome has 5200 genomic binding sites</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="687" length="32"/><text>387 liganded RXR-bound enhancers</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="970" length="20"/><text>long-range enhancers</text></annotation><annotation id="13"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="85" length="11"/><text>macrophages</text></annotation><annotation id="14"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="436" length="10"/><text>macrophage</text></annotation></passage></document>
<document><id>25153150</id><passage><offset>0</offset><text>Identification and characterization of germ cell genes expressed in the F9 testicular teratoma stem cell line. The F9 cell line, which was derived from a mouse testicular teratoma that originated from pluripotent germ cells, has been used as a model for differentiation. However, it is largely unknown whether F9 cells possess the characteristics of male germ cells. In the present study, we investigated spermatogenic stage- and cell type-specific gene expression in F9 cells. Analysis of previous microarray data showed that a large number of stage-regulated germ cell genes are expressed in F9 cells. Specifically, genes that are prominently expressed in spermatogonia and have transcriptional regulatory functions appear to be enriched in F9 cells. Our in silico and in vitro analyses identified several germ cell-specific or -predominant genes that are expressed in F9 cells. Among them, strong promoter activities were observed in the regions upstream of the spermatogonial genes, Dmrt1 (doublesex and mab-3 related transcription factor 1), Stra8 (stimulated by retinoic acid gene 8) and Tex13 (testis expressed gene 13), in F9 cells. A detailed analysis of the Tex13 promoter allowed us to identify an enhancer and a region that is implicated in germ cell-specificity. We also found that Tex13 expression is regulated by DNA methylation. Finally, analysis of GFP (green fluorescent protein) TEX13 localization revealed that the protein distributes heterogeneously in the cytoplasm and nucleus, suggesting that TEX13 shuttles between these two compartments. Taken together, our results demonstrate that F9 cells express numerous spermatogonial genes and could be used for transcriptional studies focusing on such genes. As an example of this, we use F9 cells to provide comprehensive expressional information about Tex13, and report that this gene appears to encode a germ cell-specific protein that functions in the nucleus during early spermatogenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1168" length="14"/><text>Tex13 promoter</text></annotation><annotation id="2"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1094" length="5"/><text>Tex13</text></annotation><annotation id="3"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1101" length="24"/><text>testis expressed gene 13</text></annotation><annotation id="4"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1168" length="5"/><text>Tex13</text></annotation><annotation id="5"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1295" length="5"/><text>Tex13</text></annotation><annotation id="6"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1398" length="5"/><text>TEX13</text></annotation><annotation id="7"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1517" length="5"/><text>TEX13</text></annotation><annotation id="8"><infon key="identifier">83555</infon><infon key="type">GENE</infon><location offset="1821" length="5"/><text>Tex13</text></annotation><annotation id="9"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="39" length="9"/><text>germ cell</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="72" length="37"/><text>F9 testicular teratoma stem cell line</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="213" length="10"/><text>germ cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1209" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="310" length="8"/><text>F9 cells</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="468" length="8"/><text>F9 cells</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="594" length="8"/><text>F9 cells</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="743" length="8"/><text>F9 cells</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="355" length="10"/><text>germ cells</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="871" length="8"/><text>F9 cells</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="1131" length="8"/><text>F9 cells</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="1609" length="8"/><text>F9 cells</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="1756" length="8"/><text>F9 cells</text></annotation><annotation id="22"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="561" length="9"/><text>germ cell</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0000095</infon><infon key="type">TISSUE</infon><location offset="115" length="12"/><text>F9 cell line</text></annotation><annotation id="24"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="808" length="9"/><text>germ cell</text></annotation><annotation id="25"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="1253" length="9"/><text>germ cell</text></annotation><annotation id="26"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="1874" length="9"/><text>germ cell</text></annotation><annotation id="27"><infon key="identifier">0000958</infon><infon key="type">TISSUE</infon><location offset="658" length="13"/><text>spermatogonia</text></annotation><annotation id="28"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="154" length="5"/><text>mouse</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0018193</infon><infon key="type">DISEASE</infon><location offset="160" length="19"/><text>testicular teratoma</text></annotation><annotation id="30"><infon key="identifier">50796</infon><infon key="type">GENE</infon><location offset="987" length="5"/><text>Dmrt1</text></annotation><annotation id="31"><infon key="identifier">50796</infon><infon key="type">GENE</infon><location offset="994" length="50"/><text>doublesex and mab-3 related transcription factor 1</text></annotation><annotation id="32"><infon key="identifier">20899</infon><infon key="type">GENE</infon><location offset="1047" length="5"/><text>Stra8</text></annotation><annotation id="33"><infon key="identifier">20899</infon><infon key="type">GENE</infon><location offset="1054" length="34"/><text>stimulated by retinoic acid gene 8</text></annotation></passage></document>
<document><id>25185713</id><passage><offset>0</offset><text>The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. Runx transcription factors contribute to hematopoiesis and are frequently implicated in hematologic malignancies. All three Runx isoforms are expressed at the earliest stages of hematopoiesis; however, their function in hematopoietic stem cells (HSCs) is not fully elucidated. Here, we show that Runx factors are essential in HSCs by driving the expression of the hematopoietic transcription factor PU.1. Mechanistically, by using a knockin mouse model in which all three Runx binding sites in the -14kb enhancer of PU.1 are disrupted, we observed failure to form chromosomal interactions between the PU.1 enhancer and its proximal promoter. Consequently, decreased PU.1 levels resulted in diminished long-term HSC function through HSC exhaustion, which could be rescued by reintroducing a PU.1 transgene. Similarly, in a mouse model of AML/ETO9a leukemia, disrupting the Runx binding sites resulted in decreased PU.1 levels. Leukemia onset was delayed, and limiting dilution transplantation experiments demonstrated functional loss of leukemia-initiating cells. This is surprising, because low PU.1 levels have been considered a hallmark of AML/ETO leukemia, as indicated in mouse models and as shown here in samples from leukemic patients. Our data demonstrate that Runx-dependent PU.1 chromatin interaction and transcription of PU.1 are essential for both normal and leukemia stem cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="572" length="22"/><text>-14kb enhancer of PU.1</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="675" length="13"/><text>PU.1 enhancer</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="911" length="18"/><text>AML/ETO9a leukemia</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1000" length="8"/><text>Leukemia</text></annotation><annotation id="5"><infon key="identifier">0004178</infon><infon key="type">TISSUE</infon><location offset="1110" length="25"/><text>leukemia-initiating cells</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="1216" length="16"/><text>AML/ETO leukemia</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0004178</infon><infon key="type">TISSUE</infon><location offset="1444" length="19"/><text>leukemia stem cells</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1250" length="5"/><text>mouse</text></annotation><annotation id="9"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="590" length="4"/><text>PU.1</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="946" length="18"/><text>Runx binding sites</text></annotation><annotation id="11"><infon key="identifier">0004178</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="43" length="29"/><text>AML/ETO9a leukemic stem cells</text></annotation><annotation id="12"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="320" length="4"/><text>HSCs</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="697" length="17"/><text>proximal promoter</text></annotation><annotation id="14"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="400" length="4"/><text>HSCs</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="540" length="24"/><text>three Runx binding sites</text></annotation><annotation id="16"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="987" length="4"/><text>PU.1</text></annotation><annotation id="17"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="1169" length="4"/><text>PU.1</text></annotation><annotation id="18"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="1357" length="4"/><text>PU.1</text></annotation><annotation id="19"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="9" length="4"/><text>PU.1</text></annotation><annotation id="20"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="740" length="4"/><text>PU.1</text></annotation><annotation id="21"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="864" length="4"/><text>PU.1</text></annotation><annotation id="22"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="1405" length="4"/><text>PU.1</text></annotation><annotation id="23"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="675" length="4"/><text>PU.1</text></annotation><annotation id="24"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="785" length="3"/><text>HSC</text></annotation><annotation id="25"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="806" length="3"/><text>HSC</text></annotation><annotation id="26"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="294" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="27"><infon key="identifier">0002334</infon><infon key="type">DISEASE</infon><location offset="162" length="24"/><text>hematologic malignancies</text></annotation><annotation id="28"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="473" length="4"/><text>PU.1</text></annotation><annotation id="29"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="515" length="5"/><text>mouse</text></annotation><annotation id="30"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="896" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>25194570</id><passage><offset>0</offset><text>A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Efforts to identify and annotate cancer driver genetic lesions have been focused primarily on the analysis of protein-coding genes; however, most genetic abnormalities found in human cancer are located in intergenic regions. Here we identify a new long range-acting MYC enhancer controlled by NOTCH1 that is targeted by recurrent chromosomal duplications in human T cell acute lymphoblastic leukemia (T-ALL). This highly conserved regulatory element, hereby named N-Me for NOTCH MYC enhancer, is located within a broad super-enhancer region +1.47 Mb from the MYC transcription initiating site, interacts with the MYC proximal promoter and induces orientation-independent MYC expression in reporter assays. Moreover, analysis of N-Me knockout mice demonstrates a selective and essential role of this regulatory element during thymocyte development and in NOTCH1-induced T-ALL. Together these results identify N-Me as a long-range oncogenic enhancer implicated directly in the pathogenesis of human leukemia and highlight the importance of the NOTCH1-MYC regulatory axis in T cell transformation and as a therapeutic target in T-ALL.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="26"/><text>NOTCH1-driven MYC enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="373" length="12"/><text>MYC enhancer</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="508" length="5"/><text>T-ALL</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="835" length="4"/><text>N-Me</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="284" length="5"/><text>human</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="290" length="6"/><text>cancer</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1015" length="4"/><text>N-Me</text></annotation><annotation id="8"><infon key="identifier">4851</infon><infon key="type">GENE</infon><location offset="400" length="6"/><text>NOTCH1</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="465" length="5"/><text>human</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="471" length="35"/><text>T cell acute lymphoblastic leukemia</text></annotation><annotation id="11"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="932" length="9"/><text>thymocyte</text></annotation><annotation id="12"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1179" length="6"/><text>T cell</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="580" length="18"/><text>NOTCH MYC enhancer</text></annotation><annotation id="14"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="373" length="3"/><text>MYC</text></annotation><annotation id="15"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="586" length="3"/><text>MYC</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="778" length="3"/><text>MYC</text></annotation><annotation id="17"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="849" length="4"/><text>mice</text></annotation><annotation id="18"><infon key="identifier">18128</infon><infon key="type">GENE</infon><location offset="961" length="6"/><text>NOTCH1</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="976" length="5"/><text>T-ALL</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1098" length="5"/><text>human</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1104" length="8"/><text>leukemia</text></annotation><annotation id="22"><infon key="identifier">4851</infon><infon key="type">GENE</infon><location offset="1149" length="6"/><text>NOTCH1</text></annotation><annotation id="23"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1156" length="3"/><text>MYC</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="626" length="73"/><text>super-enhancer region +1.47 Mb from the MYC transcription initiating site</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1232" length="5"/><text>T-ALL</text></annotation><annotation id="26"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="666" length="3"/><text>MYC</text></annotation><annotation id="27"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="38" length="6"/><text>T cell</text></annotation><annotation id="28"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="720" length="3"/><text>MYC</text></annotation><annotation id="29"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="16" length="3"/><text>MYC</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="720" length="21"/><text>MYC proximal promoter</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1025" length="29"/><text>long-range oncogenic enhancer</text></annotation><annotation id="32"><infon key="identifier">4851</infon><infon key="type">GENE</infon><location offset="2" length="6"/><text>NOTCH1</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="571" length="4"/><text>N-Me</text></annotation><annotation id="34"><infon key="identifier">0004967</infon><infon key="type">DISEASE</infon><location offset="77" length="28"/><text>acute lymphoblastic leukemia</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="140" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>25209250</id><passage><offset>0</offset><text>A regulatory network controls nephrocan expression and midgut patterning. Although many regulatory networks involved in defining definitive endoderm have been identified, the mechanisms through which these networks interact to pattern the endoderm are less well understood. To explore the mechanisms involved in midgut patterning, we dissected the transcriptional regulatory elements of nephrocan (Nepn), the earliest known midgut specific gene in mice. We observed that Nepn expression is dramatically reduced in Sox17(-/-) and Raldh2(-/-) embryos compared with wild-type embryos. We further show that Nepn is directly regulated by Sox17 and the retinoic acid (RA) receptor via two enhancer elements located upstream of the gene. Moreover, Nepn expression is modulated by Activin signaling, with high levels inhibiting and low levels enhancing RA-dependent expression. In Foxh1(-/-) embryos in which Nodal signaling is reduced, the Nepn expression domain is expanded into the anterior gut region, confirming that Nodal signaling can modulate its expression in vivo. Together, Sox17 is required for Nepn expression in the definitive endoderm, while RA signaling restricts expression to the midgut region. A balance of Nodal/Activin signaling regulates the anterior boundary of the midgut expression domain.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="679" length="50"/><text>two enhancer elements located upstream of the gene</text></annotation><annotation id="2"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="30" length="9"/><text>nephrocan</text></annotation><annotation id="3"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="741" length="4"/><text>Nepn</text></annotation><annotation id="4"><infon key="identifier">14106</infon><infon key="type">GENE</infon><location offset="873" length="5"/><text>Foxh1</text></annotation><annotation id="5"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="933" length="4"/><text>Nepn</text></annotation><annotation id="6"><infon key="identifier">20671</infon><infon key="type">GENE</infon><location offset="1077" length="5"/><text>Sox17</text></annotation><annotation id="7"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="1099" length="4"/><text>Nepn</text></annotation><annotation id="8"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="140" length="8"/><text>endoderm</text></annotation><annotation id="9"><infon key="identifier">4838</infon><infon key="type">GENE</infon><location offset="1218" length="5"/><text>Nodal</text></annotation><annotation id="10"><infon key="identifier">4838</infon><infon key="type">GENE</infon><location offset="901" length="5"/><text>Nodal</text></annotation><annotation id="11"><infon key="identifier">4838</infon><infon key="type">GENE</infon><location offset="1014" length="5"/><text>Nodal</text></annotation><annotation id="12"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="1133" length="8"/><text>endoderm</text></annotation><annotation id="13"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="387" length="9"/><text>nephrocan</text></annotation><annotation id="14"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="239" length="8"/><text>endoderm</text></annotation><annotation id="15"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="541" length="7"/><text>embryos</text></annotation><annotation id="16"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="573" length="7"/><text>embryos</text></annotation><annotation id="17"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="884" length="7"/><text>embryos</text></annotation><annotation id="18"><infon key="identifier">0000545</infon><infon key="type">TISSUE</infon><location offset="986" length="3"/><text>gut</text></annotation><annotation id="19"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="398" length="4"/><text>Nepn</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="448" length="4"/><text>mice</text></annotation><annotation id="21"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="471" length="4"/><text>Nepn</text></annotation><annotation id="22"><infon key="identifier">20671</infon><infon key="type">GENE</infon><location offset="514" length="5"/><text>Sox17</text></annotation><annotation id="23"><infon key="identifier">19378</infon><infon key="type">GENE</infon><location offset="529" length="6"/><text>Raldh2</text></annotation><annotation id="24"><infon key="identifier">66650</infon><infon key="type">GENE</infon><location offset="603" length="4"/><text>Nepn</text></annotation><annotation id="25"><infon key="identifier">20671</infon><infon key="type">GENE</infon><location offset="633" length="5"/><text>Sox17</text></annotation></passage></document>
<document><id>25214635</id><passage><offset>0</offset><text>Intersection of population variation and autoimmunity genetics in human T cell activation. T lymphocyte activation by antigen conditions adaptive immune responses and immunopathologies, but we know little about its variation in humans and its genetic or environmental roots. We analyzed gene expression in CD4(+) T cells during unbiased activation or in T helper 17 (T(H)17) conditions from 348 healthy participants representing European, Asian, and African ancestries. We observed interindividual variability, most marked for cytokine transcripts, with clear biases on the basis of ancestry, and following patterns more complex than simple T(H)1/2/17 partitions. We identified 39 genetic loci specifically associated in cis with activated gene expression. We further fine-mapped and validated a single-base variant that modulates YY1 binding and the activity of an enhancer element controlling the autoimmune-associated IL2RA gene, affecting its activity in activated but not regulatory T cells. Thus, interindividual variability affects the fundamental immunologic process of T helper activation, with important connections to autoimmune disease.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="866" length="16"/><text>enhancer element</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="66" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="988" length="7"/><text>T cells</text></annotation><annotation id="4"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1078" length="8"/><text>T helper</text></annotation><annotation id="5"><infon key="identifier">0005655</infon><infon key="type">TISSUE</infon><location offset="354" length="11"/><text>T helper 17</text></annotation><annotation id="6"><infon key="identifier">0005655</infon><infon key="type">TISSUE</infon><location offset="366" length="8"/><text>(T(H)17)</text></annotation><annotation id="7"><infon key="identifier">0001679</infon><infon key="type">TISSUE</infon><location offset="647" length="1"/><text>2</text></annotation><annotation id="8"><infon key="identifier">0005655</infon><infon key="type">TISSUE</infon><location offset="649" length="2"/><text>17</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="228" length="6"/><text>humans</text></annotation><annotation id="10"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="641" length="5"/><text>T(H)1</text></annotation><annotation id="11"><infon key="identifier">7528</infon><infon key="type">GENE</infon><location offset="831" length="3"/><text>YY1</text></annotation><annotation id="12"><infon key="identifier">3559</infon><infon key="type">GENE</infon><location offset="921" length="5"/><text>IL2RA</text></annotation><annotation id="13"><infon key="identifier">0007179</infon><infon key="type">DISEASE</infon><location offset="1129" length="18"/><text>autoimmune disease</text></annotation><annotation id="14"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="72" length="6"/><text>T cell</text></annotation><annotation id="15"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="91" length="12"/><text>T lymphocyte</text></annotation><annotation id="16"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="306" length="14"/><text>CD4(+) T cells</text></annotation></passage></document>
<document><id>25223790</id><passage><offset>0</offset><text>Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. The transcription activator-like effectors (TALEs) and the RNA-guided clustered regularly interspaced short palindromic repeat (CRISPR) associated protein (Cas9) utlilize distinct molecular mechanisms in targeting site recognition. The two proteins can be modified to carry additional functional domains to regulate expression of genomic loci in mammalian cells. In this study, we have compared the two systems in activation and suppression of the Oct4 and Nanog loci by targeting their enhancers. Although both are able to efficiently activate the luciferase reporters, the CRISPR/dCas9 system is much less potent in activating the endogenous loci and in the application of reprogramming somatic cells to iPS cells. Nevertheless, repression by CRISPR/dCas9 is comparable to or even better than TALE repressors. We demonstrated that dCas9 protein binding results in significant physical interference to binding of native transcription factors at enhancer, less efficient active histone markers induction or recruitment of activating complexes in gene activation. This study thus highlighted the merits and drawbacks of transcription regulation by each system. A combined approach of TALEs and CRISPR/dCas9 should provide an optimized solution to regulate genomic loci and to study genetic elements such as enhancers in biological processes including somatic cell reprogramming and guided differentiation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="615" length="9"/><text>enhancers</text></annotation><annotation id="2"><infon key="identifier">0001268</infon><infon key="type">TISSUE</infon><location offset="817" length="13"/><text>somatic cells</text></annotation><annotation id="3"><infon key="identifier">0006081</infon><infon key="type">TISSUE</infon><location offset="834" length="9"/><text>iPS cells</text></annotation><annotation id="4"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="474" length="9"/><text>mammalian</text></annotation><annotation id="5"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="576" length="4"/><text>Oct4</text></annotation><annotation id="6"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="585" length="5"/><text>Nanog</text></annotation></passage></document>
<document><id>25248036</id><passage><offset>0</offset><text>Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. GWAS have identified a breast cancer susceptibility locus on 2q35. Here we report the fine mapping of this locus using data from 101,943 subjects from 50 case-control studies. We genotype 276 SNPs using the 'iCOGS' genotyping array and impute genotypes for a further 1,284 using 1000 Genomes Project data. All but two, strongly correlated SNPs (rs4442975 G/T and rs6721996 G/A) are excluded as candidate causal variants at odds against &gt;100:1. The best functional candidate, rs4442975, is associated with oestrogen receptor positive (ER+) disease with an odds ratio (OR) in Europeans of 0.85 (95% confidence interval=0.84-0.87; P=1.7 x 10(-43)) per t-allele. This SNP flanks a transcriptional enhancer that physically interacts with the promoter of IGFBP5 (encoding insulin-like growth factor-binding protein 5) and displays allele-specific gene expression, FOXA1 binding and chromatin looping. Evidence suggests that the g-allele confers increased breast cancer susceptibility through relative downregulation of IGFBP5, a gene with known roles in breast cell biology.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="767" length="24"/><text>transcriptional enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="827" length="18"/><text>promoter of IGFBP5</text></annotation><annotation id="3"><infon key="identifier">3488</infon><infon key="type">GENE</infon><location offset="856" length="44"/><text>insulin-like growth factor-binding protein 5</text></annotation><annotation id="4"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="948" length="5"/><text>FOXA1</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="1039" length="13"/><text>breast cancer</text></annotation><annotation id="6"><infon key="identifier">3488</infon><infon key="type">GENE</infon><location offset="1103" length="6"/><text>IGFBP5</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="664" length="9"/><text>Europeans</text></annotation><annotation id="8"><infon key="identifier">0000816</infon><infon key="type">TISSUE</infon><location offset="1138" length="11"/><text>breast cell</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="14" length="13"/><text>breast cancer</text></annotation><annotation id="10"><infon key="identifier">3488</infon><infon key="type">GENE</infon><location offset="71" length="6"/><text>IGFBP5</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="113" length="13"/><text>breast cancer</text></annotation><annotation id="12"><infon key="comment">chr2:217056046,G,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4442975</infon><location offset="435" length="9"/><text>rs4442975</text></annotation><annotation id="13"><infon key="comment">chr2:217044740,G,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs6721996</infon><location offset="453" length="9"/><text>rs6721996</text></annotation><annotation id="14"><infon key="comment">chr2:217056046,G,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4442975</infon><location offset="565" length="9"/><text>rs4442975</text></annotation><annotation id="15"><infon key="identifier">0006512</infon><infon key="type">DISEASE</infon><location offset="595" length="41"/><text>oestrogen receptor positive (ER+) disease</text></annotation><annotation id="16"><infon key="identifier">3488</infon><infon key="type">GENE</infon><location offset="839" length="6"/><text>IGFBP5</text></annotation></passage></document>
<document><id>25249570</id><passage><offset>0</offset><text>Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. RATIONALE: Yes-associated protein (YAP), the nuclear effector of Hippo signaling, regulates cellular growth and survival in multiple organs, including the heart, by interacting with TEA (transcriptional enhancer activator)-domain sequence-specific DNA-binding proteins. Recent studies showed that YAP stimulates cardiomyocyte proliferation and survival. However, the direct transcriptional targets through which YAP exerts its effects are poorly defined. OBJECTIVE: To identify direct YAP targets that mediate its mitogenic and antiapoptotic effects in the heart. METHODS AND RESULTS: We identified direct YAP targets by combining differential gene expression analysis in YAP gain- and loss-of-function with genome-wide identification of YAP-bound loci using chromatin immunoprecipitation and high throughput sequencing. This screen identified Pik3cb, encoding p110beta, a catalytic subunit of phosphoinositol-3-kinase, as a candidate YAP effector that promotes cardiomyocyte proliferation and survival. YAP and TEA-domain occupied a conserved enhancer within the first intron of Pik3cb, and this enhancer drove YAP-dependent reporter gene expression. Yap gain- and loss-of-function studies indicated that YAP is necessary and sufficient to activate the phosphoinositol-3-kinase-Akt pathway. Like Yap, Pik3cb gain-of-function stimulated cardiomyocyte proliferation, and Pik3cb knockdown dampened YAP mitogenic activity. Reciprocally, impaired heart function in Yap loss-of-function was significantly rescued by adeno-associated virus-mediated Pik3cb expression. CONCLUSIONS: Pik3cb is a crucial direct target of YAP, through which the YAP activates phosphoinositol-3-kinase-AKT pathway and regulates cardiomyocyte proliferation and survival.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1152" length="42"/><text>enhancer within the first intron of Pik3cb</text></annotation><annotation id="2"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="780" length="3"/><text>YAP</text></annotation><annotation id="3"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1043" length="3"/><text>YAP</text></annotation><annotation id="4"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1314" length="3"/><text>YAP</text></annotation><annotation id="5"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1405" length="3"/><text>Yap</text></annotation><annotation id="6"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1504" length="3"/><text>YAP</text></annotation><annotation id="7"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1569" length="3"/><text>Yap</text></annotation><annotation id="8"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1720" length="3"/><text>YAP</text></annotation><annotation id="9"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1743" length="3"/><text>YAP</text></annotation><annotation id="10"><infon key="identifier">74769</infon><infon key="type">GENE</infon><location offset="952" length="6"/><text>Pik3cb</text></annotation><annotation id="11"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="593" length="3"/><text>YAP</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1205" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="714" length="3"/><text>YAP</text></annotation><annotation id="14"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="846" length="3"/><text>YAP</text></annotation><annotation id="15"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1112" length="3"/><text>YAP</text></annotation><annotation id="16"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1260" length="3"/><text>Yap</text></annotation><annotation id="17"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1220" length="3"/><text>YAP</text></annotation><annotation id="18"><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="1410" length="6"/><text>Pik3cb</text></annotation><annotation id="19"><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="1651" length="6"/><text>Pik3cb</text></annotation><annotation id="20"><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="1478" length="6"/><text>Pik3cb</text></annotation><annotation id="21"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1070" length="13"/><text>cardiomyocyte</text></annotation><annotation id="22"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1445" length="13"/><text>cardiomyocyte</text></annotation><annotation id="23"><infon key="identifier">272636</infon><infon key="type">SPECIES</infon><location offset="1619" length="22"/><text>adeno-associated virus</text></annotation><annotation id="24"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1551" length="5"/><text>heart</text></annotation><annotation id="25"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="263" length="5"/><text>heart</text></annotation><annotation id="26"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="665" length="5"/><text>heart</text></annotation><annotation id="27"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="19" length="3"/><text>YAP</text></annotation><annotation id="28"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1808" length="13"/><text>cardiomyocyte</text></annotation><annotation id="29"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="66" length="13"/><text>cardiomyocyte</text></annotation><annotation id="30"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="420" length="13"/><text>cardiomyocyte</text></annotation><annotation id="31"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="32" length="3"/><text>AKT</text></annotation><annotation id="32"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1782" length="3"/><text>AKT</text></annotation><annotation id="33"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1387" length="3"/><text>Akt</text></annotation><annotation id="34"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="119" length="22"/><text>Yes-associated protein</text></annotation><annotation id="35"><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="1188" length="6"/><text>Pik3cb</text></annotation><annotation id="36"><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="1683" length="6"/><text>Pik3cb</text></annotation><annotation id="37"><infon key="attribute">TYPO</infon><infon key="identifier">5291</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>Pi3kcb</text></annotation><annotation id="38"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="143" length="3"/><text>YAP</text></annotation><annotation id="39"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="405" length="3"/><text>YAP</text></annotation><annotation id="40"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="520" length="3"/><text>YAP</text></annotation></passage></document>
<document><id>25263592</id><passage><offset>0</offset><text>Enhancer RNA facilitates NELF release from immediate early genes. Enhancer RNAs (eRNAs) are a class of long noncoding RNAs (lncRNA) expressed from active enhancers, whose function and action mechanism are yet to be firmly established. Here we show that eRNAs facilitate the transition of paused RNA polymerase II (RNAPII) into productive elongation by acting as a decoy for the negative elongation factor (NELF) complex upon induction of immediate early genes (IEGs) in neurons. eRNAs are synthesized prior to the culmination of target gene transcription and interact with the NELF complex. Knockdown of eRNAs expressed at neuronal enhancers impairs transient release of NELF from the specific target promoters during transcriptional activation, coinciding with a decrease in target mRNA induction. The enhancer-promoter interaction was unaffected by eRNA knockdown. Instead, chromatin looping might enable eRNAs to act locally at a specific promoter. Our findings highlight the spatiotemporally regulated action mechanism of eRNAs during early transcriptional elongation.</text><annotation id="1"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="470" length="7"/><text>neurons</text></annotation></passage></document>
<document><id>25263596</id><passage><offset>0</offset><text>5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. In mammals, cytosine methylation (5mC) is widely distributed throughout the genome but is notably depleted from active promoters and enhancers. While the role of DNA methylation in promoter silencing has been well documented, the function of this epigenetic mark at enhancers remains unclear. Recent experiments have demonstrated that enhancers are enriched for 5-hydroxymethylcytosine (5hmC), an oxidization product of the Tet family of 5mC dioxygenases and an intermediate of DNA demethylation. These results support the involvement of Tet proteins in the regulation of dynamic DNA methylation at enhancers. By mapping DNA methylation and hydroxymethylation at base resolution, we find that deletion of Tet2 causes extensive loss of 5hmC at enhancers, accompanied by enhancer hypermethylation, reduction of enhancer activity, and delayed gene induction in the early steps of differentiation. Our results reveal that DNA demethylation modulates enhancer activity, and its disruption influences the timing of transcriptome reprogramming during cellular differentiation.</text><annotation id="1"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="17" length="4"/><text>Tet2</text></annotation><annotation id="2"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="821" length="4"/><text>Tet2</text></annotation><annotation id="3"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="119" length="7"/><text>mammals</text></annotation></passage></document>
<document><id>25267720</id><passage><offset>0</offset><text>SRY interference of normal regulation of the RET gene suggests a potential role of the Y-chromosome gene in sexual dimorphism in Hirschsprung disease. The Hirschsprung disease (HSCR) is a complex congenital disorder, arising from abnormalities in enteric nervous system (ENS) development. There is a gender disparity among the patients, with the male to female ratio as high as 5 : 1. Loss-of-function mutations of HSCR genes and haploinsufficiency of their gene products are the primary pathogenic mechanisms for disease development. Recent studies identified over half of the HSCR disease susceptibility genes as targets for the sex-determining factor SRY, suggesting that this Y-encoded transcription factor could be involved in sexual dimorphism in HSCR. Among the SRY targets, the tyrosine kinase receptor RET represents the most important disease gene, whose mutations account for half of the familial and up to one-third of the sporadic forms of HSCR. RET is regulated by a distal and a proximal enhancer at its promoter, in which PAX3 and NKX2-1 are the resident transcription factors respectively. We show that the SRY-box 10 (SOX10) co-activator interacts and forms transcriptional complexes with PAX3 and NKX2-1 in a sequence-independent manner and exacerbates their respective transactivation activities on the RET promoter. SRY competitively displaces SOX10 in such transcription complexes and represses their regulatory functions on RET. Hence SRY could be a Y-located negative modifier of RET expression; and if it is ectopically expressed during ENS development, such SRY repression could result in RET protein haploinsufficiency and promotion of HSCR development, thereby contributing to sexual dimorphism in HSCR.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="981" length="30"/><text>distal and a proximal enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1019" length="8"/><text>promoter</text></annotation><annotation id="3"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="578" length="4"/><text>HSCR</text></annotation><annotation id="4"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="654" length="3"/><text>SRY</text></annotation><annotation id="5"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="769" length="3"/><text>SRY</text></annotation><annotation id="6"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="811" length="3"/><text>RET</text></annotation><annotation id="7"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="959" length="3"/><text>RET</text></annotation><annotation id="8"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1038" length="4"/><text>PAX3</text></annotation><annotation id="9"><infon key="identifier">7080</infon><infon key="type">GENE</infon><location offset="1047" length="6"/><text>NKX2-1</text></annotation><annotation id="10"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="1124" length="10"/><text>SRY-box 10</text></annotation><annotation id="11"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="1136" length="5"/><text>SOX10</text></annotation><annotation id="12"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1207" length="4"/><text>PAX3</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1323" length="12"/><text>RET promoter</text></annotation><annotation id="14"><infon key="identifier">7080</infon><infon key="type">GENE</infon><location offset="1216" length="6"/><text>NKX2-1</text></annotation><annotation id="15"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="1615" length="3"/><text>RET</text></annotation><annotation id="16"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="1337" length="3"/><text>SRY</text></annotation><annotation id="17"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="1365" length="5"/><text>SOX10</text></annotation><annotation id="18"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="1447" length="3"/><text>RET</text></annotation><annotation id="19"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="1458" length="3"/><text>SRY</text></annotation><annotation id="20"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="1504" length="3"/><text>RET</text></annotation><annotation id="21"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="1584" length="3"/><text>SRY</text></annotation><annotation id="22"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>SRY</text></annotation><annotation id="23"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="415" length="4"/><text>HSCR</text></annotation><annotation id="24"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="753" length="4"/><text>HSCR</text></annotation><annotation id="25"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="953" length="4"/><text>HSCR</text></annotation><annotation id="26"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="1663" length="4"/><text>HSCR</text></annotation><annotation id="27"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="1726" length="4"/><text>HSCR</text></annotation><annotation id="28"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="45" length="3"/><text>RET</text></annotation><annotation id="29"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="129" length="20"/><text>Hirschsprung disease</text></annotation><annotation id="30"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="155" length="20"/><text>Hirschsprung disease</text></annotation><annotation id="31"><infon key="identifier">0018309</infon><infon key="type">DISEASE</infon><location offset="177" length="4"/><text>HSCR</text></annotation><annotation id="32"><infon key="identifier">0003847</infon><infon key="type">DISEASE</infon><location offset="196" length="19"/><text>congenital disorder</text></annotation><annotation id="33"><infon key="identifier">5979</infon><infon key="type">GENE</infon><location offset="1323" length="3"/><text>RET</text></annotation></passage></document>
<document><id>25303440</id><passage><offset>0</offset><text>Failed degradation of JunB contributes to overproduction of type I collagen and development of dermal fibrosis in patients with systemic sclerosis. OBJECTIVE: The excessive deposition of extracellular matrix, including type I collagen, is a key aspect in the pathogenesis of connective tissue diseases such as systemic sclerosis (SSc; scleroderma). To further our understanding of the mechanisms governing the dysregulation of type I collagen production in SSc, we investigated the role of the activator protein 1 (AP-1) family of transcription factors in regulating COL1A2 transcription. METHODS: The expression and nuclear localization of AP-1 family members (c-Jun, JunB, JunD, Fra-1, Fra-2, and c-Fos) were examined by immunohistochemistry and Western blotting in dermal biopsy specimens and explanted skin fibroblasts from patients with diffuse cutaneous SSc and healthy controls. Gene activation was determined by assessing the interaction of transcription factors with the COL1A2 enhancer using transient transfection of reporter gene constructs, electrophoretic mobility shift assays, chromatin immunoprecipitation analysis, and RNA interference involving knockdown of individual AP-1 family members. Inhibition of fibroblast mammalian target of rapamycin (mTOR), Akt, and glycogen synthase kinase 3beta (GSK-3beta) signaling pathways was achieved using small-molecule pharmacologic inhibitors. RESULTS: Binding of JunB to the COL1A2 enhancer was observed, with its coalescence directed by activation of gene transcription through the proximal promoter. Knockdown of JunB reduced enhancer activation and COL1A2 expression in response to transforming growth factor beta. In SSc dermal fibroblasts, increased mTOR/Akt signaling was associated with inactivation of GSK-3beta, leading to blockade of JunB degradation and, thus, constitutively high expression of JunB. CONCLUSION: In patients with SSc, the accumulation of JunB resulting from altered mTOR/Akt signaling and a failure of proteolytic degradation underpins the aberrant overexpression of type I collagen. These findings identify JunB as a potential target for antifibrotic therapy in SSc.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="980" length="15"/><text>COL1A2 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1435" length="15"/><text>COL1A2 enhancer</text></annotation><annotation id="3"><infon key="identifier">0019340</infon><infon key="type">DISEASE</infon><location offset="335" length="11"/><text>scleroderma</text></annotation><annotation id="4"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="457" length="3"/><text>SSc</text></annotation><annotation id="5"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="494" length="19"/><text>activator protein 1</text></annotation><annotation id="6"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="515" length="4"/><text>AP-1</text></annotation><annotation id="7"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="567" length="6"/><text>COL1A2</text></annotation><annotation id="8"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="641" length="4"/><text>AP-1</text></annotation><annotation id="9"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="662" length="5"/><text>c-Jun</text></annotation><annotation id="10"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="669" length="4"/><text>JunB</text></annotation><annotation id="11"><infon key="identifier">3727</infon><infon key="type">GENE</infon><location offset="675" length="4"/><text>JunD</text></annotation><annotation id="12"><infon key="identifier">8061</infon><infon key="type">GENE</infon><location offset="681" length="5"/><text>Fra-1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1543" length="17"/><text>proximal promoter</text></annotation><annotation id="14"><infon key="identifier">2355</infon><infon key="type">GENE</infon><location offset="688" length="5"/><text>Fra-2</text></annotation><annotation id="15"><infon key="identifier">2353</infon><infon key="type">GENE</infon><location offset="699" length="5"/><text>c-Fos</text></annotation><annotation id="16"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="850" length="13"/><text>cutaneous SSc</text></annotation><annotation id="17"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="1681" length="3"/><text>SSc</text></annotation><annotation id="18"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1188" length="4"/><text>AP-1</text></annotation><annotation id="19"><infon key="identifier">2475</infon><infon key="type">GENE</infon><location offset="1234" length="29"/><text>mammalian target of rapamycin</text></annotation><annotation id="20"><infon key="identifier">2475</infon><infon key="type">GENE</infon><location offset="1265" length="4"/><text>mTOR</text></annotation><annotation id="21"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1272" length="3"/><text>Akt</text></annotation><annotation id="22"><infon key="identifier">2932</infon><infon key="type">GENE</infon><location offset="1281" length="30"/><text>glycogen synthase kinase 3beta</text></annotation><annotation id="23"><infon key="identifier">2932</infon><infon key="type">GENE</infon><location offset="1313" length="9"/><text>GSK-3beta</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1588" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="1423" length="4"/><text>JunB</text></annotation><annotation id="26"><infon key="identifier">1277</infon><infon key="type">GENE</infon><location offset="219" length="15"/><text>type I collagen</text></annotation><annotation id="27"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="1575" length="4"/><text>JunB</text></annotation><annotation id="28"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="1612" length="6"/><text>COL1A2</text></annotation><annotation id="29"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1645" length="31"/><text>transforming growth factor beta</text></annotation><annotation id="30"><infon key="identifier">0004419</infon><infon key="type">TISSUE</infon><location offset="1685" length="18"/><text>dermal fibroblasts</text></annotation><annotation id="31"><infon key="identifier">2475</infon><infon key="type">GENE</infon><location offset="1715" length="4"/><text>mTOR</text></annotation><annotation id="32"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1720" length="3"/><text>Akt</text></annotation><annotation id="33"><infon key="identifier">2932</infon><infon key="type">GENE</infon><location offset="1770" length="9"/><text>GSK-3beta</text></annotation><annotation id="34"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="1804" length="4"/><text>JunB</text></annotation><annotation id="35"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="22" length="4"/><text>JunB</text></annotation><annotation id="36"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="1866" length="4"/><text>JunB</text></annotation><annotation id="37"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="1901" length="3"/><text>SSc</text></annotation><annotation id="38"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="1926" length="4"/><text>JunB</text></annotation><annotation id="39"><infon key="identifier">2475</infon><infon key="type">GENE</infon><location offset="1954" length="4"/><text>mTOR</text></annotation><annotation id="40"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1959" length="3"/><text>Akt</text></annotation><annotation id="41"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="2096" length="4"/><text>JunB</text></annotation><annotation id="42"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="2151" length="3"/><text>SSc</text></annotation><annotation id="43"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="1223" length="10"/><text>fibroblast</text></annotation><annotation id="44"><infon key="identifier">1277</infon><infon key="type">GENE</infon><location offset="427" length="15"/><text>type I collagen</text></annotation><annotation id="45"><infon key="identifier">0001255</infon><infon key="type">TISSUE</infon><location offset="806" length="16"/><text>skin fibroblasts</text></annotation><annotation id="46"><infon key="identifier">1277</infon><infon key="type">GENE</infon><location offset="60" length="15"/><text>type I collagen</text></annotation><annotation id="47"><infon key="identifier">1277</infon><infon key="type">GENE</infon><location offset="2055" length="15"/><text>type I collagen</text></annotation><annotation id="48"><infon key="type">DISEASE</infon><location offset="95" length="15"/><text>dermal fibrosis</text></annotation><annotation id="49"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="980" length="6"/><text>COL1A2</text></annotation><annotation id="50"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="1435" length="6"/><text>COL1A2</text></annotation><annotation id="51"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="128" length="18"/><text>systemic sclerosis</text></annotation><annotation id="52"><infon key="identifier">0003900</infon><infon key="type">DISEASE</infon><location offset="275" length="26"/><text>connective tissue diseases</text></annotation><annotation id="53"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="310" length="18"/><text>systemic sclerosis</text></annotation><annotation id="54"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="330" length="3"/><text>SSc</text></annotation></passage></document>
<document><id>25321476</id><passage><offset>0</offset><text>Identification and characterization of the novel Col10a1 regulatory mechanism during chondrocyte hypertrophic differentiation. The majority of human skeleton develops through the endochondral pathway, in which cartilage-forming chondrocytes proliferate and enlarge into hypertrophic chondrocytes that eventually undergo apoptosis and are replaced by bone. Although at a terminal differentiation stage, hypertrophic chondrocytes have been implicated as the principal engine of bone growth. Abnormal chondrocyte hypertrophy has been seen in many skeletal dysplasia and osteoarthritis. Meanwhile, as a specific marker of hypertrophic chondrocytes, the type X collagen gene (COL10A1) is also critical for endochondral bone formation, as mutation and altered COL10A1 expression are often accompanied by abnormal chondrocyte hypertrophy in many skeletal diseases. However, how the type X collagen gene is regulated during chondrocyte hypertrophy has not been fully elucidated. We have recently demonstrated that Runx2 interaction with a 150-bp mouse Col10a1 cis-enhancer is required but not sufficient for its hypertrophic chondrocyte-specific reporter expression in transgenic mice, suggesting requirement of additional Col10a1 regulators. In this study, we report in silico sequence analysis of this 150-bp enhancer and identification of its multiple binding factors, including AP1, MEF2, NFAT, Runx1 and TBX5. Using this enhancer as bait, we performed yeast one-hybrid assay and identified multiple candidate Col10a1-interacting genes, including cyclooxygenase 1 (Cox-1) and Cox-2. We have also performed mass spectrometry analysis and detected EF1-alpha, Fus, GdF7 and Runx3 as components of the specific complex formed by the cis-enhancer and nuclear extracts from hypertrophic MCT (mouse chondrocytes immortalized with large T antigen) cells that express Col10a1 abundantly. Notably, some of the candidate genes are differentially expressed in hypertrophic MCT cells and have been associated with chondrocyte hypertrophy and Runx2, an indispensible Col10a1 regulator. Intriguingly, we detected high-level Cox-2 expression in hypertrophic MCT cells. Electrophoretic mobility shift assay and chromatin immunoprecipitation assays confirmed the interaction between Cox-2 and Col10a1 cis-enhancer, supporting its role as a candidate Col10a1 regulator. Together, our data support a Cox-2-containing, Runx2-centered Col10a1 regulatory mechanism, during chondrocyte hypertrophic differentiation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1031" length="33"/><text>150-bp mouse Col10a1 cis-enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1296" length="15"/><text>150-bp enhancer</text></annotation><annotation id="3"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="671" length="7"/><text>COL10A1</text></annotation><annotation id="4"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="754" length="7"/><text>COL10A1</text></annotation><annotation id="5"><infon key="identifier">0005172</infon><infon key="type">DISEASE</infon><location offset="839" length="17"/><text>skeletal diseases</text></annotation><annotation id="6"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="1006" length="5"/><text>Runx2</text></annotation><annotation id="7"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="476" length="4"/><text>bone</text></annotation><annotation id="8"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="1117" length="11"/><text>chondrocyte</text></annotation><annotation id="9"><infon key="identifier">19224</infon><infon key="type">GENE</infon><location offset="1543" length="16"/><text>cyclooxygenase 1</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1172" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1418" length="8"/><text>enhancer</text></annotation><annotation id="12"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="1215" length="7"/><text>Col10a1</text></annotation><annotation id="13"><infon key="identifier">16476</infon><infon key="type">GENE</infon><location offset="1374" length="3"/><text>AP1</text></annotation><annotation id="14"><infon key="identifier">17260</infon><infon key="type">GENE</infon><location offset="1379" length="4"/><text>MEF2</text></annotation><annotation id="15"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1391" length="5"/><text>Runx1</text></annotation><annotation id="16"><infon key="identifier">21388</infon><infon key="type">GENE</infon><location offset="1401" length="4"/><text>TBX5</text></annotation><annotation id="17"><infon key="identifier">4932</infon><infon key="type">SPECIES</infon><location offset="1449" length="5"/><text>yeast</text></annotation><annotation id="18"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="1506" length="7"/><text>Col10a1</text></annotation><annotation id="19"><infon key="identifier">19225</infon><infon key="type">GENE</infon><location offset="1572" length="5"/><text>Cox-2</text></annotation><annotation id="20"><infon key="identifier">22608</infon><infon key="type">GENE</infon><location offset="1642" length="9"/><text>EF1-alpha</text></annotation><annotation id="21"><infon key="identifier">233908</infon><infon key="type">GENE</infon><location offset="1653" length="3"/><text>Fus</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1725" length="12"/><text>cis-enhancer</text></annotation><annotation id="23"><infon key="identifier">238057</infon><infon key="type">GENE</infon><location offset="1658" length="4"/><text>GdF7</text></annotation><annotation id="24"><infon key="identifier">12399</infon><infon key="type">GENE</infon><location offset="1667" length="5"/><text>Runx3</text></annotation><annotation id="25"><infon key="identifier">0006217</infon><infon key="type">TISSUE</infon><location offset="1777" length="3"/><text>MCT</text></annotation><annotation id="26"><infon key="identifier">0006217</infon><infon key="type">TISSUE</infon><location offset="1957" length="9"/><text>MCT cells</text></annotation><annotation id="27"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="1855" length="7"/><text>Col10a1</text></annotation><annotation id="28"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="2025" length="5"/><text>Runx2</text></annotation><annotation id="29"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="2049" length="7"/><text>Col10a1</text></annotation><annotation id="30"><infon key="identifier">19225</infon><infon key="type">GENE</infon><location offset="2105" length="5"/><text>Cox-2</text></annotation><annotation id="31"><infon key="identifier">0006217</infon><infon key="type">TISSUE</infon><location offset="2138" length="9"/><text>MCT cells</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2271" length="20"/><text>Col10a1 cis-enhancer</text></annotation><annotation id="33"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="2446" length="11"/><text>chondrocyte</text></annotation><annotation id="34"><infon key="identifier">19225</infon><infon key="type">GENE</infon><location offset="2261" length="5"/><text>Cox-2</text></annotation><annotation id="35"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="649" length="15"/><text>type X collagen</text></annotation><annotation id="36"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="2328" length="7"/><text>Col10a1</text></annotation><annotation id="37"><infon key="identifier">19225</infon><infon key="type">GENE</infon><location offset="2376" length="5"/><text>Cox-2</text></annotation><annotation id="38"><infon key="identifier">12393</infon><infon key="type">GENE</infon><location offset="2394" length="5"/><text>Runx2</text></annotation><annotation id="39"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="2409" length="7"/><text>Col10a1</text></annotation><annotation id="40"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="875" length="15"/><text>type X collagen</text></annotation><annotation id="41"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="85" length="11"/><text>chondrocyte</text></annotation><annotation id="42"><infon key="identifier">0001486</infon><infon key="type">TISSUE</infon><location offset="149" length="8"/><text>skeleton</text></annotation><annotation id="43"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="49" length="7"/><text>Col10a1</text></annotation><annotation id="44"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="210" length="30"/><text>cartilage-forming chondrocytes</text></annotation><annotation id="45"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="283" length="12"/><text>chondrocytes</text></annotation><annotation id="46"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="350" length="4"/><text>bone</text></annotation><annotation id="47"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="631" length="12"/><text>chondrocytes</text></annotation><annotation id="48"><infon key="identifier">0002157</infon><infon key="type">TISSUE</infon><location offset="701" length="17"/><text>endochondral bone</text></annotation><annotation id="49"><infon key="identifier">19224</infon><infon key="type">GENE</infon><location offset="1561" length="5"/><text>Cox-1</text></annotation><annotation id="50"><infon key="identifier">0006217</infon><infon key="type">TISSUE</infon><location offset="1782" length="59"/><text>mouse chondrocytes immortalized with large T antigen) cells</text></annotation><annotation id="51"><infon key="identifier">54446</infon><infon key="type">GENE</infon><location offset="1385" length="4"/><text>NFAT</text></annotation><annotation id="52"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="143" length="5"/><text>human</text></annotation><annotation id="53"><infon key="identifier">12813</infon><infon key="type">GENE</infon><location offset="2271" length="7"/><text>Col10a1</text></annotation><annotation id="54"><infon key="identifier">0018230</infon><infon key="type">DISEASE</infon><location offset="544" length="18"/><text>skeletal dysplasia</text></annotation><annotation id="55"><infon key="identifier">0005178</infon><infon key="type">DISEASE</infon><location offset="567" length="14"/><text>osteoarthritis</text></annotation></passage></document>
<document><id>25369933</id><passage><offset>0</offset><text>Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia. Notch is needed for T-cell development and is a common oncogenic driver in T-cell acute lymphoblastic leukemia. The protooncogene c-Myc (Myc) is a critical target of Notch in normal and malignant pre-T cells, but how Notch regulates Myc is unknown. Here, we identify a distal enhancer located &gt;1 Mb 3' of human and murine Myc that binds Notch transcription complexes and physically interacts with the Myc proximal promoter. The Notch1 binding element in this region activates reporter genes in a Notch-dependent, cell-context-specific fashion that requires a conserved Notch complex binding site. Acute changes in Notch activation produce rapid changes in H3K27 acetylation across the entire enhancer (a region spanning &gt;600 kb) that correlate with Myc expression. This broad Notch-influenced region comprises an enhancer region containing multiple domains, recognizable as discrete H3K27 acetylation peaks. Leukemia cells selected for resistance to Notch inhibitors express Myc despite epigenetic silencing of enhancer domains near the Notch transcription complex binding sites. Notch-independent expression of Myc in resistant cells is highly sensitive to inhibitors of bromodomain containing 4 (Brd4), a change in drug sensitivity that is accompanied by preferential association of the Myc promoter with more 3' enhancer domains that are strongly dependent on Brd4 for function. These findings indicate that altered long-range enhancer activity can mediate resistance to targeted therapies and provide a mechanistic rationale for combined targeting of Notch and Brd4 in leukemia.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="365" length="56"/><text>distal enhancer located &gt;1 Mb 3' of human and murine Myc</text></annotation><annotation id="2"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="497" length="3"/><text>Myc</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005525</infon><infon key="type">DISEASE</infon><location offset="79" length="15"/><text>T cell leukemia</text></annotation><annotation id="4"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1385" length="3"/><text>Myc</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="171" length="35"/><text>T-cell acute lymphoblastic leukemia</text></annotation><annotation id="6"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="226" length="5"/><text>c-Myc</text></annotation><annotation id="7"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="233" length="3"/><text>Myc</text></annotation><annotation id="8"><infon key="identifier">4851</infon><infon key="type">GENE</infon><location offset="524" length="6"/><text>Notch1</text></annotation><annotation id="9"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="329" length="3"/><text>Myc</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="497" length="21"/><text>Myc proximal promoter</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="655" length="36"/><text>conserved Notch complex binding site</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="524" length="22"/><text>Notch1 binding element</text></annotation><annotation id="13"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="845" length="3"/><text>Myc</text></annotation><annotation id="14"><infon key="identifier">0001271</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1004" length="14"/><text>Leukemia cells</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="788" length="36"/><text>enhancer (a region spanning &gt;600 kb)</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1071" length="3"/><text>Myc</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1133" length="41"/><text>Notch transcription complex binding sites</text></annotation><annotation id="18"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1208" length="3"/><text>Myc</text></annotation><annotation id="19"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1268" length="24"/><text>bromodomain containing 4</text></annotation><annotation id="20"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1294" length="4"/><text>Brd4</text></annotation><annotation id="21"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1459" length="4"/><text>Brd4</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="909" length="15"/><text>enhancer region</text></annotation><annotation id="23"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1661" length="4"/><text>Brd4</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1669" length="8"/><text>leukemia</text></annotation><annotation id="25"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="116" length="6"/><text>T-cell</text></annotation><annotation id="26"><infon key="identifier">0001145</infon><infon key="type">TISSUE</infon><location offset="292" length="11"/><text>pre-T cells</text></annotation><annotation id="27"><infon key="identifier">0001271</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1215" length="15"/><text>resistant cells</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1107" length="16"/><text>enhancer domains</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1385" length="12"/><text>Myc promoter</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1408" length="19"/><text>3' enhancer domains</text></annotation><annotation id="31"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="418" length="3"/><text>Myc</text></annotation><annotation id="32"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="40" length="3"/><text>Myc</text></annotation></passage></document>
<document><id>25403490</id><passage><offset>0</offset><text>MUNC, a long noncoding RNA that facilitates the function of MyoD in skeletal myogenesis. An in silico screen for myogenic long noncoding RNAs (lncRNAs) revealed nine lncRNAs that are upregulated more than 10-fold in myotubes versus levels in myoblasts. One of these lncRNAs, MyoD upstream noncoding (MUNC, also known as DRR(eRNA)), is encoded 5 kb upstream of the transcription start site of MyoD, a myogenic transcription factor gene. MUNC is specifically expressed in skeletal muscle and exists as in unspliced and spliced isoforms, and its 5' end overlaps with the cis-acting distal regulatory region (DRR) of MyoD. Small interfering RNA (siRNA) of MUNC reduced myoblast differentiation and specifically reduced the association of MyoD to the DRR enhancer and myogenin promoter but not to another MyoD-dependent enhancer. Stable overexpression of MUNC from a heterologous promoter increased endogenous MyoD, Myogenin, and Myh3 (myosin heavy chain, [MHC] gene) mRNAs but not the cognate proteins, suggesting that MUNC can act in trans to promote gene expression but that this activity does not require an induction of MyoD protein. MUNC also stimulates the transcription of other genes that are not recognized as MyoD-inducible genes. Knockdown of MUNC in vivo impaired murine muscle regeneration, implicating MUNC in primary satellite cell differentiation in the animal. We also discovered a human MUNC that is induced during differentiation of myoblasts and whose knockdown decreases differentiation, suggesting an evolutionarily conserved role of MUNC lncRNA in myogenesis. Although MUNC overlaps with the DRR enhancer, our results suggest that MUNC is not a classic cis-acting enhancer RNA (e-RNA) acting exclusively by stimulating the neighboring MyoD gene but more like a promyogenic lncRNA that acts directly or indirectly on multiple promoters to increase myogenic gene expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="746" length="12"/><text>DRR enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="763" length="17"/><text>myogenin promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1697" length="5"/><text>e-RNA</text></annotation><annotation id="4"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="392" length="4"/><text>MyoD</text></annotation><annotation id="5"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="800" length="4"/><text>MyoD</text></annotation><annotation id="6"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="734" length="4"/><text>MyoD</text></annotation><annotation id="7"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="905" length="4"/><text>MyoD</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="800" length="23"/><text>MyoD-dependent enhancer</text></annotation><annotation id="9"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="911" length="8"/><text>Myogenin</text></annotation><annotation id="10"><infon key="identifier">4621</infon><infon key="type">GENE</infon><location offset="925" length="4"/><text>Myh3</text></annotation><annotation id="11"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="1120" length="4"/><text>MyoD</text></annotation><annotation id="12"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="1215" length="4"/><text>MyoD</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1272" length="6"/><text>murine</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1395" length="5"/><text>human</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="875" length="8"/><text>promoter</text></annotation><annotation id="16"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="1754" length="4"/><text>MyoD</text></annotation><annotation id="17"><infon key="identifier">0000222</infon><infon key="type">TISSUE</infon><location offset="242" length="9"/><text>myoblasts</text></annotation><annotation id="18"><infon key="identifier">0001103</infon><infon key="type">TISSUE</infon><location offset="470" length="15"/><text>skeletal muscle</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1611" length="12"/><text>DRR enhancer</text></annotation><annotation id="20"><infon key="identifier">0000887</infon><infon key="type">TISSUE</infon><location offset="1279" length="6"/><text>muscle</text></annotation><annotation id="21"><infon key="identifier">0000222</infon><infon key="type">TISSUE</infon><location offset="1448" length="9"/><text>myoblasts</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="568" length="49"/><text>cis-acting distal regulatory region (DRR) of MyoD</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1672" length="23"/><text>cis-acting enhancer RNA</text></annotation><annotation id="24"><infon key="identifier">105447647</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>MUNC</text></annotation><annotation id="25"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="60" length="4"/><text>MyoD</text></annotation><annotation id="26"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="275" length="4"/><text>MyoD</text></annotation></passage></document>
<document><id>25453756</id><passage><offset>0</offset><text>A role for noncoding variation in schizophrenia. A large portion of common variant loci associated with genetic risk for schizophrenia reside within noncoding sequence of unknown function. Here, we demonstrate promoter and enhancer enrichment in schizophrenia variants associated with expression quantitative trait loci (eQTL). The enrichment is greater when functional annotations derived from the human brain are used relative to peripheral tissues. Regulatory trait concordance analysis ranked genes within schizophrenia genome-wide significant loci for a potential functional role, based on colocalization of a risk SNP, eQTL, and regulatory element sequence. We identified potential physical interactions of noncontiguous proximal and distal regulatory elements. This was verified in prefrontal cortex and -induced pluripotent stem cell-derived neurons for the L-type calcium channel (CACNA1C) risk locus. Our findings point to a functional link between schizophrenia-associated noncoding SNPs and 3D genome architecture associated with chromosomal loopings and transcriptional regulation in the brain.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="399" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">0002807</infon><infon key="type">TISSUE</infon><location offset="789" length="17"/><text>prefrontal cortex</text></annotation><annotation id="3"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="850" length="7"/><text>neurons</text></annotation><annotation id="4"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="820" length="21"/><text>pluripotent stem cell</text></annotation><annotation id="5"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="405" length="5"/><text>brain</text></annotation><annotation id="6"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="34" length="13"/><text>schizophrenia</text></annotation><annotation id="7"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="121" length="13"/><text>schizophrenia</text></annotation><annotation id="8"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="246" length="13"/><text>schizophrenia</text></annotation><annotation id="9"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="1101" length="5"/><text>brain</text></annotation><annotation id="10"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="510" length="13"/><text>schizophrenia</text></annotation><annotation id="11"><infon key="identifier">775</infon><infon key="type">GENE</infon><location offset="890" length="7"/><text>CACNA1C</text></annotation><annotation id="12"><infon key="identifier">0005090</infon><infon key="type">DISEASE</infon><location offset="959" length="13"/><text>schizophrenia</text></annotation></passage></document>
<document><id>25453903</id><passage><offset>0</offset><text>EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. The aberrant transcription factor EWS-FLI1 drives Ewing sarcoma, but its molecular function is not completely understood. We find that EWS-FLI1 reprograms gene regulatory circuits in Ewing sarcoma by directly inducing or repressing enhancers. At GGAA repeat elements, which lack evolutionary conservation and regulatory potential in other cell types, EWS-FLI1 multimers induce chromatin opening and create de novo enhancers that physically interact with target promoters. Conversely, EWS-FLI1 inactivates conserved enhancers containing canonical ETS motifs by displacing wild-type ETS transcription factors. These divergent chromatin-remodeling patterns repress tumor suppressors and mesenchymal lineage regulators while activating oncogenes and potential therapeutic targets, such as the kinase VRK1. Our findings demonstrate how EWS-FLI1 establishes an oncogenic regulatory program governing both tumor survival and differentiation.</text><annotation id="1"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="674" length="3"/><text>ETS</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="178" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="3"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="263" length="3"/><text>EWS</text></annotation><annotation id="4"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="267" length="4"/><text>FLI1</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="311" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="6"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="479" length="3"/><text>EWS</text></annotation><annotation id="7"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="483" length="4"/><text>FLI1</text></annotation><annotation id="8"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="612" length="3"/><text>EWS</text></annotation><annotation id="9"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="616" length="4"/><text>FLI1</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="790" length="5"/><text>tumor</text></annotation><annotation id="11"><infon key="identifier">7443</infon><infon key="type">GENE</infon><location offset="924" length="4"/><text>VRK1</text></annotation><annotation id="12"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="812" length="19"/><text>mesenchymal lineage</text></annotation><annotation id="13"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="959" length="3"/><text>EWS</text></annotation><annotation id="14"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="963" length="4"/><text>FLI1</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1027" length="5"/><text>tumor</text></annotation><annotation id="16"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="709" length="3"/><text>ETS</text></annotation><annotation id="17"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>EWS</text></annotation><annotation id="18"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="4" length="4"/><text>FLI1</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="113" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="20"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="162" length="3"/><text>EWS</text></annotation><annotation id="21"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="166" length="4"/><text>FLI1</text></annotation></passage></document>
<document><id>25486239</id><passage><offset>0</offset><text>Identification of hypothalamic arcuate nucleus-specific enhancer region of Kiss1 gene in mice. Pulsatile secretion of GnRH plays a pivotal role in follicular development via stimulating tonic gonadotropin secretion in mammals. Kisspeptin neurons, located in the arcuate nucleus (ARC), are considered to be an intrinsic source of the GnRH pulse generator. The present study aimed to determine ARC-specific enhancer(s) of the Kiss1 gene by an in vivo reporter assay. Three green fluorescent protein (GFP) reporter constructs (long, medium length, and short) were generated by insertion of GFP cDNA at the Kiss1 locus. Transgenic female mice bearing the long and medium-length constructs showed apparent GFP signals in kisspeptin-immunoreactive cells in both the ARC and anteroventral periventricular nucleus, in which another population of kisspeptin neurons are located. On the other hand, transgenic mice bearing 5'-truncated short construct showed few GFP signals in the ARC kisspeptin-immunoreactive cells, whereas they showed colocalization of GFP- and kisspeptin-immunoreactivities in the anteroventral periventricular nucleus. In addition, chromatin immunoprecipitation and chromosome conformation capture assays revealed recruitment of unoccupied estrogen receptor-alpha in the 5'-upstream region and intricate chromatin loop formation between the 5'-upstream and promoter regions of Kiss1 locus in the ARC. Taken together, the present results indicate that 5'-upstream region of Kiss1 locus plays a critical role in Kiss1 gene expression in an ARC-specific manner and that the recruitment of estrogen receptor-alpha and formation of a chromatin loop between the Kiss1 promoter and the 5' enhancer region may be required for the induction of ARC-specific Kiss1 gene expression. These results suggest that the 5'-upstream region of Kiss1 locus functions as an enhancer for ARC Kiss1 gene expression in mice.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="392" length="37"/><text>ARC-specific enhancer(s) of the Kiss1</text></annotation><annotation id="2"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="603" length="5"/><text>Kiss1</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="634" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="716" length="31"/><text>kisspeptin-immunoreactive cells</text></annotation><annotation id="5"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="838" length="18"/><text>kisspeptin neurons</text></annotation><annotation id="6"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1056" length="10"/><text>kisspeptin</text></annotation><annotation id="7"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="972" length="3"/><text>ARC</text></annotation><annotation id="8"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="976" length="31"/><text>kisspeptin-immunoreactive cells</text></annotation><annotation id="9"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="1409" length="3"/><text>ARC</text></annotation><annotation id="10"><infon key="identifier">13982</infon><infon key="type">GENE</infon><location offset="1253" length="23"/><text>estrogen receptor-alpha</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1815" length="33"/><text>5'-upstream region of Kiss1 locus</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1370" length="31"/><text>promoter regions of Kiss1 locus</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1865" length="22"/><text>enhancer for ARC Kiss1</text></annotation><annotation id="14"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1523" length="5"/><text>Kiss1</text></annotation><annotation id="15"><infon key="identifier">13982</infon><infon key="type">GENE</infon><location offset="1599" length="23"/><text>estrogen receptor-alpha</text></annotation><annotation id="16"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="75" length="5"/><text>Kiss1</text></annotation><annotation id="17"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1761" length="5"/><text>Kiss1</text></annotation><annotation id="18"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="424" length="5"/><text>Kiss1</text></annotation><annotation id="19"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1486" length="5"/><text>Kiss1</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1907" length="4"/><text>mice</text></annotation><annotation id="21"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1882" length="5"/><text>Kiss1</text></annotation><annotation id="22"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="31" length="15"/><text>arcuate nucleus</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1669" length="14"/><text>Kiss1 promoter</text></annotation><annotation id="24"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="218" length="7"/><text>mammals</text></annotation><annotation id="25"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="262" length="15"/><text>arcuate nucleus</text></annotation><annotation id="26"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="279" length="3"/><text>ARC</text></annotation><annotation id="27"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="392" length="3"/><text>ARC</text></annotation><annotation id="28"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="760" length="3"/><text>ARC</text></annotation><annotation id="29"><infon key="identifier">0002455</infon><infon key="type">TISSUE</infon><location offset="768" length="37"/><text>anteroventral periventricular nucleus</text></annotation><annotation id="30"><infon key="identifier">0002455</infon><infon key="type">TISSUE</infon><location offset="1093" length="37"/><text>anteroventral periventricular nucleus</text></annotation><annotation id="31"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="1551" length="3"/><text>ARC</text></annotation><annotation id="32"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="1748" length="3"/><text>ARC</text></annotation><annotation id="33"><infon key="identifier">0005534</infon><infon key="type">TISSUE</infon><location offset="1878" length="3"/><text>ARC</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1692" length="18"/><text>5' enhancer region</text></annotation><annotation id="35"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1669" length="5"/><text>Kiss1</text></annotation><annotation id="36"><infon key="identifier">280287</infon><infon key="type">GENE</infon><location offset="1390" length="5"/><text>Kiss1</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1464" length="33"/><text>5'-upstream region of Kiss1 locus</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="31" length="49"/><text>arcuate nucleus-specific enhancer region of Kiss1</text></annotation><annotation id="39"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="89" length="4"/><text>mice</text></annotation><annotation id="40"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="227" length="18"/><text>Kisspeptin neurons</text></annotation><annotation id="41"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="900" length="4"/><text>mice</text></annotation></passage></document>
<document><id>25486255</id><passage><offset>0</offset><text>CRISPR reveals a distal super-enhancer required for Sox2 expression in mouse embryonic stem cells. The pluripotency of embryonic stem cells (ESCs) is maintained by a small group of master transcription factors including Oct4, Sox2 and Nanog. These core factors form a regulatory circuit controlling the transcription of a number of pluripotency factors including themselves. Although previous studies have identified transcriptional regulators of this core network, the cis-regulatory DNA sequences required for the transcription of these key pluripotency factors remain to be defined. We analyzed epigenomic data within the 1.5 Mb gene-desert regions around the Sox2 gene and identified a 13kb-long super-enhancer (SE) located 100kb downstream of Sox2 in mouse ESCs. This SE is occupied by Oct4, Sox2, Nanog, and the mediator complex, and physically interacts with the Sox2 locus via DNA looping. Using a simple and highly efficient double-CRISPR genome editing strategy we deleted the entire 13-kb SE and characterized transcriptional defects in the resulting monoallelic and biallelic deletion clones with RNA-seq. We showed that the SE is responsible for over 90% of Sox2 expression, and Sox2 is the only target gene along the chromosome. Our results support the functional significance of a SE in maintaining the pluripotency transcription program in mouse ESCs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="17" length="21"/><text>distal super-enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="690" length="62"/><text>13kb-long super-enhancer (SE) located 100kb downstream of Sox2</text></annotation><annotation id="3"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="791" length="4"/><text>Oct4</text></annotation><annotation id="4"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="797" length="4"/><text>Sox2</text></annotation><annotation id="5"><infon key="identifier">71950</infon><infon key="type">GENE</infon><location offset="803" length="5"/><text>Nanog</text></annotation><annotation id="6"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="870" length="4"/><text>Sox2</text></annotation><annotation id="7"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1171" length="4"/><text>Sox2</text></annotation><annotation id="8"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1192" length="4"/><text>Sox2</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1356" length="5"/><text>mouse</text></annotation><annotation id="10"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="77" length="20"/><text>embryonic stem cells</text></annotation><annotation id="11"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="119" length="20"/><text>embryonic stem cells</text></annotation><annotation id="12"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="52" length="4"/><text>Sox2</text></annotation><annotation id="13"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="141" length="4"/><text>ESCs</text></annotation><annotation id="14"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="762" length="4"/><text>ESCs</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="773" length="2"/><text>SE</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="994" length="8"/><text>13-kb SE</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1137" length="2"/><text>SE</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1296" length="2"/><text>SE</text></annotation><annotation id="19"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1362" length="4"/><text>ESCs</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="71" length="5"/><text>mouse</text></annotation><annotation id="21"><infon key="identifier">18999</infon><infon key="type">GENE</infon><location offset="220" length="4"/><text>Oct4</text></annotation><annotation id="22"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="226" length="4"/><text>Sox2</text></annotation><annotation id="23"><infon key="identifier">71950</infon><infon key="type">GENE</infon><location offset="235" length="5"/><text>Nanog</text></annotation><annotation id="24"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="663" length="4"/><text>Sox2</text></annotation><annotation id="25"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="748" length="4"/><text>Sox2</text></annotation><annotation id="26"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="756" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>25487574</id><passage><offset>0</offset><text>MyoR modulates cardiac conduction by repressing Gata4. The cardiac conduction system coordinates electrical activation through a series of interconnected structures, including the atrioventricular node (AVN), the central connection point that delays impulse propagation to optimize cardiac performance. Although recent studies have uncovered important molecular details of AVN formation, relatively little is known about the transcriptional mechanisms that regulate AV delay, the primary function of the mature AVN. We identify here MyoR as a novel transcription factor expressed in Cx30.2(+) cells of the AVN. We show that MyoR specifically inhibits a Cx30.2 enhancer required for AVN-specific gene expression. Furthermore, we demonstrate that MyoR interacts directly with Gata4 to mediate transcriptional repression. Our studies reveal that MyoR contains two nonequivalent repression domains. While the MyoR C-terminal repression domain inhibits transcription in a context-dependent manner, the N-terminal repression domain can function in a heterologous context to convert the Hand2 activator into a repressor. In addition, we show that genetic deletion of MyoR in mice increases Cx30.2 expression by 50% and prolongs AV delay by 13%. Taken together, we conclude that MyoR modulates a Gata4-dependent regulatory circuit that establishes proper AV delay, and these findings may have wider implications for the variability of cardiac rhythm observed in the general population.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="653" length="15"/><text>Cx30.2 enhancer</text></annotation><annotation id="2"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>MyoR</text></annotation><annotation id="3"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="905" length="4"/><text>MyoR</text></annotation><annotation id="4"><infon key="identifier">15111</infon><infon key="type">GENE</infon><location offset="1080" length="5"/><text>Hand2</text></annotation><annotation id="5"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="1160" length="4"/><text>MyoR</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1168" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="identifier">353155</infon><infon key="type">GENE</infon><location offset="1183" length="6"/><text>Cx30.2</text></annotation><annotation id="8"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="1271" length="4"/><text>MyoR</text></annotation><annotation id="9"><infon key="identifier">14463</infon><infon key="type">GENE</infon><location offset="1288" length="5"/><text>Gata4</text></annotation><annotation id="10"><infon key="identifier">0000901</infon><infon key="type">TISSUE</infon><location offset="59" length="25"/><text>cardiac conduction system</text></annotation><annotation id="11"><infon key="identifier">353155</infon><infon key="type">GENE</infon><location offset="653" length="6"/><text>Cx30.2</text></annotation><annotation id="12"><infon key="identifier">14463</infon><infon key="type">GENE</infon><location offset="48" length="5"/><text>Gata4</text></annotation><annotation id="13"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="180" length="21"/><text>atrioventricular node</text></annotation><annotation id="14"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="203" length="3"/><text>AVN</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="583" length="15"/><text>Cx30.2(+) cells</text></annotation><annotation id="16"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="606" length="3"/><text>AVN</text></annotation><annotation id="17"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="682" length="3"/><text>AVN</text></annotation><annotation id="18"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="373" length="3"/><text>AVN</text></annotation><annotation id="19"><infon key="identifier">0005689</infon><infon key="type">TISSUE</infon><location offset="511" length="3"/><text>AVN</text></annotation><annotation id="20"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="533" length="4"/><text>MyoR</text></annotation><annotation id="21"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="624" length="4"/><text>MyoR</text></annotation><annotation id="22"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="745" length="4"/><text>MyoR</text></annotation><annotation id="23"><infon key="identifier">14463</infon><infon key="type">GENE</infon><location offset="774" length="5"/><text>Gata4</text></annotation><annotation id="24"><infon key="identifier">17681</infon><infon key="type">GENE</infon><location offset="843" length="4"/><text>MyoR</text></annotation></passage></document>
<document><id>25505291</id><passage><offset>0</offset><text>TGF-beta1, but not bone morphogenetic proteins, activates Smad1/5 pathway in primary human macrophages and induces expression of proatherogenic genes. Macrophages are responsible for the control of inflammation and healing, and their malfunction results in cardiometabolic disorders. TGF-beta is a pleiotropic growth factor with dual (protective and detrimental) roles in atherogenesis. We have previously shown that in human macrophages, TGF-beta1 activates Smad2/3 signaling and induces a complex gene expression program. However, activated genes were not limited to known Smad2/3-dependent ones, which prompted us to study TGF-beta1-induced signaling in macrophages in detail. Analysis of Id3 regulatory sequences revealed a novel enhancer, located between +4517 and 4662 bp, but the luciferase reporter assay demonstrated that this enhancer is not Smad2/3 dependent. Because Id3 expression is regulated by Smad1/5 in endothelial cells, we analyzed activation of Smad1/5 in macrophages. We demonstrate here for the first time, to our knowledge, that TGF-beta1, but not BMPs, activates Smad1/5 in macrophages. We show that an ALK5/ALK1 heterodimer is responsible for the induction of Smad1/5 signaling by TGF-beta1 in mature human macrophages. Activation of Smad1/5 by TGF-beta1 induces not only Id3, but also HAMP and PLAUR, which contribute to atherosclerotic plaque vulnerability. We suggest that the balance between Smad1/5- and Smad2/3-dependent signaling defines the outcome of the effect of TGF-beta on atherosclerosis where Smad1/5 is responsible for proatherogenic effects, whereas Smad2/3 regulate atheroprotective effects of TGF-beta.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr1,23881244,23881761</infon><infon key="type">ENHANCER</infon><infon key="identifier">1,23881244,23881761</infon><infon key="gb">unk</infon><location offset="734" length="43"/><text>enhancer, located between +4517 and 4662 bp</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr1,23881244,23881761</infon><infon key="type">ENHANCER</infon><infon key="identifier">1,23881244,23881761</infon><infon key="gb">unk</infon><location offset="836" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="575" length="5"/><text>Smad2</text></annotation><annotation id="4"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="626" length="9"/><text>TGF-beta1</text></annotation><annotation id="5"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="692" length="3"/><text>Id3</text></annotation><annotation id="6"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="852" length="5"/><text>Smad2</text></annotation><annotation id="7"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="879" length="3"/><text>Id3</text></annotation><annotation id="8"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="910" length="5"/><text>Smad1</text></annotation><annotation id="9"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="966" length="5"/><text>Smad1</text></annotation><annotation id="10"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1053" length="9"/><text>TGF-beta1</text></annotation><annotation id="11"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="1088" length="5"/><text>Smad1</text></annotation><annotation id="12"><infon key="identifier">7046</infon><infon key="type">GENE</infon><location offset="1128" length="4"/><text>ALK5</text></annotation><annotation id="13"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="0" length="9"/><text>TGF-beta1</text></annotation><annotation id="14"><infon key="identifier">94</infon><infon key="type">GENE</infon><location offset="1133" length="4"/><text>ALK1</text></annotation><annotation id="15"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="1186" length="5"/><text>Smad1</text></annotation><annotation id="16"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1207" length="9"/><text>TGF-beta1</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1227" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="1260" length="5"/><text>Smad1</text></annotation><annotation id="19"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1271" length="9"/><text>TGF-beta1</text></annotation><annotation id="20"><infon key="identifier">3399</infon><infon key="type">GENE</infon><location offset="1298" length="3"/><text>Id3</text></annotation><annotation id="21"><infon key="identifier">57817</infon><infon key="type">GENE</infon><location offset="1312" length="4"/><text>HAMP</text></annotation><annotation id="22"><infon key="identifier">5329</infon><infon key="type">GENE</infon><location offset="1321" length="5"/><text>PLAUR</text></annotation><annotation id="23"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="657" length="11"/><text>macrophages</text></annotation><annotation id="24"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="581" length="1"/><text>3</text></annotation><annotation id="25"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="1422" length="5"/><text>Smad1</text></annotation><annotation id="26"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="1435" length="5"/><text>Smad2</text></annotation><annotation id="27"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1500" length="8"/><text>TGF-beta</text></annotation><annotation id="28"><infon key="identifier">0005311</infon><infon key="type">DISEASE</infon><location offset="1512" length="15"/><text>atherosclerosis</text></annotation><annotation id="29"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="1534" length="5"/><text>Smad1</text></annotation><annotation id="30"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="1593" length="5"/><text>Smad2</text></annotation><annotation id="31"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="1638" length="8"/><text>TGF-beta</text></annotation><annotation id="32"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="19" length="4"/><text>bone</text></annotation><annotation id="33"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="1094" length="1"/><text>5</text></annotation><annotation id="34"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="465" length="1"/><text>3</text></annotation><annotation id="35"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="85" length="5"/><text>human</text></annotation><annotation id="36"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="858" length="1"/><text>3</text></annotation><annotation id="37"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="91" length="11"/><text>macrophages</text></annotation><annotation id="38"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="426" length="11"/><text>macrophages</text></annotation><annotation id="39"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="151" length="11"/><text>Macrophages</text></annotation><annotation id="40"><infon key="identifier">4087</infon><infon key="type">GENE</infon><location offset="459" length="5"/><text>Smad2</text></annotation><annotation id="41"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="977" length="11"/><text>macrophages</text></annotation><annotation id="42"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1099" length="11"/><text>macrophages</text></annotation><annotation id="43"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1233" length="11"/><text>macrophages</text></annotation><annotation id="44"><infon key="identifier">0005267</infon><infon key="type">DISEASE</infon><location offset="257" length="25"/><text>cardiometabolic disorders</text></annotation><annotation id="45"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="1441" length="1"/><text>3</text></annotation><annotation id="46"><infon key="identifier">4088</infon><infon key="type">GENE</infon><location offset="1599" length="1"/><text>3</text></annotation><annotation id="47"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="916" length="1"/><text>5</text></annotation><annotation id="48"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="972" length="1"/><text>5</text></annotation><annotation id="49"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="1266" length="1"/><text>5</text></annotation><annotation id="50"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="1428" length="1"/><text>5</text></annotation><annotation id="51"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="1540" length="1"/><text>5</text></annotation><annotation id="52"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="1192" length="1"/><text>5</text></annotation><annotation id="53"><infon key="identifier">4086</infon><infon key="type">GENE</infon><location offset="58" length="5"/><text>Smad1</text></annotation><annotation id="54"><infon key="identifier">4090</infon><infon key="type">GENE</infon><location offset="64" length="1"/><text>5</text></annotation><annotation id="55"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="284" length="8"/><text>TGF-beta</text></annotation><annotation id="56"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="420" length="5"/><text>human</text></annotation><annotation id="57"><infon key="identifier">7040</infon><infon key="type">GENE</infon><location offset="439" length="9"/><text>TGF-beta1</text></annotation><annotation id="58"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="921" length="17"/><text>endothelial cells</text></annotation></passage></document>
<document><id>25548254</id><passage><offset>0</offset><text>A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8alphaalpha+ dendritic cells. CD8 coreceptor expression is dynamically regulated during thymocyte development and is tightly controlled by the activity of at least 5 different cis-regulatory elements. Despite the detailed characterization of the Cd8 loci, the regulation of the complex expression pattern of CD8 cannot be fully explained by the activity of the known Cd8 enhancers. In this study, we revisited the Cd8ab gene complex with bioinformatics and transgenic reporter gene expression approaches to search for additional Cd8 cis-regulatory elements. This led to the identification of an ECR (ECR-4), which in transgenic reporter gene expression assays, directed expression preferentially in CD44(hi)CD62L(+) CD8(+) T cells, including innate-like CD8(+) T cells. ECR-4, designated as Cd8 enhancer E8VI, was bound by Runx/CBFbeta complexes and Bcl11b, indicating that E8VI is part of the cis-regulatory network that recruits transcription factors to the Cd8ab gene complex in CD8(+) T cells. Transgenic reporter expression was maintained in LCMV-specific CD8(+) T cells upon infection, although short-term, in vitro activation led to a down-regulation of E8VI activity. Finally, E8VI directed transgene expression also in CD8alphaalpha(+) DCs but not in CD8alphaalpha-expressing IELs. Taken together, we have identified a novel Cd8 enhancer that directs expression in CD44(hi)CD62L(+) CD8(+) T cells, including innate-like and antigen-specific effector/memory CD8(+) T cells and in CD8alphaalpha(+) DCs, and thus, our data provide further insight into the cis-regulatory networks that control CD8 expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="474" length="13"/><text>Cd8 enhancers</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="898" length="17"/><text>Cd8 enhancer E8VI</text></annotation><annotation id="3"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="636" length="3"/><text>Cd8</text></annotation><annotation id="4"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="861" length="14"/><text>CD8(+) T cells</text></annotation><annotation id="5"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="474" length="3"/><text>Cd8</text></annotation><annotation id="6"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="1089" length="14"/><text>CD8(+) T cells</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="981" length="4"/><text>E8VI</text></annotation><annotation id="8"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="957" length="6"/><text>Bcl11b</text></annotation><annotation id="9"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="1168" length="14"/><text>CD8(+) T cells</text></annotation><annotation id="10"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="1335" length="20"/><text>CD8alphaalpha(+) DCs</text></annotation><annotation id="11"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1367" length="29"/><text>CD8alphaalpha-expressing IELs</text></annotation><annotation id="12"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="1481" length="31"/><text>CD44(hi)CD62L(+) CD8(+) T cells</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1441" length="12"/><text>Cd8 enhancer</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1268" length="4"/><text>E8VI</text></annotation><annotation id="15"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="1573" length="14"/><text>CD8(+) T cells</text></annotation><annotation id="16"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="1595" length="20"/><text>CD8alphaalpha(+) DCs</text></annotation><annotation id="17"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="1441" length="3"/><text>Cd8</text></annotation><annotation id="18"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="1706" length="3"/><text>CD8</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1292" length="4"/><text>E8VI</text></annotation><annotation id="20"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="72" length="25"/><text>CD44hiCD62L+ CD8+ T cells</text></annotation><annotation id="21"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="105" length="30"/><text>CD8alphaalpha+ dendritic cells</text></annotation><annotation id="22"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="8" length="3"/><text>Cd8</text></annotation><annotation id="23"><infon key="identifier">0000289</infon><infon key="type">TISSUE</infon><location offset="806" length="31"/><text>CD44(hi)CD62L(+) CD8(+) T cells</text></annotation><annotation id="24"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="137" length="3"/><text>CD8</text></annotation><annotation id="25"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="353" length="3"/><text>Cd8</text></annotation><annotation id="26"><infon key="identifier">925</infon><infon key="type">GENE</infon><location offset="415" length="3"/><text>CD8</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="271" length="35"/><text>5 different cis-regulatory elements</text></annotation><annotation id="28"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="195" length="9"/><text>thymocyte</text></annotation></passage></document>
<document><id>25582196</id><passage><offset>0</offset><text>Dynamic switching of active promoter and enhancer domains regulates Tet1 and Tet2 expression during cell state transitions between pluripotency and differentiation. The Tet 5-methylcytosine dioxygenases catalyze DNA demethylation by producing 5-hydroxymethylcytosine and further oxidized products. Tet1 and Tet2 are highly expressed in mouse pluripotent cells and downregulated to different extents in somatic cells, but the transcriptional mechanisms are unclear. Here we defined the promoter and enhancer domains in Tet1 and Tet2. Within a 15-kb "superenhancer" of Tet1, there are two transcription start sites (TSSs) with different activation patterns during development. A 6-kb promoter region upstream of the distal TSS is highly active in naive pluripotent cells, autonomously reports Tet1 expression in a transgenic system, and rapidly undergoes DNA methylation and silencing upon differentiation in cultured cells and native epiblast. A second TSS downstream, associated with a constitutively weak CpG-rich promoter, is activated by a neighboring enhancer in naive embryonic stem cells (ESCs) and primed epiblast-like cells (EpiLCs). Tet2 has a CpG island promoter with pluripotency-independent activity and an ESC-specific distal intragenic enhancer; the latter is rapidly downregulated in EpiLCs. Our study reveals distinct modes of transcriptional regulation at Tet1 and Tet2 during cell state transitions of early development. New transgenic reporters using Tet1 and Tet2 cis-regulatory domains may serve to distinguish nuanced changes in pluripotent states and the underlying epigenetic variations.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="485" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="77" length="4"/><text>Tet2</text></annotation><annotation id="3"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="298" length="4"/><text>Tet1</text></annotation><annotation id="4"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="307" length="4"/><text>Tet2</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="336" length="5"/><text>mouse</text></annotation><annotation id="6"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="933" length="8"/><text>epiblast</text></annotation><annotation id="7"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="518" length="4"/><text>Tet1</text></annotation><annotation id="8"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="527" length="4"/><text>Tet2</text></annotation><annotation id="9"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="791" length="4"/><text>Tet1</text></annotation><annotation id="10"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="1142" length="4"/><text>Tet2</text></annotation><annotation id="11"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="1373" length="4"/><text>Tet1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="542" length="29"/><text>15-kb "superenhancer" of Tet1</text></annotation><annotation id="13"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="1382" length="4"/><text>Tet2</text></annotation><annotation id="14"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="1470" length="4"/><text>Tet1</text></annotation><annotation id="15"><infon key="identifier">214133</infon><infon key="type">GENE</infon><location offset="1479" length="4"/><text>Tet2</text></annotation><annotation id="16"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="567" length="4"/><text>Tet1</text></annotation><annotation id="17"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1219" length="3"/><text>ESC</text></annotation><annotation id="18"><infon key="identifier">0001268</infon><infon key="type">TISSUE</infon><location offset="402" length="13"/><text>somatic cells</text></annotation><annotation id="19"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1073" length="20"/><text>embryonic stem cells</text></annotation><annotation id="20"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1095" length="4"/><text>ESCs</text></annotation><annotation id="21"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="1112" length="19"/><text>epiblast-like cells</text></annotation><annotation id="22"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="1133" length="6"/><text>EpiLCs</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="498" length="33"/><text>enhancer domains in Tet1 and Tet2</text></annotation><annotation id="24"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="1299" length="6"/><text>EpiLCs</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="677" length="47"/><text>6-kb promoter region upstream of the distal TSS</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1006" length="17"/><text>CpG-rich promoter</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1055" length="8"/><text>enhancer</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1153" length="19"/><text>CpG island promoter</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1219" length="39"/><text>ESC-specific distal intragenic enhancer</text></annotation><annotation id="30"><infon key="identifier">52463</infon><infon key="type">GENE</infon><location offset="68" length="4"/><text>Tet1</text></annotation></passage></document>
<document><id>25604083</id><passage><offset>0</offset><text>Copy number variation of two separate regulatory regions upstream of SOX9 causes isolated 46,XY or 46,XX disorder of sex development. BACKGROUND: SOX9 mutations cause the skeletal malformation syndrome campomelic dysplasia in combination with XY sex reversal. Studies in mice indicate that SOX9 acts as a testis-inducing transcription factor downstream of SRY, triggering Sertoli cell and testis differentiation. An SRY-dependent testis-specific enhancer for Sox9 has been identified only in mice. A previous study has implicated copy number variations (CNVs) of a 78 kb region 517-595 kb upstream of SOX9 in the aetiology of both 46,XY and 46,XX disorders of sex development (DSD). We wanted to better define this region for both disorders. RESULTS: By CNV analysis, we identified SOX9 upstream duplications in three cases of SRY-negative 46,XX DSD, which together with previously reported duplications define a 68 kb region, 516-584 kb upstream of SOX9, designated XXSR (XX sex reversal region). More importantly, we identified heterozygous deletions in four families with SRY-positive 46,XY DSD without skeletal phenotype, which define a 32.5 kb interval 607.1-639.6 kb upstream of SOX9, designated XY sex reversal region (XYSR). To localise the suspected testis-specific enhancer, XYSR subfragments were tested in cell transfection and transgenic experiments. While transgenic experiments remained inconclusive, a 1.9 kb SRY-responsive subfragment drove expression specifically in Sertoli-like cells. CONCLUSIONS: Our results indicate that isolated 46,XY and 46,XX DSD can be assigned to two separate regulatory regions, XYSR and XXSR, far upstream of SOX9. The 1.9 kb SRY-responsive subfragment from the XYSR might constitute the core of the Sertoli-cell enhancer of human SOX9, representing the so far missing link in the genetic cascade of male sex determination.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="416" length="38"/><text>SRY-dependent testis-specific enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1259" length="24"/><text>testis-specific enhancer</text></annotation><annotation id="3"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="290" length="4"/><text>SOX9</text></annotation><annotation id="4"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="356" length="3"/><text>SRY</text></annotation><annotation id="5"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="416" length="3"/><text>SRY</text></annotation><annotation id="6"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="459" length="4"/><text>Sox9</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="492" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="601" length="4"/><text>SOX9</text></annotation><annotation id="9"><infon key="identifier">0020040</infon><infon key="type">DISEASE</infon><location offset="90" length="5"/><text>46,XY</text></annotation><annotation id="10"><infon key="identifier">0017576</infon><infon key="type">DISEASE</infon><location offset="641" length="34"/><text>46,XX disorders of sex development</text></annotation><annotation id="11"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="677" length="3"/><text>DSD</text></annotation><annotation id="12"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="782" length="4"/><text>SOX9</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1747" length="35"/><text>Sertoli-cell enhancer of human SOX9</text></annotation><annotation id="14"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="827" length="3"/><text>SRY</text></annotation><annotation id="15"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="950" length="4"/><text>SOX9</text></annotation><annotation id="16"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="1075" length="3"/><text>SRY</text></annotation><annotation id="17"><infon key="identifier">0020040</infon><infon key="type">DISEASE</infon><location offset="1088" length="9"/><text>46,XY DSD</text></annotation><annotation id="18"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1185" length="4"/><text>SOX9</text></annotation><annotation id="19"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="1425" length="3"/><text>SRY</text></annotation><annotation id="20"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1656" length="4"/><text>SOX9</text></annotation><annotation id="21"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="1673" length="3"/><text>SRY</text></annotation><annotation id="22"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="430" length="6"/><text>testis</text></annotation><annotation id="23"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="1259" length="6"/><text>testis</text></annotation><annotation id="24"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="69" length="4"/><text>SOX9</text></annotation><annotation id="25"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="1747" length="12"/><text>Sertoli-cell</text></annotation><annotation id="26"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="372" length="12"/><text>Sertoli cell</text></annotation><annotation id="27"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="389" length="6"/><text>testis</text></annotation><annotation id="28"><infon key="identifier">0020040</infon><infon key="type">DISEASE</infon><location offset="631" length="5"/><text>46,XY</text></annotation><annotation id="29"><infon key="identifier">0017576</infon><infon key="type">DISEASE</infon><location offset="840" length="9"/><text>46,XX DSD</text></annotation><annotation id="30"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="1778" length="4"/><text>SOX9</text></annotation><annotation id="31"><infon key="identifier">0004513</infon><infon key="type">TISSUE</infon><location offset="1485" length="18"/><text>Sertoli-like cells</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1772" length="5"/><text>human</text></annotation><annotation id="33"><infon key="identifier">0020040</infon><infon key="type">DISEASE</infon><location offset="1553" length="5"/><text>46,XY</text></annotation><annotation id="34"><infon key="identifier">0017576</infon><infon key="type">DISEASE</infon><location offset="1563" length="9"/><text>46,XX DSD</text></annotation><annotation id="35"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="305" length="6"/><text>testis</text></annotation><annotation id="36"><infon key="identifier">0017576</infon><infon key="type">DISEASE</infon><location offset="99" length="33"/><text>46,XX disorder of sex development</text></annotation><annotation id="37"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="146" length="4"/><text>SOX9</text></annotation><annotation id="38"><infon key="identifier">0005497</infon><infon key="type">DISEASE</infon><location offset="171" length="30"/><text>skeletal malformation syndrome</text></annotation><annotation id="39"><infon key="identifier">0007251</infon><infon key="type">DISEASE</infon><location offset="202" length="20"/><text>campomelic dysplasia</text></annotation><annotation id="40"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="271" length="4"/><text>mice</text></annotation></passage></document>
<document><id>25605944</id><passage><offset>0</offset><text>Enhancer-bound LDB1 regulates a corticotrope promoter-pausing repression program. Substantial evidence supports the hypothesis that enhancers are critical regulators of cell-type determination, orchestrating both positive and negative transcriptional programs; however, the basic mechanisms by which enhancers orchestrate interactions with cognate promoters during activation and repression events remain incompletely understood. Here we report the required actions of LIM domain-binding protein 1 (LDB1)/cofactor of LIM homeodomain protein 2/nuclear LIM interactor, interacting with the enhancer-binding protein achaete-scute complex homolog 1, to mediate looping to target gene promoters and target gene regulation in corticotrope cells. LDB1-mediated enhancer:promoter looping appears to be required for both activation and repression of these target genes. Although LDB1-dependent activated genes are regulated at the level of transcriptional initiation, the LDB1-dependent repressed transcription units appear to be regulated primarily at the level of promoter pausing, with LDB1 regulating recruitment of metastasis-associated 1 family, member 2, a component of the nucleosome remodeling deacetylase complex, on these negative enhancers, required for the repressive enhancer function. These results indicate that LDB1-dependent looping events can deliver repressive cargo to cognate promoters to mediate promoter pausing events in a pituitary cell type.</text><annotation id="1"><infon key="identifier">0000427</infon><infon key="type">TISSUE</infon><location offset="1439" length="14"/><text>pituitary cell</text></annotation><annotation id="2"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="15" length="4"/><text>LDB1</text></annotation><annotation id="3"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="469" length="28"/><text>LIM domain-binding protein 1</text></annotation><annotation id="4"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="499" length="4"/><text>LDB1</text></annotation><annotation id="5"><infon key="identifier">429</infon><infon key="type">GENE</infon><location offset="613" length="31"/><text>achaete-scute complex homolog 1</text></annotation><annotation id="6"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="740" length="4"/><text>LDB1</text></annotation><annotation id="7"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="870" length="4"/><text>LDB1</text></annotation><annotation id="8"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="963" length="4"/><text>LDB1</text></annotation><annotation id="9"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="1080" length="4"/><text>LDB1</text></annotation><annotation id="10"><infon key="identifier">9219</infon><infon key="type">GENE</infon><location offset="1111" length="40"/><text>metastasis-associated 1 family, member 2</text></annotation><annotation id="11"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="1319" length="4"/><text>LDB1</text></annotation></passage></document>
<document><id>25622893</id><passage><offset>0</offset><text>Characterization of the human TCAM1P pseudogene and its activation by a potential dual promoter-enhancer: comparison with a protein-coding mouse orthologue. TCAM1P is a unitary pseudogene, which was disabled since the human-mouse divergence. Here we found that TCAM1P was specifically expressed in the human testis, with different cell type-specificity from mouse Tcam1, and characterized its transcripts. At the mouse locus, a multifunctional dual promoter-enhancer (DPE) controls the expression of Tcam1 and Smarcd2 genes. The corresponding human sequence was found to potentially function as a DPE, although the molecular mechanism was different from mouse. Interestingly, the change in DPE activity occurred before pseudogenization of TCAM1P. These data suggest the presence of a DPE in the human genome for the first time, and provide an important model of evolutionary changes in the regulatory mechanism of a pseudogene.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="24" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">146771</infon><infon key="type">GENE</infon><location offset="30" length="6"/><text>TCAM1P</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="413" length="5"/><text>mouse</text></annotation><annotation id="4"><infon key="identifier">75870</infon><infon key="type">GENE</infon><location offset="500" length="5"/><text>Tcam1</text></annotation><annotation id="5"><infon key="identifier">83796</infon><infon key="type">GENE</infon><location offset="510" length="7"/><text>Smarcd2</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="543" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="654" length="5"/><text>mouse</text></annotation><annotation id="8"><infon key="identifier">146771</infon><infon key="type">GENE</infon><location offset="739" length="6"/><text>TCAM1P</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="795" length="5"/><text>human</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="82" length="22"/><text>dual promoter-enhancer</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="444" length="22"/><text>dual promoter-enhancer</text></annotation><annotation id="12"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="308" length="6"/><text>testis</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="139" length="5"/><text>mouse</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="468" length="3"/><text>DPE</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="597" length="3"/><text>DPE</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="690" length="3"/><text>DPE</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="784" length="3"/><text>DPE</text></annotation><annotation id="18"><infon key="identifier">146771</infon><infon key="type">GENE</infon><location offset="157" length="6"/><text>TCAM1P</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="218" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="224" length="5"/><text>mouse</text></annotation><annotation id="21"><infon key="identifier">146771</infon><infon key="type">GENE</infon><location offset="261" length="6"/><text>TCAM1P</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="302" length="5"/><text>human</text></annotation><annotation id="23"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="358" length="5"/><text>mouse</text></annotation><annotation id="24"><infon key="identifier">75870</infon><infon key="type">GENE</infon><location offset="364" length="5"/><text>Tcam1</text></annotation></passage></document>
<document><id>25628225</id><passage><offset>0</offset><text>SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. The solute carrier family 13 member 5 (SLC13A5) is a sodium-coupled transporter that mediates cellular uptake of citrate, which plays important roles in the synthesis of fatty acids and cholesterol. Recently, the pregnane X receptor (PXR, NR1I2), initially characterized as a xenobiotic sensor, has been functionally linked to the regulation of various physiologic processes that are associated with lipid metabolism and energy homeostasis. Here, we show that the SLC13A5 gene is a novel transcriptional target of PXR, and altered expression of SLC13A5 affects lipid accumulation in human liver cells. The prototypical PXR activator rifampicin markedly induced the mRNA and protein expression of SLC13A5 in human primary hepatocytes. Utilizing cell-based luciferase reporter assays, electrophoretic mobility shift assays, and chromatin immunoprecipitation assays, we identified and functionally characterized two enhancer modules located upstream of the SLC13A5 gene transcription start site that are associated with regulation of PXR-mediated SLC13A5 induction. Functional analysis further revealed that rifampicin can enhance lipid accumulation in human primary hepatocytes, and knockdown of SLC13A5 expression alone leads to a significant decrease of the lipid content in HepG2 cells. Overall, our results uncover SLC13A5 as a novel target gene of PXR and may contribute to drug-induced steatosis and metabolic disorders in humans.</text><annotation id="1"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="0" length="7"/><text>SLC13A5</text></annotation><annotation id="2"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="1077" length="7"/><text>SLC13A5</text></annotation><annotation id="3"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="668" length="7"/><text>SLC13A5</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="706" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="742" length="3"/><text>PXR</text></annotation><annotation id="6"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="819" length="7"/><text>SLC13A5</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="830" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1154" length="3"/><text>PXR</text></annotation><annotation id="9"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="1167" length="7"/><text>SLC13A5</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1273" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="1317" length="7"/><text>SLC13A5</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="110" length="5"/><text>human</text></annotation><annotation id="13"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="1440" length="7"/><text>SLC13A5</text></annotation><annotation id="14"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1474" length="3"/><text>PXR</text></annotation><annotation id="15"><infon key="identifier">0005066</infon><infon key="type">DISEASE</infon><location offset="1527" length="19"/><text>metabolic disorders</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1550" length="6"/><text>humans</text></annotation><annotation id="17"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="116" length="5"/><text>liver</text></annotation><annotation id="18"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="49" length="19"/><text>pregnane X receptor</text></annotation><annotation id="19"><infon key="identifier">0000575</infon><infon key="type">TISSUE</infon><location offset="844" length="11"/><text>hepatocytes</text></annotation><annotation id="20"><infon key="identifier">0000575</infon><infon key="type">TISSUE</infon><location offset="1287" length="11"/><text>hepatocytes</text></annotation><annotation id="21"><infon key="identifier">0000599</infon><infon key="type">TISSUE</infon><location offset="1398" length="11"/><text>HepG2 cells</text></annotation><annotation id="22"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="127" length="33"/><text>solute carrier family 13 member 5</text></annotation><annotation id="23"><infon key="identifier">0000224</infon><infon key="type">TISSUE</infon><location offset="712" length="11"/><text>liver cells</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1032" length="82"/><text>two enhancer modules located upstream of the SLC13A5 gene transcription start site</text></annotation><annotation id="25"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="162" length="7"/><text>SLC13A5</text></annotation><annotation id="26"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="336" length="19"/><text>pregnane X receptor</text></annotation><annotation id="27"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="357" length="3"/><text>PXR</text></annotation><annotation id="28"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="362" length="5"/><text>NR1I2</text></annotation><annotation id="29"><infon key="identifier">284111</infon><infon key="type">GENE</infon><location offset="587" length="7"/><text>SLC13A5</text></annotation><annotation id="30"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="637" length="3"/><text>PXR</text></annotation></passage></document>
<document><id>25651906</id><passage><offset>0</offset><text>Wnt3a signal pathways activate MyoD expression by targeting cis-elements inside and outside its distal enhancer. Wnt proteins are secreted cytokines and several Wnts are expressed in the developing somites and surrounding tissues. Without proper Wnt stimulation, the organization of the dermomyotome and myotome can become defective. These Wnt signals received by somitic cells can lead to activation of Pax3/Pax7 and myogenic regulatory factors (MRFs), especially Myf5 and MyoD. However, it is currently unknown whether Wnts activate Myf5 and MyoD through direct targeting of their cis-regulatory elements or via indirect pathways. To clarify this issue, in the present study, we tested the regulation of MyoD cis-regulatory elements by Wnt3a secreted from human embryonic kidney (HEK)-293T cells. We found that Wnt3a activated the MyoD proximal 6.0k promoter (P6P) only marginally, but highly enhanced the activity of the composite P6P plus distal enhancer (DE) reporter through canonical and non-canonical pathways. Further screening of the intervening fragments between the DE and the P6P identified a strong Wnt-response element (WRE) in the upstream -8 to -9k region (L fragment) that acted independently of the DE, but was dependent on the P6P. Deletion of a Pax3/Pax7-targeted site in the L fragment significantly reduced its response to Wnt3a, implying that Wnt3a activates the L fragment partially through Pax3/Pax7 action. Binding of beta-catenin and Pax7 to their target sites in the DE and the L fragment respectively was also demonstrated by ChIP. These observations demonstrated the first time that Wnt3a can directly activate MyoD expression through targeting cis-elements in the DE and the L fragment.</text><annotation id="1"><infon key="identifier">22416</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Wnt3a</text></annotation><annotation id="2"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="31" length="4"/><text>MyoD</text></annotation><annotation id="3"><infon key="identifier">89780</infon><infon key="type">GENE</infon><location offset="813" length="5"/><text>Wnt3a</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1266" length="23"/><text>Pax3/Pax7-targeted site</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1297" length="10"/><text>L fragment</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1387" length="10"/><text>L fragment</text></annotation><annotation id="7"><infon key="identifier">89780</infon><infon key="type">GENE</infon><location offset="1346" length="5"/><text>Wnt3a</text></annotation><annotation id="8"><infon key="identifier">89780</infon><infon key="type">GENE</infon><location offset="1367" length="5"/><text>Wnt3a</text></annotation><annotation id="9"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1416" length="4"/><text>Pax3</text></annotation><annotation id="10"><infon key="identifier">5081</infon><infon key="type">GENE</infon><location offset="1421" length="4"/><text>Pax7</text></annotation><annotation id="11"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="1445" length="12"/><text>beta-catenin</text></annotation><annotation id="12"><infon key="identifier">5081</infon><infon key="type">GENE</infon><location offset="1462" length="4"/><text>Pax7</text></annotation><annotation id="13"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="404" length="4"/><text>Pax3</text></annotation><annotation id="14"><infon key="identifier">89780</infon><infon key="type">GENE</infon><location offset="1614" length="5"/><text>Wnt3a</text></annotation><annotation id="15"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="1642" length="4"/><text>MyoD</text></annotation><annotation id="16"><infon key="identifier">0006248;0000742</infon><infon key="type">TISSUE</infon><location offset="287" length="12"/><text>dermomyotome</text></annotation><annotation id="17"><infon key="identifier">0000742</infon><infon key="type">TISSUE</infon><location offset="304" length="7"/><text>myotome</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="862" length="3"/><text>P6P</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="934" length="3"/><text>P6P</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="960" length="2"/><text>DE</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="96" length="15"/><text>distal enhancer</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="943" length="15"/><text>distal enhancer</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1078" length="2"/><text>DE</text></annotation><annotation id="24"><infon key="identifier">5081</infon><infon key="type">GENE</infon><location offset="409" length="4"/><text>Pax7</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1089" length="3"/><text>P6P</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1218" length="2"/><text>DE</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1247" length="3"/><text>P6P</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1496" length="2"/><text>DE</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1696" length="2"/><text>DE</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1113" length="59"/><text>Wnt-response element (WRE) in the upstream -8 to -9k region</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1174" length="10"/><text>L fragment</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="833" length="27"/><text>MyoD proximal 6.0k promoter</text></annotation><annotation id="33"><infon key="identifier">0001558</infon><infon key="type">TISSUE</infon><location offset="198" length="7"/><text>somites</text></annotation><annotation id="34"><infon key="identifier">0001558</infon><infon key="type">TISSUE</infon><location offset="364" length="13"/><text>somitic cells</text></annotation><annotation id="35"><infon key="identifier">4617</infon><infon key="type">GENE</infon><location offset="465" length="4"/><text>Myf5</text></annotation><annotation id="36"><infon key="identifier">0002181</infon><infon key="type">TISSUE</infon><location offset="774" length="23"/><text>kidney (HEK)-293T cells</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1507" length="10"/><text>L fragment</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1707" length="10"/><text>L fragment</text></annotation><annotation id="39"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="758" length="5"/><text>human</text></annotation><annotation id="40"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="833" length="4"/><text>MyoD</text></annotation><annotation id="41"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1266" length="4"/><text>Pax3</text></annotation><annotation id="42"><infon key="identifier">5081</infon><infon key="type">GENE</infon><location offset="1271" length="4"/><text>Pax7</text></annotation><annotation id="43"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="474" length="4"/><text>MyoD</text></annotation><annotation id="44"><infon key="identifier">4617</infon><infon key="type">GENE</infon><location offset="535" length="4"/><text>Myf5</text></annotation><annotation id="45"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="544" length="4"/><text>MyoD</text></annotation><annotation id="46"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="706" length="4"/><text>MyoD</text></annotation><annotation id="47"><infon key="identifier">89780</infon><infon key="type">GENE</infon><location offset="738" length="5"/><text>Wnt3a</text></annotation></passage></document>
<document><id>25652130</id><passage><offset>0</offset><text>Enhancer cooperativity as a novel mechanism underlying the transcriptional regulation of E-cadherin during mesenchymal to epithelial transition. Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) highlight crucial steps during embryogenesis and tumorigenesis. Induction of dramatic changes in gene expression and cell features is reflected by modulation of Cdh1 (E-cadherin) expression. We show that Cdh1 activity during MET is governed by two enhancers at +7.8 kb and at +11.5 kb within intron 2 that are activated by binding of Grhl3 and Hnf4alpha, respectively. Recruitment of Grhl3 and Hnf4alpha to the enhancers is crucial for activating Cdh1 and accomplishing MET in non-tumorigenic mouse mammary gland cells (NMuMG). Moreover, the two enhancers cooperate via Grhl3 and Hnf4alpha binding, induction of DNA-looping and clustering at the promoter to orchestrate E-cadherin re-expression. Our results provide novel insights into the cellular mechanisms whereby cells respond to MET signals and re-establish an epithelial phenotype by enhancer cooperativity. A general importance of our findings including MET-mediated colonization of metastasizing tumor cells is suggested.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="473" length="56"/><text>two enhancers at +7.8 kb and at +11.5 kb within intron 2</text></annotation><annotation id="2"><infon key="identifier">230824</infon><infon key="type">GENE</infon><location offset="563" length="5"/><text>Grhl3</text></annotation><annotation id="3"><infon key="identifier">15378</infon><infon key="type">GENE</infon><location offset="573" length="9"/><text>Hnf4alpha</text></annotation><annotation id="4"><infon key="identifier">230824</infon><infon key="type">GENE</infon><location offset="613" length="5"/><text>Grhl3</text></annotation><annotation id="5"><infon key="identifier">15378</infon><infon key="type">GENE</infon><location offset="623" length="9"/><text>Hnf4alpha</text></annotation><annotation id="6"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="676" length="4"/><text>Cdh1</text></annotation><annotation id="7"><infon key="identifier">0004183</infon><infon key="type">TISSUE</infon><location offset="706" length="41"/><text>non-tumorigenic mouse mammary gland cells</text></annotation><annotation id="8"><infon key="identifier">230824</infon><infon key="type">GENE</infon><location offset="799" length="5"/><text>Grhl3</text></annotation><annotation id="9"><infon key="identifier">15378</infon><infon key="type">GENE</infon><location offset="809" length="9"/><text>Hnf4alpha</text></annotation><annotation id="10"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="899" length="10"/><text>E-cadherin</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="640" length="9"/><text>enhancers</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="771" length="13"/><text>two enhancers</text></annotation><annotation id="13"><infon key="identifier">0004183</infon><infon key="type">TISSUE</infon><location offset="749" length="5"/><text>NMuMG</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="875" length="8"/><text>promoter</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1184" length="11"/><text>tumor cells</text></annotation><annotation id="16"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="89" length="10"/><text>E-cadherin</text></annotation><annotation id="17"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="390" length="4"/><text>Cdh1</text></annotation><annotation id="18"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="396" length="10"/><text>E-cadherin</text></annotation><annotation id="19"><infon key="identifier">12550</infon><infon key="type">GENE</infon><location offset="433" length="4"/><text>Cdh1</text></annotation></passage></document>
<document><id>25769725</id><passage><offset>0</offset><text>Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2. Aberrant reactivation of embryonic pathways occurs commonly in cancer. The transcription factor RUNX2 plays a fundamental role during embryogenesis and is aberrantly reactivated during progression and metastasization of different types of human tumors. In this study, we attempted to dissect the molecular mechanisms governing RUNX2 expression and its aberrant reactivation. We identified a new regulatory enhancer element, located within the RUNX2 gene, which is responsible for the activation of the RUNX2 promoter and for the regulation of its expression in cancer cells. Furthermore, we have shown that treatment with the anticancer compounds histone deacetylase inhibitor (HDACi) results in a profound inhibition of RUNX2 expression, which is determined by the disruption of the transcription-activating complex on the identified enhancer. These data envisage a possible targeting strategy to counteract the oncongenic function of RUNX2 in cancer cells and provide evidence that the cytotoxic activity of HDACi in cancer is not only dependent on the reactivation of silenced oncosuppressors but also on the repression of oncogenic factors that are necessary for survival and progression.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr6,45410618,45417584</infon><infon key="type">ENHANCER</infon><infon key="identifier">6,45410618,45417584</infon><infon key="gb">unk</infon><location offset="486" length="58"/><text>regulatory enhancer element, located within the RUNX2 gene</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr6,45410618,45417584</infon><infon key="type">ENHANCER</infon><infon key="identifier">6,45410618,45417584</infon><infon key="gb">unk</infon><location offset="926" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="336" length="6"/><text>tumors</text></annotation><annotation id="4"><infon key="type">TISSUE</infon><location offset="652" length="12"/><text>cancer cells</text></annotation><annotation id="5"><infon key="type">TISSUE</infon><location offset="1036" length="12"/><text>cancer cells</text></annotation><annotation id="6"><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1110" length="6"/><text>cancer</text></annotation><annotation id="7"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="593" length="5"/><text>RUNX2</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="593" length="14"/><text>RUNX2 promoter</text></annotation><annotation id="9"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="84" length="5"/><text>RUNX2</text></annotation><annotation id="10"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="187" length="5"/><text>RUNX2</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="330" length="5"/><text>human</text></annotation><annotation id="12"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="418" length="5"/><text>RUNX2</text></annotation><annotation id="13"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="534" length="5"/><text>RUNX2</text></annotation><annotation id="14"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="812" length="5"/><text>RUNX2</text></annotation><annotation id="15"><infon key="identifier">860</infon><infon key="type">GENE</infon><location offset="1027" length="5"/><text>RUNX2</text></annotation><annotation id="16"><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="154" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>25775043</id><passage><offset>0</offset><text>Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Understanding of mammalian enhancers is limited by the lack of a technology to rapidly and thoroughly test the cell type-specific function. Here, we use a nuclease-deficient Cas9 (dCas9)-histone demethylase fusion to functionally characterize previously described and new enhancer elements for their roles in the embryonic stem cell state. Further, we distinguish the mechanism of action of dCas9-LSD1 at enhancers from previous dCas9-effectors.</text><annotation id="1"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="395" length="19"/><text>embryonic stem cell</text></annotation><annotation id="2"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="99" length="9"/><text>mammalian</text></annotation><annotation id="3"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="479" length="4"/><text>LSD1</text></annotation></passage></document>
<document><id>25786345</id><passage><offset>0</offset><text>p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells. Elevated expression of chemokine receptors in tumors has been reported in many instances and is related to a number of survival advantages for tumor cells including abnormal activation of prosurvival intracellular pathways. In this work we demonstrated an inverse correlation between expression levels of p53 tumor suppressor and CXCR5 chemokine receptor in MCF-7 human breast cancer cell line. Lentiviral transduction of MCF-7 cells with p53 shRNA led to elevated CXCR5 at both mRNA and protein levels. Functional activity of CXCR5 in p53-knockdown MCF-7 cells was also increased as shown by activation of target gene expression and chemotaxis in response to B-lymphocyte chemoattractant CXCL13. Using deletion analysis and site-directed mutagenesis of the cxcr5 gene promoter and enhancer elements, we demonstrated that p53 appears to act upon cxcr5 promoter indirectly, by repressing the activity of NFkappaB transcription factors. Using chromatin immunoprecipitation and reporter gene analysis, we further demonstrated that p65/RelA was able to bind the cxcr5 promoter in p53-dependent manner and to directly transactivate it when overexpressed. Through the described mechanism, elevated CXCR5 expression may contribute to abnormal cell survival and migration in breast tumors that lack functional p53.</text><annotation id="1"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="986" length="8"/><text>NFkappaB</text></annotation><annotation id="2"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="413" length="5"/><text>CXCR5</text></annotation><annotation id="3"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="56" length="25"/><text>MCF-7 breast cancer cells</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="841" length="19"/><text>cxcr5 gene promoter</text></annotation><annotation id="5"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="522" length="3"/><text>p53</text></annotation><annotation id="6"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="548" length="5"/><text>CXCR5</text></annotation><annotation id="7"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="610" length="5"/><text>CXCR5</text></annotation><annotation id="8"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="619" length="3"/><text>p53</text></annotation><annotation id="9"><infon key="identifier">10563</infon><infon key="type">GENE</infon><location offset="772" length="6"/><text>CXCL13</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="865" length="17"/><text>enhancer elements</text></annotation><annotation id="11"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="905" length="3"/><text>p53</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="929" length="14"/><text>cxcr5 promoter</text></annotation><annotation id="13"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="441" length="35"/><text>MCF-7 human breast cancer cell line</text></annotation><annotation id="14"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1111" length="3"/><text>p65</text></annotation><annotation id="15"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1115" length="4"/><text>RelA</text></annotation><annotation id="16"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="841" length="5"/><text>cxcr5</text></annotation><annotation id="17"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1159" length="3"/><text>p53</text></annotation><annotation id="18"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="1275" length="5"/><text>CXCR5</text></annotation><annotation id="19"><infon key="identifier">0021100</infon><infon key="type">DISEASE</infon><location offset="1350" length="13"/><text>breast tumors</text></annotation><annotation id="20"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1385" length="3"/><text>p53</text></annotation><annotation id="21"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="929" length="5"/><text>cxcr5</text></annotation><annotation id="22"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="505" length="11"/><text>MCF-7 cells</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1141" length="14"/><text>cxcr5 promoter</text></annotation><annotation id="24"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="1141" length="5"/><text>cxcr5</text></annotation><annotation id="25"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>p53</text></annotation><annotation id="26"><infon key="identifier">643</infon><infon key="type">GENE</infon><location offset="28" length="5"/><text>CXCR5</text></annotation><annotation id="27"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="633" length="11"/><text>MCF-7 cells</text></annotation><annotation id="28"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="129" length="6"/><text>tumors</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="226" length="11"/><text>tumor cells</text></annotation><annotation id="30"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="388" length="3"/><text>p53</text></annotation></passage></document>
<document><id>25801169</id><passage><offset>0</offset><text>Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Super-enhancers and stretch enhancers (SEs) drive expression of genes that play prominent roles in normal and disease cells, but the functional importance of these clustered enhancer elements is poorly understood, so it is not clear why genes key to cell identity have evolved regulation by such elements. Here, we show that SEs consist of functional constituent units that concentrate multiple developmental signaling pathways at key pluripotency genes in embryonic stem cells and confer enhanced responsiveness to signaling of their associated genes. Cancer cells frequently acquire SEs at genes that promote tumorigenesis, and we show that these genes are especially sensitive to perturbation of oncogenic signaling pathways. Super-enhancers thus provide a platform for signaling pathways to regulate genes that control cell identity during development and tumorigenesis.</text><annotation id="1"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="555" length="20"/><text>embryonic stem cells</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="651" length="12"/><text>Cancer cells</text></annotation></passage></document>
<document><id>26110280</id><passage><offset>0</offset><text>An insulator element located at the cyclin B1 interacting protein 1 gene locus is highly conserved among mammalian species. Insulators are cis-elements that control the direction of enhancer and silencer activities (enhancer-blocking) and protect genes from silencing by heterochromatinization (barrier activity). Understanding insulators is critical to elucidate gene regulatory mechanisms at chromosomal domain levels. Here, we focused on a genomic region upstream of the mouse Ccnb1ip1 (cyclin B1 interacting protein 1) gene that was methylated in E9.5 embryos of the C57BL/6 strain, but unmethylated in those of the 129X1/SvJ and JF1/Ms strains. We hypothesized the existence of an insulator-type element that prevents the spread of DNA methylation within the 1.8 kbp segment, and actually identified a 242-bp and a 185-bp fragments that were located adjacent to each other and showed insulator and enhancer activities, respectively, in reporter assays. We designated these genomic regions as the Ccnb1ip1 insulator and the Ccnb1ip1 enhancer. The Ccnb1ip1 insulator showed enhancer-blocking activity in the luciferase assays and barrier activity in the colony formation assays. Further examination of the Ccnb1ip1 locus in other mammalian species revealed that the insulator and enhancer are highly conserved among a wide variety of species, and are located immediately upstream of the transcriptional start site of Ccnb1ip1. These newly identified cis-elements may be involved in transcriptional regulation of Ccnb1ip1, which is important in meiotic crossing-over and G2/M transition of the mitotic cell cycle.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="820" length="16"/><text>185-bp fragments</text></annotation><annotation id="2"><infon key="identifier">239083</infon><infon key="type">GENE</infon><location offset="490" length="31"/><text>cyclin B1 interacting protein 1</text></annotation><annotation id="3"><infon key="identifier">57820</infon><infon key="type">GENE</infon><location offset="1001" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="571" length="7"/><text>C57BL/6</text></annotation><annotation id="5"><infon key="identifier">57820</infon><infon key="type">GENE</infon><location offset="1051" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="6"><infon key="identifier">57820</infon><infon key="type">GENE</infon><location offset="1209" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="7"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1233" length="9"/><text>mammalian</text></annotation><annotation id="8"><infon key="identifier">239083</infon><infon key="type">GENE</infon><location offset="1028" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="9"><infon key="identifier">57820</infon><infon key="type">GENE</infon><location offset="1515" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="10"><infon key="identifier">239083</infon><infon key="type">GENE</infon><location offset="1420" length="8"/><text>Ccnb1ip1</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="620" length="9"/><text>129X1/SvJ</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1283" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="634" length="6"/><text>JF1/Ms</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1028" length="17"/><text>Ccnb1ip1 enhancer</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1354" length="74"/><text>located immediately upstream of the transcriptional start site of Ccnb1ip1</text></annotation><annotation id="16"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="556" length="7"/><text>embryos</text></annotation><annotation id="17"><infon key="identifier">57820</infon><infon key="type">GENE</infon><location offset="36" length="31"/><text>cyclin B1 interacting protein 1</text></annotation><annotation id="18"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="105" length="9"/><text>mammalian</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="474" length="5"/><text>mouse</text></annotation><annotation id="20"><infon key="identifier">239083</infon><infon key="type">GENE</infon><location offset="480" length="8"/><text>Ccnb1ip1</text></annotation></passage></document>
<document><id>26163528</id><passage><offset>0</offset><text>Id2 deletion attenuates Apc-deficient ileal tumor formation. The expression level of inhibitor of DNA binding 2 (Id2) is increased in colorectal carcinomas and is positively correlated with poor prognosis. However, the functional significance of Id2 in intestinal tumorigenesis has not been fully defined using genetic approaches. Here, we show that Id2 promotes ileal tumor initiation in Apc-deficient mice. Expression of Id2 was stimulated by Wnt signaling through the enhancer region of the Id2 promoter at the early stage of tumorigenesis in Apc(+/Delta716) (Apc(Delta716)) mice. Genetic depletion of Id2 in Apc(Delta716) mice caused ~80% reduction in the number of ileal polyps, but had little effect on tumor size. Notably, the lack of Id2 increased the number of apoptotic cells in the normal crypt epithelium of the mice. Furthermore, DNA microarray analysis revealed that the expression level of Max dimerization protein 1 (Mxd1), known as a c-Myc antagonist, was specifically increased by Id2 deletion in the ileal intestinal epithelium of Apc(Delta716) mice. In contrast, the protein level of c-Myc, but not the mRNA level, was decreased by loss of Id2 in these mice. These results indicate that loss of Id2 inhibits tumor initiation by up-regulation of Mxd1 and down-regulation of c-Myc in Apc(Delta716) mice.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="471" length="35"/><text>enhancer region of the Id2 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="494" length="12"/><text>Id2 promoter</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="403" length="4"/><text>mice</text></annotation><annotation id="4"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="423" length="3"/><text>Id2</text></annotation><annotation id="5"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="389" length="3"/><text>Apc</text></annotation><annotation id="6"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="546" length="3"/><text>Apc</text></annotation><annotation id="7"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="951" length="5"/><text>c-Myc</text></annotation><annotation id="8"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="563" length="3"/><text>Apc</text></annotation><annotation id="9"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="1104" length="5"/><text>c-Myc</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="578" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="605" length="3"/><text>Id2</text></annotation><annotation id="12"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="612" length="3"/><text>Apc</text></annotation><annotation id="13"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>Id2</text></annotation><annotation id="14"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="1293" length="5"/><text>c-Myc</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="626" length="4"/><text>mice</text></annotation><annotation id="16"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="494" length="3"/><text>Id2</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="709" length="5"/><text>tumor</text></annotation><annotation id="18"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="742" length="3"/><text>Id2</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="824" length="4"/><text>mice</text></annotation><annotation id="20"><infon key="identifier">17119</infon><infon key="type">GENE</infon><location offset="905" length="26"/><text>Max dimerization protein 1</text></annotation><annotation id="21"><infon key="identifier">17119</infon><infon key="type">GENE</infon><location offset="933" length="4"/><text>Mxd1</text></annotation><annotation id="22"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="999" length="3"/><text>Id2</text></annotation><annotation id="23"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="1050" length="3"/><text>Apc</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0006801</infon><infon key="type">DISEASE</infon><location offset="24" length="25"/><text>Apc-deficient ileal tumor</text></annotation><annotation id="25"><infon key="identifier">0000416</infon><infon key="type">TISSUE</infon><location offset="806" length="10"/><text>epithelium</text></annotation><annotation id="26"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1064" length="4"/><text>mice</text></annotation><annotation id="27"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="1160" length="3"/><text>Id2</text></annotation><annotation id="28"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1173" length="4"/><text>mice</text></annotation><annotation id="29"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="1215" length="3"/><text>Id2</text></annotation><annotation id="30"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1228" length="5"/><text>tumor</text></annotation><annotation id="31"><infon key="identifier">17119</infon><infon key="type">GENE</infon><location offset="1265" length="4"/><text>Mxd1</text></annotation><annotation id="32"><infon key="identifier">11789</infon><infon key="type">GENE</infon><location offset="1302" length="3"/><text>Apc</text></annotation><annotation id="33"><infon key="identifier">0000781</infon><infon key="type">TISSUE</infon><location offset="1019" length="27"/><text>ileal intestinal epithelium</text></annotation><annotation id="34"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1316" length="4"/><text>mice</text></annotation><annotation id="35"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="85" length="26"/><text>inhibitor of DNA binding 2</text></annotation><annotation id="36"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="113" length="3"/><text>Id2</text></annotation><annotation id="37"><infon key="attribute">CANCER</infon><infon key="identifier">0024331</infon><infon key="type">DISEASE</infon><location offset="134" length="21"/><text>colorectal carcinomas</text></annotation><annotation id="38"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="246" length="3"/><text>Id2</text></annotation><annotation id="39"><infon key="identifier">15902</infon><infon key="type">GENE</infon><location offset="350" length="3"/><text>Id2</text></annotation><annotation id="40"><infon key="attribute">CANCER</infon><infon key="identifier">0006801</infon><infon key="type">DISEASE</infon><location offset="363" length="11"/><text>ileal tumor</text></annotation></passage></document>
<document><id>26166704</id><passage><offset>0</offset><text>Condensin I and II Complexes License Full Estrogen Receptor alpha-Dependent Enhancer Activation. Enhancers instruct spatio-temporally specific gene expression in a manner tightly linked to higher-order chromatin architecture. Critical chromatin architectural regulators condensin I and condensin II play non-redundant roles controlling mitotic chromosomes. But the chromosomal locations of condensins and their functional roles in interphase are poorly understood. Here we report that both condensin complexes exhibit an unexpected, dramatic estrogen-induced recruitment to estrogen receptor alpha (ER-alpha)-bound eRNA(+) active enhancers in interphase breast cancer cells, exhibiting non-canonical interaction with ER-alpha via its DNA-binding domain (DBD). Condensins positively regulate ligand-dependent enhancer activation at least in part by recruiting an E3 ubiquitin ligase, HECTD1, to modulate the binding of enhancer-associated coactivators/corepressors, including p300 and RIP140, permitting full eRNA transcription, formation of enhancer:promoter looping, and the resultant coding gene activation. Collectively, our results reveal an important, unanticipated transcriptional role of interphase condensins in modulating estrogen-regulated enhancer activation and coding gene transcriptional program.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="654" length="19"/><text>breast cancer cells</text></annotation><annotation id="2"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="717" length="8"/><text>ER-alpha</text></annotation><annotation id="3"><infon key="identifier">25831</infon><infon key="type">GENE</infon><location offset="883" length="6"/><text>HECTD1</text></annotation><annotation id="4"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="975" length="4"/><text>p300</text></annotation><annotation id="5"><infon key="identifier">8204</infon><infon key="type">GENE</infon><location offset="984" length="6"/><text>RIP140</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="574" length="65"/><text>estrogen receptor alpha (ER-alpha)-bound eRNA(+) active enhancers</text></annotation><annotation id="7"><infon key="attribute">RNA,INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1008" length="4"/><text>eRNA</text></annotation><annotation id="8"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="574" length="23"/><text>estrogen receptor alpha</text></annotation><annotation id="9"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="599" length="8"/><text>ER-alpha</text></annotation><annotation id="10"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="42" length="23"/><text>Estrogen Receptor alpha</text></annotation></passage></document>
<document><id>26211970</id><passage><offset>0</offset><text>Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants. The gene(s) whose expression is regulated by allergy risk variants is unknown for many loci identified through genome-wide association studies. Addressing this knowledge gap might point to new therapeutic targets for allergic disease. The aim of this study was to identify the target gene(s) and the functional variant(s) underlying the association between rs7009110 on chromosome 8q21 and allergies. Eight genes are located within 1 Mb of rs7009110. Multivariate association analysis of publicly available exon expression levels from lymphoblastoid cell lines (LCLs) identified a significant association between rs7009110 and the expression of a single gene, PAG1 (p = 0.0017), 732 kb away. Analysis of histone modifications and DNase I hypersensitive sites in LCLs identified four putative regulatory elements (PREs) in the region. Chromosome conformation capture confirmed that two PREs interacted with the PAG1 promoter, one in allele-specific fashion. To determine whether these PREs were functional, LCLs were transfected with PAG1 promoter-driven luciferase reporter constructs. PRE3 acted as a transcriptional enhancer for PAG1 exclusively when it carried the rs2370615:C allergy predisposing allele, a variant in complete linkage disequilibrium with rs7009110. As such, rs2370615, which overlaps RelA transcription factor (TF) binding in LCLs and was found to disrupt Foxo3a binding to PRE3, represents the putative functional variant in this locus. Our studies suggest that the risk-associated allele of rs2370615 predisposes to allergic disease by increasing PAG1 expression, which might promote B cell activation and have a pro-inflammatory effect. Inhibition of PAG1 expression or function might have therapeutic potential for allergic diseases.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="982" length="13"/><text>PAG1 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1105" length="13"/><text>PAG1 promoter</text></annotation><annotation id="3"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="732" length="4"/><text>PAG1</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1158" length="4"/><text>PRE3</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1467" length="4"/><text>PRE3</text></annotation><annotation id="6"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1679" length="6"/><text>B cell</text></annotation><annotation id="7"><infon key="comment">chr8:80378152,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2370615</infon><location offset="1240" length="9"/><text>rs2370615</text></annotation><annotation id="8"><infon key="comment">chr8:80379644,T,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs7009110</infon><location offset="1331" length="9"/><text>rs7009110</text></annotation><annotation id="9"><infon key="comment">chr8:80378152,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2370615</infon><location offset="1351" length="9"/><text>rs2370615</text></annotation><annotation id="10"><infon key="identifier">2309</infon><infon key="type">GENE</infon><location offset="1449" length="6"/><text>Foxo3a</text></annotation><annotation id="11"><infon key="comment">chr8:80378152,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2370615</infon><location offset="1586" length="9"/><text>rs2370615</text></annotation><annotation id="12"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="1611" length="16"/><text>allergic disease</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1174" length="33"/><text>transcriptional enhancer for PAG1</text></annotation><annotation id="14"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="1642" length="4"/><text>PAG1</text></annotation><annotation id="15"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="1747" length="4"/><text>PAG1</text></annotation><annotation id="16"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="1812" length="17"/><text>allergic diseases</text></annotation><annotation id="17"><infon key="identifier">0000773</infon><infon key="type">TISSUE</infon><location offset="1419" length="4"/><text>LCLs</text></annotation><annotation id="18"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="49" length="7"/><text>Allergy</text></annotation><annotation id="19"><infon key="identifier">0000773</infon><infon key="type">TISSUE</infon><location offset="607" length="25"/><text>lymphoblastoid cell lines</text></annotation><annotation id="20"><infon key="identifier">0000773</infon><infon key="type">TISSUE</infon><location offset="634" length="4"/><text>LCLs</text></annotation><annotation id="21"><infon key="identifier">0000773</infon><infon key="type">TISSUE</infon><location offset="834" length="4"/><text>LCLs</text></annotation><annotation id="22"><infon key="identifier">0000773</infon><infon key="type">TISSUE</infon><location offset="1078" length="4"/><text>LCLs</text></annotation><annotation id="23"><infon key="identifier">5970</infon><infon key="type">GENE</infon><location offset="1377" length="4"/><text>RelA</text></annotation><annotation id="24"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="25" length="4"/><text>PAG1</text></annotation><annotation id="25"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="1203" length="4"/><text>PAG1</text></annotation><annotation id="26"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="982" length="4"/><text>PAG1</text></annotation><annotation id="27"><infon key="identifier">55824</infon><infon key="type">GENE</infon><location offset="1105" length="4"/><text>PAG1</text></annotation><annotation id="28"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="117" length="7"/><text>allergy</text></annotation><annotation id="29"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="289" length="16"/><text>allergic disease</text></annotation><annotation id="30"><infon key="comment">chr8:80379644,T,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs7009110</infon><location offset="429" length="9"/><text>rs7009110</text></annotation><annotation id="31"><infon key="identifier">0005271</infon><infon key="type">DISEASE</infon><location offset="462" length="9"/><text>allergies</text></annotation><annotation id="32"><infon key="comment">chr8:80379644,T,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs7009110</infon><location offset="512" length="9"/><text>rs7009110</text></annotation><annotation id="33"><infon key="comment">chr8:80379644,T,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs7009110</infon><location offset="685" length="9"/><text>rs7009110</text></annotation></passage></document>
<document><id>26214589</id><passage><offset>0</offset><text>Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite. Deciphering the ways in which somatic mutations and germline susceptibility variants cooperate to promote cancer is challenging. Ewing sarcoma is characterized by fusions between EWSR1 and members of the ETS gene family, usually EWSR1-FLI1, leading to the generation of oncogenic transcription factors that bind DNA at GGAA motifs. A recent genome-wide association study identified susceptibility variants near EGR2. Here we found that EGR2 knockdown inhibited proliferation, clonogenicity and spheroidal growth in vitro and induced regression of Ewing sarcoma xenografts. Targeted germline deep sequencing of the EGR2 locus in affected subjects and controls identified 291 Ewing-associated SNPs. At rs79965208, the A risk allele connected adjacent GGAA repeats by converting an interspaced GGAT motif into a GGAA motif, thereby increasing the number of consecutive GGAA motifs and thus the EWSR1-FLI1-dependent enhancer activity of this sequence, with epigenetic characteristics of an active regulatory element. EWSR1-FLI1 preferentially bound to the A risk allele, which increased global and allele-specific EGR2 expression. Collectively, our findings establish cooperation between a dominant oncogene and a susceptibility variant that regulates a major driver of Ewing sarcomagenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="991" length="55"/><text>EWSR1-FLI1-dependent enhancer activity of this sequence</text></annotation><annotation id="2"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="9" length="5"/><text>EWSR1</text></annotation><annotation id="3"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="511" length="4"/><text>EGR2</text></annotation><annotation id="4"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="536" length="4"/><text>EGR2</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="647" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="6"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="714" length="4"/><text>EGR2</text></annotation><annotation id="7"><infon key="comment">chr10:62977815,T,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs79965208</infon><location offset="800" length="10"/><text>rs79965208</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="891" length="10"/><text>GGAT motif</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="909" length="10"/><text>GGAA motif</text></annotation><annotation id="10"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="991" length="5"/><text>EWSR1</text></annotation><annotation id="11"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="1119" length="4"/><text>FLI1</text></annotation><annotation id="12"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="1210" length="4"/><text>EGR2</text></annotation><annotation id="13"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="15" length="4"/><text>FLI1</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="1366" length="20"/><text>Ewing sarcomagenesis</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="966" length="11"/><text>GGAA motifs</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="419" length="11"/><text>GGAA motifs</text></annotation><annotation id="17"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="1113" length="5"/><text>EWSR1</text></annotation><annotation id="18"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="997" length="4"/><text>FLI1</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="34" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="20"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="68" length="4"/><text>EGR2</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="206" length="6"/><text>cancer</text></annotation><annotation id="22"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="229" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="23"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="279" length="5"/><text>EWSR1</text></annotation><annotation id="24"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="329" length="5"/><text>EWSR1</text></annotation><annotation id="25"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="335" length="4"/><text>FLI1</text></annotation></passage></document>
<document><id>26216945</id><passage><offset>0</offset><text>MIR retrotransposon sequences provide insulators to the human genome. Insulators are regulatory elements that help to organize eukaryotic chromatin via enhancer-blocking and chromatin barrier activity. Although there are several examples of transposable element (TE)-derived insulators, the contribution of TEs to human insulators has not been systematically explored. Mammalian-wide interspersed repeats (MIRs) are a conserved family of TEs that have substantial regulatory capacity and share sequence characteristics with tRNA-related insulators. We sought to evaluate whether MIRs can serve as insulators in the human genome. We applied a bioinformatic screen using genome sequence and functional genomic data from CD4(+) T cells to identify a set of 1,178 predicted MIR insulators genome-wide. These predicted MIR insulators were computationally tested to serve as chromatin barriers and regulators of gene expression in CD4(+) T cells. The activity of predicted MIR insulators was experimentally validated using in vitro and in vivo enhancer-blocking assays. MIR insulators are enriched around genes of the T-cell receptor pathway and reside at T-cell-specific boundaries of repressive and active chromatin. A total of 58% of the MIR insulators predicted here show evidence of T-cell-specific chromatin barrier and gene regulatory activity. MIR insulators appear to be CCCTC-binding factor (CTCF) independent and show a distinct local chromatin environment with marked peaks for RNA Pol III and a number of histone modifications, suggesting that MIR insulators recruit transcriptional complexes and chromatin modifying enzymes in situ to help establish chromatin and regulatory domains in the human genome. The provisioning of insulators by MIRs across the human genome suggests a specific mechanism by which TE sequences can be used to modulate gene regulatory networks.</text><annotation id="1"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="925" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="2"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1374" length="20"/><text>CCCTC-binding factor</text></annotation><annotation id="3"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1396" length="4"/><text>CTCF</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1698" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1762" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="718" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="56" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="314" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="369" length="9"/><text>Mammalian</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="615" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1112" length="6"/><text>T-cell</text></annotation><annotation id="12"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1150" length="6"/><text>T-cell</text></annotation><annotation id="13"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1282" length="6"/><text>T-cell</text></annotation></passage></document>
<document><id>26229090</id><passage><offset>0</offset><text>Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. UNLABELLED: B-cell lymphomas frequently contain genomic rearrangements that lead to oncogene activation by heterologous distal regulatory elements. We used a novel approach called "pinpointing enhancer-associated rearrangements by chromatin immunoprecipitation," or PEAR-ChIP, to simultaneously map enhancer activity and proximal rearrangements in lymphoma cell lines and patient biopsies. This method detects rearrangements involving known cancer genes, including CCND1, BCL2, MYC, PDCD1LG2, NOTCH1, CIITA, and SGK1, as well as novel enhancer duplication events of likely oncogenic significance. We identify lymphoma subtype-specific enhancers in the MYC locus that are silenced in lymphomas with MYC-activating rearrangements and are associated with germline polymorphisms that alter lymphoma risk. We show that BCL6-locus enhancers are acetylated by the BCL6-activating transcription factor MEF2B, and can undergo genomic duplication, or target the MYC promoter for activation in the context of a "pseudo-double-hit" t(3;8)(q27;q24) rearrangement linking the BCL6 and MYC loci. Our work provides novel insights regarding enhancer-driven oncogene activation in lymphoma. SIGNIFICANCE: We demonstrate a novel approach for simultaneous detection of genomic rearrangements and enhancer activity in tumor biopsies. We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an "enhancer hijacking" translocation.</text><annotation id="1"><infon key="identifier">0000104</infon><infon key="type">TISSUE</infon><location offset="461" length="19"/><text>lymphoma cell lines</text></annotation><annotation id="2"><infon key="identifier">604</infon><infon key="type">GENE</infon><location offset="1534" length="4"/><text>BCL6</text></annotation><annotation id="3"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1065" length="3"/><text>MYC</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0004095</infon><infon key="type">DISEASE</infon><location offset="96" length="15"/><text>B-cell Lymphoma</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0004095</infon><infon key="type">DISEASE</infon><location offset="125" length="16"/><text>B-cell lymphomas</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="554" length="6"/><text>cancer</text></annotation><annotation id="7"><infon key="identifier">595</infon><infon key="type">GENE</infon><location offset="578" length="5"/><text>CCND1</text></annotation><annotation id="8"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="585" length="4"/><text>BCL2</text></annotation><annotation id="9"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="591" length="3"/><text>MYC</text></annotation><annotation id="10"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="765" length="3"/><text>MYC</text></annotation><annotation id="11"><infon key="identifier">80380</infon><infon key="type">GENE</infon><location offset="596" length="8"/><text>PDCD1LG2</text></annotation><annotation id="12"><infon key="identifier">4851</infon><infon key="type">GENE</infon><location offset="606" length="6"/><text>NOTCH1</text></annotation><annotation id="13"><infon key="identifier">4261</infon><infon key="type">GENE</infon><location offset="614" length="5"/><text>CIITA</text></annotation><annotation id="14"><infon key="identifier">6446</infon><infon key="type">GENE</infon><location offset="625" length="4"/><text>SGK1</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005062</infon><infon key="type">DISEASE</infon><location offset="796" length="9"/><text>lymphomas</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="811" length="3"/><text>MYC</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0005062</infon><infon key="type">DISEASE</infon><location offset="899" length="8"/><text>lymphoma</text></annotation><annotation id="18"><infon key="identifier">604</infon><infon key="type">GENE</infon><location offset="970" length="4"/><text>BCL6</text></annotation><annotation id="19"><infon key="identifier">100271849</infon><infon key="type">GENE</infon><location offset="1007" length="5"/><text>MEF2B</text></annotation><annotation id="20"><infon key="identifier">604</infon><infon key="type">GENE</infon><location offset="1175" length="4"/><text>BCL6</text></annotation><annotation id="21"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1184" length="3"/><text>MYC</text></annotation><annotation id="22"><infon key="attribute">CANCER</infon><infon key="identifier">0005062</infon><infon key="type">DISEASE</infon><location offset="1276" length="8"/><text>lymphoma</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1410" length="5"/><text>tumor</text></annotation><annotation id="24"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1502" length="3"/><text>MYC</text></annotation><annotation id="25"><infon key="identifier">604</infon><infon key="type">GENE</infon><location offset="1510" length="4"/><text>BCL6</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="722" length="52"/><text>lymphoma subtype-specific enhancers in the MYC locus</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="927" length="20"/><text>BCL6-locus enhancers</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1065" length="12"/><text>MYC promoter</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1534" length="10"/><text>BCL6 locus</text></annotation><annotation id="30"><infon key="identifier">0005062</infon><infon key="type">DISEASE</infon><location offset="722" length="8"/><text>lymphoma</text></annotation><annotation id="31"><infon key="identifier">604</infon><infon key="type">GENE</infon><location offset="927" length="4"/><text>BCL6</text></annotation></passage></document>
<document><id>26232425</id><passage><offset>0</offset><text>Pregnane X Receptor Represses HNF4alpha Gene to Induce Insulin-Like Growth Factor-Binding Protein IGFBP1 that Alters Morphology of and Migrates HepG2 Cells. Upon treatment with the pregnane X receptor (PXR) activator rifampicin (RIF), human hepatocellular carcinoma HepG2-derived ShP51 cells that stably express PXR showed epithelial-mesenchymal transition (EMT)-like morphological changes and migration. Our recent DNA microarrays have identified hepatocyte nuclear factor (HNF) 4alpha and insulin-like growth factor-binding protein (IGFBP) 1 mRNAs to be downregulated and upregulated, respectively, in RIF-treated ShP51 cells, and these regulations were confirmed by the subsequent real-time polymerase chain reaction and Western blot analyses. Using this cell system, we demonstrated here that the PXR-HNF4alpha-IGFBP1 pathway is an essential signal for PXR-induced morphological changes and migration. First, we characterized the molecular mechanism underlying the PXR-mediated repression of the HNF4alpha gene. Chromatin conformation capture and chromatin immunoprecipitation (ChIP) assays revealed that PXR activation by RIF disrupted enhancer-promoter communication and prompted deacetylation of histone H3 in the HNF4alpha P1 promoter. Cell-based reporter and ChIP assays showed that PXR targeted the distal enhancer of the HNF4alpha P1 promoter and stimulated dissociation of HNF3beta from the distal enhancer. Subsequently, small interfering RNA knockdown of HNF4alpha connected PXR-mediated gene regulation with the PXR-induced cellular responses, showing that the knockdown resulted in the upregulation of IGFBP1 and EMT-like morphological changes without RIF treatment. Moreover, recombinant IGFBP1 augmented migration, whereas an anti-IGFBP1 antibody attenuated both PXR-induced morphological changes and migration in ShP51 cells. PXR indirectly activated the IGFBP1 gene by repressing the HNF4alpha gene, thus enabling upregulation of IGFBP1 to change the morphology of ShP51 cells and cause migration. These results provide new insights into PXR-mediated cellular responses toward xenobiotics including therapeutics.</text><annotation id="1"><infon key="type">TISSUE</infon><location offset="1832" length="11"/><text>ShP51 cells</text></annotation><annotation id="2"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="202" length="3"/><text>PXR</text></annotation><annotation id="3"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="55" length="42"/><text>Insulin-Like Growth Factor-Binding Protein</text></annotation><annotation id="4"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="241" length="24"/><text>hepatocellular carcinoma</text></annotation><annotation id="5"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="312" length="3"/><text>PXR</text></annotation><annotation id="6"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="448" length="38"/><text>hepatocyte nuclear factor (HNF) 4alpha</text></annotation><annotation id="7"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="491" length="52"/><text>insulin-like growth factor-binding protein (IGFBP) 1</text></annotation><annotation id="8"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="801" length="3"/><text>PXR</text></annotation><annotation id="9"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="805" length="9"/><text>HNF4alpha</text></annotation><annotation id="10"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="815" length="6"/><text>IGFBP1</text></annotation><annotation id="11"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="857" length="3"/><text>PXR</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1221" length="21"/><text>HNF4alpha P1 promoter</text></annotation><annotation id="13"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="969" length="3"/><text>PXR</text></annotation><annotation id="14"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="1000" length="9"/><text>HNF4alpha</text></annotation><annotation id="15"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1109" length="3"/><text>PXR</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1403" length="15"/><text>distal enhancer</text></annotation><annotation id="17"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1292" length="3"/><text>PXR</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="235" length="5"/><text>human</text></annotation><annotation id="19"><infon key="identifier">3170</infon><infon key="type">GENE</infon><location offset="1385" length="8"/><text>HNF3beta</text></annotation><annotation id="20"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="1469" length="9"/><text>HNF4alpha</text></annotation><annotation id="21"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1489" length="3"/><text>PXR</text></annotation><annotation id="22"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1527" length="3"/><text>PXR</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1309" length="44"/><text>distal enhancer of the HNF4alpha P1 promoter</text></annotation><annotation id="24"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1618" length="6"/><text>IGFBP1</text></annotation><annotation id="25"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1705" length="6"/><text>IGFBP1</text></annotation><annotation id="26"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1749" length="6"/><text>IGFBP1</text></annotation><annotation id="27"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1781" length="3"/><text>PXR</text></annotation><annotation id="28"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="1845" length="3"/><text>PXR</text></annotation><annotation id="29"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1874" length="6"/><text>IGFBP1</text></annotation><annotation id="30"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="1904" length="9"/><text>HNF4alpha</text></annotation><annotation id="31"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1950" length="6"/><text>IGFBP1</text></annotation><annotation id="32"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="2058" length="3"/><text>PXR</text></annotation><annotation id="33"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="1221" length="9"/><text>HNF4alpha</text></annotation><annotation id="34"><infon key="type">TISSUE</infon><location offset="1985" length="11"/><text>ShP51 cells</text></annotation><annotation id="35"><infon key="identifier">0006301</infon><infon key="type">TISSUE</infon><location offset="144" length="11"/><text>HepG2 Cells</text></annotation><annotation id="36"><infon key="identifier">0006301</infon><infon key="type">TISSUE</infon><location offset="266" length="5"/><text>HepG2</text></annotation><annotation id="37"><infon key="type">TISSUE</infon><location offset="280" length="11"/><text>ShP51 cells</text></annotation><annotation id="38"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="1332" length="9"/><text>HNF4alpha</text></annotation><annotation id="39"><infon key="type">TISSUE</infon><location offset="616" length="11"/><text>ShP51 cells</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1332" length="21"/><text>HNF4alpha P1 promoter</text></annotation><annotation id="41"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="0" length="19"/><text>Pregnane X Receptor</text></annotation><annotation id="42"><infon key="identifier">3172</infon><infon key="type">GENE</infon><location offset="30" length="9"/><text>HNF4alpha</text></annotation><annotation id="43"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="98" length="6"/><text>IGFBP1</text></annotation><annotation id="44"><infon key="identifier">8856</infon><infon key="type">GENE</infon><location offset="181" length="19"/><text>pregnane X receptor</text></annotation></passage></document>
<document><id>26257179</id><passage><offset>0</offset><text>Nuclear Fractionation Reveals Thousands of Chromatin-Tethered Noncoding RNAs Adjacent to Active Genes. A number of long noncoding RNAs (lncRNAs) have been reported to regulate transcription via recruitment of chromatin modifiers or bridging distal enhancer elements to gene promoters. However, the generality of these modes of regulation and the mechanisms of chromatin attachment for thousands of unstudied human lncRNAs remain unclear. To address these questions, we performed stringent nuclear fractionation coupled to RNA sequencing. We provide genome-wide identification of human chromatin-associated lncRNAs and demonstrate tethering of RNA to chromatin by RNAPII is a pervasive mechanism of attachment. We also uncovered thousands of chromatin-enriched RNAs (cheRNAs) that share molecular properties with known lncRNAs. Although distinct from eRNAs derived from active prototypical enhancers, the production of cheRNAs is strongly correlated with the expression of neighboring protein-coding genes. This work provides an updated framework for nuclear RNA organization that includes a large chromatin-associated transcript population correlated with active genes and may prove useful in de novo enhancer annotation.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="408" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="579" length="5"/><text>human</text></annotation></passage></document>
<document><id>26300977</id><passage><offset>0</offset><text>A chromosomal rearrangement in a child with severe speech and language disorder separates FOXP2 from a functional enhancer. Mutations of FOXP2 in 7q31 cause a rare disorder involving speech apraxia, accompanied by expressive and receptive language impairments. A recent report described a child with speech and language deficits, and a genomic rearrangement affecting chromosomes 7 and 11. One breakpoint mapped to 7q31 and, although outside its coding region, was hypothesised to disrupt FOXP2 expression. We identified an element 2 kb downstream of this breakpoint with epigenetic characteristics of an enhancer. We show that this element drives reporter gene expression in human cell-lines. Thus, displacement of this element by translocation may disturb gene expression, contributing to the observed language phenotype.</text><annotation id="1"><infon key="identifier">93986</infon><infon key="type">GENE</infon><location offset="90" length="5"/><text>FOXP2</text></annotation><annotation id="2"><infon key="identifier">93986</infon><infon key="type">GENE</infon><location offset="137" length="5"/><text>FOXP2</text></annotation><annotation id="3"><infon key="identifier">0004750</infon><infon key="type">DISEASE</infon><location offset="62" length="17"/><text>language disorder</text></annotation><annotation id="4"><infon key="identifier">0004750</infon><infon key="type">DISEASE</infon><location offset="311" length="17"/><text>language deficits</text></annotation><annotation id="5"><infon key="identifier">93986</infon><infon key="type">GENE</infon><location offset="489" length="5"/><text>FOXP2</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="676" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0004730</infon><infon key="type">DISEASE</infon><location offset="51" length="6"/><text>speech</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="114" length="8"/><text>enhancer</text></annotation><annotation id="9"><infon key="identifier">0011184</infon><infon key="type">DISEASE</infon><location offset="183" length="14"/><text>speech apraxia</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="524" length="89"/><text>element 2 kb downstream of this breakpoint with epigenetic characteristics of an enhancer</text></annotation><annotation id="11"><infon key="identifier">0004730</infon><infon key="type">DISEASE</infon><location offset="300" length="6"/><text>speech</text></annotation></passage></document>
<document><id>26303528</id><passage><offset>0</offset><text>The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells. Understanding how transcriptional regulators are themselves controlled is important in attaining a complete picture of the intracellular effects that follow signaling cascades during early development and cell-restricted differentiation. We have addressed this issue by focusing on the regulation of EKLF/KLF1, a zinc finger transcription factor that plays a necessary role in the global regulation of erythroid gene expression. Using biochemical affinity purification, we have identified the DEK oncoprotein as a critical factor that interacts with an essential upstream enhancer element of the EKLF promoter and exerts a positive effect on EKLF levels. This element also binds a core set of erythroid transcription factors, suggesting that DEK is part of a tissue-restricted enhanceosome that contains BMP4-dependent and -independent components. Together with local enrichment of properly coded histones and an open chromatin domain, optimal transcriptional activation of the EKLF locus can be established.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="653" length="46"/><text>upstream enhancer element of the EKLF promoter</text></annotation><annotation id="2"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="732" length="4"/><text>EKLF</text></annotation><annotation id="3"><infon key="identifier">7913</infon><infon key="type">GENE</infon><location offset="832" length="3"/><text>DEK</text></annotation><annotation id="4"><infon key="identifier">652</infon><infon key="type">GENE</infon><location offset="894" length="4"/><text>BMP4</text></annotation><annotation id="5"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="1068" length="4"/><text>EKLF</text></annotation><annotation id="6"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="783" length="9"/><text>erythroid</text></annotation><annotation id="7"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="492" length="9"/><text>erythroid</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="849" length="30"/><text>tissue-restricted enhanceosome</text></annotation><annotation id="9"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="51" length="4"/><text>EKLF</text></annotation><annotation id="10"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="56" length="4"/><text>KLF1</text></annotation><annotation id="11"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="686" length="4"/><text>EKLF</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="686" length="13"/><text>EKLF promoter</text></annotation><annotation id="13"><infon key="identifier">7913</infon><infon key="type">GENE</infon><location offset="4" length="3"/><text>DEK</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="51" length="18"/><text>EKLF/KLF1 Enhancer</text></annotation><annotation id="15"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="73" length="15"/><text>Erythroid Cells</text></annotation><annotation id="16"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="390" length="4"/><text>EKLF</text></annotation><annotation id="17"><infon key="identifier">10661</infon><infon key="type">GENE</infon><location offset="395" length="4"/><text>KLF1</text></annotation><annotation id="18"><infon key="identifier">7913</infon><infon key="type">GENE</infon><location offset="583" length="3"/><text>DEK</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="750" length="7"/><text>element</text></annotation></passage></document>
<document><id>26321200</id><passage><offset>0</offset><text>The Isl1/Ldb1 Complex Orchestrates Genome-wide Chromatin Organization to Instruct Differentiation of Multipotent Cardiac Progenitors. Cardiac stem/progenitor cells hold great potential for regenerative therapies; however, the mechanisms regulating their expansion and differentiation remain insufficiently defined. Here we show that Ldb1 is a central regulator of genome organization in cardiac progenitor cells, which is crucial for cardiac lineage differentiation and heart development. We demonstrate that Ldb1 binds to the key regulator of cardiac progenitors, Isl1, and protects it from degradation. Furthermore, the Isl1/Ldb1 complex promotes long-range enhancer-promoter interactions at the loci of the core cardiac transcription factors Mef2c and Hand2. Chromosome conformation capture followed by sequencing identified specific Ldb1-mediated interactions of the Isl1/Ldb1 responsive Mef2c anterior heart field enhancer with genes that play key roles in cardiac progenitor cell function and cardiovascular development. Importantly, the expression of these genes was downregulated upon Ldb1 depletion and Isl1/Ldb1 haplodeficiency. In conclusion, the Isl1/Ldb1 complex orchestrates a network for heart-specific transcriptional regulation and coordination in three-dimensional space during cardiogenesis.</text><annotation id="1"><infon key="type">TISSUE</infon><location offset="434" length="15"/><text>cardiac lineage</text></annotation><annotation id="2"><infon key="identifier">4208</infon><infon key="type">GENE</infon><location offset="745" length="5"/><text>Mef2c</text></annotation><annotation id="3"><infon key="identifier">9464</infon><infon key="type">GENE</infon><location offset="755" length="5"/><text>Hand2</text></annotation><annotation id="4"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="837" length="4"/><text>Ldb1</text></annotation><annotation id="5"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="871" length="4"/><text>Isl1</text></annotation><annotation id="6"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="876" length="4"/><text>Ldb1</text></annotation><annotation id="7"><infon key="identifier">4208</infon><infon key="type">GENE</infon><location offset="892" length="5"/><text>Mef2c</text></annotation><annotation id="8"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="1093" length="4"/><text>Ldb1</text></annotation><annotation id="9"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="1112" length="4"/><text>Isl1</text></annotation><annotation id="10"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="1117" length="4"/><text>Ldb1</text></annotation><annotation id="11"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="1158" length="4"/><text>Isl1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="871" length="56"/><text>Isl1/Ldb1 responsive Mef2c anterior heart field enhancer</text></annotation><annotation id="13"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="1163" length="4"/><text>Ldb1</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="898" length="20"/><text>anterior heart field</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="101" length="31"/><text>Multipotent Cardiac Progenitors</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="134" length="29"/><text>Cardiac stem/progenitor cells</text></annotation><annotation id="17"><infon key="type">TISSUE</infon><location offset="387" length="24"/><text>cardiac progenitor cells</text></annotation><annotation id="18"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="470" length="5"/><text>heart</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="544" length="19"/><text>cardiac progenitors</text></annotation><annotation id="20"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="4" length="4"/><text>Isl1</text></annotation><annotation id="21"><infon key="type">TISSUE</infon><location offset="962" length="23"/><text>cardiac progenitor cell</text></annotation><annotation id="22"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1203" length="5"/><text>heart</text></annotation><annotation id="23"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="9" length="4"/><text>Ldb1</text></annotation><annotation id="24"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="333" length="4"/><text>Ldb1</text></annotation><annotation id="25"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="509" length="4"/><text>Ldb1</text></annotation><annotation id="26"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="565" length="4"/><text>Isl1</text></annotation><annotation id="27"><infon key="identifier">3670</infon><infon key="type">GENE</infon><location offset="622" length="4"/><text>Isl1</text></annotation><annotation id="28"><infon key="identifier">8861</infon><infon key="type">GENE</infon><location offset="627" length="4"/><text>Ldb1</text></annotation></passage></document>
<document><id>26374622</id><passage><offset>0</offset><text>Identification and functional analysis of acute myeloid leukemia susceptibility associated single nucleotide polymorphisms at non-protein coding regions of RUNX1. Little is known about the susceptibility to acute myeloid leukemia. We aim to search non-protein coding regions of key hematopoiesis transcription factors for genetic variations associated with acute myeloid leukemia susceptibility. We genotyped SNPs of RUNX1 P1 promoter, P2 promoter, +23 enhancer, intron 5.2 enhancer, PU.1 promoter, CEBPA promoter, and CEBPE promoter from acute myeloid leukemia patients and healthy controls. Rs2249650 and rs2268276 at RUNX1 intron 5.2 enhancer were found to be associated with acute myeloid leukemia susceptibility. Artificial reporters containing different rs2249650 and rs2268276 alleles showed differential activities in the K562 cell line, a human immortalized myeloid leukemia line. Rs2249650 contributes to reporter activities more than rs2268276. Gel shift assay is consistent with the luciferase assay. Supershift assay indicated that one potential binding protein was PU.1. To sum up, rs2268276 and especially rs2249650 may be qualified as new acute myeloid leukemia susceptibility-associated SNPs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="417" length="17"/><text>RUNX1 P1 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="436" length="11"/><text>P2 promoter</text></annotation><annotation id="3"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="207" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="4"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="357" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="5"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="830" length="14"/><text>K562 cell line</text></annotation><annotation id="6"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="848" length="40"/><text>human immortalized myeloid leukemia line</text></annotation><annotation id="7"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="1079" length="4"/><text>PU.1</text></annotation><annotation id="8"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="417" length="5"/><text>RUNX1</text></annotation><annotation id="9"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="539" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="10"><infon key="comment">Rs2249650</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2249650</infon><location offset="593" length="9"/><text>Rs2249650</text></annotation><annotation id="11"><infon key="comment">rs2268276</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2268276</infon><location offset="607" length="9"/><text>rs2268276</text></annotation><annotation id="12"><infon key="identifier">6688</infon><infon key="type">GENE</infon><location offset="484" length="4"/><text>PU.1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="449" length="12"/><text>+23 enhancer</text></annotation><annotation id="14"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="679" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="15"><infon key="comment">rs2249650</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2249650</infon><location offset="760" length="9"/><text>rs2249650</text></annotation><annotation id="16"><infon key="comment">rs2268276</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2268276</infon><location offset="774" length="9"/><text>rs2268276</text></annotation><annotation id="17"><infon key="identifier">1050</infon><infon key="type">GENE</infon><location offset="499" length="5"/><text>CEBPA</text></annotation><annotation id="18"><infon key="identifier">1053</infon><infon key="type">GENE</infon><location offset="519" length="5"/><text>CEBPE</text></annotation><annotation id="19"><infon key="comment">Rs2249650</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2249650</infon><location offset="890" length="9"/><text>Rs2249650</text></annotation><annotation id="20"><infon key="comment">rs2268276</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2268276</infon><location offset="945" length="9"/><text>rs2268276</text></annotation><annotation id="21"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="620" length="5"/><text>RUNX1</text></annotation><annotation id="22"><infon key="comment">rs2268276</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2268276</infon><location offset="1096" length="9"/><text>rs2268276</text></annotation><annotation id="23"><infon key="comment">rs2249650</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2249650</infon><location offset="1121" length="9"/><text>rs2249650</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="463" length="19"/><text>intron 5.2 enhancer</text></annotation><annotation id="25"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="1155" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="484" length="13"/><text>PU.1 promoter</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="499" length="14"/><text>CEBPA promoter</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="519" length="14"/><text>CEBPE promoter</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="620" length="25"/><text>RUNX1 intron 5.2 enhancer</text></annotation><annotation id="30"><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="42" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="31"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="156" length="5"/><text>RUNX1</text></annotation></passage></document>
<document><id>26382291</id><passage><offset>0</offset><text>Disruptions in a cluster of computationally identified enhancers near FOXC1 and GMDS may influence brain development. Regulatory elements are more evolutionarily conserved and provide a larger mutational target than coding regions of the human genome, suggesting that mutations in non-coding regions contribute significantly to development and disease. Using a computational approach to predict gene regulatory enhancers, we found that many known and predicted embryonic enhancers cluster in genomic loci harboring development-associated genes. One of the densest clusters of predicted enhancers in the human genome is near the genes GMDS and FOXC1. GMDS encodes a short-chain mannose dehydrogenase enzyme involved in the regulation of hindbrain neural migration, and FOXC1 encodes a developmental transcription factor required for brain, heart, and eye development. We experimentally validate four novel enhancers in this locus and demonstrate that these enhancers show consistent activity during embryonic development in domains that overlap with the expression of FOXC1 and GMDS. These four enhancers contain binding motifs for several transcription factors, including the ZIC family of transcription factors. Removal of the ZIC binding sites significantly alters enhancer activity in three of these enhancers, reducing expression in the eye, hindbrain, and limb, suggesting a mechanism whereby ZIC family members may transcriptionally regulate FOXC1 and/or GMDS expression. Our findings uncover novel enhancer regions that may control transcription in a topological domain important for embryonic development.</text><annotation id="1"><infon key="identifier">2762</infon><infon key="type">GENE</infon><location offset="634" length="4"/><text>GMDS</text></annotation><annotation id="2"><infon key="identifier">2296</infon><infon key="type">GENE</infon><location offset="70" length="5"/><text>FOXC1</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="238" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="603" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">2296</infon><infon key="type">GENE</infon><location offset="643" length="5"/><text>FOXC1</text></annotation><annotation id="6"><infon key="identifier">2296</infon><infon key="type">GENE</infon><location offset="768" length="5"/><text>FOXC1</text></annotation><annotation id="7"><infon key="identifier">2296</infon><infon key="type">GENE</infon><location offset="1067" length="5"/><text>FOXC1</text></annotation><annotation id="8"><infon key="identifier">2762</infon><infon key="type">GENE</infon><location offset="1077" length="4"/><text>GMDS</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1228" length="17"/><text>ZIC binding sites</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="894" length="34"/><text>four novel enhancers in this locus</text></annotation><annotation id="11"><infon key="identifier">2762</infon><infon key="type">GENE</infon><location offset="650" length="4"/><text>GMDS</text></annotation><annotation id="12"><infon key="identifier">2296</infon><infon key="type">GENE</infon><location offset="1448" length="5"/><text>FOXC1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="956" length="9"/><text>enhancers</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1089" length="14"/><text>four enhancers</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1288" length="24"/><text>three of these enhancers</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1505" length="16"/><text>enhancer regions</text></annotation><annotation id="17"><infon key="identifier">2762</infon><infon key="type">GENE</infon><location offset="80" length="4"/><text>GMDS</text></annotation><annotation id="18"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="99" length="5"/><text>brain</text></annotation><annotation id="19"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="832" length="5"/><text>brain</text></annotation><annotation id="20"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="839" length="5"/><text>heart</text></annotation><annotation id="21"><infon key="identifier">0000439</infon><infon key="type">TISSUE</infon><location offset="850" length="3"/><text>eye</text></annotation><annotation id="22"><infon key="identifier">0000672</infon><infon key="type">TISSUE</infon><location offset="736" length="9"/><text>hindbrain</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1112" length="74"/><text>binding motifs for several transcription factors, including the ZIC family</text></annotation><annotation id="24"><infon key="identifier">2762</infon><infon key="type">GENE</infon><location offset="1461" length="4"/><text>GMDS</text></annotation><annotation id="25"><infon key="identifier">0000439</infon><infon key="type">TISSUE</infon><location offset="1341" length="3"/><text>eye</text></annotation><annotation id="26"><infon key="identifier">0000672</infon><infon key="type">TISSUE</infon><location offset="1346" length="9"/><text>hindbrain</text></annotation><annotation id="27"><infon key="identifier">0001492</infon><infon key="type">TISSUE</infon><location offset="1361" length="4"/><text>limb</text></annotation></passage></document>
<document><id>26423156</id><passage><offset>0</offset><text>CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. Long noncoding RNAs (lncRNAs) are emerging as important regulators of developmental pathways. However, their roles in human cardiac precursor cell (CPC) remain unexplored. To characterize the long noncoding transcriptome during human CPC cardiac differentiation, we profiled the lncRNA transcriptome in CPCs isolated from the human fetal heart and identified 570 lncRNAs that were modulated during cardiac differentiation. Many of these were associated with active cardiac enhancer and super enhancers (SE) with their expression being correlated with proximal cardiac genes. One of the most upregulated lncRNAs was a SE-associated lncRNA that was named CARMEN, (CAR)diac (M)esoderm (E)nhancer-associated (N)oncoding RNA. CARMEN exhibits RNA-dependent enhancing activity and is upstream of the cardiac mesoderm-specifying gene regulatory network. Interestingly, CARMEN interacts with SUZ12 and EZH2, two components of the polycomb repressive complex 2 (PRC2). We demonstrate that CARMEN knockdown inhibits cardiac specification and differentiation in cardiac precursor cells independently of MIR-143 and -145 expression, two microRNAs located proximal to the enhancer sequences. Importantly, CARMEN expression was activated during pathological remodeling in the mouse and human hearts, and was necessary for maintaining cardiac identity in differentiated cardiomyocytes. This study demonstrates therefore that CARMEN is a crucial regulator of cardiac cell differentiation and homeostasis.</text><annotation id="1"><infon key="type">TISSUE</infon><location offset="1179" length="23"/><text>cardiac precursor cells</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="455" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="782" length="6"/><text>CARMEN</text></annotation><annotation id="4"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="850" length="6"/><text>CARMEN</text></annotation><annotation id="5"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="990" length="6"/><text>CARMEN</text></annotation><annotation id="6"><infon key="identifier">23512</infon><infon key="type">GENE</infon><location offset="1012" length="5"/><text>SUZ12</text></annotation><annotation id="7"><infon key="identifier">2146</infon><infon key="type">GENE</infon><location offset="1022" length="4"/><text>EZH2</text></annotation><annotation id="8"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="1108" length="6"/><text>CARMEN</text></annotation><annotation id="9"><infon key="identifier">406935</infon><infon key="type">GENE</infon><location offset="1220" length="7"/><text>MIR-143</text></annotation><annotation id="10"><infon key="identifier">328968</infon><infon key="type">GENE</infon><location offset="1320" length="6"/><text>CARMEN</text></annotation><annotation id="11"><infon key="identifier">406937</infon><infon key="type">GENE</infon><location offset="1232" length="4"/><text>-145</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1390" length="5"/><text>mouse</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1400" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="1538" length="6"/><text>CARMEN</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="253" length="22"/><text>cardiac precursor cell</text></annotation><annotation id="16"><infon key="type">TISSUE</infon><location offset="277" length="3"/><text>CPC</text></annotation><annotation id="17"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="790" length="58"/><text>(CAR)diac (M)esoderm (E)nhancer-associated (N)oncoding RNA</text></annotation><annotation id="18"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="467" length="5"/><text>heart</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="1571" length="12"/><text>cardiac cell</text></annotation><annotation id="20"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1406" length="6"/><text>hearts</text></annotation><annotation id="21"><infon key="identifier">0003324</infon><infon key="type">TISSUE</infon><location offset="1483" length="14"/><text>cardiomyocytes</text></annotation><annotation id="22"><infon key="identifier">728264</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>CARMEN</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="10" length="5"/><text>human</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="247" length="5"/><text>human</text></annotation><annotation id="25"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="357" length="5"/><text>human</text></annotation><annotation id="26"><infon key="type">TISSUE</infon><location offset="363" length="3"/><text>CPC</text></annotation><annotation id="27"><infon key="type">TISSUE</infon><location offset="432" length="4"/><text>CPCs</text></annotation></passage></document>
<document><id>26427657</id><passage><offset>0</offset><text>ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients. Despite one third of breast (BC) and colorectal cancer (CRC) cases having a hereditary component, only a small proportion can be explained by germline mutations. The aim of this study was to identify potential genomic alterations related to cancer predisposition. Copy number variations (CNVs) were interrogated in 113 unrelated cases fulfilling the criteria for hereditary BC/CRC and presenting non-pathogenic mutations in BRCA1, BRCA2, MLH1, MSH2, TP53, and CHEK2 genes. An identical germline deep intronic deletion of ROBO1 was identified in three index patients using two microarray platforms (Agilent 4x180K and Affymetrix CytoScan HD). The ROBO1 deletion was confirmed by quantitative PCR (qPCR). Six relatives were also evaluated by CytoScan HD Array. Genomic analysis confirmed a co-segregation of the ROBO1 deletion with the occurrence of cancer in two families. Direct sequencing revealed no pathogenic ROBO1 point mutations. Transcriptomic analysis (HTA 2.0, Affymetrix) in two breast carcinomas from a single patient revealed ROBO1 down-expression with no splicing events near the intronic deletion. Deeper in silico analysis showed several enhancer regions and a histone methylation mark in the deleted region. The ROBO1 deletion in a putative transcriptional regulatory region, its down-expression in tumor samples, and the results of the co-segregation analysis revealing the presence of the alteration in affected individuals suggest a pathogenic effect of the ROBO1 in cancer predisposition.</text><annotation id="1"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>ROBO1</text></annotation><annotation id="2"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="526" length="4"/><text>MLH1</text></annotation><annotation id="3"><infon key="identifier">4436</infon><infon key="type">GENE</infon><location offset="532" length="4"/><text>MSH2</text></annotation><annotation id="4"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="538" length="4"/><text>TP53</text></annotation><annotation id="5"><infon key="identifier">11200</infon><infon key="type">GENE</infon><location offset="548" length="5"/><text>CHEK2</text></annotation><annotation id="6"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="609" length="5"/><text>ROBO1</text></annotation><annotation id="7"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="734" length="5"/><text>ROBO1</text></annotation><annotation id="8"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="898" length="5"/><text>ROBO1</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="936" length="6"/><text>cancer</text></annotation><annotation id="10"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="1001" length="5"/><text>ROBO1</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0004989</infon><infon key="type">DISEASE</infon><location offset="1077" length="17"/><text>breast carcinomas</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="49" length="6"/><text>breast</text></annotation><annotation id="13"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="1126" length="5"/><text>ROBO1</text></annotation><annotation id="14"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="1316" length="5"/><text>ROBO1</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1403" length="5"/><text>tumor</text></annotation><annotation id="16"><infon key="identifier">6091</infon><infon key="type">GENE</infon><location offset="1565" length="5"/><text>ROBO1</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1574" length="6"/><text>cancer</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1241" length="16"/><text>enhancer regions</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="60" length="17"/><text>colorectal cancer</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="125" length="17"/><text>colorectal cancer</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="117" length="2"/><text>BC</text></annotation><annotation id="22"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="109" length="6"/><text>breast</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="144" length="3"/><text>CRC</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="329" length="6"/><text>cancer</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="462" length="2"/><text>BC</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="465" length="3"/><text>CRC</text></annotation><annotation id="27"><infon key="identifier">672</infon><infon key="type">GENE</infon><location offset="512" length="5"/><text>BRCA1</text></annotation><annotation id="28"><infon key="identifier">675</infon><infon key="type">GENE</infon><location offset="519" length="5"/><text>BRCA2</text></annotation></passage></document>
<document><id>26443750</id><passage><offset>0</offset><text>Comparison of DNA Methylation and Expression Pattern of S100 and Other Epidermal Differentiation Complex Genes in Differentiating Keratinocytes. Epidermal Differentiation Complex (EDC) is a gene cluster on human chromosome 1 q21, which comprises genes encoding four protein families: S100, S100 fused (SFTP), small proline-rich region (SPRR) and late cornified envelope (LCE) proteins. Contrary to the latter three families, which group proteins important for skin barrier formation, the role of S100 proteins has not been well defined and there are no systematic comparative data concerning their expression in the epidermis. Furthermore, little is known about epigenetic mechanisms controlling changes in S100 and other EDC genes expression in differentiating epidermis. In our study, using real-time PCR, we followed the expression of nine S100 genes at subsequent stages of differentiation of primary human keratinocytes and found that they exhibited different expression patterns. Then, we confronted the expression level in undifferentiated and differentiated keratinocytes with the extent of DNA methylation within their promoter or intragenic regions assessed by bisulfite sequencing. Methylation analysis was also performed for three other EDC genes of known expression pattern (involucrin, loricrin, and NICE-1) and a recently identified evolutionary conserved region with defined enhancer properties. The results indicate that altered EDC genes expression is not accompanied by major changes in DNA methylation.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="905" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">4014</infon><infon key="type">GENE</infon><location offset="1300" length="8"/><text>loricrin</text></annotation><annotation id="3"><infon key="identifier">54544</infon><infon key="type">GENE</infon><location offset="1314" length="6"/><text>NICE-1</text></annotation><annotation id="4"><infon key="identifier">0000667</infon><infon key="type">TISSUE</infon><location offset="130" length="13"/><text>Keratinocytes</text></annotation><annotation id="5"><infon key="identifier">0001253</infon><infon key="type">TISSUE</infon><location offset="460" length="4"/><text>skin</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="206" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0000404</infon><infon key="type">TISSUE</infon><location offset="616" length="9"/><text>epidermis</text></annotation><annotation id="8"><infon key="identifier">0000404</infon><infon key="type">TISSUE</infon><location offset="762" length="9"/><text>epidermis</text></annotation><annotation id="9"><infon key="identifier">0000667</infon><infon key="type">TISSUE</infon><location offset="911" length="13"/><text>keratinocytes</text></annotation><annotation id="10"><infon key="identifier">0000667</infon><infon key="type">TISSUE</infon><location offset="1066" length="13"/><text>keratinocytes</text></annotation><annotation id="11"><infon key="identifier">3713</infon><infon key="type">GENE</infon><location offset="1288" length="10"/><text>involucrin</text></annotation></passage></document>
<document><id>26443845</id><passage><offset>0</offset><text>Dynamic enhancer-gene body contacts during transcription elongation. Enhancers govern transcription through multiple mechanisms, including the regulation of elongation by RNA polymerase II (RNAPII). We characterized the dynamics of looped enhancer contacts during synchronous transcription elongation. We found that many distal enhancers form stable contacts with their target promoters during the entire interval of elongation. Notably, we detected additional dynamic enhancer contacts throughout the gene bodies that track with elongating RNAPII and the leading edge of RNA synthesis. These results support a model in which the gene body changes its position relative to a stable enhancer-promoter complex, which has broad ramifications for enhancer function and architectural models of transcriptional elongation.</text></passage></document>
<document><id>26445536</id><passage><offset>0</offset><text>Gold nanoparticles induce heme oxygenase-1 expression through Nrf2 activation and Bach1 export in human vascular endothelial cells. It has been reported that increased levels and activity of the heme oxygenase-1 (HO-1) protein ameliorate tissue injuries. In the present study, we investigated the effects and mechanisms of action of gold nanoparticles (AuNPs) on HO-1 protein expression in human vascular endothelial cells (ECs). The AuNPs induced HO-1 protein and mRNA expression in a concentration- and time-dependent manner. The induction was reduced by the thiol-containing antioxidants, including N-acetylcysteine and glutathione, but not by the non-thiol-containing antioxidants and inhibitors that block the enzymes for intracellular reactive oxygen species generation. The AuNPs enhanced Nrf2 protein levels but did not affect Nrf2 mRNA expression. In response to the AuNP treatment, the cytosolic Nrf2 translocated to the nucleus, and, concomitantly, Bach1 exited the nucleus and its tyrosine phosphorylation increased. The chromatin immunoprecipitation assay revealed that the translocated Nrf2 bound to the antioxidant-response element located in the E2 enhancer region of the HO-1 gene promoter and acted as a transcription factor. Although N-acetylcysteine inhibited the AuNP-induced Nrf2 nuclear translocation, the AuNPs did not promote intracellular reactive oxygen species production or endoplasmic reticulum stress in the ECs. Knockdown of Nrf2 expression by RNA interference significantly inhibited AuNP-induced HO-1 expression at the protein and mRNA levels. In summary, AuNPs enhance the levels and nuclear translocation of the Nrf2 protein and Bach1 export/tyrosine phosphorylation, leading to Nrf2 binding to the HO-1 E2 enhancer promoter region to drive HO-1 expression in ECs. This study, together with our parallel findings, demonstrates that AuNPs can act as an HO-1 inducer, which may partially contribute to their anti-inflammatory bioactivity in human vascular ECs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1188" length="18"/><text>HO-1 gene promoter</text></annotation><annotation id="2"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="363" length="4"/><text>HO-1</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="390" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="448" length="4"/><text>HO-1</text></annotation><annotation id="5"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="796" length="4"/><text>Nrf2</text></annotation><annotation id="6"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="835" length="4"/><text>Nrf2</text></annotation><annotation id="7"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="906" length="4"/><text>Nrf2</text></annotation><annotation id="8"><infon key="identifier">571</infon><infon key="type">GENE</infon><location offset="960" length="5"/><text>Bach1</text></annotation><annotation id="9"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1100" length="4"/><text>Nrf2</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1162" length="44"/><text>E2 enhancer region of the HO-1 gene promoter</text></annotation><annotation id="11"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1297" length="4"/><text>Nrf2</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1735" length="32"/><text>HO-1 E2 enhancer promoter region</text></annotation><annotation id="13"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1457" length="4"/><text>Nrf2</text></annotation><annotation id="14"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1530" length="4"/><text>HO-1</text></annotation><annotation id="15"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1648" length="4"/><text>Nrf2</text></annotation><annotation id="16"><infon key="identifier">571</infon><infon key="type">GENE</infon><location offset="1665" length="5"/><text>Bach1</text></annotation><annotation id="17"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="1715" length="4"/><text>Nrf2</text></annotation><annotation id="18"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1735" length="4"/><text>HO-1</text></annotation><annotation id="19"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1777" length="4"/><text>HO-1</text></annotation><annotation id="20"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1888" length="4"/><text>HO-1</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1975" length="5"/><text>human</text></annotation><annotation id="22"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="104" length="26"/><text>vascular endothelial cells</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1740" length="11"/><text>E2 enhancer</text></annotation><annotation id="24"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="396" length="26"/><text>vascular endothelial cells</text></annotation><annotation id="25"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="424" length="3"/><text>ECs</text></annotation><annotation id="26"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="1796" length="3"/><text>ECs</text></annotation><annotation id="27"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="1990" length="3"/><text>ECs</text></annotation><annotation id="28"><infon key="identifier">0001854</infon><infon key="type">TISSUE</infon><location offset="1439" length="3"/><text>ECs</text></annotation><annotation id="29"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="1188" length="4"/><text>HO-1</text></annotation><annotation id="30"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="26" length="16"/><text>heme oxygenase-1</text></annotation><annotation id="31"><infon key="identifier">4780</infon><infon key="type">GENE</infon><location offset="62" length="4"/><text>Nrf2</text></annotation><annotation id="32"><infon key="identifier">571</infon><infon key="type">GENE</infon><location offset="82" length="5"/><text>Bach1</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="98" length="5"/><text>human</text></annotation><annotation id="34"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="195" length="16"/><text>heme oxygenase-1</text></annotation><annotation id="35"><infon key="identifier">3162</infon><infon key="type">GENE</infon><location offset="213" length="4"/><text>HO-1</text></annotation></passage></document>
<document><id>26446995</id><passage><offset>0</offset><text>An autoregulatory enhancer controls mammary-specific STAT5 functions. Signal Transducers and Activators of Transcription (STATs) are principal transcription factors downstream of cytokine receptors. Although STAT5A is expressed in most tissues it remains to be understood why its premier, non-redundant functions are restricted to prolactin-induced mammary gland development and function. We report that the ubiquitously expressed Stat5a/b locus is subject to additional lineage-specific transcriptional control in mammary epithelium. Genome-wide surveys of epigenetic status and transcription factor occupancy uncovered a putative mammary-specific enhancer within the intergenic sequences separating the two Stat5 genes. This region exhibited several hallmarks of genomic enhancers, including DNaseI hypersensitivity, H3K27 acetylation and binding by GR, NFIB, ELF5 and MED1. Mammary-specific STAT5 binding was obtained at two canonical STAT5 binding motifs. CRISPR/Cas9-mediated genome editing was used to delete these sites in mice and determine their biological function. Mutant animals exhibited an 80% reduction of Stat5 levels in mammary epithelium and a concomitant reduction of STAT5-dependent gene expression. Transcriptome analysis identified a class of mammary-restricted genes that was particularly dependent on high STAT5 levels as a result of the intergenic enhancer. Taken together, the mammary-specific enhancer enables a positive feedback circuit that contributes to the remarkable abundance of STAT5 and, in turn, to the efficacy of STAT5-dependent mammary physiology.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="3" length="23"/><text>autoregulatory enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="632" length="88"/><text>mammary-specific enhancer within the intergenic sequences separating the two Stat5 genes</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="924" length="34"/><text>two canonical STAT5 binding motifs</text></annotation><annotation id="4"><infon key="identifier">18028</infon><infon key="type">GENE</infon><location offset="856" length="4"/><text>NFIB</text></annotation><annotation id="5"><infon key="identifier">13711</infon><infon key="type">GENE</infon><location offset="862" length="4"/><text>ELF5</text></annotation><annotation id="6"><infon key="identifier">19014</infon><infon key="type">GENE</infon><location offset="871" length="4"/><text>MED1</text></annotation><annotation id="7"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="894" length="5"/><text>STAT5</text></annotation><annotation id="8"><infon key="identifier">0001430</infon><infon key="type">TISSUE</infon><location offset="1137" length="18"/><text>mammary epithelium</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1030" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1121" length="5"/><text>Stat5</text></annotation><annotation id="11"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1187" length="5"/><text>STAT5</text></annotation><annotation id="12"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1330" length="5"/><text>STAT5</text></annotation><annotation id="13"><infon key="identifier">19109</infon><infon key="type">GENE</infon><location offset="331" length="9"/><text>prolactin</text></annotation><annotation id="14"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1513" length="5"/><text>STAT5</text></annotation><annotation id="15"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1552" length="5"/><text>STAT5</text></annotation><annotation id="16"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="938" length="5"/><text>STAT5</text></annotation><annotation id="17"><infon key="identifier">0000817</infon><infon key="type">TISSUE</infon><location offset="349" length="13"/><text>mammary gland</text></annotation><annotation id="18"><infon key="identifier">0001430</infon><infon key="type">TISSUE</infon><location offset="515" length="18"/><text>mammary epithelium</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1362" length="19"/><text>intergenic enhancer</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1403" length="25"/><text>mammary-specific enhancer</text></annotation><annotation id="21"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="53" length="5"/><text>STAT5</text></annotation><annotation id="22"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="208" length="6"/><text>STAT5A</text></annotation><annotation id="23"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="431" length="6"/><text>Stat5a</text></annotation><annotation id="24"><infon key="identifier">20851</infon><infon key="type">GENE</infon><location offset="438" length="1"/><text>b</text></annotation><annotation id="25"><infon key="identifier">20850;20851</infon><infon key="type">GENE</infon><location offset="709" length="5"/><text>Stat5</text></annotation></passage></document>
<document><id>26494787</id><passage><offset>0</offset><text>Lhx1 functions together with Otx2, Foxa2, and Ldb1 to govern anterior mesendoderm, node, and midline development. Gene regulatory networks controlling functional activities of spatially and temporally distinct endodermal cell populations in the early mouse embryo remain ill defined. The T-box transcription factor Eomes, acting downstream from Nodal/Smad signals, directly activates the LIM domain homeobox transcription factor Lhx1 in the visceral endoderm. Here we demonstrate Smad4/Eomes-dependent Lhx1 expression in the epiblast marks the entire definitive endoderm lineage, the anterior mesendoderm, and midline progenitors. Conditional inactivation of Lhx1 disrupts anterior definitive endoderm development and impedes node and midline morphogenesis in part due to severe disturbances in visceral endoderm displacement. Transcriptional profiling and ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) experiments identified Lhx1 target genes, including numerous anterior definitive endoderm markers and components of the Wnt signaling pathway. Interestingly, Lhx1-binding sites were enriched at enhancers, including the Nodal-proximal epiblast enhancer element and enhancer regions controlling Otx2 and Foxa2 expression. Moreover, in proteomic experiments, we characterized a complex comprised of Lhx1, Otx2, and Foxa2 as well as the chromatin-looping protein Ldb1. These partnerships cooperatively regulate development of the anterior mesendoderm, node, and midline cell populations responsible for establishment of the left-right body axis and head formation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1163" length="40"/><text>Nodal-proximal epiblast enhancer element</text></annotation><annotation id="2"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="429" length="4"/><text>Lhx1</text></annotation><annotation id="3"><infon key="identifier">17128</infon><infon key="type">GENE</infon><location offset="480" length="5"/><text>Smad4</text></annotation><annotation id="4"><infon key="identifier">13813</infon><infon key="type">GENE</infon><location offset="486" length="5"/><text>Eomes</text></annotation><annotation id="5"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="502" length="4"/><text>Lhx1</text></annotation><annotation id="6"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="659" length="4"/><text>Lhx1</text></annotation><annotation id="7"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="967" length="4"/><text>Lhx1</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1102" length="18"/><text>Lhx1-binding sites</text></annotation><annotation id="9"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="1470" length="20"/><text>anterior mesendoderm</text></annotation><annotation id="10"><infon key="type">TISSUE</infon><location offset="1492" length="4"/><text>node</text></annotation><annotation id="11"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="1340" length="4"/><text>Lhx1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1208" length="54"/><text>enhancer regions controlling Otx2 and Foxa2 expression</text></annotation><annotation id="13"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1346" length="4"/><text>Otx2</text></annotation><annotation id="14"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1356" length="5"/><text>Foxa2</text></annotation><annotation id="15"><infon key="identifier">16825</infon><infon key="type">GENE</infon><location offset="1403" length="4"/><text>Ldb1</text></annotation><annotation id="16"><infon key="identifier">0000282</infon><infon key="type">TISSUE</infon><location offset="1589" length="4"/><text>head</text></annotation><annotation id="17"><infon key="type">TISSUE</infon><location offset="93" length="7"/><text>midline</text></annotation><annotation id="18"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="61" length="20"/><text>anterior mesendoderm</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="83" length="4"/><text>node</text></annotation><annotation id="20"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="210" length="15"/><text>endodermal cell</text></annotation><annotation id="21"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="388" length="40"/><text>LIM domain homeobox transcription factor</text></annotation><annotation id="22"><infon key="identifier">0003487</infon><infon key="type">TISSUE</infon><location offset="441" length="17"/><text>visceral endoderm</text></annotation><annotation id="23"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>Lhx1</text></annotation><annotation id="24"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="525" length="8"/><text>epiblast</text></annotation><annotation id="25"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="562" length="8"/><text>endoderm</text></annotation><annotation id="26"><infon key="identifier">0003953</infon><infon key="type">TISSUE</infon><location offset="584" length="20"/><text>anterior mesendoderm</text></annotation><annotation id="27"><infon key="type">TISSUE</infon><location offset="610" length="19"/><text>midline progenitors</text></annotation><annotation id="28"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="673" length="28"/><text>anterior definitive endoderm</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="726" length="4"/><text>node</text></annotation><annotation id="30"><infon key="type">TISSUE</infon><location offset="735" length="7"/><text>midline</text></annotation><annotation id="31"><infon key="identifier">0003487</infon><infon key="type">TISSUE</infon><location offset="795" length="17"/><text>visceral endoderm</text></annotation><annotation id="32"><infon key="identifier">0000800</infon><infon key="type">TISSUE</infon><location offset="1005" length="28"/><text>anterior definitive endoderm</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="1502" length="12"/><text>midline cell</text></annotation><annotation id="34"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="29" length="4"/><text>Otx2</text></annotation><annotation id="35"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="1178" length="8"/><text>epiblast</text></annotation><annotation id="36"><infon key="identifier">18424</infon><infon key="type">GENE</infon><location offset="1237" length="4"/><text>Otx2</text></annotation><annotation id="37"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="1246" length="5"/><text>Foxa2</text></annotation><annotation id="38"><infon key="identifier">16869</infon><infon key="type">GENE</infon><location offset="1102" length="4"/><text>Lhx1</text></annotation><annotation id="39"><infon key="identifier">15376</infon><infon key="type">GENE</infon><location offset="35" length="5"/><text>Foxa2</text></annotation><annotation id="40"><infon key="identifier">16825</infon><infon key="type">GENE</infon><location offset="46" length="4"/><text>Ldb1</text></annotation><annotation id="41"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="251" length="5"/><text>mouse</text></annotation><annotation id="42"><infon key="identifier">13813</infon><infon key="type">GENE</infon><location offset="315" length="5"/><text>Eomes</text></annotation><annotation id="43"><infon key="identifier">18119</infon><infon key="type">GENE</infon><location offset="345" length="5"/><text>Nodal</text></annotation></passage></document>
<document><id>26501517</id><passage><offset>0</offset><text>Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Epigenome editing with the CRISPR (clustered, regularly interspaced, short palindromic repeats)-Cas9 platform is a promising technology for modulating gene expression to direct cell phenotype and to dissect the causal epigenetic mechanisms of gene regulation. Fusions of nuclease-inactive dCas9 to the Kruppel-associated box (KRAB) repressor (dCas9-KRAB) can silence target gene expression, but the genome-wide specificity and the extent of heterochromatin formation catalyzed by dCas9-KRAB are not known. We targeted dCas9-KRAB to the HS2 enhancer, a distal regulatory element that orchestrates the expression of multiple globin genes, and observed highly specific induction of H3K9 trimethylation (H3K9me3) at the enhancer and decreased chromatin accessibility of both the enhancer and its promoter targets. Targeted epigenetic modification of HS2 silenced the expression of multiple globin genes, with minimal off-target changes in global gene expression. These results demonstrate that repression mediated by dCas9-KRAB is sufficiently specific to disrupt the activity of individual enhancers via local modification of the epigenome.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="641" length="12"/><text>HS2 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="880" length="8"/><text>enhancer</text></annotation></passage></document>
<document><id>26537192</id><passage><offset>0</offset><text>Identification of the 187 bp EphA7 Genomic DNA as the Dorsal Midline-Specific Enhancer of the Diencephalon and Mesencephalon. EphA7 is a key molecule in regulating the development of the dien- and mesencephalon. To get insight into the mechanism of how EphA7 gene expression is regulated during the dorsal specification of the dien- and mesencephalon, we investigated the cis-acting regulatory sequence driving EphA7 to the dorsal midline of the dien- and mesencephalon. Transgenic LacZ reporter analysis, using overlapping EphA7 BACs, was used to narrow down the dorsal midline-specific enhancer, revealing the 25.3 kb genomic region as the enhancer candidate. Strikingly, this genomic DNA was located far downstream of the EphA7 transcription start site, +302.6 kb to +327.9 kb. Further enhancer mapping, using comparative genomic analysis and transgenic methods, showed that the 187 bp genomic DNA alone, approximately 305 kb downstream of the EphA7 transcription start site, was sufficient to act as the dorsal midline-specific enhancer of EphA7. Importantly, our results indicate that the 187 bp dorsal midline-specific enhancer is critically regulated by homeobox transcription factors during the development of the dien- and mesencephalon.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="564" length="32"/><text>dorsal midline-specific enhancer</text></annotation><annotation id="2"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="524" length="5"/><text>EphA7</text></annotation><annotation id="3"><infon key="type">TISSUE</infon><location offset="54" length="14"/><text>Dorsal Midline</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="922" length="55"/><text>305 kb downstream of the EphA7 transcription start site</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="707" length="72"/><text>downstream of the EphA7 transcription start site, +302.6 kb to +327.9 kb</text></annotation><annotation id="6"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="197" length="13"/><text>mesencephalon</text></annotation><annotation id="7"><infon key="identifier">0000342</infon><infon key="type">TISSUE</infon><location offset="327" length="4"/><text>dien</text></annotation><annotation id="8"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="337" length="13"/><text>mesencephalon</text></annotation><annotation id="9"><infon key="identifier">0000342</infon><infon key="type">TISSUE</infon><location offset="446" length="4"/><text>dien</text></annotation><annotation id="10"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="456" length="13"/><text>mesencephalon</text></annotation><annotation id="11"><infon key="identifier">0000342</infon><infon key="type">TISSUE</infon><location offset="1222" length="4"/><text>dien</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="54" length="32"/><text>Dorsal Midline-Specific Enhancer</text></annotation><annotation id="13"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="1232" length="13"/><text>mesencephalon</text></annotation><annotation id="14"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="29" length="5"/><text>EphA7</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="424" length="14"/><text>dorsal midline</text></annotation><annotation id="16"><infon key="identifier">0000342</infon><infon key="type">TISSUE</infon><location offset="94" length="12"/><text>Diencephalon</text></annotation><annotation id="17"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="111" length="13"/><text>Mesencephalon</text></annotation><annotation id="18"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="725" length="5"/><text>EphA7</text></annotation><annotation id="19"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="947" length="5"/><text>EphA7</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="1008" length="14"/><text>dorsal midline</text></annotation><annotation id="21"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="1044" length="5"/><text>EphA7</text></annotation><annotation id="22"><infon key="type">TISSUE</infon><location offset="1101" length="14"/><text>dorsal midline</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1008" length="41"/><text>dorsal midline-specific enhancer of EphA7</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="612" length="22"/><text>25.3 kb genomic region</text></annotation><annotation id="25"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1094" length="39"/><text>187 bp dorsal midline-specific enhancer</text></annotation><annotation id="26"><infon key="identifier">0000342</infon><infon key="type">TISSUE</infon><location offset="187" length="4"/><text>dien</text></annotation><annotation id="27"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="126" length="5"/><text>EphA7</text></annotation><annotation id="28"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="253" length="5"/><text>EphA7</text></annotation><annotation id="29"><infon key="identifier">2045</infon><infon key="type">GENE</infon><location offset="411" length="5"/><text>EphA7</text></annotation></passage></document>
<document><id>26550034</id><passage><offset>0</offset><text>Tip60 complex binds to active Pol II promoters and a subset of enhancers and co-regulates the c-Myc network in mouse embryonic stem cells. BACKGROUND: Tip60 (KAT5) is the histone acetyltransferase (HAT) of the mammalian Tip60/NuA4 complex. While Tip60 is important for early mouse development and mouse embryonic stem cell (mESC) pluripotency, the function of Tip60 as reflected in a genome-wide context is not yet well understood. RESULTS: Gel filtration of nuclear mESCs extracts indicate incorporation of Tip60 into large molecular complexes and exclude the existence of large quantities of "free" Tip60 within the nuclei of ESCs. Thus, monitoring of Tip60 binding to the genome should reflect the behaviour of Tip60-containing complexes. The genome-wide mapping of Tip60 binding in mESCs by chromatin immunoprecipitation (ChIP) coupled with high-throughput sequencing (ChIP-seq) shows that the Tip60 complex is present at promoter regions of predominantly active genes that are bound by RNA polymerase II (Pol II) and contain the H3K4me3 histone mark. The coactivator HAT complexes, Tip60- and Mof (KAT8)-containing (NSL and MSL), show a global overlap at promoters, whereas distinct binding profiles at enhancers suggest different regulatory functions of each essential HAT complex. Interestingly, Tip60 enrichment peaks at about 200 bp downstream of the transcription start sites suggesting a function for the Tip60 complexes in addition to histone acetylation. The comparison of genome-wide binding profiles of Tip60 and c-Myc, a somatic cell reprogramming factor that binds predominantly to active genes in mESCs, demonstrate that Tip60 and c-Myc co-bind at 50-60 % of their binding sites. We also show that the Tip60 complex binds to a subset of bivalent developmental genes and defines a set of mESC-specific enhancer as well as super-enhancer regions. CONCLUSIONS: Our study suggests that the Tip60 complex functions as a global transcriptional co-activator at most active Pol II promoters, co-regulates the ESC-specific c-Myc network, important for ESC self-renewal and cell metabolism and acts at a subset of active distal regulatory elements, or super enhancers, in mESCs.</text><annotation id="1"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1528" length="5"/><text>c-Myc</text></annotation><annotation id="2"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="297" length="25"/><text>mouse embryonic stem cell</text></annotation><annotation id="3"><infon key="identifier">10524</infon><infon key="type">GENE</infon><location offset="151" length="5"/><text>Tip60</text></annotation><annotation id="4"><infon key="identifier">10524</infon><infon key="type">GENE</infon><location offset="158" length="4"/><text>KAT5</text></annotation><annotation id="5"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="210" length="9"/><text>mammalian</text></annotation><annotation id="6"><infon key="identifier">10524</infon><infon key="type">GENE</infon><location offset="220" length="5"/><text>Tip60</text></annotation><annotation id="7"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="246" length="5"/><text>Tip60</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="275" length="5"/><text>mouse</text></annotation><annotation id="9"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="467" length="5"/><text>mESCs</text></annotation><annotation id="10"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="360" length="5"/><text>Tip60</text></annotation><annotation id="11"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="508" length="5"/><text>Tip60</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1639" length="57"/><text>Tip60 and c-Myc co-bind at 50-60 % of their binding sites</text></annotation><annotation id="13"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="601" length="5"/><text>Tip60</text></annotation><annotation id="14"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="654" length="5"/><text>Tip60</text></annotation><annotation id="15"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="714" length="5"/><text>Tip60</text></annotation><annotation id="16"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="769" length="5"/><text>Tip60</text></annotation><annotation id="17"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="898" length="5"/><text>Tip60</text></annotation><annotation id="18"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1087" length="5"/><text>Tip60</text></annotation><annotation id="19"><infon key="identifier">67773</infon><infon key="type">GENE</infon><location offset="1103" length="4"/><text>KAT8</text></annotation><annotation id="20"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1303" length="5"/><text>Tip60</text></annotation><annotation id="21"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1416" length="5"/><text>Tip60</text></annotation><annotation id="22"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1518" length="5"/><text>Tip60</text></annotation><annotation id="23"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="2032" length="5"/><text>c-Myc</text></annotation><annotation id="24"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1639" length="5"/><text>Tip60</text></annotation><annotation id="25"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1720" length="5"/><text>Tip60</text></annotation><annotation id="26"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="1904" length="5"/><text>Tip60</text></annotation><annotation id="27"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1649" length="5"/><text>c-Myc</text></annotation><annotation id="28"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="117" length="20"/><text>embryonic stem cells</text></annotation><annotation id="29"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="324" length="4"/><text>mESC</text></annotation><annotation id="30"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="628" length="4"/><text>ESCs</text></annotation><annotation id="31"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="786" length="5"/><text>mESCs</text></annotation><annotation id="32"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1615" length="5"/><text>mESCs</text></annotation><annotation id="33"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1805" length="4"/><text>mESC</text></annotation><annotation id="34"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="2061" length="3"/><text>ESC</text></annotation><annotation id="35"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="111" length="5"/><text>mouse</text></annotation><annotation id="36"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="2180" length="5"/><text>mESCs</text></annotation><annotation id="37"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="2019" length="3"/><text>ESC</text></annotation><annotation id="38"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="94" length="5"/><text>c-Myc</text></annotation><annotation id="39"><infon key="identifier">81601</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Tip60</text></annotation></passage></document>
<document><id>26560027</id><passage><offset>0</offset><text>Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Neuroblastoma is a paediatric malignancy that typically arises in early childhood, and is derived from the developing sympathetic nervous system. Clinical phenotypes range from localized tumours with excellent outcomes to widely metastatic disease in which long-term survival is approximately 40% despite intensive therapy. A previous genome-wide association study identified common polymorphisms at the LMO1 gene locus that are highly associated with neuroblastoma susceptibility and oncogenic addiction to LMO1 in the tumour cells. Here we investigate the causal DNA variant at this locus and the mechanism by which it leads to neuroblastoma tumorigenesis. We first imputed all possible genotypes across the LMO1 locus and then mapped highly associated single nucleotide polymorphism (SNPs) to areas of chromatin accessibility, evolutionary conservation and transcription factor binding sites. We show that SNP rs2168101 G&gt;T is the most highly associated variant (combined P = 7.47 x 10(-29), odds ratio 0.65, 95% confidence interval 0.60-0.70), and resides in a super-enhancer defined by extensive acetylation of histone H3 lysine 27 within the first intron of LMO1. The ancestral G allele that is associated with tumour formation resides in a conserved GATA transcription factor binding motif. We show that the newly evolved protective TATA allele is associated with decreased total LMO1 expression (P = 0.028) in neuroblastoma primary tumours, and ablates GATA3 binding (P &lt; 0.0001). We demonstrate allelic imbalance favouring the G-containing strand in tumours heterozygous for this SNP, as demonstrated both by RNA sequencing (P &lt; 0.0001) and reporter assays (P = 0.002). These findings indicate that a recently evolved polymorphism within a super-enhancer element in the first intron of LMO1 influences neuroblastoma susceptibility through differential GATA transcription factor binding and direct modulation of LMO1 expression in cis, and this leads to an oncogenic dependency in tumour cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="54" length="19"/><text>LMO1 super-enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1153" length="14"/><text>super-enhancer</text></annotation><annotation id="3"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="596" length="4"/><text>LMO1</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="608" length="12"/><text>tumour cells</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="718" length="13"/><text>neuroblastoma</text></annotation><annotation id="6"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="798" length="4"/><text>LMO1</text></annotation><annotation id="7"><infon key="comment">chr11:8233861,C,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2168101 g&gt;t</infon><location offset="1001" length="13"/><text>rs2168101 G&gt;T</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1837" length="50"/><text>super-enhancer element in the first intron of LMO1</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1305" length="6"/><text>tumour</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1528" length="7"/><text>tumours</text></annotation><annotation id="11"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="1475" length="4"/><text>LMO1</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="1506" length="13"/><text>neuroblastoma</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1345" length="39"/><text>GATA transcription factor binding motif</text></annotation><annotation id="14"><infon key="identifier">2625</infon><infon key="type">GENE</infon><location offset="1549" length="5"/><text>GATA3</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1647" length="7"/><text>tumours</text></annotation><annotation id="16"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="54" length="4"/><text>LMO1</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="1899" length="13"/><text>neuroblastoma</text></annotation><annotation id="18"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="1252" length="4"/><text>LMO1</text></annotation><annotation id="19"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="2008" length="4"/><text>LMO1</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="2077" length="12"/><text>tumour cells</text></annotation><annotation id="21"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="1883" length="4"/><text>LMO1</text></annotation><annotation id="22"><infon key="identifier">0001832</infon><infon key="type">TISSUE</infon><location offset="206" length="26"/><text>sympathetic nervous system</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="26" length="13"/><text>neuroblastoma</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1225" length="31"/><text>within the first intron of LMO1</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="88" length="13"/><text>Neuroblastoma</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="type">DISEASE</infon><location offset="107" length="21"/><text>paediatric malignancy</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="275" length="7"/><text>tumours</text></annotation><annotation id="28"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="492" length="4"/><text>LMO1</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="540" length="13"/><text>neuroblastoma</text></annotation></passage></document>
<document><id>26581162</id><passage><offset>0</offset><text>Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex. HIV-1 provirus integration results in a persistent latently infected reservoir that is recalcitrant to combined antiretroviral therapy (cART) with lifelong treatment being the only option. The "shock and kill" strategy aims to eradicate latent HIV by reactivating proviral gene expression in the context of cART treatment. Gene-specific transcriptional activation can be achieved using the RNA-guided CRISPR-Cas9 system comprising single guide RNAs (sgRNAs) with a nuclease-deficient Cas9 mutant (dCas9) fused to the VP64 transactivation domain (dCas9-VP64). We engineered this system to target 23 sites within the long terminal repeat promoter of HIV-1 and identified a "hotspot" for activation within the viral enhancer sequence. Activating sgRNAs transcriptionally modulated the latent proviral genome across multiple different in vitro latency cell models including T cells comprising a clonally integrated mCherry-IRES-Tat (LChIT) latency system. We detected consistent and effective activation of latent virus mediated by activator sgRNAs, whereas latency reversal agents produced variable activation responses. Transcriptomic analysis revealed dCas9-VP64/sgRNAs to be highly specific, while the well-characterized chemical activator TNFalpha induced widespread gene dysregulation. CRISPR-mediated gene activation represents a novel system which provides enhanced efficiency and specificity in a targeted latency reactivation strategy and represents a promising approach to a "functional cure" of HIV/AIDS.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="704" length="38"/><text>long terminal repeat promoter of HIV-1</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="796" length="23"/><text>viral enhancer sequence</text></annotation><annotation id="3"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="959" length="7"/><text>T cells</text></annotation><annotation id="4"><infon key="identifier">11676</infon><infon key="type">SPECIES</infon><location offset="41" length="5"/><text>HIV-1</text></annotation><annotation id="5"><infon key="identifier">11676</infon><infon key="type">SPECIES</infon><location offset="89" length="5"/><text>HIV-1</text></annotation><annotation id="6"><infon key="identifier">12721</infon><infon key="type">SPECIES</infon><location offset="333" length="3"/><text>HIV</text></annotation><annotation id="7"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1329" length="8"/><text>TNFalpha</text></annotation><annotation id="8"><infon key="identifier">0005109</infon><infon key="type">DISEASE</infon><location offset="1592" length="3"/><text>HIV</text></annotation><annotation id="9"><infon key="identifier">0012268</infon><infon key="type">DISEASE</infon><location offset="1596" length="4"/><text>AIDS</text></annotation></passage></document>
<document><id>26595656</id><passage><offset>0</offset><text>Stimulus-specific combinatorial functionality of neuronal c-fos enhancers. The c-fos gene (also known as Fos) is induced by a broad range of stimuli and is a reliable marker for neural activity. Its induction mechanism and available reporter mouse lines are based exclusively on c-fos promoter activity. Here we demonstrate that multiple enhancers surrounding the c-fos gene are crucial for ensuring robust c-fos response to various stimuli. Membrane depolarization, brain-derived neurotrophic factor (BDNF) and forskolin activate distinct subsets of the enhancers to induce c-fos transcription in neurons, suggesting that stimulus-specific combinatorial activation of multiple enhancers underlies the broad inducibility of the c-fos gene. Accordingly, the functional requirement of key transcription factors varies depending on the type of stimulation. Combinatorial enhancer activation also occurs in the brain. Providing a comprehensive picture of the c-fos induction mechanism beyond the minimal promoter, our study should help in understanding the physiological nature of c-fos induction in relation to neural activity and plasticity.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="279" length="14"/><text>c-fos promoter</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="242" length="5"/><text>mouse</text></annotation><annotation id="3"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="279" length="5"/><text>c-fos</text></annotation><annotation id="4"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="407" length="5"/><text>c-fos</text></annotation><annotation id="5"><infon key="identifier">12064</infon><infon key="type">GENE</infon><location offset="467" length="33"/><text>brain-derived neurotrophic factor</text></annotation><annotation id="6"><infon key="identifier">12064</infon><infon key="type">GENE</infon><location offset="502" length="4"/><text>BDNF</text></annotation><annotation id="7"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="575" length="5"/><text>c-fos</text></annotation><annotation id="8"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="728" length="5"/><text>c-fos</text></annotation><annotation id="9"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="955" length="5"/><text>c-fos</text></annotation><annotation id="10"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="1077" length="5"/><text>c-fos</text></annotation><annotation id="11"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="907" length="5"/><text>brain</text></annotation><annotation id="12"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="364" length="5"/><text>c-fos</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="329" length="45"/><text>multiple enhancers surrounding the c-fos gene</text></annotation><annotation id="14"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="598" length="7"/><text>neurons</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="992" length="16"/><text>minimal promoter</text></annotation><annotation id="16"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="58" length="5"/><text>c-fos</text></annotation><annotation id="17"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="79" length="5"/><text>c-fos</text></annotation><annotation id="18"><infon key="identifier">14281</infon><infon key="type">GENE</infon><location offset="105" length="3"/><text>Fos</text></annotation></passage></document>
<document><id>26604133</id><passage><offset>0</offset><text>Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells. Notch signaling has recently emerged as an important regulator of immune responses in autoimmune diseases. The recombination signal-binding protein for immunoglobulin kappa J region (RBPJ) is a transcriptional repressor, but converts into a transcriptional activator upon activation of the canonical Notch pathway. Genome-wide association studies of rheumatoid arthritis (RA) identified a susceptibility locus, rs874040(CC), which implicated the RBPJ gene. Here, chromatin state mapping generated using the chromHMM algorithm reveals strong enhancer regions containing DNase I hypersensitive sites overlapping the rs874040 linkage disequilibrium block in human memory, but not in naive CD4(+) T cells. The rs874040 overlapping this chromatin state was associated with increased RBPJ expression in stimulated memory CD4(+) T cells from healthy subjects homozygous for the risk allele (CC) compared with memory CD4(+) T cells bearing the protective allele (GG). Transcriptomic analysis of rs874040(CC) memory T cells showed a repression of canonical Notch target genes IL (interleukin)-9, IL-17 and interferon (IFN)gamma in the basal state. Interestingly, activation of the Notch pathway using soluble Notch ligand, Jagged2-Fc, induced IL-9 and IL-17A while delta-like 4Fc, another Notch ligand, induced higher IFNgamma expression in the rs874040(CC) memory CD4(+) T cells compared with their rs874040(GG) counterparts. In RA, RBPJ expression is elevated in memory T cells from RA patients compared with control subjects, and this was associated with induced inflammatory cytokines IL-9, IL-17A and IFNgamma in response to Notch ligation in vitro. These findings demonstrate that the rs874040(CC) allele skews memory T cells toward a pro-inflammatory phenotype involving Notch signaling, thus increasing the susceptibility to develop RA.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="619" length="110"/><text>enhancer regions containing DNase I hypersensitive sites overlapping the rs874040 linkage disequilibrium block</text></annotation><annotation id="2"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="0" length="20"/><text>Rheumatoid arthritis</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="733" length="5"/><text>human</text></annotation><annotation id="4"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="784" length="8"/><text>rs874040</text></annotation><annotation id="5"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="856" length="4"/><text>RBPJ</text></annotation><annotation id="6"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="1065" length="8"/><text>rs874040</text></annotation><annotation id="7"><infon key="identifier">3578</infon><infon key="type">GENE</infon><location offset="1145" length="18"/><text>IL (interleukin)-9</text></annotation><annotation id="8"><infon key="identifier">3714</infon><infon key="type">GENE</infon><location offset="1292" length="7"/><text>Jagged2</text></annotation><annotation id="9"><infon key="identifier">3578</infon><infon key="type">GENE</infon><location offset="1312" length="4"/><text>IL-9</text></annotation><annotation id="10"><infon key="identifier">3605</infon><infon key="type">GENE</infon><location offset="1321" length="6"/><text>IL-17A</text></annotation><annotation id="11"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1387" length="8"/><text>IFNgamma</text></annotation><annotation id="12"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="1414" length="8"/><text>rs874040</text></annotation><annotation id="13"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="32" length="4"/><text>RBPJ</text></annotation><annotation id="14"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="1469" length="8"/><text>rs874040</text></annotation><annotation id="15"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="1499" length="2"/><text>RA</text></annotation><annotation id="16"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="1503" length="4"/><text>RBPJ</text></annotation><annotation id="17"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="1554" length="2"/><text>RA</text></annotation><annotation id="18"><infon key="identifier">3578</infon><infon key="type">GENE</infon><location offset="1658" length="4"/><text>IL-9</text></annotation><annotation id="19"><infon key="identifier">3605</infon><infon key="type">GENE</infon><location offset="1664" length="6"/><text>IL-17A</text></annotation><annotation id="20"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1675" length="8"/><text>IFNgamma</text></annotation><annotation id="21"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="1760" length="8"/><text>rs874040</text></annotation><annotation id="22"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="1910" length="2"/><text>RA</text></annotation><annotation id="23"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1541" length="7"/><text>T cells</text></annotation><annotation id="24"><infon key="identifier">0007179</infon><infon key="type">DISEASE</infon><location offset="164" length="19"/><text>autoimmune diseases</text></annotation><annotation id="25"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="64" length="12"/><text>CD4+ T cells</text></annotation><annotation id="26"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="764" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="27"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="893" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="28"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="987" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="29"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1175" length="21"/><text>interferon (IFN)gamma</text></annotation><annotation id="30"><infon key="identifier">3605</infon><infon key="type">GENE</infon><location offset="1165" length="5"/><text>IL-17</text></annotation><annotation id="31"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1793" length="7"/><text>T cells</text></annotation><annotation id="32"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1078" length="14"/><text>memory T cells</text></annotation><annotation id="33"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1434" length="14"/><text>CD4(+) T cells</text></annotation><annotation id="34"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="189" length="70"/><text>recombination signal-binding protein for immunoglobulin kappa J region</text></annotation><annotation id="35"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="261" length="4"/><text>RBPJ</text></annotation><annotation id="36"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="428" length="20"/><text>rheumatoid arthritis</text></annotation><annotation id="37"><infon key="identifier">0008383</infon><infon key="type">DISEASE</infon><location offset="450" length="2"/><text>RA</text></annotation><annotation id="38"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="489" length="8"/><text>rs874040</text></annotation><annotation id="39"><infon key="identifier">3516</infon><infon key="type">GENE</infon><location offset="524" length="4"/><text>RBPJ</text></annotation><annotation id="40"><infon key="comment">chr4:26106575,G,C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs874040</infon><location offset="692" length="8"/><text>rs874040</text></annotation></passage></document>
<document><id>26610392</id><passage><offset>0</offset><text>Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Glioma is the most common malignant primary brain tumor and is associated with poor prognosis. Genetic factors contributing to glioma risk have recently been investigated through genome-wide association studies (GWAS), implicating seven independent glioma risk loci in six chromosomal regions. Here, we performed an in-depth functional analysis of the risk locus proximal to the PHLDB1 gene on 11q23.3. We retrieved all SNPs in linkage disequilibrium (r(2) &gt;= 0.2) with the glioma-associated SNP (rs498872) and performed a comprehensive bioinformatics and experimental functional analysis for the region. After testing candidate SNPs for allele-specific activity in a luciferase-based enhancer scanning assay, we established a subset of 10 functional SNPs in the promoters of PHLDB1 and DDX6, and in a putative enhancer element. Chromatin conformation capture (3C) identified a physical interaction between the enhancer element containing a functional SNP (rs73001406) and the promoter of the DDX6 gene. Knockdown experiments in cell culture and 3D assays to evaluate the role of PHLDB1 and DDX6 suggest that both genes may contribute to the phenotype. These studies reveal the functional landscape of the 11q23.3 glioma susceptibility locus and identify a network of functional SNPs in regulatory elements and two target genes as a possible mechanism driving glioma risk association.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="879" length="28"/><text>promoters of PHLDB1 and DDX6</text></annotation><annotation id="2"><infon key="identifier">0021211</infon><infon key="type">DISEASE</infon><location offset="160" length="11"/><text>brain tumor</text></annotation><annotation id="3"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="243" length="6"/><text>glioma</text></annotation><annotation id="4"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="365" length="6"/><text>glioma</text></annotation><annotation id="5"><infon key="identifier">23187</infon><infon key="type">GENE</infon><location offset="495" length="6"/><text>PHLDB1</text></annotation><annotation id="6"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="590" length="6"/><text>glioma</text></annotation><annotation id="7"><infon key="type">VARIANT</infon><infon key="identifier">rs498872</infon><location offset="613" length="8"/><text>rs498872</text></annotation><annotation id="8"><infon key="identifier">23187</infon><infon key="type">GENE</infon><location offset="892" length="6"/><text>PHLDB1</text></annotation><annotation id="9"><infon key="identifier">1656</infon><infon key="type">GENE</infon><location offset="903" length="4"/><text>DDX6</text></annotation><annotation id="10"><infon key="type">VARIANT</infon><infon key="identifier">rs73001406</infon><location offset="1073" length="10"/><text>rs73001406</text></annotation><annotation id="11"><infon key="identifier">1656</infon><infon key="type">GENE</infon><location offset="1109" length="4"/><text>DDX6</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="927" length="16"/><text>enhancer element</text></annotation><annotation id="13"><infon key="identifier">23187</infon><infon key="type">GENE</infon><location offset="1196" length="6"/><text>PHLDB1</text></annotation><annotation id="14"><infon key="identifier">1656</infon><infon key="type">GENE</infon><location offset="1207" length="4"/><text>DDX6</text></annotation><annotation id="15"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="1330" length="6"/><text>glioma</text></annotation><annotation id="16"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="1476" length="6"/><text>glioma</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1027" length="44"/><text>enhancer element containing a functional SNP</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1093" length="25"/><text>promoter of the DDX6 gene</text></annotation><annotation id="19"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="35" length="6"/><text>glioma</text></annotation><annotation id="20"><infon key="identifier">23187</infon><infon key="type">GENE</infon><location offset="74" length="6"/><text>PHLDB1</text></annotation><annotation id="21"><infon key="identifier">1656</infon><infon key="type">GENE</infon><location offset="85" length="4"/><text>DDX6</text></annotation><annotation id="22"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="93" length="6"/><text>glioma</text></annotation><annotation id="23"><infon key="identifier">0021042</infon><infon key="type">DISEASE</infon><location offset="116" length="6"/><text>Glioma</text></annotation></passage></document>
<document><id>26615198</id><passage><offset>0</offset><text>Analysis of long-range interactions in primary human cells identifies cooperative CFTR regulatory elements. A mechanism by which control DNA elements regulate transcription over large linear genomic distances is by achieving close physical proximity with genes, and looping of the intervening chromatin paths. Alterations of such regulatory 'chromatin looping' systems are likely to play a critical role in human genetic disease at large. Here, we studied the spatial organization of a  790 kb locus encompassing the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Dysregulation of CFTR is responsible for cystic fibrosis, which is the most common lethal genetic disorder in Caucasian populations. CFTR is a relatively large gene of 189 kb with a rather complex tissue-specific and temporal expression profile. We used chromatin conformation at the CFTR locus to identify new DNA sequences that regulate its transcription. By comparing 5C chromatin interaction maps of the CFTR locus in expressing and non-expressing human primary cells, we identified several new contact points between the CFTR promoter and its surroundings, in addition to regions featuring previously described regulatory elements. We demonstrate that two of these novel interacting regions cooperatively increase CFTR expression, and suggest that the new enhancer elements located on either side of the gene are brought together through chromatin looping via CTCF.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1108" length="13"/><text>CFTR promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1343" length="52"/><text>enhancer elements located on either side of the gene</text></annotation><annotation id="3"><infon key="identifier">0009061</infon><infon key="type">DISEASE</infon><location offset="623" length="15"/><text>cystic fibrosis</text></annotation><annotation id="4"><infon key="identifier">0003847</infon><infon key="type">DISEASE</infon><location offset="672" length="16"/><text>genetic disorder</text></annotation><annotation id="5"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="715" length="4"/><text>CFTR</text></annotation><annotation id="6"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="866" length="4"/><text>CFTR</text></annotation><annotation id="7"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="990" length="4"/><text>CFTR</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1034" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">0001413</infon><infon key="type">TISSUE</infon><location offset="39" length="19"/><text>primary human cells</text></annotation><annotation id="10"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="1301" length="4"/><text>CFTR</text></annotation><annotation id="11"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1447" length="4"/><text>CTCF</text></annotation><annotation id="12"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="1108" length="4"/><text>CFTR</text></annotation><annotation id="13"><infon key="identifier">0001413</infon><infon key="type">TISSUE</infon><location offset="1040" length="13"/><text>primary cells</text></annotation><annotation id="14"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="82" length="4"/><text>CFTR</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="407" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">0003847</infon><infon key="type">DISEASE</infon><location offset="413" length="15"/><text>genetic disease</text></annotation><annotation id="17"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="517" length="51"/><text>cystic fibrosis transmembrane conductance regulator</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="692" length="9"/><text>Caucasian</text></annotation><annotation id="19"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="570" length="4"/><text>CFTR</text></annotation><annotation id="20"><infon key="identifier">1080</infon><infon key="type">GENE</infon><location offset="599" length="4"/><text>CFTR</text></annotation></passage></document>
<document><id>26656844</id><passage><offset>0</offset><text>Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Whole-genome analysis approaches are identifying recurrent cancer-associated somatic alterations in noncoding DNA regions. We combined somatic copy number analysis of 12 tumor types with tissue-specific epigenetic profiling to identify significant regions of focal amplification harboring super-enhancers. Copy number gains of noncoding regions harboring super-enhancers near KLF5, USP12, PARD6B and MYC are associated with overexpression of these cancer-related genes. We show that two distinct focal amplifications of super-enhancers 3' to MYC in lung adenocarcinoma (MYC-LASE) and endometrial carcinoma (MYC-ECSE) are physically associated with the MYC promoter and correlate with MYC overexpression. CRISPR/Cas9-mediated repression or deletion of a constituent enhancer within the MYC-LASE region led to significant reductions in the expression of MYC and its target genes and to the impairment of anchorage-independent and clonogenic growth, consistent with an oncogenic function. Our results suggest that genomic amplification of super-enhancers represents a common mechanism to activate cancer driver genes in multiple cancer types.</text><annotation id="1"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="640" length="3"/><text>MYC</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="268" length="5"/><text>tumor</text></annotation><annotation id="3"><infon key="identifier">688</infon><infon key="type">GENE</infon><location offset="474" length="4"/><text>KLF5</text></annotation><annotation id="4"><infon key="identifier">219333</infon><infon key="type">GENE</infon><location offset="480" length="5"/><text>USP12</text></annotation><annotation id="5"><infon key="identifier">84612</infon><infon key="type">GENE</infon><location offset="487" length="6"/><text>PARD6B</text></annotation><annotation id="6"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="498" length="3"/><text>MYC</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="546" length="6"/><text>cancer</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="668" length="8"/><text>MYC-LASE</text></annotation><annotation id="9"><infon key="identifier">0002447</infon><infon key="type">DISEASE</infon><location offset="682" length="21"/><text>endometrial carcinoma</text></annotation><annotation id="10"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="705" length="3"/><text>MYC</text></annotation><annotation id="11"><infon key="type">ENHANCER</infon><location offset="705" length="8"/><text>MYC-ECSE</text></annotation><annotation id="12"><infon key="identifier">0005061</infon><infon key="type">DISEASE</infon><location offset="647" length="19"/><text>lung adenocarcinoma</text></annotation><annotation id="13"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="883" length="3"/><text>MYC</text></annotation><annotation id="14"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="750" length="3"/><text>MYC</text></annotation><annotation id="15"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="782" length="3"/><text>MYC</text></annotation><annotation id="16"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="950" length="3"/><text>MYC</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1192" length="6"/><text>cancer</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1224" length="6"/><text>cancer</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="618" length="48"/><text>super-enhancers 3' to MYC in lung adenocarcinoma</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="750" length="12"/><text>MYC promoter</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="863" length="35"/><text>enhancer within the MYC-LASE region</text></annotation><annotation id="22"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="668" length="3"/><text>MYC</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="72" length="5"/><text>human</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0004993</infon><infon key="type">DISEASE</infon><location offset="78" length="18"/><text>epithelial cancers</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="157" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>26659182</id><passage><offset>0</offset><text>The histone chaperone CAF-1 safeguards somatic cell identity. Cellular differentiation involves profound remodelling of chromatic landscapes, yet the mechanisms by which somatic cell identity is subsequently maintained remain incompletely understood. To further elucidate regulatory pathways that safeguard the somatic state, we performed two comprehensive RNA interference (RNAi) screens targeting chromatin factors during transcription-factor-mediated reprogramming of mouse fibroblasts to induced pluripotent stem cells (iPS cells). Subunits of the chromatin assembly factor-1 (CAF-1) complex, including Chaf1a and Chaf1b, emerged as the most prominent hits from both screens, followed by modulators of lysine sumoylation and heterochromatin maintenance. Optimal modulation of both CAF-1 and transcription factor levels increased reprogramming efficiency by several orders of magnitude and facilitated iPS cell formation in as little as 4 days. Mechanistically, CAF-1 suppression led to a more accessible chromatin structure at enhancer elements early during reprogramming. These changes were accompanied by a decrease in somatic heterochromatin domains, increased binding of Sox2 to pluripotency-specific targets and activation of associated genes. Notably, suppression of CAF-1 also enhanced the direct conversion of B cells into macrophages and fibroblasts into neurons. Together, our findings reveal the histone chaperone CAF-1 to be a novel regulator of somatic cell identity during transcription-factor-induced cell-fate transitions and provide a potential strategy to modulate cellular plasticity in a regenerative setting.</text><annotation id="1"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="22" length="5"/><text>CAF-1</text></annotation><annotation id="2"><infon key="identifier">20674</infon><infon key="type">GENE</infon><location offset="1179" length="4"/><text>Sox2</text></annotation><annotation id="3"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="1277" length="5"/><text>CAF-1</text></annotation><annotation id="4"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="1429" length="5"/><text>CAF-1</text></annotation><annotation id="5"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="492" length="30"/><text>induced pluripotent stem cells</text></annotation><annotation id="6"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="524" length="9"/><text>iPS cells</text></annotation><annotation id="7"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1322" length="7"/><text>B cells</text></annotation><annotation id="8"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1335" length="11"/><text>macrophages</text></annotation><annotation id="9"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="1351" length="11"/><text>fibroblasts</text></annotation><annotation id="10"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="1368" length="7"/><text>neurons</text></annotation><annotation id="11"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="477" length="11"/><text>fibroblasts</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="471" length="5"/><text>mouse</text></annotation><annotation id="13"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="552" length="27"/><text>chromatin assembly factor-1</text></annotation><annotation id="14"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="581" length="5"/><text>CAF-1</text></annotation><annotation id="15"><infon key="identifier">27221</infon><infon key="type">GENE</infon><location offset="607" length="6"/><text>Chaf1a</text></annotation><annotation id="16"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="618" length="6"/><text>Chaf1b</text></annotation><annotation id="17"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="785" length="5"/><text>CAF-1</text></annotation><annotation id="18"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="905" length="8"/><text>iPS cell</text></annotation><annotation id="19"><infon key="identifier">110749</infon><infon key="type">GENE</infon><location offset="965" length="5"/><text>CAF-1</text></annotation></passage></document>
<document><id>26663721</id><passage><offset>0</offset><text>Enhancer Turnover Is Associated with a Divergent Transcriptional Response to Glucocorticoid in Mouse and Human Macrophages. Phenotypic differences between individuals and species are controlled in part through differences in expression of a relatively conserved set of genes. Genes expressed in the immune system are subject to especially powerful selection. We have investigated the evolution of both gene expression and candidate enhancers in human and mouse macrophages exposed to glucocorticoid (GC), a regulator of innate immunity and an important therapeutic agent. Our analyses revealed a very limited overlap in the repertoire of genes responsive to GC in human and mouse macrophages. Peaks of inducible binding of the GC receptor (GR) detected by chromatin immunoprecipitation-Seq correlated with induction, but not repression, of target genes in both species, occurred at distal regulatory sites not promoters, and were strongly enriched for the consensus GR-binding motif. Turnover of GR binding between mice and humans was associated with gain and loss of the motif. There was no detectable signal of positive selection at species-specific GR binding sites, but clear evidence of purifying selection at the small number of conserved sites. We conclude that enhancer divergence underlies the difference in transcriptional activation after GC treatment between mouse and human macrophages. Only the shared inducible loci show evidence of selection, and therefore these loci may be important for the subset of responses to GC that is shared between species.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1152" length="16"/><text>GR binding sites</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1015" length="4"/><text>mice</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1024" length="6"/><text>humans</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1371" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1381" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="111" length="11"/><text>Macrophages</text></annotation><annotation id="7"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="461" length="11"/><text>macrophages</text></annotation><annotation id="8"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="680" length="11"/><text>macrophages</text></annotation><annotation id="9"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1387" length="11"/><text>macrophages</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="956" length="26"/><text>consensus GR-binding motif</text></annotation><annotation id="11"><infon key="identifier">0005810</infon><infon key="type">TISSUE</infon><location offset="299" length="13"/><text>immune system</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="95" length="5"/><text>Mouse</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="105" length="5"/><text>Human</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="445" length="5"/><text>human</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="455" length="5"/><text>mouse</text></annotation><annotation id="16"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="664" length="5"/><text>human</text></annotation><annotation id="17"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="674" length="5"/><text>mouse</text></annotation></passage></document>
<document><id>26673693</id><passage><offset>0</offset><text>Dynamic recruitment of Ets1 to both nucleosome-occupied and -depleted enhancer regions mediates a transcriptional program switch during early T-cell differentiation. Ets1 is a sequence-specific transcription factor that plays an important role during hematopoiesis, and is essential for the transition of CD4(-)/CD8(-) double negative (DN) to CD4(+)/CD8(+) double positive (DP) thymocytes. Using genome-wide and functional approaches, we investigated the binding properties, transcriptional role and chromatin environment of Ets1 during this transition. We found that while Ets1 binding at distal sites was associated with active genes at both DN and DP stages, its enhancer activity was attained at the DP stage, as reflected by levels of the core transcriptional hallmarks H3K4me1/3, RNA Polymerase II and eRNA. This dual, stage-specific ability reflected a switch from non-T hematopoietic toward T-cell specific gene expression programs during the DN-to-DP transition, as indicated by transcriptome analyses of Ets1(-/-) thymic cells. Coincidentally, Ets1 associates more specifically with Runx1 in DN and with TCF1 in DP cells. We also provide evidence that Ets1 predominantly binds distal nucleosome-occupied regions in DN and nucleosome-depleted regions in DP. Finally and importantly, we demonstrate that Ets1 induces chromatin remodeling by displacing H3K4me1-marked nucleosomes. Our results thus provide an original model whereby the ability of a transcription factor to bind nucleosomal DNA changes during differentiation with consequences on its cognate enhancer activity.</text><annotation id="1"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="899" length="6"/><text>T-cell</text></annotation><annotation id="2"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="574" length="4"/><text>Ets1</text></annotation><annotation id="3"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="704" length="2"/><text>DP</text></annotation><annotation id="4"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="951" length="2"/><text>DN</text></annotation><annotation id="5"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="957" length="2"/><text>DP</text></annotation><annotation id="6"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="1054" length="4"/><text>Ets1</text></annotation><annotation id="7"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="1093" length="5"/><text>Runx1</text></annotation><annotation id="8"><infon key="identifier">6932</infon><infon key="type">GENE</infon><location offset="1114" length="4"/><text>TCF1</text></annotation><annotation id="9"><infon key="type">TISSUE</infon><location offset="1122" length="8"/><text>DP cells</text></annotation><annotation id="10"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="1162" length="4"/><text>Ets1</text></annotation><annotation id="11"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="305" length="29"/><text>CD4(-)/CD8(-) double negative</text></annotation><annotation id="12"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1225" length="2"/><text>DN</text></annotation><annotation id="13"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1263" length="2"/><text>DP</text></annotation><annotation id="14"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="1312" length="4"/><text>Ets1</text></annotation><annotation id="15"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="142" length="6"/><text>T-cell</text></annotation><annotation id="16"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="1014" length="22"/><text>Ets1(-/-) thymic cells</text></annotation><annotation id="17"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="23" length="4"/><text>Ets1</text></annotation><annotation id="18"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="166" length="4"/><text>Ets1</text></annotation><annotation id="19"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="336" length="2"/><text>DN</text></annotation><annotation id="20"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="343" length="45"/><text>CD4(+)/CD8(+) double positive (DP) thymocytes</text></annotation><annotation id="21"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="644" length="2"/><text>DN</text></annotation><annotation id="22"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="651" length="2"/><text>DP</text></annotation><annotation id="23"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="525" length="4"/><text>Ets1</text></annotation></passage></document>
<document><id>26679052</id><passage><offset>0</offset><text>Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms. Bladder cancer is the ninth most common cancer around the world, and is a severe urological cancer irrespective of sex. Approximately 65% of the bladder cancers will recur following surgery; with more than 20% of those patients showing an advanced and metastatic stage, with reducing prognosis. Metastasis causes the most death of bladder cancer yet current therapeutic options remain limited. Antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, has been identified as a strong cytotoxic agent against lung and metastatic breast cancer cells; however, the effects and mechanisms of antrocin on cancer growth and metastasis remain largely unclear. This study showed that treatment with cytotoxic concentration of antrocin induced both intrinsic and extrinsic apoptotic pathways in human bladder cancer 5637 cells, evidenced by increase of Fas, DR5, Bax expression and caspase-3, -8 and -9 activation. Exposure to non-cytotoxic concentrations of antrocin significantly inhibited cell growth, migration, and invasion, which was associated with decreased phosphorylation of focal adhesion kinase (FAK) and paxillin. Antrocin also reduced subcellular distribution of FAK and paxillin at the focal adhesion contacts of the cell periphery site, and disrupted the formation of filopodia and lamellipodia. Moreover, antrocin increased epithelial-to-mesenchymal transition-related gene E-cadherin and decreased vimentin expression. Real-time PCR analysis showed that antrocin downregulated the expression of mRNA of several MMPs, including MMP-2. Moreover, the phosphorylation of ERK and c-Fos were also attenuated by antrocin. Data from chromatin immunoprecipitation assay demonstrated that antrocin decreased the DNA binding activity of c-Fos to the upstream/enhancer region of MMP-2 promoter, an action likely to result in the reducing MMP-2 expression. Overall, this is the first study which demonstrates that antrocin-inhibited migration and invasion of bladder cancer cells is partly via inactivation of FAK-paxillin and ERK-c-Fos-MMP2 signaling pathways. Both antrocin-induced intrinsic and extrinsic apoptosis is through upregulation of pro-apoptotic proteins, including Bax, Fas, and DR5. These results provide insights for understanding the anti-cancer effects and mechanisms of antrocin in human bladder cancer cells and indicate that antrocin may be a potential therapeutic agent for invasive bladder cancer cells by inhibition of metastasis and induction of apoptosis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1936" length="42"/><text>upstream/enhancer region of MMP-2 promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1964" length="14"/><text>MMP-2 promoter</text></annotation><annotation id="3"><infon key="identifier">196114</infon><infon key="type">SPECIES</infon><location offset="619" length="19"/><text>Antrodia cinnamomea</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="716" length="19"/><text>breast cancer cells</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="788" length="6"/><text>cancer</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="974" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">355</infon><infon key="type">GENE</infon><location offset="2368" length="3"/><text>Fas</text></annotation><annotation id="8"><infon key="identifier">8795</infon><infon key="type">GENE</infon><location offset="1037" length="3"/><text>DR5</text></annotation><annotation id="9"><infon key="identifier">581</infon><infon key="type">GENE</infon><location offset="1042" length="3"/><text>Bax</text></annotation><annotation id="10"><infon key="identifier">5747</infon><infon key="type">GENE</infon><location offset="1264" length="27"/><text>focal adhesion kinase (FAK)</text></annotation><annotation id="11"><infon key="identifier">5829</infon><infon key="type">GENE</infon><location offset="1296" length="8"/><text>paxillin</text></annotation><annotation id="12"><infon key="identifier">0000362</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="54" length="20"/><text>bladder cancer cells</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="48" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">5747</infon><infon key="type">GENE</infon><location offset="1356" length="3"/><text>FAK</text></annotation><annotation id="15"><infon key="identifier">999</infon><infon key="type">GENE</infon><location offset="1570" length="10"/><text>E-cadherin</text></annotation><annotation id="16"><infon key="identifier">7431</infon><infon key="type">GENE</infon><location offset="1595" length="8"/><text>vimentin</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0003137</infon><infon key="type">TISSUE</infon><location offset="980" length="25"/><text>bladder cancer 5637 cells</text></annotation><annotation id="18"><infon key="identifier">4313</infon><infon key="type">GENE</infon><location offset="1724" length="5"/><text>MMP-2</text></annotation><annotation id="19"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="1764" length="3"/><text>ERK</text></annotation><annotation id="20"><infon key="identifier">2353</infon><infon key="type">GENE</infon><location offset="1772" length="5"/><text>c-Fos</text></annotation><annotation id="21"><infon key="identifier">2353</infon><infon key="type">GENE</infon><location offset="1923" length="5"/><text>c-Fos</text></annotation><annotation id="22"><infon key="identifier">355</infon><infon key="type">GENE</infon><location offset="1032" length="3"/><text>Fas</text></annotation><annotation id="23"><infon key="identifier">4313</infon><infon key="type">GENE</infon><location offset="2023" length="5"/><text>MMP-2</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0000551</infon><infon key="type">TISSUE</infon><location offset="696" length="4"/><text>lung</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0000362</infon><infon key="type">TISSUE</infon><location offset="2143" length="20"/><text>bladder cancer cells</text></annotation><annotation id="26"><infon key="identifier">5747</infon><infon key="type">GENE</infon><location offset="2194" length="3"/><text>FAK</text></annotation><annotation id="27"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="2211" length="3"/><text>ERK</text></annotation><annotation id="28"><infon key="identifier">2353</infon><infon key="type">GENE</infon><location offset="2215" length="5"/><text>c-Fos</text></annotation><annotation id="29"><infon key="identifier">4313</infon><infon key="type">GENE</infon><location offset="2221" length="4"/><text>MMP2</text></annotation><annotation id="30"><infon key="identifier">581</infon><infon key="type">GENE</infon><location offset="2363" length="3"/><text>Bax</text></annotation><annotation id="31"><infon key="identifier">8795</infon><infon key="type">GENE</infon><location offset="2377" length="3"/><text>DR5</text></annotation><annotation id="32"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="2440" length="6"/><text>cancer</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2485" length="5"/><text>human</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0000362</infon><infon key="type">TISSUE</infon><location offset="2491" length="20"/><text>bladder cancer cells</text></annotation><annotation id="35"><infon key="identifier">196114</infon><infon key="type">SPECIES</infon><location offset="126" length="19"/><text>Antrodia cinnamomea</text></annotation><annotation id="36"><infon key="attribute">CANCER</infon><infon key="identifier">0000362</infon><infon key="type">TISSUE</infon><location offset="2589" length="20"/><text>bladder cancer cells</text></annotation><annotation id="37"><infon key="identifier">4313</infon><infon key="type">GENE</infon><location offset="1964" length="5"/><text>MMP-2</text></annotation><annotation id="38"><infon key="identifier">836</infon><infon key="type">GENE</infon><location offset="1061" length="9"/><text>caspase-3</text></annotation><annotation id="39"><infon key="identifier">841</infon><infon key="type">GENE</infon><location offset="1072" length="2"/><text>-8</text></annotation><annotation id="40"><infon key="identifier">842</infon><infon key="type">GENE</infon><location offset="1079" length="2"/><text>-9</text></annotation><annotation id="41"><infon key="attribute">CANCER</infon><infon key="identifier">0001187</infon><infon key="type">DISEASE</infon><location offset="177" length="14"/><text>Bladder cancer</text></annotation><annotation id="42"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="217" length="6"/><text>cancer</text></annotation><annotation id="43"><infon key="attribute">CANCER</infon><infon key="identifier">0006295</infon><infon key="type">DISEASE</infon><location offset="258" length="17"/><text>urological cancer</text></annotation><annotation id="44"><infon key="attribute">CANCER</infon><infon key="identifier">0001187</infon><infon key="type">DISEASE</infon><location offset="322" length="15"/><text>bladder cancers</text></annotation><annotation id="45"><infon key="attribute">CANCER</infon><infon key="identifier">0001187</infon><infon key="type">DISEASE</infon><location offset="508" length="14"/><text>bladder cancer</text></annotation></passage></document>
<document><id>26728555</id><passage><offset>0</offset><text>Regulation of the imprinted Dlk1-Dio3 locus by allele-specific enhancer activity. Genomic imprinting is a critical developmental process characteristic of parent of origin-specific gene expression. It is well accepted that differentially DNA-methylated regions (DMRs) and enhancers are two major classes of cis-elements determining parent of origin-specific gene expression, with each recruiting different sets of transcription factors. Previously, we identified the AF4/FMR2 (AFF) family protein AFF3 within the transcription elongation complex SEC-L3. Here, we report that AFF3 can specifically bind both gametic DMRs (gDMRs) and enhancers within imprinted loci in an allele-specific manner. We identify the molecular regulators involved in the recruitment of AFF3 to gDMRs and provide mechanistic insight into the requirement of AFF3 at an enhancer for the expression of an ~200-kb polycistronic transcript within the imprinted Dlk1-Dio3 locus. Our data suggest that the heterochromatic environment at the gDMR reinforces silencing of its related enhancer by controlling the binding and activity of AFF3 in an allele-specific manner. In summary, this study provides molecular details about the regulation of dosage-critical imprinted gene expression through the regulated binding of the transcription elongation factor AFF3 between a DMR and an enhancer.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1050" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="497" length="4"/><text>AFF3</text></annotation><annotation id="3"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="575" length="4"/><text>AFF3</text></annotation><annotation id="4"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="762" length="4"/><text>AFF3</text></annotation><annotation id="5"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="832" length="4"/><text>AFF3</text></annotation><annotation id="6"><infon key="identifier">8788</infon><infon key="type">GENE</infon><location offset="931" length="4"/><text>Dlk1</text></annotation><annotation id="7"><infon key="identifier">1735</infon><infon key="type">GENE</infon><location offset="936" length="4"/><text>Dio3</text></annotation><annotation id="8"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="1102" length="4"/><text>AFF3</text></annotation><annotation id="9"><infon key="identifier">3899</infon><infon key="type">GENE</infon><location offset="1322" length="4"/><text>AFF3</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1348" length="8"/><text>enhancer</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="843" length="8"/><text>enhancer</text></annotation><annotation id="12"><infon key="identifier">8788</infon><infon key="type">GENE</infon><location offset="28" length="4"/><text>Dlk1</text></annotation><annotation id="13"><infon key="identifier">1735</infon><infon key="type">GENE</infon><location offset="33" length="4"/><text>Dio3</text></annotation><annotation id="14"><infon key="identifier">4299</infon><infon key="type">GENE</infon><location offset="467" length="3"/><text>AF4</text></annotation><annotation id="15"><infon key="identifier">2334</infon><infon key="type">GENE</infon><location offset="471" length="4"/><text>FMR2</text></annotation></passage></document>
<document><id>26748758</id><passage><offset>0</offset><text>Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification. Following implantation, mouse epiblast cells transit from a naive to a primed state in which they are competent for both somatic and primordial germ cell (PGC) specification. Using mouse embryonic stem cells as an in vitro model to study the transcriptional regulatory principles orchestrating peri-implantation development, here we show that the transcription factor Foxd3 is necessary for exit from naive pluripotency and progression to a primed pluripotent state. During this transition, Foxd3 acts as a repressor that dismantles a significant fraction of the naive pluripotency expression program through decommissioning of active enhancers associated with key naive pluripotency and early germline genes. Subsequently, Foxd3 needs to be silenced in primed pluripotent cells to allow re-activation of relevant genes required for proper PGC specification. Our findings therefore uncover a cycle of activation and deactivation of Foxd3 required for exit from naive pluripotency and subsequent PGC specification.</text><annotation id="1"><infon key="identifier">0001268</infon><infon key="type">TISSUE</infon><location offset="235" length="7"/><text>somatic</text></annotation><annotation id="2"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="247" length="20"/><text>primordial germ cell</text></annotation><annotation id="3"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="269" length="3"/><text>PGC</text></annotation><annotation id="4"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="301" length="20"/><text>embryonic stem cells</text></annotation><annotation id="5"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="875" length="17"/><text>pluripotent cells</text></annotation><annotation id="6"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="954" length="3"/><text>PGC</text></annotation><annotation id="7"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="1109" length="3"/><text>PGC</text></annotation><annotation id="8"><infon key="identifier">15221</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>Foxd3</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="138" length="5"/><text>mouse</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="295" length="5"/><text>mouse</text></annotation><annotation id="11"><infon key="identifier">15221</infon><infon key="type">GENE</infon><location offset="482" length="5"/><text>Foxd3</text></annotation><annotation id="12"><infon key="identifier">15221</infon><infon key="type">GENE</infon><location offset="605" length="5"/><text>Foxd3</text></annotation><annotation id="13"><infon key="identifier">15221</infon><infon key="type">GENE</infon><location offset="838" length="5"/><text>Foxd3</text></annotation><annotation id="14"><infon key="identifier">15221</infon><infon key="type">GENE</infon><location offset="1046" length="5"/><text>Foxd3</text></annotation><annotation id="15"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="144" length="14"/><text>epiblast cells</text></annotation></passage></document>
<document><id>26751080</id><passage><offset>0</offset><text>Up-Regulation of Human Inducible Nitric Oxide Synthase by p300 Transcriptional Complex. p300, a ubiquitous transcription coactivator, plays an important role in gene activation. Our previous work demonstrated that human inducible nitric oxide synthase (hiNOS) expression can be highly induced with the cytokine mixture (CM) of TNF-alpha + IL-1beta + IFN-gamma. In this study, we investigated the functional role of p300 in the regulation of hiNOS gene expression. Our initial data showed that overexpression of p300 significantly increased the basal and cytokine-induced hiNOS promoter activities in A549 cells. Interestingly, p300 activated cytokine-induced hiNOS transcriptional activity was completely abrogated by deleting the upstream hiNOS enhancer at -5 kb to -6 kb in the promoter. Furthermore, p300 over-expression increased cytokine-induced transcriptional activity on a heterologous minimal TK promoter with the same hiNOS enhancer. Site-directed mutagenesis of the hiNOS AP-1 motifs revealed that an intact upstream (-5.3 kb) AP-1 binding site was critical for p300 mediated cytokine-induced hiNOS transcription. Furthermore, our ChIP analysis demonstrated that p300 was binding to Jun D and Fra-2 proteins at -5.3 kb AP-1 binding site in vivo. Lastly, our 3C assay was able to detect a long DNA loop between the hiNOS enhancer and core promoter site, and ChIP loop assay confirmed that p300 binds to AP-1 and RNA pol II proteins. Overall, our results suggest that coactivator p300 mediates cytokine-induced hiNOS transactivation by forming a distant DNA loop between its enhancer and core promoter region.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="571" length="14"/><text>hiNOS promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="731" length="58"/><text>upstream hiNOS enhancer at -5 kb to -6 kb in the promoter.</text></annotation><annotation id="3"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="58" length="4"/><text>p300</text></annotation><annotation id="4"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="88" length="4"/><text>p300</text></annotation><annotation id="5"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="214" length="37"/><text>human inducible nitric oxide synthase</text></annotation><annotation id="6"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="327" length="9"/><text>TNF-alpha</text></annotation><annotation id="7"><infon key="identifier">3553</infon><infon key="type">GENE</infon><location offset="339" length="8"/><text>IL-1beta</text></annotation><annotation id="8"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="350" length="9"/><text>IFN-gamma</text></annotation><annotation id="9"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="415" length="4"/><text>p300</text></annotation><annotation id="10"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="511" length="4"/><text>p300</text></annotation><annotation id="11"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="627" length="4"/><text>p300</text></annotation><annotation id="12"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="803" length="4"/><text>p300</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="780" length="8"/><text>promoter</text></annotation><annotation id="14"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1073" length="4"/><text>p300</text></annotation><annotation id="15"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1174" length="4"/><text>p300</text></annotation><annotation id="16"><infon key="identifier">3727</infon><infon key="type">GENE</infon><location offset="1194" length="5"/><text>Jun D</text></annotation><annotation id="17"><infon key="identifier">2355</infon><infon key="type">GENE</infon><location offset="1204" length="5"/><text>Fra-2</text></annotation><annotation id="18"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1399" length="4"/><text>p300</text></annotation><annotation id="19"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1489" length="4"/><text>p300</text></annotation><annotation id="20"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="253" length="5"/><text>hiNOS</text></annotation><annotation id="21"><infon key="identifier">0000018</infon><infon key="type">TISSUE</infon><location offset="600" length="10"/><text>A549 cells</text></annotation><annotation id="22"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="441" length="5"/><text>hiNOS</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="977" length="17"/><text>hiNOS AP-1 motifs</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="902" length="11"/><text>TK promoter</text></annotation><annotation id="25"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="659" length="5"/><text>hiNOS</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1019" length="36"/><text>upstream (-5.3 kb) AP-1 binding site</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1222" length="25"/><text>-5.3 kb AP-1 binding site</text></annotation><annotation id="28"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1520" length="5"/><text>hiNOS</text></annotation><annotation id="29"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1104" length="5"/><text>hiNOS</text></annotation><annotation id="30"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1413" length="4"/><text>AP-1</text></annotation><annotation id="31"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="740" length="5"/><text>hiNOS</text></annotation><annotation id="32"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="1325" length="5"/><text>hiNOS</text></annotation><annotation id="33"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="928" length="5"/><text>hiNOS</text></annotation><annotation id="34"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="571" length="5"/><text>hiNOS</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="928" length="14"/><text>hiNOS enhancer</text></annotation><annotation id="36"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="977" length="5"/><text>hiNOS</text></annotation><annotation id="37"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1038" length="4"/><text>AP-1</text></annotation><annotation id="38"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1230" length="4"/><text>AP-1</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1325" length="14"/><text>hiNOS enhancer</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1344" length="18"/><text>core promoter site</text></annotation><annotation id="41"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1584" length="8"/><text>enhancer</text></annotation><annotation id="42"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1597" length="20"/><text>core promoter region</text></annotation><annotation id="43"><infon key="identifier">4843</infon><infon key="type">GENE</infon><location offset="17" length="37"/><text>Human Inducible Nitric Oxide Synthase</text></annotation></passage></document>
<document><id>26766440</id><passage><offset>0</offset><text>Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. Enhancers are the primary determinants of cell identity, but the regulatory components controlling enhancer turnover during lineage commitment remain largely unknown. Here we compare the enhancer landscape, transcriptional factor occupancy, and transcriptomic changes in human fetal and adult hematopoietic stem/progenitor cells and committed erythroid progenitors. We find that enhancers are modulated pervasively and direct lineage- and stage-specific transcription. GATA2-to-GATA1 switch is prevalent at dynamic enhancers and drives erythroid enhancer commissioning. Examination of lineage-specific enhancers identifies transcription factors and their combinatorial patterns in enhancer turnover. Importantly, by CRISPR/Cas9-mediated genomic editing, we uncover functional hierarchy of constituent enhancers within the SLC25A37 super-enhancer. Despite indistinguishable chromatin features, we reveal through genomic editing the functional diversity of several GATA switch enhancers in which enhancers with opposing functions cooperate to coordinate transcription. Thus, genome-wide enhancer profiling coupled with in situ enhancer editing provide critical insights into the functional complexity of enhancers during development.</text><annotation id="1"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="403" length="35"/><text>hematopoietic stem/progenitor cells</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="932" length="23"/><text>SLC25A37 super-enhancer</text></annotation><annotation id="3"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="579" length="5"/><text>GATA2</text></annotation><annotation id="4"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="588" length="5"/><text>GATA1</text></annotation><annotation id="5"><infon key="identifier">0004911</infon><infon key="type">TISSUE</infon><location offset="453" length="21"/><text>erythroid progenitors</text></annotation><annotation id="6"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="646" length="9"/><text>erythroid</text></annotation><annotation id="7"><infon key="identifier">51312</infon><infon key="type">GENE</infon><location offset="932" length="8"/><text>SLC25A37</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="381" length="5"/><text>human</text></annotation></passage></document>
<document><id>26771354</id><passage><offset>0</offset><text>BMP Sustains Embryonic Stem Cell Self-Renewal through Distinct Functions of Different Kruppel-like Factors. Bone morphogenetic protein (BMP) signaling exerts paradoxical roles in pluripotent stem cells (PSCs); it sustains self-renewal of mouse embryonic stem cells (ESCs), while it induces differentiation in other PSCs, including human ESCs. Here, we revisit the roles of BMP-4 using mouse ESCs (mESCs) in naive and primed states. SMAD1 and SMAD5, which transduce BMP signals, recognize enhancer regions together with KLF4 and KLF5 in naive mESCs. KLF4 physically interacts with SMAD1 and suppresses its activity. Consistently, a subpopulation of cells with active BMP-SMAD can be ablated without disturbing the naive state of the culture. Moreover, Smad1/5 double-knockout mESCs stay in the naive state, indicating that the BMP-SMAD pathway is dispensable for it. In contrast, the MEK5-ERK5 pathway mediates BMP-4-induced self-renewal of mESCs by inducing Klf2, a critical factor for the ground state pluripotency. Our study illustrates that BMP exerts its self-renewing effect through distinct functions of different Kruppel-like factors.</text><annotation id="1"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="337" length="4"/><text>ESCs</text></annotation><annotation id="2"><infon key="identifier">16600</infon><infon key="type">GENE</infon><location offset="549" length="4"/><text>KLF4</text></annotation><annotation id="3"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="580" length="5"/><text>SMAD1</text></annotation><annotation id="4"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="775" length="5"/><text>mESCs</text></annotation><annotation id="5"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="751" length="5"/><text>Smad1</text></annotation><annotation id="6"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="940" length="5"/><text>mESCs</text></annotation><annotation id="7"><infon key="identifier">23938</infon><infon key="type">GENE</infon><location offset="883" length="4"/><text>MEK5</text></annotation><annotation id="8"><infon key="identifier">23939</infon><infon key="type">GENE</infon><location offset="888" length="4"/><text>ERK5</text></annotation><annotation id="9"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="910" length="5"/><text>BMP-4</text></annotation><annotation id="10"><infon key="identifier">16598</infon><infon key="type">GENE</infon><location offset="958" length="4"/><text>Klf2</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="238" length="5"/><text>mouse</text></annotation><annotation id="12"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="315" length="4"/><text>PSCs</text></annotation><annotation id="13"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="179" length="22"/><text>pluripotent stem cells</text></annotation><annotation id="14"><infon key="identifier">0006078</infon><infon key="type">TISSUE</infon><location offset="203" length="4"/><text>PSCs</text></annotation><annotation id="15"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="244" length="20"/><text>embryonic stem cells</text></annotation><annotation id="16"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="266" length="4"/><text>ESCs</text></annotation><annotation id="17"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="542" length="5"/><text>mESCs</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="331" length="5"/><text>human</text></annotation><annotation id="19"><infon key="identifier">17129</infon><infon key="type">GENE</infon><location offset="757" length="1"/><text>5</text></annotation><annotation id="20"><infon key="type">TISSUE</infon><location offset="23" length="9"/><text>Stem Cell</text></annotation><annotation id="21"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="385" length="10"/><text>mouse ESCs</text></annotation><annotation id="22"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="373" length="5"/><text>BMP-4</text></annotation><annotation id="23"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="397" length="5"/><text>mESCs</text></annotation><annotation id="24"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="432" length="5"/><text>SMAD1</text></annotation><annotation id="25"><infon key="identifier">17129</infon><infon key="type">GENE</infon><location offset="442" length="5"/><text>SMAD5</text></annotation><annotation id="26"><infon key="identifier">16600</infon><infon key="type">GENE</infon><location offset="519" length="4"/><text>KLF4</text></annotation><annotation id="27"><infon key="identifier">12224</infon><infon key="type">GENE</infon><location offset="528" length="4"/><text>KLF5</text></annotation></passage></document>
<document><id>26774474</id><passage><offset>0</offset><text>Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1alpha. The Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1alpha) is a transcriptional co-activator that plays a central role in adapted metabolic responses. PGC-1alpha is dynamically methylated and unmethylated at the residue K779 by the methyltransferase SET7/9 and the Lysine Specific Demethylase 1A (LSD1), respectively. Interactions of methylated PGC-1alpha[K779me] with the Spt-Ada-Gcn5-acetyltransferase (SAGA) complex, the Mediator members MED1 and MED17, and the NOP2/Sun RNA methytransferase 7 (NSUN7) reinforce transcription, and are concomitant with the m(5)C mark on enhancer RNAs (eRNAs). Consistently, loss of Set7/9 and NSun7 in liver cell model systems resulted in depletion of the PGC-1alpha target genes Pfkl, Sirt5, Idh3b, and Hmox2, which was accompanied by a decrease in the eRNAs levels associated with these loci. Enrichment of m(5)C within eRNA species coincides with metabolic stress of fasting in vivo. Collectively, these findings illustrate the complex epigenetic circuitry imposed by PGC-1alpha at the eRNA level to fine-tune energy metabolism.</text><annotation id="1"><infon key="identifier">9440</infon><infon key="type">GENE</infon><location offset="573" length="5"/><text>MED17</text></annotation><annotation id="2"><infon key="identifier">79730</infon><infon key="type">GENE</infon><location offset="588" length="31"/><text>NOP2/Sun RNA methytransferase 7</text></annotation><annotation id="3"><infon key="identifier">79730</infon><infon key="type">GENE</infon><location offset="621" length="5"/><text>NSUN7</text></annotation><annotation id="4"><infon key="identifier">73251</infon><infon key="type">GENE</infon><location offset="741" length="6"/><text>Set7/9</text></annotation><annotation id="5"><infon key="identifier">70918</infon><infon key="type">GENE</infon><location offset="752" length="5"/><text>NSun7</text></annotation><annotation id="6"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="815" length="10"/><text>PGC-1alpha</text></annotation><annotation id="7"><infon key="identifier">18641</infon><infon key="type">GENE</infon><location offset="839" length="4"/><text>Pfkl</text></annotation><annotation id="8"><infon key="identifier">68346</infon><infon key="type">GENE</infon><location offset="845" length="5"/><text>Sirt5</text></annotation><annotation id="9"><infon key="identifier">170718</infon><infon key="type">GENE</infon><location offset="852" length="5"/><text>Idh3b</text></annotation><annotation id="10"><infon key="identifier">15369</infon><infon key="type">GENE</infon><location offset="863" length="5"/><text>Hmox2</text></annotation><annotation id="11"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="84" length="10"/><text>PGC-1alpha</text></annotation><annotation id="12"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="1130" length="10"/><text>PGC-1alpha</text></annotation><annotation id="13"><infon key="identifier">80854</infon><infon key="type">GENE</infon><location offset="373" length="6"/><text>SET7/9</text></annotation><annotation id="14"><infon key="identifier">0000224</infon><infon key="type">TISSUE</infon><location offset="761" length="10"/><text>liver cell</text></annotation><annotation id="15"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="100" length="68"/><text>Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha</text></annotation><annotation id="16"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="170" length="10"/><text>PGC-1alpha</text></annotation><annotation id="17"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="274" length="10"/><text>PGC-1alpha</text></annotation><annotation id="18"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="388" length="30"/><text>Lysine Specific Demethylase 1A</text></annotation><annotation id="19"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="420" length="4"/><text>LSD1</text></annotation><annotation id="20"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="468" length="10"/><text>PGC-1alpha</text></annotation><annotation id="21"><infon key="identifier">5469</infon><infon key="type">GENE</infon><location offset="564" length="4"/><text>MED1</text></annotation></passage></document>
<document><id>26776159</id><passage><offset>0</offset><text>A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response. Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 (linc-475). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="25"/><text>p53-bound enhancer region</text></annotation><annotation id="2"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="165" length="3"/><text>p53</text></annotation><annotation id="3"><infon key="identifier">1026</infon><infon key="type">GENE</infon><location offset="1154" length="3"/><text>p21</text></annotation><annotation id="4"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="257" length="3"/><text>p53</text></annotation><annotation id="5"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="421" length="3"/><text>p53</text></annotation><annotation id="6"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="539" length="3"/><text>p53</text></annotation><annotation id="7"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="818" length="3"/><text>p53</text></annotation><annotation id="8"><infon key="identifier">1026</infon><infon key="type">GENE</infon><location offset="943" length="6"/><text>CDKN1A</text></annotation><annotation id="9"><infon key="identifier">1026</infon><infon key="type">GENE</infon><location offset="950" length="3"/><text>p21</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1266" length="26"/><text>p53-bound enhancer domains</text></annotation><annotation id="11"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="997" length="3"/><text>p53</text></annotation><annotation id="12"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1024" length="3"/><text>p53</text></annotation><annotation id="13"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1100" length="3"/><text>p53</text></annotation><annotation id="14"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1204" length="3"/><text>p53</text></annotation><annotation id="15"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1349" length="3"/><text>p53</text></annotation><annotation id="16"><infon key="attribute">RNA</infon><infon key="type">ENHANCER</infon><location offset="292" length="13"/><text>enhancer RNAs</text></annotation><annotation id="17"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="2" length="3"/><text>p53</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="646" length="27"/><text>p53-bound intronic enhancer</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1142" length="15"/><text>promoter of p21</text></annotation><annotation id="20"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="646" length="3"/><text>p53</text></annotation><annotation id="21"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1266" length="3"/><text>p53</text></annotation><annotation id="22"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="82" length="3"/><text>p53</text></annotation></passage></document>
<document><id>26780995</id><passage><offset>0</offset><text>Enhanced Identification of Transcriptional Enhancers Provides Mechanistic Insights into Diseases. Enhancers are distal cis-regulatory DNA elements that increase the expression of target genes. Various experimental and computational approaches including chromatin signature profiling have been developed to predict enhancers on a genome-wide scale, although each method has its advantages and disadvantages. Here we overview an emerging method to identify transcribed enhancers at exceedingly high nucleotide resolution based on enhancer RNA transcripts captured by Cap Analysis of Gene Expression (CAGE) technology. We further argue that disease-causative regulatory mutations at enhancers are increasingly recognized, emphasizing the importance of enhancer identification in functional and clinical genomics including, but not limited to, genome-wide association studies (GWASs) and cancer genomics studies.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="884" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>26795348</id><passage><offset>0</offset><text>Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. The findings from genome-wide association studies hold enormous potential for novel insight into disease mechanisms. A major challenge in the field is to map these low-risk association signals to their underlying functional sequence variants (FSV). Simple sequence study designs are insufficient, as the vast numbers of statistically comparable variants and a limited knowledge of noncoding regulatory elements complicate prioritization. Furthermore, large sample sizes are typically required for adequate power to identify the initial association signals. One important question is whether similar sample sizes need to be sequenced to identify the FSVs. Here, we present a proof-of-principle example of an extreme discordant design to map FSVs within the 2q33 low-risk breast cancer locus. Our approach employed DNA sequencing of a small number of discordant haplotypes to efficiently identify candidate FSVs. Our results were consistent with those from a 2,000-fold larger, traditional imputation-based fine-mapping study. To prioritize further, we used expression-quantitative trait locus analysis of RNA sequencing from breast tissues, gene regulation annotations from the ENCODE consortium, and functional assays for differential enhancer activities. Notably, we implicate three regulatory variants at 2q33 that target CASP8 (rs3769823, rs3769821 in CASP8, and rs10197246 in ALS2CR12) as functionally relevant. We conclude that nested discordant haplotype sequencing is a promising approach to aid mapping of low-risk association loci. The ability to include more efficient sequencing designs into mapping efforts presents an opportunity for the field to capitalize on the potential of association loci and accelerate translation of association signals to their underlying FSVs. Cancer Res; 76(7); 1916-25.  2016 AACR.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="75" length="13"/><text>Breast Cancer</text></annotation><annotation id="2"><infon key="identifier">0000149</infon><infon key="type">TISSUE</infon><location offset="1225" length="6"/><text>breast</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="871" length="13"/><text>breast cancer</text></annotation><annotation id="4"><infon key="identifier">841</infon><infon key="type">GENE</infon><location offset="1425" length="5"/><text>CASP8</text></annotation><annotation id="5"><infon key="comment">rs3769823</infon><infon key="type">VARIANT</infon><infon key="identifier">rs3769823</infon><location offset="1432" length="9"/><text>rs3769823</text></annotation><annotation id="6"><infon key="comment">rs3769821</infon><infon key="type">VARIANT</infon><infon key="identifier">rs3769821</infon><location offset="1443" length="9"/><text>rs3769821</text></annotation><annotation id="7"><infon key="identifier">841</infon><infon key="type">GENE</infon><location offset="1456" length="5"/><text>CASP8</text></annotation><annotation id="8"><infon key="comment">rs10197246</infon><infon key="type">VARIANT</infon><infon key="identifier">rs10197246</infon><location offset="1467" length="10"/><text>rs10197246</text></annotation><annotation id="9"><infon key="identifier">130540</infon><infon key="type">GENE</infon><location offset="1481" length="8"/><text>ALS2CR12</text></annotation></passage></document>
<document><id>26809031</id><passage><offset>0</offset><text>E2F/Rb Family Proteins Mediate Interferon Induced Repression of Adenovirus Immediate Early Transcription to Promote Persistent Viral Infection. Interferons (IFNs) are cytokines that have pleiotropic effects and play important roles in innate and adaptive immunity. IFNs have broad antiviral properties and function by different mechanisms. IFNs fail to inhibit wild-type Adenovirus (Ad) replication in established cancer cell lines. In this study, we analyzed the effects of IFNs on Ad replication in normal human cells. Our data demonstrate that both IFNalpha and IFNgamma blocked wild-type Ad5 replication in primary human bronchial epithelial cells (NHBEC) and TERT-immortalized normal human diploid fibroblasts (HDF-TERT). IFNs inhibited the replication of divergent adenoviruses. The inhibition of Ad5 replication by IFNalpha and IFNgamma is the consequence of repression of transcription of the E1A immediate early gene product. Both IFNalpha and IFNgamma impede the association of the transactivator GABP with the E1A enhancer region during the early phase of infection. The repression of E1A expression by IFNs requires a conserved E2F binding site in the E1A enhancer, and IFNs increased the enrichment of the E2F-associated pocket proteins, Rb and p107, at the E1A enhancer in vivo. PD0332991 (Pabociclib), a specific CDK4/6 inhibitor, dephosphoryles pocket proteins to promote their interaction with E2Fs and inhibited wild-type Ad5 replication dependent on the conserved E2F binding site. Consistent with this result, expression of the small E1A oncoprotein, which abrogates E2F/pocket protein interactions, rescued Ad replication in the presence of IFNalpha or IFNgamma. Finally, we established a persistent Ad infection model in vitro and demonstrated that IFNgamma suppresses productive Ad replication in a manner dependent on the E2F binding site in the E1A enhancer. This is the first study that probes the molecular basis of persistent adenovirus infection and reveals a novel mechanism by which adenoviruses utilize IFN signaling to suppress lytic virus replication and to promote persistent infection.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1021" length="19"/><text>E1A enhancer region</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1164" length="12"/><text>E1A enhancer</text></annotation><annotation id="3"><infon key="identifier">2551</infon><infon key="type">GENE</infon><location offset="1007" length="4"/><text>GABP</text></annotation><annotation id="4"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="716" length="8"/><text>HDF-TERT</text></annotation><annotation id="5"><infon key="identifier">8081</infon><infon key="type">GENE</infon><location offset="803" length="3"/><text>Ad5</text></annotation><annotation id="6"><infon key="identifier">3439</infon><infon key="type">GENE</infon><location offset="822" length="8"/><text>IFNalpha</text></annotation><annotation id="7"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="835" length="8"/><text>IFNgamma</text></annotation><annotation id="8"><infon key="identifier">3439</infon><infon key="type">GENE</infon><location offset="940" length="8"/><text>IFNalpha</text></annotation><annotation id="9"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="953" length="8"/><text>IFNgamma</text></annotation><annotation id="10"><infon key="identifier">1019</infon><infon key="type">GENE</infon><location offset="1328" length="4"/><text>CDK4</text></annotation><annotation id="11"><infon key="identifier">8081</infon><infon key="type">GENE</infon><location offset="1440" length="3"/><text>Ad5</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1271" length="12"/><text>E1A enhancer</text></annotation><annotation id="13"><infon key="identifier">3439</infon><infon key="type">GENE</infon><location offset="1662" length="8"/><text>IFNalpha</text></annotation><annotation id="14"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1674" length="8"/><text>IFNgamma</text></annotation><annotation id="15"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1771" length="8"/><text>IFNgamma</text></annotation><annotation id="16"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="483" length="2"/><text>Ad</text></annotation><annotation id="17"><infon key="identifier">0043479</infon><infon key="type">DISEASE</infon><location offset="1954" length="20"/><text>adenovirus infection</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1140" length="36"/><text>E2F binding site in the E1A enhancer</text></annotation><annotation id="19"><infon key="type">TISSUE</infon><location offset="414" length="17"/><text>cancer cell lines</text></annotation><annotation id="20"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="664" length="50"/><text>TERT-immortalized normal human diploid fibroblasts</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1846" length="36"/><text>E2F binding site in the E1A enhancer</text></annotation><annotation id="22"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="371" length="10"/><text>Adenovirus</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1870" length="12"/><text>E1A enhancer</text></annotation><annotation id="24"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="383" length="2"/><text>Ad</text></annotation><annotation id="25"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="1721" length="2"/><text>Ad</text></annotation><annotation id="26"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="1802" length="2"/><text>Ad</text></annotation><annotation id="27"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="64" length="10"/><text>Adenovirus</text></annotation><annotation id="28"><infon key="identifier">10239</infon><infon key="type">SPECIES</infon><location offset="127" length="5"/><text>Viral</text></annotation><annotation id="29"><infon key="identifier">5933</infon><infon key="type">GENE</infon><location offset="1258" length="4"/><text>p107</text></annotation><annotation id="30"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="1628" length="2"/><text>Ad</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1483" length="16"/><text>E2F binding site</text></annotation><annotation id="32"><infon key="identifier">1967472</infon><infon key="type">SPECIES</infon><location offset="771" length="12"/><text>adenoviruses</text></annotation><annotation id="33"><infon key="identifier">0002922</infon><infon key="type">TISSUE</infon><location offset="611" length="40"/><text>primary human bronchial epithelial cells</text></annotation><annotation id="34"><infon key="identifier">1021</infon><infon key="type">GENE</infon><location offset="1333" length="1"/><text>6</text></annotation><annotation id="35"><infon key="identifier">2652980</infon><infon key="type">GENE</infon><location offset="1554" length="3"/><text>E1A</text></annotation><annotation id="36"><infon key="identifier">2652980</infon><infon key="type">GENE</infon><location offset="901" length="3"/><text>E1A</text></annotation><annotation id="37"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="619" length="5"/><text>human</text></annotation><annotation id="38"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="508" length="5"/><text>human</text></annotation><annotation id="39"><infon key="identifier">3439</infon><infon key="type">GENE</infon><location offset="552" length="8"/><text>IFNalpha</text></annotation><annotation id="40"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="565" length="8"/><text>IFNgamma</text></annotation><annotation id="41"><infon key="identifier">8081</infon><infon key="type">GENE</infon><location offset="592" length="3"/><text>Ad5</text></annotation><annotation id="42"><infon key="identifier">0002922</infon><infon key="type">TISSUE</infon><location offset="653" length="5"/><text>NHBEC</text></annotation></passage></document>
<document><id>26809507</id><passage><offset>0</offset><text>Integrated genome-scale analysis of the transcriptional regulatory landscape in a blood stem/progenitor cell model. Comprehensive study of transcriptional control processes will be required to enhance our understanding of both normal and malignant hematopoiesis. Modern sequencing technologies have revolutionized our ability to generate genome-scale expression and histone modification profiles, transcription factor (TF)-binding maps, and also comprehensive chromatin-looping information. Many of these technologies, however, require large numbers of cells, and therefore cannot be applied to rare hematopoietic stem/progenitor cell (HSPC) populations. The stem cell factor-dependent multipotent progenitor cell line HPC-7 represents a well-recognized cell line model for HSPCs. Here we report genome-wide maps for 17 TFs, 3 histone modifications, DNase I hypersensitive sites, and high-resolution promoter-enhancer interactomes in HPC-7 cells. Integrated analysis of these complementary data sets revealed TF occupancy patterns of genomic regions involved in promoter-anchored loops. Moreover, preferential associations between pairs of TFs bound at either ends of chromatin loops led to the identification of 4 previously unrecognized protein-protein interactions between key blood stem cell regulators. All HPC-7 data sets are freely available both through standard repositories and a user-friendly Web interface. Together with previously generated genome-wide data sets, this study integrates HPC-7 data into a genomic resource on par with ENCODE tier 1 cell lines and, importantly, is the only current model with comprehensive genome-scale data that is relevant to HSPC biology.</text><annotation id="1"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="82" length="5"/><text>blood</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="1280" length="15"/><text>blood stem cell</text></annotation><annotation id="3"><infon key="type">TISSUE</infon><location offset="1672" length="4"/><text>HSPC</text></annotation><annotation id="4"><infon key="type">TISSUE</infon><location offset="659" length="65"/><text>stem cell factor-dependent multipotent progenitor cell line HPC-7</text></annotation><annotation id="5"><infon key="type">TISSUE</infon><location offset="600" length="34"/><text>hematopoietic stem/progenitor cell</text></annotation><annotation id="6"><infon key="type">TISSUE</infon><location offset="636" length="4"/><text>HSPC</text></annotation><annotation id="7"><infon key="type">TISSUE</infon><location offset="1312" length="5"/><text>HPC-7</text></annotation><annotation id="8"><infon key="type">TISSUE</infon><location offset="1499" length="5"/><text>HPC-7</text></annotation><annotation id="9"><infon key="type">TISSUE</infon><location offset="774" length="5"/><text>HSPCs</text></annotation><annotation id="10"><infon key="type">TISSUE</infon><location offset="934" length="11"/><text>HPC-7 cells</text></annotation></passage></document>
<document><id>26813977</id><passage><offset>0</offset><text>A new class of temporarily phenotypic enhancers identified by CRISPR/Cas9-mediated genetic screening. With &lt;2% of the human genome coding for proteins, a major challenge is to interpret the function of the noncoding DNA. Millions of regulatory sequences have been predicted in the human genome through analysis of DNA methylation, chromatin modification, hypersensitivity to nucleases, and transcription factor binding, but few have been shown to regulate transcription in their native contexts. We have developed a high-throughput CRISPR/Cas9-based genome-editing strategy and used it to interrogate 174 candidate regulatory sequences within the 1-Mbp POU5F1 locus in human embryonic stem cells (hESCs). We identified two classical regulatory elements, including a promoter and a proximal enhancer, that are essential for POU5F1 transcription in hESCs. Unexpectedly, we also discovered a new class of enhancers that contribute to POU5F1 transcription in an unusual way: Disruption of such sequences led to a temporary loss of POU5F1 transcription that is fully restored after a few rounds of cell division. These results demonstrate the utility of high-throughput screening for functional characterization of noncoding DNA and reveal a previously unrecognized layer of gene regulation in human cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="766" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1027" length="6"/><text>POU5F1</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1289" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="697" length="5"/><text>hESCs</text></annotation><annotation id="5"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="847" length="5"/><text>hESCs</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="781" length="17"/><text>proximal enhancer</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="118" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="281" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="653" length="6"/><text>POU5F1</text></annotation><annotation id="10"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="669" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="11"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="823" length="6"/><text>POU5F1</text></annotation><annotation id="12"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="931" length="6"/><text>POU5F1</text></annotation></passage></document>
<document><id>26817450</id><passage><offset>0</offset><text>Looking beyond GWAS: allele-specific transcription factor binding drives the association of GALNT2 to HDL-C plasma levels. BACKGROUND: Plasma levels of high-density lipoprotein cholesterol (HDL-C) have been associated to cardiovascular disease. The high heritability of HDL-C plasma levels has been an incentive for several genome wide association studies (GWASs) which identified, among others, variants in the first intron of the GALNT2 gene strongly associated to HDL-C levels. However, the lead GWAS SNP associated to HDL-C levels in this genomic region, rs4846914, is located outside of transcription factor (TF) binding sites defined by chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) experiments in the ENCODE project and is therefore unlikely to be functional. In this study we apply a bioinformatics approach which rely on the premise that ChIP-seq reads can identify allele specific binding of a TF at cell specific regulatory elements harboring allele specific SNPs (AS-SNPs). EMSA and luciferase assays were used to validate the allele specific binding and to test the enhancer activity of the regulatory element harboring the AS-SNP rs4846913 as well as the neighboring rs2144300 which are in high LD with rs4846914. FINDINGS: Using luciferase assays we found that rs4846913 and the neighboring rs2144300 displayed allele specific enhancer activity. We propose that an inhibitor binds preferentially to the rs4846913-C allele with an inhibitory boost from the synergistic binding of other TFs at the neighboring SNP rs2144300. These events influence the transcription level of GALNT2. CONCLUSIONS: The results suggest that rs4846913 and rs2144300 drive the association to HDL-C plasma levels through an inhibitory regulation of GALNT2 rather than the reported lead GWAS SNP rs4846914.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1126" length="86"/><text>regulatory element harboring the AS-SNP rs4846913 as well as the neighboring rs2144300</text></annotation><annotation id="2"><infon key="comment">hg38:1,230159169,C,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2144300</infon><location offset="1328" length="9"/><text>rs2144300</text></annotation><annotation id="3"><infon key="comment">hg38:1,230158968,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846913</infon><location offset="1440" length="9"/><text>rs4846913</text></annotation><annotation id="4"><infon key="comment">hg38:1,230159169,C,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2144300</infon><location offset="1549" length="9"/><text>rs2144300</text></annotation><annotation id="5"><infon key="identifier">2590</infon><infon key="type">GENE</infon><location offset="1610" length="6"/><text>GALNT2</text></annotation><annotation id="6"><infon key="comment">hg38:1,230158968,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846913</infon><location offset="1656" length="9"/><text>rs4846913</text></annotation><annotation id="7"><infon key="comment">hg38:1,230159169,C,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2144300</infon><location offset="1670" length="9"/><text>rs2144300</text></annotation><annotation id="8"><infon key="identifier">2590</infon><infon key="type">GENE</infon><location offset="1761" length="6"/><text>GALNT2</text></annotation><annotation id="9"><infon key="comment">hg38:1,230159944,G,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846914</infon><location offset="1807" length="9"/><text>rs4846914</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1298" length="39"/><text>rs4846913 and the neighboring rs2144300</text></annotation><annotation id="11"><infon key="identifier">2590</infon><infon key="type">GENE</infon><location offset="92" length="6"/><text>GALNT2</text></annotation><annotation id="12"><infon key="identifier">0004995</infon><infon key="type">DISEASE</infon><location offset="221" length="22"/><text>cardiovascular disease</text></annotation><annotation id="13"><infon key="identifier">2590</infon><infon key="type">GENE</infon><location offset="432" length="6"/><text>GALNT2</text></annotation><annotation id="14"><infon key="comment">hg38:1,230159944,G,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846914</infon><location offset="559" length="9"/><text>rs4846914</text></annotation><annotation id="15"><infon key="comment">hg38:1,230158968,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846913</infon><location offset="1166" length="9"/><text>rs4846913</text></annotation><annotation id="16"><infon key="comment">hg38:1,230159169,C,T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs2144300</infon><location offset="1203" length="9"/><text>rs2144300</text></annotation><annotation id="17"><infon key="comment">hg38:1,230159944,G,A</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846914</infon><location offset="1239" length="9"/><text>rs4846914</text></annotation><annotation id="18"><infon key="comment">hg38:1,230158968,C,A/T</infon><infon key="type">VARIANT</infon><infon key="identifier">rs4846913</infon><location offset="1298" length="9"/><text>rs4846913</text></annotation></passage></document>
<document><id>26818267</id><passage><offset>0</offset><text>Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses. Several studies have shown that human endogenous retroviruses and endogenous retrovirus-like repeats (here collectively HERVs) impose direct regulation on human genes through enhancer and promoter motifs present in their long terminal repeats (LTRs). Although chimeric transcription in which novel gene isoforms containing retroviral and human sequence are transcribed from viral promoters are commonly associated with disease, regulation by HERVs is beneficial in other settings; for example, in human testis chimeric isoforms of TP63 induced by an ERV9 LTR protect the male germ line upon DNA damage by inducing apoptosis, whereas in the human globin locus the gamma- and beta-globin switch during normal hematopoiesis is mediated by complex interactions of an ERV9 LTR and surrounding human sequence. The advent of deep sequencing or next-generation sequencing (NGS) has revolutionized the way researchers solve important scientific questions and develop novel hypotheses in relation to human genome regulation. We recently applied next-generation paired-end RNA-sequencing (RNA-seq) together with chromatin immunoprecipitation with sequencing (ChIP-seq) to examine ERV9 chimeric transcription in human reference cell lines from Encyclopedia of DNA Elements (ENCODE). This led to the discovery of advanced regulation mechanisms by ERV9s and other HERVs across numerous human loci including transcription of large gene-unannotated genomic regions, as well as cooperative regulation by multiple HERVs and non-LTR repeats such as Alu elements. In this article, well-established examples of human gene regulation by HERVs are reviewed followed by a description of paired-end RNA-seq, and its application in identifying chimeric transcription genome-widely. Based on integrative analyses of RNA-seq and ChIP-seq, data we then present novel examples of regulation by ERV9s of tumor suppressor genes CADM2 and SEMA3A, as well as transcription of an unannotated region. Taken together, this article highlights the high suitability of contemporary sequencing methods in future analyses of human biology in relation to evolutionary acquired retroviruses in the human genome.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="618" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="909" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1111" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1321" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1493" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1711" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1994" length="5"/><text>tumor</text></annotation><annotation id="8"><infon key="identifier">253559</infon><infon key="type">GENE</infon><location offset="2017" length="5"/><text>CADM2</text></annotation><annotation id="9"><infon key="identifier">10371</infon><infon key="type">GENE</infon><location offset="2027" length="6"/><text>SEMA3A</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2204" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2275" length="5"/><text>human</text></annotation><annotation id="12"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="563" length="5"/><text>HERVs</text></annotation><annotation id="13"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="795" length="11"/><text>beta-globin</text></annotation><annotation id="14"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="187" length="21"/><text>endogenous retrovirus</text></annotation><annotation id="15"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="241" length="5"/><text>HERVs</text></annotation><annotation id="16"><infon key="identifier">11632</infon><infon key="type">SPECIES</infon><location offset="444" length="10"/><text>retroviral</text></annotation><annotation id="17"><infon key="identifier">10239</infon><infon key="type">SPECIES</infon><location offset="495" length="5"/><text>viral</text></annotation><annotation id="18"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="624" length="6"/><text>testis</text></annotation><annotation id="19"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="884" length="4"/><text>ERV9</text></annotation><annotation id="20"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="1290" length="4"/><text>ERV9</text></annotation><annotation id="21"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="1985" length="5"/><text>ERV9s</text></annotation><annotation id="22"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="1455" length="5"/><text>ERV9s</text></annotation><annotation id="23"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="90" length="29"/><text>human endogenous retroviruses</text></annotation><annotation id="24"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="1617" length="5"/><text>HERVs</text></annotation><annotation id="25"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="1736" length="5"/><text>HERVs</text></annotation><annotation id="26"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="1471" length="5"/><text>HERVs</text></annotation><annotation id="27"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="2255" length="12"/><text>retroviruses</text></annotation><annotation id="28"><infon key="identifier">206037</infon><infon key="type">SPECIES</infon><location offset="153" length="29"/><text>human endogenous retroviruses</text></annotation><annotation id="29"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="276" length="5"/><text>human</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="459" length="5"/><text>human</text></annotation><annotation id="31"><infon key="identifier">2692414</infon><infon key="type">SPECIES</infon><location offset="671" length="4"/><text>ERV9</text></annotation><annotation id="32"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="652" length="4"/><text>TP63</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="761" length="5"/><text>human</text></annotation></passage></document>
<document><id>26829750</id><passage><offset>0</offset><text>An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Translocation events are frequent in cancer and may create chimeric fusions or 'regulatory rearrangements' that drive oncogene overexpression. Here we identify super-enhancer translocations that drive overexpression of the oncogenic transcription factor MYB as a recurrent theme in adenoid cystic carcinoma (ACC). Whole-genome sequencing data and chromatin maps highlight distinct chromosomal rearrangements that juxtapose super-enhancers to the MYB locus. Chromosome conformation capture confirms that the translocated enhancers interact with the MYB promoter. Remarkably, MYB protein binds to the translocated enhancers, creating a positive feedback loop that sustains its expression. MYB also binds enhancers that drive different regulatory programs in alternate cell lineages in ACC, cooperating with TP63 in myoepithelial cells and a Notch program in luminal epithelial cells. Bromodomain inhibitors slow tumor growth in ACC primagraft models in vivo. Thus, our study identifies super-enhancer translocations that drive MYB expression and provides insight into downstream MYB functions in alternate ACC lineages.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="871" length="3"/><text>ACC</text></annotation><annotation id="2"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="342" length="3"/><text>MYB</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="370" length="24"/><text>adenoid cystic carcinoma</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="396" length="3"/><text>ACC</text></annotation><annotation id="5"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="534" length="3"/><text>MYB</text></annotation><annotation id="6"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="636" length="3"/><text>MYB</text></annotation><annotation id="7"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="662" length="3"/><text>MYB</text></annotation><annotation id="8"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="775" length="3"/><text>MYB</text></annotation><annotation id="9"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="893" length="4"/><text>TP63</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="1014" length="3"/><text>ACC</text></annotation><annotation id="11"><infon key="identifier">0002309</infon><infon key="type">TISSUE</infon><location offset="901" length="19"/><text>myoepithelial cells</text></annotation><annotation id="12"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="1113" length="3"/><text>MYB</text></annotation><annotation id="13"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="1165" length="3"/><text>MYB</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="636" length="12"/><text>MYB promoter</text></annotation><annotation id="15"><infon key="identifier">0005437</infon><infon key="type">TISSUE</infon><location offset="944" length="24"/><text>luminal epithelial cells</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="1192" length="3"/><text>ACC</text></annotation><annotation id="17"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="998" length="5"/><text>tumor</text></annotation><annotation id="18"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="13" length="3"/><text>MYB</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0004971</infon><infon key="type">DISEASE</infon><location offset="62" length="24"/><text>adenoid cystic carcinoma</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="125" length="6"/><text>cancer</text></annotation></passage></document>
<document><id>26855180</id><passage><offset>0</offset><text>Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation. Inflammatory response is essential to host defense and repair, and requires tight regulation as excessive and constant inflammatory response is deleterious. We recently identified that one of the general but key mechanisms for inflammatory gene transcription regulation is controlled by the formation of super enhancers mediated by NF-kappaB, and bromodomain and extraterminal (BET) proteins. Given that microRNA transcription shares a similar mechanism to mRNA, we assume that the inflammatory microRNAs transcription could be NF-kappaB and BET bromodomain dependent. In the present study, we confirmed that inflammatory stimuli changed human umbilical vein endothelial cells (HUVEC) microRNA profile. Among these microRNAs, miR-146a and miR-155, two well-established inflammatory microRNAs, are both downregulated at transcriptional level by NF-kappaB and BET bromodomain inhibition. To pursue this mechanism, we analyzed the ChIP-seq data and found that NF-kappaB, BRD4 and RNA POL II were rapidly distributed at the upstream regions of miR-146a and miR-155, and more importantly mediated the formation of the super enhancers that drive miR-146a and miR-155 transcription. These microRNAs transcription driven by super enhancers in turn downregulate both in vitro and in vivo canonical inflammatory genes expression through targeting inflammatory mediators. This novel finding demonstrated how the host self-regulates inflammatory genes expression at both transcriptional and post-transcriptional level to ensure the appropriate level of the host inflammatory response.</text><annotation id="1"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="625" length="9"/><text>NF-kappaB</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1210" length="61"/><text>super enhancers that drive miR-146a and miR-155 transcription</text></annotation><annotation id="3"><infon key="identifier">406938</infon><infon key="type">GENE</infon><location offset="823" length="8"/><text>miR-146a</text></annotation><annotation id="4"><infon key="identifier">406947</infon><infon key="type">GENE</infon><location offset="836" length="7"/><text>miR-155</text></annotation><annotation id="5"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1065" length="4"/><text>BRD4</text></annotation><annotation id="6"><infon key="identifier">406938</infon><infon key="type">GENE</infon><location offset="1137" length="8"/><text>miR-146a</text></annotation><annotation id="7"><infon key="identifier">406947</infon><infon key="type">GENE</infon><location offset="1150" length="7"/><text>miR-155</text></annotation><annotation id="8"><infon key="identifier">406938</infon><infon key="type">GENE</infon><location offset="1237" length="8"/><text>miR-146a</text></annotation><annotation id="9"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="941" length="9"/><text>NF-kappaB</text></annotation><annotation id="10"><infon key="identifier">406947</infon><infon key="type">GENE</infon><location offset="1250" length="7"/><text>miR-155</text></annotation><annotation id="11"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="1054" length="9"/><text>NF-kappaB</text></annotation><annotation id="12"><infon key="identifier">406938</infon><infon key="type">GENE</infon><location offset="23" length="8"/><text>miR-146a</text></annotation><annotation id="13"><infon key="identifier">406947</infon><infon key="type">GENE</infon><location offset="36" length="7"/><text>miR-155</text></annotation><annotation id="14"><infon key="identifier">0004296</infon><infon key="type">TISSUE</infon><location offset="735" length="38"/><text>human umbilical vein endothelial cells</text></annotation><annotation id="15"><infon key="identifier">0004296</infon><infon key="type">TISSUE</infon><location offset="775" length="5"/><text>HUVEC</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="0" length="49"/><text>Super enhancers at the miR-146a and miR-155 genes</text></annotation><annotation id="17"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="429" length="9"/><text>NF-kappaB</text></annotation></passage></document>
<document><id>26859151</id><passage><offset>0</offset><text>Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. Dual-specificity phosphatases (DUSPs) dephosphorylate threonine/serine and tyrosine residues on their substrates. Here we show that DUSP1, DUSP4, and DUSP6 are involved in epithelial-to-mesenchymal transition (EMT) and breast cancer stem cell (CSC) regulation. DUSP1, DUSP4, and DUSP6 are induced during EMT in a PKC pathway signal-mediated EMT model. We show for the first time that the key chromatin-associated kinase PKC-theta directly regulates a subset of DUSP family members. DUSP1, DUSP4, and DUSP6 globally but differentially co-exist with enhancer and permissive active histone post-translational modifications, suggesting that they play distinct roles in gene regulation in EMT/CSCs. We show that nuclear DUSP4 associates with the key acetyltransferase p300 in the context of the chromatin template and dynamically regulates the interplay between two key phosphorylation marks: the 1834 (active) and 89 (inhibitory) residues central to p300's acetyltransferase activity. Furthermore, knockdown with small-interfering RNAs (siRNAs) shows that DUSP4 is required for maintaining H3K27ac, a mark mediated by p300. DUSP1, DUSP4, and DUSP6 knockdown with siRNAs shows that they participate in the formation of CD44hi/CD24lo/EpCAM+ breast CSCs: DUSP1 knockdown reduces CSC formation, while DUSP4 and DUSP6 knockdown enhance CSC formation. Moreover, DUSP6 is overexpressed in patient-derived HER2+ breast carcinomas compared to benign mammary tissue. Taken together, these findings illustrate novel pleiotropic roles for DUSP family members in EMT and CSC regulation in breast cancer.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="118" length="13"/><text>Breast Cancer</text></annotation><annotation id="2"><infon key="identifier">1843</infon><infon key="type">GENE</infon><location offset="265" length="5"/><text>DUSP1</text></annotation><annotation id="3"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="848" length="5"/><text>DUSP4</text></annotation><annotation id="4"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="896" length="4"/><text>p300</text></annotation><annotation id="5"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1079" length="4"/><text>p300</text></annotation><annotation id="6"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="1185" length="5"/><text>DUSP4</text></annotation><annotation id="7"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1247" length="4"/><text>p300</text></annotation><annotation id="8"><infon key="identifier">1843</infon><infon key="type">GENE</infon><location offset="1253" length="5"/><text>DUSP1</text></annotation><annotation id="9"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="1260" length="5"/><text>DUSP4</text></annotation><annotation id="10"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="1271" length="5"/><text>DUSP6</text></annotation><annotation id="11"><infon key="identifier">100133941</infon><infon key="type">GENE</infon><location offset="1354" length="6"/><text>CD24lo</text></annotation><annotation id="12"><infon key="identifier">4072</infon><infon key="type">GENE</infon><location offset="1361" length="5"/><text>EpCAM</text></annotation><annotation id="13"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="272" length="5"/><text>DUSP4</text></annotation><annotation id="14"><infon key="identifier">1843</infon><infon key="type">GENE</infon><location offset="1381" length="5"/><text>DUSP1</text></annotation><annotation id="15"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="1426" length="5"/><text>DUSP4</text></annotation><annotation id="16"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="1436" length="5"/><text>DUSP6</text></annotation><annotation id="17"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="1485" length="5"/><text>DUSP6</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0004989</infon><infon key="type">DISEASE</infon><location offset="1527" length="23"/><text>HER2+ breast carcinomas</text></annotation><annotation id="19"><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="1705" length="13"/><text>breast cancer</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0006293</infon><infon key="type">TISSUE</infon><location offset="352" length="23"/><text>breast cancer stem cell</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="377" length="3"/><text>CSC</text></annotation><annotation id="22"><infon key="identifier">5588</infon><infon key="type">GENE</infon><location offset="553" length="9"/><text>PKC-theta</text></annotation><annotation id="23"><infon key="identifier">960</infon><infon key="type">GENE</infon><location offset="1347" length="6"/><text>CD44hi</text></annotation><annotation id="24"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="283" length="5"/><text>DUSP6</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0006293</infon><infon key="type">TISSUE</infon><location offset="1368" length="11"/><text>breast CSCs</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="1405" length="3"/><text>CSC</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="1460" length="3"/><text>CSC</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="1687" length="3"/><text>CSC</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="87" length="16"/><text>Cancer Stem Cell</text></annotation><annotation id="30"><infon key="identifier">1843</infon><infon key="type">GENE</infon><location offset="394" length="5"/><text>DUSP1</text></annotation><annotation id="31"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="401" length="5"/><text>DUSP4</text></annotation><annotation id="32"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="412" length="5"/><text>DUSP6</text></annotation><annotation id="33"><infon key="identifier">1843</infon><infon key="type">GENE</infon><location offset="615" length="5"/><text>DUSP1</text></annotation><annotation id="34"><infon key="identifier">1846</infon><infon key="type">GENE</infon><location offset="622" length="5"/><text>DUSP4</text></annotation><annotation id="35"><infon key="identifier">1848</infon><infon key="type">GENE</infon><location offset="633" length="5"/><text>DUSP6</text></annotation></passage></document>
<document><id>26864944</id><passage><offset>0</offset><text>Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. The human DHRS4 gene cluster consists of DHRS4 and two immediately downstream homologous genes, DHRS4L2 and DHRS4L1, generated by evolutionarily gene-duplication events. We previously demonstrated that a head-to-head natural antisense transcript (NAT) of DHRS4, denoted DHRS4-AS1, regulates all three genes of the DHRS4 gene cluster. However, it is puzzling that DHRS4L2 and DHRS4L1 did not evolve their own specific NATs to regulate themselves, as it seems both have retained sequences highly homologous to DHRS4-AS1. In a search of the DHRS4-AS1 region for nearby enhancers, we identified an enhancer located 13.8 kb downstream of the DHRS4-AS1 transcriptional start site. We further showed, by using a chromosome conformation capture (3C) assay, that this enhancer is capable of physically interacting with the DHRS4-AS1 promoter through chromosomal looping. The enhancer produced an eRNA, termed AS1eRNA, that enhanced DHRS4-AS1 transcription by mediating the spatial interactions of the enhancer and DHRS4-AS1 promoter in cooperation with RNA polymerase II and p300/CBP. Moreover, the distributions of activating acetyl-H3 and H3K4me3 modifications were found to be greater at the DHRS4-AS1 promoter than at the homologous duplicated regions. We propose that AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster.</text><annotation id="1"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="769" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="2"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="112" length="5"/><text>DHRS4</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="136" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="142" length="5"/><text>DHRS4</text></annotation><annotation id="5"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="173" length="5"/><text>DHRS4</text></annotation><annotation id="6"><infon key="identifier">317749</infon><infon key="type">GENE</infon><location offset="228" length="7"/><text>DHRS4L2</text></annotation><annotation id="7"><infon key="identifier">728635</infon><infon key="type">GENE</infon><location offset="240" length="7"/><text>DHRS4L1</text></annotation><annotation id="8"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="387" length="5"/><text>DHRS4</text></annotation><annotation id="9"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="402" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="10"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="446" length="5"/><text>DHRS4</text></annotation><annotation id="11"><infon key="identifier">317749</infon><infon key="type">GENE</infon><location offset="495" length="7"/><text>DHRS4L2</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="726" length="79"/><text>enhancer located 13.8 kb downstream of the DHRS4-AS1 transcriptional start site</text></annotation><annotation id="13"><infon key="identifier">728635</infon><infon key="type">GENE</infon><location offset="507" length="7"/><text>DHRS4L1</text></annotation><annotation id="14"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="640" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1019" length="4"/><text>eRNA</text></annotation><annotation id="16"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="1055" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="17"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="1486" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1032" length="7"/><text>AS1eRNA</text></annotation><annotation id="19"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="1137" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1396" length="7"/><text>AS1eRNA</text></annotation><annotation id="21"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="1318" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="22"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="946" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="891" length="8"/><text>enhancer</text></annotation><annotation id="24"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1198" length="4"/><text>p300</text></annotation><annotation id="25"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="1203" length="3"/><text>CBP</text></annotation><annotation id="26"><infon key="identifier">10901</infon><infon key="type">GENE</infon><location offset="1524" length="5"/><text>DHRS4</text></annotation><annotation id="27"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="670" length="9"/><text>DHRS4-AS1</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="946" length="18"/><text>DHRS4-AS1 promoter</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="998" length="8"/><text>enhancer</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1124" length="8"/><text>enhancer</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1137" length="18"/><text>DHRS4-AS1 promoter</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1318" length="18"/><text>DHRS4-AS1 promoter</text></annotation><annotation id="33"><infon key="identifier">55449</infon><infon key="type">GENE</infon><location offset="81" length="9"/><text>DHRS4-AS1</text></annotation></passage></document>
<document><id>26883548</id><passage><offset>0</offset><text>Deciphering the importance of the palindromic architecture of the immunoglobulin heavy-chain 3' regulatory region. The IgH 3' regulatory region (3'RR) controls class switch recombination (CSR) and somatic hypermutation (SHM) in B cells. The mouse 3'RR contains four enhancer elements with hs1,2 flanked by inverted repeated sequences and the centre of a 25-kb palindrome bounded by two hs3 enhancer inverted copies (hs3a and hs3b). hs4 lies downstream of the palindrome. In mammals, evolution maintained this unique palindromic arrangement, suggesting that it is functionally significant. Here we report that deconstructing the palindromic IgH 3'RR strongly affects its function even when enhancers are preserved. CSR and IgH transcription appear to be poorly dependent on the 3'RR architecture and it is more or less preserved, provided 3'RR enhancers are present. By contrast, a 'palindromic effect' significantly lowers VH germline transcription, AID recruitment and SHM. In conclusion, this work indicates that the IgH 3'RR does not simply pile up enhancer units but also optimally exposes them into a functional architecture of crucial importance.</text><annotation id="1"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="241" length="5"/><text>mouse</text></annotation><annotation id="2"><infon key="identifier">111507</infon><infon key="type">GENE</infon><location offset="722" length="3"/><text>IgH</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="432" length="3"/><text>hs4</text></annotation><annotation id="4"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="474" length="7"/><text>mammals</text></annotation><annotation id="5"><infon key="identifier">111507</infon><infon key="type">GENE</infon><location offset="640" length="3"/><text>IgH</text></annotation><annotation id="6"><infon key="identifier">111507</infon><infon key="type">GENE</infon><location offset="1019" length="3"/><text>IgH</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="261" length="22"/><text>four enhancer elements</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="838" length="14"/><text>3'RR enhancers</text></annotation><annotation id="9"><infon key="identifier">111507</infon><infon key="type">GENE</infon><location offset="119" length="3"/><text>IgH</text></annotation><annotation id="10"><infon key="identifier">111507</infon><infon key="type">GENE</infon><location offset="66" length="26"/><text>immunoglobulin heavy-chain</text></annotation><annotation id="11"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="228" length="7"/><text>B cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="289" length="3"/><text>hs1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="293" length="1"/><text>2</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="416" length="4"/><text>hs3a</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="425" length="4"/><text>hs3b</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="382" length="32"/><text>two hs3 enhancer inverted copies</text></annotation></passage></document>
<document><id>26884396</id><passage><offset>0</offset><text>Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators. Nephron endowment is determined by the self-renewal and induction of a nephron progenitor pool established at the onset of kidney development. In the mouse, the related transcriptional regulators Six1 and Six2 play non-overlapping roles in nephron progenitors. Transient Six1 activity prefigures, and is essential for, active nephrogenesis. By contrast, Six2 maintains later progenitor self-renewal from the onset of nephrogenesis. We compared the regulatory actions of Six2 in mouse and human nephron progenitors by chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq). Surprisingly, SIX1 was identified as a SIX2 target unique to the human nephron progenitors. Furthermore, RNA-seq and immunostaining revealed overlapping SIX1 and SIX2 activity in 16 week human fetal nephron progenitors. Comparative bioinformatic analysis of human SIX1 and SIX2 ChIP-seq showed each factor targeted a similar set of cis-regulatory modules binding an identical target recognition motif. In contrast to the mouse where Six2 binds its own enhancers but does not interact with DNA around Six1, both human SIX1 and SIX2 bind homologous SIX2 enhancers and putative enhancers positioned around SIX1. Transgenic analysis of a putative human SIX1 enhancer in the mouse revealed a transient, mouse-like, pre-nephrogenic, Six1 regulatory pattern. Together, these data demonstrate a divergence in SIX-factor regulation between mouse and human nephron progenitors. In the human, an auto/cross-regulatory loop drives continued SIX1 and SIX2 expression during active nephrogenesis. By contrast, the mouse establishes only an auto-regulatory Six2 loop. These data suggest differential SIX-factor regulation might have contributed to species differences in nephron progenitor programs such as the duration of nephrogenesis and the final nephron count.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1245" length="14"/><text>SIX2 enhancers</text></annotation><annotation id="2"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="466" length="4"/><text>Six2</text></annotation><annotation id="3"><infon key="identifier">20472</infon><infon key="type">GENE</infon><location offset="582" length="4"/><text>Six2</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="590" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="600" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="712" length="4"/><text>SIX1</text></annotation><annotation id="7"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="737" length="4"/><text>SIX2</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="763" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="851" length="4"/><text>SIX1</text></annotation><annotation id="10"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="860" length="4"/><text>SIX2</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="885" length="5"/><text>human</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1347" length="13"/><text>SIX1 enhancer</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="956" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="962" length="4"/><text>SIX1</text></annotation><annotation id="15"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="971" length="4"/><text>SIX2</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1119" length="5"/><text>mouse</text></annotation><annotation id="17"><infon key="identifier">20472</infon><infon key="type">GENE</infon><location offset="1131" length="4"/><text>Six2</text></annotation><annotation id="18"><infon key="identifier">20471</infon><infon key="type">GENE</infon><location offset="1198" length="4"/><text>Six1</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1209" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="1215" length="4"/><text>SIX1</text></annotation><annotation id="21"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="1224" length="4"/><text>SIX2</text></annotation><annotation id="22"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="1301" length="4"/><text>SIX1</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1341" length="5"/><text>human</text></annotation><annotation id="24"><infon key="identifier">EntrezGene:6495</infon><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1273" length="32"/><text>enhancers positioned around SIX1</text></annotation><annotation id="25"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="1347" length="4"/><text>SIX1</text></annotation><annotation id="26"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="1245" length="4"/><text>SIX2</text></annotation><annotation id="27"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1368" length="5"/><text>mouse</text></annotation><annotation id="28"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1396" length="5"/><text>mouse</text></annotation><annotation id="29"><infon key="identifier">20471</infon><infon key="type">GENE</infon><location offset="1425" length="4"/><text>Six1</text></annotation><annotation id="30"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1529" length="5"/><text>mouse</text></annotation><annotation id="31"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1539" length="5"/><text>human</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1573" length="5"/><text>human</text></annotation><annotation id="33"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="1627" length="4"/><text>SIX1</text></annotation><annotation id="34"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="27" length="5"/><text>mouse</text></annotation><annotation id="35"><infon key="identifier">10736</infon><infon key="type">GENE</infon><location offset="1636" length="4"/><text>SIX2</text></annotation><annotation id="36"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1698" length="5"/><text>mouse</text></annotation><annotation id="37"><infon key="identifier">20472</infon><infon key="type">GENE</infon><location offset="1740" length="4"/><text>Six2</text></annotation><annotation id="38"><infon key="type">TISSUE</infon><location offset="43" length="19"/><text>nephron progenitors</text></annotation><annotation id="39"><infon key="identifier">0000924</infon><infon key="type">TISSUE</infon><location offset="112" length="7"/><text>Nephron</text></annotation><annotation id="40"><infon key="type">TISSUE</infon><location offset="183" length="18"/><text>nephron progenitor</text></annotation><annotation id="41"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="235" length="6"/><text>kidney</text></annotation><annotation id="42"><infon key="type">TISSUE</infon><location offset="352" length="19"/><text>nephron progenitors</text></annotation><annotation id="43"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="37" length="5"/><text>human</text></annotation><annotation id="44"><infon key="type">TISSUE</infon><location offset="606" length="19"/><text>nephron progenitors</text></annotation><annotation id="45"><infon key="type">TISSUE</infon><location offset="769" length="19"/><text>nephron progenitors</text></annotation><annotation id="46"><infon key="type">TISSUE</infon><location offset="897" length="19"/><text>nephron progenitors</text></annotation><annotation id="47"><infon key="type">TISSUE</infon><location offset="1545" length="19"/><text>nephron progenitors</text></annotation><annotation id="48"><infon key="type">TISSUE</infon><location offset="1854" length="18"/><text>nephron progenitor</text></annotation><annotation id="49"><infon key="identifier">0000924</infon><infon key="type">TISSUE</infon><location offset="1934" length="7"/><text>nephron</text></annotation><annotation id="50"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="262" length="5"/><text>mouse</text></annotation><annotation id="51"><infon key="identifier">20471</infon><infon key="type">GENE</infon><location offset="308" length="4"/><text>Six1</text></annotation><annotation id="52"><infon key="identifier">20472</infon><infon key="type">GENE</infon><location offset="317" length="4"/><text>Six2</text></annotation><annotation id="53"><infon key="identifier">6495</infon><infon key="type">GENE</infon><location offset="383" length="4"/><text>Six1</text></annotation></passage></document>
<document><id>26912657</id><passage><offset>0</offset><text>Inhibition of Interleukin 1beta (IL-1beta) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages. Many pathogenic microbes often release toxins that subvert the host's immune responses to render the environment suitable for their survival and proliferation. LeTx is one of the toxins causing immune paralysis by cleaving and inactivating the mitogen-activated protein kinase (MAPK) kinases (MEKs). Here, we show that inhibition of the histone deacetylase 8 (HDAC8) by either the HDAC8-specific inhibitor PCI-34051 or small interference (si)RNAs rendered LeTx-exposed murine macrophages responsive to LPS in pro-IL-1beta production. HDAC8 selectively targeted acetylated histone H3 lysine 27 (H3K27Ac), which is known to associate with active enhancers. LeTx induced HDAC8 expression, in part through inhibiting p38 MAPK, which resulted in a decrease of H3K27Ac levels. Inhibition of HDAC8 increased H3K27Ac levels and enhanced NF-kappaB-mediated pro-IL-1beta enhancer and messenger RNA production in LeTx-exposed macrophages. Collectively, this study demonstrates a novel role of HDAC8 in LeTx immunotoxicity and regulation of pro-IL-1beta production likely through eRNAs. Targeting HDAC8 could be a strategy for enhancing immune responses in macrophages exposed to LeTx or other toxins that inhibit MAPKs.</text><annotation id="1"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="33" length="8"/><text>IL-1beta</text></annotation><annotation id="2"><infon key="identifier">1392</infon><infon key="type">SPECIES</infon><location offset="57" length="7"/><text>Anthrax</text></annotation><annotation id="3"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="698" length="5"/><text>HDAC8</text></annotation><annotation id="4"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="832" length="5"/><text>HDAC8</text></annotation><annotation id="5"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="949" length="5"/><text>HDAC8</text></annotation><annotation id="6"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="1146" length="5"/><text>HDAC8</text></annotation><annotation id="7"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="1197" length="8"/><text>IL-1beta</text></annotation><annotation id="8"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="1249" length="5"/><text>HDAC8</text></annotation><annotation id="9"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="14" length="17"/><text>Interleukin 1beta</text></annotation><annotation id="10"><infon key="identifier">1432</infon><infon key="type">GENE</infon><location offset="877" length="3"/><text>p38</text></annotation><annotation id="11"><infon key="identifier">19697</infon><infon key="type">GENE</infon><location offset="993" length="9"/><text>NF-kappaB</text></annotation><annotation id="12"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="151" length="11"/><text>Macrophages</text></annotation><annotation id="13"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="100" length="21"/><text>Histone Deacetylase 8</text></annotation><annotation id="14"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="640" length="11"/><text>macrophages</text></annotation><annotation id="15"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1079" length="11"/><text>macrophages</text></annotation><annotation id="16"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="1309" length="11"/><text>macrophages</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1012" length="21"/><text>pro-IL-1beta enhancer</text></annotation><annotation id="18"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="1016" length="8"/><text>IL-1beta</text></annotation><annotation id="19"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="123" length="5"/><text>HDAC8</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="144" length="6"/><text>Murine</text></annotation><annotation id="21"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="501" length="21"/><text>histone deacetylase 8</text></annotation><annotation id="22"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="524" length="5"/><text>HDAC8</text></annotation><annotation id="23"><infon key="identifier">70315</infon><infon key="type">GENE</infon><location offset="545" length="5"/><text>HDAC8</text></annotation><annotation id="24"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="633" length="6"/><text>murine</text></annotation><annotation id="25"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="677" length="8"/><text>IL-1beta</text></annotation></passage></document>
<document><id>26916345</id><passage><offset>0</offset><text>An ankylosing spondylitis-associated genetic variant in the IL23R-IL12RB2 intergenic region modulates enhancer activity and is associated with increased Th1-cell differentiation. OBJECTIVES: To explore the functional basis for the association between ankylosing spondylitis (AS) and single-nucleotide polymorphisms (SNPs) in the IL23R-IL12RB2 intergenic region. METHODS: We performed conditional analysis on genetic association data and used epigenetic data on chromatin remodelling and transcription factor (TF) binding to identify the primary AS-associated IL23R-IL12RB2 intergenic SNP. Functional effects were tested in luciferase reporter assays in HEK293T cells and allele-specific TF binding was investigated by electrophoretic mobility gel shift assays. IL23R and IL12RB2 mRNA levels in CD4+ T cells were compared between cases homozygous for the AS-risk 'A' allele and the protective 'G' allele. The proportions of interleukin (IL)-17A+ and interferon (IFN)-gamma+ CD4+ T-cells were measured by fluorescence-activated cell sorting and compared between these AS-risk and protective genotypes. RESULTS: Conditional analysis identified rs11209032 as the probable causal SNP within a 1.14 kb putative enhancer between IL23R and IL12RB2. Reduced luciferase activity was seen for the risk allele (p&lt;0.001) and reduced H3K4me1 methylation observed in CD4+ T-cells from 'A/A' homozygotes (p=0.02). The binding of nuclear extract to the risk allele was decreased ~3.5-fold compared with the protective allele (p&lt;0.001). The proportion of IFN-gamma+ CD4+ T-cells was increased in 'A/A' homozygotes (p=0.004), but neither IL23R nor IL12RB2 mRNA was affected. CONCLUSIONS: The rs11209032 SNP downstream of IL23R forms part of an enhancer, allelic variation of which may influence Th1-cell numbers. Homozygosity for the risk 'A' allele is associated with more IFN-gamma-secreting (Th1) cells. Further work is necessary to explain the mechanisms for these important observations.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1188" length="51"/><text>1.14 kb putative enhancer between IL23R and IL12RB2</text></annotation><annotation id="2"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="335" length="7"/><text>IL12RB2</text></annotation><annotation id="3"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="559" length="5"/><text>IL23R</text></annotation><annotation id="4"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="565" length="7"/><text>IL12RB2</text></annotation><annotation id="5"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="761" length="5"/><text>IL23R</text></annotation><annotation id="6"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="771" length="7"/><text>IL12RB2</text></annotation><annotation id="7"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="794" length="12"/><text>CD4+ T cells</text></annotation><annotation id="8"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="854" length="2"/><text>AS</text></annotation><annotation id="9"><infon key="identifier">23765</infon><infon key="type">GENE</infon><location offset="923" length="20"/><text>interleukin (IL)-17A</text></annotation><annotation id="10"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="1066" length="2"/><text>AS</text></annotation><annotation id="11"><infon key="comment">rs11209032</infon><infon key="type">VARIANT</infon><infon key="identifier">rs11209032</infon><location offset="1141" length="10"/><text>rs11209032</text></annotation><annotation id="12"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="1702" length="5"/><text>IL23R</text></annotation><annotation id="13"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="949" length="22"/><text>interferon (IFN)-gamma</text></annotation><annotation id="14"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1352" length="12"/><text>CD4+ T-cells</text></annotation><annotation id="15"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="973" length="12"/><text>CD4+ T-cells</text></annotation><annotation id="16"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1537" length="9"/><text>IFN-gamma</text></annotation><annotation id="17"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="545" length="2"/><text>AS</text></annotation><annotation id="18"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="1619" length="5"/><text>IL23R</text></annotation><annotation id="19"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="1629" length="7"/><text>IL12RB2</text></annotation><annotation id="20"><infon key="comment">rs11209032</infon><infon key="type">VARIANT</infon><infon key="identifier">rs11209032</infon><location offset="1673" length="10"/><text>rs11209032</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1725" length="8"/><text>enhancer</text></annotation><annotation id="22"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="1776" length="8"/><text>Th1-cell</text></annotation><annotation id="23"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="3" length="22"/><text>ankylosing spondylitis</text></annotation><annotation id="24"><infon key="identifier">3458</infon><infon key="type">GENE</infon><location offset="1855" length="9"/><text>IFN-gamma</text></annotation><annotation id="25"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="1875" length="11"/><text>(Th1) cells</text></annotation><annotation id="26"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1548" length="12"/><text>CD4+ T-cells</text></annotation><annotation id="27"><infon key="identifier">0002181</infon><infon key="type">TISSUE</infon><location offset="653" length="7"/><text>HEK293T</text></annotation><annotation id="28"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="1222" length="5"/><text>IL23R</text></annotation><annotation id="29"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="1232" length="7"/><text>IL12RB2</text></annotation><annotation id="30"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="60" length="5"/><text>IL23R</text></annotation><annotation id="31"><infon key="identifier">3595</infon><infon key="type">GENE</infon><location offset="66" length="7"/><text>IL12RB2</text></annotation><annotation id="32"><infon key="identifier">0001678</infon><infon key="type">TISSUE</infon><location offset="153" length="8"/><text>Th1-cell</text></annotation><annotation id="33"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="251" length="22"/><text>ankylosing spondylitis</text></annotation><annotation id="34"><infon key="identifier">0005306</infon><infon key="type">DISEASE</infon><location offset="275" length="2"/><text>AS</text></annotation><annotation id="35"><infon key="identifier">149233</infon><infon key="type">GENE</infon><location offset="329" length="5"/><text>IL23R</text></annotation></passage></document>
<document><id>26919345</id><passage><offset>0</offset><text>Putting cryptogenic stroke into perspective. In patients who have a cryptogenic stroke and have their PFO closed, the recurrence rate of "cerebral ischemia" is much greater in patients who are older than 55 years. Most of these recurrent events (2 strokes and 4TIAs) in the older age group were due to identifiable causes. These findings corroborate the long-term results from the RESPECT randomized clinical trial of PFO closure versus medical therapy.</text><annotation id="1"><infon key="identifier">0005299</infon><infon key="type">DISEASE</infon><location offset="138" length="17"/><text>cerebral ischemia</text></annotation></passage></document>
<document><id>26934861</id><passage><offset>0</offset><text>4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus. Genome-wide association studies (GWAS) have identified &gt;100 independent susceptibility loci for prostate cancer, including the hot spot at 8q24. However, how genetic variants at this locus confer disease risk hasn't been fully characterized. Using circularized chromosome conformation capture (4C) coupled with next-generation sequencing and an enhancer at 8q24 as "bait", we identified genome-wide partners interacting with this enhancer in cell lines LNCaP and C4-2B. These 4C-identified regions are distributed in open nuclear compartments, featuring active histone marks (H3K4me1, H3K4me2 and H3K27Ac). Transcription factors NKX3-1, FOXA1 and AR (androgen receptor) tend to occupy these 4C regions. We identified genes located at the interacting regions, and found them linked to positive regulation of mesenchymal cell proliferation in LNCaP and C4-2B, and several pathways (TGF beta signaling pathway in LNCaP and p53 pathway in C4-2B). Common genes (e.g. MYC and POU5F1B) were identified in both prostate cancer cell lines. However, each cell line also had exclusive genes (e.g. ELAC2 and PTEN in LNCaP and BRCA2 and ZFHX3 in C4-2B). In addition, BCL-2 identified in C4-2B might contribute to the progression of androgen-refractory prostate cancer. Overall, our work reveals key genes and pathways involved in prostate cancer onset and progression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="450" length="16"/><text>enhancer at 8q24</text></annotation><annotation id="2"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="1025" length="3"/><text>p53</text></annotation><annotation id="3"><infon key="identifier">5462</infon><infon key="type">GENE</infon><location offset="1075" length="7"/><text>POU5F1B</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0001033</infon><infon key="type">TISSUE</infon><location offset="1108" length="26"/><text>prostate cancer cell lines</text></annotation><annotation id="5"><infon key="identifier">60528</infon><infon key="type">GENE</infon><location offset="1191" length="5"/><text>ELAC2</text></annotation><annotation id="6"><infon key="identifier">5728</infon><infon key="type">GENE</infon><location offset="1201" length="4"/><text>PTEN</text></annotation><annotation id="7"><infon key="identifier">675</infon><infon key="type">GENE</infon><location offset="1219" length="5"/><text>BRCA2</text></annotation><annotation id="8"><infon key="identifier">463</infon><infon key="type">GENE</infon><location offset="1229" length="5"/><text>ZFHX3</text></annotation><annotation id="9"><infon key="identifier">596</infon><infon key="type">GENE</infon><location offset="1259" length="5"/><text>BCL-2</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="1344" length="15"/><text>prostate cancer</text></annotation><annotation id="11"><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="1422" length="15"/><text>prostate cancer</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="535" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="56" length="20"/><text>enhancer at the 8q24</text></annotation><annotation id="14"><infon key="identifier">0004959</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="568" length="5"/><text>C4-2B</text></annotation><annotation id="15"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="912" length="16"/><text>mesenchymal cell</text></annotation><annotation id="16"><infon key="identifier">0001321</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="946" length="5"/><text>LNCaP</text></annotation><annotation id="17"><infon key="identifier">0004959</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="956" length="5"/><text>C4-2B</text></annotation><annotation id="18"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1067" length="3"/><text>MYC</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="1209" length="5"/><text>LNCaP</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0004959</infon><infon key="type">TISSUE</infon><location offset="1238" length="5"/><text>C4-2B</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0004959</infon><infon key="type">TISSUE</infon><location offset="1279" length="5"/><text>C4-2B</text></annotation><annotation id="22"><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="77" length="15"/><text>prostate cancer</text></annotation><annotation id="23"><infon key="identifier">0001321</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="558" length="5"/><text>LNCaP</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0008315</infon><infon key="type">DISEASE</infon><location offset="201" length="15"/><text>prostate cancer</text></annotation><annotation id="25"><infon key="identifier">4824</infon><infon key="type">GENE</infon><location offset="734" length="6"/><text>NKX3-1</text></annotation><annotation id="26"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="742" length="5"/><text>FOXA1</text></annotation><annotation id="27"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="752" length="2"/><text>AR</text></annotation><annotation id="28"><infon key="identifier">367</infon><infon key="type">GENE</infon><location offset="756" length="17"/><text>androgen receptor</text></annotation><annotation id="29"><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="1015" length="5"/><text>LNCaP</text></annotation></passage></document>
<document><id>26937964</id><passage><offset>0</offset><text>In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis. The murine Cebpa gene contains a +37 kb, evolutionarily conserved 440 bp enhancer that directs high-level expression to myeloid progenitors in transgenic mice. The enhancer is bound and activated by Runx1, Scl, GATA2, C/EBPalpha, c-Myb, Pu.1, and additional Ets factors in myeloid cells. CRISPR/Cas9-mediated replacement of the wild-type enhancer with a variant mutant in its seven Ets sites leads to 20-fold reduction of Cebpa mRNA in the 32Dcl3 myeloid cell line. To determine the effect of deleting the enhancer in vivo, we now characterize C57BL/6 mice in which loxP sites flank a 688 bp DNA segment containing the enhancer. CMV-Cre mediated germline deletion resulted in diminution of the expected number of viable Enh(f/f);CMV-Cre offspring, with 28-fold reduction in marrow Cebpa mRNA but normal levels in liver, lung, adipose, intestine, muscle, and kidney. Cre-transduction of lineage-negative marrow cells in vitro reduced Cebpa mRNA 12-fold, with impairment of granulocytic maturation, morphologic blast accumulation, and IL-3 dependent myeloid colony replating for &gt;12 generations. Exposure of Enh(f/f);Mx1-Cre mice to pIpC led to 14-fold reduction of Cebpa mRNA in GMP or CMP, 30-fold reduction in LSK, and &lt;2-fold reduction in the LSK/SLAM subset. FACS analysis of marrow from these mice revealed 10-fold reduced neutrophils, 3-fold decreased GMP, and 3-fold increased LSK cells. Progenitor cell cycle progression was mildly impaired. Granulocyte and B lymphoid colony forming units were reduced while monocytic and erythroid colonies were increased, with reduced Pu.1 and Gfi1 and increased Egr1 and Klf4 in GMP. Finally, competitive transplantation indicated preservation of functional long-term hematopoietic stem cells upon enhancer deletion and confirmed marrow-intrinsic impairment of granulopoiesis and B cell generation with LSK and monocyte lineage expansion. These findings demonstrate a critical role for the +37 kb Cebpa enhancer for hematopoietic-specific Cebpa expression, with enhancer deletion leading to impaired myelopoiesis and potentially preleukemic progenitor expansion.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="24" length="21"/><text>Cebpa +37 kb Enhancer</text></annotation><annotation id="2"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1690" length="18"/><text>erythroid colonies</text></annotation><annotation id="3"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="63" length="5"/><text>Cebpa</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="164" length="6"/><text>murine</text></annotation><annotation id="5"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="171" length="5"/><text>Cebpa</text></annotation><annotation id="6"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="433" length="13"/><text>myeloid cells</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="314" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="359" length="5"/><text>Runx1</text></annotation><annotation id="9"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="371" length="5"/><text>GATA2</text></annotation><annotation id="10"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="378" length="10"/><text>C/EBPalpha</text></annotation><annotation id="11"><infon key="identifier">17863</infon><infon key="type">GENE</infon><location offset="390" length="5"/><text>c-Myb</text></annotation><annotation id="12"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="582" length="5"/><text>Cebpa</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="324" length="8"/><text>enhancer</text></annotation><annotation id="14"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="704" length="12"/><text>C57BL/6 mice</text></annotation><annotation id="15"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="941" length="5"/><text>Cebpa</text></annotation><annotation id="16"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="1093" length="5"/><text>Cebpa</text></annotation><annotation id="17"><infon key="identifier">16187</infon><infon key="type">GENE</infon><location offset="1193" length="4"/><text>IL-3</text></annotation><annotation id="18"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1283" length="4"/><text>mice</text></annotation><annotation id="19"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="1324" length="5"/><text>Cebpa</text></annotation><annotation id="20"><infon key="identifier">16818</infon><infon key="type">GENE</infon><location offset="1371" length="3"/><text>LSK</text></annotation><annotation id="21"><infon key="identifier">16818</infon><infon key="type">GENE</infon><location offset="1405" length="3"/><text>LSK</text></annotation><annotation id="22"><infon key="identifier">27218</infon><infon key="type">GENE</infon><location offset="1409" length="4"/><text>SLAM</text></annotation><annotation id="23"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1457" length="4"/><text>mice</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="498" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">16818</infon><infon key="type">GENE</infon><location offset="1543" length="3"/><text>LSK</text></annotation><annotation id="26"><infon key="identifier">14581</infon><infon key="type">GENE</infon><location offset="1747" length="4"/><text>Gfi1</text></annotation><annotation id="27"><infon key="identifier">13653</infon><infon key="type">GENE</infon><location offset="1766" length="4"/><text>Egr1</text></annotation><annotation id="28"><infon key="identifier">16600</infon><infon key="type">GENE</infon><location offset="1775" length="4"/><text>Klf4</text></annotation><annotation id="29"><infon key="identifier">16818</infon><infon key="type">GENE</infon><location offset="2007" length="3"/><text>LSK</text></annotation><annotation id="30"><infon key="identifier">0000829</infon><infon key="type">TISSUE</infon><location offset="934" length="6"/><text>marrow</text></annotation><annotation id="31"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="2143" length="5"/><text>Cebpa</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="193" length="48"/><text>+37 kb, evolutionarily conserved 440 bp enhancer</text></annotation><annotation id="33"><infon key="identifier">0004730</infon><infon key="type">TISSUE</infon><location offset="280" length="19"/><text>myeloid progenitors</text></annotation><annotation id="34"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="600" length="24"/><text>32Dcl3 myeloid cell line</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="666" length="8"/><text>enhancer</text></annotation><annotation id="36"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="973" length="5"/><text>liver</text></annotation><annotation id="37"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="980" length="4"/><text>lung</text></annotation><annotation id="38"><infon key="identifier">0001487</infon><infon key="type">TISSUE</infon><location offset="986" length="7"/><text>adipose</text></annotation><annotation id="39"><infon key="identifier">0000648</infon><infon key="type">TISSUE</infon><location offset="995" length="9"/><text>intestine</text></annotation><annotation id="40"><infon key="identifier">0000887</infon><infon key="type">TISSUE</infon><location offset="1006" length="6"/><text>muscle</text></annotation><annotation id="41"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="1018" length="6"/><text>kidney</text></annotation><annotation id="42"><infon key="identifier">0001441</infon><infon key="type">TISSUE</infon><location offset="1063" length="12"/><text>marrow cells</text></annotation><annotation id="43"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="366" length="3"/><text>Scl</text></annotation><annotation id="44"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="1208" length="7"/><text>myeloid</text></annotation><annotation id="45"><infon key="identifier">0000829</infon><infon key="type">TISSUE</infon><location offset="1439" length="6"/><text>marrow</text></annotation><annotation id="46"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="779" length="8"/><text>enhancer</text></annotation><annotation id="47"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="2015" length="16"/><text>monocyte lineage</text></annotation><annotation id="48"><infon key="identifier">0000539</infon><infon key="type">TISSUE</infon><location offset="1609" length="11"/><text>Granulocyte</text></annotation><annotation id="49"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1625" length="10"/><text>B lymphoid</text></annotation><annotation id="50"><infon key="identifier">20375</infon><infon key="type">GENE</infon><location offset="397" length="4"/><text>Pu.1</text></annotation><annotation id="51"><infon key="identifier">17857</infon><infon key="type">GENE</infon><location offset="1275" length="3"/><text>Mx1</text></annotation><annotation id="52"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1872" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="53"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="1984" length="6"/><text>B cell</text></annotation><annotation id="54"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="24" length="5"/><text>Cebpa</text></annotation><annotation id="55"><infon key="identifier">12606</infon><infon key="type">GENE</infon><location offset="2101" length="5"/><text>Cebpa</text></annotation><annotation id="56"><infon key="identifier">0000829</infon><infon key="type">TISSUE</infon><location offset="1934" length="6"/><text>marrow</text></annotation><annotation id="57"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2094" length="21"/><text>+37 kb Cebpa enhancer</text></annotation><annotation id="58"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="1676" length="9"/><text>monocytic</text></annotation><annotation id="59"><infon key="identifier">0004730</infon><infon key="type">TISSUE</infon><location offset="77" length="19"/><text>Myeloid Progenitors</text></annotation></passage></document>
<document><id>26957309</id><passage><offset>0</offset><text>Comprehensive benchmarking reveals H2BK20 acetylation as a distinctive signature of cell-state-specific enhancers and promoters. Although over 35 different histone acetylation marks have been described, the overwhelming majority of regulatory genomics studies focus exclusively on H3K27ac and H3K9ac. In order to identify novel epigenomic traits of regulatory elements, we constructed a benchmark set of validated enhancers by performing 140 enhancer assays in human T cells. We tested 40 chromatin signatures on this unbiased enhancer set and identified H2BK20ac, a little-studied histone modification, as the most predictive mark of active enhancers. Notably, we detected a novel class of functionally distinct enhancers enriched in H2BK20ac but lacking H3K27ac, which was present in all examined cell lines and also in embryonic forebrain tissue. H2BK20ac was also unique in highlighting cell-type-specific promoters. In contrast, other acetylation marks were present in all active promoters, regardless of cell-type specificity. In stimulated microglial cells, H2BK20ac was more correlated with cell-state-specific expression changes than H3K27ac, with TGF-beta signaling decoupling the two acetylation marks at a subset of regulatory elements. In summary, our study reveals a previously unknown connection between histone acetylation and cell-type-specific gene regulation and indicates that H2BK20ac profiling can be used to uncover new dimensions of gene regulation.</text><annotation id="1"><infon key="type">TISSUE</infon><location offset="1047" length="16"/><text>microglial cells</text></annotation><annotation id="2"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="467" length="7"/><text>T cells</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="461" length="5"/><text>human</text></annotation></passage></document>
<document><id>26968549</id><passage><offset>0</offset><text>Identification of a novel putative mitochondrial protein FAM210B associated with erythroid differentiation. The transcription factor GATA-1 plays an essential role in erythroid differentiation. To identify novel GATA-1 target genes, we analyzed a merged ChIP-seq and expression profiling dataset. We identified FAM210B as a putative novel GATA-1 target gene. Study results demonstrated that GATA-1 directly regulates FAM210B expression, presumably by binding to an intronic enhancer region. Both human and murine FAM210B are abundantly expressed in the later stages of erythroblast development. Moreover, the deduced amino acid sequence predicted that FAM210B is a membrane protein, and Western blot analysis demonstrated its mitochondrial localization. Loss-of-function analysis in erythroid cells suggested that FAM210B may be involved in erythroid differentiation. The identification and characterization of FAM210B provides new insights in the study of erythropoiesis and hereditary anemias.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="465" length="24"/><text>intronic enhancer region</text></annotation><annotation id="2"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="57" length="7"/><text>FAM210B</text></annotation><annotation id="3"><infon key="identifier">67017</infon><infon key="type">GENE</infon><location offset="513" length="7"/><text>FAM210B</text></annotation><annotation id="4"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="652" length="7"/><text>FAM210B</text></annotation><annotation id="5"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="814" length="7"/><text>FAM210B</text></annotation><annotation id="6"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="911" length="7"/><text>FAM210B</text></annotation><annotation id="7"><infon key="identifier">0000577</infon><infon key="type">DISEASE</infon><location offset="976" length="18"/><text>hereditary anemias</text></annotation><annotation id="8"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="167" length="9"/><text>erythroid</text></annotation><annotation id="9"><infon key="identifier">0001571</infon><infon key="type">TISSUE</infon><location offset="569" length="12"/><text>erythroblast</text></annotation><annotation id="10"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="783" length="15"/><text>erythroid cells</text></annotation><annotation id="11"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="841" length="9"/><text>erythroid</text></annotation><annotation id="12"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="133" length="6"/><text>GATA-1</text></annotation><annotation id="13"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="81" length="9"/><text>erythroid</text></annotation><annotation id="14"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="212" length="6"/><text>GATA-1</text></annotation><annotation id="15"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="311" length="7"/><text>FAM210B</text></annotation><annotation id="16"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="339" length="6"/><text>GATA-1</text></annotation><annotation id="17"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="391" length="6"/><text>GATA-1</text></annotation><annotation id="18"><infon key="identifier">116151</infon><infon key="type">GENE</infon><location offset="417" length="7"/><text>FAM210B</text></annotation><annotation id="19"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="496" length="5"/><text>human</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="506" length="6"/><text>murine</text></annotation></passage></document>
<document><id>27166834</id><passage><offset>0</offset><text>Long-range enhancers modulate Foxf1 transcription in blood vessels of pulmonary vascular network. Intimate crosstalk occurs between the pulmonary epithelium and the vascular network during lung development. The transcription factor forkhead box f1 (Foxf1) is expressed in the lung mesenchyme and plays an indispensable role in pulmonary angiogenesis. Sonic hedgehog (Shh), a signalling molecule, is expressed in lung epithelium and is required to establish proper angiogenesis. It has been suggested that Foxf1, a downstream target of the Shh signalling pathway, mediates interaction between angiogenesis and the epithelium in lung. However, there has been no clear evidence showing the mechanism how Foxf1 is regulated by Shh signalling pathway during lung development. In this study, we investigated the lung-specific enhancers of Foxf1 and the Gli binding on the enhancers. At first, we found three evolutionarily conserved Foxf1 enhancers, two of which were long-range enhancers. Of the long-range enhancers, one demonstrated tissue-specific activity in the proximal and distal pulmonary blood vessels, while the other one demonstrated activity only in distal blood vessels. At analogous positions in human, these long-range enhancers were included in a regulatory region that was reportedly repeatedly deleted in alveolar capillary dysplasia with misalignment of pulmonary vein patients, which indicates the importance of these enhancers in pulmonary blood vessel formation. We also determined that Gli increased the activity of one of these long-range enhancers, which was specific to distal blood vessel, suggesting that Shh regulates Foxf1 transcription in pulmonary distal blood vessel formation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="806" length="32"/><text>lung-specific enhancers of Foxf1</text></annotation><annotation id="2"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="232" length="15"/><text>forkhead box f1</text></annotation><annotation id="3"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="249" length="5"/><text>Foxf1</text></annotation><annotation id="4"><infon key="identifier">6469</infon><infon key="type">GENE</infon><location offset="351" length="14"/><text>Sonic hedgehog</text></annotation><annotation id="5"><infon key="identifier">6469</infon><infon key="type">GENE</infon><location offset="367" length="3"/><text>Shh</text></annotation><annotation id="6"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="505" length="5"/><text>Foxf1</text></annotation><annotation id="7"><infon key="identifier">6469</infon><infon key="type">GENE</infon><location offset="539" length="3"/><text>Shh</text></annotation><annotation id="8"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="701" length="5"/><text>Foxf1</text></annotation><annotation id="9"><infon key="identifier">6469</infon><infon key="type">GENE</infon><location offset="723" length="3"/><text>Shh</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="866" length="9"/><text>enhancers</text></annotation><annotation id="11"><infon key="identifier">2735</infon><infon key="type">GENE</infon><location offset="847" length="3"/><text>Gli</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="896" length="46"/><text>three evolutionarily conserved Foxf1 enhancers</text></annotation><annotation id="13"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="1082" length="23"/><text>pulmonary blood vessels</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1205" length="5"/><text>human</text></annotation><annotation id="15"><infon key="identifier">0009934</infon><infon key="type">DISEASE</infon><location offset="1318" length="64"/><text>alveolar capillary dysplasia with misalignment of pulmonary vein</text></annotation><annotation id="16"><infon key="identifier">2735</infon><infon key="type">GENE</infon><location offset="1504" length="3"/><text>Gli</text></annotation><annotation id="17"><infon key="identifier">6469</infon><infon key="type">GENE</infon><location offset="1628" length="3"/><text>Shh</text></annotation><annotation id="18"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1642" length="5"/><text>Foxf1</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="0" length="20"/><text>Long-range enhancers</text></annotation><annotation id="20"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="833" length="5"/><text>Foxf1</text></annotation><annotation id="21"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="927" length="5"/><text>Foxf1</text></annotation><annotation id="22"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="53" length="13"/><text>blood vessels</text></annotation><annotation id="23"><infon key="identifier">0001653</infon><infon key="type">TISSUE</infon><location offset="136" length="20"/><text>pulmonary epithelium</text></annotation><annotation id="24"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="189" length="4"/><text>lung</text></annotation><annotation id="25"><infon key="identifier">0001085</infon><infon key="type">TISSUE</infon><location offset="165" length="16"/><text>vascular network</text></annotation><annotation id="26"><infon key="identifier">0001393</infon><infon key="type">TISSUE</infon><location offset="276" length="15"/><text>lung mesenchyme</text></annotation><annotation id="27"><infon key="identifier">0001653</infon><infon key="type">TISSUE</infon><location offset="412" length="15"/><text>lung epithelium</text></annotation><annotation id="28"><infon key="identifier">0001653</infon><infon key="type">TISSUE</infon><location offset="613" length="18"/><text>epithelium in lung</text></annotation><annotation id="29"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="753" length="4"/><text>lung</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="991" length="20"/><text>long-range enhancers</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="944" length="38"/><text>two of which were long-range enhancers</text></annotation><annotation id="32"><infon key="identifier">0001085</infon><infon key="type">TISSUE</infon><location offset="70" length="26"/><text>pulmonary vascular network</text></annotation><annotation id="33"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="1446" length="22"/><text>pulmonary blood vessel</text></annotation><annotation id="34"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="1598" length="12"/><text>blood vessel</text></annotation><annotation id="35"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="1665" length="29"/><text>pulmonary distal blood vessel</text></annotation><annotation id="36"><infon key="identifier">0001102</infon><infon key="type">TISSUE</infon><location offset="1164" length="13"/><text>blood vessels</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1218" length="20"/><text>long-range enhancers</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1433" length="9"/><text>enhancers</text></annotation><annotation id="39"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1534" length="33"/><text>one of these long-range enhancers</text></annotation><annotation id="40"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="30" length="5"/><text>Foxf1</text></annotation></passage></document>
<document><id>27207652</id><passage><offset>0</offset><text>Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity. DNA hypomethylation was previously implicated in cancer progression and metastasis. The purpose of this study was to examine whether stilbenoids, resveratrol and pterostilbene thought to exert anticancer effects, target genes with oncogenic function for de novo methylation and silencing, leading to inactivation of related signaling pathways. Following Illumina 450K, genome-wide DNA methylation analysis reveals that stilbenoids alter DNA methylation patterns in breast cancer cells. On average, 75% of differentially methylated genes have increased methylation, and these genes are enriched for oncogenic functions, including NOTCH signaling pathway. MAML2, a coactivator of NOTCH targets, is methylated at the enhancer region and transcriptionally silenced in response to stilbenoids, possibly explaining the downregulation of NOTCH target genes. The increased DNA methylation at MAML2 enhancer coincides with increased occupancy of repressive histone marks and decrease in activating marks. This condensed chromatin structure is associated with binding of DNMT3B and decreased occupancy of OCT1 transcription factor at MAML2 enhancer, suggesting a role of DNMT3B in increasing methylation of MAML2 after stilbenoid treatment. Our results deliver a novel insight into epigenetic regulation of oncogenic signals in cancer and provide support for epigenetic-targeting strategies as an effective anticancer approach.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="889" length="15"/><text>enhancer region</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1059" length="14"/><text>MAML2 enhancer</text></annotation><annotation id="3"><infon key="identifier">84441</infon><infon key="type">GENE</infon><location offset="1059" length="5"/><text>MAML2</text></annotation><annotation id="4"><infon key="identifier">1789</infon><infon key="type">GENE</infon><location offset="1336" length="6"/><text>DNMT3B</text></annotation><annotation id="5"><infon key="identifier">84441</infon><infon key="type">GENE</infon><location offset="1372" length="5"/><text>MAML2</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1493" length="6"/><text>cancer</text></annotation><annotation id="7"><infon key="identifier">84441</infon><infon key="type">GENE</infon><location offset="1299" length="5"/><text>MAML2</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1299" length="14"/><text>MAML2 enhancer</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="52" length="19"/><text>breast cancer cells</text></annotation><annotation id="10"><infon key="identifier">84441</infon><infon key="type">GENE</infon><location offset="143" length="5"/><text>MAML2</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="224" length="6"/><text>cancer</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="640" length="19"/><text>breast cancer cells</text></annotation><annotation id="13"><infon key="identifier">84441</infon><infon key="type">GENE</infon><location offset="829" length="5"/><text>MAML2</text></annotation><annotation id="14"><infon key="identifier">5451</infon><infon key="type">GENE</infon><location offset="1270" length="4"/><text>OCT1</text></annotation><annotation id="15"><infon key="identifier">1789</infon><infon key="type">GENE</infon><location offset="1236" length="6"/><text>DNMT3B</text></annotation></passage></document>
<document><id>27333824</id><passage><offset>0</offset><text>Regulation of Laminin gamma2 Expression by CDX2 in Colonic Epithelial Cells Is Impaired During Active Inflammation. The expression of Caudal-related homeobox transcription factor 2 (CDX2) is impaired by tumor necrosis factor-alpha (TNF-alpha)-mediated activation of nuclear factor-kappaB (NF-kappaB) in ulcerative colitis (UC). Laminin subunit gamma2 (LAMC2) is an epithelial basement membrane protein implicated in cell migration, proliferation, differentiation, as well as tumor invasion and intestinal inflammation, and its expression is enhanced by TNF-alpha in a NF-kappaB-dependent regulation of the recently identified LAMC2 enhancer. The aim was to determine whether CDX2 is involved in the basal regulation of LAMC2 in epithelial cells and to assess the influence of inflammation. Transcriptional regulation of LAMC2 was examined by reporter gene assays, overexpression, and shRNA-mediated knock-down of CDX2. CDX2-DNA interactions were assessed by chromatin immunoprecipitation on Caco-2 cells without or with TNF-alpha, as well as in purified colonic human epithelial cells. Immunohistochemical staining and quantitative reverse-transcription polymerase chain reaction analyses were used to measure the expression of CDX2 and LAMC2 in colonic biopsies from healthy controls and patients with UC. These data indicate that CDX2 directly regulates LAMC2 gene expression through interaction with elements in the LAMC2 promoter region. We further revealed an inverse effect of inflammation on CDX2 and LAMC2. The data presented provide a novel insight into how CDX2 is implicated in the transcriptional regulation of LAMC2 in intestinal epithelial cells, a function that is impaired during mucosal inflammation where a high level of TNF-alpha is present. J. Cell. Biochem. 118: 298-307, 2017.   2016 Wiley Periodicals, Inc.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="626" length="14"/><text>LAMC2 enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1419" length="21"/><text>LAMC2 promoter region</text></annotation><annotation id="3"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="328" length="22"/><text>Laminin subunit gamma2</text></annotation><annotation id="4"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="352" length="5"/><text>LAMC2</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="475" length="5"/><text>tumor</text></annotation><annotation id="6"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="1419" length="5"/><text>LAMC2</text></annotation><annotation id="7"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="553" length="9"/><text>TNF-alpha</text></annotation><annotation id="8"><infon key="identifier">0000414</infon><infon key="type">TISSUE</infon><location offset="728" length="16"/><text>epithelial cells</text></annotation><annotation id="9"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="675" length="4"/><text>CDX2</text></annotation><annotation id="10"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="719" length="5"/><text>LAMC2</text></annotation><annotation id="11"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="820" length="5"/><text>LAMC2</text></annotation><annotation id="12"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="913" length="4"/><text>CDX2</text></annotation><annotation id="13"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="14" length="14"/><text>Laminin gamma2</text></annotation><annotation id="14"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="919" length="4"/><text>CDX2</text></annotation><annotation id="15"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1020" length="9"/><text>TNF-alpha</text></annotation><annotation id="16"><infon key="identifier">0004297</infon><infon key="type">TISSUE</infon><location offset="1054" length="30"/><text>colonic human epithelial cells</text></annotation><annotation id="17"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="1228" length="4"/><text>CDX2</text></annotation><annotation id="18"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="1237" length="5"/><text>LAMC2</text></annotation><annotation id="19"><infon key="identifier">0005101</infon><infon key="type">DISEASE</infon><location offset="1303" length="2"/><text>UC</text></annotation><annotation id="20"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="1332" length="4"/><text>CDX2</text></annotation><annotation id="21"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="1356" length="5"/><text>LAMC2</text></annotation><annotation id="22"><infon key="identifier">0005937</infon><infon key="type">TISSUE</infon><location offset="1632" length="27"/><text>intestinal epithelial cells</text></annotation><annotation id="23"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="1499" length="4"/><text>CDX2</text></annotation><annotation id="24"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="43" length="4"/><text>CDX2</text></annotation><annotation id="25"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="1508" length="5"/><text>LAMC2</text></annotation><annotation id="26"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="1567" length="4"/><text>CDX2</text></annotation><annotation id="27"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="1623" length="5"/><text>LAMC2</text></annotation><annotation id="28"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="1739" length="9"/><text>TNF-alpha</text></annotation><annotation id="29"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="266" length="21"/><text>nuclear factor-kappaB</text></annotation><annotation id="30"><infon key="identifier">0004297</infon><infon key="type">TISSUE</infon><location offset="51" length="24"/><text>Colonic Epithelial Cells</text></annotation><annotation id="31"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="134" length="46"/><text>Caudal-related homeobox transcription factor 2</text></annotation><annotation id="32"><infon key="identifier">0000195</infon><infon key="type">TISSUE</infon><location offset="991" length="12"/><text>Caco-2 cells</text></annotation><annotation id="33"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="1246" length="16"/><text>colonic biopsies</text></annotation><annotation id="34"><infon key="identifier">1045</infon><infon key="type">GENE</infon><location offset="182" length="4"/><text>CDX2</text></annotation><annotation id="35"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="289" length="9"/><text>NF-kappaB</text></annotation><annotation id="36"><infon key="identifier">4790</infon><infon key="type">GENE</infon><location offset="568" length="9"/><text>NF-kappaB</text></annotation><annotation id="37"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="203" length="27"/><text>tumor necrosis factor-alpha</text></annotation><annotation id="38"><infon key="identifier">3918</infon><infon key="type">GENE</infon><location offset="626" length="5"/><text>LAMC2</text></annotation><annotation id="39"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="232" length="9"/><text>TNF-alpha</text></annotation><annotation id="40"><infon key="identifier">0005101</infon><infon key="type">DISEASE</infon><location offset="303" length="18"/><text>ulcerative colitis</text></annotation><annotation id="41"><infon key="identifier">0005101</infon><infon key="type">DISEASE</infon><location offset="323" length="2"/><text>UC</text></annotation></passage></document>
<document><id>27651453</id><passage><offset>0</offset><text>Identification of a novel distal regulatory element of the human Neuroglobin gene by the chromosome conformation capture approach. Neuroglobin (NGB) is predominantly expressed in the brain and retina. Studies suggest that NGB exerts protective effects to neuronal cells and is implicated in reducing the severity of stroke and Alzheimer's disease. However, little is known about the mechanisms which regulate the cell type-specific expression of the gene. In this study, we hypothesized that distal regulatory elements (DREs) are involved in optimal expression of the NGB gene. By chromosome conformation capture we identified two novel DREs located -70 kb upstream and +100 kb downstream from the NGB gene. ENCODE database showed the presence of DNaseI hypersensitive and transcription factors binding sites in these regions. Further analyses using luciferase reporters and chromatin immunoprecipitation suggested that the -70 kb region upstream of the NGB gene contained a neuronal-specific enhancer and GATA transcription factor binding sites. Knockdown of GATA-2 caused NGB expression to drop dramatically, indicating GATA-2 as an essential transcription factor for the activation of NGB expression. The crucial role of the DRE in NGB expression activation was further confirmed by the drop in NGB level after CRISPR-mediated deletion of the DRE. Taken together, we show that the NGB gene is regulated by a cell type-specific loop formed between its promoter and the novel DRE.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="975" length="26"/><text>neuronal-specific enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1454" length="8"/><text>promoter</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1346" length="3"/><text>DRE</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1006" length="39"/><text>GATA transcription factor binding sites</text></annotation><annotation id="5"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="1060" length="6"/><text>GATA-2</text></annotation><annotation id="6"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1074" length="3"/><text>NGB</text></annotation><annotation id="7"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="1122" length="6"/><text>GATA-2</text></annotation><annotation id="8"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1188" length="3"/><text>NGB</text></annotation><annotation id="9"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1235" length="3"/><text>NGB</text></annotation><annotation id="10"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1298" length="3"/><text>NGB</text></annotation><annotation id="11"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="1384" length="3"/><text>NGB</text></annotation><annotation id="12"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="59" length="5"/><text>human</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1228" length="3"/><text>DRE</text></annotation><annotation id="14"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="183" length="5"/><text>brain</text></annotation><annotation id="15"><infon key="identifier">0001175</infon><infon key="type">TISSUE</infon><location offset="193" length="6"/><text>retina</text></annotation><annotation id="16"><infon key="identifier">0000947</infon><infon key="type">TISSUE</infon><location offset="255" length="14"/><text>neuronal cells</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="627" length="79"/><text>two novel DREs located -70 kb upstream and +100 kb downstream from the NGB gene</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1477" length="3"/><text>DRE</text></annotation><annotation id="19"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="65" length="11"/><text>Neuroglobin</text></annotation><annotation id="20"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="131" length="11"/><text>Neuroglobin</text></annotation><annotation id="21"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="144" length="3"/><text>NGB</text></annotation><annotation id="22"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="222" length="3"/><text>NGB</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="26" length="25"/><text>distal regulatory element</text></annotation><annotation id="24"><infon key="identifier">0004975</infon><infon key="type">DISEASE</infon><location offset="327" length="19"/><text>Alzheimer's disease</text></annotation><annotation id="25"><infon key="identifier">58157</infon><infon key="type">GENE</infon><location offset="568" length="3"/><text>NGB</text></annotation></passage></document>
<document><id>27881681</id><passage><offset>0</offset><text>A Novel Regulatory Mechanism of Type II Collagen Expression via a SOX9-dependent Enhancer in Intron 6. Type II collagen alpha1 is specific for cartilaginous tissues, and mutations in its gene are associated with skeletal diseases. Its expression has been shown to be dependent on SOX9, a master transcription factor required for chondrogenesis that binds to an enhancer region in intron 1. However, ChIP sequencing revealed that SOX9 does not strongly bind to intron 1, but rather it binds to intron 6 and a site 30 kb upstream of the transcription start site. Here, we aimed to determine the role of the novel SOX9-binding site in intron 6. We prepared reporter constructs that contain a Col2a1 promoter, intron 1 with or without intron 6, and the luciferase gene. Although the reporter constructs were not activated by SOX9 alone, the construct that contained both introns 1 and 6 was activated 5-10-fold by the SOX9/SOX5 or the SOX9/SOX6 combination in transient-transfection assays in 293T cells. This enhancement was also observed in rat chondrosarcoma cells that stably expressed the construct. CRISPR/Cas9-induced deletion of intron 6 in RCS cells revealed that a 10-bp region of intron 6 is necessary both for Col2a1 expression and SOX9 binding. Furthermore, SOX9, but not SOX5, binds to this region as demonstrated in an electrophoretic mobility shift assay, although both SOX9 and SOX5 bind to a larger 325-bp fragment of intron 6 containing this small sequence. These findings suggest a novel mechanism of action of SOX5/6; namely, the SOX9/5/6 combination enhances Col2a1 transcription through a novel enhancer in intron 6 together with the enhancer in intron 1.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="66" length="35"/><text>SOX9-dependent Enhancer in Intron 6</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="361" length="27"/><text>enhancer region in intron 1</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1413" length="58"/><text>325-bp fragment of intron 6 containing this small sequence</text></annotation><annotation id="4"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="821" length="4"/><text>SOX9</text></annotation><annotation id="5"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="914" length="4"/><text>SOX9</text></annotation><annotation id="6"><infon key="identifier">140587</infon><infon key="type">GENE</infon><location offset="919" length="4"/><text>SOX5</text></annotation><annotation id="7"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="931" length="4"/><text>SOX9</text></annotation><annotation id="8"><infon key="identifier">293165</infon><infon key="type">GENE</infon><location offset="936" length="4"/><text>SOX6</text></annotation><annotation id="9"><infon key="identifier">0000250</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1145" length="3"/><text>RCS</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0000250</infon><infon key="type">TISSUE</infon><location offset="1043" length="20"/><text>chondrosarcoma cells</text></annotation><annotation id="11"><infon key="identifier">293165</infon><infon key="type">GENE</infon><location offset="1532" length="1"/><text>6</text></annotation><annotation id="12"><infon key="identifier">25412</infon><infon key="type">GENE</infon><location offset="1218" length="6"/><text>Col2a1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="689" length="15"/><text>Col2a1 promoter</text></annotation><annotation id="14"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="1240" length="4"/><text>SOX9</text></annotation><annotation id="15"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="1267" length="4"/><text>SOX9</text></annotation><annotation id="16"><infon key="identifier">140587</infon><infon key="type">GENE</infon><location offset="1281" length="4"/><text>SOX5</text></annotation><annotation id="17"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="1382" length="4"/><text>SOX9</text></annotation><annotation id="18"><infon key="identifier">140587</infon><infon key="type">GENE</infon><location offset="1391" length="4"/><text>SOX5</text></annotation><annotation id="19"><infon key="identifier">140587</infon><infon key="type">GENE</infon><location offset="1527" length="4"/><text>SOX5</text></annotation><annotation id="20"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="1547" length="4"/><text>SOX9</text></annotation><annotation id="21"><infon key="identifier">25412</infon><infon key="type">GENE</infon><location offset="1577" length="6"/><text>Col2a1</text></annotation><annotation id="22"><infon key="identifier">10116</infon><infon key="type">SPECIES</infon><location offset="1039" length="3"/><text>rat</text></annotation><annotation id="23"><infon key="identifier">0002181</infon><infon key="type">TISSUE</infon><location offset="989" length="10"/><text>293T cells</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1614" length="20"/><text>enhancer in intron 6</text></annotation><annotation id="25"><infon key="identifier">140587</infon><infon key="type">GENE</infon><location offset="1552" length="1"/><text>5</text></annotation><annotation id="26"><infon key="identifier">293165</infon><infon key="type">GENE</infon><location offset="1554" length="1"/><text>6</text></annotation><annotation id="27"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="66" length="4"/><text>SOX9</text></annotation><annotation id="28"><infon key="identifier">25412</infon><infon key="type">GENE</infon><location offset="689" length="6"/><text>Col2a1</text></annotation><annotation id="29"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="611" length="4"/><text>SOX9</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1653" length="20"/><text>enhancer in intron 1</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="611" length="29"/><text>SOX9-binding site in intron 6</text></annotation><annotation id="32"><infon key="identifier">0005172</infon><infon key="type">DISEASE</infon><location offset="212" length="17"/><text>skeletal diseases</text></annotation><annotation id="33"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="280" length="4"/><text>SOX9</text></annotation><annotation id="34"><infon key="identifier">140586</infon><infon key="type">GENE</infon><location offset="429" length="4"/><text>SOX9</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1171" length="24"/><text>10-bp region of intron 6</text></annotation></passage></document>
<document><id>27895109</id><passage><offset>0</offset><text>Enhancers and super-enhancers have an equivalent regulatory role in embryonic stem cells through regulation of single or multiple genes. Transcriptional enhancers are critical for maintaining cell-type-specific gene expression and driving cell fate changes during development. Highly transcribed genes are often associated with a cluster of individual enhancers such as those found in locus control regions. Recently, these have been termed stretch enhancers or super-enhancers, which have been predicted to regulate critical cell identity genes. We employed a CRISPR/Cas9-mediated deletion approach to study the function of several enhancer clusters (ECs) and isolated enhancers in mouse embryonic stem (ES) cells. Our results reveal that the effect of deleting ECs, also classified as ES cell super-enhancers, is highly variable, resulting in target gene expression reductions ranging from 12% to as much as 92%. Partial deletions of these ECs which removed only one enhancer or a subcluster of enhancers revealed partially redundant control of the regulated gene by multiple enhancers within the larger cluster. Many highly transcribed genes in ES cells are not associated with a super-enhancer; furthermore, super-enhancer predictions ignore 81% of the potentially active regulatory elements predicted by cobinding of five or more pluripotency-associated transcription factors. Deletion of these additional enhancer regions revealed their robust regulatory role in gene transcription. In addition, select super-enhancers and enhancers were identified that regulated clusters of paralogous genes. We conclude that, whereas robust transcriptional output can be achieved by an isolated enhancer, clusters of enhancers acting on a common target gene act in a partially redundant manner to fine tune transcriptional output of their target genes.</text><annotation id="1"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="683" length="5"/><text>mouse</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="68" length="20"/><text>embryonic stem cells</text></annotation><annotation id="3"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="689" length="25"/><text>embryonic stem (ES) cells</text></annotation><annotation id="4"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="787" length="7"/><text>ES cell</text></annotation><annotation id="5"><infon key="type">TISSUE</infon><location offset="1148" length="8"/><text>ES cells</text></annotation></passage></document>
<document><id>27920250</id><passage><offset>0</offset><text>Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements. The erythropoietin (Epo) gene is under tissue-specific inducible regulation. Because the kidney is the primary EPO-producing tissue in adults, impaired EPO production in chronic kidney disorders results in serious renal anemia. The Epo gene contains a liver-specific enhancer in the 3' region, but the kidney-specific enhancer for gene expression in renal EPO-producing (REP) cells remains elusive. Here, we examined a conserved upstream element for renal Epo regulation (CURE) region that spans 17.4 kb to 3.6 kb upstream of the Epo gene and harbors several phylogenetically conserved elements. We prepared various Epo gene-reporter constructs utilizing a bacterial artificial chromosome and generated a number of transgenic-mouse lines. We observed that deletion of the CURE region (deltaCURE) abrogated Epo gene expression in REP cells. Although transgenic expression of the deltaCURE construct rescued Epo-deficient mice from embryonic lethality, the rescued mice had severe EPO-dependent anemia. These mouse lines serve as an elaborate model for the search for erythroid stimulatory activity and are referred to as AnRED (anemic model with renal EPO deficiency) mice. We also dissected the CURE region by exploiting a minigene harboring four phylogenetically conserved elements in reporter transgenic-mouse analyses. Our analyses revealed that Epo gene regulation in REP cells is a complex process that utilizes multiple regulatory influences.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="383" length="40"/><text>liver-specific enhancer in the 3' region</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="433" length="24"/><text>kidney-specific enhancer</text></annotation><annotation id="3"><infon key="identifier">0002280</infon><infon key="type">DISEASE</infon><location offset="351" length="6"/><text>anemia</text></annotation><annotation id="4"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="363" length="3"/><text>Epo</text></annotation><annotation id="5"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="383" length="5"/><text>liver</text></annotation><annotation id="6"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="587" length="3"/><text>Epo</text></annotation><annotation id="7"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="661" length="3"/><text>Epo</text></annotation><annotation id="8"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="747" length="3"/><text>Epo</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="857" length="5"/><text>mouse</text></annotation><annotation id="10"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="937" length="3"/><text>Epo</text></annotation><annotation id="11"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="1037" length="3"/><text>Epo</text></annotation><annotation id="12"><infon key="identifier">0002280</infon><infon key="type">DISEASE</infon><location offset="1124" length="6"/><text>anemia</text></annotation><annotation id="13"><infon key="identifier">0002280</infon><infon key="type">DISEASE</infon><location offset="6" length="6"/><text>Anemia</text></annotation><annotation id="14"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1051" length="4"/><text>mice</text></annotation><annotation id="15"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1197" length="9"/><text>erythroid</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1094" length="4"/><text>mice</text></annotation><annotation id="17"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="1110" length="3"/><text>EPO</text></annotation><annotation id="18"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="1282" length="3"/><text>EPO</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1138" length="5"/><text>mouse</text></annotation><annotation id="20"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="433" length="6"/><text>kidney</text></annotation><annotation id="21"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1298" length="4"/><text>mice</text></annotation><annotation id="22"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1437" length="5"/><text>mouse</text></annotation><annotation id="23"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="1480" length="3"/><text>Epo</text></annotation><annotation id="24"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="19" length="5"/><text>Mouse</text></annotation><annotation id="25"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="94" length="6"/><text>Kidney</text></annotation><annotation id="26"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="220" length="6"/><text>kidney</text></annotation><annotation id="27"><infon key="type">TISSUE</infon><location offset="481" length="31"/><text>renal EPO-producing (REP) cells</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="960" length="9"/><text>REP cells</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="1503" length="9"/><text>REP cells</text></annotation><annotation id="30"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="66" length="14"/><text>Erythropoietin</text></annotation><annotation id="31"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="135" length="14"/><text>erythropoietin</text></annotation><annotation id="32"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="151" length="3"/><text>Epo</text></annotation><annotation id="33"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="242" length="3"/><text>EPO</text></annotation><annotation id="34"><infon key="identifier">13856</infon><infon key="type">GENE</infon><location offset="283" length="3"/><text>EPO</text></annotation><annotation id="35"><infon key="identifier">0005300</infon><infon key="type">DISEASE</infon><location offset="301" length="24"/><text>chronic kidney disorders</text></annotation></passage></document>
<document><id>27932455</id><passage><offset>0</offset><text>Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription. Enhancers are intergenic DNA elements that regulate the transcription of target genes in response to signaling pathways by interacting with promoters over large genomic distances. Recent studies have revealed that enhancers are bi-directionally transcribed into enhancer RNAs (eRNAs). Using single-molecule fluorescence in situ hybridization (smFISH), we investigated the eRNA-mediated regulation of transcription during estrogen induction in MCF-7 cells. We demonstrate that eRNAs are localized exclusively in the nucleus and are induced with similar kinetics as target mRNAs. However, eRNAs are mostly nascent at enhancers and their steady-state levels remain lower than those of their cognate mRNAs. Surprisingly, at the single-allele level, eRNAs are rarely co-expressed with their target loci, demonstrating that active gene transcription does not require the continuous transcription of eRNAs or their accumulation at enhancers. When co-expressed, sub-diffraction distance measurements between nascent mRNA and eRNA signals reveal that co-transcription of eRNAs and mRNAs rarely occurs within closed enhancer-promoter loops. Lastly, basal eRNA transcription at enhancers, but not E2-induced transcription, is maintained upon depletion of MLL1 and ERalpha, suggesting some degree of chromatin accessibility prior to signal-dependent activation of transcription. Together, our findings suggest that eRNA accumulation at enhancer-promoter loops is not required to sustain target gene transcription.</text><annotation id="1"><infon key="identifier">4297</infon><infon key="type">GENE</infon><location offset="1366" length="4"/><text>MLL1</text></annotation><annotation id="2"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="1375" length="7"/><text>ERalpha</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="565" length="11"/><text>MCF-7 cells</text></annotation></passage></document>
<document><id>27941798</id><passage><offset>0</offset><text>ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Genes encoding subunits of SWI/SNF (BAF) chromatin-remodeling complexes are collectively mutated in ~20% of all human cancers. Although ARID1A is the most frequent target of mutations, the mechanism by which its inactivation promotes tumorigenesis is unclear. Here we demonstrate that Arid1a functions as a tumor suppressor in the mouse colon, but not the small intestine, and that invasive ARID1A-deficient adenocarcinomas resemble human colorectal cancer (CRC). These tumors lack deregulation of APC/beta-catenin signaling components, which are crucial gatekeepers in common forms of intestinal cancer. We find that ARID1A normally targets SWI/SNF complexes to enhancers, where they function in coordination with transcription factors to facilitate gene activation. ARID1B preserves SWI/SNF function in ARID1A-deficient cells, but defects in SWI/SNF targeting and control of enhancer activity cause extensive dysregulation of gene expression. These findings represent an advance in colon cancer modeling and implicate enhancer-mediated gene regulation as a principal tumor-suppressor function of ARID1A.</text><annotation id="1"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>ARID1A</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="81" length="4"/><text>mice</text></annotation><annotation id="3"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="1185" length="6"/><text>ARID1A</text></annotation><annotation id="4"><infon key="identifier">0021063</infon><infon key="type">DISEASE</infon><location offset="65" length="12"/><text>colon cancer</text></annotation><annotation id="5"><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="205" length="7"/><text>cancers</text></annotation><annotation id="6"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="394" length="5"/><text>tumor</text></annotation><annotation id="7"><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="526" length="17"/><text>colorectal cancer</text></annotation><annotation id="8"><infon key="identifier">0005575</infon><infon key="type">DISEASE</infon><location offset="545" length="3"/><text>CRC</text></annotation><annotation id="9"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="557" length="6"/><text>tumors</text></annotation><annotation id="10"><infon key="identifier">324</infon><infon key="type">GENE</infon><location offset="585" length="3"/><text>APC</text></annotation><annotation id="11"><infon key="identifier">1499</infon><infon key="type">GENE</infon><location offset="589" length="12"/><text>beta-catenin</text></annotation><annotation id="12"><infon key="identifier">0005814</infon><infon key="type">DISEASE</infon><location offset="673" length="17"/><text>intestinal cancer</text></annotation><annotation id="13"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="199" length="5"/><text>human</text></annotation><annotation id="14"><infon key="identifier">0021063</infon><infon key="type">DISEASE</infon><location offset="1071" length="12"/><text>colon cancer</text></annotation><annotation id="15"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1156" length="5"/><text>tumor</text></annotation><annotation id="16"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="424" length="5"/><text>colon</text></annotation><annotation id="17"><infon key="identifier">0000651</infon><infon key="type">TISSUE</infon><location offset="443" length="15"/><text>small intestine</text></annotation><annotation id="18"><infon key="identifier">0004970</infon><infon key="type">DISEASE</infon><location offset="495" length="15"/><text>adenocarcinomas</text></annotation><annotation id="19"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="478" length="6"/><text>ARID1A</text></annotation><annotation id="20"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="223" length="6"/><text>ARID1A</text></annotation><annotation id="21"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="372" length="6"/><text>Arid1a</text></annotation><annotation id="22"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="418" length="5"/><text>mouse</text></annotation><annotation id="23"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="520" length="5"/><text>human</text></annotation><annotation id="24"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="705" length="6"/><text>ARID1A</text></annotation><annotation id="25"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="855" length="6"/><text>ARID1B</text></annotation><annotation id="26"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="892" length="6"/><text>ARID1A</text></annotation></passage></document>
<document><id>27980063</id><passage><offset>0</offset><text>BRD4 promotes p63 and GRHL3 expression downstream of FOXO in mammary epithelial cells. Bromodomain-containing protein 4 (BRD4) is a member of the bromo- and extraterminal (BET) domain-containing family of epigenetic readers which is under intensive investigation as a target for anti-tumor therapy. BRD4 plays a central role in promoting the expression of select subsets of genes including many driven by oncogenic transcription factors and signaling pathways. However, the role of BRD4 and the effects of BET inhibitors in non-transformed cells remain mostly unclear. We demonstrate that BRD4 is required for the maintenance of a basal epithelial phenotype by regulating the expression of epithelial-specific genes including TP63 and Grainy Head-like transcription factor-3 (GRHL3) in non-transformed basal-like mammary epithelial cells. Moreover, BRD4 occupancy correlates with enhancer activity and enhancer RNA (eRNA) transcription. Motif analyses of cell context-specific BRD4-enriched regions predicted the involvement of FOXO transcription factors. Consistently, activation of FOXO1 function via inhibition of EGFR-AKT signaling promoted the expression of TP63 and GRHL3. Moreover, activation of Src kinase signaling and FOXO1 inhibition decreased the expression of FOXO/BRD4 target genes. Together, our findings support a function for BRD4 in promoting basal mammary cell epithelial differentiation, at least in part, by regulating FOXO factor function on enhancers to activate TP63 and GRHL3 expression.</text><annotation id="1"><infon key="identifier">6714</infon><infon key="type">GENE</infon><location offset="1203" length="10"/><text>Src kinase</text></annotation><annotation id="2"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="299" length="4"/><text>BRD4</text></annotation><annotation id="3"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="482" length="4"/><text>BRD4</text></annotation><annotation id="4"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="589" length="4"/><text>BRD4</text></annotation><annotation id="5"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="726" length="4"/><text>TP63</text></annotation><annotation id="6"><infon key="identifier">57822</infon><infon key="type">GENE</infon><location offset="735" length="39"/><text>Grainy Head-like transcription factor-3</text></annotation><annotation id="7"><infon key="identifier">57822</infon><infon key="type">GENE</infon><location offset="776" length="5"/><text>GRHL3</text></annotation><annotation id="8"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="849" length="4"/><text>BRD4</text></annotation><annotation id="9"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="977" length="4"/><text>BRD4</text></annotation><annotation id="10"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1084" length="5"/><text>FOXO1</text></annotation><annotation id="11"><infon key="identifier">0003568</infon><infon key="type">TISSUE</infon><location offset="1367" length="12"/><text>mammary cell</text></annotation><annotation id="12"><infon key="identifier">1956</infon><infon key="type">GENE</infon><location offset="1117" length="4"/><text>EGFR</text></annotation><annotation id="13"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="1163" length="4"/><text>TP63</text></annotation><annotation id="14"><infon key="identifier">57822</infon><infon key="type">GENE</infon><location offset="1172" length="5"/><text>GRHL3</text></annotation><annotation id="15"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1228" length="5"/><text>FOXO1</text></annotation><annotation id="16"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1278" length="4"/><text>BRD4</text></annotation><annotation id="17"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="1343" length="4"/><text>BRD4</text></annotation><annotation id="18"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="1486" length="4"/><text>TP63</text></annotation><annotation id="19"><infon key="identifier">57822</infon><infon key="type">GENE</infon><location offset="1495" length="5"/><text>GRHL3</text></annotation><annotation id="20"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>BRD4</text></annotation><annotation id="21"><infon key="identifier">0004300</infon><infon key="type">TISSUE</infon><location offset="61" length="24"/><text>mammary epithelial cells</text></annotation><annotation id="22"><infon key="identifier">0004300</infon><infon key="type">TISSUE</infon><location offset="813" length="24"/><text>mammary epithelial cells</text></annotation><annotation id="23"><infon key="identifier">8626</infon><infon key="type">GENE</infon><location offset="14" length="3"/><text>p63</text></annotation><annotation id="24"><infon key="identifier">57822</infon><infon key="type">GENE</infon><location offset="22" length="5"/><text>GRHL3</text></annotation><annotation id="25"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="87" length="32"/><text>Bromodomain-containing protein 4</text></annotation><annotation id="26"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="121" length="4"/><text>BRD4</text></annotation><annotation id="27"><infon key="identifier">207</infon><infon key="type">GENE</infon><location offset="1122" length="3"/><text>AKT</text></annotation><annotation id="28"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="284" length="5"/><text>tumor</text></annotation></passage></document>
<document><id>27986456</id><passage><offset>0</offset><text>Isoform-Specific Expression and Feedback Regulation of E Protein TCF4 Control Dendritic Cell Lineage Specification. The cell fate decision between interferon-producing plasmacytoid DC (pDC) and antigen-presenting classical DC (cDC) is controlled by the E protein transcription factor TCF4 (E2-2). We report that TCF4 comprises two transcriptional isoforms, both of which are required for optimal pDC development in vitro. The long Tcf4 isoform is expressed specifically in pDCs, and its deletion in mice impaired pDCs development and led to the expansion of non-canonical CD8+ cDCs. The expression of Tcf4 commenced in progenitors and was further upregulated in pDCs, correlating with stage-specific activity of multiple enhancer elements. A conserved enhancer downstream of Tcf4 was required for its upregulation during pDC differentiation, revealing a positive feedback loop. The expression of Tcf4 and the resulting pDC differentiation were selectively sensitive to the inhibition of enhancer-binding BET protein activity. Thus, lineage-specifying function of E proteins is facilitated by lineage-specific isoform expression and by BET-dependent feedback regulation through distal regulatory elements.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="752" length="27"/><text>enhancer downstream of Tcf4</text></annotation><annotation id="2"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="601" length="4"/><text>Tcf4</text></annotation><annotation id="3"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="896" length="4"/><text>Tcf4</text></annotation><annotation id="4"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="78" length="14"/><text>Dendritic Cell</text></annotation><annotation id="5"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="168" length="15"/><text>plasmacytoid DC</text></annotation><annotation id="6"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="185" length="3"/><text>pDC</text></annotation><annotation id="7"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="213" length="12"/><text>classical DC</text></annotation><annotation id="8"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="290" length="5"/><text>E2-2)</text></annotation><annotation id="9"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="227" length="3"/><text>cDC</text></annotation><annotation id="10"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="473" length="4"/><text>pDCs</text></annotation><annotation id="11"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="513" length="4"/><text>pDCs</text></annotation><annotation id="12"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="572" length="9"/><text>CD8+ cDCs</text></annotation><annotation id="13"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="662" length="4"/><text>pDCs</text></annotation><annotation id="14"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="821" length="3"/><text>pDC</text></annotation><annotation id="15"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="919" length="3"/><text>pDC</text></annotation><annotation id="16"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="65" length="4"/><text>TCF4</text></annotation><annotation id="17"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="284" length="4"/><text>TCF4</text></annotation><annotation id="18"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="775" length="4"/><text>Tcf4</text></annotation><annotation id="19"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="312" length="4"/><text>TCF4</text></annotation><annotation id="20"><infon key="identifier">0004625</infon><infon key="type">TISSUE</infon><location offset="396" length="3"/><text>pDC</text></annotation><annotation id="21"><infon key="identifier">21413</infon><infon key="type">GENE</infon><location offset="431" length="4"/><text>Tcf4</text></annotation><annotation id="22"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="499" length="4"/><text>mice</text></annotation></passage></document>
<document><id>27989796</id><passage><offset>0</offset><text>Altered SOX9 genital tubercle enhancer region in hypospadias. Human mutations in the SOX9 gene or its regulatory region can disrupt testicular development, leading to disorders of sex development (DSDs). Our previous work involving the genomic analysis of isolated DSD patients revealed a 78kb minimal sex determining region (RevSex) far upstream of SOX9 that was duplicated in 46,XX and deleted in 46,XY DSDs. It was postulated that RevSex contains a gonadal enhancer. However, the most highly conserved sub-region within RevSex, called SR4, was neither responsive to sex determining factors in vitro nor active in the gonads of transgenic mice, suggesting that SR4 may not be functioning as a testicular enhancer. Interestingly, SR4 transgenic mice showed reporter activity in the genital tubercle, the primordium of the penis and clitoris, a previously unreported domain of Sox9 expression. SOX9 protein was detected in the genital tubercle, notably in the urethral plate epithelium, preputial glands, ventral surface ectoderm and corpus cavernosa. SR4 may therefore function as a Sox9 genital tubercle enhancer, mutations of which could possibly lead to hypospadias, a birth defect seen in the DSD patients in the RevSex study. SR4 activity and the observed SOX9 expression pattern suggest that SR4 may function as a Sox9 genital tubercle enhancer. However, conditional ablation of Sox9 in the genital tubercle using Shh-Cre/+;Sox9flox/flox mice revealed no genital tubercle abnormalities, possibly due to compensation by similar Sox factors. To conclude, we have identified a novel regulatory enhancer driving Sox9 expression during external genitalia development.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="8" length="37"/><text>SOX9 genital tubercle enhancer region</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="695" length="19"/><text>testicular enhancer</text></annotation><annotation id="3"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="167" length="28"/><text>disorders of sex development</text></annotation><annotation id="4"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="197" length="4"/><text>DSDs</text></annotation><annotation id="5"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="265" length="3"/><text>DSD</text></annotation><annotation id="6"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="350" length="4"/><text>SOX9</text></annotation><annotation id="7"><infon key="identifier">0020040</infon><infon key="type">DISEASE</infon><location offset="399" length="10"/><text>46,XY DSDs</text></annotation><annotation id="8"><infon key="identifier">0002433</infon><infon key="type">TISSUE</infon><location offset="805" length="36"/><text>primordium of the penis and clitoris</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="641" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="type">TISSUE</infon><location offset="927" length="16"/><text>genital tubercle</text></annotation><annotation id="11"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="746" length="4"/><text>mice</text></annotation><annotation id="12"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="877" length="4"/><text>Sox9</text></annotation><annotation id="13"><infon key="type">TISSUE</infon><location offset="783" length="16"/><text>genital tubercle</text></annotation><annotation id="14"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="894" length="4"/><text>SOX9</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="1398" length="16"/><text>genital tubercle</text></annotation><annotation id="16"><infon key="identifier">0005345</infon><infon key="type">DISEASE</infon><location offset="1158" length="11"/><text>hypospadias</text></annotation><annotation id="17"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="1198" length="3"/><text>DSD</text></annotation><annotation id="18"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="1262" length="4"/><text>SOX9</text></annotation><annotation id="19"><infon key="identifier">0017576</infon><infon key="type">DISEASE</infon><location offset="378" length="5"/><text>46,XX</text></annotation><annotation id="20"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1386" length="4"/><text>Sox9</text></annotation><annotation id="21"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1445" length="4"/><text>mice</text></annotation><annotation id="22"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1421" length="3"/><text>Shh</text></annotation><annotation id="23"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="1615" length="4"/><text>Sox9</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1084" length="30"/><text>Sox9 genital tubercle enhancer</text></annotation><annotation id="25"><infon key="identifier">0000534</infon><infon key="type">TISSUE</infon><location offset="620" length="6"/><text>gonads</text></annotation><annotation id="26"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="8" length="4"/><text>SOX9</text></annotation><annotation id="27"><infon key="identifier">0003906</infon><infon key="type">TISSUE</infon><location offset="960" length="25"/><text>urethral plate epithelium</text></annotation><annotation id="28"><infon key="identifier">0001111</infon><infon key="type">TISSUE</infon><location offset="987" length="16"/><text>preputial glands</text></annotation><annotation id="29"><infon key="identifier">0000315</infon><infon key="type">TISSUE</infon><location offset="1005" length="24"/><text>ventral surface ectoderm</text></annotation><annotation id="30"><infon key="identifier">0005454</infon><infon key="type">TISSUE</infon><location offset="1034" length="16"/><text>corpus cavernosa</text></annotation><annotation id="31"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1084" length="4"/><text>Sox9</text></annotation><annotation id="32"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1321" length="4"/><text>Sox9</text></annotation><annotation id="33"><infon key="type">TISSUE</infon><location offset="1326" length="16"/><text>genital tubercle</text></annotation><annotation id="34"><infon key="type">TISSUE</infon><location offset="1089" length="16"/><text>genital tubercle</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1321" length="30"/><text>Sox9 genital tubercle enhancer</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1587" length="19"/><text>regulatory enhancer</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="452" length="16"/><text>gonadal enhancer</text></annotation><annotation id="38"><infon key="identifier">0005345</infon><infon key="type">DISEASE</infon><location offset="49" length="11"/><text>hypospadias</text></annotation><annotation id="39"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="62" length="5"/><text>Human</text></annotation><annotation id="40"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="85" length="4"/><text>SOX9</text></annotation></passage></document>
<document><id>28028313</id><passage><offset>0</offset><text>Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia. The transcription factor TAL1/SCL is one of the most prevalent oncogenes in T-cell acute lymphoblastic leukemia (T-ALL), a malignant disorder resulting from leukemic transformation of thymus T-cell precursors. TAL1 is normally expressed in hematopoietic stem cells (HSCs) but is silenced in immature thymocytes. We hypothesize that TAL1 contributes to leukemogenesis by activating genes that are normally repressed in immature thymocytes. Herein, we identified a novel TAL1-regulated super-enhancer controlling the GIMAP locus, which resides within an insulated chromosomal locus in T-ALL cells. The GIMAP genes are expressed in HSCs and mature T cells but are downregulated during the immature stage of thymocyte differentiation. The GIMAP enhancer is activated by TAL1, RUNX1 and GATA3 in human T-ALL cells but is repressed by E-proteins. Overexpression of human GIMAP genes in immature thymocytes alone does not induce tumorigenesis but accelerates leukemia development in zebrafish. Our results demonstrate that aberrant activation of the GIMAP enhancer contributes to T-cell leukemogenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="27" length="14"/><text>GIMAP enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="580" length="35"/><text>novel TAL1-regulated super-enhancer</text></annotation><annotation id="3"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="449" length="4"/><text>TAL1</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="700" length="11"/><text>T-ALL cells</text></annotation><annotation id="5"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="746" length="4"/><text>HSCs</text></annotation><annotation id="6"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="883" length="4"/><text>TAL1</text></annotation><annotation id="7"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="889" length="5"/><text>RUNX1</text></annotation><annotation id="8"><infon key="identifier">2625</infon><infon key="type">GENE</infon><location offset="899" length="5"/><text>GATA3</text></annotation><annotation id="9"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="908" length="5"/><text>human</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="914" length="11"/><text>T-ALL cells</text></annotation><annotation id="11"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="976" length="5"/><text>human</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="852" length="14"/><text>GIMAP enhancer</text></annotation><annotation id="13"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1069" length="8"/><text>leukemia</text></annotation><annotation id="14"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1093" length="9"/><text>zebrafish</text></annotation><annotation id="15"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1190" length="6"/><text>T-cell</text></annotation><annotation id="16"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="308" length="6"/><text>T-cell</text></annotation><annotation id="17"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="357" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="18"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="383" length="4"/><text>HSCs</text></annotation><annotation id="19"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="417" length="10"/><text>thymocytes</text></annotation><annotation id="20"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="544" length="10"/><text>thymocytes</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1160" length="14"/><text>GIMAP enhancer</text></annotation><annotation id="22"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="762" length="7"/><text>T cells</text></annotation><annotation id="23"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="821" length="9"/><text>thymocyte</text></annotation><annotation id="24"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="1006" length="10"/><text>thymocytes</text></annotation><annotation id="25"><infon key="identifier">0001374</infon><infon key="type">TISSUE</infon><location offset="301" length="6"/><text>thymus</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="80" length="35"/><text>T-cell acute lymphoblastic leukemia</text></annotation><annotation id="27"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="142" length="8"/><text>TAL1/SCL</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="193" length="35"/><text>T-cell acute lymphoblastic leukemia</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="230" length="5"/><text>T-ALL</text></annotation><annotation id="30"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="586" length="4"/><text>TAL1</text></annotation><annotation id="31"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="327" length="4"/><text>TAL1</text></annotation></passage></document>
<document><id>28045957</id><passage><offset>0</offset><text>Normal Levels of Sox9 Expression in the Developing Mouse Testis Depend on the TES/TESCO Enhancer, but This Does Not Act Alone. During mouse sex determination, transient expression of the Y-linked gene Sry up-regulates its direct target gene Sox9, via a 3.2 kb testis specific enhancer of Sox9 (TES), which includes a core 1.4 kb element, TESCO. SOX9 activity leads to differentiation of Sertoli cells, rather than granulosa cells from the bipotential supporting cell precursor lineage. Here, we present functional analysis of TES/TESCO, using CRISPR/Cas9 genome editing in mice. Deletion of TESCO or TES reduced Sox9 expression levels in XY fetal gonads to 60 or 45% respectively relative to wild type gonads, and reduced expression of the SOX9 target Amh. Although human patients heterozygous for null mutations in SOX9, which are assumed to have 50% of normal expression, often show XY female sex reversal, mice deleted for one copy of Sox9 do not. Consistent with this, we did not observe sex reversal in either TESCO-/- or TES-/- XY embryos or adult mice. However, embryos carrying both a conditional Sox9 null allele and the TES deletion developed ovotestes. Quantitative analysis of these revealed levels of 23% expression of Sox9 compared to wild type, and a significant increase in the expression of the granulosa cell marker Foxl2. This indicates that the threshold in mice where sex reversal begins to be seen is about half that of the ~50% levels predicted in humans. Our results demonstrate that TES/TESCO is a crucial enhancer regulating Sox9 expression in the gonad, but point to the existence of additional enhancers that act redundantly.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1531" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="17" length="4"/><text>Sox9</text></annotation><annotation id="3"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="740" length="4"/><text>SOX9</text></annotation><annotation id="4"><infon key="identifier">11705</infon><infon key="type">GENE</infon><location offset="752" length="3"/><text>Amh</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="766" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="816" length="4"/><text>SOX9</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="909" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="938" length="4"/><text>Sox9</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1027" length="3"/><text>TES</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1054" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1105" length="4"/><text>Sox9</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1130" length="3"/><text>TES</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="51" length="5"/><text>Mouse</text></annotation><annotation id="14"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1232" length="4"/><text>Sox9</text></annotation><annotation id="15"><infon key="identifier">26927</infon><infon key="type">GENE</infon><location offset="1334" length="5"/><text>Foxl2</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1378" length="4"/><text>mice</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1471" length="6"/><text>humans</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1508" length="3"/><text>TES</text></annotation><annotation id="19"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="1551" length="4"/><text>Sox9</text></annotation><annotation id="20"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="57" length="6"/><text>Testis</text></annotation><annotation id="21"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="387" length="13"/><text>Sertoli cells</text></annotation><annotation id="22"><infon key="identifier">0000542</infon><infon key="type">TISSUE</infon><location offset="414" length="15"/><text>granulosa cells</text></annotation><annotation id="23"><infon key="identifier">0000534</infon><infon key="type">TISSUE</infon><location offset="647" length="6"/><text>gonads</text></annotation><annotation id="24"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="134" length="5"/><text>mouse</text></annotation><annotation id="25"><infon key="identifier">0000981</infon><infon key="type">TISSUE</infon><location offset="1153" length="9"/><text>ovotestes</text></annotation><annotation id="26"><infon key="identifier">0000542</infon><infon key="type">TISSUE</infon><location offset="1312" length="14"/><text>granulosa cell</text></annotation><annotation id="27"><infon key="identifier">21674</infon><infon key="type">GENE</infon><location offset="201" length="3"/><text>Sry</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="591" length="5"/><text>TESCO</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="530" length="5"/><text>TESCO</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1015" length="5"/><text>TESCO</text></annotation><annotation id="31"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1512" length="5"/><text>TESCO</text></annotation><annotation id="32"><infon key="identifier">0000534</infon><infon key="type">TISSUE</infon><location offset="1574" length="5"/><text>gonad</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="253" length="39"/><text>3.2 kb testis specific enhancer of Sox9</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="294" length="3"/><text>TES</text></annotation><annotation id="35"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="241" length="4"/><text>Sox9</text></annotation><annotation id="36"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1037" length="7"/><text>embryos</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="78" length="3"/><text>TES</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="82" length="14"/><text>TESCO Enhancer</text></annotation><annotation id="39"><infon key="identifier">0000534</infon><infon key="type">TISSUE</infon><location offset="702" length="6"/><text>gonads</text></annotation><annotation id="40"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="317" length="26"/><text>core 1.4 kb element, TESCO</text></annotation><annotation id="41"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1069" length="7"/><text>embryos</text></annotation><annotation id="42"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="260" length="6"/><text>testis</text></annotation><annotation id="43"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="288" length="4"/><text>Sox9</text></annotation><annotation id="44"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="345" length="4"/><text>SOX9</text></annotation><annotation id="45"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="526" length="3"/><text>TES</text></annotation><annotation id="46"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="573" length="4"/><text>mice</text></annotation><annotation id="47"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="600" length="3"/><text>TES</text></annotation><annotation id="48"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="612" length="4"/><text>Sox9</text></annotation></passage></document>
<document><id>28082341</id><passage><offset>0</offset><text>The transcription factor GATA1 regulates NBEAL2 expression through a long-distance enhancer. Gray platelet syndrome is named after the gray appearance of platelets due to the absence of alpha-granules. It is caused by recessive mutations in NBEAL2, resulting in macrothrombocytopenia and myelofibrosis. Though using the term gray platelets for GATA1 deficiency has been debated, a reduced number of alpha-granules has been described for macrothrombocytopenia due to GATA1 mutations. We compared platelet size and number of alpha-granules for two NBEAL2 and two GATA1-deficient patients and found reduced numbers of alpha-granules for all, with the defect being more pronounced for NBEAL2 deficiency. We further hypothesized that the granule defect for GATA1 is due to a defective control of NBEAL2 expression. Remarkably, platelets from two patients, and Gata1-deficient mice, expressed almost no NBEAL2. The differentiation of GATA1 patient-derived CD34+ stem cells to megakaryocytes showed defective proplatelet and alpha-granule formation with strongly reduced NBEAL2 protein and ribonucleic acid expression. Chromatin immunoprecipitation sequencing revealed 5 GATA binding sites in a regulatory region 31 kb upstream of NBEAL2 covered by a H3K4Me1 mark indicative of an enhancer locus. Luciferase reporter constructs containing this region confirmed its enhancer activity in K562 cells, and mutagenesis of the GATA1 binding sites resulted in significantly reduced enhancer activity. Moreover, DNA binding studies showed that GATA1 and GATA2 physically interact with this enhancer region. GATA1 depletion using small interfering ribonucleic acid in K562 cells also resulted in reduced NBEAL2 expression. In conclusion, we herein show a long-distance regulatory region with GATA1 binding sites as being a strong enhancer for NBEAL2 expression.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,46988575,46990242</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,46988575,46990242</infon><infon key="gb">unk</infon><location offset="69" length="22"/><text>long-distance enhancer</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,46988575,46990242</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,46988575,46990242</infon><infon key="gb">unk</infon><location offset="1274" length="14"/><text>enhancer locus</text></annotation><annotation id="3"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="791" length="6"/><text>NBEAL2</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="871" length="4"/><text>mice</text></annotation><annotation id="5"><infon key="identifier">235627</infon><infon key="type">GENE</infon><location offset="897" length="6"/><text>NBEAL2</text></annotation><annotation id="6"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="928" length="5"/><text>GATA1</text></annotation><annotation id="7"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="1064" length="6"/><text>NBEAL2</text></annotation><annotation id="8"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="1414" length="5"/><text>GATA1</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1414" length="19"/><text>GATA1 binding sites</text></annotation><annotation id="10"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="1529" length="5"/><text>GATA1</text></annotation><annotation id="11"><infon key="identifier">2624</infon><infon key="type">GENE</infon><location offset="1539" length="5"/><text>GATA2</text></annotation><annotation id="12"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="1592" length="5"/><text>GATA1</text></annotation><annotation id="13"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,46988575,46990242</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,46988575,46990242</infon><infon key="gb">unk</infon><location offset="1575" length="15"/><text>enhancer region</text></annotation><annotation id="14"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="1688" length="6"/><text>NBEAL2</text></annotation><annotation id="15"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="1827" length="6"/><text>NBEAL2</text></annotation><annotation id="16"><infon key="identifier">0007686</infon><infon key="type">DISEASE</infon><location offset="93" length="22"/><text>Gray platelet syndrome</text></annotation><annotation id="17"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="344" length="5"/><text>GATA1</text></annotation><annotation id="18"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="561" length="5"/><text>GATA1</text></annotation><annotation id="19"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="681" length="6"/><text>NBEAL2</text></annotation><annotation id="20"><infon key="identifier">14460</infon><infon key="type">GENE</infon><location offset="855" length="5"/><text>Gata1</text></annotation><annotation id="21"><infon key="identifier">0015372</infon><infon key="type">DISEASE</infon><location offset="437" length="21"/><text>macrothrombocytopenia</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1162" length="20"/><text>5 GATA binding sites</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1776" length="19"/><text>GATA1 binding sites</text></annotation><annotation id="24"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr3,46988575,46990242</infon><infon key="type">ENHANCER</infon><infon key="identifier">3,46988575,46990242</infon><infon key="gb">unk</infon><location offset="1814" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">0015372</infon><infon key="type">DISEASE</infon><location offset="262" length="21"/><text>macrothrombocytopenia</text></annotation><annotation id="26"><infon key="identifier">0044903</infon><infon key="type">DISEASE</infon><location offset="288" length="13"/><text>myelofibrosis</text></annotation><annotation id="27"><infon key="identifier">0000132</infon><infon key="type">TISSUE</infon><location offset="495" length="8"/><text>platelet</text></annotation><annotation id="28"><infon key="identifier">0000132</infon><infon key="type">TISSUE</infon><location offset="154" length="9"/><text>platelets</text></annotation><annotation id="29"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="1652" length="10"/><text>K562 cells</text></annotation><annotation id="30"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="1379" length="10"/><text>K562 cells</text></annotation><annotation id="31"><infon key="identifier">0004408</infon><infon key="type">TISSUE</infon><location offset="950" length="16"/><text>CD34+ stem cells</text></annotation><annotation id="32"><infon key="identifier">0000843</infon><infon key="type">TISSUE</infon><location offset="970" length="14"/><text>megakaryocytes</text></annotation><annotation id="33"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="1776" length="5"/><text>GATA1</text></annotation><annotation id="34"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="25" length="5"/><text>GATA1</text></annotation><annotation id="35"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="41" length="6"/><text>NBEAL2</text></annotation><annotation id="36"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="241" length="6"/><text>NBEAL2</text></annotation><annotation id="37"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="466" length="5"/><text>GATA1</text></annotation><annotation id="38"><infon key="identifier">23218</infon><infon key="type">GENE</infon><location offset="546" length="6"/><text>NBEAL2</text></annotation><annotation id="39"><infon key="identifier">2623</infon><infon key="type">GENE</infon><location offset="752" length="5"/><text>GATA1</text></annotation></passage></document>
<document><id>28086087</id><passage><offset>0</offset><text>RNA Binding to CBP Stimulates Histone Acetylation and Transcription. CBP/p300 are transcription co-activators whose binding is a signature of enhancers, cis-regulatory elements that control patterns of gene expression in multicellular organisms. Active enhancers produce bi-directional enhancer RNAs (eRNAs) and display CBP/p300-dependent histone acetylation. Here, we demonstrate that CBP binds directly to RNAs in vivo and in vitro. RNAs bound to CBP in vivo include a large number of eRNAs. Using steady-state histone acetyltransferase (HAT) assays, we show that an RNA binding region in the HAT domain of CBP-a regulatory motif unique to CBP/p300-allows RNA to stimulate CBP's HAT activity. At enhancers where CBP interacts with eRNAs, stimulation manifests in RNA-dependent changes in the histone acetylation mediated by CBP, such as H3K27ac, and by corresponding changes in gene expression. By interacting directly with CBP, eRNAs contribute to the unique chromatin structure at active enhancers, which, in turn, is required for regulation of target genes.</text><annotation id="1"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="646" length="4"/><text>p300</text></annotation><annotation id="2"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="449" length="3"/><text>CBP</text></annotation><annotation id="3"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="642" length="3"/><text>CBP</text></annotation><annotation id="4"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="675" length="3"/><text>CBP</text></annotation><annotation id="5"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="714" length="3"/><text>CBP</text></annotation><annotation id="6"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="826" length="3"/><text>CBP</text></annotation><annotation id="7"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="926" length="3"/><text>CBP</text></annotation><annotation id="8"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="73" length="4"/><text>p300</text></annotation><annotation id="9"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="609" length="3"/><text>CBP</text></annotation><annotation id="10"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="15" length="3"/><text>CBP</text></annotation><annotation id="11"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="69" length="3"/><text>CBP</text></annotation><annotation id="12"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="320" length="3"/><text>CBP</text></annotation><annotation id="13"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="324" length="4"/><text>p300</text></annotation><annotation id="14"><infon key="identifier">1387</infon><infon key="type">GENE</infon><location offset="386" length="3"/><text>CBP</text></annotation></passage></document>
<document><id>28087634</id><passage><offset>0</offset><text>Genome-wide identification of regulatory elements in Sertoli cells. A current goal of molecular biology is to identify transcriptional networks that regulate cell differentiation. However, identifying functional gene regulatory elements has been challenging in the context of developing tissues where material is limited and cell types are mixed. To identify regulatory sites during sex determination, we subjected Sertoli cells from mouse fetal testes to DNaseI-seq and ChIP-seq for H3K27ac. DNaseI-seq identified putative regulatory sites around genes enriched in Sertoli and pregranulosa cells; however, active enhancers marked by H3K27ac were enriched proximal to only Sertoli-enriched genes. Sequence analysis identified putative binding sites of known and novel transcription factors likely controlling Sertoli cell differentiation. As a validation of this approach, we identified a novel Sertoli cell enhancer upstream of Wt1, and used it to drive expression of a transgenic reporter in Sertoli cells. This work furthers our understanding of the complex genetic network that underlies sex determination and identifies regions that potentially harbor non-coding mutations underlying disorders of sexual development.</text><annotation id="1"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="994" length="13"/><text>Sertoli cells</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="578" length="18"/><text>pregranulosa cells</text></annotation><annotation id="3"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="566" length="7"/><text>Sertoli</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="895" length="37"/><text>Sertoli cell enhancer upstream of Wt1</text></annotation><annotation id="5"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="446" length="6"/><text>testes</text></annotation><annotation id="6"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="895" length="12"/><text>Sertoli cell</text></annotation><annotation id="7"><infon key="identifier">7490</infon><infon key="type">GENE</infon><location offset="929" length="3"/><text>Wt1</text></annotation><annotation id="8"><infon key="identifier">0002145</infon><infon key="type">DISEASE</infon><location offset="1189" length="31"/><text>disorders of sexual development</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="434" length="5"/><text>mouse</text></annotation><annotation id="10"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="53" length="13"/><text>Sertoli cells</text></annotation><annotation id="11"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="415" length="13"/><text>Sertoli cells</text></annotation><annotation id="12"><infon key="identifier">0001238</infon><infon key="type">TISSUE</infon><location offset="809" length="12"/><text>Sertoli cell</text></annotation></passage></document>
<document><id>28104492</id><passage><offset>0</offset><text>Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression. High vitamin D status is associated with reduced colon cancer risk but these studies ignore the diversity in the molecular etiology of colon cancer. RAS activating mutations are common in colon cancer and they activate pro-proliferative signaling pathways. We examined the impact of RAS activating mutations on 1,25 dihydroxyvitamin D (1,25(OH)2D)-mediated gene expression in cultured colon and intestinal cell lines. Transient transfection of Caco-2 cells with a constitutively active mutant K-RAS (G12 V) significantly reduced 1,25(OH)2D-induced activity of both a human 25-hydroxyvitamin D, 24 hydroxyase (CYP24A1) promoter-luciferase and an artificial 3X vitamin D response element (VDRE) promoter-luciferase reporter gene. Young Adult Mouse Colon (YAMC) and Rat Intestinal Epithelial (RIE) cell lines with stable expression of mutant H-RAS had suppressed 1,25(OH)2D-mediated induction of CYP24A1 mRNA. The RAS effects were associated with lower Vitamin D receptor (VDR) mRNA and protein levels in YAMC and RIE cells and they could be partially reversed by VDR overexpression. RAS-mediated suppression of VDR levels was not due to either reduced VDR mRNA stability or increased VDR gene methylation. However, chromatin accessibility to the VDR gene at the proximal promoter (-300bp), an enhancer region at -6kb, and an enhancer region located in exon 3 was significantly reduced in RAS transformed YAMC cells (YAMC-RAS). These data show that constitutively active RAS signaling suppresses 1,25(OH)2D-mediated gene transcription in colon epithelial cells by reducing VDR gene transcription but the mechanism for this suppression is not yet known. These data suggest that cancers with RAS-activating mutations may be less responsive to vitamin D mediated treatment or chemoprevention.</text><annotation id="1"><infon key="identifier">1591</infon><infon key="type">GENE</infon><location offset="743" length="34"/><text>25-hydroxyvitamin D, 24 hydroxyase</text></annotation><annotation id="2"><infon key="comment">12,25245350,C,A/G/T</infon><infon key="type">VARIANT</infon><infon key="identifier">12,25245350,C,A/G/T</infon><location offset="670" length="5"/><text>G12 V</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="737" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">1591</infon><infon key="type">GENE</infon><location offset="779" length="7"/><text>CYP24A1</text></annotation><annotation id="5"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="898" length="23"/><text>Young Adult Mouse Colon</text></annotation><annotation id="6"><infon key="identifier">0005937</infon><infon key="type">TISSUE</infon><location offset="933" length="42"/><text>Rat Intestinal Epithelial (RIE) cell lines</text></annotation><annotation id="7"><infon key="identifier">15461</infon><infon key="type">GENE</infon><location offset="1009" length="5"/><text>H-RAS</text></annotation><annotation id="8"><infon key="identifier">13081</infon><infon key="type">GENE</infon><location offset="1063" length="7"/><text>CYP24A1</text></annotation><annotation id="9"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1120" length="18"/><text>Vitamin D receptor</text></annotation><annotation id="10"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1140" length="3"/><text>VDR</text></annotation><annotation id="11"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1231" length="3"/><text>VDR</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1430" length="26"/><text>proximal promoter (-300bp)</text></annotation><annotation id="13"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1279" length="3"/><text>VDR</text></annotation><annotation id="14"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1320" length="3"/><text>VDR</text></annotation><annotation id="15"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1352" length="3"/><text>VDR</text></annotation><annotation id="16"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1414" length="3"/><text>VDR</text></annotation><annotation id="17"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="1740" length="3"/><text>VDR</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1844" length="7"/><text>cancers</text></annotation><annotation id="19"><infon key="identifier">0004297</infon><infon key="type">TISSUE</infon><location offset="1705" length="22"/><text>colon epithelial cells</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="910" length="5"/><text>Mouse</text></annotation><annotation id="21"><infon key="identifier">0005937</infon><infon key="type">TISSUE</infon><location offset="99" length="27"/><text>intestinal epithelial cells</text></annotation><annotation id="22"><infon key="identifier">0000188</infon><infon key="type">TISSUE</infon><location offset="555" length="5"/><text>colon</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1461" length="23"/><text>enhancer region at -6kb</text></annotation><annotation id="24"><infon key="identifier">0000003</infon><infon key="type">TISSUE</infon><location offset="565" length="21"/><text>intestinal cell lines</text></annotation><annotation id="25"><infon key="identifier">0000195</infon><infon key="type">TISSUE</infon><location offset="614" length="12"/><text>Caco-2 cells</text></annotation><annotation id="26"><infon key="identifier">10116</infon><infon key="type">SPECIES</infon><location offset="933" length="3"/><text>Rat</text></annotation><annotation id="27"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="923" length="4"/><text>YAMC</text></annotation><annotation id="28"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="1172" length="4"/><text>YAMC</text></annotation><annotation id="29"><infon key="identifier">0005937</infon><infon key="type">TISSUE</infon><location offset="1181" length="9"/><text>RIE cells</text></annotation><annotation id="30"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="1584" length="4"/><text>YAMC</text></annotation><annotation id="31"><infon key="identifier">0000269</infon><infon key="type">TISSUE</infon><location offset="1572" length="10"/><text>YAMC cells</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1493" length="33"/><text>enhancer region located in exon 3</text></annotation><annotation id="33"><infon key="identifier">22337</infon><infon key="type">GENE</infon><location offset="139" length="18"/><text>vitamin D receptor</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0021063</infon><infon key="type">DISEASE</infon><location offset="219" length="12"/><text>colon cancer</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0021063</infon><infon key="type">DISEASE</infon><location offset="305" length="12"/><text>colon cancer</text></annotation><annotation id="36"><infon key="attribute">CANCER</infon><infon key="identifier">0021063</infon><infon key="type">DISEASE</infon><location offset="358" length="12"/><text>colon cancer</text></annotation><annotation id="37"><infon key="identifier">3845</infon><infon key="type">GENE</infon><location offset="663" length="5"/><text>K-RAS</text></annotation></passage></document>
<document><id>28121289</id><passage><offset>0</offset><text>Mapping cell type-specific transcriptional enhancers using high affinity, lineage-specific Ep300 bioChIP-seq. Understanding the mechanisms that regulate cell type-specific transcriptional programs requires developing a lexicon of their genomic regulatory elements. We developed a lineage-selective method to map transcriptional enhancers, regulatory genomic regions that activate transcription, in mice. Since most tissue-specific enhancers are bound by the transcriptional co-activator Ep300, we used Cre-directed, lineage-specific Ep300 biotinylation and pulldown on immobilized streptavidin followed by next generation sequencing of co-precipitated DNA to identify lineage-specific enhancers. By driving this system with lineage-specific Cre transgenes, we mapped enhancers active in embryonic endothelial cells/blood or skeletal muscle. Analysis of these enhancers identified new transcription factor heterodimer motifs that likely regulate transcription in these lineages. Furthermore, we identified candidate enhancers that regulate adult heart- or lung- specific endothelial cell specialization. Our strategy for tissue-specific protein biotinylation opens new avenues for studying lineage-specific protein-DNA and protein-protein interactions.</text><annotation id="1"><infon key="type">TISSUE</infon><location offset="787" length="27"/><text>embryonic endothelial cells</text></annotation><annotation id="2"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="533" length="5"/><text>Ep300</text></annotation><annotation id="3"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="815" length="5"/><text>blood</text></annotation><annotation id="4"><infon key="identifier">0001103</infon><infon key="type">TISSUE</infon><location offset="824" length="15"/><text>skeletal muscle</text></annotation><annotation id="5"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="1070" length="16"/><text>endothelial cell</text></annotation><annotation id="6"><infon key="identifier">0000562</infon><infon key="type">TISSUE</infon><location offset="1045" length="5"/><text>heart</text></annotation><annotation id="7"><infon key="identifier">0000763</infon><infon key="type">TISSUE</infon><location offset="1055" length="4"/><text>lung</text></annotation><annotation id="8"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="91" length="5"/><text>Ep300</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="398" length="4"/><text>mice</text></annotation><annotation id="10"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="487" length="5"/><text>Ep300</text></annotation></passage></document>
<document><id>28210006</id><passage><offset>0</offset><text>A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers. Lysine-specific demethylase 1 (LSD1) regulates gene expression by affecting histone modifications and is a promising target for acute myeloid leukemia (AML) with specific genetic abnormalities. Novel LSD1 inhibitors, NCD25 and NCD38, inhibited growth of MLL-AF9 leukemia as well as erythroleukemia, megakaryoblastic leukemia and myelodysplastic syndromes (MDSs) overt leukemia cells in the concentration range that normal hematopoiesis was spared. NCD25 and NCD38 invoked the myeloid development programs, hindered the MDS and AML oncogenic programs, and commonly upregulated 62 genes in several leukemia cells. NCD38 elevated H3K27ac level on enhancers of these LSD1 signature genes and newly activated ~500 super-enhancers. Upregulated genes with super-enhancer activation in erythroleukemia cells were enriched in leukocyte differentiation. Eleven genes including GFI1 and ERG, but not CEBPA, were identified as the LSD1 signature with super-enhancer activation. Super-enhancers of these genes were activated prior to induction of the transcripts and myeloid differentiation. Depletion of GFI1 attenuated myeloid differentiation by NCD38. Finally, a single administration of NCD38 causes the in vivo eradication of primary MDS-related leukemia cells with a complex karyotype. Together, NCD38 derepresses super-enhancers of hematopoietic regulators that are silenced abnormally by LSD1, attenuates leukemogenic programs and consequently exerts anti-leukemic effect against MDS-related leukemia with adverse outcome.</text><annotation id="1"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="150" length="29"/><text>Lysine-specific demethylase 1</text></annotation><annotation id="2"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="181" length="4"/><text>LSD1</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="278" length="22"/><text>acute myeloid leukemia</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="302" length="3"/><text>AML</text></annotation><annotation id="5"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="350" length="4"/><text>LSD1</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="404" length="16"/><text>MLL-AF9 leukemia</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0017858</infon><infon key="type">DISEASE</infon><location offset="432" length="15"/><text>erythroleukemia</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0018872</infon><infon key="type">DISEASE</infon><location offset="449" length="25"/><text>megakaryoblastic leukemia</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0018881</infon><infon key="type">DISEASE</infon><location offset="479" length="25"/><text>myelodysplastic syndromes</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0018881</infon><infon key="type">DISEASE</infon><location offset="506" length="4"/><text>MDSs</text></annotation><annotation id="11"><infon key="identifier">0018881</infon><infon key="type">DISEASE</infon><location offset="41" length="3"/><text>MDS</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="518" length="14"/><text>leukemia cells</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0018881</infon><infon key="type">DISEASE</infon><location offset="669" length="3"/><text>MDS</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="677" length="3"/><text>AML</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="746" length="14"/><text>leukemia cells</text></annotation><annotation id="16"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="813" length="4"/><text>LSD1</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0000426</infon><infon key="type">TISSUE</infon><location offset="928" length="21"/><text>erythroleukemia cells</text></annotation><annotation id="18"><infon key="identifier">2672</infon><infon key="type">GENE</infon><location offset="1017" length="4"/><text>GFI1</text></annotation><annotation id="19"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1026" length="3"/><text>ERG</text></annotation><annotation id="20"><infon key="identifier">1050</infon><infon key="type">GENE</infon><location offset="1039" length="5"/><text>CEBPA</text></annotation><annotation id="21"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="1069" length="4"/><text>LSD1</text></annotation><annotation id="22"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="53" length="8"/><text>leukemia</text></annotation><annotation id="23"><infon key="identifier">2672</infon><infon key="type">GENE</infon><location offset="1242" length="4"/><text>GFI1</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1376" length="26"/><text>MDS-related leukemia cells</text></annotation><annotation id="25"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="1533" length="4"/><text>LSD1</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0018881</infon><infon key="type">DISEASE</infon><location offset="1625" length="3"/><text>MDS</text></annotation><annotation id="27"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="626" length="7"/><text>myeloid</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="967" length="9"/><text>leukocyte</text></annotation><annotation id="29"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="1204" length="7"/><text>myeloid</text></annotation><annotation id="30"><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1637" length="8"/><text>leukemia</text></annotation><annotation id="31"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="1258" length="7"/><text>myeloid</text></annotation><annotation id="32"><infon key="type">TISSUE</infon><location offset="1476" length="13"/><text>hematopoietic</text></annotation><annotation id="33"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="8" length="4"/><text>LSD1</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="100" length="8"/><text>leukemia</text></annotation></passage></document>
<document><id>28213503</id><passage><offset>0</offset><text>Inhibition of Inflammatory Gene Transcription by IL-10 Is Associated with Rapid Suppression of Lipopolysaccharide-Induced Enhancer Activation. IL-10 limits the magnitude of inflammatory gene expression following microbial stimuli and is essential to prevent inflammatory disease; however, the molecular basis for IL-10-mediated inhibition remains elusive. Using a genome-wide approach, we demonstrate that inhibition of transcription is the primary mechanism for IL-10-mediated suppression in LPS-stimulated macrophages and that inhibited genes can be divided into two clusters. Genes in the first cluster are inhibited only if IL-10 is included early in the course of LPS stimulation and is strongly enriched for IFN-inducible genes. Genes in the second cluster can be rapidly suppressed by IL-10 even after transcription is initiated, and this is associated with suppression of LPS-induced enhancer activation. Interestingly, the ability of IL-10 to rapidly suppress active transcription exhibits a delay following LPS stimulation. Thus, a key pathway for IL-10-mediated suppression involves rapid inhibition of enhancer function during the secondary phase of the response to LPS.</text><annotation id="1"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="943" length="5"/><text>IL-10</text></annotation><annotation id="2"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="1058" length="5"/><text>IL-10</text></annotation><annotation id="3"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="493" length="26"/><text>LPS-stimulated macrophages</text></annotation><annotation id="4"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="49" length="5"/><text>IL-10</text></annotation><annotation id="5"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="143" length="5"/><text>IL-10</text></annotation><annotation id="6"><infon key="identifier">0021166</infon><infon key="type">DISEASE</infon><location offset="258" length="20"/><text>inflammatory disease</text></annotation><annotation id="7"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="313" length="5"/><text>IL-10</text></annotation><annotation id="8"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="463" length="5"/><text>IL-10</text></annotation><annotation id="9"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="628" length="5"/><text>IL-10</text></annotation><annotation id="10"><infon key="identifier">3586</infon><infon key="type">GENE</infon><location offset="792" length="5"/><text>IL-10</text></annotation></passage></document>
<document><id>28244015</id><passage><offset>0</offset><text>Bisphenol A Induces Sox2 in ER+ Breast Cancer Stem-Like Cells. Bisphenol A (BPA) is an endocrine disrupting compound used in food and beverage plastic containers and has been shown to increase breast cancer cellular proliferation. However, the concentrations of BPA used in these experiments are far higher than the physiological levels of BPA detected in the human body. We observed in vitro that exposure of MCF-7 cells to physiological concentrations of BPA failed to increase cell proliferation or to induce canonical estrogen-responsive genes (pS2 and progesterone receptor (PR)), in contrast to 17beta-estradiol (E2) treatment. However, MCF-7 cells treated with 10 nM BPA induced ALDH1 expression, a marker of human mammary stem cells. When treated with 10 nM BPA, mammospheres derived either from MCF-7 cells, a patient-derived xenograft, or the normal mouse mammary gland exhibited increased size; however, these effects were not observed in MDA-MB-231 mammospheres. Mechanistically, BPA induced SOX2 mRNA and protein in MCF-7 mammospheres, resulting from enhanced CREB phosphorylation, and subsequent binding of pCREB to a SOX2 downstream enhancer. These findings suggest that physiological levels of BPA increase estrogen receptor-positive breast cancer tumor maintenance through enhanced cancer stem-like cell activity via direct regulation of SOX2 transcription.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1132" length="24"/><text>SOX2 downstream enhancer</text></annotation><annotation id="2"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="20" length="4"/><text>Sox2</text></annotation><annotation id="3"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="1029" length="5"/><text>MCF-7</text></annotation><annotation id="4"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1004" length="4"/><text>SOX2</text></annotation><annotation id="5"><infon key="identifier">1385</infon><infon key="type">GENE</infon><location offset="1073" length="4"/><text>CREB</text></annotation><annotation id="6"><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="1299" length="21"/><text>cancer stem-like cell</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0006512</infon><infon key="type">DISEASE</infon><location offset="1223" length="40"/><text>estrogen receptor-positive breast cancer</text></annotation><annotation id="8"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="716" length="5"/><text>human</text></annotation><annotation id="9"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1355" length="4"/><text>SOX2</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="860" length="5"/><text>mouse</text></annotation><annotation id="11"><infon key="identifier">0006293</infon><infon key="type">TISSUE</infon><location offset="32" length="29"/><text>Breast Cancer Stem-Like Cells</text></annotation><annotation id="12"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="643" length="11"/><text>MCF-7 cells</text></annotation><annotation id="13"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="410" length="11"/><text>MCF-7 cells</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="722" length="18"/><text>mammary stem cells</text></annotation><annotation id="15"><infon key="identifier">0000817</infon><infon key="type">TISSUE</infon><location offset="866" length="13"/><text>mammary gland</text></annotation><annotation id="16"><infon key="identifier">0000815</infon><infon key="type">TISSUE</infon><location offset="950" length="10"/><text>MDA-MB-231</text></annotation><annotation id="17"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1264" length="5"/><text>tumor</text></annotation><annotation id="18"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1132" length="4"/><text>SOX2</text></annotation><annotation id="19"><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="193" length="13"/><text>breast cancer</text></annotation><annotation id="20"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="360" length="5"/><text>human</text></annotation><annotation id="21"><infon key="identifier">7031</infon><infon key="type">GENE</infon><location offset="549" length="3"/><text>pS2</text></annotation><annotation id="22"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="557" length="21"/><text>progesterone receptor</text></annotation><annotation id="23"><infon key="identifier">5241</infon><infon key="type">GENE</infon><location offset="580" length="2"/><text>PR</text></annotation><annotation id="24"><infon key="identifier">216</infon><infon key="type">GENE</infon><location offset="686" length="5"/><text>ALDH1</text></annotation><annotation id="25"><infon key="identifier">0000093</infon><infon key="type">TISSUE</infon><location offset="804" length="11"/><text>MCF-7 cells</text></annotation></passage></document>
<document><id>28260788</id><passage><offset>0</offset><text>APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL. Oncogenic driver mutations are those that provide a proliferative or survival advantage to neoplastic cells, resulting in clonal selection. Although most cancer-causing mutations have been detected in the protein-coding regions of the cancer genome; driver mutations have recently also been discovered within noncoding genomic sequences. Thus, a current challenge is to gain precise understanding of how these unique genomic elements function in cancer pathogenesis, while clarifying mechanisms of gene regulation and identifying new targets for therapeutic intervention. Here we report a C-to-T single nucleotide transition that occurs as a somatic mutation in noncoding sequences 4 kb upstream of the transcriptional start site of the LMO1 oncogene in primary samples from patients with T-cell acute lymphoblastic leukaemia. This single nucleotide alteration conforms to an APOBEC-like cytidine deaminase mutational signature, and generates a new binding site for the MYB transcription factor, leading to the formation of an aberrant transcriptional enhancer complex that drives high levels of expression of the LMO1 oncogene. Since APOBEC-signature mutations are common in a broad spectrum of human cancers, we suggest that noncoding nucleotide transitions such as the one described here may activate potent oncogenic enhancers not only in T-lymphoid cells but in other cell lineages as well.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr11,8240851,8242851</infon><infon key="type">ENHANCER</infon><infon key="identifier">11,8240851,8242851</infon><infon key="gb">unk</infon><location offset="39" length="18"/><text>oncogenic enhancer</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr11,8240851,8242851</infon><infon key="type">ENHANCER</infon><infon key="identifier">11,8240851,8242851</infon><infon key="gb">unk</infon><location offset="1132" length="32"/><text>transcriptional enhancer complex</text></annotation><annotation id="3"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="1210" length="4"/><text>LMO1</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1292" length="5"/><text>human</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1298" length="7"/><text>cancers</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1045" length="45"/><text>binding site for the MYB transcription factor</text></annotation><annotation id="7"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1439" length="16"/><text>T-lymphoid cells</text></annotation><annotation id="8"><infon key="type">TISSUE</infon><location offset="187" length="16"/><text>neoplastic cells</text></annotation><annotation id="9"><infon key="identifier">4602</infon><infon key="type">GENE</infon><location offset="1066" length="3"/><text>MYB</text></annotation><annotation id="10"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="70" length="4"/><text>LMO1</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="89" length="5"/><text>T-ALL</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="250" length="6"/><text>cancer</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="331" length="6"/><text>cancer</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="542" length="6"/><text>cancer</text></annotation><annotation id="15"><infon key="identifier">4004</infon><infon key="type">GENE</infon><location offset="833" length="4"/><text>LMO1</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="885" length="36"/><text>T-cell acute lymphoblastic leukaemia</text></annotation><annotation id="17"><infon key="identifier">978</infon><infon key="type">GENE</infon><location offset="984" length="18"/><text>cytidine deaminase</text></annotation></passage></document>
<document><id>28262751</id><passage><offset>0</offset><text>The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Genes encoding subunits of SWI/SNF (BAF) chromatin remodelling complexes are collectively altered in over 20% of human malignancies, but the mechanisms by which these complexes alter chromatin to modulate transcription and cell fate are poorly understood. Utilizing mouse embryonic fibroblast and cancer cell line models, here we show via ChIP-seq and biochemical assays that SWI/SNF complexes are preferentially targeted to distal lineage specific enhancers and interact with p300 to modulate histone H3 lysine 27 acetylation. We identify a greater requirement for SWI/SNF at typical enhancers than at most super-enhancers and at enhancers in untranscribed regions than in transcribed regions. Our data further demonstrate that SWI/SNF-dependent distal enhancers are essential for controlling expression of genes linked to developmental processes. Our findings thus establish SWI/SNF complexes as regulators of the enhancer landscape and provide insight into the roles of SWI/SNF in cellular fate control.</text><annotation id="1"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="383" length="10"/><text>fibroblast</text></annotation><annotation id="2"><infon key="type">TISSUE</infon><location offset="398" length="16"/><text>cancer cell line</text></annotation><annotation id="3"><infon key="identifier">328572</infon><infon key="type">GENE</infon><location offset="578" length="4"/><text>p300</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="367" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">8815</infon><infon key="type">GENE</infon><location offset="137" length="3"/><text>BAF</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="214" length="5"/><text>human</text></annotation></passage></document>
<document><id>28262837</id><passage><offset>0</offset><text>Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression. Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers in the world. Elevated glucose metabolism in the availability of oxygen, a phenomenon called the Warburg effect, is important for cancer cell growth. Fructose-1,6-bisphosphatase (FBP1) is a rate-limiting enzyme in gluconeogenesis and is frequently lost in various types of cancer. Here, we demonstrated that expression of FBP1 was downregulated in HCC patient specimens and decreased expression of FBP1 associated with poor prognosis. Low expression of FBP1 correlated with high levels of histone deacetylase 1 (HDAC1) and HDAC2 proteins in HCC patient tissues. Treatment of HCC cells with HDAC inhibitors or knockdown of HDAC1 and/or HDAC2 restored FBP1 expression and inhibited HCC cell growth. HDAC-mediated suppression of FBP1 expression correlated with decreased histone H3 lysine 27 acetylation (H3K27Ac) in the FBP1 enhancer. Restored expression of FBP1 decreased glucose reduction and lactate secretion and inhibited HCC cell growth in vitro and tumor growth in mice. Our data reveal that loss of FBP1 due to histone deacetylation associates with poor prognosis of HCC and restored FBP1 expression by HDAC inhibitors suppresses HCC growth. Our findings suggest that repression of FBP1 by HDACs has important implications for HCC prognosis and treatment.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1023" length="13"/><text>FBP1 enhancer</text></annotation><annotation id="2"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="66" length="24"/><text>hepatocellular carcinoma</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="553" length="3"/><text>HCC</text></annotation><annotation id="4"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="603" length="4"/><text>FBP1</text></annotation><annotation id="5"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="658" length="4"/><text>FBP1</text></annotation><annotation id="6"><infon key="identifier">3065</infon><infon key="type">GENE</infon><location offset="694" length="21"/><text>histone deacetylase 1</text></annotation><annotation id="7"><infon key="identifier">3065</infon><infon key="type">GENE</infon><location offset="717" length="5"/><text>HDAC1</text></annotation><annotation id="8"><infon key="identifier">3066</infon><infon key="type">GENE</infon><location offset="728" length="5"/><text>HDAC2</text></annotation><annotation id="9"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="746" length="3"/><text>HCC</text></annotation><annotation id="10"><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="885" length="8"/><text>HCC cell</text></annotation><annotation id="11"><infon key="identifier">3065</infon><infon key="type">GENE</infon><location offset="827" length="5"/><text>HDAC1</text></annotation><annotation id="12"><infon key="identifier">3066</infon><infon key="type">GENE</infon><location offset="840" length="5"/><text>HDAC2</text></annotation><annotation id="13"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="111" length="4"/><text>FBP1</text></annotation><annotation id="14"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="855" length="4"/><text>FBP1</text></annotation><annotation id="15"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="1061" length="4"/><text>FBP1</text></annotation><annotation id="16"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="931" length="4"/><text>FBP1</text></annotation><annotation id="17"><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="1130" length="8"/><text>HCC cell</text></annotation><annotation id="18"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="1023" length="4"/><text>FBP1</text></annotation><annotation id="19"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1159" length="5"/><text>tumor</text></annotation><annotation id="20"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1175" length="4"/><text>mice</text></annotation><annotation id="21"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="1210" length="4"/><text>FBP1</text></annotation><annotation id="22"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1278" length="3"/><text>HCC</text></annotation><annotation id="23"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="1295" length="4"/><text>FBP1</text></annotation><annotation id="24"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="128" length="24"/><text>Hepatocellular carcinoma</text></annotation><annotation id="25"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1341" length="3"/><text>HCC</text></annotation><annotation id="26"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="1393" length="4"/><text>FBP1</text></annotation><annotation id="27"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1438" length="3"/><text>HCC</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="335" length="11"/><text>cancer cell</text></annotation><annotation id="29"><infon key="identifier">0000608</infon><infon key="type">TISSUE</infon><location offset="780" length="9"/><text>HCC cells</text></annotation><annotation id="30"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="154" length="3"/><text>HCC</text></annotation><annotation id="31"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="197" length="7"/><text>cancers</text></annotation><annotation id="32"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="355" length="27"/><text>Fructose-1,6-bisphosphatase</text></annotation><annotation id="33"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="384" length="4"/><text>FBP1</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="478" length="6"/><text>cancer</text></annotation><annotation id="35"><infon key="identifier">2203</infon><infon key="type">GENE</infon><location offset="527" length="4"/><text>FBP1</text></annotation></passage></document>
<document><id>28335007</id><passage><offset>0</offset><text>A class of circadian long non-coding RNAs mark enhancers modulating long-range circadian gene regulation. Circadian rhythm exerts its influence on animal physiology and behavior by regulating gene expression at various levels. Here we systematically explored circadian long non-coding RNAs (lncRNAs) in mouse liver and examined their circadian regulation. We found that a significant proportion of circadian lncRNAs are expressed at enhancer regions, mostly bound by two key circadian transcription factors, BMAL1 and REV-ERBalpha. These circadian lncRNAs showed similar circadian phases with their nearby genes. The extent of their nuclear localization is higher than protein coding genes but less than enhancer RNAs. The association between enhancer and circadian lncRNAs is also observed in tissues other than liver. Comparative analysis between mouse and rat circadian liver transcriptomes showed that circadian transcription at lncRNA loci tends to be conserved despite of low sequence conservation of lncRNAs. One such circadian lncRNA termed lnc-Crot led us to identify a super-enhancer region interacting with a cluster of genes involved in circadian regulation of metabolism through long-range interactions. Further experiments showed that lnc-Crot locus has enhancer function independent of lnc-Crot's transcription. Our results suggest that the enhancer-associated circadian lncRNAs mark the genomic loci modulating long-range circadian gene regulation and shed new lights on the evolutionary origin of lncRNAs.</text><annotation id="1"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="813" length="5"/><text>liver</text></annotation><annotation id="2"><infon key="identifier">10116</infon><infon key="type">SPECIES</infon><location offset="859" length="3"/><text>rat</text></annotation><annotation id="3"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="309" length="5"/><text>liver</text></annotation><annotation id="4"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="873" length="5"/><text>liver</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="303" length="5"/><text>mouse</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="849" length="5"/><text>mouse</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1249" length="36"/><text>lnc-Crot locus has enhancer function</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1079" length="21"/><text>super-enhancer region</text></annotation><annotation id="9"><infon key="identifier">11865</infon><infon key="type">GENE</infon><location offset="508" length="5"/><text>BMAL1</text></annotation><annotation id="10"><infon key="identifier">217166</infon><infon key="type">GENE</infon><location offset="518" length="12"/><text>REV-ERBalpha</text></annotation></passage></document>
<document><id>28446439</id><passage><offset>0</offset><text>PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Alveolar rhabdomyosarcoma is a life-threatening myogenic cancer of children and adolescent young adults, driven primarily by the chimeric transcription factor PAX3-FOXO1. The mechanisms by which PAX3-FOXO1 dysregulates chromatin are unknown. We find PAX3-FOXO1 reprograms the cis-regulatory landscape by inducing de novo super enhancers. PAX3-FOXO1 uses super enhancers to set up autoregulatory loops in collaboration with the master transcription factors MYOG, MYOD, and MYCN. This myogenic super enhancer circuitry is consistent across cell lines and primary tumors. Cells harboring the fusion gene are selectively sensitive to small-molecule inhibition of protein targets induced by, or bound to, PAX3-FOXO1-occupied super enhancers. Furthermore, PAX3-FOXO1 recruits and requires the BET bromodomain protein BRD4 to function at super enhancers, resulting in a complete dependence on BRD4 and a significant susceptibility to BRD inhibition. These results yield insights into the epigenetic functions of PAX3-FOXO1 and reveal a specific vulnerability that can be exploited for precision therapy.Significance: PAX3-FOXO1 drives pediatric fusion-positive rhabdomyosarcoma, and its chromatin-level functions are critical to understanding its oncogenic activity. We find that PAX3-FOXO1 establishes a myoblastic super enhancer landscape and creates a profound subtype-unique dependence on BET bromodomains, the inhibition of which ablates PAX3-FOXO1 function, providing a mechanistic rationale for exploring BET inhibitors for patients bearing PAX-fusion rhabdomyosarcoma. Cancer Discov; 7(8); 884-99.  2017 AACR.This article is highlighted in the In This Issue feature, p. 783.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="791" length="35"/><text>PAX3-FOXO1-occupied super enhancers</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0009994</infon><infon key="type">DISEASE</infon><location offset="91" length="25"/><text>Alveolar rhabdomyosarcoma</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0018078</infon><infon key="type">DISEASE</infon><location offset="139" length="15"/><text>myogenic cancer</text></annotation><annotation id="4"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="250" length="4"/><text>PAX3</text></annotation><annotation id="5"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="255" length="5"/><text>FOXO1</text></annotation><annotation id="6"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="286" length="4"/><text>PAX3</text></annotation><annotation id="7"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="291" length="5"/><text>FOXO1</text></annotation><annotation id="8"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="341" length="4"/><text>PAX3</text></annotation><annotation id="9"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="346" length="5"/><text>FOXO1</text></annotation><annotation id="10"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="429" length="4"/><text>PAX3</text></annotation><annotation id="11"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="791" length="4"/><text>PAX3</text></annotation><annotation id="12"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="434" length="5"/><text>FOXO1</text></annotation><annotation id="13"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="547" length="4"/><text>MYOG</text></annotation><annotation id="14"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="553" length="4"/><text>MYOD</text></annotation><annotation id="15"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="563" length="4"/><text>MYCN</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="652" length="6"/><text>tumors</text></annotation><annotation id="17"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="841" length="4"/><text>PAX3</text></annotation><annotation id="18"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="846" length="5"/><text>FOXO1</text></annotation><annotation id="19"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="796" length="5"/><text>FOXO1</text></annotation><annotation id="20"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="902" length="4"/><text>BRD4</text></annotation><annotation id="21"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="977" length="4"/><text>BRD4</text></annotation><annotation id="22"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1096" length="4"/><text>PAX3</text></annotation><annotation id="23"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1101" length="5"/><text>FOXO1</text></annotation><annotation id="24"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1201" length="4"/><text>PAX3</text></annotation><annotation id="25"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1206" length="5"/><text>FOXO1</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0005212</infon><infon key="type">DISEASE</infon><location offset="1245" length="16"/><text>rhabdomyosarcoma</text></annotation><annotation id="27"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1364" length="4"/><text>PAX3</text></annotation><annotation id="28"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1369" length="5"/><text>FOXO1</text></annotation><annotation id="29"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="1527" length="4"/><text>PAX3</text></annotation><annotation id="30"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1532" length="5"/><text>FOXO1</text></annotation><annotation id="31"><infon key="attribute">CANCER</infon><infon key="identifier">0005212</infon><infon key="type">DISEASE</infon><location offset="1643" length="16"/><text>rhabdomyosarcoma</text></annotation><annotation id="32"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1661" length="6"/><text>Cancer</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1389" length="35"/><text>myoblastic super enhancer landscape</text></annotation><annotation id="34"><infon key="identifier">5077</infon><infon key="type">GENE</infon><location offset="0" length="4"/><text>PAX3</text></annotation><annotation id="35"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="5" length="5"/><text>FOXO1</text></annotation></passage></document>
<document><id>28536097</id><passage><offset>0</offset><text>Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network. The transcriptional pathways activated downstream of vascular endothelial growth factor (VEGF) signaling during angiogenesis remain incompletely characterized. By assessing the signals responsible for induction of the Notch ligand delta-like 4 (DLL4) in endothelial cells, we find that activation of the MAPK/ERK pathway mirrors the rapid and dynamic induction of DLL4 transcription and that this pathway is required for DLL4 expression. Furthermore, VEGF/ERK signaling induces phosphorylation and activation of the ETS transcription factor ERG, a prerequisite for DLL4 induction. Transcription of DLL4 coincides with dynamic ERG-dependent recruitment of the transcriptional co-activator p300. Genome-wide gene expression profiling identified a network of VEGF-responsive and ERG-dependent genes, and ERG chromatin immunoprecipitation (ChIP)-seq revealed the presence of conserved ERG-bound putative enhancer elements near these target genes. Functional experiments performed in vitro and in vivo confirm that this network of genes requires ERK, ERG and p300 activity. Finally, genome-editing and transgenic approaches demonstrate that a highly conserved ERG-bound enhancer located upstream of HLX (which encodes a transcription factor implicated in sprouting angiogenesis) is required for its VEGF-mediated induction. Collectively, these findings elucidate a novel transcriptional pathway contributing to VEGF-dependent angiogenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1242" length="42"/><text>ERG-bound enhancer located upstream of HLX</text></annotation><annotation id="2"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="1493" length="4"/><text>VEGF</text></annotation><annotation id="3"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="451" length="4"/><text>DLL4</text></annotation><annotation id="4"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="508" length="4"/><text>DLL4</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="968" length="60"/><text>ERG-bound putative enhancer elements near these target genes</text></annotation><annotation id="6"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="22" length="4"/><text>VEGF</text></annotation><annotation id="7"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="628" length="3"/><text>ERG</text></annotation><annotation id="8"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="652" length="4"/><text>DLL4</text></annotation><annotation id="9"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="685" length="4"/><text>DLL4</text></annotation><annotation id="10"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="713" length="3"/><text>ERG</text></annotation><annotation id="11"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="775" length="4"/><text>p300</text></annotation><annotation id="12"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="140" length="34"/><text>vascular endothelial growth factor</text></annotation><annotation id="13"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="396" length="3"/><text>ERK</text></annotation><annotation id="14"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="863" length="3"/><text>ERG</text></annotation><annotation id="15"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="888" length="3"/><text>ERG</text></annotation><annotation id="16"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="543" length="3"/><text>ERK</text></annotation><annotation id="17"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="1128" length="3"/><text>ERK</text></annotation><annotation id="18"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1133" length="3"/><text>ERG</text></annotation><annotation id="19"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1141" length="4"/><text>p300</text></annotation><annotation id="20"><infon key="identifier">2048</infon><infon key="type">GENE</infon><location offset="49" length="3"/><text>ERK</text></annotation><annotation id="21"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="968" length="3"/><text>ERG</text></annotation><annotation id="22"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1242" length="3"/><text>ERG</text></annotation><annotation id="23"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="176" length="4"/><text>VEGF</text></annotation><annotation id="24"><infon key="identifier">3142</infon><infon key="type">GENE</infon><location offset="1281" length="3"/><text>HLX</text></annotation><annotation id="25"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="305" length="25"/><text>Notch ligand delta-like 4</text></annotation><annotation id="26"><infon key="identifier">0001176</infon><infon key="type">TISSUE</infon><location offset="341" length="17"/><text>endothelial cells</text></annotation><annotation id="27"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="53" length="3"/><text>ERG</text></annotation><annotation id="28"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="57" length="4"/><text>p300</text></annotation><annotation id="29"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="538" length="4"/><text>VEGF</text></annotation><annotation id="30"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="843" length="4"/><text>VEGF</text></annotation><annotation id="31"><infon key="identifier">54567</infon><infon key="type">GENE</infon><location offset="332" length="4"/><text>DLL4</text></annotation><annotation id="32"><infon key="identifier">7422</infon><infon key="type">GENE</infon><location offset="1381" length="4"/><text>VEGF</text></annotation></passage></document>
<document><id>28578223</id><passage><offset>0</offset><text>SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs. The SERPINB2 gene is strongly upregulated in inflammatory states. In monocytes, it can constitute up to 1% of total cellular protein. It functions in protection from proteotoxic stress and plays a role in angioedema. The purpose of this study was to define the roles of enhancer RNAs embedded in the SERPIN gene complex. We found that the upstream enhancer RNAs upregulated SERPINB2 and the enhancer RNAs were expressed prior to those of SERPINB2 mRNA. Studies of the SERPINB2 promoter demonstrated the presence of an RNA polymerase II pause-inducing protein, NELF. Stimulation with LPS led to recruitment of the pause-releasing kinase P-TEFb and departure of the pause-inducing protein NELF. RNA immunoprecipitation revealed that NELF and the CDK9 component of P-TEFb bound to the enhancer RNAs after stimulation with distinct kinetics. Knock-down of the enhancer RNAs compromised stimulus induction of promoter and enhancer chromatin changes. Conversely, over-expression was associated with enhanced recruitment of c-JUN and increased expression of SERPINB2 mRNA expression. This study is the first to associate enhancer RNAs with SERPINB2 and is the first demonstration of acquisition of NELF binding by enhancer RNAs on chromatin.</text><annotation id="1"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="561" length="8"/><text>SERPINB2</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="1300" length="13"/><text>enhancer RNAs</text></annotation><annotation id="3"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="0" length="8"/><text>SERPINB2</text></annotation><annotation id="4"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="97" length="8"/><text>SERPINB2</text></annotation><annotation id="5"><infon key="identifier">0010481</infon><infon key="type">DISEASE</infon><location offset="298" length="10"/><text>angioedema</text></annotation><annotation id="6"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="467" length="8"/><text>SERPINB2</text></annotation><annotation id="7"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="531" length="8"/><text>SERPINB2</text></annotation><annotation id="8"><infon key="identifier">26012</infon><infon key="type">GENE</infon><location offset="653" length="4"/><text>NELF</text></annotation><annotation id="9"><infon key="identifier">26012</infon><infon key="type">GENE</infon><location offset="780" length="4"/><text>NELF</text></annotation><annotation id="10"><infon key="identifier">26012</infon><infon key="type">GENE</infon><location offset="824" length="4"/><text>NELF</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="484" length="13"/><text>enhancer RNAs</text></annotation><annotation id="12"><infon key="identifier">1025</infon><infon key="type">GENE</infon><location offset="837" length="4"/><text>CDK9</text></annotation><annotation id="13"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1110" length="5"/><text>c-JUN</text></annotation><annotation id="14"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="1144" length="8"/><text>SERPINB2</text></annotation><annotation id="15"><infon key="identifier">5055</infon><infon key="type">GENE</infon><location offset="1226" length="8"/><text>SERPINB2</text></annotation><annotation id="16"><infon key="identifier">26012</infon><infon key="type">GENE</infon><location offset="1284" length="4"/><text>NELF</text></annotation><annotation id="17"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="162" length="9"/><text>monocytes</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="432" length="22"/><text>upstream enhancer RNAs</text></annotation><annotation id="19"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="561" length="17"/><text>SERPINB2 promoter</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="875" length="13"/><text>enhancer RNAs</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="949" length="13"/><text>enhancer RNAs</text></annotation><annotation id="22"><infon key="attribute">RNA,INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="363" length="49"/><text>enhancer RNAs embedded in the SERPIN gene complex</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT,RNA</infon><infon key="type">ENHANCER</infon><location offset="1207" length="13"/><text>enhancer RNAs</text></annotation></passage></document>
<document><id>28614915</id><passage><offset>0</offset><text>Identification of an Enhancer Critical for the ephirn-A5 Gene Expression in the Posterior Region of the Mesencephalon. Ephrin-A5 has been implicated in the regulation of brain morphogenesis and axon pathfinding. In this study, we used bacterial homologous recombination to express a LacZ reporter in various ephrin-A5 BAC clones to identify elements that regulate ephrin-A5 gene expression during mesencephalon development. We found that there is mesencephalon-specific enhancer activity localized to a specific +25.0 kb to +30.5 kb genomic region in the first intron of ephrin-A5. Further comparative genomic analysis indicated that two evolutionary conserved regions, ECR1 and ECR2, were present within this 5.5 kb region. Deletion of ECR1 from the enhancer resulted in disrupted mesencephalon-specific enhancer activity in transgenic embryos. We also found a consensus binding site for basic helix-loop-helix (bHLH) transcription factors (TFs) in a highly conserved region at the 3'-end of ECR1. We further demonstrated that specific deletion of the bHLH TF binding site abrogated the mesencephalon-specific enhancer activity in transgenic embryos. Finally, both electrophoretic mobility shift assay and luciferase-based transactivation assay revealed that the transcription factor Ascl1 bound the bHLH consensus binding site in the mesencephalon-specific ephrin-A5 enhancer in vitro. Together, these results suggest that the bHLH TF binding site in ECR1 is involved in the positive regulation of ephrin-A5 gene expression during the development of the mesencephalon.</text><annotation id="1"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="837" length="7"/><text>embryos</text></annotation><annotation id="2"><infon key="identifier">429</infon><infon key="type">GENE</infon><location offset="1285" length="5"/><text>Ascl1</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="862" length="56"/><text>consensus binding site for basic helix-loop-helix (bHLH)</text></annotation><annotation id="4"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="1500" length="9"/><text>ephrin-A5</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1301" length="27"/><text>bHLH consensus binding site</text></annotation><annotation id="6"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="21" length="8"/><text>Enhancer</text></annotation><annotation id="7"><infon key="attribute">TYPO</infon><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="47" length="9"/><text>ephirn-A5</text></annotation><annotation id="8"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="104" length="13"/><text>Mesencephalon</text></annotation><annotation id="9"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="170" length="5"/><text>brain</text></annotation><annotation id="10"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="447" length="13"/><text>mesencephalon</text></annotation><annotation id="11"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="571" length="9"/><text>ephrin-A5</text></annotation><annotation id="12"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="751" length="8"/><text>enhancer</text></annotation><annotation id="13"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="397" length="13"/><text>mesencephalon</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1053" length="20"/><text>bHLH TF binding site</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1429" length="20"/><text>bHLH TF binding site</text></annotation><annotation id="16"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="1556" length="13"/><text>mesencephalon</text></annotation><annotation id="17"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="447" length="133"/><text>mesencephalon-specific enhancer activity localized to a specific +25.0 kb to +30.5 kb genomic region in the first intron of ephrin-A5</text></annotation><annotation id="18"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="782" length="13"/><text>mesencephalon</text></annotation><annotation id="19"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="1088" length="13"/><text>mesencephalon</text></annotation><annotation id="20"><infon key="identifier">0000138</infon><infon key="type">TISSUE</infon><location offset="1336" length="13"/><text>mesencephalon</text></annotation><annotation id="21"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="1359" length="9"/><text>ephrin-A5</text></annotation><annotation id="22"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="782" length="31"/><text>mesencephalon-specific enhancer</text></annotation><annotation id="23"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="1088" length="31"/><text>mesencephalon-specific enhancer</text></annotation><annotation id="24"><infon key="attribute">SUFFICIENT</infon><infon key="comment">17,63158922,63161934</infon><infon key="type">ENHANCER</infon><infon key="identifier">17,63158922,63161934</infon><infon key="gb">unk</infon><location offset="1336" length="41"/><text>mesencephalon-specific ephrin-A5 enhancer</text></annotation><annotation id="25"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="119" length="9"/><text>Ephrin-A5</text></annotation><annotation id="26"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="308" length="9"/><text>ephrin-A5</text></annotation><annotation id="27"><infon key="identifier">1946</infon><infon key="type">GENE</infon><location offset="364" length="9"/><text>ephrin-A5</text></annotation><annotation id="28"><infon key="identifier">0000379</infon><infon key="type">TISSUE</infon><location offset="1143" length="7"/><text>embryos</text></annotation></passage></document>
<document><id>28637769</id><passage><offset>0</offset><text>Potential contribution of tandem circadian enhancers to nonlinear oscillations in clock gene expression. Limit-cycle oscillations require the presence of nonlinear processes. Although mathematical studies have long suggested that multiple nonlinear processes are required for autonomous circadian oscillation in clock gene expression, the underlying mechanism remains controversial. Here we show experimentally that cell-autonomous circadian transcription of a mammalian clock gene requires a functionally interdependent tandem E-box motif; the lack of either of the two E-boxes results in arrhythmic transcription. Although previous studies indicated the role of the tandem motifs in increasing circadian amplitude, enhancing amplitude does not explain the mechanism for limit-cycle oscillations in transcription. In this study, mathematical analysis suggests that the interdependent behavior of enhancer elements including not only E-boxes but also ROR response elements might contribute to limit-cycle oscillations by increasing transcriptional nonlinearity. As expected, introduction of the interdependence of circadian enhancer elements into mathematical models resulted in autonomous transcriptional oscillation with low Hill coefficients. Together these findings suggest that interdependent tandem enhancer motifs on multiple clock genes might cooperatively enhance nonlinearity in the whole circadian feedback system, which would lead to limit-cycle oscillations in clock gene expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="934" length="7"/><text>E-boxes</text></annotation><annotation id="2"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="461" length="9"/><text>mammalian</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="951" length="21"/><text>ROR response elements</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="521" length="18"/><text>tandem E-box motif</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="567" length="11"/><text>two E-boxes</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="668" length="13"/><text>tandem motifs</text></annotation></passage></document>
<document><id>28652246</id><passage><offset>0</offset><text>MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. Evolution of tumor cell phenotypes promotes heterogeneity and therapy resistance. Here we found that induction of CD73, the enzyme that generates immunosuppressive adenosine, is linked to melanoma phenotype switching. Activating MAPK mutations and growth factors drove CD73 expression, which marked both nascent and full activation of a mesenchymal-like melanoma cell state program. Proinflammatory cytokines like TNFalpha cooperated with MAPK signaling through the c-Jun/AP-1 transcription factor complex to activate CD73 transcription by binding to an intronic enhancer. In a mouse model of T-cell immunotherapy, CD73 was induced in relapse melanomas, which acquired a mesenchymal-like phenotype. We also detected CD73 upregulation in melanoma patients progressing under adoptive T-cell transfer or immune checkpoint blockade, arguing for an adaptive resistance mechanism. Our work substantiates CD73 as a target to combine with current immunotherapies, but its dynamic regulation suggests limited value of CD73 pretreatment expression as a biomarker to stratify melanoma patients. Cancer Res; 77(17); 4697-709.  2017 AACR.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="663" length="17"/><text>intronic enhancer</text></annotation><annotation id="2"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="37" length="8"/><text>Melanoma</text></annotation><annotation id="3"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="627" length="4"/><text>CD73</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="687" length="5"/><text>mouse</text></annotation><annotation id="5"><infon key="identifier">23959</infon><infon key="type">GENE</infon><location offset="724" length="4"/><text>CD73</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="752" length="9"/><text>melanomas</text></annotation><annotation id="7"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="825" length="4"/><text>CD73</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="846" length="8"/><text>melanoma</text></annotation><annotation id="9"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="1007" length="4"/><text>CD73</text></annotation><annotation id="10"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="1118" length="4"/><text>CD73</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="1174" length="8"/><text>melanoma</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1193" length="6"/><text>Cancer</text></annotation><annotation id="13"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="82" length="4"/><text>CD73</text></annotation><annotation id="14"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="702" length="6"/><text>T-cell</text></annotation><annotation id="15"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="581" length="4"/><text>AP-1</text></annotation><annotation id="16"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="891" length="6"/><text>T-cell</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="122" length="10"/><text>tumor cell</text></annotation><annotation id="18"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="223" length="4"/><text>CD73</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="297" length="8"/><text>melanoma</text></annotation><annotation id="20"><infon key="identifier">4907</infon><infon key="type">GENE</infon><location offset="378" length="4"/><text>CD73</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0000848</infon><infon key="type">TISSUE</infon><location offset="463" length="13"/><text>melanoma cell</text></annotation><annotation id="22"><infon key="identifier">7124</infon><infon key="type">GENE</infon><location offset="523" length="8"/><text>TNFalpha</text></annotation><annotation id="23"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="575" length="5"/><text>c-Jun</text></annotation></passage></document>
<document><id>28717659</id><passage><offset>0</offset><text>Identification and characterization of variants and a novel 4 bp deletion in the regulatory region of SIX6, a risk factor for primary open-angle glaucoma. BACKGROUND: Primary open-angle glaucoma (POAG) is a complex disease of multigenic inheritance and the most common subtype of glaucoma. SIX6 encodes a transcription factor involved in retina, optic nerve, and pituitary development. Previous studies showed a genetic association between the SIX6 locus and POAG, identifying risk alleles. Whether these alleles are present also in the south Indian population is unclear. METHODS: To address this question, the SIX6 gene and an already characterized and highly conserved SIX6 enhancer (Ch14:60974427-60974430) were sequenced in two south Indian cohorts, respectively, composed of 65/65 and 200/200 POAG cases/age-matched controls. We next used Taqman-based allelic discrimination assay to genotype a common variant (rs33912345: c.421A&gt;C) and the rs1048372 SNP in two cohorts, respectively, composed of 557/387 and 590/448 POAG cases/age-matched controls. An additional cohort of 153 POAG cases was subsequently recruited to assess the association of the rs33912345:c.421A&gt;C and rs10483727 variants with more prominent changes in two POAG diagnostic parameters: retinal nerve fiber layer thickness and vertical cup/disc ratio, using spectral domain optical coherence tomography. The activity of the newly identified enhancer variants was assessed by transgenesis in zebrafish and luciferase assays. RESULTS: We identified two known rare and two common variants in the SIX6 locus and a novel 4 bp deletion in the analyzed enhancer. Contrary to previous studies, we could not establish a significant association between the rs10483727 and rs33912345:c.421A&gt;C variants and PAOG in the south Indian ethnicity but patients carrying the corresponding C or T risk alleles exhibited a dose-dependent reduction of the thickness of the retinal nerve fiber layer and a significant increase in the vertical cup/disc ratio. Transgenesis in zebrafish and luciferase assays demonstrated that the newly identified 4 bp deletion significantly reduced reporter expression in cells of the retinal ganglion and amacrine layers, where human SIX6 is expressed. CONCLUSION: Altogether, our data further support the implication of SIX6 variants as POAG risk factors and implicates SIX6 haploinsufficiency in POAG pathogenesis.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr14,60974427,60974430</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,60974427,60974430</infon><infon key="gb">unk</infon><location offset="1416" length="8"/><text>enhancer</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr14,60974427,60974430</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,60974427,60974430</infon><infon key="gb">unk</infon><location offset="1621" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="612" length="4"/><text>SIX6</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="799" length="4"/><text>POAG</text></annotation><annotation id="5"><infon key="comment">hg38:14,60509819,C,A/G</infon><infon key="type">VARIANT</infon><infon key="identifier">rs33912345</infon><location offset="917" length="10"/><text>rs33912345</text></annotation><annotation id="6"><infon key="attribute">TYPO</infon><infon key="comment">hg38:6,32642659,T,A/C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs1048372</infon><location offset="947" length="9"/><text>rs1048372</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="1023" length="4"/><text>POAG</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="1084" length="4"/><text>POAG</text></annotation><annotation id="9"><infon key="comment">hg38:14,60509819,C,A/G</infon><infon key="type">VARIANT</infon><infon key="identifier">rs33912345</infon><location offset="1155" length="10"/><text>rs33912345</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="1234" length="4"/><text>POAG</text></annotation><annotation id="11"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1466" length="9"/><text>zebrafish</text></annotation><annotation id="12"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="1568" length="4"/><text>SIX6</text></annotation><annotation id="13"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="102" length="4"/><text>SIX6</text></annotation><annotation id="14"><infon key="comment">hg38:14,60606157,T,A/C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs10483727</infon><location offset="1722" length="10"/><text>rs10483727</text></annotation><annotation id="15"><infon key="comment">hg38:14,60509819,C,A/G</infon><infon key="type">VARIANT</infon><infon key="identifier">rs33912345</infon><location offset="1737" length="10"/><text>rs33912345</text></annotation><annotation id="16"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="2027" length="9"/><text>zebrafish</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="2214" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="2220" length="4"/><text>SIX6</text></annotation><annotation id="19"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="2307" length="4"/><text>SIX6</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="2324" length="4"/><text>POAG</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="2384" length="4"/><text>POAG</text></annotation><annotation id="22"><infon key="identifier">0001175</infon><infon key="type">TISSUE</infon><location offset="338" length="6"/><text>retina</text></annotation><annotation id="23"><infon key="identifier">0000966</infon><infon key="type">TISSUE</infon><location offset="346" length="11"/><text>optic nerve</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="126" length="27"/><text>primary open-angle glaucoma</text></annotation><annotation id="25"><infon key="identifier">0000427</infon><infon key="type">TISSUE</infon><location offset="363" length="9"/><text>pituitary</text></annotation><annotation id="26"><infon key="comment">hg38:14,60606157,T,A/C</infon><infon key="type">VARIANT</infon><infon key="identifier">rs10483727</infon><location offset="1179" length="10"/><text>rs10483727</text></annotation><annotation id="27"><infon key="attribute">TYPO</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="1770" length="4"/><text>PAOG</text></annotation><annotation id="28"><infon key="type">TISSUE</infon><location offset="1926" length="25"/><text>retinal nerve fiber layer</text></annotation><annotation id="29"><infon key="type">TISSUE</infon><location offset="1262" length="25"/><text>retinal nerve fiber layer</text></annotation><annotation id="30"><infon key="identifier">0003650</infon><infon key="type">TISSUE</infon><location offset="2170" length="16"/><text>retinal ganglion</text></annotation><annotation id="31"><infon key="identifier">0004044</infon><infon key="type">TISSUE</infon><location offset="2191" length="15"/><text>amacrine layers</text></annotation><annotation id="32"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="2357" length="4"/><text>SIX6</text></annotation><annotation id="33"><infon key="identifier">0005351</infon><infon key="type">TISSUE</infon><location offset="1311" length="3"/><text>cup</text></annotation><annotation id="34"><infon key="attribute">SUFFICIENT</infon><infon key="comment">chr14,60974427,60974430</infon><infon key="type">ENHANCER</infon><infon key="identifier">14,60974427,60974430</infon><infon key="gb">unk</infon><location offset="672" length="38"/><text>SIX6 enhancer (Ch14:60974427-60974430)</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="167" length="27"/><text>Primary open-angle glaucoma</text></annotation><annotation id="36"><infon key="type">TISSUE</infon><location offset="1315" length="4"/><text>disc</text></annotation><annotation id="37"><infon key="identifier">0005351</infon><infon key="type">TISSUE</infon><location offset="1995" length="3"/><text>cup</text></annotation><annotation id="38"><infon key="type">TISSUE</infon><location offset="1999" length="4"/><text>disc</text></annotation><annotation id="39"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="672" length="4"/><text>SIX6</text></annotation><annotation id="40"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="196" length="4"/><text>POAG</text></annotation><annotation id="41"><infon key="attribute">CANCER</infon><infon key="identifier">0005041</infon><infon key="type">DISEASE</infon><location offset="280" length="8"/><text>glaucoma</text></annotation><annotation id="42"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="290" length="4"/><text>SIX6</text></annotation><annotation id="43"><infon key="identifier">4990</infon><infon key="type">GENE</infon><location offset="444" length="4"/><text>SIX6</text></annotation><annotation id="44"><infon key="attribute">CANCER</infon><infon key="identifier">0007665</infon><infon key="type">DISEASE</infon><location offset="459" length="4"/><text>POAG</text></annotation></passage></document>
<document><id>28737489</id><passage><offset>0</offset><text>NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma. Tumor-initiating cells (TIC) are dynamic cancer cell subsets that display enhanced tumor functions and resilience to treatment but the mechanism of TIC induction or maintenance in lung cancer is not fully understood. In this study, we show the calcium pathway transcription factor NFATc2 is a novel regulator of lung TIC phenotypes, including tumorspheres, cell motility, tumorigenesis, as well as in vitro and in vivo responses to chemotherapy and targeted therapy. In human lung cancers, high NFATc2 expression predicted poor tumor differentiation, adverse recurrence-free and cancer-specific overall survivals. Mechanistic investigations identified NFATc2 response elements in the 3' enhancer region of SOX2, and NFATc2/SOX2 coupling upregulates ALDH1A1 by binding to its 5' enhancer. Through this axis, oxidative stress induced by cancer drug treatment is attenuated, leading to increased resistance in a mutation-independent manner. Targeting this axis provides a novel approach for the long-term treatment of lung cancer through TIC elimination.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="877" length="11"/><text>5' enhancer</text></annotation><annotation id="2"><infon key="identifier">0008903</infon><infon key="type">DISEASE</infon><location offset="282" length="11"/><text>lung cancer</text></annotation><annotation id="3"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="383" length="6"/><text>NFATc2</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="572" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">0008903</infon><infon key="type">DISEASE</infon><location offset="578" length="12"/><text>lung cancers</text></annotation><annotation id="6"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="597" length="6"/><text>NFATc2</text></annotation><annotation id="7"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="630" length="5"/><text>tumor</text></annotation><annotation id="8"><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="681" length="6"/><text>cancer</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="754" length="24"/><text>NFATc2 response elements</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="1137" length="3"/><text>TIC</text></annotation><annotation id="11"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="818" length="6"/><text>NFATc2</text></annotation><annotation id="12"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>NFATc2</text></annotation><annotation id="13"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="825" length="4"/><text>SOX2</text></annotation><annotation id="14"><infon key="identifier">216</infon><infon key="type">GENE</infon><location offset="851" length="7"/><text>ALDH1A1</text></annotation><annotation id="15"><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="937" length="6"/><text>cancer</text></annotation><annotation id="16"><infon key="identifier">0008903</infon><infon key="type">DISEASE</infon><location offset="1117" length="11"/><text>lung cancer</text></annotation><annotation id="17"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="808" length="4"/><text>SOX2</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="126" length="3"/><text>TIC</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="250" length="3"/><text>TIC</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="414" length="8"/><text>lung TIC</text></annotation><annotation id="21"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="786" length="26"/><text>3' enhancer region of SOX2</text></annotation><annotation id="22"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="754" length="6"/><text>NFATc2</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="16" length="5"/><text>tumor</text></annotation><annotation id="24"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="56" length="6"/><text>NFATc2</text></annotation><annotation id="25"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="63" length="4"/><text>SOX2</text></annotation><annotation id="26"><infon key="identifier">0005061</infon><infon key="type">DISEASE</infon><location offset="81" length="19"/><text>lung adenocarcinoma</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="102" length="22"/><text>Tumor-initiating cells</text></annotation><annotation id="28"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="143" length="11"/><text>cancer cell</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="185" length="5"/><text>tumor</text></annotation></passage></document>
<document><id>28751304</id><passage><offset>0</offset><text>A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic MIR335 locus. Mutations in the Lamin A/C (LMNA) gene-encoding nuclear LMNA cause laminopathies, which include partial lipodystrophies associated with metabolic syndromes. The lipodystrophy-associated LMNA p.R482W mutation is known to impair adipogenic differentiation, but the mechanisms involved are unclear. We show in this study that the lamin A p.R482W hot spot mutation prevents adipogenic gene expression by epigenetically deregulating long-range enhancers of the anti-adipogenic MIR335 microRNA gene in human adipocyte progenitor cells. The R482W mutation results in a loss of function of differentiation-dependent lamin A binding to the MIR335 locus. This impairs H3K27 methylation and instead favors H3K27 acetylation on MIR335 enhancers. The lamin A mutation further promotes spatial clustering of MIR335 enhancer and promoter elements along with overexpression of the MIR355 gene after adipogenic induction. Our results link a laminopathy-causing lamin A mutation to an unsuspected deregulation of chromatin states and spatial conformation of an miRNA locus critical for adipose progenitor cell fate.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="550" length="64"/><text>long-range enhancers of the anti-adipogenic MIR335 microRNA gene</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="838" length="16"/><text>MIR335 enhancers</text></annotation><annotation id="3"><infon key="identifier">0006573</infon><infon key="type">DISEASE</infon><location offset="226" length="15"/><text>lipodystrophies</text></annotation><annotation id="4"><infon key="identifier">0004955</infon><infon key="type">DISEASE</infon><location offset="258" length="19"/><text>metabolic syndromes</text></annotation><annotation id="5"><infon key="identifier">0006573</infon><infon key="type">DISEASE</infon><location offset="283" length="13"/><text>lipodystrophy</text></annotation><annotation id="6"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="308" length="4"/><text>LMNA</text></annotation><annotation id="7"><infon key="comment">p.R482W</infon><infon key="type">VARIANT</infon><infon key="identifier">p.R482W</infon><location offset="313" length="7"/><text>p.R482W</text></annotation><annotation id="8"><infon key="identifier">0006112</infon><infon key="type">TISSUE</infon><location offset="624" length="26"/><text>adipocyte progenitor cells</text></annotation><annotation id="9"><infon key="comment">p.R482W</infon><infon key="type">VARIANT</infon><infon key="identifier">p.R482W</infon><location offset="457" length="7"/><text>p.R482W</text></annotation><annotation id="10"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="987" length="6"/><text>MIR355</text></annotation><annotation id="11"><infon key="identifier">0006112</infon><infon key="type">TISSUE</infon><location offset="1190" length="23"/><text>adipose progenitor cell</text></annotation><annotation id="12"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="753" length="6"/><text>MIR335</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="916" length="15"/><text>MIR335 enhancer</text></annotation><annotation id="14"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="24" length="7"/><text>lamin A</text></annotation><annotation id="15"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="449" length="7"/><text>lamin A</text></annotation><annotation id="16"><infon key="identifier">0021106</infon><infon key="type">DISEASE</infon><location offset="1046" length="11"/><text>laminopathy</text></annotation><annotation id="17"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="594" length="6"/><text>MIR335</text></annotation><annotation id="18"><infon key="type">VARIANT</infon><location offset="656" length="5"/><text>R482W</text></annotation><annotation id="19"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="730" length="7"/><text>lamin A</text></annotation><annotation id="20"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="860" length="7"/><text>lamin A</text></annotation><annotation id="21"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="1066" length="7"/><text>lamin A</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT,INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="936" length="17"/><text>promoter elements</text></annotation><annotation id="23"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="838" length="6"/><text>MIR335</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="618" length="5"/><text>human</text></annotation><annotation id="25"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="916" length="6"/><text>MIR335</text></annotation><annotation id="26"><infon key="identifier">0006573</infon><infon key="type">DISEASE</infon><location offset="2" length="13"/><text>lipodystrophy</text></annotation><annotation id="27"><infon key="identifier">442904</infon><infon key="type">GENE</infon><location offset="108" length="6"/><text>MIR335</text></annotation><annotation id="28"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="139" length="9"/><text>Lamin A/C</text></annotation><annotation id="29"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="150" length="4"/><text>LMNA</text></annotation><annotation id="30"><infon key="identifier">4000</infon><infon key="type">GENE</infon><location offset="178" length="4"/><text>LMNA</text></annotation><annotation id="31"><infon key="identifier">0021106</infon><infon key="type">DISEASE</infon><location offset="189" length="13"/><text>laminopathies</text></annotation></passage></document>
<document><id>28836200</id><passage><offset>0</offset><text>Characterization of Mesenchymal-Fibroblast Cells Using the Col1a2 Promoter/Enhancer. Excessive deposition of extracellular matrix (ECM) is a common hallmark of fibrotic diseases in various organs. Chiefly among this ECM are collagen types I and III, secreted by local fibroblasts, and other mesenchymal cells recruited for repair purposes. In the last two decades, the search for a fibroblast-specific promoter/enhancer has intensified in order to control the regulation of ECM in these cells and limit the scarring of the fibrotic process. In our previous work, we characterized an enhancer region 17 kb upstream of the Col1a2 gene transcription start site. This enhancer in transgenic mice is expressed mainly in mesenchymal cells during development and in adults upon injury. When driving transgenes such as beta-galactosidase or luciferase, this construct acts as an informative reporter of collagen transcription and is predictive of collagen type I deposition. In this chapter, we provide detailed protocols for identifying similar enhancers and using the sequence to generate a construct for transfection and producing transgenic animals. We also provided information on the use of luminescence in transgenic mice, tissue processing, as well as using cre/lox system to obtain conditional gain and loss of function in mice.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="59" length="24"/><text>Col1a2 Promoter/Enhancer</text></annotation><annotation id="2"><infon key="identifier">1281</infon><infon key="type">GENE</infon><location offset="245" length="3"/><text>III</text></annotation><annotation id="3"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="715" length="17"/><text>mesenchymal cells</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="687" length="4"/><text>mice</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1216" length="4"/><text>mice</text></annotation><annotation id="6"><infon key="identifier">16948</infon><infon key="type">GENE</infon><location offset="1262" length="3"/><text>lox</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1324" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="identifier">0000453</infon><infon key="type">TISSUE</infon><location offset="32" length="16"/><text>Fibroblast Cells</text></annotation><annotation id="9"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="268" length="11"/><text>fibroblasts</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="382" length="37"/><text>fibroblast-specific promoter/enhancer</text></annotation><annotation id="11"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="20" length="11"/><text>Mesenchymal</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="583" length="74"/><text>enhancer region 17 kb upstream of the Col1a2 gene transcription start site</text></annotation><annotation id="13"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="939" length="15"/><text>collagen type I</text></annotation><annotation id="14"><infon key="identifier">12842</infon><infon key="type">GENE</infon><location offset="224" length="16"/><text>collagen types I</text></annotation><annotation id="15"><infon key="identifier">0002625</infon><infon key="type">TISSUE</infon><location offset="291" length="17"/><text>mesenchymal cells</text></annotation><annotation id="16"><infon key="type">DISEASE</infon><location offset="160" length="17"/><text>fibrotic diseases</text></annotation><annotation id="17"><infon key="identifier">12843</infon><infon key="type">GENE</infon><location offset="621" length="6"/><text>Col1a2</text></annotation></passage></document>
<document><id>28905448</id><passage><offset>0</offset><text>Myeloid Zinc Finger 1 and GA Binding Protein Co-Operate with Sox2 in Regulating the Expression of Yes-Associated Protein 1 in Cancer Cells. The transcription factor (TF) yes-associated protein 1 (YAP1) is a major effector of the tumor suppressive Hippo signaling pathway and is also necessary to maintain pluripotency in embryonic stem cells. Elevated levels of YAP1 expression antagonize the tumor suppressive effects of the Hippo pathway that normally represses YAP1 function. High YAP1 expression is observed in several types of human cancers and is particularly prominent in cancer stem cells (CSCs). The stem cell TF Sox2, which marks and maintains CSCs in osteosarcomas (OSs), promotes YAP1 expression by binding to an intronic enhancer element and YAP1 expression is also crucial for the maintainance of OS stem cells. To further understand the regulation of YAP1 expression in OSs, we subjected the YAP1 intronic enhancer to scanning mutagenesis to identify all DNA cis-elements critical for enhancer function. Through this approach, we identified two novel TFs, GA binding protein (GABP) and myeloid zinc finger 1 (MZF1), which are essential for basal YAP1 transcription. These factors are highly expressed in OSs and bind to distinct sites in the YAP1 enhancer. Depletion of either factor leads to drastically reduced YAP1 expression and thus a reversal of stem cell properties. We also found that YAP1 can regulate the expression of Sox2 by binding to two distinct DNA binding sites upstream and downstream of the Sox2 gene. Thus, Sox2 and YAP1 reinforce each others expression to maintain stemness and tumorigenicity in OSs, but the activity of MZF1 and GABP is essential for YAP1 transcription. Stem Cells 2017;35:2340-2350.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="725" length="25"/><text>intronic enhancer element</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="907" length="22"/><text>YAP1 intronic enhancer</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="393" length="5"/><text>tumor</text></annotation><annotation id="4"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="464" length="4"/><text>YAP1</text></annotation><annotation id="5"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="484" length="4"/><text>YAP1</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="532" length="5"/><text>human</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="538" length="7"/><text>cancers</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="811" length="13"/><text>OS stem cells</text></annotation><annotation id="9"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="622" length="4"/><text>Sox2</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0009807</infon><infon key="type">DISEASE</infon><location offset="662" length="13"/><text>osteosarcomas</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0009807</infon><infon key="type">DISEASE</infon><location offset="677" length="3"/><text>OSs</text></annotation><annotation id="12"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="692" length="4"/><text>YAP1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1463" length="71"/><text>two distinct DNA binding sites upstream and downstream of the Sox2 gene</text></annotation><annotation id="14"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="755" length="4"/><text>YAP1</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0009807</infon><infon key="type">DISEASE</infon><location offset="1219" length="3"/><text>OSs</text></annotation><annotation id="16"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="866" length="4"/><text>YAP1</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0009807</infon><infon key="type">DISEASE</infon><location offset="885" length="3"/><text>OSs</text></annotation><annotation id="18"><infon key="identifier">2551</infon><infon key="type">GENE</infon><location offset="26" length="18"/><text>GA Binding Protein</text></annotation><annotation id="19"><infon key="identifier">7593</infon><infon key="type">GENE</infon><location offset="1101" length="21"/><text>myeloid zinc finger 1</text></annotation><annotation id="20"><infon key="identifier">7593</infon><infon key="type">GENE</infon><location offset="1124" length="4"/><text>MZF1</text></annotation><annotation id="21"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1161" length="4"/><text>YAP1</text></annotation><annotation id="22"><infon key="type">TISSUE</infon><location offset="609" length="9"/><text>stem cell</text></annotation><annotation id="23"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1328" length="4"/><text>YAP1</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1257" length="13"/><text>YAP1 enhancer</text></annotation><annotation id="25"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1408" length="4"/><text>YAP1</text></annotation><annotation id="26"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1444" length="4"/><text>Sox2</text></annotation><annotation id="27"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="907" length="4"/><text>YAP1</text></annotation><annotation id="28"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1542" length="4"/><text>Sox2</text></annotation><annotation id="29"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1551" length="4"/><text>YAP1</text></annotation><annotation id="30"><infon key="attribute">CANCER</infon><infon key="identifier">0009807</infon><infon key="type">DISEASE</infon><location offset="1632" length="3"/><text>OSs</text></annotation><annotation id="31"><infon key="identifier">7593</infon><infon key="type">GENE</infon><location offset="1657" length="4"/><text>MZF1</text></annotation><annotation id="32"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1688" length="4"/><text>YAP1</text></annotation><annotation id="33"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="98" length="24"/><text>Yes-Associated Protein 1</text></annotation><annotation id="34"><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="126" length="12"/><text>Cancer Cells</text></annotation><annotation id="35"><infon key="identifier">7593</infon><infon key="type">GENE</infon><location offset="0" length="21"/><text>Myeloid Zinc Finger 1</text></annotation><annotation id="36"><infon key="identifier">0004254</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="579" length="17"/><text>cancer stem cells</text></annotation><annotation id="37"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="170" length="24"/><text>yes-associated protein 1</text></annotation><annotation id="38"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="598" length="4"/><text>CSCs</text></annotation><annotation id="39"><infon key="attribute">CANCER</infon><infon key="identifier">0004254</infon><infon key="type">TISSUE</infon><location offset="654" length="4"/><text>CSCs</text></annotation><annotation id="40"><infon key="identifier">2551</infon><infon key="type">GENE</infon><location offset="1071" length="18"/><text>GA binding protein</text></annotation><annotation id="41"><infon key="identifier">2551</infon><infon key="type">GENE</infon><location offset="1091" length="4"/><text>GABP</text></annotation><annotation id="42"><infon key="type">TISSUE</infon><location offset="1367" length="9"/><text>stem cell</text></annotation><annotation id="43"><infon key="identifier">2551</infon><infon key="type">GENE</infon><location offset="1666" length="4"/><text>GABP</text></annotation><annotation id="44"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="1257" length="4"/><text>YAP1</text></annotation><annotation id="45"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="1525" length="4"/><text>Sox2</text></annotation><annotation id="46"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="61" length="4"/><text>Sox2</text></annotation><annotation id="47"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="321" length="20"/><text>embryonic stem cells</text></annotation><annotation id="48"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="196" length="4"/><text>YAP1</text></annotation><annotation id="49"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="229" length="5"/><text>tumor</text></annotation><annotation id="50"><infon key="identifier">10413</infon><infon key="type">GENE</infon><location offset="362" length="4"/><text>YAP1</text></annotation></passage></document>
<document><id>28916725</id><passage><offset>0</offset><text>Characterization of enhancers and the role of the transcription factor KLF7 in regulating corneal epithelial differentiation. During tissue development, transcription factors bind regulatory DNA regions called enhancers, often located at great distances from the genes they regulate, to control gene expression. The enhancer landscape during embryonic stem cell differentiation has been well characterized. By contrast, little is known about the shared and unique enhancer regulatory mechanisms in different ectodermally derived epithelial cells. Here we use ChIP sequencing (ChIP-seq) to identify domains enriched for the histone marks histone H3 lysine 4 trimethylation, histone H3 lysine 4 monomethylation, and histone H3 lysine 27 acetylation (H3K4me3, H3K4me1, and H3K27ac) and define, for the first time, the super enhancers and typical enhancers active in primary human corneal epithelial cells. We show that regulatory regions are often shared between cell types of the ectodermal lineage and that corneal epithelial super enhancers are already marked as potential regulatory domains in embryonic stem cells. Kruppel-like factor (KLF) motifs were enriched in corneal epithelial enhancers, consistent with the important roles of KLF4 and KLF5 in promoting corneal epithelial differentiation. We now show that the Kruppel family member KLF7 promotes the corneal progenitor cell state; on many genes, KLF7 antagonized the corneal differentiation-promoting KLF4. Furthermore, we found that two SNPs linked previously to corneal diseases, astigmatism, and Stevens-Johnson syndrome fall within corneal epithelial enhancers and alter their activity by disrupting transcription factor motifs that overlap these SNPs. Taken together, our work defines regulatory enhancers in corneal epithelial cells, highlights global gene-regulatory relationships shared among different epithelial cells, identifies a role for KLF7 as a KLF4 antagonist in corneal epithelial cell differentiation, and explains how two SNPs may contribute to corneal diseases.</text><annotation id="1"><infon key="identifier">8609</infon><infon key="type">GENE</infon><location offset="71" length="4"/><text>KLF7</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="871" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">9314</infon><infon key="type">GENE</infon><location offset="1236" length="4"/><text>KLF4</text></annotation><annotation id="4"><infon key="identifier">688</infon><infon key="type">GENE</infon><location offset="1245" length="4"/><text>KLF5</text></annotation><annotation id="5"><infon key="identifier">8609</infon><infon key="type">GENE</infon><location offset="1342" length="4"/><text>KLF7</text></annotation><annotation id="6"><infon key="identifier">8609</infon><infon key="type">GENE</infon><location offset="1406" length="4"/><text>KLF7</text></annotation><annotation id="7"><infon key="identifier">9314</infon><infon key="type">GENE</infon><location offset="1461" length="4"/><text>KLF4</text></annotation><annotation id="8"><infon key="identifier">0000942</infon><infon key="type">DISEASE</infon><location offset="1524" length="16"/><text>corneal diseases</text></annotation><annotation id="9"><infon key="identifier">0011284</infon><infon key="type">DISEASE</infon><location offset="1542" length="11"/><text>astigmatism</text></annotation><annotation id="10"><infon key="identifier">0018229</infon><infon key="type">DISEASE</infon><location offset="1559" length="24"/><text>Stevens-Johnson syndrome</text></annotation><annotation id="11"><infon key="identifier">0000414</infon><infon key="type">TISSUE</infon><location offset="529" length="16"/><text>epithelial cells</text></annotation><annotation id="12"><infon key="identifier">8609</infon><infon key="type">GENE</infon><location offset="1911" length="4"/><text>KLF7</text></annotation><annotation id="13"><infon key="identifier">9314</infon><infon key="type">GENE</infon><location offset="1921" length="4"/><text>KLF4</text></annotation><annotation id="14"><infon key="identifier">0000942</infon><infon key="type">DISEASE</infon><location offset="2025" length="16"/><text>corneal diseases</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="1360" length="23"/><text>corneal progenitor cell</text></annotation><annotation id="16"><infon key="identifier">0004298</infon><infon key="type">TISSUE</infon><location offset="1940" length="23"/><text>corneal epithelial cell</text></annotation><annotation id="17"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="342" length="19"/><text>embryonic stem cell</text></annotation><annotation id="18"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1117" length="32"/><text>Kruppel-like factor (KLF) motifs</text></annotation><annotation id="19"><infon key="identifier">0004298</infon><infon key="type">TISSUE</infon><location offset="877" length="24"/><text>corneal epithelial cells</text></annotation><annotation id="20"><infon key="identifier">0000315</infon><infon key="type">TISSUE</infon><location offset="978" length="18"/><text>ectodermal lineage</text></annotation><annotation id="21"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="1095" length="20"/><text>embryonic stem cells</text></annotation><annotation id="22"><infon key="identifier">0004298</infon><infon key="type">TISSUE</infon><location offset="1774" length="24"/><text>corneal epithelial cells</text></annotation><annotation id="23"><infon key="identifier">0000414</infon><infon key="type">TISSUE</infon><location offset="1871" length="16"/><text>epithelial cells</text></annotation></passage></document>
<document><id>28991225</id><passage><offset>0</offset><text>Super-enhancers define a proliferative PGC-1alpha-expressing melanoma subgroup sensitive to BET inhibition. Metabolic changes are linked to epigenetic reprogramming and play important roles in several tumor types. PGC-1alpha is a transcriptional coactivator controlling mitochondrial biogenesis and is linked to oxidative phosphorylation. We provide evidence that melanoma models with elevated PGC-1alpha levels are characteristic of the proliferative phenotype and are sensitive to bromodomain and extra-terminal domain (BET) inhibitor treatment. A super-enhancer region highly occupied by the BET family member BRD4 was identified for the PGC-1alpha gene. BET inhibitor treatment prevented this interaction, leading to a dramatic reduction of PGC-1alpha expression. Accordingly, BET inhibition diminished respiration and mitochondrial function in cells. In vivo, melanoma models with high PGC-1alpha expression strongly responded to BET inhibition by reduction of PGC-1alpha and impaired tumor growth. Altogether, our findings identify epigenetic regulatory elements that define a subset of melanomas with high sensitivity to BET inhibition, which opens up the opportunity to define melanoma patients most likely to respond to this treatment, depending on their tumor characteristics.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="550" length="21"/><text>super-enhancer region</text></annotation><annotation id="2"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="745" length="10"/><text>PGC-1alpha</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="865" length="8"/><text>melanoma</text></annotation><annotation id="4"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="891" length="10"/><text>PGC-1alpha</text></annotation><annotation id="5"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="966" length="10"/><text>PGC-1alpha</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="990" length="5"/><text>tumor</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="1093" length="9"/><text>melanomas</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="1185" length="8"/><text>melanoma</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1264" length="5"/><text>tumor</text></annotation><annotation id="10"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="39" length="10"/><text>PGC-1alpha</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="61" length="8"/><text>melanoma</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="201" length="5"/><text>tumor</text></annotation><annotation id="13"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="214" length="10"/><text>PGC-1alpha</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="364" length="8"/><text>melanoma</text></annotation><annotation id="15"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="394" length="10"/><text>PGC-1alpha</text></annotation><annotation id="16"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="613" length="4"/><text>BRD4</text></annotation><annotation id="17"><infon key="identifier">10891</infon><infon key="type">GENE</infon><location offset="641" length="10"/><text>PGC-1alpha</text></annotation></passage></document>
<document><id>29035388</id><passage><offset>0</offset><text>A novel HER2 gene body enhancer contributes to HER2 expression. The transcriptional regulation of the human epidermal growth factor receptor-2 (HER2) contributes to an enhanced HER2 expression in HER2-positive breast cancers with HER2 gene amplification and HER2-low or HER2-negative breast cancers following radiotherapy or endocrine therapy, and this drives tumorigenesis and the resistance to therapy. Epigenetic mechanisms are critical for transcription regulation, however, such mechanisms in the transcription regulation of HER2 are limited to the involvement of tri-methylated histone 3 lysine 4 (H3K4me3) and acetylated histone 3 lysine 9 (H3K9ac) at the HER2 promoter region. Here, we report the identification of a novel enhancer in the HER2 3' gene body, which we have termed HER2 gene body enhancer (HGE). The HGE starts from the 3' end of intron 19 and extends into intron 22, possesses enhancer histone modification marks in specific cells and enhances the transcriptional activity of the HER2 promoters. We also found that TFAP2C, a known regulator of HER2, binds to HGE and is required for its enhancer function and that DNA methylation in the HGE region inhibits the histone modifications characterizing enhancer and is inversely correlated with HER2 expression in breast cancer samples. The identification of this novel enhancer sheds a light on the roles of epigenetic mechanisms in HER2 transcription, in both HER2-positive breast cancer samples and individuals with HER2-low or HER2-negative breast cancers undergoing radiotherapy or endocrine therapy.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="8" length="23"/><text>HER2 gene body enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="663" length="20"/><text>HER2 promoter region</text></annotation><annotation id="3"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="47" length="4"/><text>HER2</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="102" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="108" length="34"/><text>epidermal growth factor receptor-2</text></annotation><annotation id="6"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="144" length="4"/><text>HER2</text></annotation><annotation id="7"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="177" length="4"/><text>HER2</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="812" length="3"/><text>HGE</text></annotation><annotation id="9"><infon key="identifier">0006244</infon><infon key="type">DISEASE</infon><location offset="196" length="28"/><text>HER2-positive breast cancers</text></annotation><annotation id="10"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="230" length="4"/><text>HER2</text></annotation><annotation id="11"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="8" length="4"/><text>HER2</text></annotation><annotation id="12"><infon key="identifier">0000618</infon><infon key="type">DISEASE</infon><location offset="270" length="28"/><text>HER2-negative breast cancers</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="731" length="33"/><text>enhancer in the HER2 3' gene body</text></annotation><annotation id="14"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="530" length="4"/><text>HER2</text></annotation><annotation id="15"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="747" length="4"/><text>HER2</text></annotation><annotation id="16"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="787" length="4"/><text>HER2</text></annotation><annotation id="17"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="663" length="4"/><text>HER2</text></annotation><annotation id="18"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="1003" length="14"/><text>HER2 promoters</text></annotation><annotation id="19"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="1038" length="6"/><text>TFAP2C</text></annotation><annotation id="20"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="1067" length="4"/><text>HER2</text></annotation><annotation id="21"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="1263" length="4"/><text>HER2</text></annotation><annotation id="22"><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="1282" length="13"/><text>breast cancer</text></annotation><annotation id="23"><infon key="identifier">2064</infon><infon key="type">GENE</infon><location offset="1402" length="4"/><text>HER2</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="787" length="23"/><text>HER2 gene body enhancer</text></annotation><annotation id="25"><infon key="identifier">0006244</infon><infon key="type">DISEASE</infon><location offset="1430" length="27"/><text>HER2-positive breast cancer</text></annotation><annotation id="26"><infon key="identifier">0000618</infon><infon key="type">DISEASE</infon><location offset="1499" length="28"/><text>HER2-negative breast cancers</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1082" length="3"/><text>HGE</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1160" length="10"/><text>HGE region</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="822" length="66"/><text>HGE starts from the 3' end of intron 19 and extends into intron 22</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1338" length="8"/><text>enhancer</text></annotation><annotation id="31"><infon key="identifier">0000618</infon><infon key="type">DISEASE</infon><location offset="1487" length="8"/><text>HER2-low</text></annotation><annotation id="32"><infon key="identifier">0000618</infon><infon key="type">DISEASE</infon><location offset="258" length="8"/><text>HER2-low</text></annotation></passage></document>
<document><id>29042628</id><passage><offset>0</offset><text>A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers. The transcription factor Runx1 is essential for definitive haematopoiesis, and the RUNX1 gene is frequently translocated or mutated in leukaemia. Runx1 is transcribed from two promoters, P1 and P2, to give rise to different protein isoforms. Although the expression of Runx1 must be tightly regulated for normal blood development, the mechanisms that regulate Runx1 isoform expression during haematopoiesis remain poorly understood. Gene regulatory elements located in non-coding DNA are likely to be important for Runx1 transcription. Here we use circular chromosome conformation capture sequencing to identify DNA interactions with the P1 and P2 promoters of Runx1, and the previously identified +24 enhancer, in the mouse multipotent haematopoietic progenitor cell line HPC-7. The active promoter, P1, interacts with nine non-coding regions that are occupied by transcription factors within a 1 Mb topologically associated domain. Eight of nine regions function as blood-specific enhancers in zebrafish, of which two were previously shown to harbour blood-specific enhancer activity in mice. Interestingly, the +24 enhancer interacted with multiple distant regions on chromosome 16, suggesting it may regulate the expression of additional genes. The Runx1 DNA contact map identifies connections with multiple novel and known haematopoietic enhancers that are likely to be involved in regulating Runx1 expression in haematopoietic progenitor cells.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="273" length="2"/><text>P1</text></annotation><annotation id="2"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="32" length="5"/><text>Runx1</text></annotation><annotation id="3"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="111" length="5"/><text>Runx1</text></annotation><annotation id="4"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="169" length="5"/><text>RUNX1</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="221" length="9"/><text>leukaemia</text></annotation><annotation id="6"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="232" length="5"/><text>Runx1</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="280" length="2"/><text>P2</text></annotation><annotation id="8"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="355" length="5"/><text>Runx1</text></annotation><annotation id="9"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="446" length="5"/><text>Runx1</text></annotation><annotation id="10"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="601" length="5"/><text>Runx1</text></annotation><annotation id="11"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1139" length="5"/><text>blood</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="724" length="28"/><text>P1 and P2 promoters of Runx1</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1020" length="58"/><text>Eight of nine regions function as blood-specific enhancers</text></annotation><annotation id="14"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="805" length="5"/><text>mouse</text></annotation><annotation id="15"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1082" length="9"/><text>zebrafish</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1175" length="4"/><text>mice</text></annotation><annotation id="17"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1339" length="5"/><text>Runx1</text></annotation><annotation id="18"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1484" length="5"/><text>Runx1</text></annotation><annotation id="19"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="747" length="5"/><text>Runx1</text></annotation><annotation id="20"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="398" length="5"/><text>blood</text></annotation><annotation id="21"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="823" length="41"/><text>haematopoietic progenitor cell line HPC-7</text></annotation><annotation id="22"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="784" length="12"/><text>+24 enhancer</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1102" length="69"/><text>two were previously shown to harbour blood-specific enhancer activity</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="877" length="12"/><text>promoter, P1</text></annotation><annotation id="25"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1054" length="5"/><text>blood</text></annotation><annotation id="26"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1504" length="31"/><text>haematopoietic progenitor cells</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1200" length="12"/><text>+24 enhancer</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="258" length="13"/><text>two promoters</text></annotation><annotation id="29"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="26" length="5"/><text>Mouse</text></annotation></passage></document>
<document><id>29078395</id><passage><offset>0</offset><text>STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus. Cytokines critically control immune responses, but how regulatory programs are altered to allow T cells to differentially respond to distinct cytokine stimuli remains poorly understood. Here, we have globally analyzed enhancer elements bound by IL-2-activated STAT5 and IL-21-activated STAT3 in T cells and identified Il2ra as the top-ranked gene regulated by an IL-2-activated STAT5-bound superenhancer and one of the top genes regulated by STAT3-bound superenhancers. Moreover, we found that STAT5 binding was rapidly superenriched at genes highly induced by IL-2 and that IL-2-activated STAT5 binding induces new and augmented chromatin interactions within superenhancer-containing genes. Based on chromatin interaction analysis by paired-end tag (ChIA-PET) sequencing data, we used CRISPR-Cas9 gene editing to target three of the STAT5 binding sites within the Il2ra superenhancer in mice. Each mutation decreased STAT5 binding and altered IL-2-induced Il2ra gene expression, revealing that individual elements within the superenhancer were not functionally redundant and that all were required for normal gene expression. Thus, we demonstrate cooperative utilization of superenhancer elements to optimize gene expression and show that STAT5 mediates IL-2-induced chromatin looping at superenhancers to preferentially regulate highly inducible genes, thereby providing new insights into the mechanisms underlying cytokine-dependent superenhancer function.</text><annotation id="1"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>STAT5</text></annotation><annotation id="2"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="504" length="4"/><text>IL-2</text></annotation><annotation id="3"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="401" length="5"/><text>STAT5</text></annotation><annotation id="4"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="635" length="5"/><text>STAT5</text></annotation><annotation id="5"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="702" length="4"/><text>IL-2</text></annotation><annotation id="6"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="716" length="4"/><text>IL-2</text></annotation><annotation id="7"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="731" length="5"/><text>STAT5</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="962" length="63"/><text>three of the STAT5 binding sites within the Il2ra superenhancer</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1006" length="19"/><text>Il2ra superenhancer</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1029" length="4"/><text>mice</text></annotation><annotation id="11"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1059" length="5"/><text>STAT5</text></annotation><annotation id="12"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="65" length="4"/><text>IL-2</text></annotation><annotation id="13"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="1085" length="4"/><text>IL-2</text></annotation><annotation id="14"><infon key="identifier">16184</infon><infon key="type">GENE</infon><location offset="1098" length="5"/><text>Il2ra</text></annotation><annotation id="15"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="1381" length="5"/><text>STAT5</text></annotation><annotation id="16"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="1396" length="4"/><text>IL-2</text></annotation><annotation id="17"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="519" length="5"/><text>STAT5</text></annotation><annotation id="18"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="237" length="7"/><text>T cells</text></annotation><annotation id="19"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="436" length="7"/><text>T cells</text></annotation><annotation id="20"><infon key="identifier">20848</infon><infon key="type">GENE</infon><location offset="583" length="5"/><text>STAT3</text></annotation><annotation id="21"><infon key="identifier">20848</infon><infon key="type">GENE</infon><location offset="427" length="5"/><text>STAT3</text></annotation><annotation id="22"><infon key="identifier">60505</infon><infon key="type">GENE</infon><location offset="411" length="5"/><text>IL-21</text></annotation><annotation id="23"><infon key="identifier">16184</infon><infon key="type">GENE</infon><location offset="123" length="5"/><text>Il2ra</text></annotation><annotation id="24"><infon key="identifier">16184</infon><infon key="type">GENE</infon><location offset="1006" length="5"/><text>Il2ra</text></annotation><annotation id="25"><infon key="identifier">20850</infon><infon key="type">GENE</infon><location offset="975" length="5"/><text>STAT5</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="359" length="73"/><text>enhancer elements bound by IL-2-activated STAT5 and IL-21-activated STAT3</text></annotation><annotation id="27"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="504" length="40"/><text>IL-2-activated STAT5-bound superenhancer</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="583" length="26"/><text>STAT3-bound superenhancers</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1167" length="13"/><text>superenhancer</text></annotation><annotation id="30"><infon key="identifier">16184</infon><infon key="type">GENE</infon><location offset="459" length="5"/><text>Il2ra</text></annotation><annotation id="31"><infon key="identifier">16183</infon><infon key="type">GENE</infon><location offset="386" length="4"/><text>IL-2</text></annotation></passage></document>
<document><id>29091765</id><passage><offset>0</offset><text>Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2. Low-grade astrocytomas (LGAs) carry neomorphic mutations in isocitrate dehydrogenase (IDH) concurrently with P53 and ATRX loss. To model LGA formation, we introduced R132H IDH1, P53 shRNA, and ATRX shRNA into human neural stem cells (NSCs). These oncogenic hits blocked NSC differentiation, increased invasiveness in vivo, and led to a DNA methylation and transcriptional profile resembling IDH1 mutant human LGAs. The differentiation block was caused by transcriptional silencing of the transcription factor SOX2 secondary to disassociation of its promoter from a putative enhancer. This occurred because of reduced binding of the chromatin organizer CTCF to its DNA motifs and disrupted chromatin looping. Our human model of IDH mutant LGA formation implicates impaired NSC differentiation because of repression of SOX2 as an early driver of gliomagenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="690" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="715" length="8"/><text>enhancer</text></annotation><annotation id="3"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="201" length="24"/><text>isocitrate dehydrogenase</text></annotation><annotation id="4"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="227" length="3"/><text>IDH</text></annotation><annotation id="5"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="250" length="3"/><text>P53</text></annotation><annotation id="6"><infon key="identifier">546</infon><infon key="type">GENE</infon><location offset="258" length="4"/><text>ATRX</text></annotation><annotation id="7"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="278" length="3"/><text>LGA</text></annotation><annotation id="8"><infon key="comment">R132H</infon><infon key="type">VARIANT</infon><infon key="identifier">R132H</infon><location offset="307" length="5"/><text>R132H</text></annotation><annotation id="9"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="313" length="4"/><text>IDH1</text></annotation><annotation id="10"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="319" length="3"/><text>P53</text></annotation><annotation id="11"><infon key="identifier">546</infon><infon key="type">GENE</infon><location offset="334" length="4"/><text>ATRX</text></annotation><annotation id="12"><infon key="identifier">0002881</infon><infon key="type">TISSUE</infon><location offset="375" length="4"/><text>NSCs</text></annotation><annotation id="13"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="0" length="21"/><text>Low-Grade Astrocytoma</text></annotation><annotation id="14"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="532" length="4"/><text>IDH1</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="544" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="650" length="4"/><text>SOX2</text></annotation><annotation id="17"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="793" length="4"/><text>CTCF</text></annotation><annotation id="18"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="853" length="5"/><text>human</text></annotation><annotation id="19"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="868" length="3"/><text>IDH</text></annotation><annotation id="20"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="879" length="3"/><text>LGA</text></annotation><annotation id="21"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="958" length="4"/><text>SOX2</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="93" length="5"/><text>Human</text></annotation><annotation id="23"><infon key="identifier">0002881</infon><infon key="type">TISSUE</infon><location offset="99" length="17"/><text>Neural Stem Cells</text></annotation><annotation id="24"><infon key="identifier">3417</infon><infon key="type">GENE</infon><location offset="35" length="4"/><text>IDH1</text></annotation><annotation id="25"><infon key="identifier">0002881</infon><infon key="type">TISSUE</infon><location offset="411" length="3"/><text>NSC</text></annotation><annotation id="26"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="550" length="4"/><text>LGAs</text></annotation><annotation id="27"><infon key="identifier">0002881</infon><infon key="type">TISSUE</infon><location offset="913" length="3"/><text>NSC</text></annotation><annotation id="28"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="350" length="5"/><text>human</text></annotation><annotation id="29"><infon key="identifier">7157</infon><infon key="type">GENE</infon><location offset="41" length="3"/><text>P53</text></annotation><annotation id="30"><infon key="identifier">546</infon><infon key="type">GENE</infon><location offset="50" length="4"/><text>ATRX</text></annotation><annotation id="31"><infon key="identifier">0002881</infon><infon key="type">TISSUE</infon><location offset="356" length="17"/><text>neural stem cells</text></annotation><annotation id="32"><infon key="identifier">6657</infon><infon key="type">GENE</infon><location offset="135" length="4"/><text>SOX2</text></annotation><annotation id="33"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="141" length="22"/><text>Low-grade astrocytomas</text></annotation><annotation id="34"><infon key="identifier">0016685</infon><infon key="type">DISEASE</infon><location offset="165" length="4"/><text>LGAs</text></annotation></passage></document>
<document><id>29113912</id><passage><offset>0</offset><text>Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma. BACKGROUND &amp; AIMS: AT-rich interaction domain 1a (Arid1a), a component of the chromatin remodeling complex, has emerged as a tumor suppressor gene. It is frequently mutated in hepatocellular carcinoma (HCC). However, it remains unknown how Arid1a suppresses HCC development and whether Arid1a deficiency could be exploited for therapy, we aimed to explore these questions. METHODS: The expression of Arid1a in human and mouse HCCs was determined by immunohistochemical (IHC) staining. Gene expression was determined by quantitative PCR, ELISA or western blotting. Arid1a knockdown HCC cell lines were established by lentiviral-based shRNA. Tumor angiogenesis was quantified based on vessel density. The regulation of angiopoietin (Ang2) expression by Arid1a was identified by chromatin immunoprecipitation (ChIP) assay. The tumor promoting function of Arid1a loss was studied with a xenograft model in nude mice and diethylnitrosamine (DEN)-induced HCC in Arid1a conditional knockout mice. The therapeutic values of Ang2 antibody and sorafenib treatment were evaluated both in vitro and in vivo. RESULTS: We demonstrate that Arid1a deficiency, occurring in advanced human HCCs, is associated with increased vessel density. Mechanistically, loss of Arid1a causes aberrant histone H3K27ac deposition at the angiopoietin-2 (Ang2) enhancer and promoter, which eventually leads to ectopic expression of Ang2 and promotes HCC development. Ang2 blockade in Arid1a-deficient HCCs significantly reduces vessel density and tumor progression. Importantly, sorafenib treatment, which suppresses H3K27 acetylation and Ang2 expression, profoundly halts the progression of Arid1a-deficient HCCs. CONCLUSIONS: Arid1a-deficiency activates Ang2-dependent angiogenesis and promotes HCC progression. Loss of Arid1a in HCCs confers sensitivity to Ang2 blockade and sorafenib treatment. LAY SUMMARY: AT-rich interaction domain 1a (Arid1a), is a tumor suppressor gene. Arid1a-deficiency promotes Ang2-dependent angiogenesis leading to hepatocellular carcinoma progression. Arid1a-deficiency also sensitizes tumors to Ang2 blockade by sorafenib treatment.</text><annotation id="1"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="110" length="29"/><text>AT-rich interaction domain 1a</text></annotation><annotation id="2"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1396" length="14"/><text>angiopoietin-2</text></annotation><annotation id="3"><infon key="identifier">8289</infon><infon key="type">GENE</infon><location offset="491" length="6"/><text>Arid1a</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="501" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="511" length="5"/><text>mouse</text></annotation><annotation id="6"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="517" length="4"/><text>HCCs</text></annotation><annotation id="7"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="655" length="6"/><text>Arid1a</text></annotation><annotation id="8"><infon key="identifier">0000578</infon><infon key="type">TISSUE</infon><location offset="672" length="14"/><text>HCC cell lines</text></annotation><annotation id="9"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="731" length="5"/><text>Tumor</text></annotation><annotation id="10"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="822" length="4"/><text>Ang2</text></annotation><annotation id="11"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="842" length="6"/><text>Arid1a</text></annotation><annotation id="12"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>Arid1a</text></annotation><annotation id="13"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="915" length="5"/><text>tumor</text></annotation><annotation id="14"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="943" length="6"/><text>Arid1a</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="998" length="4"/><text>mice</text></annotation><annotation id="16"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1040" length="3"/><text>HCC</text></annotation><annotation id="17"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="1047" length="6"/><text>Arid1a</text></annotation><annotation id="18"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1075" length="4"/><text>mice</text></annotation><annotation id="19"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1107" length="4"/><text>Ang2</text></annotation><annotation id="20"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1412" length="4"/><text>Ang2</text></annotation><annotation id="21"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1257" length="5"/><text>human</text></annotation><annotation id="22"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1263" length="4"/><text>HCCs</text></annotation><annotation id="23"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="65" length="24"/><text>hepatocellular carcinoma</text></annotation><annotation id="24"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="1339" length="6"/><text>Arid1a</text></annotation><annotation id="25"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="808" length="12"/><text>angiopoietin</text></annotation><annotation id="26"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1889" length="4"/><text>HCCs</text></annotation><annotation id="27"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1489" length="4"/><text>Ang2</text></annotation><annotation id="28"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1507" length="3"/><text>HCC</text></annotation><annotation id="29"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1524" length="4"/><text>Ang2</text></annotation><annotation id="30"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1558" length="4"/><text>HCCs</text></annotation><annotation id="31"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1604" length="5"/><text>tumor</text></annotation><annotation id="32"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1696" length="4"/><text>Ang2</text></annotation><annotation id="33"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1766" length="4"/><text>HCCs</text></annotation><annotation id="34"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="141" length="6"/><text>Arid1a</text></annotation><annotation id="35"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="1216" length="6"/><text>Arid1a</text></annotation><annotation id="36"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1813" length="4"/><text>Ang2</text></annotation><annotation id="37"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="1854" length="3"/><text>HCC</text></annotation><annotation id="38"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="1879" length="6"/><text>Arid1a</text></annotation><annotation id="39"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="1969" length="29"/><text>AT-rich interaction domain 1a</text></annotation><annotation id="40"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="1917" length="4"/><text>Ang2</text></annotation><annotation id="41"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="2000" length="6"/><text>Arid1a</text></annotation><annotation id="42"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="2014" length="5"/><text>tumor</text></annotation><annotation id="43"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="2064" length="4"/><text>Ang2</text></annotation><annotation id="44"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="216" length="5"/><text>tumor</text></annotation><annotation id="45"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="2103" length="24"/><text>hepatocellular carcinoma</text></annotation><annotation id="46"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="2175" length="6"/><text>tumors</text></annotation><annotation id="47"><infon key="identifier">11601</infon><infon key="type">GENE</infon><location offset="2185" length="4"/><text>Ang2</text></annotation><annotation id="48"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1396" length="30"/><text>angiopoietin-2 (Ang2) enhancer</text></annotation><annotation id="49"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1431" length="8"/><text>promoter</text></annotation><annotation id="50"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="267" length="24"/><text>hepatocellular carcinoma</text></annotation><annotation id="51"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="293" length="3"/><text>HCC</text></annotation><annotation id="52"><infon key="identifier">93760</infon><infon key="type">GENE</infon><location offset="331" length="6"/><text>Arid1a</text></annotation><annotation id="53"><infon key="identifier">0007256</infon><infon key="type">DISEASE</infon><location offset="349" length="3"/><text>HCC</text></annotation></passage></document>
<document><id>29133016</id><passage><offset>0</offset><text>Dynamic transcriptional control of macrophage miRNA signature via inflammation responsive enhancers revealed using a combination of next generation sequencing-based approaches. MicroRNAs are important components of the post-transcriptional fine-tuning of macrophage gene expression in physiological and pathological conditions. However, the mechanistic underpinnings and the cis-acting genomic factors of how macrophage polarizing signals induce miRNA expression changes are not well characterized. Therefore, we systematically evaluated the transcriptional basis underlying the inflammation-mediated regulation of macrophage microRNome using the combination of different next generation sequencing datasets. We investigated the LPS-induced expression changes at mature miRNA and pri-miRNA levels in mouse macrophages utilizing a small RNA-seq method and publicly available GRO-seq dataset, respectively. Next, we identified an enhancer set associated with LPS-responsive pri-miRNAs based on publicly available H3K4 mono-methylation-specific ChIP-seq and GRO-seq datasets. This enhancer set was further characterized by the combination of publicly available ChIP and ATAC-seq datasets. Finally, direct interactions between the miR-155-coding genomic region and its distal regulatory elements were identified using a 3C-seq approach. Our analysis revealed 15 robustly LPS-regulated miRNAs at the transcriptional level. In addition, we found that these miRNA genes are associated with an inflammation-responsive enhancer network. Based on NFkappaB-p65 and JunB transcription factor binding, we showed two distinct enhancer subsets associated with LPS-activated miRNAs that possess distinct epigenetic characteristics and LPS-responsiveness. Finally, our 3C-seq analysis revealed the LPS-induced extensive reorganization of the pri-miR-155-associated functional chromatin domain as well as chromatin loop formation between LPS-responsive enhancers and the promoter region. Our genomic approach successfully combines various genome-wide datasets and allows the identification of the putative regulatory elements controlling miRNA expression in classically activated macrophages.</text><annotation id="1"><infon key="identifier">19697</infon><infon key="type">GENE</infon><location offset="1537" length="12"/><text>NFkappaB-p65</text></annotation><annotation id="2"><infon key="identifier">387173</infon><infon key="type">GENE</infon><location offset="1227" length="7"/><text>miR-155</text></annotation><annotation id="3"><infon key="identifier">16477</infon><infon key="type">GENE</infon><location offset="1554" length="4"/><text>JunB</text></annotation><annotation id="4"><infon key="identifier">387173</infon><infon key="type">GENE</infon><location offset="1829" length="7"/><text>miR-155</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1920" length="24"/><text>LPS-responsive enhancers</text></annotation><annotation id="6"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="806" length="11"/><text>macrophages</text></annotation><annotation id="7"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="2162" length="11"/><text>macrophages</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1599" length="29"/><text>two distinct enhancer subsets</text></annotation><annotation id="9"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="255" length="10"/><text>macrophage</text></annotation><annotation id="10"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="409" length="10"/><text>macrophage</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1953" length="15"/><text>promoter region</text></annotation><annotation id="12"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="800" length="5"/><text>mouse</text></annotation><annotation id="13"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="615" length="10"/><text>macrophage</text></annotation><annotation id="14"><infon key="identifier">0000801</infon><infon key="type">TISSUE</infon><location offset="35" length="10"/><text>macrophage</text></annotation></passage></document>
<document><id>29142074</id><passage><offset>0</offset><text>STAT3 controls COL1A2 enhancer activation cooperatively with JunB, regulates type I collagen synthesis posttranscriptionally, and is essential for lung myofibroblast differentiation. Fibroblast differentiation is a key cellular process that underlies the process of fibrosis, a deadly complication of fibrotic diseases like scleroderma (SSc). This transition coincides with the overproduction of collagen type I (COL1) and other extracellular matrix proteins. High-level expression of the collagen type 1alpha2 subunit (COL1A2), requires the engagement of a far-upstream enhancer, whose activation is strongly dependent on the AP1 factor JunB. We now report that STAT3 also binds the COL1A2 enhancer and is essential for RNA polymerase recruitment, without affecting JunB binding. STAT3 is required for the increased COL1A2 expression observed in myofibroblasts. We also report that TGFbeta partially activates STAT3 and show that inhibiting STAT3 potently blocks TGFbeta signaling, matrix remodeling, and TGFbeta-induced myofibroblast differentiation. Activation of STAT3 with IL6 transsignaling alone, however, only increased COL1A2 protein expression, leaving COL1A2 mRNA levels unchanged. Our results suggest that activated STAT3 is not the limiting factor for collagen enhancer activation in human lung fibroblasts. Yet, a certain threshold level of STAT3 activity is essential to support activation of the COL1A2 enhancer and TGFbeta signaling in fibroblasts. We propose that STAT3 operates at the posttranscriptional as well as the transcriptional level.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="558" length="21"/><text>far-upstream enhancer</text></annotation><annotation id="2"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>STAT3</text></annotation><annotation id="3"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="767" length="4"/><text>JunB</text></annotation><annotation id="4"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="781" length="5"/><text>STAT3</text></annotation><annotation id="5"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="817" length="6"/><text>COL1A2</text></annotation><annotation id="6"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="684" length="6"/><text>COL1A2</text></annotation><annotation id="7"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="911" length="5"/><text>STAT3</text></annotation><annotation id="8"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="942" length="5"/><text>STAT3</text></annotation><annotation id="9"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="1412" length="6"/><text>COL1A2</text></annotation><annotation id="10"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="15" length="6"/><text>COL1A2</text></annotation><annotation id="11"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1067" length="5"/><text>STAT3</text></annotation><annotation id="12"><infon key="identifier">3569</infon><infon key="type">GENE</infon><location offset="1078" length="3"/><text>IL6</text></annotation><annotation id="13"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="61" length="4"/><text>JunB</text></annotation><annotation id="14"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="1128" length="6"/><text>COL1A2</text></annotation><annotation id="15"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="1163" length="6"/><text>COL1A2</text></annotation><annotation id="16"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1228" length="5"/><text>STAT3</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1297" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1355" length="5"/><text>STAT3</text></annotation><annotation id="19"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="1482" length="5"/><text>STAT3</text></annotation><annotation id="20"><infon key="identifier">0001946</infon><infon key="type">TISSUE</infon><location offset="147" length="18"/><text>lung myofibroblast</text></annotation><annotation id="21"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="489" length="29"/><text>collagen type 1alpha2 subunit</text></annotation><annotation id="22"><infon key="identifier">0001946</infon><infon key="type">TISSUE</infon><location offset="847" length="14"/><text>myofibroblasts</text></annotation><annotation id="23"><infon key="type">DISEASE</infon><location offset="266" length="8"/><text>fibrosis</text></annotation><annotation id="24"><infon key="identifier">0001946</infon><infon key="type">TISSUE</infon><location offset="1022" length="13"/><text>myofibroblast</text></annotation><annotation id="25"><infon key="identifier">0000764</infon><infon key="type">TISSUE</infon><location offset="1303" length="16"/><text>lung fibroblasts</text></annotation><annotation id="26"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="1453" length="11"/><text>fibroblasts</text></annotation><annotation id="27"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="183" length="10"/><text>Fibroblast</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="15" length="15"/><text>COL1A2 enhancer</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="684" length="15"/><text>COL1A2 enhancer</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1412" length="15"/><text>COL1A2 enhancer</text></annotation><annotation id="31"><infon key="identifier">1277</infon><infon key="type">GENE</infon><location offset="77" length="15"/><text>type I collagen</text></annotation><annotation id="32"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1265" length="17"/><text>collagen enhancer</text></annotation><annotation id="33"><infon key="type">DISEASE</infon><location offset="301" length="17"/><text>fibrotic diseases</text></annotation><annotation id="34"><infon key="identifier">0019340</infon><infon key="type">DISEASE</infon><location offset="324" length="11"/><text>scleroderma</text></annotation><annotation id="35"><infon key="identifier">0005100</infon><infon key="type">DISEASE</infon><location offset="337" length="3"/><text>SSc</text></annotation><annotation id="36"><infon key="identifier">1278</infon><infon key="type">GENE</infon><location offset="520" length="6"/><text>COL1A2</text></annotation><annotation id="37"><infon key="identifier">3726</infon><infon key="type">GENE</infon><location offset="627" length="15"/><text>AP1 factor JunB</text></annotation><annotation id="38"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="663" length="5"/><text>STAT3</text></annotation></passage></document>
<document><id>29151363</id><passage><offset>0</offset><text>Functional assessment of human enhancer activities using whole-genome STARR-sequencing. BACKGROUND: Genome-wide quantification of enhancer activity in the human genome has proven to be a challenging problem. Recent efforts have led to the development of powerful tools for enhancer quantification. However, because of genome size and complexity, these tools have yet to be applied to the whole human genome. RESULTS:  In the current study, we use a human prostate cancer cell line, LNCaP as a model to perform whole human genome STARR-seq (WHG-STARR-seq) to reliably obtain an assessment of enhancer activity. This approach builds upon previously developed STARR-seq in the fly genome and CapSTARR-seq techniques in targeted human genomic regions. With an improved library preparation strategy, our approach greatly increases the library complexity per unit of starting material, which makes it feasible and cost-effective to explore the landscape of regulatory activity in the much larger human genome. In addition to our ability to identify active, accessible enhancers located in open chromatin regions, we can also detect sequences with the potential for enhancer activity that are located in inaccessible, closed chromatin regions. When treated with the histone deacetylase inhibitor, Trichostatin A, genes nearby this latter class of enhancers are up-regulated, demonstrating the potential for endogenous functionality of these regulatory elements. CONCLUSION: WHG-STARR-seq provides an improved approach to current pipelines for analysis of high complexity genomes to gain a better understanding of the intricacies of transcriptional regulation.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="25" length="5"/><text>human</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="155" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="394" length="5"/><text>human</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="449" length="5"/><text>human</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="516" length="5"/><text>human</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="725" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="990" length="5"/><text>human</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0001321</infon><infon key="type">TISSUE</infon><location offset="482" length="5"/><text>LNCaP</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0001033</infon><infon key="type">TISSUE</infon><location offset="455" length="25"/><text>prostate cancer cell line</text></annotation></passage></document>
<document><id>29254942</id><passage><offset>0</offset><text>Transcription factor activity rhythms and tissue-specific chromatin interactions explain circadian gene expression across organs. Temporal control of physiology requires the interplay between gene networks involved in daily timekeeping and tissue function across different organs. How the circadian clock interweaves with tissue-specific transcriptional programs is poorly understood. Here, we dissected temporal and tissue-specific regulation at multiple gene regulatory layers by examining mouse tissues with an intact or disrupted clock over time. Integrated analysis uncovered two distinct regulatory modes underlying tissue-specific rhythms: tissue-specific oscillations in transcription factor (TF) activity, which were linked to feeding-fasting cycles in liver and sodium homeostasis in kidney; and colocalized binding of clock and tissue-specific transcription factors at distal enhancers. Chromosome conformation capture (4C-seq) in liver and kidney identified liver-specific chromatin loops that recruited clock-bound enhancers to promoters to regulate liver-specific transcriptional rhythms. Furthermore, this looping was remarkably promoter-specific on the scale of less than 10 kilobases (kb). Enhancers can contact a rhythmic promoter while looping out nearby nonrhythmic alternative promoters, confining rhythmic enhancer activity to specific promoters. These findings suggest that chromatin folding enables the clock to regulate rhythmic transcription of specific promoters to output temporal transcriptional programs tailored to different tissues.</text><annotation id="1"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="1063" length="5"/><text>liver</text></annotation><annotation id="2"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="492" length="5"/><text>mouse</text></annotation><annotation id="3"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="762" length="5"/><text>liver</text></annotation><annotation id="4"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="794" length="6"/><text>kidney</text></annotation><annotation id="5"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="942" length="5"/><text>liver</text></annotation><annotation id="6"><infon key="identifier">0000671</infon><infon key="type">TISSUE</infon><location offset="952" length="6"/><text>kidney</text></annotation><annotation id="7"><infon key="identifier">0000759</infon><infon key="type">TISSUE</infon><location offset="970" length="5"/><text>liver</text></annotation></passage></document>
<document><id>29256171</id><passage><offset>0</offset><text>Multiple enhancer regions govern the transcription of CCN2 during embryonic development. CCN2 is a critical matricellular protein that is expressed in several cells with major implications in physiology and different pathologies. However, the transcriptional regulation of this gene remains obscure. We used the Encyclopaedia of DNA Elements browser (ENCODE) to visualise the region spanning from 300 kb upstream to the CCN2 start site in silico in order to identify enhancer regions that regulate transcription of this gene. Selection was based on three criteria associated with enhancer regions: 1) H3K4me1 and H3K27ac histone modifications, 2) DNase I hypersensitivity of chromatin and 3) inter-species conservation. Reporter constructs were created with sequences spanning each of the regions of interest placed upstream of an Hsp68 silent proximal promoter sequence in order to drive the expression of beta-galactosidase transgene. Each of these constructs was subsequently used to create transgenic mice in which reporter gene production was assessed at the E15.5 developmental stage. Four functional enhancers were identified, with each driving distinct, tissue-specific patterns of transgene expression. An enhancer located -100 kb from the CCN2 transcription start site facilitated expression within vascular tissue. An enhancer -135 kb upstream of CCN2 drove expression within the articular chondrocytes of synovial joints. The other two enhancers, located at -198 kb and -229 kb, mediated transgene expression within dermal fibroblasts, however the most prevalent activity was found within hypertrophic chondrocytes and periosteal tissue, respectively. These findings suggest that the global expression of CCN2 during development results from the activity of several tissue-specific enhancer regions in addition to proximal regulatory elements that have previously been demonstrated to drive transcription of the gene during development.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1091" length="25"/><text>Four functional enhancers</text></annotation><annotation id="2"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="89" length="4"/><text>CCN2</text></annotation><annotation id="3"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="420" length="4"/><text>CCN2</text></annotation><annotation id="4"><infon key="identifier">0000452</infon><infon key="type">TISSUE</infon><location offset="1535" length="11"/><text>fibroblasts</text></annotation><annotation id="5"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="1358" length="4"/><text>CCN2</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1005" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1444" length="45"/><text>two enhancers, located at -198 kb and -229 kb</text></annotation><annotation id="8"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="1717" length="4"/><text>CCN2</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="831" length="39"/><text>Hsp68 silent proximal promoter sequence</text></annotation><annotation id="10"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="1401" length="12"/><text>chondrocytes</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1215" length="63"/><text>enhancer located -100 kb from the CCN2 transcription start site</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1329" length="33"/><text>enhancer -135 kb upstream of CCN2</text></annotation><annotation id="13"><infon key="identifier">0000249</infon><infon key="type">TISSUE</infon><location offset="1614" length="12"/><text>chondrocytes</text></annotation><annotation id="14"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="1249" length="4"/><text>CCN2</text></annotation><annotation id="15"><infon key="identifier">14219</infon><infon key="type">GENE</infon><location offset="54" length="4"/><text>CCN2</text></annotation></passage></document>
<document><id>29277702</id><passage><offset>0</offset><text>The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis. BACKGROUND: Histamine is a critical mediator of IgE/mast cell-mediated anaphylaxis. Histamine is synthesized by decarboxylating the amino acid histidine, a reaction catalyzed by the histidine decarboxylase (Hdc) gene-encoded enzyme HDC. However, regulation of the Hdc gene in mast cells is poorly understood. OBJECTIVE: We sought to investigate the in vivo regulation of IgE/mast cell-mediated anaphylaxis by the transcription factors GATA2 and microphthalmia-associated transcription factor (MITF) and the mechanisms by which GATA2 and MITF regulate Hdc gene expression in mouse and human mast cells. METHODS: Mice deficient in the transcription factors Gata2, aryl hydrocarbon receptor (Ahr), aryl hydrocarbon receptor repressor (Ahrr), or basic helix-loop-helix family member E40 (Bhlhe40) were assessed for anaphylactic reactions. Chromatin immunoprecipitation sequencing analysis identified putative Hdc enhancers. Luciferase reporter transcription assay confirmed enhancer activities of putative enhancers in the Hdc gene. The short hairpin RNA knockdown approach was used to determine the role of MITF in regulating mouse and human HDC gene expression. RESULTS: Connective tissue mast cell-specific Gata2-deficient mice did not have IgE/mast cell-mediated anaphylaxis. GATA2 induced the expression of Mitf, Ahr, Ahrr, and Bhlhe40 in mast cells. MITF, but not AHR, AHRR, or BHLHE40, was required for anaphylaxis. MITF bound to an enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene and directed enhancer activity. MITF overexpression largely restored Hdc gene expression in the Gata2-deficient mast cells. In the human mast cell line LAD2, MITF was required for the HDC gene expression and histamine synthesis. CONCLUSION: The transcription factors GATA2 and MITF regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis.</text><annotation id="1"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="558" length="9"/><text>mast cell</text></annotation><annotation id="2"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="390" length="3"/><text>Hdc</text></annotation><annotation id="3"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="415" length="3"/><text>HDC</text></annotation><annotation id="4"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="447" length="3"/><text>Hdc</text></annotation><annotation id="5"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="618" length="5"/><text>GATA2</text></annotation><annotation id="6"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="628" length="46"/><text>microphthalmia-associated transcription factor</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1185" length="25"/><text>enhancers in the Hdc gene</text></annotation><annotation id="8"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="676" length="4"/><text>MITF</text></annotation><annotation id="9"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="710" length="5"/><text>GATA2</text></annotation><annotation id="10"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="720" length="4"/><text>MITF</text></annotation><annotation id="11"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="734" length="3"/><text>Hdc</text></annotation><annotation id="12"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="1370" length="9"/><text>mast cell</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="757" length="5"/><text>mouse</text></annotation><annotation id="14"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="767" length="5"/><text>human</text></annotation><annotation id="15"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="794" length="4"/><text>Mice</text></annotation><annotation id="16"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="838" length="5"/><text>Gata2</text></annotation><annotation id="17"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="845" length="25"/><text>aryl hydrocarbon receptor</text></annotation><annotation id="18"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="872" length="3"/><text>Ahr</text></annotation><annotation id="19"><infon key="identifier">11624</infon><infon key="type">GENE</infon><location offset="878" length="35"/><text>aryl hydrocarbon receptor repressor</text></annotation><annotation id="20"><infon key="identifier">11624</infon><infon key="type">GENE</infon><location offset="915" length="4"/><text>Ahrr</text></annotation><annotation id="21"><infon key="identifier">20893</infon><infon key="type">GENE</infon><location offset="925" length="40"/><text>basic helix-loop-helix family member E40</text></annotation><annotation id="22"><infon key="identifier">20893</infon><infon key="type">GENE</infon><location offset="967" length="7"/><text>Bhlhe40</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1619" length="80"/><text>enhancer located 8.8 kb upstream of the transcription start site of the Hdc gene</text></annotation><annotation id="24"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1831" length="5"/><text>human</text></annotation><annotation id="25"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="1088" length="3"/><text>Hdc</text></annotation><annotation id="26"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1287" length="4"/><text>MITF</text></annotation><annotation id="27"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1306" length="5"/><text>mouse</text></annotation><annotation id="28"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1316" length="5"/><text>human</text></annotation><annotation id="29"><infon key="identifier">3067</infon><infon key="type">GENE</infon><location offset="1322" length="3"/><text>HDC</text></annotation><annotation id="30"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="1202" length="3"/><text>Hdc</text></annotation><annotation id="31"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1405" length="4"/><text>mice</text></annotation><annotation id="32"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="1459" length="5"/><text>GATA2</text></annotation><annotation id="33"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1491" length="4"/><text>Mitf</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1088" length="13"/><text>Hdc enhancers</text></annotation><annotation id="35"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="1497" length="3"/><text>Ahr</text></annotation><annotation id="36"><infon key="identifier">11624</infon><infon key="type">GENE</infon><location offset="1502" length="4"/><text>Ahrr</text></annotation><annotation id="37"><infon key="identifier">20893</infon><infon key="type">GENE</infon><location offset="1512" length="7"/><text>Bhlhe40</text></annotation><annotation id="38"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1535" length="4"/><text>MITF</text></annotation><annotation id="39"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="1549" length="3"/><text>AHR</text></annotation><annotation id="40"><infon key="identifier">11624</infon><infon key="type">GENE</infon><location offset="1554" length="4"/><text>AHRR</text></annotation><annotation id="41"><infon key="identifier">20893</infon><infon key="type">GENE</infon><location offset="1563" length="7"/><text>BHLHE40</text></annotation><annotation id="42"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1602" length="4"/><text>MITF</text></annotation><annotation id="43"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="1796" length="26"/><text>Gata2-deficient mast cells</text></annotation><annotation id="44"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1732" length="4"/><text>MITF</text></annotation><annotation id="45"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="26" length="5"/><text>GATA2</text></annotation><annotation id="46"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="1769" length="3"/><text>Hdc</text></annotation><annotation id="47"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="1691" length="3"/><text>Hdc</text></annotation><annotation id="48"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="1858" length="4"/><text>MITF</text></annotation><annotation id="49"><infon key="identifier">3067</infon><infon key="type">GENE</infon><location offset="1884" length="3"/><text>HDC</text></annotation><annotation id="50"><infon key="identifier">14461</infon><infon key="type">GENE</infon><location offset="1967" length="5"/><text>GATA2</text></annotation><annotation id="51"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="1977" length="4"/><text>MITF</text></annotation><annotation id="52"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="1991" length="3"/><text>Hdc</text></annotation><annotation id="53"><infon key="identifier">17342</infon><infon key="type">GENE</infon><location offset="36" length="46"/><text>microphthalmia-associated transcription factor</text></annotation><annotation id="54"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="151" length="9"/><text>mast cell</text></annotation><annotation id="55"><infon key="identifier">0100053</infon><infon key="type">DISEASE</infon><location offset="170" length="11"/><text>anaphylaxis</text></annotation><annotation id="56"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="235" length="9"/><text>mast cell</text></annotation><annotation id="57"><infon key="identifier">0100053</infon><infon key="type">DISEASE</infon><location offset="254" length="11"/><text>anaphylaxis</text></annotation><annotation id="58"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="459" length="10"/><text>mast cells</text></annotation><annotation id="59"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="773" length="10"/><text>mast cells</text></annotation><annotation id="60"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="1427" length="9"/><text>mast cell</text></annotation><annotation id="61"><infon key="identifier">0100053</infon><infon key="type">DISEASE</infon><location offset="1446" length="11"/><text>anaphylaxis</text></annotation><annotation id="62"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="1523" length="10"/><text>mast cells</text></annotation><annotation id="63"><infon key="identifier">0100053</infon><infon key="type">DISEASE</infon><location offset="1589" length="11"/><text>anaphylaxis</text></annotation><annotation id="64"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="115" length="10"/><text>mast cells</text></annotation><annotation id="65"><infon key="identifier">0004139</infon><infon key="type">TISSUE</infon><location offset="1837" length="19"/><text>mast cell line LAD2</text></annotation><annotation id="66"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="2014" length="10"/><text>mast cells</text></annotation><annotation id="67"><infon key="identifier">0000830</infon><infon key="type">TISSUE</infon><location offset="2050" length="9"/><text>mast cell</text></annotation><annotation id="68"><infon key="identifier">0100053</infon><infon key="type">DISEASE</infon><location offset="2069" length="11"/><text>anaphylaxis</text></annotation><annotation id="69"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="92" length="3"/><text>Hdc</text></annotation><annotation id="70"><infon key="identifier">15186</infon><infon key="type">GENE</infon><location offset="365" length="23"/><text>histidine decarboxylase</text></annotation></passage></document>
<document><id>29284139</id><passage><offset>0</offset><text>Coordinated d-cyclin/Foxd1 activation drives mitogenic activity of the Sonic Hedgehog signaling pathway. Sonic Hedgehog (Shh) signaling plays key regulatory roles in embryonic development and postnatal homeostasis and repair. Modulation of the Shh pathway is known to cause malformations and malignancies associated with dysregulated tissue growth. However, our understanding of the molecular mechanisms by which Shh regulates cellular proliferation is incomplete. Here, using mouse embryonic fibroblasts, we demonstrate that the Forkhead box gene Foxd1 is transcriptionally regulated by canonical Shh signaling and required for downstream proliferative activity. We show that Foxd1 deletion abrogates the proliferative response to SHH ligand while FOXD1 overexpression alone is sufficient to induce cellular proliferation. The proliferative response to both SHH ligand and FOXD1 overexpression was blocked by pharmacologic inhibition of cyclin-dependent kinase signaling. Time-course experiments revealed that Shh pathway activation of Foxd1 is followed by downregulation of Cdkn1c, which encodes a cyclin-dependent kinase inhibitor. Consistent with a direct transcriptional regulation mechanism, we found that FOXD1 reduces reporter activity of a Fox enhancer sequence in the second intron of Cdkn1c. Supporting the applicability of these findings to specific biological contexts, we show that Shh regulation of Foxd1 and Cdkn1c is recapitulated in cranial neural crest cells and provide evidence that this mechanism is operational during upper lip morphogenesis. These results reveal a novel Shh-Foxd1-Cdkn1c regulatory circuit that drives the mitogenic action of Shh signaling and may have broad implications in development and disease.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1249" length="52"/><text>Fox enhancer sequence in the second intron of Cdkn1c</text></annotation><annotation id="2"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="71" length="14"/><text>Sonic Hedgehog</text></annotation><annotation id="3"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="598" length="3"/><text>Shh</text></annotation><annotation id="4"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="677" length="5"/><text>Foxd1</text></annotation><annotation id="5"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="732" length="3"/><text>SHH</text></annotation><annotation id="6"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="749" length="5"/><text>FOXD1</text></annotation><annotation id="7"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="859" length="3"/><text>SHH</text></annotation><annotation id="8"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="874" length="5"/><text>FOXD1</text></annotation><annotation id="9"><infon key="identifier">0003825</infon><infon key="type">TISSUE</infon><location offset="1451" length="26"/><text>cranial neural crest cells</text></annotation><annotation id="10"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1011" length="3"/><text>Shh</text></annotation><annotation id="11"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="1037" length="5"/><text>Foxd1</text></annotation><annotation id="12"><infon key="identifier">12577</infon><infon key="type">GENE</infon><location offset="1076" length="6"/><text>Cdkn1c</text></annotation><annotation id="13"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="21" length="5"/><text>Foxd1</text></annotation><annotation id="14"><infon key="identifier">0001647</infon><infon key="type">TISSUE</infon><location offset="1541" length="9"/><text>upper lip</text></annotation><annotation id="15"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="1212" length="5"/><text>FOXD1</text></annotation><annotation id="16"><infon key="identifier">12577</infon><infon key="type">GENE</infon><location offset="1295" length="6"/><text>Cdkn1c</text></annotation><annotation id="17"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1396" length="3"/><text>Shh</text></annotation><annotation id="18"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="1414" length="5"/><text>Foxd1</text></annotation><annotation id="19"><infon key="identifier">12577</infon><infon key="type">GENE</infon><location offset="1424" length="6"/><text>Cdkn1c</text></annotation><annotation id="20"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1595" length="3"/><text>Shh</text></annotation><annotation id="21"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="1599" length="5"/><text>Foxd1</text></annotation><annotation id="22"><infon key="identifier">12577</infon><infon key="type">GENE</infon><location offset="1605" length="6"/><text>Cdkn1c</text></annotation><annotation id="23"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="1667" length="3"/><text>Shh</text></annotation><annotation id="24"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="121" length="3"/><text>Shh</text></annotation><annotation id="25"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="105" length="14"/><text>Sonic Hedgehog</text></annotation><annotation id="26"><infon key="identifier">0004725</infon><infon key="type">TISSUE</infon><location offset="483" length="21"/><text>embryonic fibroblasts</text></annotation><annotation id="27"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="244" length="3"/><text>Shh</text></annotation><annotation id="28"><infon key="identifier">0021147</infon><infon key="type">DISEASE</infon><location offset="274" length="13"/><text>malformations</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="292" length="12"/><text>malignancies</text></annotation><annotation id="30"><infon key="identifier">20423</infon><infon key="type">GENE</infon><location offset="413" length="3"/><text>Shh</text></annotation><annotation id="31"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="477" length="5"/><text>mouse</text></annotation><annotation id="32"><infon key="identifier">15229</infon><infon key="type">GENE</infon><location offset="548" length="5"/><text>Foxd1</text></annotation></passage></document>
<document><id>29326336</id><passage><offset>0</offset><text>ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. The oncogenic transcription factor TAL1/SCL induces an aberrant transcriptional program in T-cell acute lymphoblastic leukemia (T-ALL) cells. However, the critical factors that are directly activated by TAL1 and contribute to T-ALL pathogenesis are largely unknown. Here, we identified AT-rich interactive domain 5B (ARID5B) as a collaborating oncogenic factor involved in the transcriptional program in T-ALL. ARID5B expression is down-regulated at the double-negative 2-4 stages in normal thymocytes, while it is induced by the TAL1 complex in human T-ALL cells. The enhancer located 135 kb upstream of the ARID5B gene locus is activated under a superenhancer in T-ALL cells but not in normal T cells. Notably, ARID5B-bound regions are associated predominantly with active transcription. ARID5B and TAL1 frequently co-occupy target genes and coordinately control their expression. ARID5B positively regulates the expression of TAL1 and its regulatory partners. ARID5B also activates the expression of the oncogene MYC Importantly, ARID5B is required for the survival and growth of T-ALL cells, and forced expression of ARID5B in immature thymocytes results in thymus retention, differentiation arrest, radioresistance, and tumor formation in zebrafish. Our results indicate that ARID5B reinforces the oncogenic transcriptional program by positively regulating the TAL1-induced regulatory circuit and MYC in T-ALL, thereby contributing to T-cell leukemogenesis.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="717" length="57"/><text>enhancer located 135 kb upstream of the ARID5B gene locus</text></annotation><annotation id="2"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>ARID5B</text></annotation><annotation id="3"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="552" length="5"/><text>T-ALL</text></annotation><annotation id="4"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="559" length="6"/><text>ARID5B</text></annotation><annotation id="5"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="678" length="4"/><text>TAL1</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="796" length="13"/><text>superenhancer</text></annotation><annotation id="7"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="434" length="29"/><text>AT-rich interactive domain 5B</text></annotation><annotation id="8"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="843" length="7"/><text>T cells</text></annotation><annotation id="9"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="861" length="6"/><text>ARID5B</text></annotation><annotation id="10"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="938" length="6"/><text>ARID5B</text></annotation><annotation id="11"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="949" length="4"/><text>TAL1</text></annotation><annotation id="12"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="1031" length="6"/><text>ARID5B</text></annotation><annotation id="13"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="46" length="4"/><text>TAL1</text></annotation><annotation id="14"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="1077" length="4"/><text>TAL1</text></annotation><annotation id="15"><infon key="identifier">572528</infon><infon key="type">GENE</infon><location offset="1111" length="6"/><text>ARID5B</text></annotation><annotation id="16"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="1181" length="6"/><text>ARID5B</text></annotation><annotation id="17"><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="1231" length="11"/><text>T-ALL cells</text></annotation><annotation id="18"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="1269" length="6"/><text>ARID5B</text></annotation><annotation id="19"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1373" length="5"/><text>tumor</text></annotation><annotation id="20"><infon key="identifier">7955</infon><infon key="type">SPECIES</infon><location offset="1392" length="9"/><text>zebrafish</text></annotation><annotation id="21"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="1429" length="6"/><text>ARID5B</text></annotation><annotation id="22"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="1514" length="4"/><text>TAL1</text></annotation><annotation id="23"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1557" length="5"/><text>T-ALL</text></annotation><annotation id="24"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="125" length="6"/><text>T-cell</text></annotation><annotation id="25"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="1588" length="6"/><text>T-cell</text></annotation><annotation id="26"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="694" length="5"/><text>human</text></annotation><annotation id="27"><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="239" length="49"/><text>T-cell acute lymphoblastic leukemia (T-ALL) cells</text></annotation><annotation id="28"><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="813" length="11"/><text>T-ALL cells</text></annotation><annotation id="29"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="1288" length="10"/><text>thymocytes</text></annotation><annotation id="30"><infon key="identifier">0001374</infon><infon key="type">TISSUE</infon><location offset="1310" length="6"/><text>thymus</text></annotation><annotation id="31"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1164" length="3"/><text>MYC</text></annotation><annotation id="32"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1550" length="3"/><text>MYC</text></annotation><annotation id="33"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="757" length="6"/><text>ARID5B</text></annotation><annotation id="34"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="183" length="8"/><text>TAL1/SCL</text></annotation><annotation id="35"><infon key="identifier">0001372</infon><infon key="type">TISSUE</infon><location offset="639" length="10"/><text>thymocytes</text></annotation><annotation id="36"><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="700" length="11"/><text>T-ALL cells</text></annotation><annotation id="37"><infon key="identifier">6886</infon><infon key="type">GENE</infon><location offset="351" length="4"/><text>TAL1</text></annotation><annotation id="38"><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="374" length="5"/><text>T-ALL</text></annotation><annotation id="39"><infon key="identifier">84159</infon><infon key="type">GENE</infon><location offset="465" length="6"/><text>ARID5B</text></annotation></passage></document>
<document><id>29342133</id><passage><offset>0</offset><text>A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies. The transcription factor Myc is essential for the regulation of haematopoietic stem cells and progenitors and has a critical function in haematopoietic malignancies. Here we show that an evolutionarily conserved region located 1.7 megabases downstream of the Myc gene that has previously been labelled as a 'super-enhancer' is essential for the regulation of Myc expression levels in both normal haematopoietic and leukaemic stem cell hierarchies in mice and humans. Deletion of this region in mice leads to a complete loss of Myc expression in haematopoietic stem cells and progenitors. This caused an accumulation of differentiation-arrested multipotent progenitors and loss of myeloid and B cells, mimicking the phenotype caused by Mx1-Cre-mediated conditional deletion of the Myc gene in haematopoietic stem cells. This super-enhancer comprises multiple enhancer modules with selective activity that recruits a compendium of transcription factors, including GFI1b, RUNX1 and MYB. Analysis of mice carrying deletions of individual enhancer modules suggests that specific Myc expression levels throughout most of the haematopoietic hierarchy are controlled by the combinatorial and additive activity of individual enhancer modules, which collectively function as a 'blood enhancer cluster' (BENC). We show that BENC is also essential for the maintenance of MLL-AF9-driven leukaemia in mice. Furthermore, a BENC module, which controls Myc expression in mouse haematopoietic stem cells and progenitors, shows increased chromatin accessibility in human acute myeloid leukaemia stem cells compared to blasts. This difference correlates with MYC expression and patient outcome. We propose that clusters of enhancers, such as BENC, form highly combinatorial systems that allow precise control of gene expression across normal cellular hierarchies and which also can be hijacked in malignancies.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="20"/><text>Myc enhancer cluster</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="400" length="14"/><text>super-enhancer</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0002334</infon><infon key="type">DISEASE</infon><location offset="229" length="27"/><text>haematopoietic malignancies</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1500" length="11"/><text>BENC module</text></annotation><annotation id="5"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="451" length="3"/><text>Myc</text></annotation><annotation id="6"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="542" length="4"/><text>mice</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="551" length="6"/><text>humans</text></annotation><annotation id="8"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="586" length="4"/><text>mice</text></annotation><annotation id="9"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="619" length="3"/><text>Myc</text></annotation><annotation id="10"><infon key="identifier">17857</infon><infon key="type">GENE</infon><location offset="827" length="3"/><text>Mx1</text></annotation><annotation id="11"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="872" length="3"/><text>Myc</text></annotation><annotation id="12"><infon key="identifier">14582</infon><infon key="type">GENE</infon><location offset="1054" length="5"/><text>GFI1b</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="916" length="14"/><text>super-enhancer</text></annotation><annotation id="14"><infon key="identifier">12394</infon><infon key="type">GENE</infon><location offset="1061" length="5"/><text>RUNX1</text></annotation><annotation id="15"><infon key="identifier">17863</infon><infon key="type">GENE</infon><location offset="1071" length="3"/><text>MYB</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1088" length="4"/><text>mice</text></annotation><annotation id="17"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="1166" length="3"/><text>Myc</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1466" length="9"/><text>leukaemia</text></annotation><annotation id="19"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1479" length="4"/><text>mice</text></annotation><annotation id="20"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="1528" length="3"/><text>Myc</text></annotation><annotation id="21"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1546" length="5"/><text>mouse</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1638" length="5"/><text>human</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0018874</infon><infon key="type">DISEASE</infon><location offset="1644" length="23"/><text>acute myeloid leukaemia</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="950" length="16"/><text>enhancer modules</text></annotation><annotation id="25"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1731" length="3"/><text>MYC</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1969" length="12"/><text>malignancies</text></annotation><annotation id="27"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="156" length="25"/><text>haematopoietic stem cells</text></annotation><annotation id="28"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1360" length="22"/><text>blood enhancer cluster</text></annotation><annotation id="29"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="488" length="14"/><text>haematopoietic</text></annotation><annotation id="30"><infon key="identifier">0004178</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="507" length="19"/><text>leukaemic stem cell</text></annotation><annotation id="31"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="637" length="25"/><text>haematopoietic stem cells</text></annotation><annotation id="32"><infon key="identifier">0000906</infon><infon key="type">TISSUE</infon><location offset="772" length="7"/><text>myeloid</text></annotation><annotation id="33"><infon key="identifier">0000776</infon><infon key="type">TISSUE</infon><location offset="784" length="7"/><text>B cells</text></annotation><annotation id="34"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="884" length="25"/><text>haematopoietic stem cells</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1126" length="16"/><text>enhancer modules</text></annotation><annotation id="36"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="2" length="3"/><text>Myc</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1385" length="4"/><text>BENC</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1405" length="4"/><text>BENC</text></annotation><annotation id="39"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="1552" length="25"/><text>haematopoietic stem cells</text></annotation><annotation id="40"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="351" length="3"/><text>Myc</text></annotation><annotation id="41"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1360" length="5"/><text>blood</text></annotation><annotation id="42"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="279" length="80"/><text>evolutionarily conserved region located 1.7 megabases downstream of the Myc gene</text></annotation><annotation id="43"><infon key="attribute">CANCER</infon><infon key="identifier">0004178</infon><infon key="type">TISSUE</infon><location offset="44" length="34"/><text>leukaemic haematopoietic stem cell</text></annotation><annotation id="44"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1814" length="4"/><text>BENC</text></annotation><annotation id="45"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1308" length="16"/><text>enhancer modules</text></annotation><annotation id="46"><infon key="identifier">17869</infon><infon key="type">GENE</infon><location offset="117" length="3"/><text>Myc</text></annotation></passage></document>
<document><id>29379199</id><passage><offset>0</offset><text>Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining feature of high-risk neuroblastoma. Here we present the first dynamic chromatin and transcriptional landscape of MYCN perturbation in neuroblastoma. At oncogenic levels, MYCN associates with E-box binding motifs in an affinity-dependent manner, binding to strong canonical E-boxes at promoters and invading abundant weaker non-canonical E-boxes clustered at enhancers. Loss of MYCN leads to a global reduction in transcription, which is most pronounced at MYCN target genes with the greatest enhancer occupancy. These highly occupied MYCN target genes show tissue-specific expression and are linked to poor patient survival. The activity of genes with MYCN-occupied enhancers is dependent on the tissue-specific transcription factor TWIST1, which co-occupies enhancers with MYCN and is required for MYCN-dependent proliferation. These data implicate tissue-specific enhancers in defining often highly tumor-specific 'MYC target gene signatures' and identify disruption of the MYCN enhancer regulatory axis as a promising therapeutic strategy in neuroblastoma.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="501" length="21"/><text>non-canonical E-boxes</text></annotation><annotation id="2"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="159" length="4"/><text>MYCN</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="199" length="13"/><text>neuroblastoma</text></annotation><annotation id="4"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="291" length="4"/><text>MYCN</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="312" length="13"/><text>neuroblastoma</text></annotation><annotation id="6"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="348" length="4"/><text>MYCN</text></annotation><annotation id="7"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="555" length="4"/><text>MYCN</text></annotation><annotation id="8"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="634" length="4"/><text>MYCN</text></annotation><annotation id="9"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="712" length="4"/><text>MYCN</text></annotation><annotation id="10"><infon key="identifier">7291</infon><infon key="type">GENE</infon><location offset="911" length="6"/><text>TWIST1</text></annotation><annotation id="11"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="952" length="4"/><text>MYCN</text></annotation><annotation id="12"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="977" length="4"/><text>MYCN</text></annotation><annotation id="13"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="1223" length="13"/><text>neuroblastoma</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="369" length="20"/><text>E-box binding motifs</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="441" length="17"/><text>canonical E-boxes</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1079" length="5"/><text>tumor</text></annotation><annotation id="17"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="830" length="4"/><text>MYCN</text></annotation><annotation id="18"><infon key="identifier">4609</infon><infon key="type">GENE</infon><location offset="1095" length="3"/><text>MYC</text></annotation><annotation id="19"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="1154" length="4"/><text>MYCN</text></annotation><annotation id="20"><infon key="identifier">4613</infon><infon key="type">GENE</infon><location offset="25" length="4"/><text>MYCN</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0005072</infon><infon key="type">DISEASE</infon><location offset="73" length="13"/><text>neuroblastoma</text></annotation></passage></document>
<document><id>29385519</id><passage><offset>0</offset><text>Genomic dissection of enhancers uncovers principles of combinatorial regulation and cell type-specific wiring of enhancer-promoter contacts. Genomic binding of transcription factors, like the glucocorticoid receptor (GR), is linked to the regulation of genes. However, as we show here, GR binding is a poor predictor of GR-dependent gene regulation even when taking the 3D organization of the genome into account. To connect GR binding sites to the regulation of genes in the endogenous genomic context, we turned to genome editing. By deleting GR binding sites, individually or in combination, we uncovered how cooperative interactions between binding sites contribute to the regulation of genes. Specifically, for the GR target gene GILZ, we show that the simultaneous presence of a cluster of GR binding sites is required for the activity of an individual enhancer and that the GR-dependent regulation of GILZ depends on multiple GR-bound enhancers. Further, by deleting GR binding sites that are shared between different cell types, we show how cell type-specific genome organization and enhancer-blocking can result in cell type-specific wiring of promoter-enhancer contacts. This rewiring allows an individual GR binding site shared between different cell types to direct the expression of distinct transcripts and thereby contributes to the cell type-specific consequences of glucocorticoid signaling.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="425" length="16"/><text>GR binding sites</text></annotation><annotation id="2"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="286" length="2"/><text>GR</text></annotation><annotation id="3"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="320" length="2"/><text>GR</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="796" length="16"/><text>GR binding sites</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="974" length="16"/><text>GR binding sites</text></annotation><annotation id="6"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="720" length="2"/><text>GR</text></annotation><annotation id="7"><infon key="identifier">1831</infon><infon key="type">GENE</infon><location offset="735" length="4"/><text>GILZ</text></annotation><annotation id="8"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="881" length="2"/><text>GR</text></annotation><annotation id="9"><infon key="identifier">1831</infon><infon key="type">GENE</infon><location offset="908" length="4"/><text>GILZ</text></annotation><annotation id="10"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="933" length="2"/><text>GR</text></annotation><annotation id="11"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="974" length="2"/><text>GR</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="545" length="16"/><text>GR binding sites</text></annotation><annotation id="13"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="1216" length="2"/><text>GR</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="933" length="18"/><text>GR-bound enhancers</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="859" length="8"/><text>enhancer</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1216" length="15"/><text>GR binding site</text></annotation><annotation id="17"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="425" length="2"/><text>GR</text></annotation><annotation id="18"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="545" length="2"/><text>GR</text></annotation><annotation id="19"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="796" length="2"/><text>GR</text></annotation><annotation id="20"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="192" length="23"/><text>glucocorticoid receptor</text></annotation><annotation id="21"><infon key="identifier">2908</infon><infon key="type">GENE</infon><location offset="217" length="2"/><text>GR</text></annotation></passage></document>
<document><id>29408204</id><passage><offset>0</offset><text>High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. Cutaneous melanoma is an aggressive tumor that accounts for most skin cancer deaths. Among the physiological barriers against therapeutic success is a strong survival program driven by genes such as MITF that specify melanocyte identity, a phenomenon known in melanoma biology as lineage dependency. MITF overexpression is occasionally explained by gene amplification, but here we show that super-enhancers are also important determinants of MITF overexpression in some melanoma cell lines and tumors. Although compounds that directly inhibit MITF are unavailable, a covalent CDK7 inhibitor, THZ1, has recently been shown to potently suppress the growth of various cancers through the depletion of master transcription-regulating oncogenes and the disruption of their attendant super-enhancers. We also show that melanoma cells are highly sensitive to CDK7 inhibition both in vitro and in vivo and that THZ1 can dismantle the super-enhancer apparatus at MITF and SOX10 in some cell lines, thereby extinguishing their intracellular levels. Our results show a dimension to MITF regulation in melanoma cells and point to CDK7 inhibition as a potential strategy to deprive oncogenic transcription and suppress tumor growth in melanoma.</text><annotation id="1"><infon key="identifier">0000849</infon><infon key="type">TISSUE</infon><location offset="573" length="19"/><text>melanoma cell lines</text></annotation><annotation id="2"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="302" length="4"/><text>MITF</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="363" length="8"/><text>melanoma</text></annotation><annotation id="4"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="403" length="4"/><text>MITF</text></annotation><annotation id="5"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="545" length="4"/><text>MITF</text></annotation><annotation id="6"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="1057" length="4"/><text>MITF</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="597" length="6"/><text>tumors</text></annotation><annotation id="8"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="646" length="4"/><text>MITF</text></annotation><annotation id="9"><infon key="identifier">1022</infon><infon key="type">GENE</infon><location offset="679" length="4"/><text>CDK7</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="768" length="7"/><text>cancers</text></annotation><annotation id="11"><infon key="identifier">6663</infon><infon key="type">GENE</infon><location offset="1066" length="5"/><text>SOX10</text></annotation><annotation id="12"><infon key="identifier">0000848</infon><infon key="type">TISSUE</infon><location offset="916" length="14"/><text>melanoma cells</text></annotation><annotation id="13"><infon key="identifier">1022</infon><infon key="type">GENE</infon><location offset="955" length="4"/><text>CDK7</text></annotation><annotation id="14"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="1174" length="4"/><text>MITF</text></annotation><annotation id="15"><infon key="attribute">CANCER</infon><infon key="identifier">0000848</infon><infon key="type">TISSUE</infon><location offset="1193" length="14"/><text>melanoma cells</text></annotation><annotation id="16"><infon key="identifier">1022</infon><infon key="type">GENE</infon><location offset="1221" length="4"/><text>CDK7</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="1309" length="5"/><text>tumor</text></annotation><annotation id="18"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="1325" length="8"/><text>melanoma</text></annotation><annotation id="19"><infon key="identifier">0000847</infon><infon key="type">TISSUE</infon><location offset="320" length="10"/><text>melanocyte</text></annotation><annotation id="20"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1029" length="42"/><text>super-enhancer apparatus at MITF and SOX10</text></annotation><annotation id="21"><infon key="identifier">4286</infon><infon key="type">GENE</infon><location offset="5" length="4"/><text>MITF</text></annotation><annotation id="22"><infon key="identifier">1022</infon><infon key="type">GENE</infon><location offset="74" length="4"/><text>CDK7</text></annotation><annotation id="23"><infon key="attribute">CANCER</infon><infon key="identifier">0005105</infon><infon key="type">DISEASE</infon><location offset="93" length="8"/><text>Melanoma</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0005012</infon><infon key="type">DISEASE</infon><location offset="103" length="18"/><text>Cutaneous melanoma</text></annotation><annotation id="25"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="139" length="5"/><text>tumor</text></annotation><annotation id="26"><infon key="attribute">CANCER</infon><infon key="identifier">0002898</infon><infon key="type">DISEASE</infon><location offset="168" length="11"/><text>skin cancer</text></annotation></passage></document>
<document><id>29416716</id><passage><offset>0</offset><text>Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets. Ewing sarcoma is an undifferentiated small-round-cell sarcoma. Although molecular detection of pathognomonic EWSR1-ETS fusions such as EWSR1-FLI1 enables definitive diagnosis, substantial confusion can arise if molecular diagnostics are unavailable. Diagnosis based on the conventional immunohistochemical marker CD99 is unreliable due to its abundant expression in morphological mimics. To identify novel diagnostic immunohistochemical markers for Ewing sarcoma, we performed comparative expression analyses in 768 tumors representing 21 entities including Ewing-like sarcomas, which confirmed that CIC-DUX4-, BCOR-CCNB3-, EWSR1-NFATc2-, and EWSR1-ETS-translocated sarcomas are distinct entities, and revealed that ATP1A1, BCL11B, and GLG1 constitute specific markers for Ewing sarcoma. Their high expression was validated by immunohistochemistry and proved to depend on EWSR1-FLI1-binding to highly active proximal super-enhancers. Automated cut-off-finding and combination-testing in a tissue-microarray comprising 174 samples demonstrated that detection of high BCL11B and/or GLG1 expression is sufficient to reach 96% specificity for Ewing sarcoma. While 88% of tested Ewing-like sarcomas displayed strong CD99-immunoreactivity, none displayed combined strong BCL11B- and GLG1-immunoreactivity. Collectively, we show that ATP1A1, BCL11B, and GLG1 are EWSR1-FLI1 targets, of which BCL11B and GLG1 offer a fast, simple, and cost-efficient way to diagnose Ewing sarcoma by immunohistochemistry. These markers may significantly reduce the number of misdiagnosed patients, and thus improve patient care.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="560" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="2"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="98" length="3"/><text>ETS</text></annotation><annotation id="3"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="669" length="19"/><text>Ewing-like sarcomas</text></annotation><annotation id="4"><infon key="identifier">54880</infon><infon key="type">GENE</infon><location offset="722" length="4"/><text>BCOR</text></annotation><annotation id="5"><infon key="identifier">85417</infon><infon key="type">GENE</infon><location offset="727" length="5"/><text>CCNB3</text></annotation><annotation id="6"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="735" length="5"/><text>EWSR1</text></annotation><annotation id="7"><infon key="identifier">4773</infon><infon key="type">GENE</infon><location offset="741" length="6"/><text>NFATc2</text></annotation><annotation id="8"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="754" length="5"/><text>EWSR1</text></annotation><annotation id="9"><infon key="attribute">CANCER</infon><infon key="identifier">0005089</infon><infon key="type">DISEASE</infon><location offset="777" length="8"/><text>sarcomas</text></annotation><annotation id="10"><infon key="identifier">476</infon><infon key="type">GENE</infon><location offset="827" length="6"/><text>ATP1A1</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="20" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="12"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="835" length="6"/><text>BCL11B</text></annotation><annotation id="13"><infon key="identifier">2734</infon><infon key="type">GENE</infon><location offset="847" length="4"/><text>GLG1</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="884" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="15"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="983" length="5"/><text>EWSR1</text></annotation><annotation id="16"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="989" length="4"/><text>FLI1</text></annotation><annotation id="17"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="1177" length="6"/><text>BCL11B</text></annotation><annotation id="18"><infon key="identifier">2734</infon><infon key="type">GENE</infon><location offset="1191" length="4"/><text>GLG1</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="1250" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="1285" length="19"/><text>Ewing-like sarcomas</text></annotation><annotation id="21"><infon key="identifier">4267</infon><infon key="type">GENE</infon><location offset="1322" length="4"/><text>CD99</text></annotation><annotation id="22"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="92" length="5"/><text>EWSR1</text></annotation><annotation id="23"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="1376" length="6"/><text>BCL11B</text></annotation><annotation id="24"><infon key="identifier">2734</infon><infon key="type">GENE</infon><location offset="1388" length="4"/><text>GLG1</text></annotation><annotation id="25"><infon key="identifier">476</infon><infon key="type">GENE</infon><location offset="1438" length="6"/><text>ATP1A1</text></annotation><annotation id="26"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="1446" length="6"/><text>BCL11B</text></annotation><annotation id="27"><infon key="identifier">2734</infon><infon key="type">GENE</infon><location offset="1458" length="4"/><text>GLG1</text></annotation><annotation id="28"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="1467" length="5"/><text>EWSR1</text></annotation><annotation id="29"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="1473" length="4"/><text>FLI1</text></annotation><annotation id="30"><infon key="identifier">64919</infon><infon key="type">GENE</infon><location offset="1496" length="6"/><text>BCL11B</text></annotation><annotation id="31"><infon key="identifier">2734</infon><infon key="type">GENE</infon><location offset="1507" length="4"/><text>GLG1</text></annotation><annotation id="32"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="1569" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="33"><infon key="attribute">CANCER</infon><infon key="identifier">0012817</infon><infon key="type">DISEASE</infon><location offset="111" length="13"/><text>Ewing sarcoma</text></annotation><annotation id="34"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="226" length="3"/><text>ETS</text></annotation><annotation id="35"><infon key="attribute">CANCER</infon><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="627" length="6"/><text>tumors</text></annotation><annotation id="36"><infon key="identifier">2113</infon><infon key="type">GENE</infon><location offset="760" length="3"/><text>ETS</text></annotation><annotation id="37"><infon key="identifier">100288687</infon><infon key="type">GENE</infon><location offset="715" length="4"/><text>DUX4</text></annotation><annotation id="38"><infon key="identifier">23152</infon><infon key="type">GENE</infon><location offset="711" length="3"/><text>CIC</text></annotation><annotation id="39"><infon key="attribute">CANCER</infon><infon key="identifier">0006974</infon><infon key="type">DISEASE</infon><location offset="148" length="24"/><text>small-round-cell sarcoma</text></annotation><annotation id="40"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="220" length="5"/><text>EWSR1</text></annotation><annotation id="41"><infon key="identifier">2130</infon><infon key="type">GENE</infon><location offset="246" length="5"/><text>EWSR1</text></annotation><annotation id="42"><infon key="identifier">2313</infon><infon key="type">GENE</infon><location offset="252" length="4"/><text>FLI1</text></annotation><annotation id="43"><infon key="identifier">4267</infon><infon key="type">GENE</infon><location offset="424" length="4"/><text>CD99</text></annotation></passage></document>
<document><id>29453285</id><passage><offset>0</offset><text>The distal upstream region of insulin-like growth factor-binding protein-1 enhances its expression in endometrial stromal cells during decidualization. We have previously shown that decidualization of human endometrial stromal cells (ESCs) causes a genome-wide increase in the levels of acetylation of histone-H3 Lys-27 (H3K27ac). We also reported that the distal gene regions, more than 3 kb up- or downstream of gene transcription start sites have increased H3K27ac levels. Insulin-like growth factor-binding protein-1 (IGFBP-1) is a specific decidualization marker and has increased H3K27ac levels in its distal upstream region (-4701 to -7501 bp). Here, using a luciferase reporter gene construct containing this IGFBP-1 upstream region, we tested the hypothesis that it is an IGFBP-1 enhancer. To induce decidualization, we incubated ESCs with cAMP and found that cAMP increased luciferase expression, indicating that decidualization increased the transcriptional activity from the IGFBP-1 upstream region. Furthermore, CRISPR/Cas9-mediated deletion of this region in HepG2 cells significantly reduced IGFBP-1 expression, confirming its role as an IGFBP-1 enhancer. A ChIP assay revealed that cAMP increased the recruitment of the transcriptional regulators CCAAT enhancer-binding protein beta (C/EBPbeta), forkhead box O1 (FOXO1), and p300 to the IGFBP-1 enhancer in ESCs. Of note, C/EBPbeta knockdown inhibited the stimulatory effects of cAMP on the levels of H3K27ac, chromatin opening, and p300 recruitment at the IGFBP-1 enhancer. These results indicate that the region -4701 to -7501 bp upstream of IGFBP-1 functions as an enhancer for IGFBP-1 expression in ESCs undergoing decidualization, that C/EBPbeta and FOXO1 bind to the enhancer region to up-regulate IGFBP-1 expression, and that C/EBPbeta induces H3K27ac by recruiting p300 to the IGFBP-1 enhancer.</text><annotation id="1"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="781" length="16"/><text>IGFBP-1 enhancer</text></annotation><annotation id="2"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1153" length="16"/><text>IGFBP-1 enhancer</text></annotation><annotation id="3"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="476" length="44"/><text>Insulin-like growth factor-binding protein-1</text></annotation><annotation id="4"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="522" length="7"/><text>IGFBP-1</text></annotation><annotation id="5"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="717" length="23"/><text>IGFBP-1 upstream region</text></annotation><annotation id="6"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="839" length="4"/><text>ESCs</text></annotation><annotation id="7"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="987" length="23"/><text>IGFBP-1 upstream region</text></annotation><annotation id="8"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1107" length="7"/><text>IGFBP-1</text></annotation><annotation id="9"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="30" length="44"/><text>insulin-like growth factor-binding protein-1</text></annotation><annotation id="10"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1263" length="35"/><text>CCAAT enhancer-binding protein beta</text></annotation><annotation id="11"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1300" length="9"/><text>C/EBPbeta</text></annotation><annotation id="12"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1312" length="15"/><text>forkhead box O1</text></annotation><annotation id="13"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="1373" length="4"/><text>ESCs</text></annotation><annotation id="14"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1329" length="5"/><text>FOXO1</text></annotation><annotation id="15"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1341" length="4"/><text>p300</text></annotation><annotation id="16"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1573" length="44"/><text>region -4701 to -7501 bp upstream of IGFBP-1</text></annotation><annotation id="17"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1388" length="9"/><text>C/EBPbeta</text></annotation><annotation id="18"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1499" length="4"/><text>p300</text></annotation><annotation id="19"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="1669" length="4"/><text>ESCs</text></annotation><annotation id="20"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="608" length="42"/><text>distal upstream region (-4701 to -7501 bp)</text></annotation><annotation id="21"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="717" length="7"/><text>IGFBP-1</text></annotation><annotation id="22"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1707" length="9"/><text>C/EBPbeta</text></annotation><annotation id="23"><infon key="identifier">2308</infon><infon key="type">GENE</infon><location offset="1721" length="5"/><text>FOXO1</text></annotation><annotation id="24"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1353" length="16"/><text>IGFBP-1 enhancer</text></annotation><annotation id="25"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1770" length="7"/><text>IGFBP-1</text></annotation><annotation id="26"><infon key="identifier">1051</infon><infon key="type">GENE</infon><location offset="1799" length="9"/><text>C/EBPbeta</text></annotation><annotation id="27"><infon key="identifier">2033</infon><infon key="type">GENE</infon><location offset="1839" length="4"/><text>p300</text></annotation><annotation id="28"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="781" length="7"/><text>IGFBP-1</text></annotation><annotation id="29"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1610" length="7"/><text>IGFBP-1</text></annotation><annotation id="30"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="102" length="25"/><text>endometrial stromal cells</text></annotation><annotation id="31"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="207" length="25"/><text>endometrial stromal cells</text></annotation><annotation id="32"><infon key="identifier">0003697</infon><infon key="type">TISSUE</infon><location offset="234" length="4"/><text>ESCs</text></annotation><annotation id="33"><infon key="identifier">0000599</infon><infon key="type">TISSUE</infon><location offset="1073" length="11"/><text>HepG2 cells</text></annotation><annotation id="34"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1647" length="7"/><text>IGFBP-1</text></annotation><annotation id="35"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1523" length="16"/><text>IGFBP-1 enhancer</text></annotation><annotation id="36"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1851" length="7"/><text>IGFBP-1</text></annotation><annotation id="37"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1523" length="7"/><text>IGFBP-1</text></annotation><annotation id="38"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1153" length="7"/><text>IGFBP-1</text></annotation><annotation id="39"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="987" length="7"/><text>IGFBP-1</text></annotation><annotation id="40"><infon key="identifier">3484</infon><infon key="type">GENE</infon><location offset="1353" length="7"/><text>IGFBP-1</text></annotation><annotation id="41"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1634" length="20"/><text>enhancer for IGFBP-1</text></annotation><annotation id="42"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1739" length="15"/><text>enhancer region</text></annotation><annotation id="43"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="1851" length="16"/><text>IGFBP-1 enhancer</text></annotation><annotation id="44"><infon key="attribute">SUFFICIENT</infon><infon key="comment">hg19:7,45920458,45923258</infon><infon key="type">ENHANCER</infon><infon key="identifier">7,45920458,45923258</infon><infon key="gb">hg</infon><location offset="4" length="70"/><text>distal upstream region of insulin-like growth factor-binding protein-1</text></annotation><annotation id="45"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="201" length="5"/><text>human</text></annotation></passage></document>
<document><id>29507293</id><passage><offset>0</offset><text>Dissecting super-enhancer hierarchy based on chromatin interactions. Recent studies have highlighted super-enhancers (SEs) as important regulatory elements for gene expression, but their intrinsic properties remain incompletely characterized. Through an integrative analysis of Hi-C and ChIP-seq data, here we find that a significant fraction of SEs are hierarchically organized, containing both hub and non-hub enhancers. Hub enhancers share similar histone marks with non-hub enhancers, but are distinctly associated with cohesin and CTCF binding sites and disease-associated genetic variants. Genetic ablation of hub enhancers results in profound defects in gene activation and local chromatin landscape. As such, hub enhancers are the major constituents responsible for SE functional and structural organization.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="536" length="18"/><text>CTCF binding sites</text></annotation><annotation id="2"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="536" length="4"/><text>CTCF</text></annotation></passage></document>
<document><id>29514092</id><passage><offset>0</offset><text>Transcription Factor IRF8 Governs Enhancer Landscape Dynamics in Mononuclear Phagocyte Progenitors. Monocytes and dendritic cells (DCs), mononuclear phagocytes essential for immune responses, develop from hematopoietic stem cells via monocyte-DC progenitors (MDPs). The molecular basis of their development remains unclear. Because promoter-distal enhancers are key to cell fate decisions, we analyzed enhancer landscapes during mononuclear phagocyte development in vivo. Monocyte- and DC-specific enhancers were gradually established at progenitor stages before the expression of associated genes. Of the transcription factors predicted to bind to these enhancers, IRF8, essential for monocyte and DC development, was found to be required for the establishment of these enhancers, particularly those common to both monocyte and DC lineages. Although Irf8-/- mononuclear phagocyte progenitors, including MDPs, displayed grossly normal gene expression patterns, their enhancer landscapes resembled that of an upstream progenitor population. Our results illustrate the dynamic process by which key transcription factors regulate enhancer formation and, therefore, direct future gene expression to achieve mononuclear phagocyte development.</text><annotation id="1"><infon key="identifier">0001433</infon><infon key="type">TISSUE</infon><location offset="429" length="21"/><text>mononuclear phagocyte</text></annotation><annotation id="2"><infon key="identifier">3394</infon><infon key="type">GENE</infon><location offset="666" length="4"/><text>IRF8</text></annotation><annotation id="3"><infon key="identifier">3394</infon><infon key="type">GENE</infon><location offset="851" length="4"/><text>Irf8</text></annotation><annotation id="4"><infon key="identifier">0001433</infon><infon key="type">TISSUE</infon><location offset="65" length="21"/><text>Mononuclear Phagocyte</text></annotation><annotation id="5"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="100" length="9"/><text>Monocytes</text></annotation><annotation id="6"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="486" length="2"/><text>DC</text></annotation><annotation id="7"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="114" length="15"/><text>dendritic cells</text></annotation><annotation id="8"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="131" length="3"/><text>DCs</text></annotation><annotation id="9"><infon key="identifier">0001433</infon><infon key="type">TISSUE</infon><location offset="137" length="22"/><text>mononuclear phagocytes</text></annotation><annotation id="10"><infon key="identifier">0000725</infon><infon key="type">TISSUE</infon><location offset="205" length="24"/><text>hematopoietic stem cells</text></annotation><annotation id="11"><infon key="type">TISSUE</infon><location offset="234" length="23"/><text>monocyte-DC progenitors</text></annotation><annotation id="12"><infon key="type">TISSUE</infon><location offset="259" length="4"/><text>MDPs</text></annotation><annotation id="13"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="829" length="11"/><text>DC lineages</text></annotation><annotation id="14"><infon key="type">TISSUE</infon><location offset="859" length="33"/><text>mononuclear phagocyte progenitors</text></annotation><annotation id="15"><infon key="type">TISSUE</infon><location offset="904" length="4"/><text>MDPs</text></annotation><annotation id="16"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="472" length="8"/><text>Monocyte</text></annotation><annotation id="17"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="686" length="8"/><text>monocyte</text></annotation><annotation id="18"><infon key="identifier">0002042</infon><infon key="type">TISSUE</infon><location offset="699" length="2"/><text>DC</text></annotation><annotation id="19"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="816" length="8"/><text>monocyte</text></annotation><annotation id="20"><infon key="identifier">0001433</infon><infon key="type">TISSUE</infon><location offset="1203" length="21"/><text>mononuclear phagocyte</text></annotation><annotation id="21"><infon key="identifier">3394</infon><infon key="type">GENE</infon><location offset="21" length="4"/><text>IRF8</text></annotation></passage></document>
<document><id>29527594</id><passage><offset>0</offset><text>A Novel Distal Enhancer Mediates Inflammation-, PTH-, and Early Onset Murine Kidney Disease-Induced Expression of the Mouse Fgf23 Gene. Fibroblast growth factor 23 (FGF23) production is regulated by both calciotropic hormones and inflammation. Consistent with this, elevated FGF23 levels are associated with inflammatory markers as well as parathyroid hormone (PTH) in various disease states, including chronic kidney disease (CKD). However, the molecular mechanisms underpinning Fgf23 transcription in response to these regulators are largely unknown. We therefore utilized chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) data from an osteocyte cell line to identify potential regulatory regions of the Fgf23 gene. Based on ChIP-seq analysis of enhancer-associated histone modifications, including H3K4 methylation and H3K9 acetylation, we discovered several potential enhancers for Fgf23, one of which was located 16kb upstream of the gene's transcriptional start site. Deletion of this putative enhancer from the mouse genome using CRISPR-Cas9 technology led to lower bone, thymus, and spleen expression of Fgf23 mRNA without altering circulating levels of the intact hormone, although as previously reported, only bone displayed significant basal expression. Nevertheless, lack of the -16kb enhancer blunted FGF23 upregulation in a tissue-specific manner by the acute inflammatory inducers lipopolysaccharide (LPS), interleukin-1-beta (IL-1beta), and tumor necrosis factor-alpha (TNFalpha) in bone, non-osseous tissues, and in circulation. Lack of the -16kb enhancer also inhibited PTH-induced bone Fgf23 mRNA. Moreover, the absence of this Fgf23 enhancer in an oxalate diet-induced murine CKD model prevented the early onset induction of osseous, renal, and thymic Fgf23 mRNA levels and led to a significant blunting of elevated circulating intact FGF23 levels. These results suggest that -16kb enhancer mediates the induction of Fgf23 by inflammation and PTH and facilitates the increase in FGF23 expression in a murine model of CKD. As exemplified herein, these Fgf23 enhancer-deleted mice will provide a unique model in which to study the role of FGF23 expression in inflammatory diseases.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="8" length="15"/><text>Distal Enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="911" length="79"/><text>one of which was located 16kb upstream of the gene's transcriptional start site</text></annotation><annotation id="3"><infon key="identifier">0005240</infon><infon key="type">DISEASE</infon><location offset="77" length="14"/><text>Kidney Disease</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="118" length="5"/><text>Mouse</text></annotation><annotation id="5"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="124" length="5"/><text>Fgf23</text></annotation><annotation id="6"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="136" length="27"/><text>Fibroblast growth factor 23</text></annotation><annotation id="7"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="165" length="5"/><text>FGF23</text></annotation><annotation id="8"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="275" length="5"/><text>FGF23</text></annotation><annotation id="9"><infon key="identifier">19226</infon><infon key="type">GENE</infon><location offset="340" length="19"/><text>parathyroid hormone</text></annotation><annotation id="10"><infon key="identifier">0005300</infon><infon key="type">DISEASE</infon><location offset="403" length="22"/><text>chronic kidney disease</text></annotation><annotation id="11"><infon key="identifier">0005300</infon><infon key="type">DISEASE</infon><location offset="427" length="3"/><text>CKD</text></annotation><annotation id="12"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="480" length="5"/><text>Fgf23</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="890" length="19"/><text>enhancers for Fgf23</text></annotation><annotation id="14"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="724" length="5"/><text>Fgf23</text></annotation><annotation id="15"><infon key="identifier">19226</infon><infon key="type">GENE</infon><location offset="48" length="3"/><text>PTH</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1036" length="5"/><text>mouse</text></annotation><annotation id="17"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1130" length="5"/><text>Fgf23</text></annotation><annotation id="18"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1332" length="5"/><text>FGF23</text></annotation><annotation id="19"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="1440" length="18"/><text>interleukin-1-beta</text></annotation><annotation id="20"><infon key="identifier">16176</infon><infon key="type">GENE</infon><location offset="1460" length="8"/><text>IL-1beta</text></annotation><annotation id="21"><infon key="identifier">21926</infon><infon key="type">GENE</infon><location offset="1475" length="27"/><text>tumor necrosis factor-alpha</text></annotation><annotation id="22"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="1517" length="4"/><text>bone</text></annotation><annotation id="23"><infon key="identifier">21926</infon><infon key="type">GENE</infon><location offset="1504" length="8"/><text>TNFalpha</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1018" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1623" length="5"/><text>Fgf23</text></annotation><annotation id="26"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="904" length="5"/><text>Fgf23</text></annotation><annotation id="27"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1707" length="6"/><text>murine</text></annotation><annotation id="28"><infon key="identifier">0005300</infon><infon key="type">DISEASE</infon><location offset="1714" length="3"/><text>CKD</text></annotation><annotation id="29"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1790" length="5"/><text>Fgf23</text></annotation><annotation id="30"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1873" length="5"/><text>FGF23</text></annotation><annotation id="31"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1955" length="5"/><text>Fgf23</text></annotation><annotation id="32"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="2017" length="5"/><text>FGF23</text></annotation><annotation id="33"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="2039" length="6"/><text>murine</text></annotation><annotation id="34"><infon key="identifier">0005300</infon><infon key="type">DISEASE</infon><location offset="2055" length="3"/><text>CKD</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1309" length="14"/><text>-16kb enhancer</text></annotation><annotation id="36"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="1665" length="5"/><text>Fgf23</text></annotation><annotation id="37"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="2112" length="4"/><text>mice</text></annotation><annotation id="38"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="2175" length="5"/><text>FGF23</text></annotation><annotation id="39"><infon key="identifier">0021166</infon><infon key="type">DISEASE</infon><location offset="2195" length="21"/><text>inflammatory diseases</text></annotation><annotation id="40"><infon key="identifier">64654</infon><infon key="type">GENE</infon><location offset="2089" length="5"/><text>Fgf23</text></annotation><annotation id="41"><infon key="identifier">19226</infon><infon key="type">GENE</infon><location offset="361" length="3"/><text>PTH</text></annotation><annotation id="42"><infon key="identifier">0005488</infon><infon key="type">TISSUE</infon><location offset="656" length="19"/><text>osteocyte cell line</text></annotation><annotation id="43"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="1091" length="4"/><text>bone</text></annotation><annotation id="44"><infon key="identifier">0001374</infon><infon key="type">TISSUE</infon><location offset="1097" length="6"/><text>thymus</text></annotation><annotation id="45"><infon key="identifier">0001281</infon><infon key="type">TISSUE</infon><location offset="1109" length="6"/><text>spleen</text></annotation><annotation id="46"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1576" length="14"/><text>-16kb enhancer</text></annotation><annotation id="47"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="1238" length="4"/><text>bone</text></annotation><annotation id="48"><infon key="identifier">0000140</infon><infon key="type">TISSUE</infon><location offset="1606" length="16"/><text>PTH-induced bone</text></annotation><annotation id="49"><infon key="identifier">19226</infon><infon key="type">GENE</infon><location offset="1981" length="3"/><text>PTH</text></annotation><annotation id="50"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1665" length="14"/><text>Fgf23 enhancer</text></annotation><annotation id="51"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1914" length="14"/><text>-16kb enhancer</text></annotation><annotation id="52"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2089" length="14"/><text>Fgf23 enhancer</text></annotation><annotation id="53"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="70" length="6"/><text>Murine</text></annotation></passage></document>
<document><id>29695788</id><passage><offset>0</offset><text>TFAP2C regulates transcription in human naive pluripotency by opening enhancers. Naive and primed pluripotent human embryonic stem cells bear transcriptional similarity to pre- and post-implantation epiblast and thus constitute a developmental model for understanding the pluripotent stages in human embryo development. To identify new transcription factors that differentially regulate the unique pluripotent stages, we mapped open chromatin using ATAC-seq and found enrichment of the activator protein-2 (AP2) transcription factor binding motif at naive-specific open chromatin. We determined that the AP2 family member TFAP2C is upregulated during primed to naive reversion and becomes widespread at naive-specific enhancers. TFAP2C functions to maintain pluripotency and repress neuroectodermal differentiation during the transition from primed to naive by facilitating the opening of enhancers proximal to pluripotency factors. Additionally, we identify a previously undiscovered naive-specific POU5F1 (OCT4) enhancer enriched for TFAP2C binding. Taken together, TFAP2C establishes and maintains naive human pluripotency and regulates OCT4 expression by mechanisms that are distinct from mouse.</text><annotation id="1"><infon key="identifier">0004593</infon><infon key="type">TISSUE</infon><location offset="199" length="8"/><text>epiblast</text></annotation><annotation id="2"><infon key="identifier">7020</infon><infon key="type">GENE</infon><location offset="604" length="3"/><text>AP2</text></annotation><annotation id="3"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="622" length="6"/><text>TFAP2C</text></annotation><annotation id="4"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="729" length="6"/><text>TFAP2C</text></annotation><annotation id="5"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="1036" length="6"/><text>TFAP2C</text></annotation><annotation id="6"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="1068" length="6"/><text>TFAP2C</text></annotation><annotation id="7"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1107" length="5"/><text>human</text></annotation><annotation id="8"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1140" length="4"/><text>OCT4</text></annotation><annotation id="9"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1193" length="5"/><text>mouse</text></annotation><annotation id="10"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1000" length="6"/><text>POU5F1</text></annotation><annotation id="11"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="110" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="486" length="60"/><text>activator protein-2 (AP2) transcription factor binding motif</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="985" length="37"/><text>naive-specific POU5F1 (OCT4) enhancer</text></annotation><annotation id="14"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="0" length="6"/><text>TFAP2C</text></annotation><annotation id="15"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="34" length="5"/><text>human</text></annotation><annotation id="16"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="1008" length="4"/><text>OCT4</text></annotation><annotation id="17"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="294" length="5"/><text>human</text></annotation><annotation id="18"><infon key="identifier">7020</infon><infon key="type">GENE</infon><location offset="486" length="19"/><text>activator protein-2</text></annotation><annotation id="19"><infon key="identifier">7020</infon><infon key="type">GENE</infon><location offset="507" length="3"/><text>AP2</text></annotation></passage></document>
<document><id>29706059</id><passage><offset>0</offset><text>Identification of Smoking-Associated Differentially Methylated Regions Using Reduced Representation Bisulfite Sequencing and Cell type-Specific Enhancer Activation and Gene Expression. BACKGROUND: Cigarette smoke is a causal factor in cancers and cardiovascular disease. Smoking-associated differentially methylated regions (SM-DMRs) have been observed in disease studies, but the causal link between altered DNA methylation and transcriptional change is obscure. OBJECTIVE: Our objectives were to finely resolve SM-DMRs and to interrogate the mechanistic link between SM-DMRs and altered transcription of enhancer noncoding RNA (eRNA) and mRNA in human circulating monocytes. METHOD: We integrated SM-DMRs identified by reduced representation bisulfite sequencing (RRBS) of circulating CD14+ monocyte DNA collected from two independent human studies [n=38 from Clinical Research Unit (CRU) and n=55 from the Multi-Ethnic Study of Atherosclerosis (MESA), about half of whom were active smokers] with gene expression for protein-coding genes and noncoding RNAs measured by RT-PCR or RNA sequencing. Candidate SM-DMRs were compared with RRBS of purified CD4+ T cells, CD8+ T cells, CD15+ granulocytes, CD19+ B cells, and CD56+ NK cells (n=19 females, CRU). DMRs were validated using pyrosequencing or bisulfite amplicon sequencing in up to 85 CRU volunteers, who also provided saliva DNA. RESULTS: RRBS identified monocyte SM-DMRs frequently located in putative gene regulatory regions. The most significant monocyte DMR occurred at a poised enhancer in the aryl-hydrocarbon receptor repressor gene (AHRR) and it was also detected in both granulocytes and saliva DNA. To our knowledge, we identify for the first time that SM-DMRs in or near AHRR, C5orf55-EXOC-AS, and SASH1 were associated with increased noncoding eRNA as well as mRNA in monocytes. Functionally, the AHRR SM-DMR appeared to up-regulate AHRR mRNA through activating the AHRR enhancer, as suggested by increased eRNA in the monocytes, but not granulocytes, from smokers compared with nonsmokers. CONCLUSIONS: Our findings suggest that AHRR SM-DMR up-regulates AHRR mRNA in a monocyte-specific manner by activating the AHRR enhancer. Cell type-specific activation of enhancers at SM-DMRs may represent a mechanism driving smoking-related disease. https://doi.org/10.1289/EHP2395.</text><annotation id="1"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="666" length="9"/><text>monocytes</text></annotation><annotation id="2"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="837" length="5"/><text>human</text></annotation><annotation id="3"><infon key="identifier">0005311</infon><infon key="type">DISEASE</infon><location offset="931" length="15"/><text>Atherosclerosis</text></annotation><annotation id="4"><infon key="identifier">0000539</infon><infon key="type">TISSUE</infon><location offset="1180" length="18"/><text>CD15+ granulocytes</text></annotation><annotation id="5"><infon key="identifier">0005244</infon><infon key="type">TISSUE</infon><location offset="1200" length="13"/><text>CD19+ B cells</text></annotation><annotation id="6"><infon key="identifier">0003287</infon><infon key="type">TISSUE</infon><location offset="1219" length="14"/><text>CD56+ NK cells</text></annotation><annotation id="7"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="1412" length="8"/><text>monocyte</text></annotation><annotation id="8"><infon key="identifier">0000539</infon><infon key="type">TISSUE</infon><location offset="1637" length="12"/><text>granulocytes</text></annotation><annotation id="9"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="1837" length="9"/><text>monocytes</text></annotation><annotation id="10"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1739" length="4"/><text>AHRR</text></annotation><annotation id="11"><infon key="identifier">116349</infon><infon key="type">GENE</infon><location offset="1745" length="15"/><text>C5orf55-EXOC-AS</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1540" length="56"/><text>enhancer in the aryl-hydrocarbon receptor repressor gene</text></annotation><annotation id="13"><infon key="identifier">23328</infon><infon key="type">GENE</infon><location offset="1766" length="5"/><text>SASH1</text></annotation><annotation id="14"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1866" length="4"/><text>AHRR</text></annotation><annotation id="15"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1902" length="4"/><text>AHRR</text></annotation><annotation id="16"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="1988" length="9"/><text>monocytes</text></annotation><annotation id="17"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="2099" length="4"/><text>AHRR</text></annotation><annotation id="18"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="2124" length="4"/><text>AHRR</text></annotation><annotation id="19"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="1506" length="8"/><text>monocyte</text></annotation><annotation id="20"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1556" length="35"/><text>aryl-hydrocarbon receptor repressor</text></annotation><annotation id="21"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1598" length="4"/><text>AHRR</text></annotation><annotation id="22"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1152" length="12"/><text>CD4+ T cells</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1935" length="13"/><text>AHRR enhancer</text></annotation><annotation id="24"><infon key="identifier">0002417</infon><infon key="type">TISSUE</infon><location offset="1166" length="12"/><text>CD8+ T cells</text></annotation><annotation id="25"><infon key="identifier">0000539</infon><infon key="type">TISSUE</infon><location offset="2007" length="12"/><text>granulocytes</text></annotation><annotation id="26"><infon key="identifier">0000876</infon><infon key="type">TISSUE</infon><location offset="2139" length="8"/><text>monocyte</text></annotation><annotation id="27"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="1935" length="4"/><text>AHRR</text></annotation><annotation id="28"><infon key="identifier">57491</infon><infon key="type">GENE</infon><location offset="2182" length="4"/><text>AHRR</text></annotation><annotation id="29"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2182" length="13"/><text>AHRR enhancer</text></annotation><annotation id="30"><infon key="type">DISEASE</infon><location offset="2285" length="23"/><text>smoking-related disease</text></annotation><annotation id="31"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="235" length="7"/><text>cancers</text></annotation><annotation id="32"><infon key="identifier">0004995</infon><infon key="type">DISEASE</infon><location offset="247" length="22"/><text>cardiovascular disease</text></annotation><annotation id="33"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="648" length="5"/><text>human</text></annotation><annotation id="34"><infon key="type">TISSUE</infon><location offset="787" length="14"/><text>CD14+ monocyte</text></annotation></passage></document>
<document><id>29765516</id><passage><offset>0</offset><text>Selective dissociation between LSD1 and GFI1B by a LSD1 inhibitor NCD38 induces the activation of ERG super-enhancer in erythroleukemia cells. Lysine-specific demethylase 1 (LSD1) is a histone modifier for transcriptional repression involved in the regulation of hematopoiesis. We previously reported that a LSD1 inhibitor NCD38 induces transdifferentiation from erythroid lineage to granulomonocytic lineage and exerts anti-leukemia effect through de-repression of the specific super-enhancers of hematopoietic regulators including ERG in a human erythroleukemia cell line, HEL. However, the mechanistic basis for this specificity of NCD38 has remained unclear. Herein, we report major partners associated with LSD1 and clarify the mechanism in HEL cells. Proteome analysis identified 54 candidate proteins associated with LSD1, including several transcription factors such as GFI1B and RUNX1 as well as BRAF-histone deacetylase complex (BHC) components such as CoREST, HDAC1, and HDAC2. NCD38 selectively disrupted the interaction of LSD1 with GFI1B but not with RUNX1, CoREST, HDAC1 and HDAC2. Erg was downregulated in murine erythroid progenitors with prominent upregulation of Gfi1b. NCD38 induced ERG and attenuated an erythroid marker CD235a in HEL while this attenuation was mimicked by the lentiviral overexpression of ERG. The ERG super-enhancer contained the conserved binding motif of GFI1B and was actually occupied by GFI1B. NCD38 dissociated LSD1 and CoREST but not GFI1B from the ERG super-enhancer. Collectively, the selective separation of LSD1 from GFI1B by NCD38 restores the ERG super-enhancer activation and consequently upregulates ERG expression, inducing the transdifferentiation linked to the anti-leukemia effect.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0000565</infon><infon key="type">TISSUE</infon><location offset="542" length="31"/><text>human erythroleukemia cell line</text></annotation><annotation id="2"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="143" length="29"/><text>Lysine-specific demethylase 1</text></annotation><annotation id="3"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="174" length="4"/><text>LSD1</text></annotation><annotation id="4"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="308" length="4"/><text>LSD1</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="425" length="8"/><text>leukemia</text></annotation><annotation id="6"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="533" length="3"/><text>ERG</text></annotation><annotation id="7"><infon key="type">TISSUE</infon><location offset="384" length="24"/><text>granulomonocytic lineage</text></annotation><annotation id="8"><infon key="identifier">0000565</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="575" length="3"/><text>HEL</text></annotation><annotation id="9"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="712" length="4"/><text>LSD1</text></annotation><annotation id="10"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="824" length="4"/><text>LSD1</text></annotation><annotation id="11"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="878" length="5"/><text>GFI1B</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1337" length="18"/><text>ERG super-enhancer</text></annotation><annotation id="13"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="888" length="5"/><text>RUNX1</text></annotation><annotation id="14"><infon key="identifier">23186</infon><infon key="type">GENE</infon><location offset="963" length="6"/><text>CoREST</text></annotation><annotation id="15"><infon key="identifier">3065</infon><infon key="type">GENE</infon><location offset="971" length="5"/><text>HDAC1</text></annotation><annotation id="16"><infon key="identifier">3066</infon><infon key="type">GENE</infon><location offset="982" length="5"/><text>HDAC2</text></annotation><annotation id="17"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="1036" length="4"/><text>LSD1</text></annotation><annotation id="18"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="1046" length="5"/><text>GFI1B</text></annotation><annotation id="19"><infon key="identifier">861</infon><infon key="type">GENE</infon><location offset="1065" length="5"/><text>RUNX1</text></annotation><annotation id="20"><infon key="identifier">23186</infon><infon key="type">GENE</infon><location offset="1072" length="6"/><text>CoREST</text></annotation><annotation id="21"><infon key="identifier">3065</infon><infon key="type">GENE</infon><location offset="1080" length="5"/><text>HDAC1</text></annotation><annotation id="22"><infon key="identifier">3066</infon><infon key="type">GENE</infon><location offset="1090" length="5"/><text>HDAC2</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1496" length="18"/><text>ERG super-enhancer</text></annotation><annotation id="24"><infon key="identifier">13876</infon><infon key="type">GENE</infon><location offset="1097" length="3"/><text>Erg</text></annotation><annotation id="25"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1122" length="6"/><text>murine</text></annotation><annotation id="26"><infon key="identifier">14582</infon><infon key="type">GENE</infon><location offset="1182" length="5"/><text>Gfi1b</text></annotation><annotation id="27"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1203" length="3"/><text>ERG</text></annotation><annotation id="28"><infon key="identifier">2993</infon><infon key="type">GENE</infon><location offset="1242" length="6"/><text>CD235a</text></annotation><annotation id="29"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1328" length="3"/><text>ERG</text></annotation><annotation id="30"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1380" length="22"/><text>binding motif of GFI1B</text></annotation><annotation id="31"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="98" length="3"/><text>ERG</text></annotation><annotation id="32"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="1432" length="5"/><text>GFI1B</text></annotation><annotation id="33"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="1457" length="4"/><text>LSD1</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1596" length="18"/><text>ERG super-enhancer</text></annotation><annotation id="35"><infon key="identifier">23186</infon><infon key="type">GENE</infon><location offset="1466" length="6"/><text>CoREST</text></annotation><annotation id="36"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="1481" length="5"/><text>GFI1B</text></annotation><annotation id="37"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1337" length="3"/><text>ERG</text></annotation><annotation id="38"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="1558" length="4"/><text>LSD1</text></annotation><annotation id="39"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="1568" length="5"/><text>GFI1B</text></annotation><annotation id="40"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1596" length="3"/><text>ERG</text></annotation><annotation id="41"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1655" length="3"/><text>ERG</text></annotation><annotation id="42"><infon key="attribute">CANCER</infon><infon key="identifier">0005059</infon><infon key="type">DISEASE</infon><location offset="1724" length="8"/><text>leukemia</text></annotation><annotation id="43"><infon key="identifier">2078</infon><infon key="type">GENE</infon><location offset="1496" length="3"/><text>ERG</text></annotation><annotation id="44"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="363" length="17"/><text>erythroid lineage</text></annotation><annotation id="45"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="31" length="4"/><text>LSD1</text></annotation><annotation id="46"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="1397" length="5"/><text>GFI1B</text></annotation><annotation id="47"><infon key="identifier">0000565</infon><infon key="attribute">CANCER</infon><infon key="type">TISSUE</infon><location offset="746" length="9"/><text>HEL cells</text></annotation><annotation id="48"><infon key="identifier">673</infon><infon key="type">GENE</infon><location offset="905" length="4"/><text>BRAF</text></annotation><annotation id="49"><infon key="identifier">0004911</infon><infon key="type">TISSUE</infon><location offset="1129" length="21"/><text>erythroid progenitors</text></annotation><annotation id="50"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1225" length="9"/><text>erythroid</text></annotation><annotation id="51"><infon key="attribute">CANCER</infon><infon key="identifier">0000565</infon><infon key="type">TISSUE</infon><location offset="1252" length="3"/><text>HEL</text></annotation><annotation id="52"><infon key="identifier">8328</infon><infon key="type">GENE</infon><location offset="40" length="5"/><text>GFI1B</text></annotation><annotation id="53"><infon key="identifier">23028</infon><infon key="type">GENE</infon><location offset="51" length="4"/><text>LSD1</text></annotation><annotation id="54"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="98" length="18"/><text>ERG super-enhancer</text></annotation><annotation id="55"><infon key="attribute">CANCER</infon><infon key="identifier">0000426</infon><infon key="type">TISSUE</infon><location offset="120" length="21"/><text>erythroleukemia cells</text></annotation></passage></document>
<document><id>29898989</id><passage><offset>0</offset><text>Disruption of a -35 kb Enhancer Impairs CTCF Binding and MLH1 Expression in Colorectal Cells. Purpose:MLH1 is a major tumor suppressor gene involved in the pathogenesis of Lynch syndrome and various sporadic cancers. Despite their potential pathogenic importance, genomic regions capable of regulating MLH1 expression over long distances have yet to be identified.Experimental Design: Here, we use chromosome conformation capture (3C) to screen a 650-kb region flanking the MLH1 locus to identify interactions between the MLH1 promoter and distal regions in MLH1-expressing and nonexpressing cells. Putative enhancers were functionally validated using luciferase reporter assays, chromatin immunoprecipitation, and CRISPR-Cas9-mediated deletion of endogenous regions. To evaluate whether germline variants in the enhancer might contribute to impaired MLH1 expression in patients with suspected Lynch syndrome, we also screened germline DNA from a cohort of 74 patients with no known coding mutations or epimutations at the MLH1 promoter.Results: A 1.8-kb DNA fragment, 35 kb upstream of the MLH1 transcription start site enhances MLH1 gene expression in colorectal cells. The enhancer was bound by CTCF and CRISPR-Cas9-mediated deletion of a core binding region impairs endogenous MLH1 expression. A total of 5.4% of suspected Lynch syndrome patients have a rare single-nucleotide variant (G &gt; A; rs143969848; 2.5% in gnomAD European, non-Finnish) within a highly conserved CTCF-binding motif, which disrupts enhancer activity in SW620 colorectal carcinoma cells.Conclusions: A CTCF-bound region within the MLH1-35 enhancer regulates MLH1 expression in colorectal cells and is worthy of scrutiny in future genetic screening strategies for suspected Lynch syndrome associated with loss of MLH1 expression. Clin Cancer Res; 24(18); 4602-11.  2018 AACR.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="16" length="15"/><text>-35 kb Enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="522" length="13"/><text>MLH1 promoter</text></annotation><annotation id="3"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="102" length="4"/><text>MLH1</text></annotation><annotation id="4"><infon key="identifier">0005070</infon><infon key="type">DISEASE</infon><location offset="118" length="5"/><text>tumor</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005835</infon><infon key="type">DISEASE</infon><location offset="172" length="14"/><text>Lynch syndrome</text></annotation><annotation id="6"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="199" length="16"/><text>sporadic cancers</text></annotation><annotation id="7"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="302" length="4"/><text>MLH1</text></annotation><annotation id="8"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="474" length="4"/><text>MLH1</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1578" length="45"/><text>CTCF-bound region within the MLH1-35 enhancer</text></annotation><annotation id="10"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="558" length="4"/><text>MLH1</text></annotation><annotation id="11"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="851" length="4"/><text>MLH1</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0005835</infon><infon key="type">DISEASE</infon><location offset="894" length="14"/><text>Lynch syndrome</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1048" length="72"/><text>1.8-kb DNA fragment, 35 kb upstream of the MLH1 transcription start site</text></annotation><annotation id="14"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1091" length="4"/><text>MLH1</text></annotation><annotation id="15"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1023" length="4"/><text>MLH1</text></annotation><annotation id="16"><infon key="identifier">17350</infon><infon key="type">GENE</infon><location offset="1130" length="4"/><text>MLH1</text></annotation><annotation id="17"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1198" length="4"/><text>CTCF</text></annotation><annotation id="18"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1281" length="4"/><text>MLH1</text></annotation><annotation id="19"><infon key="attribute">CANCER</infon><infon key="identifier">0005835</infon><infon key="type">DISEASE</infon><location offset="1327" length="14"/><text>Lynch syndrome</text></annotation><annotation id="20"><infon key="type">VARIANT</infon><infon key="identifier">rs143969848</infon><location offset="1397" length="11"/><text>rs143969848</text></annotation><annotation id="21"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1607" length="4"/><text>MLH1</text></annotation><annotation id="22"><infon key="identifier">0000035</infon><infon key="type">TISSUE</infon><location offset="1530" length="32"/><text>SW620 colorectal carcinoma cells</text></annotation><annotation id="23"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1578" length="4"/><text>CTCF</text></annotation><annotation id="24"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="813" length="8"/><text>enhancer</text></annotation><annotation id="25"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="522" length="4"/><text>MLH1</text></annotation><annotation id="26"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1634" length="4"/><text>MLH1</text></annotation><annotation id="27"><infon key="attribute">CANCER</infon><infon key="identifier">0005835</infon><infon key="type">DISEASE</infon><location offset="1749" length="14"/><text>Lynch syndrome</text></annotation><annotation id="28"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="1788" length="4"/><text>MLH1</text></annotation><annotation id="29"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1474" length="4"/><text>CTCF</text></annotation><annotation id="30"><infon key="identifier">0001614</infon><infon key="type">TISSUE</infon><location offset="76" length="16"/><text>Colorectal Cells</text></annotation><annotation id="31"><infon key="identifier">0001614</infon><infon key="type">TISSUE</infon><location offset="1154" length="16"/><text>colorectal cells</text></annotation><annotation id="32"><infon key="identifier">0001614</infon><infon key="type">TISSUE</infon><location offset="1653" length="16"/><text>colorectal cells</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1023" length="13"/><text>MLH1 promoter</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1176" length="8"/><text>enhancer</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1474" length="19"/><text>CTCF-binding motif,</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1607" length="16"/><text>MLH1-35 enhancer</text></annotation><annotation id="37"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="40" length="4"/><text>CTCF</text></annotation><annotation id="38"><infon key="identifier">4292</infon><infon key="type">GENE</infon><location offset="57" length="4"/><text>MLH1</text></annotation></passage></document>
<document><id>29903884</id><passage><offset>0</offset><text>Sex reversal following deletion of a single distal enhancer of Sox9. Cell fate decisions require appropriate regulation of key genes. Sox9, a direct target of SRY, is pivotal in mammalian sex determination. In vivo high-throughput chromatin accessibility techniques, transgenic assays, and genome editing revealed several novel gonadal regulatory elements in the 2-megabase gene desert upstream of Sox9 Although others are redundant, enhancer 13 (Enh13), a 557-base pair element located 565 kilobases 5' from the transcriptional start site, is essential to initiate mouse testis development; its deletion results in XY females with Sox9 transcript levels equivalent to those in XX gonads. Our data are consistent with the time-sensitive activity of SRY and indicate a strict order of enhancer usage. Enh13 is conserved and embedded within a 32.5-kilobase region whose deletion in humans is associated with XY sex reversal, suggesting that it is also critical in humans.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="44" length="23"/><text>distal enhancer of Sox9</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="434" length="11"/><text>enhancer 13</text></annotation><annotation id="3"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="749" length="3"/><text>SRY</text></annotation><annotation id="4"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="880" length="6"/><text>humans</text></annotation><annotation id="5"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="962" length="6"/><text>humans</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="457" length="82"/><text>557-base pair element located 565 kilobases 5' from the transcriptional start site</text></annotation><annotation id="7"><infon key="identifier">0001363</infon><infon key="type">TISSUE</infon><location offset="572" length="6"/><text>testis</text></annotation><annotation id="8"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="63" length="4"/><text>Sox9</text></annotation><annotation id="9"><infon key="identifier">0000534</infon><infon key="type">TISSUE</infon><location offset="681" length="6"/><text>gonads</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="800" length="5"/><text>Enh13</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="447" length="5"/><text>Enh13</text></annotation><annotation id="12"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="134" length="4"/><text>Sox9</text></annotation><annotation id="13"><infon key="identifier">6736</infon><infon key="type">GENE</infon><location offset="159" length="3"/><text>SRY</text></annotation><annotation id="14"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="178" length="9"/><text>mammalian</text></annotation><annotation id="15"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="398" length="4"/><text>Sox9</text></annotation><annotation id="16"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="566" length="5"/><text>mouse</text></annotation><annotation id="17"><infon key="identifier">20682</infon><infon key="type">GENE</infon><location offset="632" length="4"/><text>Sox9</text></annotation></passage></document>
<document><id>29967281</id><passage><offset>0</offset><text>SP8 and SP9 coordinately promote D2-type medium spiny neuron production by activating Six3 expression. Dopamine receptor DRD1-expressing medium spiny neurons (D1 MSNs) and dopamine receptor DRD2-expressing medium spiny neurons (D2 MSNs) are the principal projection neurons in the striatum, which is divided into dorsal striatum (caudate nucleus and putamen) and ventral striatum (nucleus accumbens and olfactory tubercle). Progenitors of these neurons arise in the lateral ganglionic eminence (LGE). Using conditional deletion, we show that mice lacking the transcription factor genes Sp8 and Sp9 lose virtually all D2 MSNs as a result of reduced neurogenesis in the LGE, whereas D1 MSNs are largely unaffected. SP8 and SP9 together drive expression of the transcription factor Six3 in a spatially restricted domain of the LGE subventricular zone. Conditional deletion of Six3 also prevents the formation of most D2 MSNs, phenocopying the Sp8/9 mutants. Finally, ChIP-Seq reveals that SP9 directly binds to the promoter and a putative enhancer of Six3 Thus, this study defines components of a transcription pathway in a regionally restricted LGE progenitor domain that selectively drives the generation of D2 MSNs.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1012" length="8"/><text>promoter</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1036" length="16"/><text>enhancer of Six3</text></annotation><annotation id="3"><infon key="identifier">320145</infon><infon key="type">GENE</infon><location offset="713" length="3"/><text>SP8</text></annotation><annotation id="4"><infon key="identifier">381373</infon><infon key="type">GENE</infon><location offset="721" length="3"/><text>SP9</text></annotation><annotation id="5"><infon key="identifier">20473</infon><infon key="type">GENE</infon><location offset="779" length="4"/><text>Six3</text></annotation><annotation id="6"><infon key="identifier">20473</infon><infon key="type">GENE</infon><location offset="873" length="4"/><text>Six3</text></annotation><annotation id="7"><infon key="identifier">320145</infon><infon key="type">GENE</infon><location offset="940" length="3"/><text>Sp8</text></annotation><annotation id="8"><infon key="identifier">381373</infon><infon key="type">GENE</infon><location offset="986" length="3"/><text>SP9</text></annotation><annotation id="9"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="41" length="19"/><text>medium spiny neuron</text></annotation><annotation id="10"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="137" length="20"/><text>medium spiny neurons</text></annotation><annotation id="11"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="266" length="7"/><text>neurons</text></annotation><annotation id="12"><infon key="identifier">0000938</infon><infon key="type">TISSUE</infon><location offset="445" length="7"/><text>neurons</text></annotation><annotation id="13"><infon key="identifier">320145</infon><infon key="type">GENE</infon><location offset="0" length="3"/><text>SP8</text></annotation><annotation id="14"><infon key="identifier">0000418</infon><infon key="type">TISSUE</infon><location offset="281" length="8"/><text>striatum</text></annotation><annotation id="15"><infon key="identifier">0004701</infon><infon key="type">TISSUE</infon><location offset="313" length="15"/><text>dorsal striatum</text></annotation><annotation id="16"><infon key="identifier">0004702</infon><infon key="type">TISSUE</infon><location offset="363" length="16"/><text>ventral striatum</text></annotation><annotation id="17"><infon key="identifier">0001862</infon><infon key="type">TISSUE</infon><location offset="381" length="17"/><text>nucleus accumbens</text></annotation><annotation id="18"><infon key="identifier">0001869</infon><infon key="type">TISSUE</infon><location offset="403" length="18"/><text>olfactory tubercle</text></annotation><annotation id="19"><infon key="identifier">0000211</infon><infon key="type">TISSUE</infon><location offset="330" length="15"/><text>caudate nucleus</text></annotation><annotation id="20"><infon key="identifier">0000212</infon><infon key="type">TISSUE</infon><location offset="350" length="7"/><text>putamen</text></annotation><annotation id="21"><infon key="identifier">0000497</infon><infon key="type">TISSUE</infon><location offset="466" length="27"/><text>lateral ganglionic eminence</text></annotation><annotation id="22"><infon key="identifier">0000497</infon><infon key="type">TISSUE</infon><location offset="495" length="3"/><text>LGE</text></annotation><annotation id="23"><infon key="identifier">0000497</infon><infon key="type">TISSUE</infon><location offset="668" length="3"/><text>LGE</text></annotation><annotation id="24"><infon key="identifier">381373</infon><infon key="type">GENE</infon><location offset="8" length="3"/><text>SP9</text></annotation><annotation id="25"><infon key="identifier">0000497</infon><infon key="type">TISSUE</infon><location offset="824" length="3"/><text>LGE</text></annotation><annotation id="26"><infon key="identifier">0000497</infon><infon key="type">TISSUE</infon><location offset="1143" length="3"/><text>LGE</text></annotation><annotation id="27"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="162" length="4"/><text>MSNs</text></annotation><annotation id="28"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="620" length="4"/><text>MSNs</text></annotation><annotation id="29"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="684" length="4"/><text>MSNs</text></annotation><annotation id="30"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="917" length="4"/><text>MSNs</text></annotation><annotation id="31"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="1210" length="4"/><text>MSNs</text></annotation><annotation id="32"><infon key="identifier">381373</infon><infon key="type">GENE</infon><location offset="944" length="1"/><text>9</text></annotation><annotation id="33"><infon key="identifier">0004778</infon><infon key="type">TISSUE</infon><location offset="231" length="4"/><text>MSNs</text></annotation><annotation id="34"><infon key="identifier">20473</infon><infon key="type">GENE</infon><location offset="1048" length="4"/><text>Six3</text></annotation><annotation id="35"><infon key="identifier">20473</infon><infon key="type">GENE</infon><location offset="86" length="4"/><text>Six3</text></annotation><annotation id="36"><infon key="identifier">13488</infon><infon key="type">GENE</infon><location offset="121" length="4"/><text>DRD1</text></annotation><annotation id="37"><infon key="identifier">13489</infon><infon key="type">GENE</infon><location offset="190" length="4"/><text>DRD2</text></annotation><annotation id="38"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="542" length="4"/><text>mice</text></annotation><annotation id="39"><infon key="identifier">320145</infon><infon key="type">GENE</infon><location offset="586" length="3"/><text>Sp8</text></annotation><annotation id="40"><infon key="identifier">381373</infon><infon key="type">GENE</infon><location offset="594" length="3"/><text>Sp9</text></annotation></passage></document>
<document><id>29979962</id><passage><offset>0</offset><text>A Muscle-Specific Enhancer RNA Mediates Cohesin Recruitment and Regulates Transcription In trans. The enhancer regions of the myogenic master regulator MyoD give rise to at least two enhancer RNAs. Core enhancer eRNA (CEeRNA) regulates transcription of the adjacent MyoD gene, whereas DRReRNA affects expression of Myogenin in trans. We found that DRReRNA is recruited at the Myogenin locus, where it colocalizes with Myogenin nascent transcripts. DRReRNA associates with the cohesin complex, and this association correlates with its transactivating properties. Despite being expressed in undifferentiated cells, cohesin is not loaded on Myogenin until the cells start expressing DRReRNA, which is then required for cohesin chromatin recruitment and maintenance. Functionally, depletion of either cohesin or DRReRNA reduces chromatin accessibility, prevents Myogenin activation, and hinders muscle cell differentiation. Thus, DRReRNA ensures spatially appropriate cohesin loading in trans to regulate gene expression.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="218" length="6"/><text>CEeRNA</text></annotation><annotation id="2"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="858" length="8"/><text>Myogenin</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="179" length="17"/><text>two enhancer RNAs</text></annotation><annotation id="4"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="348" length="7"/><text>DRReRNA</text></annotation><annotation id="5"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="448" length="7"/><text>DRReRNA</text></annotation><annotation id="6"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="680" length="7"/><text>DRReRNA</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="808" length="7"/><text>DRReRNA</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="926" length="7"/><text>DRReRNA</text></annotation><annotation id="9"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="2" length="28"/><text>Muscle-Specific Enhancer RNA</text></annotation><annotation id="10"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="152" length="4"/><text>MyoD</text></annotation><annotation id="11"><infon key="identifier">0000887</infon><infon key="type">TISSUE</infon><location offset="891" length="11"/><text>muscle cell</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="285" length="7"/><text>DRReRNA</text></annotation><annotation id="13"><infon key="identifier">0000887</infon><infon key="type">TISSUE</infon><location offset="2" length="6"/><text>Muscle</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="198" length="18"/><text>Core enhancer eRNA</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="102" length="54"/><text>enhancer regions of the myogenic master regulator MyoD</text></annotation><annotation id="16"><infon key="identifier">4654</infon><infon key="type">GENE</infon><location offset="266" length="4"/><text>MyoD</text></annotation><annotation id="17"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="315" length="8"/><text>Myogenin</text></annotation><annotation id="18"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="376" length="8"/><text>Myogenin</text></annotation><annotation id="19"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="418" length="8"/><text>Myogenin</text></annotation><annotation id="20"><infon key="identifier">4656</infon><infon key="type">GENE</infon><location offset="638" length="8"/><text>Myogenin</text></annotation></passage></document>
<document><id>30008316</id><passage><offset>0</offset><text>Targeted Enhancer Activation by a Subunit of the Integrator Complex. The control of cell fate is an epigenetic process initiated by transcription factors (TFs) that recognize DNA motifs and recruit activator complexes and transcriptional machineries to chromatin. Lineage specificity is thought to be provided solely by TF-motif pairing, while the recruited activators are passive. Here, we show that INTS13, a subunit of the Integrator complex, operates as monocytic/macrophagic differentiation factor. Integrator is a general activator of transcription at coding genes and is required for eRNA maturation. Here, we show that INTS13 functions as an independent sub-module and targets enhancers through Early Growth Response (EGR1/2) TFs and their co-factor NAB2. INTS13 binds poised monocytic enhancers eliciting chromatin looping and activation. Independent depletion of INTS13, EGR1, or NAB2 impairs monocytic differentiation of cell lines and primary human progenitors. Our data demonstrate that Integrator is not functionally homogeneous and has TF-specific regulatory potential, revealing a new enhancer regulatory axis that controls myeloid differentiation.</text><annotation id="1"><infon key="identifier">55726</infon><infon key="type">GENE</infon><location offset="764" length="6"/><text>INTS13</text></annotation><annotation id="2"><infon key="identifier">55726</infon><infon key="type">GENE</infon><location offset="873" length="6"/><text>INTS13</text></annotation><annotation id="3"><infon key="identifier">1959</infon><infon key="type">GENE</infon><location offset="731" length="1"/><text>2</text></annotation><annotation id="4"><infon key="identifier">55726</infon><infon key="type">GENE</infon><location offset="401" length="6"/><text>INTS13</text></annotation><annotation id="5"><infon key="identifier">55726</infon><infon key="type">GENE</infon><location offset="627" length="6"/><text>INTS13</text></annotation><annotation id="6"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="726" length="4"/><text>EGR1</text></annotation><annotation id="7"><infon key="identifier">4665</infon><infon key="type">GENE</infon><location offset="758" length="4"/><text>NAB2</text></annotation><annotation id="8"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="881" length="4"/><text>EGR1</text></annotation><annotation id="9"><infon key="identifier">4665</infon><infon key="type">GENE</infon><location offset="890" length="4"/><text>NAB2</text></annotation><annotation id="10"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="955" length="5"/><text>human</text></annotation><annotation id="11"><infon key="identifier">0000734</infon><infon key="type">TISSUE</infon><location offset="1140" length="7"/><text>myeloid</text></annotation></passage></document>
<document><id>30012865</id><passage><offset>0</offset><text>Identification of a Novel Enhancer/Chromatin Opening Element Associated with High-Level gamma-Globin Gene Expression. The organization of the five beta-type globin genes on chromosome 11 reflects the timing of expression during erythroid cell development, with the embryonic epsilon-globin gene being located at the 5' end, followed by the two fetal gamma-globin genes, and with the adult beta- and delta-globin genes being located at the 3' end. Here, we functionally characterized a DNase I-hypersensitive site (HS) located 4 kb upstream of the Ggamma-globin gene (HBG-4kb HS). This site is occupied by transcription factors USF1, USF2, EGR1, MafK, and NF-E2 in the human erythroleukemia cell line K562 and exhibits histone modifications typical for enhancers. We generated a synthetic zinc finger (ZF) DNA-binding domain targeting the HBG-4kb HS (HBG-4kb ZF). The HBG-4kb ZF interacted with the target site in vitro and in the context of cells with a high affinity and specificity. Direct delivery of the HBG-4kb ZF to K562 and primary human erythroid cells caused a reduction in gamma-globin gene expression which was associated with decreased binding of transcription factors and active histone marks at and downstream of the HS. The data demonstrate that the HBG-4kb HS is important for fetal globin production and suggest that it may act by opening chromatin in a directional manner.</text><annotation id="1"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="1045" length="15"/><text>erythroid cells</text></annotation><annotation id="2"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="668" length="36"/><text>human erythroleukemia cell line K562</text></annotation><annotation id="3"><infon key="identifier">0000664</infon><infon key="type">TISSUE</infon><location offset="1022" length="4"/><text>K562</text></annotation><annotation id="4"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="547" length="13"/><text>Ggamma-globin</text></annotation><annotation id="5"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="1083" length="12"/><text>gamma-globin</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="1039" length="5"/><text>human</text></annotation><annotation id="7"><infon key="identifier">0002731</infon><infon key="type">TISSUE</infon><location offset="228" length="14"/><text>erythroid cell</text></annotation><annotation id="8"><infon key="identifier">3046</infon><infon key="type">GENE</infon><location offset="275" length="14"/><text>epsilon-globin</text></annotation><annotation id="9"><infon key="identifier">3045</infon><infon key="type">GENE</infon><location offset="399" length="12"/><text>delta-globin</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="485" length="80"/><text>DNase I-hypersensitive site (HS) located 4 kb upstream of the Ggamma-globin gene</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="567" length="10"/><text>HBG-4kb HS</text></annotation><annotation id="12"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="88" length="12"/><text>gamma-Globin</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="838" length="10"/><text>HBG-4kb HS</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="850" length="10"/><text>HBG-4kb ZF</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="867" length="10"/><text>HBG-4kb ZF</text></annotation><annotation id="16"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1008" length="10"/><text>HBG-4kb ZF</text></annotation><annotation id="17"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1265" length="10"/><text>HBG-4kb HS</text></annotation><annotation id="18"><infon key="identifier">3047</infon><infon key="type">GENE</infon><location offset="350" length="12"/><text>gamma-globin</text></annotation><annotation id="19"><infon key="identifier">3043</infon><infon key="type">GENE</infon><location offset="389" length="5"/><text>beta-</text></annotation><annotation id="20"><infon key="identifier">7391</infon><infon key="type">GENE</infon><location offset="627" length="4"/><text>USF1</text></annotation><annotation id="21"><infon key="identifier">7392</infon><infon key="type">GENE</infon><location offset="633" length="4"/><text>USF2</text></annotation><annotation id="22"><infon key="identifier">1958</infon><infon key="type">GENE</infon><location offset="639" length="4"/><text>EGR1</text></annotation><annotation id="23"><infon key="identifier">7975</infon><infon key="type">GENE</infon><location offset="645" length="4"/><text>MafK</text></annotation><annotation id="24"><infon key="identifier">4778</infon><infon key="type">GENE</infon><location offset="655" length="5"/><text>NF-E2</text></annotation></passage></document>
<document><id>30033119</id><passage><offset>0</offset><text>Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells. Enhancers are genetic elements that regulate spatiotemporal gene expression. Enhancer function requires transcription factor (TF) binding and correlates with histone modifications. However, the extent to which TF binding and histone modifications functionally define active enhancers remains unclear. Here, we combine chromatin immunoprecipitation with a massively parallel reporter assay (ChIP-STARR-seq) to identify functional enhancers in human embryonic stem cells (ESCs) genome-wide in a quantitative unbiased manner. Although active enhancers associate with TFs, only a minority of regions marked by NANOG, OCT4, H3K27ac, and H3K4me1 function as enhancers, with activity markedly changing under naive versus primed culture conditions. We identify an enhancer set associated with functions extending to non-ESC-specific processes. Moreover, although transposable elements associate with putative enhancers, only some exhibit activity. Similarly, within super-enhancers, large tracts are non-functional, with activity restricted to small sub-domains. This catalog of validated enhancers provides a valuable resource for further functional dissection of the regulatory genome.</text><annotation id="1"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="522" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="2"><infon key="identifier">79923</infon><infon key="type">GENE</infon><location offset="686" length="5"/><text>NANOG</text></annotation><annotation id="3"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="693" length="4"/><text>OCT4</text></annotation><annotation id="4"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="52" length="26"/><text>Human Embryonic Stem Cells</text></annotation><annotation id="5"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="550" length="4"/><text>ESCs</text></annotation><annotation id="6"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="892" length="3"/><text>ESC</text></annotation></passage></document>
<document><id>30119690</id><passage><offset>0</offset><text>Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence. BACKGROUND: Functional characterization of non-coding elements in the human genome is a major genomic challenge and the maturation of genome-editing technologies is revolutionizing our ability to achieve this task. Oncogene-induced senescence, a cellular state of irreversible proliferation arrest that is enforced following excessive oncogenic activity, is a major barrier against cancer transformation; therefore, bypassing oncogene-induced senescence is a critical step in tumorigenesis. Here, we aim at further identification of enhancer elements that are required for the establishment of this state. RESULTS: We first apply genome-wide profiling of enhancer-RNAs (eRNAs) to systematically identify enhancers that are activated upon oncogenic stress. DNA motif analysis of these enhancers indicates AP-1 as a major regulator of the transcriptional program induced by oncogene-induced senescence. We thus constructed a CRISPR-Cas9 sgRNA library designed to target senescence-induced enhancers that are putatively regulated by AP-1 and used it in a functional screen. We identify a critical enhancer that we name EnhAP1-OIS1 and validate that mutating the AP-1 binding site within this element results in oncogene-induced senescence bypass. Furthermore, we identify FOXF1 as the gene regulated by this enhancer and demonstrate that FOXF1 mediates EnhAP1-OIS1 effect on the senescence phenotype. CONCLUSIONS: Our study elucidates a novel cascade mediated by AP-1 and FOXF1 that regulates oncogene-induced senescence and further demonstrates the power of CRISPR-based functional genomic screens in deciphering the function of non-coding regulatory elements in the genome.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="36" length="23"/><text>AP1-associated enhancer</text></annotation><annotation id="2"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="922" length="4"/><text>AP-1</text></annotation><annotation id="3"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="188" length="5"/><text>human</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="500" length="6"/><text>cancer</text></annotation><annotation id="5"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1387" length="5"/><text>FOXF1</text></annotation><annotation id="6"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1453" length="5"/><text>FOXF1</text></annotation><annotation id="7"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="1587" length="5"/><text>FOXF1</text></annotation><annotation id="8"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="36" length="3"/><text>AP1</text></annotation><annotation id="9"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1277" length="4"/><text>AP-1</text></annotation><annotation id="10"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1148" length="4"/><text>AP-1</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1234" length="11"/><text>EnhAP1-OIS1</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="1277" length="17"/><text>AP-1 binding site</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1468" length="11"/><text>EnhAP1-OIS1</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1212" length="8"/><text>enhancer</text></annotation><annotation id="15"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1423" length="8"/><text>enhancer</text></annotation><annotation id="16"><infon key="identifier">3725</infon><infon key="type">GENE</infon><location offset="1578" length="4"/><text>AP-1</text></annotation><annotation id="17"><infon key="identifier">2294</infon><infon key="type">GENE</infon><location offset="71" length="5"/><text>FOXF1</text></annotation></passage></document>
<document><id>30139998</id><passage><offset>0</offset><text>Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms. Polycomb repressive complex 1 (PRC1) plays essential roles in cell fate decisions and development. However, its role in cancer is less well understood. Here, we show that RNF2, encoding RING1B, and canonical PRC1 (cPRC1) genes are overexpressed in breast cancer. We find that cPRC1 complexes functionally associate with ERalpha and its pioneer factor FOXA1 in ER+ breast cancer cells, and with BRD4 in triple-negative breast cancer cells (TNBC). While cPRC1 still exerts its repressive function, it is also recruited to oncogenic active enhancers. RING1B regulates enhancer activity and gene transcription not only by promoting the expression of oncogenes but also by regulating chromatin accessibility. Functionally, RING1B plays a divergent role in ER+ and TNBC metastasis. Finally, we show that concomitant recruitment of RING1B to active enhancers occurs across multiple cancers, highlighting an under-explored function of cPRC1 in regulating oncogenic transcriptional programs in cancer.</text><annotation id="1"><infon key="identifier">0006512</infon><infon key="type">DISEASE</infon><location offset="881" length="3"/><text>ER+</text></annotation><annotation id="2"><infon key="identifier">3169</infon><infon key="type">GENE</infon><location offset="481" length="5"/><text>FOXA1</text></annotation><annotation id="3"><infon key="identifier">23476</infon><infon key="type">GENE</infon><location offset="524" length="4"/><text>BRD4</text></annotation><annotation id="4"><infon key="attribute">CANCER</infon><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="532" length="35"/><text>triple-negative breast cancer cells</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0005494</infon><infon key="type">DISEASE</infon><location offset="569" length="4"/><text>TNBC</text></annotation><annotation id="6"><infon key="identifier">6045</infon><infon key="type">GENE</infon><location offset="678" length="6"/><text>RING1B</text></annotation><annotation id="7"><infon key="identifier">6045</infon><infon key="type">GENE</infon><location offset="848" length="6"/><text>RING1B</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0005494</infon><infon key="type">DISEASE</infon><location offset="889" length="4"/><text>TNBC</text></annotation><annotation id="9"><infon key="identifier">6045</infon><infon key="type">GENE</infon><location offset="955" length="6"/><text>RING1B</text></annotation><annotation id="10"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1005" length="7"/><text>cancers</text></annotation><annotation id="11"><infon key="identifier">0000150</infon><infon key="type">TISSUE</infon><location offset="490" length="23"/><text>ER+ breast cancer cells</text></annotation><annotation id="12"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="1115" length="6"/><text>cancer</text></annotation><annotation id="13"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="406" length="5"/><text>cPRC1</text></annotation><annotation id="14"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="338" length="4"/><text>PRC1</text></annotation><annotation id="15"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="344" length="5"/><text>cPRC1</text></annotation><annotation id="16"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="582" length="5"/><text>cPRC1</text></annotation><annotation id="17"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="1057" length="5"/><text>cPRC1</text></annotation><annotation id="18"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="161" length="4"/><text>PRC1</text></annotation><annotation id="19"><infon key="identifier">9055</infon><infon key="type">GENE</infon><location offset="130" length="29"/><text>Polycomb repressive complex 1</text></annotation><annotation id="20"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="94" length="6"/><text>cancer</text></annotation><annotation id="21"><infon key="attribute">CANCER</infon><infon key="identifier">0004992</infon><infon key="type">DISEASE</infon><location offset="250" length="6"/><text>cancer</text></annotation><annotation id="22"><infon key="identifier">6045</infon><infon key="type">GENE</infon><location offset="301" length="4"/><text>RNF2</text></annotation><annotation id="23"><infon key="identifier">6045</infon><infon key="type">GENE</infon><location offset="316" length="6"/><text>RING1B</text></annotation><annotation id="24"><infon key="attribute">CANCER</infon><infon key="identifier">0007254</infon><infon key="type">DISEASE</infon><location offset="378" length="13"/><text>breast cancer</text></annotation><annotation id="25"><infon key="identifier">2099</infon><infon key="type">GENE</infon><location offset="450" length="7"/><text>ERalpha</text></annotation></passage></document>
<document><id>30146478</id><passage><offset>0</offset><text>Combinatorial CRISPR/Cas9 Approach to Elucidate a Far-Upstream Enhancer Complex for Tissue-Specific Sox9 Expression. SRY-box 9 (SOX9) is a master transcription factor that regulates cartilage development. SOX9 haploinsufficiency resulting from breakpoints in a ~1-Mb region upstream of SOX9 was reported in acampomelic campomelic dysplasia (ACD) patients, suggesting that essential enhancer regions of SOX9 for cartilage development are located in this long non-coding sequence. However, the cis-acting enhancer region regulating cartilage-specific SOX9 expression remains to be identified. To identify distant cartilage Sox9 enhancers, we utilized the combination of multiple CRISPR/Cas9 technologies including enrichment of the promoter-enhancer complex followed by next-generation sequencing and mass spectrometry (MS), SIN3A-dCas9-mediated epigenetic silencing, and generation of enhancer deletion mice. As a result, we could identify a critical far-upstream cis-element and Stat3 as a trans-acting factor, regulating cartilage-specific Sox9 expression and subsequent skeletal development. Our strategy could facilitate definitive ACD diagnosis and should be useful to reveal the detailed chromatin conformation and regulation.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="382" length="24"/><text>enhancer regions of SOX9</text></annotation><annotation id="2"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="549" length="4"/><text>SOX9</text></annotation><annotation id="3"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="621" length="4"/><text>Sox9</text></annotation><annotation id="4"><infon key="identifier">0007251</infon><infon key="type">DISEASE</infon><location offset="307" length="32"/><text>acampomelic campomelic dysplasia</text></annotation><annotation id="5"><infon key="identifier">0007251</infon><infon key="type">DISEASE</infon><location offset="341" length="3"/><text>ACD</text></annotation><annotation id="6"><infon key="identifier">20466</infon><infon key="type">GENE</infon><location offset="823" length="5"/><text>SIN3A</text></annotation><annotation id="7"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="902" length="4"/><text>mice</text></annotation><annotation id="8"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="492" length="72"/><text>cis-acting enhancer region regulating cartilage-specific SOX9 expression</text></annotation><annotation id="9"><infon key="identifier">6774</infon><infon key="type">GENE</infon><location offset="979" length="5"/><text>Stat3</text></annotation><annotation id="10"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="1041" length="4"/><text>Sox9</text></annotation><annotation id="11"><infon key="identifier">0007251</infon><infon key="type">DISEASE</infon><location offset="1135" length="3"/><text>ACD</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">REGULATORY_REGION</infon><location offset="950" length="24"/><text>far-upstream cis-element</text></annotation><annotation id="13"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="603" length="32"/><text>distant cartilage Sox9 enhancers</text></annotation><annotation id="14"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="286" length="4"/><text>SOX9</text></annotation><annotation id="15"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="402" length="4"/><text>SOX9</text></annotation><annotation id="16"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="100" length="4"/><text>Sox9</text></annotation><annotation id="17"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="117" length="9"/><text>SRY-box 9</text></annotation><annotation id="18"><infon key="identifier">6662</infon><infon key="type">GENE</infon><location offset="128" length="4"/><text>SOX9</text></annotation></passage></document>
<document><id>30295986</id><passage><offset>0</offset><text>Identification of Novel Gata3 Distal Enhancers Active in Mouse Embryonic Lens. BACKGROUND: The tissue-specific transcriptional programs during normal development require tight control by distal cis-regulatory elements, such as enhancers, with specific DNA sequences recognized by transcription factors, coactivators, and chromatin remodeling enzymes. Gata3 is a sequence-specific DNA-binding transcription factor that regulates formation of multiple tissues and organs, including inner ear, lens, mammary gland, T-cells, urogenital system, and thyroid gland. In the eye, Gata3 has a highly restricted expression domain in the posterior part of the lens vesicle; however, the underlying regulatory mechanisms are unknown. RESULTS: Here we describe the identification of a novel bipartite Gata3 lens-specific enhancer located ~18 kb upstream from its transcriptional start site. We also found that a 5-kb Gata3 promoter possesses low activity in the lens. The bipartite enhancer contains arrays of AP-1, Ets-, and Smad1/5-binding sites as well as binding sites for lens-associated DNA-binding factors. Transient transfection studies of the promoter with the bipartite enhancer showed enhanced activation by BMP4 and FGF2. CONCLUSIONS: These studies identify a novel distal enhancer of Gata3 with high activity in lens and indicate that BMP and FGF signaling can up-regulate expression of Gata3 in differentiating lens fiber cells through the identified Gata3 enhancer and promoter elements. Developmental Dynamics 247:1186-1198, 2018.   2018 The Authors. Developmental Dynamics published by Wiley Periodicals, Inc. on behalf of American Association of Anatomists.</text><annotation id="1"><infon key="identifier">0000630</infon><infon key="type">TISSUE</infon><location offset="480" length="9"/><text>inner ear</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1470" length="17"/><text>promoter elements</text></annotation><annotation id="3"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="57" length="5"/><text>Mouse</text></annotation><annotation id="4"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="351" length="5"/><text>Gata3</text></annotation><annotation id="5"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="571" length="5"/><text>Gata3</text></annotation><annotation id="6"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="948" length="4"/><text>lens</text></annotation><annotation id="7"><infon key="attribute">INSUFFICIENT</infon><infon key="type">TFBS</infon><location offset="996" length="37"/><text>AP-1, Ets-, and Smad1/5-binding sites</text></annotation><annotation id="8"><infon key="identifier">12159</infon><infon key="type">GENE</infon><location offset="1205" length="4"/><text>BMP4</text></annotation><annotation id="9"><infon key="identifier">14173</infon><infon key="type">GENE</infon><location offset="1214" length="4"/><text>FGF2</text></annotation><annotation id="10"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="1311" length="4"/><text>lens</text></annotation><annotation id="11"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="24" length="5"/><text>Gata3</text></annotation><annotation id="12"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="777" length="98"/><text>bipartite Gata3 lens-specific enhancer located ~18 kb upstream from its transcriptional start site</text></annotation><annotation id="13"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="1386" length="5"/><text>Gata3</text></annotation><annotation id="14"><infon key="identifier">0000724</infon><infon key="type">TISSUE</infon><location offset="1411" length="10"/><text>lens fiber</text></annotation><annotation id="15"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="787" length="5"/><text>Gata3</text></annotation><annotation id="16"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="793" length="4"/><text>lens</text></annotation><annotation id="17"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="73" length="4"/><text>Lens</text></annotation><annotation id="18"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="491" length="4"/><text>lens</text></annotation><annotation id="19"><infon key="identifier">0000817</infon><infon key="type">TISSUE</infon><location offset="497" length="13"/><text>mammary gland</text></annotation><annotation id="20"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="512" length="7"/><text>T-cells</text></annotation><annotation id="21"><infon key="identifier">0003091</infon><infon key="type">TISSUE</infon><location offset="521" length="17"/><text>urogenital system</text></annotation><annotation id="22"><infon key="identifier">0001379</infon><infon key="type">TISSUE</infon><location offset="544" length="13"/><text>thyroid gland</text></annotation><annotation id="23"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="898" length="19"/><text>5-kb Gata3 promoter</text></annotation><annotation id="24"><infon key="identifier">0000439</infon><infon key="type">TISSUE</infon><location offset="566" length="3"/><text>eye</text></annotation><annotation id="25"><infon key="type">TISSUE</infon><location offset="648" length="12"/><text>lens vesicle</text></annotation><annotation id="26"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="903" length="5"/><text>Gata3</text></annotation><annotation id="27"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="1451" length="5"/><text>Gata3</text></annotation><annotation id="28"><infon key="identifier">0000723</infon><infon key="type">TISSUE</infon><location offset="1063" length="4"/><text>lens</text></annotation><annotation id="29"><infon key="identifier">14462</infon><infon key="type">GENE</infon><location offset="1283" length="5"/><text>Gata3</text></annotation><annotation id="30"><infon key="identifier">16476</infon><infon key="type">GENE</infon><location offset="996" length="4"/><text>AP-1</text></annotation><annotation id="31"><infon key="identifier">17125</infon><infon key="type">GENE</infon><location offset="1012" length="5"/><text>Smad1</text></annotation><annotation id="32"><infon key="identifier">17129</infon><infon key="type">GENE</infon><location offset="1018" length="1"/><text>5</text></annotation><annotation id="33"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="958" length="18"/><text>bipartite enhancer</text></annotation><annotation id="34"><infon key="attribute">INSUFFICIENT</infon><infon key="type">PROMOTER</infon><location offset="1138" length="8"/><text>promoter</text></annotation><annotation id="35"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1156" length="18"/><text>bipartite enhancer</text></annotation><annotation id="36"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1264" length="24"/><text>distal enhancer of Gata3</text></annotation><annotation id="37"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1451" length="14"/><text>Gata3 enhancer</text></annotation><annotation id="38"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="24" length="22"/><text>Gata3 Distal Enhancers</text></annotation></passage></document>
<document><id>30328555</id><passage><offset>0</offset><text>STAT5-Driven Enhancers Tightly Control Temporal Expression of Mammary-Specific Genes. The de novo formation of milk-secreting mammary epithelium during pregnancy is regulated by prolactin through activation of the transcription factor STAT5, which stimulates the expression of several hundred mammary-specific genes. In addition to its key role in activating gene expression in mammary tissue, STAT5, which is ubiquitously expressed in most cell types, implements T cell-specific programs controlled by interleukins. However, the mechanisms by which STAT5 controls cell-specific genetic programs activated by distinct cytokines remain relatively unknown. Integration of data from genome-wide surveys of chromatin markers and transcription factor binding at regulatory elements may shed light on the mechanisms that drive cell-specific programs. Here, we have illustrated how STAT5 controls cell-specific gene expression through its concentration and an auto-regulatory enhancer supporting its high levels in mammary tissue. The unique genomic features of STAT5-driven enhancers or super-enhancers that regulate mammary-specific genes and their dynamic remodeling in response to pregnancy hormone levels are described. We have further provided biological evidence supporting the in vivo function of a STAT5-driven super-enhancer with the aid of CRISPR/Cas9 genome editing. Finally, we discuss how the functions of mammary-specific super-enhancers are confined by the zinc finger protein, CTCF, to allow exclusive activation of mammary-specific genes without affecting common neighboring genes. This review comprehensively summarizes the molecular pathways underlying differential control of cell-specific gene sets by STAT5 and provides novel insights into STAT5-dependent mammary physiology.</text><annotation id="1"><infon key="identifier">5617</infon><infon key="type">GENE</infon><location offset="178" length="9"/><text>prolactin</text></annotation><annotation id="2"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="875" length="5"/><text>STAT5</text></annotation><annotation id="3"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1300" length="27"/><text>STAT5-driven super-enhancer</text></annotation><annotation id="4"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="1055" length="5"/><text>STAT5</text></annotation><annotation id="5"><infon key="identifier">10664</infon><infon key="type">GENE</infon><location offset="1487" length="4"/><text>CTCF</text></annotation><annotation id="6"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="1717" length="5"/><text>STAT5</text></annotation><annotation id="7"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="1756" length="5"/><text>STAT5</text></annotation><annotation id="8"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="1300" length="5"/><text>STAT5</text></annotation><annotation id="9"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="464" length="6"/><text>T cell</text></annotation><annotation id="10"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="953" length="24"/><text>auto-regulatory enhancer</text></annotation><annotation id="11"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="0" length="22"/><text>STAT5-Driven Enhancers</text></annotation><annotation id="12"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="0" length="5"/><text>STAT5</text></annotation><annotation id="13"><infon key="identifier">0001430</infon><infon key="type">TISSUE</infon><location offset="126" length="18"/><text>mammary epithelium</text></annotation><annotation id="14"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="1055" length="41"/><text>STAT5-driven enhancers or super-enhancers</text></annotation><annotation id="15"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="235" length="5"/><text>STAT5</text></annotation><annotation id="16"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="394" length="5"/><text>STAT5</text></annotation><annotation id="17"><infon key="identifier">6776</infon><infon key="type">GENE</infon><location offset="550" length="5"/><text>STAT5</text></annotation></passage></document>
<document><id>30518632</id><passage><offset>0</offset><text>Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor. PURPOSE: Lysine-specific demethylase 1 (LSD1) regulates several biological processes via the bifunctional modulation of enhancer functions. Recently, we reported that LSD1 overexpression is a founder abnormality of T-cell leukemogenesis and is maintained in fully transformed T-cell acute lymphoblastic leukemia (T-ALL) cells. On the basis of this finding, we attempted to develop novel LSD1 inhibitors effective for T-ALL with central nervous system (CNS) involvement. EXPERIMENTAL DESIGN: We chemically modified the prototype LSD inhibitor tranylcypromine (TCP) and screened for cytotoxicity against TCP-resistant T-ALL cell lines. In vivo efficacy of novel LSD1 inhibitors was examined in immunodeficient mice transplanted with luciferase-expressing T-ALL cell lines, which faithfully reproduce human T-ALL with CNS involvement. RESULTS: We found robust cytotoxicity against T-ALL cells, but not normal bone marrow progenitors, for two N-alkylated TCP derivatives, S2116 and S2157. The two compounds induced apoptosis in TCP-resistant T-ALL cells in vitro and in vivo by repressing transcription of the NOTCH3 and TAL1 genes through increased H3K9 methylation and reciprocal H3K27 deacetylation at superenhancer regions. Both S2116 and S2157 significantly retarded the growth of T-ALL cells in xenotransplanted mice and prolonged the survival of recipients as monotherapy and in combination with dexamethasone. Notably, S2157 could almost completely eradicate CNS leukemia because of its ability to efficiently pass through the blood-brain barrier. CONCLUSIONS: These findings provide a molecular basis and rationale for the inclusion of a brain-permeable LSD1 inhibitor, S2157, in treatment strategies for T-ALL with CNS involvement.</text><annotation id="1"><infon key="attribute">CANCER</infon><infon key="identifier">0005525</infon><infon key="type">DISEASE</infon><location offset="38" length="25"/><text>Leukemia of T-Cell Origin</text></annotation><annotation id="2"><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="719" length="16"/><text>T-ALL cell lines</text></annotation><annotation id="3"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="763" length="4"/><text>LSD1</text></annotation><annotation id="4"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="811" length="4"/><text>mice</text></annotation><annotation id="5"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="856" length="16"/><text>T-ALL cell lines</text></annotation><annotation id="6"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="901" length="5"/><text>human</text></annotation><annotation id="7"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="907" length="5"/><text>T-ALL</text></annotation><annotation id="8"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="1141" length="11"/><text>T-ALL cells</text></annotation><annotation id="9"><infon key="identifier">18131</infon><infon key="type">GENE</infon><location offset="1209" length="6"/><text>NOTCH3</text></annotation><annotation id="10"><infon key="identifier">21349</infon><infon key="type">GENE</infon><location offset="1220" length="4"/><text>TAL1</text></annotation><annotation id="11"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="1385" length="11"/><text>T-ALL cells</text></annotation><annotation id="12"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="87" length="4"/><text>LSD1</text></annotation><annotation id="13"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="1417" length="4"/><text>mice</text></annotation><annotation id="14"><infon key="attribute">CANCER</infon><infon key="identifier">0001606</infon><infon key="type">DISEASE</infon><location offset="1566" length="12"/><text>CNS leukemia</text></annotation><annotation id="15"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="1762" length="4"/><text>LSD1</text></annotation><annotation id="16"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="1813" length="5"/><text>T-ALL</text></annotation><annotation id="17"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="981" length="11"/><text>T-ALL cells</text></annotation><annotation id="18"><infon key="identifier">0000089</infon><infon key="type">TISSUE</infon><location offset="1634" length="5"/><text>blood</text></annotation><annotation id="19"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="15" length="22"/><text>Central Nervous System</text></annotation><annotation id="20"><infon key="identifier">0000142</infon><infon key="type">TISSUE</infon><location offset="1640" length="5"/><text>brain</text></annotation><annotation id="21"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="531" length="22"/><text>central nervous system</text></annotation><annotation id="22"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="555" length="3"/><text>CNS</text></annotation><annotation id="23"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="112" length="29"/><text>Lysine-specific demethylase 1</text></annotation><annotation id="24"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="918" length="3"/><text>CNS</text></annotation><annotation id="25"><infon key="identifier">0000227</infon><infon key="type">TISSUE</infon><location offset="1824" length="3"/><text>CNS</text></annotation><annotation id="26"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="143" length="4"/><text>LSD1</text></annotation><annotation id="27"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="270" length="4"/><text>LSD1</text></annotation><annotation id="28"><infon key="identifier">0000782</infon><infon key="type">TISSUE</infon><location offset="318" length="6"/><text>T-cell</text></annotation><annotation id="29"><infon key="attribute">CANCER</infon><infon key="identifier">0001106</infon><infon key="type">TISSUE</infon><location offset="379" length="49"/><text>T-cell acute lymphoblastic leukemia (T-ALL) cells</text></annotation><annotation id="30"><infon key="identifier">99982</infon><infon key="type">GENE</infon><location offset="490" length="4"/><text>LSD1</text></annotation><annotation id="31"><infon key="attribute">CANCER</infon><infon key="identifier">0004963</infon><infon key="type">DISEASE</infon><location offset="520" length="5"/><text>T-ALL</text></annotation></passage></document>
<document><id>30527662</id><passage><offset>0</offset><text>Promoter-Enhancer Communication Occurs Primarily within Insulated Neighborhoods. Metazoan chromosomes are sequentially partitioned into topologically associating domains (TADs) and then into smaller sub-domains. One class of sub-domains, insulated neighborhoods, are proposed to spatially sequester and insulate the enclosed genes through self-association and chromatin looping. However, it has not been determined functionally whether promoter-enhancer interactions and gene regulation are broadly restricted to within these loops. Here, we employed published datasets from murine embryonic stem cells (mESCs) to identify insulated neighborhoods that confine promoter-enhancer interactions and demarcate gene regulatory regions. To directly address the functionality of these regions, we depleted estrogen-related receptor beta (Esrrb), which binds the Mediator co-activator complex, to impair enhancers of genes within 222 insulated neighborhoods without causing mESC differentiation. Esrrb depletion reduces Mediator binding, promoter-enhancer looping, and expression of both nascent RNA and mRNA within the insulated neighborhoods without significantly affecting the flanking genes. Our data indicate that insulated neighborhoods represent functional regulons in mammalian genomes.</text><annotation id="1"><infon key="identifier">33208</infon><infon key="type">SPECIES</infon><location offset="81" length="8"/><text>Metazoan</text></annotation><annotation id="2"><infon key="identifier">13983</infon><infon key="type">GENE</infon><location offset="798" length="30"/><text>estrogen-related receptor beta</text></annotation><annotation id="3"><infon key="identifier">13983</infon><infon key="type">GENE</infon><location offset="830" length="5"/><text>Esrrb</text></annotation><annotation id="4"><infon key="identifier">13983</infon><infon key="type">GENE</infon><location offset="987" length="5"/><text>Esrrb</text></annotation><annotation id="5"><infon key="identifier">40674</infon><infon key="type">SPECIES</infon><location offset="1267" length="9"/><text>mammalian</text></annotation><annotation id="6"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="575" length="27"/><text>murine embryonic stem cells</text></annotation><annotation id="7"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="604" length="5"/><text>mESCs</text></annotation><annotation id="8"><infon key="identifier">0001086</infon><infon key="type">TISSUE</infon><location offset="965" length="4"/><text>mESC</text></annotation></passage></document>
<document><id>30544251</id><passage><offset>0</offset><text>Temporal enhancer profiling of parallel lineages identifies AHR and GLIS1 as regulators of mesenchymal multipotency. Temporal data on gene expression and context-specific open chromatin states can improve identification of key transcription factors (TFs) and the gene regulatory networks (GRNs) controlling cellular differentiation. However, their integration remains challenging. Here, we delineate a general approach for data-driven and unbiased identification of key TFs and dynamic GRNs, called EPIC-DREM. We generated time-series transcriptomic and epigenomic profiles during differentiation of mouse multipotent bone marrow stromal cell line (ST2) toward adipocytes and osteoblasts. Using our novel approach we constructed time-resolved GRNs for both lineages and identifed the shared TFs involved in both differentiation processes. To take an alternative approach to prioritize the identified shared regulators, we mapped dynamic super-enhancers in both lineages and associated them to target genes with correlated expression profiles. The combination of the two approaches identified aryl hydrocarbon receptor (AHR) and Glis family zinc finger 1 (GLIS1) as mesenchymal key TFs controlled by dynamic cell type-specific super-enhancers that become repressed in both lineages. AHR and GLIS1 control differentiation-induced genes and their overexpression can inhibit the lineage commitment of the multipotent bone marrow-derived ST2 cells.</text><annotation id="1"><infon key="identifier">230587</infon><infon key="type">GENE</infon><location offset="1128" length="25"/><text>Glis family zinc finger 1</text></annotation><annotation id="2"><infon key="identifier">230587</infon><infon key="type">GENE</infon><location offset="1290" length="5"/><text>GLIS1</text></annotation><annotation id="3"><infon key="identifier">0003296</infon><infon key="type">TISSUE</infon><location offset="618" length="29"/><text>bone marrow stromal cell line</text></annotation><annotation id="4"><infon key="identifier">0003296</infon><infon key="type">TISSUE</infon><location offset="649" length="3"/><text>ST2</text></annotation><annotation id="5"><infon key="identifier">0000443</infon><infon key="type">TISSUE</infon><location offset="661" length="10"/><text>adipocytes</text></annotation><annotation id="6"><infon key="identifier">0001593</infon><infon key="type">TISSUE</infon><location offset="676" length="11"/><text>osteoblasts</text></annotation><annotation id="7"><infon key="identifier">0003296</infon><infon key="type">TISSUE</infon><location offset="1413" length="29"/><text>bone marrow-derived ST2 cells</text></annotation><annotation id="8"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="60" length="3"/><text>AHR</text></annotation><annotation id="9"><infon key="identifier">230587</infon><infon key="type">GENE</infon><location offset="68" length="5"/><text>GLIS1</text></annotation><annotation id="10"><infon key="identifier">10090</infon><infon key="type">SPECIES</infon><location offset="600" length="5"/><text>mouse</text></annotation><annotation id="11"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="1092" length="25"/><text>aryl hydrocarbon receptor</text></annotation><annotation id="12"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="1119" length="3"/><text>AHR</text></annotation><annotation id="13"><infon key="identifier">230587</infon><infon key="type">GENE</infon><location offset="1155" length="5"/><text>GLIS1</text></annotation><annotation id="14"><infon key="identifier">11622</infon><infon key="type">GENE</infon><location offset="1282" length="3"/><text>AHR</text></annotation></passage></document>
<document><id>30568279</id><passage><offset>0</offset><text>High-resolution genome-wide functional dissection of transcriptional regulatory regions and nucleotides in human. Genome-wide epigenomic maps have revealed millions of putative enhancers and promoters, but experimental validation of their function and high-resolution dissection of their driver nucleotides remain limited. Here, we present HiDRA (High-resolution Dissection of Regulatory Activity), a combined experimental and computational method for high-resolution genome-wide testing and dissection of putative regulatory regions. We test ~7 million accessible DNA fragments in a single experiment, by coupling accessible chromatin extraction with self-transcribing episomal reporters (ATAC-STARR-seq). By design, fragments are highly overlapping in densely-sampled accessible regions, enabling us to pinpoint driver regulatory nucleotides by exploiting differences in activity between partially-overlapping fragments using a machine learning model (SHARPR-RE). In GM12878 lymphoblastoid cells, we find ~65,000 regions showing enhancer function, and pinpoint ~13,000 high-resolution driver elements. These are enriched for regulatory motifs, evolutionarily-conserved nucleotides, and disease-associated genetic variants from genome-wide association studies. Overall, HiDRA provides a high-throughput, high-resolution approach for dissecting regulatory regions and driver nucleotides.</text><annotation id="1"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="107" length="5"/><text>human</text></annotation></passage></document>
<document><id>30590035</id><passage><offset>0</offset><text>The TFAP2C-Regulated OCT4 Naive Enhancer Is Involved in Human Germline Formation. Human primordial germ cells (hPGCs) are the first embryonic progenitors in the germ cell lineage, yet the molecular mechanisms required for hPGC formation are not well characterized. To identify regulatory regions in hPGC development, we used the assay for transposase-accessible chromatin using sequencing (ATAC-seq) to systematically characterize regions of open chromatin in hPGCs and hPGC-like cells (hPGCLCs) differentiated from human embryonic stem cells (hESCs). We discovered regions of open chromatin unique to hPGCs and hPGCLCs that significantly overlap with TFAP2C-bound enhancers identified in the naive ground state of pluripotency. Using CRISPR/Cas9, we show that deleting the TFAP2C-bound naive enhancer at the OCT4 locus (also called POU5F1) results in impaired OCT4 expression and a negative effect on hPGCLC identity.</text><annotation id="1"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="4" length="36"/><text>TFAP2C-Regulated OCT4 Naive Enhancer</text></annotation><annotation id="2"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="774" length="45"/><text>TFAP2C-bound naive enhancer at the OCT4 locus</text></annotation><annotation id="3"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="62" length="8"/><text>Germline</text></annotation><annotation id="4"><infon key="type">GENE</infon><location offset="21" length="4"/><text>OCT4</text></annotation><annotation id="5"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="833" length="6"/><text>POU5F1</text></annotation><annotation id="6"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="861" length="4"/><text>OCT4</text></annotation><annotation id="7"><infon key="identifier">5460</infon><infon key="type">GENE</infon><location offset="809" length="4"/><text>OCT4</text></annotation><annotation id="8"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="774" length="6"/><text>TFAP2C</text></annotation><annotation id="9"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="652" length="6"/><text>TFAP2C</text></annotation><annotation id="10"><infon key="identifier">0005319</infon><infon key="type">TISSUE</infon><location offset="132" length="21"/><text>embryonic progenitors</text></annotation><annotation id="11"><infon key="identifier">0000535</infon><infon key="type">TISSUE</infon><location offset="161" length="9"/><text>germ cell</text></annotation><annotation id="12"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="222" length="4"/><text>hPGC</text></annotation><annotation id="13"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="902" length="6"/><text>hPGCLC</text></annotation><annotation id="14"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="460" length="5"/><text>hPGCs</text></annotation><annotation id="15"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="470" length="15"/><text>hPGC-like cells</text></annotation><annotation id="16"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="487" length="7"/><text>hPGCLCs</text></annotation><annotation id="17"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="544" length="5"/><text>hESCs</text></annotation><annotation id="18"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="602" length="5"/><text>hPGCs</text></annotation><annotation id="19"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="612" length="7"/><text>hPGCLCs</text></annotation><annotation id="20"><infon key="identifier">7022</infon><infon key="type">GENE</infon><location offset="4" length="6"/><text>TFAP2C</text></annotation><annotation id="21"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="82" length="27"/><text>Human primordial germ cells</text></annotation><annotation id="22"><infon key="identifier">9606</infon><infon key="type">SPECIES</infon><location offset="56" length="5"/><text>Human</text></annotation><annotation id="23"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="111" length="5"/><text>hPGCs</text></annotation><annotation id="24"><infon key="identifier">0004982</infon><infon key="type">TISSUE</infon><location offset="299" length="4"/><text>hPGC</text></annotation><annotation id="25"><infon key="identifier">0006080</infon><infon key="type">TISSUE</infon><location offset="516" length="26"/><text>human embryonic stem cells</text></annotation><annotation id="26"><infon key="attribute">INSUFFICIENT</infon><infon key="type">ENHANCER</infon><location offset="652" length="22"/><text>TFAP2C-bound enhancers</text></annotation></passage></document>
</collection>